Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.8957535713358908,2.1370381579971034,0.0,0.0,0.0,57/125,3.45%,KIF11;CENPF;BUB1;KNL1;CENPE;NUSAP1;DLGAP5;NDC80;KIF4A;BUB1B;NUF2;ZWILCH;CENPA;TTK;CDCA8;SPC24;STIL;NSL1;SPC25;BIRC5;AURKB;CENPP;SKA1;TACC3;CENPK;MAD2L1;ERCC6L;KIF2C;KNTC1;PMF1;CENPN;CENPM;SPDL1;CCNB1;SKA2;KIF18A;CENPH;CDC20;CKAP5;INCENP;CENPL;PLK1;CENPI;STMN1;ESPL1;WDR62;GPSM2;RCC1;XPO1;NUP43;AURKA;NDE1;SGO1;MAD1L1;PCNT;SUN2;PTPA
prerank,mitotic spindle organization (GO:0007052),0.8774400581650603,2.1039358472642817,0.0,0.0,0.0,60/153,3.45%,KIF11;CENPF;BUB1;KNL1;CENPE;KIF23;TPX2;DLGAP5;PRC1;NDC80;KIF4A;BUB1B;NUF2;ZWILCH;CENPA;TTK;CDCA8;KIFC1;SPC24;STIL;NSL1;SPC25;BIRC5;AURKB;CENPP;SKA1;CENPK;MAD2L1;ERCC6L;KIF2C;KNTC1;PMF1;CENPN;CENPM;SPDL1;CCNB1;SKA2;KIF18A;CENPH;CDC20;CKAP5;INCENP;CENPL;PLK1;CENPI;STMN1;WDR62;GPSM2;CHEK2;RCC1;XPO1;NUP43;AURKA;NDE1;SGO1;MAD1L1;PCNT;FLNA;SUN2;PTPA
prerank,mitotic sister chromatid segregation (GO:0000070),0.8881779783156901,2.1022916359691317,0.0,0.0,0.0,37/98,4.58%,CENPE;NUSAP1;KIF23;DLGAP5;PRC1;KIF18B;NDC80;NCAPG;KIF14;CDCA8;KIFC1;CDK1;NSL1;SMC4;KIF22;KNSTRN;NCAPD2;CEP55;CENPK;KIF2C;NCAPH;SPDL1;CCNB1;KIF18A;SMC2;SPAG5;PLK1;RAD21;ESPL1;NCAPD3;RB1;SGO1;MCPH1;HASPIN;CDC23;NCAPH2;NCAPG2
prerank,chromosome condensation (GO:0030261),0.9251947989437276,2.0866358088889725,0.0,0.0,0.0,16/36,4.58%,TOP2A;NUSAP1;NCAPG;CDK1;SMC4;NCAPD2;NCAPH;CCNB1;INCENP;SMC2;PLK1;NCAPD3;RB1;MCPH1;NCAPH2;NCAPG2
prerank,centromere complex assembly (GO:0034508),0.91434757105922,2.065624690686756,0.0,0.0,0.0,20/36,4.13%,CENPF;KNL1;MIS18BP1;CENPE;DLGAP5;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;HELLS;NASP
prerank,sister chromatid segregation (GO:0000819),0.9253962479576834,2.0522753470301187,0.0,0.0,0.0,18/31,4.58%,TOP2A;NUSAP1;KIF18B;NDC80;CDCA8;KIFC1;NSL1;SMC4;KNSTRN;CENPK;KIF18A;SPAG5;PLK1;ESPL1;RB1;SGO1;CHAMP1;NCAPG2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.8672959375858188,2.037748522710624,0.0,0.00012864030151761512,0.001,18/56,2.09%,NUSAP1;KIF23;KIF4A;CENPA;CKAP2;AURKB;CEP55;ECT2;CIT;RACGAP1;CECR2;KIF20A;INCENP;PLK1;STMN1;ESPL1;ANLN;ALKBH4
prerank,mitotic chromosome condensation (GO:0007076),0.9254045759978501,2.0206501701779422,0.0,0.00011256026382791323,0.001,14/26,4.58%,NUSAP1;NCAPG;CDK1;SMC4;NCAPD2;NCAPH;CCNB1;SMC2;PLK1;NCAPD3;RB1;MCPH1;NCAPH2;NCAPG2
prerank,mitotic nuclear division (GO:0140014),0.8567455814098479,2.0177245240669093,0.0,0.00010005356784703399,0.001,23/71,4.58%,KIF11;NUSAP1;TPX2;KIF18B;NDC80;CDCA8;KIFC1;NSL1;SMC4;UBE2C;KNSTRN;CENPK;KIF18A;SPAG5;PLK1;ESPL1;CHEK2;NDE1;SGO1;FLNA;CEP192;ABRAXAS1;NCAPG2
prerank,positive regulation of lipid localization (GO:1905954),-0.7756704513398373,-2.0121320372940534,0.0,0.3654856573101531,0.193,5/11,7.92%,LRP1;LPL;ZC3H12A;IKBKE;VSTM2A
prerank,chromatin remodeling at centromere (GO:0031055),0.9019922011352792,2.0049480562063327,0.0,0.00018009642212466116,0.002,17/31,4.13%,KNL1;MIS18BP1;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;HELLS;NASP
prerank,mitotic metaphase plate congression (GO:0007080),0.8641742949941129,2.00021119995658,0.0,0.0002455860301699925,0.002,15/51,4.03%,CENPE;NDC80;KIF14;NUF2;CDCA8;KIFC1;KIF22;CEP55;KIF2C;SPDL1;CCNB1;KIF18A;MAD1L1;CHAMP1;CDC23
prerank,mitotic cytokinesis (GO:0000281),0.8671311176129418,1.9983586494594363,0.0,0.00022512052765582643,0.002,15/47,1.89%,NUSAP1;KIF23;KIF4A;CENPA;CKAP2;CEP55;ECT2;CIT;RACGAP1;KIF20A;INCENP;PLK1;STMN1;ESPL1;ANLN
prerank,positive regulation of cell cycle process (GO:0090068),0.835783951369368,1.9949156730439572,0.0,0.00020780356398999363,0.002,31/91,8.16%,NUSAP1;KIF23;KIF20B;NDC80;KIF14;E2F7;GEN1;AURKB;ECT2;E2F8;CIT;MAD2L1;RACGAP1;CCNB1;SPAG5;CXCR5;RAD21;GPSM2;DBF4;AURKA;DDX11;PRKCE;FEN1;CEP295;XRCC3;CSPP1;TGFA;CDC25B;PKN2;DYNC1H1;RHNO1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.9023940730474422,1.9853470855558588,0.0,0.00018009642212466116,0.002,16/29,4.13%,KNL1;MIS18BP1;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;NASP
prerank,CENP-A containing chromatin organization (GO:0061641),0.9023940730474422,1.9853470855558588,0.0,0.00018009642212466116,0.002,16/29,4.13%,KNL1;MIS18BP1;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;NASP
prerank,regulation of cell cycle process (GO:0010564),0.8196257977284074,1.9653380469748158,0.0,0.00033768079148373964,0.005,22/104,2.97%,KIF11;MKI67;BUB1;PRC1;KIF20B;CDC25C;KNSTRN;AURKB;ECT2;RACGAP1;NEK2;BORA;KIF20A;SPAG5;TIPIN;PLK1;RMI2;DBF4;RCC1;AURKA;FBXO5;MAD1L1
prerank,carbohydrate catabolic process (GO:0016052),-0.5385683764952748,-1.9620497742134277,0.0,0.3617099790321556,0.332,21/38,20.87%,HK2;HK3;MANBA;GPI;DERA;MAN2B1;PFKL;ENO1;ALDOA;LDHA;TPI1;PGM1;PKM;PGAM1;PGAM4;ALDOC;MAN2C1;MAN2B2;ENO2;PFKFB2;PFKM
prerank,mitotic spindle assembly (GO:0090307),0.8511995920502319,1.9440608226475038,0.0,0.0013242383979754496,0.018,12/42,4.54%,KIF11;KIF23;TPX2;PRC1;KIF4A;KIFC1;AURKB;RACGAP1;CHEK2;FLNA;CEP192;ABRAXAS1
prerank,histone exchange (GO:0043486),0.869434115952967,1.9417795896282628,0.0,0.0013006963820114416,0.019,16/37,4.13%,KNL1;MIS18BP1;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;NASP
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.8617361073602167,1.936497285648002,0.0,0.0017061766306546845,0.027,17/38,4.13%,KNL1;MIS18BP1;CENPA;CENPP;ASF1B;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;NASP
prerank,positive regulation of cytokinesis (GO:0032467),0.8738117605037148,1.9360798160277917,0.0,0.001710916010184281,0.029,12/32,7.47%,KIF23;KIF20B;KIF14;AURKB;ECT2;CIT;RACGAP1;CXCR5;PRKCE;CSPP1;CDC25B;PKN2
prerank,positive regulation of cell division (GO:0051781),0.8568618182327098,1.9360686763949246,0.0,0.0016294438192231246,0.029,12/38,7.47%,KIF23;KIF20B;KIF14;AURKB;ECT2;CIT;RACGAP1;CXCR5;PRKCE;CSPP1;CDC25B;PKN2
prerank,kinetochore organization (GO:0051383),0.9722118015986299,1.9271751784355866,0.0,0.00196468824135994,0.036,8/13,1.14%,CENPF;CENPE;DLGAP5;NDC80;NUF2;CENPA;CENPW;CENPH
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.8727014172082441,1.9146917989615493,0.0,0.0033278686696948255,0.065,13/26,6.89%,CENPE;DLGAP5;UBE2C;CCNB1;PLK1;CDK5RAP2;ESPL1;RB1;FBXO5;CDC23;CDC27;LCMT1;ANAPC7
prerank,regulation of mitotic nuclear division (GO:0007088),0.834730816013043,1.9137081809629117,0.0,0.0034143280027800343,0.069,16/55,7.18%,MKI67;NUSAP1;KIF20B;CDC25C;NEK2;BORA;CCNB1;CDK5RAP2;RCC1;AURKA;FBXO5;AURKAIP1;CHEK1;LCMT1;TGFA;PIN1
prerank,manganese ion transport (GO:0006828),-0.6833149047732561,-1.906959566393373,0.004,0.4858039384356717,0.562,8/14,17.07%,TRPC5;TRPC4;TRPC1;TMEM165;SLC11A2;SLC39A14;SLC39A8;TRPC3
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.9141235941629422,1.9045111706505253,0.0,0.004502410553116528,0.092,12/17,4.90%,KNL1;ZWILCH;CENPA;TTK;CDK1;AURKB;SPDL1;RB1;CHAMP1;HASPIN;CTCF;IK
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.9073956265156916,1.8999261673733723,0.0,0.005264356954413172,0.108,11/21,2.97%,CENPF;BUB1;BUB1B;TTK;MAD2L1;KNTC1;CDC20;PLK1;TRIP13;FBXO5;MAD1L1
prerank,zinc ion homeostasis (GO:0055069),-0.5672127901951953,-1.8954829230131933,0.0,0.4149470427519197,0.614,17/28,23.09%,PRKN;SLC39A7;SLC39A14;MT1B;MT1G;MT1E;MT1A;MT1H;MT1F;MT1M;MT1X;SLC39A8;SLC39A6;MT2A;SLC39A12;SLC30A1;MT3
prerank,apoptotic nuclear changes (GO:0030262),0.8856701407663982,1.8939584696472316,0.0,0.006436779531492519,0.131,3/24,1.06%,TOP2A;HMGB2;CECR2
prerank,spindle assembly checkpoint signaling (GO:0071173),0.9058884862957138,1.889207508887459,0.0,0.0068736801110912335,0.152,10/20,2.97%,CENPF;BUB1;BUB1B;TTK;MAD2L1;KNTC1;CDC20;PLK1;TRIP13;MAD1L1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.9058884862957138,1.889207508887459,0.0,0.0068736801110912335,0.152,10/20,2.97%,CENPF;BUB1;BUB1B;TTK;MAD2L1;KNTC1;CDC20;PLK1;TRIP13;MAD1L1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.9058884862957138,1.889207508887459,0.0,0.0068736801110912335,0.152,10/20,2.97%,CENPF;BUB1;BUB1B;TTK;MAD2L1;KNTC1;CDC20;PLK1;TRIP13;MAD1L1
prerank,interstrand cross-link repair (GO:0036297),0.8104199852975104,1.8890464740504966,0.0,0.006680996304624527,0.153,20/53,7.63%,NEIL3;RAD51AP1;RAD51;UBE2T;EME1;FANCD2;RFWD3;ERCC4;RPA2;FANCA;USP1;SLX4;NUCKS1;MSH6;MCM9;XRCC3;POLN;DCLRE1C;DCLRE1B;FAAP24
prerank,membrane fusion (GO:0061025),-0.5203479469317489,-1.8887465482716865,0.0,0.3597466263275969,0.643,14/33,9.80%,RIMS1;DNM2;NSF;USO1;VTI1B;NAPA;UBXN2A;DNM3;DNM1L;UBXN2B;RABIF;MYOF;HUWE1;VAMP2
prerank,regulation of cytokinesis (GO:0032465),0.7891339510494804,1.8880238205493536,0.0,0.00664105556584688,0.157,23/78,9.63%,KIF23;PRC1;KIF20B;KIF14;E2F7;AURKB;ECT2;E2F8;CIT;RACGAP1;KIF20A;CXCR5;PLK1;AURKA;PRKCE;CSPP1;CDC25B;PIN1;PKN2;BIRC6;KLHL9;CUL3;AHCTF1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5764857065751002,-1.8829177675307107,0.0,0.32269463682618194,0.673,16/26,23.09%,SLC39A7;SLC39A14;MT1B;MT1G;MT1E;MT1A;MT1H;MT1F;MT1M;MT1X;SLC39A8;SLC39A6;MT2A;SLC39A12;SLC30A1;MT3
prerank,positive regulation of lipid transport (GO:0032370),-0.7248269068574188,-1.882681600932966,0.0,0.2774584151716982,0.675,3/12,1.49%,LRP1;APOE;SPP1
prerank,establishment of mitotic spindle localization (GO:0040001),0.8627618122593906,1.874874744811691,0.0,0.010451049950567459,0.235,11/28,4.06%,NUSAP1;NDC80;CENPA;MAD2L1;SPDL1;PLK1;CDK5RAP2;ESPL1;GPSM2;NDE1;FBXW11
prerank,response to hexose (GO:0009746),-0.5699225882345768,-1.8734853750447857,0.0,0.2682619416517188,0.709,13/25,21.74%,EIF2B3;LPL;SELENOT;PFKL;VAMP2;IRS2;SELENOS;EIF2B4;ZBED3;SLC2A5;GPLD1;THBS1;EIF2B2
prerank,regulation of nuclear division (GO:0051783),0.9013508143702113,1.8711522065628212,0.0,0.011441419758507885,0.255,7/20,2.73%,MKI67;KIF20B;CDC25C;NEK2;BORA;RCC1;FBXO5
prerank,reverse cholesterol transport (GO:0043691),-0.7092104489472497,-1.8705578134369607,0.0,0.24701326334276646,0.722,4/13,10.91%,APOE;ABCA1;ABCA5;SCARB1
prerank,recombinational repair (GO:0000725),0.7790389742481685,1.8702691983052888,0.0,0.01150044295567479,0.262,30/77,9.38%,RAD51AP1;GEN1;RAD51;POLQ;MMS22L;RFWD3;RAD54B;ERCC4;BRCA1;RPA2;BLM;BRCA2;XRCC1;RAD51B;RAD51C;TONSL;SLX4;SMC6;NUCKS1;MCM9;RBBP8;FEN1;XRCC3;HELQ;POLN;PALB2;RHNO1;HUS1;NABP2;RPA1
prerank,cyclooxygenase pathway (GO:0019371),-0.7861563334902258,-1.8669111289830311,0.0064516129032258064,0.23243075479352293,0.742,4/10,5.68%,HPGDS;TBXAS1;PTGS1;PTGDS
prerank,negative regulation of cell cycle process (GO:0010948),0.7939702470491157,1.8615018389396374,0.0,0.014507767337819926,0.324,27/61,10.75%,E2F7;RAD51;AURKB;E2F8;RRM2;NEK2;EZH2;BRCA1;ESPL1;E2F1;UXT;FBXO5;AURKAIP1;CBX5;APAF1;SUZ12;EPC1;RBBP8;CHEK1;E2F6;TERF2;RBBP4;TFDP1;MAX;TERF1;TFDP2;EHMT1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.5648627203683432,-1.8612168887598532,0.006060606060606061,0.20728473746205991,0.761,15/24,23.15%,HK2;HK3;GPI;PFKL;ENO1;ALDOA;TPI1;FOXK1;PKM;PGAM1;ALDOC;ENO2;PFKP;PFKM;ENO3
prerank,canonical glycolysis (GO:0061621),-0.5648627203683432,-1.8612168887598532,0.006060606060606061,0.20728473746205991,0.761,15/24,23.15%,HK2;HK3;GPI;PFKL;ENO1;ALDOA;TPI1;FOXK1;PKM;PGAM1;ALDOC;ENO2;PFKP;PFKM;ENO3
prerank,microtubule depolymerization (GO:0007019),0.905750031964864,1.858879906528581,0.0,0.015381207943619711,0.346,8/17,1.62%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;CCSAP;STMN1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.9377533959902882,1.8487267521106152,0.0,0.02009496920548851,0.424,6/12,3.69%,CENPE;NDC80;NUF2;KIF2C;MAD1L1;CHAMP1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.7789926540864667,1.841154884194559,0.0,0.02445155269615592,0.477,38/83,11.96%,CENPF;TPX2;HMMR;KIF14;CDK1;GTSE1;NEK2;CKAP5;PLK1;CDK5RAP2;AURKA;CEP152;NDE1;PCNT;HAUS5;HAUS6;CEP192;ATAD5;TUBB4B;ODF2;CLASP1;CENPJ;CEP72;CEP76;DYNC1H1;ALMS1;OFD1;CEP250;PRKACA;NEDD1;CEP70;NINL;PCM1;PAFAH1B1;HAUS4;TUBB;ATF5;HAUS7
prerank,DNA integrity checkpoint signaling (GO:0031570),0.8051293540034261,1.8390422731612022,0.0011198208286674132,0.025596203994467465,0.495,15/36,8.81%,BRIP1;CLSPN;TIPIN;RAD1;CDC45;CHEK2;E2F1;RAD9A;PRPF19;TIMELESS;CHEK1;ATM;RHNO1;DNA2;HUS1
prerank,regulation of chromosome segregation (GO:0051983),0.8931709380696695,1.8381715559753928,0.0013089005235602095,0.025630795685302386,0.501,6/16,3.61%,MKI67;BUB1;AURKB;KIF2C;RMI2;SMC6
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.893373539718982,1.8345783559808206,0.0012804097311139564,0.02778630512780486,0.535,4/16,3.46%,TOP2A;EME1;ERCC4;SLX4
prerank,lysosome organization (GO:0007040),-0.5224337743392031,-1.8334325826466504,0.0,0.25604907460635007,0.846,19/36,20.17%,CLVS1;TPCN2;ABCA1;MBTPS1;ACP2;GRN;MYO7A;HPS1;CLN5;TMEM165;HOOK2;ZKSCAN3;NAGPA;SNAPIN;TFEB;HOOK3;TMEM106B;CLN6;ATP10B
prerank,mitochondrial protein processing (GO:0034982),-0.7497107430012929,-1.831937144250623,0.006896551724137931,0.24067252109178022,0.848,7/11,21.07%,IMMP1L;SPG7;STOML2;ATP23;PMPCA;OMA1;AFG3L2
prerank,establishment of mitotic spindle orientation (GO:0000132),0.8654780082447497,1.8316838663012445,0.0,0.029045783428709886,0.558,9/23,4.06%,NDC80;CENPA;MAD2L1;SPDL1;PLK1;CDK5RAP2;GPSM2;NDE1;FBXW11
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.795631843784034,1.8316498244424375,0.0,0.0283856519871483,0.558,11/50,2.55%,CCNF;CDC25C;CDKN3;CCNB2;CCNB1;CCNA2;CCNE1;CDKN2C;CDC25A;BLM;CCNE2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.7698045867926441,1.8251443860840861,0.0,0.03241735598243901,0.607,9/80,1.12%,KIF11;CENPE;KIF23;KIF15;KIF4A;KIF22;KIF2C;RACGAP1;KIF18A
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.5523576128639209,-1.8242254258744164,0.00641025641025641,0.24426121339791496,0.869,15/25,23.15%,HK2;HK3;GPI;PFKL;ENO1;ALDOA;TPI1;FOXK1;PKM;PGAM1;ALDOC;ENO2;PFKP;PFKM;ENO3
prerank,cellular response to radiation (GO:0071478),0.7876727657208275,1.823602996723594,0.0011074197120708748,0.03304377832026392,0.616,13/40,8.81%,RAD51AP1;RAD51;ECT2;RAD1;BLM;NET1;LIG4;RAD9A;TANK;MAPK14;RHNO1;GRB2;HUS1
prerank,organonitrogen compound catabolic process (GO:1901565),-0.45649428961305927,-1.8167101468916855,0.0,0.24702375133798307,0.896,30/57,30.63%,CAPN3;PLA2G15;PLA2G7;ENPP2;PPT1;CPQ;NAGK;NPEPPS;ANPEP;CLN5;IDE;CLN8;TXN2;PLA2G6;RIDA;SIAH1;NPL;GNPDA1;CLN6;GNPDA2;TRIM24;AMDHD2;ADO;USE1;PLA2G4A;IL4I1;RENBP;SMPD2;TST;SGPL1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.8252062038803402,1.8136767012970862,0.002386634844868735,0.04057917255957791,0.704,7/25,1.62%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,establishment of spindle orientation (GO:0051294),0.8416933268932061,1.8124709491197877,0.0,0.040934415945417774,0.717,11/28,5.95%,NDC80;CENPA;MAD2L1;SPDL1;PLK1;CDK5RAP2;GPSM2;NDE1;FBXW11;MAP4;CLASP1
prerank,regulation of chromosome organization (GO:0033044),0.8471147845625476,1.8122903521971627,0.0,0.04033792311873788,0.718,8/22,6.10%,BUB1;PIF1;RMI2;SMG6;RB1;LIG4;SMG5;TERF2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.770840195813825,1.812278257377675,0.0,0.039531164656363124,0.718,24/56,11.64%,DLGAP5;CDC25C;CDK1;UBE2C;CCNB1;ESPL1;CDC25A;RAD51B;RB1;FBXO5;DTL;RAD51C;CDC23;CDC27;TFDP1;ANAPC7;BRD4;CDC25B;EGFR;CUL3;MECP2;NSMCE2;RDX;PLCB1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.9564190322665891,1.8091986846106902,0.0,0.041245611968942004,0.743,6/10,1.30%,KNSTRN;ECT2;RACGAP1;NEK2;CCNB1;SPAG5
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.8501380344565388,1.8084344832045518,0.0035545023696682463,0.041300958343011236,0.745,5/23,1.74%,BUB1;BUB1B;ZWILCH;AURKB;WEE1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.7524672346997027,1.8057655025647434,0.0010183299389002036,0.043410033823444265,0.757,32/95,9.38%,RAD51AP1;GEN1;RAD51;POLQ;MMS22L;RFWD3;RAD54B;ERCC4;CDC45;RAD21;BRCA1;RPA2;BLM;BRCA2;XRCC1;RAD51B;RAD51C;TONSL;SLX4;SMC6;MCM6;NUCKS1;MCM9;RBBP8;FEN1;XRCC3;HELQ;POLN;PALB2;HUS1;NABP2;RPA1
prerank,regulation of exit from mitosis (GO:0007096),0.7949104950293465,1.8026060564865816,0.0021929824561403508,0.04567445372217101,0.781,10/38,4.40%,BUB1B;UBE2C;MAD2L1;KNTC1;NEK2;CDC20;ANLN;PPP1R9B;CDC23;CDC27
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.8938224773292646,1.798474507894104,0.0013477088948787063,0.04990308133054248,0.812,7/13,6.03%,NDC80;GEN1;MAD2L1;CCNB1;CDK5RAP2;XRCC3;LCMT1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.8108236827275077,1.798317355207857,0.0,0.04917275525510838,0.813,19/40,7.30%,GEN1;RAD51;EME1;MMS22L;RFWD3;TIPIN;BLM;POLE;DDX11;TONSL;TIMELESS;NUCKS1;POLD1;MCM9;PCNA;TRAIP;PRIMPOL;ZRANB3;RTEL1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.773283516068711,1.7961618385814564,0.0,0.05086934028433411,0.831,16/54,6.84%,CDC25C;E2F7;CDK1;E2F8;GTSE1;CCNB1;CHEK2;E2F1;AURKA;PML;PIDD1;PCNA;CASP2;MDM4;ATM;TFDP1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.47785380056069987,-1.7932118664322496,0.0,0.29361451079486045,0.942,11/43,7.44%,SIRPA;PTPN6;HAVCR2;VSIR;CD274;CD34;IGF1;TNFAIP3;ZC3H12A;TLR4;TRIM27
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.8422193427410476,1.7904773774941882,0.0,0.05679247518379401,0.869,11/21,7.11%,CDC25C;CDK1;CCNB1;CDC25A;RAD51B;FBXO5;DTL;RAD51C;ATAD5;BRD4;CDC25B
prerank,negative regulation of cell division (GO:0051782),0.9062647478691908,1.7899055971574014,0.0,0.0566082737000312,0.876,4/11,2.12%,E2F7;AURKB;E2F8;BLM
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.7936840789357039,1.788751495937716,0.003444316877152698,0.05689546135621587,0.883,16/32,11.93%,E2F7;GFI1;RRM2;CCNE1;CDC45;POLA1;E2F1;RB1;FBXO5;PCNA;TFDP1;BRD4;CDK17;TFDP2;TYMS;NPAT
prerank,protein localization to kinetochore (GO:0034501),0.9027525704522019,1.7876943575662143,0.0013513513513513514,0.05718799502548667,0.892,8/14,4.90%,KNL1;ZWILCH;TTK;CDK1;AURKB;SPDL1;CHAMP1;IK
prerank,response to ionizing radiation (GO:0010212),0.7530637652556191,1.7875026105441068,0.0,0.056454418774077246,0.892,27/70,8.96%,RAD51AP1;RAD51;ECT2;TICRR;FANCD2;RFWD3;MEN1;RAD1;BRCA1;BLM;NET1;BABAM1;TOPBP1;LIG4;RAD9A;TANK;BRAT1;ABRAXAS1;STK11;ATM;MRNIP;EYA3;MAPK14;RHNO1;GRB2;HUS1;NABP2
prerank,cell cycle checkpoint signaling (GO:0000075),0.924833422661403,1.7871594027067985,0.00273224043715847,0.05598711789383315,0.894,4/12,1.74%,BUB1;BUB1B;ZWILCH;WEE1
prerank,DNA replication checkpoint signaling (GO:0000076),0.865163675847993,1.7845531340140945,0.0026560424966799467,0.05829214662988056,0.903,9/16,8.81%,TICRR;CLSPN;TIPIN;CDC45;TOPBP1;RAD9A;TIMELESS;DNA2;HUS1
prerank,chromosome organization (GO:0051276),0.7457522881408318,1.7840371569668512,0.0,0.0579910479241409,0.91,21/99,7.97%,TOP2A;NDC80;NUF2;CDCA8;HMGB2;EZH2;CENPW;CENPH;RFWD3;SUV39H1;LIG4;NUCKS1;HDAC10;MSH6;TCF7L1;HMGN2;LRWD1;PHF19;H3-3A;PHF1;SMARCA4
prerank,regulation of G0 to G1 transition (GO:0070316),0.7930172869153748,1.7826470654188835,0.0011185682326621924,0.0586404865372571,0.913,20/38,12.16%,RAD51;RRM2;EZH2;BRCA1;E2F1;UXT;CBX5;APAF1;SUZ12;EPC1;RBBP8;CHEK1;E2F6;RBBP4;TFDP1;MAX;RHNO1;TFDP2;EHMT1;RNF2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.8718155731095704,1.7769834939158338,0.0026246719160104987,0.06476751180736881,0.931,7/15,6.89%,CENPE;UBE2C;TACC3;PLK1;CDC23;CDC27;ANAPC7
prerank,protein depolymerization (GO:0051261),0.8250369380563569,1.7767136826683199,0.0036231884057971015,0.06418583514987004,0.932,7/27,1.62%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.85654246076438,1.7738314048958972,0.0012987012987012987,0.06696193782040843,0.941,7/17,9.01%,NEIL3;MUTYH;SMUG1;MBD4;TERF2;NEIL1;TERF1
prerank,DNA replication (GO:0006260),0.7402467961196849,1.7713901738624152,0.0,0.06967158730194035,0.947,52/105,15.00%,CDK1;BRIP1;PIF1;TICRR;CLSPN;MCM10;BARD1;PCLAF;TIPIN;POLE2;RAD1;CDC45;BRCA1;RMI2;EXO1;RPA2;DBF4;POLA1;BLM;POLE;WDHD1;TOPBP1;MCM6;RFC5;RAD9A;ORC5;TIMELESS;POLD1;MCM9;RBBP8;FEN1;DUT;CHEK1;ORC3;ATM;POLD2;RHNO1;DNA2;HUS1;RPA1;RFC2;RFC1;FAM111A;TOP3A;RPAIN;KIN;ING5;NAP1L1;CDC7;RPA3;RAD50;RNASEH2A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.7501026055608462,1.7710323528461525,0.0,0.0683991203194286,0.948,9/78,1.12%,KIF11;CENPE;KIF23;KIF15;KIF4A;KIF22;KIF2C;RACGAP1;KIF18A
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.7501026055608462,1.7710323528461525,0.0,0.0683991203194286,0.948,9/78,1.12%,KIF11;CENPE;KIF23;KIF15;KIF4A;KIF22;KIF2C;RACGAP1;KIF18A
prerank,regulation of sister chromatid cohesion (GO:0007063),0.8984057757139435,1.770694140959474,0.0,0.06768418275328875,0.948,7/12,4.82%,BUB1;RAD21;ESPL1;RB1;DDX11;CTCF;FEN1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.7910579134275195,1.7691403710563258,0.001122334455667789,0.06893555617136524,0.951,19/36,12.16%,RAD51;RRM2;EZH2;BRCA1;E2F1;UXT;CBX5;APAF1;SUZ12;EPC1;RBBP8;CHEK1;E2F6;RBBP4;TFDP1;MAX;TFDP2;EHMT1;RNF2
prerank,protein localization to condensed chromosome (GO:1903083),0.9089091581420502,1.7684353649360753,0.001402524544179523,0.06879683325162056,0.952,8/12,4.90%,KNL1;ZWILCH;TTK;CDK1;AURKB;SPDL1;CHAMP1;IK
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.7993125736437331,1.7677695739787023,0.0022522522522522522,0.06883948766738693,0.955,9/34,6.89%,NUSAP1;DLGAP5;ESPL1;RB1;AURKA;CDC23;CDC27;ANAPC7;TGFA
prerank,lytic vacuole organization (GO:0080171),-0.5188099426658161,-1.7666005347082576,0.0,0.35818601263935795,0.97,17/32,20.11%,CLVS1;TPCN2;ABCA1;MBTPS1;ACP2;GRN;MYO7A;HPS1;CLN5;HOOK2;ZKSCAN3;NAGPA;SNAPIN;TFEB;HOOK3;TMEM106B;CLN6
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.7486675984362623,1.7658774778163593,0.0,0.07104453015631926,0.961,9/79,1.12%,KIF11;CENPE;KIF23;KIF15;KIF4A;KIF22;KIF2C;RACGAP1;KIF18A
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.7519029007462322,1.763119588258446,0.0,0.07378180985889163,0.963,18/63,6.84%,CDC25C;E2F7;CDK1;E2F8;GTSE1;CCNB1;RFWD3;RPA2;CHEK2;E2F1;AURKA;PML;PIDD1;PCNA;CASP2;MDM4;ATM;TFDP1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.7984031966716153,1.7629002103114924,0.0,0.07306443454551126,0.963,13/32,7.23%,CDK1;TICRR;CLSPN;PLK1;BRCA1;BLM;DTL;BABAM1;TOPBP1;ABRAXAS1;CHEK1;ATM;MRNIP
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.7558738797605059,1.7627776008151816,0.0,0.07231996950943424,0.964,20/57,7.23%,CDK1;TICRR;CLSPN;EME1;FANCD2;RFWD3;TIPIN;PLK1;BRCA1;RPA2;CHEK2;BLM;DTL;BABAM1;TOPBP1;RAD9A;ABRAXAS1;CHEK1;ATM;MRNIP
prerank,double-strand break repair (GO:0006302),0.72832445482572,1.7621862944012752,0.0,0.07232761249031144,0.966,63/158,12.18%,RAD51AP1;BRIP1;GEN1;RAD51;DNTT;EME1;POLQ;HMGB2;BARD1;MMS22L;RFWD3;RAD54B;ERCC4;RAD21;BRCA1;TRIP13;RPA2;CHEK2;POLA1;BLM;BRCA2;SMARCA5;XRCC1;NSD2;RAD51B;RAD51C;TONSL;BABAM1;SLX4;SMC6;LIG4;PRPF19;NUCKS1;ABRAXAS1;MCM9;RBBP8;FEN1;ACTR5;XRCC3;HELQ;POLN;ATM;DCLRE1C;SETX;XRCC6;DCLRE1B;HMGB1;EYA3;BAZ1B;CIB1;TDP2;PALB2;DNA2;HUS1;NABP2;RPA1;EME2;NSMCE2;SUMO1;RNF168;RNF8;BAP1;PAXIP1
prerank,placenta development (GO:0001890),0.8945273710782475,1.7611903966047293,0.001375515818431912,0.07307082883033508,0.968,2/12,0.44%,E2F7;E2F8
prerank,glycerophospholipid catabolic process (GO:0046475),-0.5317318610448987,-1.7520853923058937,0.005988023952095809,0.3864704797394441,0.979,7/27,6.43%,PLA2G15;GPCPD1;ABHD12;PLA2G7;ENPP2;GDE1;ABHD16A
prerank,positive regulation of cell communication (GO:0010647),-0.5401922645316639,-1.752058005389634,0.013422818791946308,0.3672979828835918,0.979,13/28,20.28%,RIMS1;ANK3;RIMS2;WLS;SYT1;KCTD13;CLSTN3;GRIK2;CLSTN1;DLG4;SOX11;CLSTN2;PTPN23
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.8487542763499911,1.7513386757792517,0.0024752475247524753,0.08652222689422728,0.983,10/18,7.11%,CDC25C;CDK1;CCNB1;CDC25A;RAD51B;FBXO5;DTL;RAD51C;BRD4;CDC25B
prerank,base-excision repair (GO:0006284),0.7502410710441091,1.7509263290475043,0.002162162162162162,0.08604964169015804,0.983,21/48,12.36%,NEIL3;POLQ;RPA2;MUTYH;POLE;XRCC1;RFC5;POLD1;SMUG1;FEN1;PCNA;LIG1;MBD4;NEIL1;POLD2;DNA2;RPA1;RFC2;RFC1;POLD3;APEX1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.7730176434806049,1.74945163824992,0.0,0.08743151598793109,0.985,14/42,7.30%,RAD51AP1;RAD51;POLQ;PARPBP;RMI2;RPA2;RADX;SMCHD1;TIMELESS;ARID2;CHEK1;CGAS;MRNIP;RTEL1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.6540092149658783,-1.7482963316808113,0.011111111111111112,0.363328126865583,0.983,7/13,25.59%,SLC9A1;ATP1A1;ATP1B2;ATP1B1;ATP1A2;ATP1A3;ATP1B3
prerank,DNA damage checkpoint signaling (GO:0000077),0.7895223877722375,1.7481774039096272,0.0034403669724770644,0.08845666128541498,0.986,11/28,8.81%,BRIP1;CLSPN;RAD1;CHEK2;E2F1;RAD9A;PRPF19;CHEK1;ATM;RHNO1;HUS1
prerank,DNA metabolic process (GO:0006259),0.7254291558245993,1.7471415557935144,0.0,0.0888993200936043,0.988,97/270,12.66%,TOP2A;NEIL3;RAD51AP1;CDK1;GEN1;RAD51;TICRR;DNTT;UBE2T;POLK;POLQ;MCM10;UHRF1;HMGB2;BARD1;MEN1;POLE2;RAD1;ERCC4;CDC45;RAD21;BRCA1;PRIM2;RMI2;PRIM1;EXO1;RPA2;DBF4;POLA1;BLM;FANCA;MUTYH;POLE;XRCC1;CHD1L;RAD51B;WDHD1;RAD51C;SLX4;TOPBP1;MCM6;LIG4;RFC5;RAD9A;HMGB3;HELLS;ORC5;TIMELESS;POLD1;POLH;MSH6;SMUG1;RBBP8;FEN1;PCNA;CHEK1;SP100;LIG1;ORC3;XRCC3;MBD4;ATM;TERF2;GMNN;LRWD1;PRIMPOL;XRCC6;ZRANB3;DCLRE1B;RTEL1;HMGB1;ASF1A;NEIL1;POLD2;DNA2;RAD18;DNASE1L1;HUS1;NABP2;TERF1;RPA1;ERCC3;LONP1;RFC2;DNMT1;PARK7;SUMO1;RFC1;TYMS;KMT5C;CTC1;POLD3;APEX1;TOP3A;PDS5B;RPAIN;TDP1
prerank,DNA recombination (GO:0006310),0.7820846744441854,1.7461224073103927,0.003278688524590164,0.0894342459869056,0.991,16/37,9.38%,GEN1;RAD51;RAD54B;RAD21;EXO1;BLM;RAD51B;RAD51C;LIG4;HMGB3;HDAC10;XRCC3;RTEL1;HMGB1;RHNO1;RPA1
prerank,regulation of potassium ion transport (GO:0043266),-0.5014561244781104,-1.7405858429468688,0.008547008547008548,0.3724878242984392,0.987,8/31,9.84%,ANK3;DPP10;KCNIP3;KCNN2;KCNAB1;ANK2;CD63;FHL1
prerank,replication fork processing (GO:0031297),0.7763571155081441,1.7393137895617383,0.002197802197802198,0.09897208995637279,0.995,18/38,11.27%,GEN1;RAD51;EME1;MMS22L;RFWD3;BLM;BRCA2;DDX11;TONSL;NUCKS1;PCNA;TRAIP;PRIMPOL;ZRANB3;RTEL1;DNA2;EME2;FAM111A
prerank,glycolytic process (GO:0006096),-0.5202743443932976,-1.737386700275404,0.022727272727272728,0.3667332727411435,0.988,17/28,23.15%,HK2;HK3;GPI;PFKL;ENO1;ALDOA;LDHA;TPI1;PGM1;PKM;PGAM1;PGAM4;ALDOC;ENO2;PFKFB2;PFKM;ENO3
prerank,regulation of osteoclast differentiation (GO:0045670),-0.4881624642767084,-1.7318699948216218,0.0,0.366933000650052,0.989,10/33,24.55%,UBASH3B;TLR4;FBN1;TCTA;CAMK4;CSF1;CCL3;TMEM178A;MAFB;CCR1
prerank,DNA modification (GO:0006304),0.8178631725140628,1.7312808936832722,0.004895960832313341,0.11216004955652509,0.997,7/22,9.01%,NEIL3;MUTYH;SMUG1;MBD4;TERF2;NEIL1;TERF1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.7289750199247323,1.7312282208198195,0.0,0.11097699857846564,0.997,19/72,6.84%,CDC25C;E2F7;CDK1;E2F8;GTSE1;FOXM1;CCNB1;CHEK2;E2F1;AURKA;BATF;PML;PIDD1;PCNA;SP100;CASP2;MDM4;ATM;TFDP1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.7557071427622756,1.7307991261975662,0.0021231422505307855,0.11058311832415335,0.997,10/45,8.96%,BUB1;BUB1B;ZWILCH;MAD2L1;WEE1;AURKAIP1;CHEK1;ZFP36L1;ZW10;NABP2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.7189021449188197,1.728777346764854,0.0,0.1128797897381344,0.997,61/185,12.13%,CENPF;CENPE;TPX2;HMMR;BUB1B;KIF14;CDK1;UBE2C;MAD2L1;KNTC1;NEK2;CCNB1;CDC20;CKAP5;PLK1;CDK5RAP2;ANLN;PPP1R9B;E2F1;AURKA;CEP152;FBXO5;NDE1;PSMB7;PCNT;HAUS5;PSMD11;HAUS6;CDC23;CEP192;CDC27;PSMF1;TUBB4B;ODF2;CLASP1;CENPJ;CEP72;ZFP36L1;CEP76;PSMC1;ANAPC7;DYNC1H1;ALMS1;OFD1;CEP250;PRKACA;ZW10;NEDD1;CEP70;ERCC3;CUL3;NINL;PCM1;PSMC3;PAFAH1B1;HAUS4;PSMA4;TUBB;HAUS7;FZR1;PSMC4
prerank,signal transduction in response to DNA damage (GO:0042770),0.7361637556094184,1.7278536723118152,0.0031847133757961785,0.11326915400010604,0.997,16/49,8.81%,E2F7;BRIP1;CLSPN;RAD1;CHEK2;E2F1;BATF;RAD9A;PRPF19;CHEK1;MDM4;ATM;MAPK14;RHNO1;GRB2;HUS1
prerank,regulation of spindle organization (GO:0090224),0.8346455239768142,1.726444844465814,0.010282776349614395,0.11450340943504772,0.997,7/18,8.25%,TPX2;TACC3;BORA;GPSM2;GNAI1;DYNC1H1;CLTC
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.4600662448182559,-1.724858089335574,0.0,0.3718287968171888,0.993,10/41,7.44%,SIRPA;PTPN6;HAVCR2;VSIR;CD34;IGF1;TNFAIP3;ZC3H12A;TLR4;TRIM27
prerank,negative regulation of leukocyte activation (GO:0002695),-0.5975602307192616,-1.722539211518808,0.028169014084507043,0.36513713316141483,0.994,7/15,6.30%,CD84;LRFN5;HAVCR2;CD300LF;GRN;CD300A;ZC3H12A
prerank,nucleosome assembly (GO:0006334),0.7793029875532299,1.7211608145376822,0.003468208092485549,0.12281262785823899,0.997,17/31,12.09%,ASF1B;HMGB2;CHAF1A;ANP32B;SMARCA5;RSF1;NASP;NAP1L4;RBBP4;H3-3A;ASF1A;SART3;UBN1;HIRA;SPTY2D1;CHAF1B;HAT1
prerank,cellular response to ionizing radiation (GO:0071479),0.7319180997851983,1.7189152132200234,0.0,0.1256961626581398,0.998,16/47,8.81%,RAD51AP1;RAD51;ECT2;RAD1;BLM;NET1;LIG4;RAD9A;TANK;NUCKS1;ATM;XRCC6;MAPK14;RHNO1;GRB2;HUS1
prerank,DNA conformation change (GO:0071103),0.8375365848248512,1.7188257769215143,0.006631299734748011,0.12456975483387915,0.998,8/17,12.44%,TOP2A;HMGB2;HMGB3;HMGB1;ERCC3;KAT6A;HAT1;TOP3A
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.7209234600042755,1.715213885544653,0.0,0.12994229729661158,0.998,50/146,11.28%,CENPF;TPX2;HMMR;KIF14;CDC25C;CDK1;NEK2;CCNB1;CKAP5;PLK1;CDK5RAP2;CDC25A;RAD51B;AURKA;CEP152;FBXO5;NDE1;DTL;RAD51C;PSMB7;PCNT;HAUS5;PSMD11;HAUS6;CEP192;PSMF1;TUBB4B;ODF2;CLASP1;CENPJ;CEP72;CEP76;PSMC1;BRD4;CDC25B;DYNC1H1;ALMS1;OFD1;CEP250;PRKACA;NEDD1;CEP70;MECP2;NINL;PCM1;PSMC3;PAFAH1B1;HAUS4;PSMA4;TUBB
prerank,acylglycerol catabolic process (GO:0046464),-0.5122416625845868,-1.7135984179475587,0.015748031496062992,0.37963745885583233,0.996,7/30,16.20%,MGLL;LPL;ABHD12;ABHD16A;ABHD6;DAGLA;LIPH
prerank,telomere maintenance (GO:0000723),0.7395139438701951,1.713332096693984,0.001076426264800861,0.1327670823903002,0.998,27/50,14.98%,RAD51;ERCC4;RPA2;BLM;SMC6;POLD1;PCNA;SP100;XRCC3;ATM;TERF2;XRCC6;DCLRE1B;RTEL1;POLD2;DNA2;HUS1;TERF1;RPA1;NSMCE2;TEP1;CTC1;POLD3;APEX1;PRKDC;RPA3;RAD50
prerank,response to nutrient levels (GO:0031667),-0.5875660365354671,-1.7110608776354377,0.025,0.37352245821617613,0.997,4/17,9.42%,PRKAA2;CD68;ATF4;ULK1
prerank,regulation of centrosome duplication (GO:0010824),0.7706954921188017,1.7086587522312602,0.0033821871476888386,0.14082292017123876,0.998,8/30,7.68%,CCNF;STIL;GEN1;CEP295;XRCC3;CENPJ;CEP76;ALMS1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.5632289157264886,-1.7076267998964851,0.01020408163265306,0.3715267425549489,0.998,9/19,22.89%,POLR3C;AR;ZC3H8;ZNF76;NAB2;TENM1;POLR3G;MAF1;ICE1
prerank,regulation of mitotic spindle organization (GO:0060236),0.7597657156783383,1.7055193000913396,0.0033707865168539327,0.14622240390444916,0.999,9/35,8.25%,TPX2;TACC3;BORA;CCSAP;PLK1;GPSM2;GNAI1;DYNC1H1;CLTC
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.794778464198721,1.704434460039202,0.008187134502923977,0.14732062180692548,0.999,14/24,12.32%,POLK;RPA2;POLE;XRCC1;LIG4;RFC5;POLD1;PCNA;LIG1;POLD2;RPA1;RFC2;RFC1;POLD3
prerank,spindle assembly (GO:0051225),0.728123018551955,1.7036949454000043,0.0,0.14756650587839423,0.999,25/67,13.80%,KIF11;TPX2;KIFC1;NEK2;TUBGCP6;CHEK2;RCC1;FLNA;HAUS5;HAUS6;CEP192;ABRAXAS1;TUBGCP4;CLASP1;STAG1;MAPRE3;OFD1;KIF2A;HAUS4;HAUS7;TUBGCP3;CCDC61;NUMA1;LSM14A;PIBF1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.7507471293198625,1.702609002250617,0.0011049723756906078,0.1483651477503161,0.999,15/43,8.96%,CDK1;TICRR;CLSPN;PLK1;BRCA1;BLM;DTL;BABAM1;TOPBP1;ABRAXAS1;CHEK1;ATM;MRNIP;HUS1;NABP2
prerank,DNA replication initiation (GO:0006270),0.7652869210718943,1.696922362433894,0.007751937984496124,0.15897756809626928,0.999,15/37,6.79%,MCM10;POLE2;CDC45;PRIM2;PRIM1;RPA2;DBF4;POLA1;POLE;TOPBP1;MCM6;ORC5;ORC3;GMNN;LRWD1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6182028731424088,-1.6963643744904349,0.013043478260869565,0.39503663263261307,0.999,5/15,18.64%,APOE;ABCA5;PLTP;SCARB1;APOC1
prerank,microtubule polymerization (GO:0046785),0.7619495396682243,1.6874685529393023,0.010309278350515464,0.17895188411489696,1.0,12/29,13.07%,TPX2;CKAP5;TUBGCP6;NDE1;TUBGCP4;CLASP1;CENPJ;PIN1;SLAIN2;CCDC57;TUBGCP3;FGF13
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6922024056666299,-1.686719947690251,0.013605442176870748,0.41590923173244154,0.999,5/10,15.99%,IRF1;LAG3;ZC3H8;GLI3;MDK
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.7111730479468675,1.6846854529267858,0.0010362694300518134,0.1841069026358631,1.0,24/78,12.48%,CCNF;CDC25C;CDKN3;CCNB2;CCNB1;CCNA2;MEN1;CCNE1;PLK1;CDKN2C;CDC25A;BLM;CCNE2;CCNYL1;CDKN2A;MAPRE3;EGFR;CDKN2D;NR2F2;IPO7;CCNJ;CCNT1;PTEN;CDK5RAP3
prerank,microglial cell activation (GO:0001774),-0.5326680714680536,-1.6830968664681494,0.006097560975609756,0.41546619851514427,0.999,8/21,10.09%,APP;TREM2;ITGAM;AIF1;GRN;C1QA;CX3CR1;C5AR1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.7591154787038877,1.6826679114884895,0.007945516458569807,0.18756464073019757,1.0,6/32,6.64%,RNASE6;PGLYRP1;CAMP;S100A9;RPS19;HMGN2
prerank,protein localization to chromosome (GO:0034502),0.7516008919478725,1.6820138021976707,0.004509582863585118,0.18751312023579494,1.0,11/34,9.38%,CENPA;PLK1;RAD21;RPA2;RB1;HASPIN;MCM9;CTCF;TERF2;MRNIP;RPA1
prerank,DNA repair (GO:0006281),0.6931957373691695,1.6802945182714508,0.0,0.19026132378782334,1.0,114/284,15.00%,NEIL3;RAD51AP1;CDK1;BRIP1;RAD51;TICRR;UBE2T;EME1;POLK;POLQ;BARD1;FANCD2;RFWD3;MEN1;POLE2;RAD1;ERCC4;RAD21;BRCA1;TRIP13;RMI2;EXO1;RPA2;CHEK2;POLA1;BLM;FANCA;MUTYH;BRCA2;POLE;SMARCA5;XRCC1;CHD1L;NSD2;RAD51B;WDHD1;USP1;RAD51C;BABAM1;SLX4;TOPBP1;LIG4;RFC5;RAD9A;TIMELESS;NUCKS1;POLD1;POLH;MSH6;SMUG1;ABRAXAS1;PMS2;RBBP8;FEN1;PCNA;CHEK1;ACTR5;LIG1;XRCC3;MBD4;POLN;ATM;DCLRE1C;TRAIP;SETX;FTO;PRIMPOL;ZRANB3;DCLRE1B;EYA3;ASF1A;NEIL1;FAAP24;BAZ1B;CIB1;TDP2;POLD2;UBE2V1;RHNO1;DNA2;RAD18;HUS1;NABP2;CDKN2D;RPA1;ERCC3;RFC2;EME2;PMS1;PARK7;SUMO1;RAD23A;RNF168;FAM111A;RNF8;KMT5C;BAP1;POLD3;APEX1;PDS5B;RPAIN;TDP1;REXO4;PRKDC;APTX;FANCM;FANCL;RAD52;RPA3;VCPIP1;EYA1;TP53;RAD50;RNASEH2A
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.8529726069692224,1.679633510956004,0.016597510373443983,0.18709490589669844,1.0,8/12,10.73%,DLGAP5;ESPL1;RB1;CDC23;CDC27;ANAPC7;CUL3;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.8529726069692224,1.679633510956004,0.016597510373443983,0.18709490589669844,1.0,8/12,10.73%,DLGAP5;ESPL1;RB1;CDC23;CDC27;ANAPC7;CUL3;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.8529726069692224,1.679633510956004,0.016597510373443983,0.18709490589669844,1.0,8/12,10.73%,DLGAP5;ESPL1;RB1;CDC23;CDC27;ANAPC7;CUL3;NSMCE2
prerank,mitotic cell cycle phase transition (GO:0044772),0.7012467736433957,1.6796211869411555,0.0,0.18548365422995536,1.0,74/204,11.96%,CCNF;CDC25C;CDK1;UBE2C;CDKN3;TACC3;FOXM1;CCNB2;NEK2;BORA;CCNB1;MASTL;CKAP5;CCNA2;CCNE1;PLK1;CDKN2C;CDK5RAP2;FBXL15;WEE1;DBF4;CHEK2;CDC25A;RCC1;POLE;E2F1;SKP2;CCNE2;RB1;AURKA;CEP152;NDE1;PCNT;HAUS5;HAUS6;CDC23;FBXW11;NASP;CEP192;CDC27;CDK6;CDKN2A;PPP1CB;TUBB4B;ODF2;CLASP1;CENPJ;LCMT1;CEP72;CEP76;ANAPC7;CDC25B;PIM2;DYNC1H1;ALMS1;MAX;OFD1;CEP250;PRKACA;NEDD1;PPP1R12B;CEP70;CDKN2D;CUL3;NINL;PCM1;PAFAH1B1;MELK;HAUS4;CCNJ;TUBB;PLCB1;CCDC57;HAUS7
prerank,DNA geometric change (GO:0032392),0.7890984288031218,1.6768578225255584,0.007220216606498195,0.19040538973593488,1.0,11/24,8.32%,PIF1;HMGB2;BLM;DDX11;HMGB3;MCM9;ZRANB3;RTEL1;HMGB1;HNRNPA2B1;DNA2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.7013017429910572,1.676565854349174,0.0,0.18956302892864976,1.0,51/129,11.96%,CDC25C;CDK1;FOXM1;CCNB2;NEK2;BORA;CCNB1;MASTL;CKAP5;CCNA2;PLK1;CDK5RAP2;FBXL15;WEE1;CHEK2;CDC25A;SKP2;AURKA;CEP152;NDE1;PCNT;HAUS5;HAUS6;FBXW11;CEP192;PPP1CB;TUBB4B;ODF2;CLASP1;CENPJ;LCMT1;CEP72;CEP76;CDC25B;DYNC1H1;ALMS1;OFD1;CEP250;PRKACA;NEDD1;PPP1R12B;CEP70;NINL;PCM1;PAFAH1B1;MELK;HAUS4;TUBB;PLCB1;CCDC57;HAUS7
prerank,cell cycle G2/M phase transition (GO:0044839),0.7024928359721274,1.6763597846716825,0.0,0.1884296972500904,1.0,51/130,11.96%,CDC25C;CDK1;FOXM1;CCNB2;NEK2;BORA;CCNB1;MASTL;CKAP5;CCNA2;PLK1;CDK5RAP2;FBXL15;WEE1;CHEK2;CDC25A;SKP2;AURKA;CEP152;NDE1;PCNT;HAUS5;HAUS6;FBXW11;CEP192;PPP1CB;TUBB4B;ODF2;CLASP1;CENPJ;LCMT1;CEP72;CEP76;CDC25B;DYNC1H1;ALMS1;OFD1;CEP250;PRKACA;NEDD1;PPP1R12B;CEP70;NINL;PCM1;PAFAH1B1;MELK;HAUS4;TUBB;PLCB1;CCDC57;HAUS7
prerank,regulation of double-strand break repair (GO:2000779),0.7397999111731608,1.6733640418383822,0.006674082313681869,0.19439062974623617,1.0,13/39,9.17%,RAD51AP1;RAD51;FOXM1;RPA2;DDX11;TWIST1;DEK;PML;TIMELESS;CHEK1;MRNIP;RTEL1;RNF169
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.7869380628315497,1.6732078121079648,0.010025062656641603,0.19308587657040235,1.0,6/21,5.23%,UBE2C;MAD2L1;CDC20;PLK1;FBXO5;RPS7
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.5020130922352194,-1.6730078254438685,0.01875,0.4365141747338141,0.999,11/24,14.35%,ITGAM;CTNNB1;GRN;MCL1;ATF4;NF1;CDK5R1;CDK5;SRPK2;PRNP;FBXW7
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.700028067884424,1.666212618622678,0.001017293997965412,0.20951465173866057,1.0,28/84,13.47%,BUB1B;CDK1;UBE2C;AURKB;MAD2L1;CCNB1;CDC20;PLK1;SKP2;RB1;AURKA;FBXO5;PSMB7;PSMD11;CDC23;CDC27;PSMF1;PSMC1;ANAPC7;CUL3;PTTG1;PSMC3;PSMA4;FZR1;PSMC4;BUB3;PSMD13;PSME1
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.5483646986121119,-1.6645021513042144,0.02262443438914027,0.45259277617077653,0.999,7/18,23.25%,TLR4;FBN1;TCTA;FBXW7;CCL3;TMEM178A;MAFB
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.8486980157370537,1.6640587997736764,0.011095700416088766,0.21327402120049527,1.0,4/12,3.58%,TICRR;CLSPN;CHEK2;TOPBP1
prerank,positive regulation of viral genome replication (GO:0045070),0.7577666781393821,1.663959021093868,0.011834319526627219,0.21191345670001796,1.0,1/29,0.01%,TOP2A
prerank,bicarbonate transport (GO:0015701),0.7685460662336064,1.6632206800545728,0.013002364066193853,0.21220151414938404,1.0,3/25,1.86%,SLC4A1;RHAG;AQP1
prerank,microtubule nucleation (GO:0007020),0.78434194738049,1.6617569215951815,0.01256281407035176,0.21411303433556714,1.0,9/20,12.68%,TPX2;TUBGCP6;NDE1;TUBGCP4;CLASP1;CENPJ;SLAIN2;CCDC57;TUBGCP3
prerank,negative regulation of hemostasis (GO:1900047),-0.6374195803523011,-1.65914075633362,0.02888086642599278,0.4597697377378608,0.999,5/12,14.35%,SERPINE2;APOE;CD34;TFPI;SERPINE1
prerank,telomere organization (GO:0032200),0.729386914885339,1.653285016158125,0.00547645125958379,0.2349758040887593,1.0,23/43,14.98%,ERCC4;RPA2;BLM;POLD1;PCNA;SP100;ATM;TERF2;XRCC6;DCLRE1B;RTEL1;H3-3A;POLD2;DNA2;HUS1;TERF1;RPA1;CTC1;POLD3;APEX1;PRKDC;RPA3;RAD50
prerank,regulation of telomerase activity (GO:0051972),0.7186609546251678,1.653249040105933,0.008705114254624592,0.23318232418951698,1.0,12/45,9.01%,AURKB;PIF1;NEK2;MEN1;ERCC4;MAPK1;SMG6;ATM;CCT2;TCP1;NABP2;TERF1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.44037541736184443,-1.6505661244940972,0.02247191011235955,0.4795950452674093,0.999,15/40,16.13%,RIMS1;PCLO;RIMS2;SNAP47;STX4;STX3;SYT1;STX2;VAMP2;SYT7;CDK5;UNC13A;STX1A;PIP5K1C;SNAPIN
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.812409327560907,1.650305754823309,0.014360313315926894,0.23946492627739613,1.0,7/15,9.85%,EME1;FANCD2;TIPIN;CHEK2;RAD9A;HUS1;EME2
prerank,translesion synthesis (GO:0019985),0.7274881599957075,1.6490876694727246,0.006550218340611353,0.24129430323965745,1.0,18/42,12.32%,POLK;PCLAF;POLE2;RPA2;DTL;USP43;RFC5;POLD1;POLH;PCNA;POLN;NPLOC4;PRIMPOL;POLD2;RPA1;RFC2;RFC1;POLD3
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.443981481424944,-1.645700544768992,0.0,0.4859399989141582,0.999,9/47,14.35%,SPOCK1;SERPINE2;TIMP2;SPOCK2;BIN1;TIMP3;RECK;SERPINI1;SERPINE1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7349153617607946,1.6423770309380257,0.01384083044982699,0.25863231574194606,1.0,8/31,5.36%,E2F7;CDKN2C;JADE1;WEE1;RB1;RBL1;CDK6;CDKN2A
prerank,mitotic nuclear membrane organization (GO:0101024),0.7103171769742462,1.6415639223043073,0.004301075268817204,0.25711492991963936,1.0,21/51,10.94%,CDK1;CCNB2;CCNB1;LBR;RCC1;NUP43;POM121;NDC1;REEP4;ANKLE2;NUP107;UBE2I;RANGAP1;NUP160;NUP205;AHCTF1;SEC13;NUP188;EMD;SUMO1;VRK1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.7103171769742462,1.6415639223043073,0.004301075268817204,0.25711492991963936,1.0,21/51,10.94%,CDK1;CCNB2;CCNB1;LBR;RCC1;NUP43;POM121;NDC1;REEP4;ANKLE2;NUP107;UBE2I;RANGAP1;NUP160;NUP205;AHCTF1;SEC13;NUP188;EMD;SUMO1;VRK1
prerank,"phagocytosis, engulfment (GO:0006911)",-0.46202107666009473,-1.6413789767169271,0.0,0.48992406455657417,0.999,17/36,19.93%,ARHGAP25;FCGR1A;ITGAM;AIF1;GULP1;RHOBTB1;XKR6;RHOBTB2;SH3BP1;RHOG;VAMP7;RHOH;CD36;THBS1;CDC42;ADGRB1;XKR4
prerank,regulation of DNA replication (GO:0006275),0.7210538234405918,1.6406273927853054,0.00644468313641246,0.2577409999038196,1.0,21/49,12.25%,ESCO2;CCNA2;BLM;DSCC1;FBXO5;CCDC88A;S100A11;ORC5;NUCKS1;PCNA;ORC3;ATAD5;FAF1;GMNN;DNA2;TERF1;EGFR;DHX9;BRPF3;CDAN1;CTC1
prerank,establishment of spindle localization (GO:0051293),0.8323333972734476,1.6393629572265995,0.014686248331108143,0.25929852776500656,1.0,5/14,7.64%,NUSAP1;ESPL1;MAP4;CLASP1;DYNC1H1
prerank,regulation of chromatin organization (GO:1902275),0.8217098895620997,1.63911842689037,0.013140604467805518,0.2580448217153571,1.0,4/14,8.53%,MKI67;ALKBH4;TLK1;METTL4
prerank,mitotic DNA replication (GO:1902969),0.8542567963730373,1.6380306295456624,0.011095700416088766,0.25945802931532985,1.0,5/10,5.34%,CDC45;GINS1;POLA1;MCM6;LIG1
prerank,regulation of telomere capping (GO:1904353),0.7741229714119283,1.637557687679013,0.015853658536585366,0.25899705902920245,1.0,8/23,8.96%,AURKB;NEK2;MAPK1;SMG6;ATM;TERF2;RTEL1;NABP2
prerank,regulation of mitotic cell cycle (GO:0007346),0.6830227960105599,1.6371668475953651,0.0,0.25843184051620305,1.0,46/171,13.78%,MKI67;DLGAP5;KIF20B;BUB1B;CDC25C;CDK1;UBE2C;MAD2L1;NEK2;BORA;CKS2;CCNB1;CDC20;PLK1;RCC1;DYNLT3;RB1;FBXO5;PSMB7;PSMD11;CDC23;CDC27;PSMF1;PSMC1;ANAPC7;CDC25B;PIN1;PIM2;PKN2;PIM3;PRKCA;SMOC2;CAV2;ERCC3;PSMC3;PSMA4;CCDC57;FZR1;PSMC4;CDK5RAP3;BUB3;CUL9;PSMD13;HNRNPU;PSME1;INTS13
prerank,error-prone translesion synthesis (GO:0042276),0.7638759788983631,1.6351629629457267,0.02002503128911139,0.2625585572766328,1.0,10/21,11.16%,POLK;POLE2;RPA2;RFC5;POLH;PCNA;PRIMPOL;RPA1;RFC2;RFC1
prerank,cardiac muscle cell action potential (GO:0086001),-0.4856692365631928,-1.6348855754415625,0.04032258064516129,0.5031139711563369,1.0,13/30,18.68%,CACNA1C;SCN1A;ANK2;ATP1A1;DMD;SCN1B;HCN2;ATP1B1;FGF12;SLC8A1;KCND3;CACNA1G;ATP1A2
prerank,defense response to Gram-positive bacterium (GO:0050830),0.7326183218324209,1.6302179336843463,0.00995575221238938,0.275039396659737,1.0,8/40,6.84%,IL12A;HMGB2;RNASE6;PGLYRP1;GBP4;CAMP;PPP1R11;GBP2
prerank,acetyl-CoA metabolic process (GO:0006084),-0.5854894926207475,-1.6298961500120968,0.03286384976525822,0.5096788107468755,1.0,8/15,26.62%,ACLY;ACACA;ACAT1;NUDT7;PMVK;MLYCD;PPCS;MVK
prerank,B cell proliferation (GO:0042100),0.8188352586554808,1.6294364106914754,0.015444015444015444,0.27559223063636534,1.0,4/17,5.36%,CD19;MS4A1;CD79A;RASGRP1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.8087313343444495,1.6266561300111173,0.03050397877984085,0.2819587048214369,1.0,9/16,9.01%,ERCC4;SMG6;SLX4;SMG5;ATM;TERF2;RTEL1;HNRNPA2B1;TERF1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.5107823129924579,-1.6255638295273351,0.012345679012345678,0.5125345127810391,1.0,16/24,44.41%,PLA2G15;SLC27A1;CDS2;CRLS1;LPCAT1;SERAC1;PGS1;PLA2G12A;PLA2G4A;PLA2G3;ABCA3;PNPLA8;LPCAT4;PLA2G5;PLA2G4F;PLA2G2D
prerank,positive regulation of signaling (GO:0023056),-0.4692034061619593,-1.6252906486086778,0.008695652173913044,0.501230281114347,1.0,15/37,21.81%,RIMS1;NSF;RIMS2;WLS;SYT1;KCTD13;ECE1;CLSTN3;GRIK2;CLSTN1;DLG4;SOX11;CLSTN2;PTPN23;ANXA2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.7217787436369659,1.6245306602559462,0.00544069640914037,0.28640368779978453,1.0,19/42,12.32%,POLK;PCLAF;RPA2;POLA1;POLE;DTL;USP43;RFC5;POLD1;POLH;PCNA;POLN;PRIMPOL;POLD2;CDKN2D;RPA1;RFC2;RFC1;POLD3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.8571102093599537,1.6240755989357016,0.02244039270687237,0.2858030165550526,1.0,3/10,1.92%,E2F7;E2F8;DBF4
prerank,synaptic vesicle localization (GO:0097479),-0.6283277244679095,-1.6233576858874001,0.0163265306122449,0.49631729996634366,1.0,8/13,16.13%,DNM2;KIF5C;SYNJ1;SPG11;SYNDIG1;KIF5A;CDK5;SNAPIN
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.683196428804668,1.6230803111230043,0.0010193679918450561,0.28693707199475327,1.0,14/104,2.67%,CCNF;CDC25C;CDKN3;CCNB2;EZH2;CCNB1;CCNA2;INCENP;CCNE1;CDKN2C;CDC25A;BLM;CCNE2;RB1
prerank,acylglycerol metabolic process (GO:0006639),-0.45315639039933286,-1.6225459538676268,0.00980392156862745,0.48805790395314286,1.0,13/37,13.76%,DGKH;MGLL;APOE;LPL;ABHD12;DGKA;ABHD6;DGKI;DGKZ;DGKQ;LMF1;DGKB;DGAT1
prerank,positive regulation of telomere capping (GO:1904355),0.7956479143977429,1.6220391497198041,0.026854219948849106,0.2883084675416879,1.0,5/17,8.96%,AURKB;NEK2;MAPK1;RTEL1;NABP2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.8353596655897177,1.6220191952722869,0.013440860215053764,0.2864268199219356,1.0,5/12,8.53%,TICRR;TIPIN;BLM;GMNN;METTL4
prerank,negative regulation of coagulation (GO:0050819),-0.6083325558150408,-1.6197869323184173,0.017316017316017316,0.4871464018234042,1.0,6/14,16.25%,SERPINE2;APOE;CD34;TFPI;SERPINE1;HS3ST5
prerank,nitric oxide metabolic process (GO:0046209),0.790218771321176,1.6186491269647665,0.033738191632928474,0.2949626502764003,1.0,2/14,2.63%,CYP1B1;DDAH2
prerank,postreplication repair (GO:0006301),0.7095138858787533,1.6185797805480957,0.011789924973204717,0.29325499285829054,1.0,19/45,12.32%,POLK;PCLAF;BRCA1;RPA2;DTL;USP43;RFC5;POLD1;POLH;PCNA;POLN;PRIMPOL;POLD2;UBE2V1;RAD18;RPA1;RFC2;RFC1;POLD3
prerank,synaptic membrane adhesion (GO:0099560),-0.6049842437380097,-1.618496359347355,0.031007751937984496,0.4804304368864058,1.0,6/14,10.68%,LRFN5;PTPRD;LRRC4;PTPRS;NTNG1;LRRC4B
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.6951037369932607,1.6183464808594665,0.005213764337851929,0.2920083388329256,1.0,23/58,12.18%,DNTT;POLQ;HMGB2;BARD1;ERCC4;BRCA1;POLA1;NSD2;BABAM1;LIG4;PRPF19;ABRAXAS1;ATM;DCLRE1C;XRCC6;DCLRE1B;HMGB1;ZBTB7A;NSMCE2;SUMO1;RNF168;RNF8;PAXIP1
prerank,negative regulation of hormone secretion (GO:0046888),-0.6515369487747449,-1.6178842781723026,0.0297029702970297,0.47210438519437037,1.0,6/10,31.77%,RAB11FIP3;GJA1;RAB11FIP5;RAB11FIP1;OSM;IL1B
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6538586478161843,-1.6142497459304856,0.022151898734177215,0.4736903039604299,1.0,4/10,12.72%,PLA2G15;PLA2G7;ENPP2;PLA2G6
prerank,regulation of DNA recombination (GO:0000018),0.7265309531466044,1.613569383872052,0.0136986301369863,0.30509645868608576,1.0,9/32,7.30%,RAD51AP1;RAD51;RPA2;BLM;IL7R;MSH6;CHEK1;ZRANB3;RTEL1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.6674503347929164,1.6096745263684584,0.0,0.3156249039978807,1.0,116/336,14.98%,TOP2A;RAD51AP1;CDK1;RAD51;BLK;TICRR;UBE2T;POLK;POLQ;MCM10;BARD1;MASTL;RFWD3;PCLAF;MEN1;POLE2;RAD1;ERCC4;SUV39H1;BRCA1;RMI2;EXO1;CHEK2;POLA1;BLM;FANCA;MUTYH;E2F1;CHD1L;RAD51B;WDHD1;DDX11;DTL;RAD51C;BATF;CBX5;SLX4;TOPBP1;SMC6;RFC5;RAD9A;PML;MAP2K6;TIMELESS;PIDD1;TANK;POLD1;BRAT1;POLH;MSH6;MCM9;RBBP8;STK11;FEN1;FOXP1;CHEK1;CGAS;LIG1;XRCC3;MBD4;TAF1;IKBKG;FOXO1;CASP2;ATM;TRAIP;SETX;FBXO45;MRNIP;ZRANB3;RTEL1;ASF1A;BOK;BAZ1B;CIB1;PHF1;MAPK14;GRB2;RAD18;HUS1;NABP2;RNF169;RPA1;ERCC3;ALKBH7;RFC2;PPP1R15A;PARK7;SUMO1;RNF168;FAM111A;XIAP;RNF8;KMT5C;APEX1;PDS5B;RPAIN;TDP1;KIN;SIRT7;REXO4;PRKDC;NIPBL;DDIT3;MYC;BCL6;PSEN1;APTX;FANCL;CASP9;RAD52;RBBP5;CCNK;VCPIP1;TP53;RAD50
prerank,"base-excision repair, gap-filling (GO:0006287)",0.7240974469194759,1.6088308800918834,0.01583710407239819,0.3165165191320965,1.0,18/35,12.36%,RPA2;MUTYH;POLE;XRCC1;RFC5;POLD1;SMUG1;FEN1;PCNA;LIG1;MBD4;NEIL1;POLD2;RPA1;RFC2;RFC1;POLD3;APEX1
prerank,positive regulation of nuclear division (GO:0051785),0.7634958722648141,1.607891642884234,0.02026221692491061,0.31753104243693503,1.0,3/25,6.89%,NUSAP1;AURKA;TGFA
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.447256062830793,-1.605812490307277,0.01639344262295082,0.4929340628572506,1.0,12/34,12.98%,UBASH3B;PTPN2;PTPRZ1;PTPN6;PTPRS;PTPRJ;DUSP3;DUSP10;PTPRO;PTPRT;DUSP7;PTPN9
prerank,nitric oxide biosynthetic process (GO:0006809),0.7902204190322278,1.605209574062925,0.03983516483516483,0.3237029853020643,1.0,2/13,2.63%,CYP1B1;DDAH2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.7171318816909473,1.6044802497649553,0.018306636155606407,0.32390803304818067,1.0,8/33,5.36%,E2F7;CDKN2C;JADE1;WEE1;RB1;RBL1;CDK6;CDKN2A
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.5612628056057773,-1.603621392399778,0.03418803418803419,0.4901736567627407,1.0,9/15,39.68%,SMOX;PAOX;SAT1;DDC;ASMT;SAT2;MOXD1;SRM;AANAT
prerank,nuclear membrane reassembly (GO:0031468),0.6919794171511215,1.6035188823095252,0.007470651013874066,0.32482741307668983,1.0,21/54,10.94%,CDK1;CCNB2;CCNB1;LBR;RCC1;NUP43;POM121;NDC1;REEP4;ANKLE2;NUP107;UBE2I;RANGAP1;NUP160;NUP205;AHCTF1;SEC13;NUP188;EMD;SUMO1;VRK1
prerank,nucleosome organization (GO:0034728),0.695952050055075,1.6021538401570201,0.010638297872340425,0.32714287108790113,1.0,24/55,13.91%,HMGB2;CHAF1A;ANP32B;SMARCC2;HMGA1;SMARCA5;SMARCD2;RSF1;NASP;ARID2;CTCF;LIN54;NAP1L4;H3-3A;ASF1A;SMARCA4;SART3;SMARCC1;SPTY2D1;NFE2;CHAF1B;RNF8;ANP32E;NAP1L1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.728240182177367,1.601534835640283,0.022485207100591716,0.32706189866978563,1.0,7/28,7.06%,SKA3;SKA1;SKA2;STMN1;CLASP1;MAPRE3;GBA2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.7787363864421519,1.6011219259980256,0.03363518758085381,0.32630657682392905,1.0,4/16,3.64%,RAD51;HMGA1;BLM;MCM6
prerank,gas transport (GO:0015669),0.8194310949944177,1.6010413623808124,0.03884892086330935,0.32446999182353936,1.0,3/10,6.61%,RHAG;AQP1;IPCEF1
prerank,negative regulation of cell aging (GO:0090344),0.8050563435835244,1.6006737551025305,0.01891891891891892,0.3235232116333843,1.0,7/16,7.47%,FOXM1;FBXO5;TWIST1;RBL1;CDK6;TERF2;AKT3
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.6752428784514003,1.6006293006314365,0.00815494393476045,0.32169309069758106,1.0,35/83,15.28%,CDKN3;GFI1;RRM2;CCNE1;CDKN2C;CDC45;DBF4;POLA1;CDC25A;RCC1;POLE;E2F1;CCNE2;RB1;FBXO5;NASP;PCNA;CDK6;CDKN2A;TFDP1;BRD4;PIM2;CDK17;MAX;CDKN2D;CUL3;TFDP2;TYMS;NPAT;LATS1;CDK16;MYC;CDC7;E2F3;PPP6C
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.831819671033809,1.60014212144992,0.013736263736263736,0.3213238633889419,1.0,4/12,4.25%,CD19;PAX5;BLK;PTPN22
prerank,B cell receptor signaling pathway (GO:0050853),0.7218102293136248,1.5987870045190433,0.028004667444574097,0.3232185030403956,1.0,10/32,11.86%,CD19;BLK;MS4A1;CD79A;CD38;CD79B;NFAM1;PLCG2;BTK;PRKCB
prerank,protein palmitoylation (GO:0018345),-0.4710164052186554,-1.5983002377202442,0.02459016393442623,0.49874489065123945,1.0,20/30,35.76%,GLUL;ZDHHC17;ZDHHC13;ZDHHC5;GOLGA7;ZDHHC8;SELENOK;CLIP3;ZDHHC24;ZDHHC16;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;HHAT;ZDHHC4;ZDHHC23;ZDHHC22;ZDHHC1;GOLGA7B
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.7957446817987451,1.5973394417276807,0.02925531914893617,0.32554598135443646,1.0,3/16,8.62%,IL12A;KLRD1;CYRIB
prerank,chromatin disassembly (GO:0031498),0.793535832809285,1.5967270604867285,0.02710027100271003,0.3237769188947108,1.0,7/14,10.88%,SMARCC2;HMGA1;SMARCD2;ARID2;SMARCA4;SMARCC1;NFE2
prerank,nucleosome disassembly (GO:0006337),0.793535832809285,1.5967270604867285,0.02710027100271003,0.3237769188947108,1.0,7/14,10.88%,SMARCC2;HMGA1;SMARCD2;ARID2;SMARCA4;SMARCC1;NFE2
prerank,outer dynein arm assembly (GO:0036158),0.7892411700907782,1.5966714748251822,0.023166023166023165,0.3220742109984399,1.0,2/15,0.95%,CCDC63;DNAH8
prerank,mitotic recombination (GO:0006312),0.7868874908885762,1.5961130628308258,0.02666666666666667,0.32200710580530223,1.0,9/15,14.98%,GEN1;RAD51;RAD54B;SMC6;XRCC3;NSMCE2;TEP1;RAD52;RAD50
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.7880255981183479,1.5927295630720544,0.034666666666666665,0.3308982127791618,1.0,6/15,9.54%,FAM83D;EZH2;ATAD5;DDRGK1;PLCG2;CUL3
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.8191291836544379,1.592373320685315,0.023222060957910014,0.3299324570434926,1.0,8/11,12.09%,ASF1B;NASP;RBBP4;H3-3A;ASF1A;UBN1;HIRA;HAT1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.7946850672297805,1.5916895960577107,0.016883116883116882,0.3302635255436344,1.0,6/16,5.11%,POLQ;PARPBP;RMI2;RADX;SMCHD1;CGAS
prerank,negative regulation of DNA recombination (GO:0045910),0.707449596703264,1.5915918407784662,0.010810810810810811,0.328665620008419,1.0,14/43,9.01%,POLQ;PARPBP;RMI2;RADX;BLM;SMCHD1;POLR2I;POLR2A;MSH6;CGAS;TERF2;ZRANB3;RTEL1;TERF1
prerank,negative regulation of axon extension (GO:0030517),-0.4610781941728707,-1.5908253623304858,0.014285714285714285,0.5160190458860051,1.0,13/30,24.33%,RTN4;DIP2B;SEMA3D;PTPRS;SEMA3E;SEMA4C;MAG;SEMA4G;SEMA3A;CDKL3;SEMA7A;MT3;SEMA4D
prerank,cellular response to zinc ion (GO:0071294),-0.573308181917342,-1.5884297623739905,0.04979253112033195,0.5150880041742029,1.0,12/15,23.09%,GLRA2;MT1B;MT1G;MT1E;MT1A;MT1H;MT1F;MT1M;MT1X;MT2A;P2RX4;MT3
prerank,negative regulation of centrosome duplication (GO:0010826),0.820262500741604,1.587716590137379,0.03428571428571429,0.3390701067401299,1.0,3/11,1.57%,CCNF;CDK5RAP2;BRCA1
prerank,glycerolipid catabolic process (GO:0046503),-0.5272278805484107,-1.5866798842155172,0.027522935779816515,0.5113946467643211,1.0,5/19,7.09%,MGLL;GPCPD1;ABHD12;GDE1;ABHD6
prerank,positive regulation of telomere maintenance (GO:0032206),0.7241883087148698,1.5852158824507887,0.02511415525114155,0.3448283682368122,1.0,9/31,8.96%,AURKB;NEK2;MAPK1;SLX4;PML;ATM;RTEL1;HNRNPA2B1;NABP2
prerank,glycine transport (GO:0015816),0.8337430325477738,1.5834425177911227,0.03253182461103253,0.34852218909808014,1.0,2/10,3.20%,SLC38A5;SLC6A5
prerank,embryonic axis specification (GO:0000578),0.7818722109598689,1.5821252447808256,0.034482758620689655,0.3508693131825878,1.0,1/15,0.26%,STIL
prerank,activin receptor signaling pathway (GO:0032924),-0.5714867984938602,-1.5815711585791408,0.044444444444444446,0.5198079258363033,1.0,3/15,4.32%,ACVR1;TGFBR1;SMAD3
prerank,protein sumoylation (GO:0016925),0.6808747128020576,1.5811451570514592,0.02023429179978701,0.3523199140642638,1.0,28/49,17.11%,NUP43;POM121;NDC1;SAE1;NUP107;UBE2I;RANGAP1;NUP42;UBA2;NUP50;BCL11A;NUP214;NUP160;NUP205;PIAS3;NUP188;NSMCE2;SUMO1;NUP98;RANBP2;NUP210;SUMO2;EYA1;PIAS1;TRIM28;AAAS;NUP37;TRPM4
prerank,mismatch repair (GO:0006298),0.7350485185307882,1.579705514117143,0.019653179190751446,0.35498005336449184,1.0,17/27,17.81%,EXO1;RPA2;MUTYH;POLD1;MSH6;MCM9;PMS2;PCNA;LIG1;POLD2;RPA1;PMS1;POLD3;RPA3;RNASEH2A;MSH5;TDG
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.8203696090227959,1.5793664985268696,0.03536067892503536,0.35411832128207893,1.0,8/12,12.35%,CDK1;CCNB2;CCNB1;PLK1;PRKCA;VRK1;PRKCB;CNEP1R1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7823143719209874,1.5772995215741108,0.03758389261744966,0.359084558574709,1.0,2/13,8.62%,IL12A;CYRIB
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.8157708559700424,1.5759745876335247,0.03112313937753721,0.36149190040891005,1.0,6/11,7.26%,TIPIN;BLM;FBXO5;TIMELESS;GMNN;ZRANB3
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.7074516769099095,1.5755544072489085,0.027210884353741496,0.36089756937937534,1.0,17/30,19.63%,PIF1;MEN1;ERCC4;DACH1;HNRNPC;TERF2;EXOSC10;DCP2;TERF1;CTC1;HNRNPU;TP53;NAT10;HNRNPA1;GNL3L;CDKN1A;XRN1
prerank,regulation of cell division (GO:0051302),0.6633937007960995,1.5750049807160165,0.013402061855670102,0.36078667569524686,1.0,18/72,13.88%,PRC1;KIF18B;AURKB;KIF20A;PLK1;BLM;AURKA;CSPP1;PIN1;BIRC6;CIB1;KLHL9;AHCTF1;KIF13A;BECN1;RACK1;BBS4;MYC
prerank,vasodilation (GO:0042311),-0.5776956489217776,-1.5748172516473724,0.03759398496240601,0.5338809085088393,1.0,6/13,33.43%,KCNMA1;ADRB1;ADRB2;KLF2;SOD2;NOS1
prerank,regulation of cell cycle phase transition (GO:1901987),0.6606771269617348,1.5735355663171138,0.003045685279187817,0.3637076292617552,1.0,31/91,16.34%,BUB1B;CDK1;UBE2C;GTSE1;MAD2L1;CCNB1;CDC20;PLK1;DBF4;FBXO5;PSMB7;PSMD11;CDC23;CDC27;PSMF1;TAF1;PSMC1;ANAPC7;ERCC3;PSMC3;PSMA4;FZR1;PSMC4;BUB3;PSMD13;PSME1;PSMB1;TP53;PSMD8;TFAP4;PSME4
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.654765727489982,1.5734755818893735,0.0,0.361960100584075,1.0,51/148,13.63%,TPX2;CDK1;BRIP1;AURKB;BARD1;RAD1;BRCA1;RMI2;EXO1;RPA2;MBD3;CHEK2;BLM;AURKA;RPS20;TOPBP1;RFC5;RAD9A;PML;MAP2K6;RBBP8;STK11;CHEK1;BRPF1;TAF1;MDM4;ATM;RBBP4;TAF7;PIN1;TAF15;MAPK14;RHNO1;DNA2;HUS1;RPA1;RFC2;PDPK1;HIPK2;KAT6A;EHMT1;TAF6;MLST8;TTC5;MTA2;TOP3A;CDK5RAP3;ING2;ING5;PRKAG2;TAF2
prerank,actin nucleation (GO:0045010),-0.5146546561680421,-1.5725553755946393,0.027649769585253458,0.5317214854937039,1.0,7/21,13.05%,TRIM27;SPIRE1;JMY;ARPC5L;WASHC1;ARPC3;ARPC2
prerank,neurotransmitter secretion (GO:0007269),-0.4173474807892775,-1.571542157349386,0.010101010101010102,0.5257827295815481,1.0,20/44,25.97%,RIMS1;PCLO;RIMS2;SYT1;VAMP2;GAD2;CDK5;UNC13A;STX1A;PIP5K1C;SNAPIN;RAB3A;STXBP1;PTPRN2;PDZD11;CPLX1;SLC32A1;DVL1;CPLX2;SNAP25
prerank,prostaglandin biosynthetic process (GO:0001516),-0.5377753441082851,-1.5709581080628279,0.024154589371980676,0.5191237659511069,1.0,5/18,5.68%,HPGDS;TBXAS1;DAGLB;PTGS1;PTGDS
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.8010068855553367,1.568945550591631,0.036290322580645164,0.37515617464074363,1.0,3/12,1.42%,UBE2C;CDC20;PLK1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.7642334581233963,1.5684807973186874,0.035398230088495575,0.3749150120896716,1.0,4/17,5.54%,IL12A;KLRD1;RASGRP1;RAET1E
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.7689738856626784,1.5678197338019721,0.03732303732303732,0.37519298046049476,1.0,4/16,5.54%,IL12A;KLRD1;RASGRP1;RAET1E
prerank,regulation of protein export from nucleus (GO:0046825),0.7240058584366805,1.5672590553212749,0.033373063170441,0.37512387484798204,1.0,15/23,17.67%,GTSE1;BARD1;ANP32B;SP100;RANGAP1;PARK7;EMD;PTPN14;SIRT7;BAG3;GSK3B;TP53;TCF7L2;XPO4;YWHAE
prerank,nuclear membrane disassembly (GO:0051081),0.7915908990295557,1.5657917454765786,0.03773584905660377,0.3780993062199462,1.0,8/14,12.35%,CDK1;CCNB2;CCNB1;PLK1;PRKCA;VRK1;PRKCB;CNEP1R1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.6937992907800067,1.5640369197459865,0.02622950819672131,0.38212634892310554,1.0,13/37,12.32%,POLK;ERCC4;RPA2;CHD1L;RFC5;POLD1;PCNA;POLD2;RPA1;ERCC3;RFC2;RFC1;POLD3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.721589151309447,1.5636108979741645,0.03760282021151586,0.3816698067537246,1.0,14/24,19.63%,PIF1;ERCC4;SLX4;HNRNPC;TERF2;EXOSC10;DCP2;TERF1;CTC1;HNRNPU;NAT10;HNRNPA1;GNL3L;XRN1
prerank,cholesterol efflux (GO:0033344),-0.5119296429633663,-1.5624863840725478,0.02857142857142857,0.5396954530569553,1.0,8/20,18.64%,APOE;ABCA1;ABCA5;STX12;SCARB1;NPC2;NPC1;APOC1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.6601333647513553,1.5623192347041444,0.01026694045174538,0.38404869339537356,1.0,30/72,17.70%,ANKLE1;POLK;ERCC4;RNASE6;RPA2;CHD1L;RFC5;POLD1;FEN1;PCNA;PDE12;DCP1B;POLD2;DNA2;DNASE1L1;EDC3;RPA1;ERCC3;RFC2;RFC1;DCP1A;POLD3;DXO;REXO4;RPA3;RAD50;MEI4;RNASE1;UBA52;DDB2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.6787662856193987,1.5572290578468109,0.021321961620469083,0.399749736965989,1.0,18/51,13.32%,AURKB;PIF1;NEK2;MAPK1;SMG6;SMG5;CCT7;HNRNPC;ATM;TERF2;CCT2;TCP1;EXOSC10;DCP2;TERF1;CCT5;CTC1;HNRNPU
prerank,regulation of centriole replication (GO:0046599),0.7589443472316354,1.5562828866309804,0.03768844221105527,0.400956800911955,1.0,9/18,13.12%,STIL;CDK5RAP2;BRCA1;CEP295;CENPJ;CEP76;ALMS1;KAT2B;MDM1
prerank,regulation of cell cycle (GO:0051726),0.6467892301838172,1.5549430526115735,0.0,0.4033659587753175,1.0,66/271,13.88%,CENPF;DLGAP5;KIF20B;PRR11;CDKN3;BIRC5;FOXM1;CCNB2;DDIAS;IL12A;CKS2;BARD1;CCNB1;MASTL;PCLAF;MEN1;PLK1;CDKN2C;BRCA1;CDC25A;PHACTR4;PPP1R9B;SKP2;DYNLT3;RB1;FBXO5;DTL;LIN9;FAP;PML;MAP2K6;STK11;CHEK1;CDK6;CDKN2A;LIN54;ATM;RBBP4;GMNN;RUNX3;BIRC2;NOTCH1;PIM2;PIM3;PRKACA;HPGD;CDKN2D;PPP1R15A;WHAMM;HIPK2;RAD23A;PUM1;TAF6;XIAP;JUN;KAT2B;RPRD1B;BAP1;CDK5RAP3;HCFC1;RACK1;RPS15A;HNRNPU;BEX2;INTS13;MYC
prerank,regulation of cation transmembrane transport (GO:1904062),-0.4501834941002443,-1.5517521612105767,0.014388489208633094,0.5690504232229072,1.0,8/29,15.82%,DPP10;KCNIP3;KCNN2;KCNAB1;CD63;SNTA1;FGF12;DLG1
prerank,response to acidic pH (GO:0010447),-0.5852876746732933,-1.551179160697954,0.037815126050420166,0.5618696461954138,1.0,8/13,22.72%,CTSS;IMPACT;SLC9A1;LGMN;GPR65;RAB11FIP5;PKD2L1;CHP1
prerank,positive regulation of DNA repair (GO:0045739),0.6733189716807283,1.550320141556654,0.027085590465872156,0.4177105734359195,1.0,26/46,20.53%,FOXM1;BRCA1;SMCHD1;XRCC1;DDX11;BABAM1;TIMELESS;HDAC10;ABRAXAS1;PCNA;HMGB1;EYA3;EGFR;RNF168;RNF8;DHX9;CEBPG;EYA1;TRIM28;SIRT1;WRAP53;SLF1;RPS3;NPAS2;ZCWPW1;UBE2N
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.7847676308925372,1.5496154490740934,0.03978779840848806,0.41816588253125075,1.0,4/14,7.23%,RAD51AP1;TIMELESS;ARID2;MRNIP
prerank,synaptic vesicle transport (GO:0048489),-0.6250406731512483,-1.5492520342619298,0.03383458646616541,0.5598312052449169,1.0,7/11,16.13%,DNM2;KIF5C;SYNJ1;SPG11;KIF5A;CDK5;SNAPIN
prerank,retinol metabolic process (GO:0042572),0.7827627268117578,1.5489638346561638,0.046296296296296294,0.4184912208938053,1.0,2/14,1.40%,LRAT;CYP1B1
prerank,cellular response to cAMP (GO:0071320),0.6928816985519379,1.5481512996944669,0.026285714285714287,0.41916996466291806,1.0,8/30,7.52%,SLC5A5;AQP1;EZR;HCN3;CRHBP;ZFP36L1;PDE2A;AHR
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.6849027570450372,1.5480848598750399,0.027442371020856202,0.41731800986807566,1.0,13/39,12.32%,POLK;ERCC4;RPA2;CHD1L;RFC5;POLD1;PCNA;POLD2;RPA1;ERCC3;RFC2;RFC1;POLD3
prerank,fibrinolysis (GO:0042730),-0.5912826561414345,-1.5467938424954084,0.041353383458646614,0.5603814504225338,1.0,4/13,23.52%,PLAUR;PLAU;SERPINE1;PLAT
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.5153948504654184,-1.5465525830769975,0.024390243902439025,0.5526895950690788,1.0,8/20,17.37%,SLC27A1;HAGH;CNDP2;PTDSS2;GSS;PLOD2;CHAC2;OPLAH
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7460420528471139,1.5450015084177762,0.02679658952496955,0.4266872683396629,1.0,10/21,15.17%,CD19;PAX5;BLK;PTPN22;FOXP1;NFAM1;PRKCB;CBFB;ELF1;RUNX1
prerank,replicative senescence (GO:0090399),0.7931697304197773,1.5449448677561102,0.04201680672268908,0.4248035338354599,1.0,5/12,5.98%,PLA2R1;CHEK2;CHEK1;CDKN2A;ATM
prerank,response to UV (GO:0009411),0.6501469347863563,1.5441854954985677,0.0060790273556231,0.4255652227171453,1.0,28/95,11.34%,AURKB;POLK;IL12A;PCLAF;MEN1;ERCC4;AQP1;CDC25A;USP1;DTL;EIF2S1;USF1;POLD1;POLH;MSH6;COPS9;FEN1;PCNA;TAF1;PRIMPOL;ZRANB3;UBE4B;RHNO1;EGFR;CDKN2D;ERCC3;RUVBL2;CCAR2
prerank,protein localization to microtubule organizing center (GO:1905508),0.762347312542452,1.5428697076581657,0.050955414012738856,0.42823797069555297,1.0,8/15,13.80%,STIL;SPAG5;CEP83;CEP192;NEDD1;PCM1;BBS4;PIBF1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.6482181569209906,1.5428614367475402,0.008121827411167513,0.4262137682253099,1.0,41/95,15.93%,CDK1;NEK2;KIF24;CKAP5;PLK1;CDK5RAP2;CEP152;NDE1;PCNT;HAUS5;HAUS6;CEP83;CEP192;TUBB4B;ODF2;CEP89;CLASP1;CENPJ;CEP72;CEP76;DYNC1H1;ALMS1;OFD1;CEP250;PRKACA;NEDD1;CEP70;NINL;PCM1;PAFAH1B1;HAUS4;TUBB;CEP162;HAUS7;SCLT1;MKS1;CNTRL;DYNLL1;CEP57;SDCCAG8;MARK4
prerank,chromatin assembly (GO:0031497),0.6848776792102178,1.5418315386050603,0.035595105672969966,0.4277419281266055,1.0,19/38,16.94%,HMGB2;CHAF1A;ANP32B;SMARCA5;RSF1;CTCF;LIN54;NAP1L4;RBBP4;H3-3A;ASF1A;SART3;SPTY2D1;CHAF1B;CDAN1;NAP1L1;TP53;ATRX;SIRT1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.642485157120013,-1.5396956367324783,0.03470031545741325,0.5686400315650703,1.0,5/10,11.75%,LRP1;PTPN2;APOD;PTPRJ;NDRG4
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.6976979150338846,1.5392810165454887,0.02733485193621868,0.4349242834109555,1.0,14/33,15.28%,RAD51;PIF1;NOP10;TERF2;ANKRD28;DCLRE1B;RTEL1;TERF1;RPA1;RFC1;CTC1;PPP6R3;RAD50;PPP6C
prerank,positive regulation of integrin activation (GO:0033625),-0.6285386790093227,-1.539191837028374,0.048484848484848485,0.5618885518545815,1.0,5/11,18.49%,RAP1B;P2RY12;FERMT2;SKAP1;PLEK
prerank,regulation of DNA repair (GO:0006282),0.6728601411007923,1.5390207602733088,0.033953997809419496,0.43388300824995085,1.0,25/44,19.47%,BRCA1;RADX;SMCHD1;USP1;BABAM1;DEK;PML;POLH;ABRAXAS1;PCNA;EYA3;UBE2V1;EGFR;RNF168;RNF8;DHX9;SIRT7;CEBPG;RAD52;EYA1;TRIM28;SIRT1;WRAP53;RPS3;NPAS2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.7371789240883192,1.5388764760700138,0.03945745992601726,0.43236308737007983,1.0,12/19,19.63%,PIF1;HNRNPC;TERF2;EXOSC10;DCP2;TERF1;CTC1;HNRNPU;NAT10;HNRNPA1;GNL3L;XRN1
prerank,T-helper cell differentiation (GO:0042093),0.7761048798423029,1.538704939496325,0.05114401076716016,0.43100540459176534,1.0,6/14,10.65%,LEF1;BATF;ZFPM1;FOXP1;HMGB1;ATP7A
prerank,negative regulation of telomere maintenance (GO:0032205),0.7779452454114699,1.536720650310353,0.04336043360433604,0.4362709590160016,1.0,7/15,9.01%,ERCC4;SMG6;SLX4;ATM;TERF2;RTEL1;TERF1
prerank,androgen metabolic process (GO:0008209),0.7231106101468128,1.5359912872328538,0.047058823529411764,0.43680921285226243,1.0,2/18,1.35%,HSD17B3;SRD5A2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.6635658085365542,1.5356689925056013,0.01810436634717785,0.4358041592510579,1.0,25/53,19.47%,ANKLE1;PLA2R1;BRCA1;PMAIP1;SMCHD1;BABAM1;ABRAXAS1;PCNA;ATM;EYA3;EGFR;RNF168;CCAR2;RNF8;DHX9;FXR1;SPRED2;MYC;CEBPG;EYA1;TRIM28;SIRT1;WRAP53;RPS3;NPAS2
prerank,somite development (GO:0061053),-0.6052182118108985,-1.5350209824103498,0.05211726384364821,0.5689502967497686,1.0,4/11,19.01%,SMO;PPP2R3A;LOXL3;SOX11
prerank,ion homeostasis (GO:0050801),0.6914635281373742,1.5342826865404797,0.033105022831050226,0.4389414572138314,1.0,2/30,0.51%,SLC4A1;RHAG
prerank,DNA duplex unwinding (GO:0032508),0.668666537060791,1.5342546633618908,0.02696871628910464,0.43701883863227126,1.0,11/50,9.42%,RAD51;PIF1;HMGA1;BLM;CHD1L;DDX11;MCM6;MCM9;RTEL1;RPA1;ERCC3
prerank,histone H4 acetylation (GO:0043967),0.6679802542759639,1.5339223536605657,0.02813852813852814,0.4362486323780862,1.0,19/47,14.81%,KANSL1;JADE1;NAA40;BRCA2;LEF1;EPC1;BRD8;KANSL3;MSL2;YEATS4;RUVBL2;RUVBL1;HAT1;HCFC1;KMT2A;ING3;ING5;KANSL2;TADA3
prerank,protein-DNA complex disassembly (GO:0032986),0.7435677490344753,1.5314687485630127,0.051248357424441525,0.44266472628090864,1.0,8/16,13.88%,SMARCC2;HMGA1;SMARCD2;ARID2;SMARCA4;SMARCC1;NFE2;MYC
prerank,cellular response to alkaloid (GO:0071312),0.7416742336581523,1.5297744118946819,0.05605095541401274,0.44668802182539263,1.0,3/17,4.05%,RAD51;BLM;CRHBP
prerank,glycerolipid metabolic process (GO:0046486),-0.6134699983158968,-1.529655517714452,0.044673539518900345,0.5793969837499736,1.0,5/11,13.69%,PLA2G15;DGKA;DGKZ;DGKQ;DGKB
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.6211052697671998,-1.5294016308688345,0.04878048780487805,0.5719397455510535,1.0,5/10,13.79%,TREM2;APPL2;CD300A;RAB31;NCKAP1L
prerank,telomere maintenance via recombination (GO:0000722),0.7851723001250789,1.528579121799093,0.055632823365785816,0.4491539868177473,1.0,7/11,14.98%,RAD51;ERCC4;SMC6;XRCC3;NSMCE2;TEP1;RAD50
prerank,regulation of multicellular organismal development (GO:2000026),0.7162215038908658,1.5284487662180395,0.04566744730679157,0.44764863596178667,1.0,3/25,1.31%,CDK1;RACGAP1;CCSAP
prerank,regulation of spindle assembly (GO:0090169),0.6977519318917149,1.525855849881972,0.05306603773584906,0.45521782697661567,1.0,13/25,18.26%,SPAG5;CCSAP;PLK1;GPSM2;DYNC1H1;CHMP1B;HNRNPU;NUMA1;CHMP3;CHMP2B;RNF4;DRG1;SENP6
prerank,regulation of interferon-alpha production (GO:0032647),-0.4845034304649436,-1.5244304601898027,0.05421686746987952,0.5819224262038096,1.0,6/23,7.24%,HAVCR2;HSPD1;PTPRS;TLR7;MAVS;TLR4
prerank,liver development (GO:0001889),0.6754500079342555,1.522897523712381,0.048,0.4643005826655181,1.0,15/32,21.23%,E2F7;E2F8;AURKA;PHF2;ARID5B;CDK5RAP3;CEBPG;PRKCSH;XBP1;NKX2-8;PROX1;PKD2;MET;CITED2;PCK2
prerank,regulation of telomere maintenance (GO:0032204),0.7041516249563134,1.5227721796238738,0.0513126491646778,0.4627163185344917,1.0,7/26,7.30%,PIF1;ERCC4;SMG6;PML;SMG5;TERF2;RTEL1
prerank,Golgi ribbon formation (GO:0090161),-0.5773607319626546,-1.5218006672084206,0.051470588235294115,0.5840345016349054,1.0,8/13,20.41%,STX6;STX16;TRIP11;OPTN;GOLGA2;PRMT5;FHDC1;MYO18A
prerank,positive regulation of cellular protein localization (GO:1903829),0.644302972009406,1.5212502976599418,0.020876826722338204,0.46606494579304664,1.0,22/69,16.10%,NDC80;CDK1;GTSE1;PLK1;CARD10;CCDC88A;FYN;SNX33;TFRC;GPD1L;DDRGK1;CEP250;ABCA7;PARK7;ORMDL3;CDK5RAP3;NUMA1;TYROBP;CENPQ;GSK3B;MARK4;LIMK2
prerank,regulation of embryonic development (GO:0045995),0.6897132330730195,1.5206644640812808,0.04342857142857143,0.46618906742874466,1.0,13/34,14.47%,CDK1;RACGAP1;FOXA2;CCSAP;WDPCP;CLASP1;RBM19;NR2C2;EHMT1;PLCB1;RPS6KA6;NIPBL;DAG1
prerank,intracellular pH reduction (GO:0051452),-0.435101204674463,-1.5206232964488056,0.026785714285714284,0.5799648721485067,1.0,15/33,22.02%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;DMXL2;RAB20;ATP6V0B;TCIRG1;ATP6V1H;ATP6V1A;ATP6V1F;ATP6V1G2;ATP6V0C;TMEM9;RAB38
prerank,DNA double-strand break processing (GO:0000729),0.7254583645369471,1.5198611076181687,0.05,0.4670828233457124,1.0,7/18,8.32%,BARD1;BRCA1;BLM;SLX4;RBBP8;ATM;DNA2
prerank,V(D)J recombination (GO:0033151),0.7933423646626813,1.5197878018564575,0.04065040650406504,0.465306512536342,1.0,5/11,7.33%,HMGB2;LIG4;LIG1;TCF3;HMGB1
prerank,granulocyte differentiation (GO:0030851),0.729239525458396,1.5193029261415578,0.04713375796178344,0.464952827976122,1.0,5/18,3.86%,LBR;LEF1;E2F1;DEK;PML
prerank,dendritic cell differentiation (GO:0097028),0.7221321869866875,1.5188970508359938,0.038944723618090454,0.4645245646525743,1.0,3/22,3.17%,BLK;PRTN3;BATF
prerank,lipid droplet formation (GO:0140042),-0.6337243474593677,-1.518565350276133,0.060790273556231005,0.5791278206294898,1.0,5/10,20.41%,CDS1;AUP1;CDS2;ZFYVE1;SQLE
prerank,natural killer cell mediated immunity (GO:0002228),0.7473606807816987,1.5172843650280878,0.058823529411764705,0.4684284751081905,1.0,7/15,13.89%,ULBP1;KLRD1;RAET1E;TUBB4B;SLAMF7;TUBB;CEBPG
prerank,regulation of axon extension (GO:0030516),-0.416339307765719,-1.5164972467885467,0.009174311926605505,0.5783130904843132,1.0,17/37,20.27%,RTN4;DNM2;RUFY3;MACF1;MAP3K13;DIP2B;APOE;PTPRS;LIMK1;MAG;GOLGA4;SEMA3A;L1CAM;TWF2;CTTN;CDKL3;SEMA7A
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.660009644040311,1.5145531900057974,0.033261802575107295,0.47493342433657454,1.0,29/50,22.39%,NUP43;POM121;NDC1;POLR2I;NUP107;POLR2A;NUP42;NUP50;PUM2;H3-3A;NUP214;NUP160;NUP205;SEC13;NUP188;PUM1;NUP98;RANBP2;NUP210;POLR2K;AAAS;NUP37;POLR2J;NUP85;AGO2;TPR;NUP93;AGO1;POLR2B
prerank,regulation of gene silencing by RNA (GO:0060966),0.660009644040311,1.5145531900057974,0.033261802575107295,0.47493342433657454,1.0,29/50,22.39%,NUP43;POM121;NDC1;POLR2I;NUP107;POLR2A;NUP42;NUP50;PUM2;H3-3A;NUP214;NUP160;NUP205;SEC13;NUP188;PUM1;NUP98;RANBP2;NUP210;POLR2K;AAAS;NUP37;POLR2J;NUP85;AGO2;TPR;NUP93;AGO1;POLR2B
prerank,regulation of lymphocyte differentiation (GO:0045619),0.7350847037756636,1.5143847961271557,0.04645161290322581,0.47359254055324035,1.0,8/18,15.99%,CD2;IKZF3;CCR2;ZFP36L1;XRCC6;PRKDC;SLAMF8;ZFP36L2
prerank,positive regulation of neuron migration (GO:2001224),0.7948850112862075,1.5140132726165316,0.05742296918767507,0.47301907325758846,1.0,1/11,0.11%,KIF20B
prerank,t-circle formation (GO:0090656),0.8032861440638686,1.5134213375010845,0.043041606886657105,0.4693425320832498,1.0,6/10,9.01%,EXO1;BLM;SLX4;XRCC3;DNA2;TERF1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.8032861440638686,1.5134213375010845,0.043041606886657105,0.4693425320832498,1.0,6/10,9.01%,EXO1;BLM;SLX4;XRCC3;DNA2;TERF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.8032861440638686,1.5134213375010845,0.043041606886657105,0.4693425320832498,1.0,6/10,9.01%,EXO1;BLM;SLX4;XRCC3;DNA2;TERF1
prerank,DNA-dependent DNA replication (GO:0006261),0.6333491940415389,1.5133366821014973,0.001006036217303823,0.4677051772413348,1.0,49/128,16.92%,RAD51;MCM10;POLE2;CDC45;PRIM2;GINS1;PRIM1;RPA2;DBF4;HMGA1;POLA1;BLM;POLE;WDHD1;PSMB7;TOPBP1;PSMD11;MCM6;RFC5;ORC5;POLD1;PSMF1;ORC3;GMNN;PSMC1;LRWD1;PRIMPOL;POLD2;DNA2;RPA1;RFC2;PSMC3;PSMA4;RFC1;PSMC4;POLD3;TEFM;RPAIN;PSMD13;SIRT7;PSME1;CDC7;PSMB1;RPA3;PSMD8;MCM3;PSME4;BAZ1A;PSMD4
prerank,B cell activation involved in immune response (GO:0002312),0.7553501956673375,1.5114783300946928,0.05006587615283267,0.47282380708592087,1.0,6/13,11.39%,CD19;BATF;LIG4;MSH6;RNF168;RNF8
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.8034796221083292,1.5109410139613766,0.03943661971830986,0.472897629897459,1.0,1/10,0.41%,BLK
prerank,anion transport (GO:0006820),0.6732760304628393,1.5095471676728462,0.0375,0.47615943999569993,1.0,6/33,11.15%,SLC4A1;VDAC2;TSPO;LRRC8B;LRRC8C;SLC19A1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.7311606063686129,1.508268492673019,0.059278350515463915,0.4790491319772262,1.0,5/16,3.80%,RAD21;DSCC1;RB1;SGO1;HASPIN
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.5743514254290946,-1.5081528788078593,0.06844106463878327,0.6013463177393725,1.0,6/12,22.19%,DPYD;ALDH6A1;UMPS;CRMP1;DPYSL2;DPYSL3
prerank,negative regulation of double-strand break repair (GO:2000780),0.6868087822836085,1.5072819231295058,0.04838709677419355,0.48075495317407513,1.0,7/30,5.11%,POLQ;PARPBP;RMI2;RADX;SMCHD1;TWIST1;CGAS
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.7244520956771485,1.5060707437077145,0.048628428927680795,0.4832927590157456,1.0,2/18,0.41%,CD19;BLK
prerank,regulation of B cell apoptotic process (GO:0002902),0.7782885241123346,1.505391194059183,0.054775280898876406,0.4839256220062191,1.0,6/12,13.90%,AURKB;BLK;FOXP1;ORMDL3;BTK;BCL6
prerank,cell cycle G1/S phase transition (GO:0044843),0.6489761732234806,1.5052660534826088,0.022821576763485476,0.48244142765297787,1.0,24/61,15.28%,CDKN3;CCNA2;CCNE1;CDKN2C;DBF4;CDC25A;RCC1;POLE;E2F1;CCNE2;RB1;NASP;CDK6;CDKN2A;PIM2;MAX;CDKN2D;CUL3;MAP3K11;LATS1;MYC;CDC7;E2F3;PPP6C
prerank,regulation of DNA metabolic process (GO:0051052),0.6529843643141906,1.5040723695879827,0.0350109409190372,0.48508971299277487,1.0,11/44,8.02%,PIF1;TICRR;RADX;SMG6;USP1;IL7R;SMG5;NUCKS1;POLH;TERF2;UBE2V1
prerank,regulation of catabolic process (GO:0009894),0.7322339130457856,1.5039165068654363,0.04871794871794872,0.4837346847330839,1.0,8/18,15.64%,FAM83D;CHEK2;FAP;FAF1;NEDD4L;HPGD;ZDHHC7;HGS
prerank,hyaluronan catabolic process (GO:0030214),0.7342378129508798,1.5032300544090598,0.05454545454545454,0.4844129220731238,1.0,2/18,3.89%,HMMR;CD44
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.672228283384796,1.5025125000213762,0.04090909090909091,0.4851783375167057,1.0,7/33,8.37%,KIF14;FAM83D;EZH2;E2F1;TAF1;DDRGK1;PLCG2
prerank,piRNA metabolic process (GO:0034587),0.7232201853605875,1.5019838448628249,0.056818181818181816,0.48528186311244326,1.0,1/19,1.37%,MYBL1
prerank,protein K11-linked ubiquitination (GO:0070979),0.6825190877421701,1.5017636099626024,0.06690140845070422,0.48420512174292724,1.0,6/27,6.89%,UBE2C;UBE2T;RNF26;CDC23;CDC27;ANAPC7
prerank,inorganic ion transmembrane transport (GO:0098660),0.7505579673112385,1.5008769060521534,0.06284916201117319,0.4855322155299483,1.0,1/12,0.51%,RHAG
prerank,RNA biosynthetic process (GO:0032774),0.6788252461476578,1.500300282447943,0.045871559633027525,0.4858994461280474,1.0,9/31,7.12%,PRIM2;PRIM1;POLA1;SMARCA5;RSF1;POLR2A;SETX;BRF1;TAF7
prerank,cellular potassium ion homeostasis (GO:0030007),-0.5828847011143052,-1.5000013895834086,0.04980842911877394,0.6238793489171056,1.0,8/13,25.59%,KCNMA1;SLC12A2;ATP1A1;ATP1B2;ATP1B1;ATP1A2;ATP1A3;ATP1B3
prerank,regulation of centrosome cycle (GO:0046605),0.7078033820226988,1.4990906318458694,0.048327137546468404,0.48859531079087576,1.0,10/21,17.24%,GEN1;AURKA;XRCC3;ATF5;CHMP1B;MARK4;SIRT1;CHMP3;NAT10;CHMP2B
prerank,regulation of macrophage migration (GO:1905521),-0.6059228036255518,-1.4980877809990831,0.06796116504854369,0.6231030905858251,1.0,8/10,34.21%,P2RY12;CX3CR1;CD200;CSF1;CD81;PTK2B;MTUS1;EMILIN1
prerank,cellular response to amyloid-beta (GO:1904646),-0.4318919525790716,-1.4980202392641162,0.028846153846153848,0.615540704784617,1.0,17/35,18.36%,IGF1R;APP;TREM2;LRP1;CASP4;IGF1;ABCC1;GRM5;TLR4;LGMN;CDK5;PRNP;GJA1;CD36;EPHA4;SNX6;ADRB2
prerank,negative regulation of blood coagulation (GO:0030195),-0.4044858261222498,-1.4970851504328657,0.028037383177570093,0.6111879212508369,1.0,8/38,16.94%,SERPINE2;APOE;CD34;PLAUR;TFPI;PLAU;SERPINE1;F8
prerank,nucleotide-excision repair (GO:0006289),0.6268267571901679,1.4956335830951213,0.009183673469387756,0.5000352822936875,1.0,36/101,17.70%,BRIP1;POLK;ERCC4;RPA2;POLA1;BRCA2;POLE;XRCC1;CHD1L;SLX4;LIG4;RFC5;POLR2I;PRPF19;POLR2A;POLD1;PCNA;LIG1;POLD2;HUS1;RPA1;ERCC3;RFC2;RAD23A;RFC1;POLD3;RPA3;RNF111;TP53;FANCC;POLR2K;SIRT1;POLR2J;UBA52;USP7;DDB2
prerank,heterochromatin assembly (GO:0031507),0.7119932000129845,1.4939770408280797,0.060945273631840796,0.5044673953348418,1.0,7/20,7.36%,SUV39H1;HMGA1;SMCHD1;HELLS;CDKN2A;MBD2;H3-3A
prerank,embryonic heart tube development (GO:0035050),-0.551437654903427,-1.4934611937389048,0.06374501992031872,0.6167873453637314,1.0,3/14,11.75%,ACVR1;RYR2;NDRG4
prerank,phagosome maturation (GO:0090382),-0.4171312151923295,-1.49337712498524,0.028037383177570093,0.6095786534969833,1.0,16/35,22.02%,RAB14;ATP6V1B2;ATP6V1C1;ATP6V0D2;MCOLN1;ATP6V0A1;RAB20;ATP6V0B;TCIRG1;RAB31;ATP6V1H;ATP6V1A;ATP6V1F;ATP6V1G2;ATP6V0C;RAB38
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.6650617915953747,1.4931142366146881,0.041666666666666664,0.5058259874352241,1.0,14/40,14.29%,ANKLE1;RFWD3;RPA2;RADX;USP1;FBXO5;POLH;ARMT1;UBE2V1;FXR1;ING2;SIRT7;MYC;CASP9
prerank,cell-cell junction maintenance (GO:0045217),0.7796724091693464,1.4926934457302432,0.06801736613603473,0.5056207051149861,1.0,2/11,1.29%,PRTN3;CD177
prerank,regulation of nervous system development (GO:0051960),0.6657284494237388,1.4920453496398554,0.04515418502202643,0.5060435550794804,1.0,3/37,2.10%,KIF14;HMGB2;HEY2
prerank,phagosome acidification (GO:0090383),-0.45609918631845736,-1.4915690071076138,0.07142857142857142,0.6083118096950973,1.0,13/26,22.02%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;RAB20;ATP6V0B;TCIRG1;ATP6V1H;ATP6V1A;ATP6V1F;ATP6V1G2;ATP6V0C;RAB38
prerank,response to cAMP (GO:0051591),0.6530349691469849,1.4910020203926175,0.03425414364640884,0.5080765654166861,1.0,8/37,7.52%,SLC5A5;AQP1;EZR;HCN3;CRHBP;ZFP36L1;PDE2A;AHR
prerank,dopaminergic neuron differentiation (GO:0071542),0.7145150519425807,1.489044988920523,0.06303030303030303,0.5137233450877458,1.0,2/19,1.81%,FOXA2;NR4A2
prerank,signal release from synapse (GO:0099643),-0.39394929728833367,-1.4884445265260073,0.009708737864077669,0.6117317987170723,1.0,19/43,25.97%,RIMS1;PCLO;SYT1;VAMP2;GAD2;CDK5;UNC13A;STX1A;PIP5K1C;SNAPIN;RAB3A;STXBP1;PTPRN2;PDZD11;CPLX1;SLC32A1;DVL1;CPLX2;SNAP25
prerank,hyaluronan metabolic process (GO:0030212),0.6951784090200933,1.4875873737277006,0.05048076923076923,0.517563941529569,1.0,3/23,3.94%,HMMR;CD44;HAS1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.5712007013360709,-1.4872821085521224,0.06405693950177936,0.6086215705154099,1.0,7/12,39.73%,TLR4;STRAP;NOD2;RBP4;SOX9;TLR9;INAVA
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.6129708862916959,1.486814921127254,0.0,0.5186608327581511,1.0,96/306,15.00%,CDK1;BRIP1;MRPL36;PIF1;TICRR;CLSPN;MCM10;BARD1;PCLAF;TIPIN;POLE2;RAD1;CDC45;BRCA1;RMI2;NR4A2;EXO1;RPA2;DBF4;POLA1;BLM;RPL7;POLE;E2F1;RPL18A;RPS20;MRPL18;ALAS2;TOPBP1;MCM6;RFC5;RAD9A;POLR2I;ORC5;RPL36;RPL14;POLR2A;TIMELESS;POLD1;MCM9;EPC1;RBBP8;RPS19;FEN1;DUT;CHEK1;RPS7;EXT1;ORC3;RPS4X;RPS18;MRPL10;ATM;PTMA;RPL23A;EEF1B2;RPL28;POLD2;ST3GAL2;MRPL37;RHNO1;RPS14;DNA2;RPL41;RPLP2;HUS1;RPA1;RNPS1;RPS27;MRPL51;MRPS7;RFC2;MRPL43;RPS5;DHPS;RPS29;RPLP0;RPS11;FAM111A;MRPS17;TYMS;IGF2BP3;RPL27A;POLD3;TOP3A;KIN;RPS9;RPS15A;ING5;MRPL24;NAP1L1;CDC7;RPL12;RPA3;RAD50;RNASEH2A
prerank,positive regulation of DNA metabolic process (GO:0051054),0.6408032377208858,1.4865791040641496,0.03882476390346275,0.5176192932382542,1.0,31/61,20.91%,RAD51;BRCA1;SMCHD1;BABAM1;PML;ABRAXAS1;PCNA;RTEL1;HMGB1;EYA3;SMOC2;EGFR;MECP2;RNF168;RNF8;DHX9;MYC;CEBPG;EYA1;RAD50;TRIM28;ATRX;SIRT1;USP7;WRAP53;RPS3;NPAS2;PRKD2;ZCWPW1;UBE2N;WRN
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.6239976657866504,1.4854476987202143,0.028154327424400417,0.5200669153320675,1.0,16/66,11.98%,KIF14;E2F7;CDKN2C;JADE1;WEE1;E2F1;RB1;RBL1;CDK6;CDKN2A;TFDP1;EGFR;CDKN2D;RDX;PLCB1;PTEN
prerank,intestinal absorption (GO:0050892),-0.5435612201549467,-1.4823043437757417,0.043795620437956206,0.6199136893642323,1.0,7/13,32.25%,F11R;TJP2;CD36;SLC2A5;SLC26A6;SLC46A1;ADRA2A
prerank,protein localization to centrosome (GO:0071539),0.717757139876244,1.4807021512336247,0.07481296758104738,0.5369341367321796,1.0,8/17,13.80%,STIL;SPAG5;CEP83;CEP192;NEDD1;PCM1;BBS4;PIBF1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5381787413847903,-1.4787948721450668,0.06538461538461539,0.6250960878731501,1.0,8/15,27.19%,BCL2L1;GHITM;HGF;IGF1;PRKN;GPX1;PRELID1;PSMD10
prerank,antibacterial humoral response (GO:0019731),0.7314869592165265,1.478787703647979,0.06964520367936924,0.5427115964796824,1.0,3/16,5.04%,RNASE6;CAMP;SLPI
prerank,histone H4-K16 acetylation (GO:0043984),0.7090504783718984,1.4785809444565707,0.07407407407407407,0.541497633912136,1.0,7/19,13.88%,KANSL1;JADE1;KANSL3;MSL2;HCFC1;KMT2A;KANSL2
prerank,regulation of T cell differentiation (GO:0045580),0.6642355632627324,1.4779057534799613,0.0622876557191393,0.5421364091650057,1.0,5/33,5.31%,TNFRSF18;CD2;FANCA;IL2RA;CCR2
prerank,apoptotic DNA fragmentation (GO:0006309),0.7272722610053337,1.4778107638984581,0.07631578947368421,0.5405160301171696,1.0,3/16,7.33%,HMGB2;CECR2;HMGB1
prerank,negative regulation of platelet activation (GO:0010544),-0.5321964478660344,-1.4771734226391524,0.0603448275862069,0.6236734028292149,1.0,7/16,32.35%,SERPINE2;APOE;SH2B3;PRKG1;CEACAM1;PDGFRA;THBD
prerank,cellular protein-containing complex assembly (GO:0034622),0.613155521424919,1.4765439999814554,0.003006012024048096,0.5433378076284937,1.0,24/160,9.63%,CENPF;CENPE;DLGAP5;CENPA;CENPW;ANLN;FMOD;NDC1;STXBP6;TIAM1;EIF4B;PSMD11;AXIN1;NUP107;CHCHD4;CCT2;TCP1;SNX9;CLTC;VBP1;NUP205;NDUFAF1;LONP1;AHCTF1
prerank,DNA biosynthetic process (GO:0071897),0.7301436864712392,1.4763171604205334,0.06852791878172589,0.5422761997267719,1.0,10/16,16.94%,POLA1;POLE;POLD1;POLH;POLD2;CDKN2D;TYMS;POLD3;PPIA;SIRT1
prerank,chromatin assembly or disassembly (GO:0006333),0.7581132882398882,1.4763071436022617,0.08250355618776671,0.5403542831328733,1.0,7/11,14.97%,CHAF1A;HIRIP3;RBBP4;CHAF1B;MTA2;CDAN1;TP53
prerank,Rap protein signal transduction (GO:0032486),-0.6079724828908836,-1.4762792432663006,0.07096774193548387,0.6196524404465386,1.0,8/10,27.20%,RAP1B;RAP2A;RAP2B;RAP1A;RAP2C;RAPGEF1;RAPGEF3;PLK2
prerank,synaptic vesicle cycle (GO:0099504),-0.4362049787237706,-1.4738300333487042,0.023255813953488372,0.6209396592032871,1.0,15/30,25.97%,RIMS1;PCLO;SYNDIG1;SLC17A6;VAMP2;SYT7;CDK5;STX1A;PIP5K1C;SNAPIN;RAB3A;CPLX1;SLC32A1;CPLX2;SNAP25
prerank,positive regulation of protein kinase activity (GO:0045860),0.6152190599534011,1.4735188620045627,0.003015075376884422,0.5493685877987213,1.0,23/148,8.51%,CENPE;TPX2;KIF14;ECT2;CLSPN;BORA;EZH2;INCENP;CCDC88A;ERBB3;CCN1;AXIN1;NEDD9;STK11;GPRC5B;MMD2;MAPRE3;MMD;XRCC6;MRNIP;CIB1;SNX9;MARK2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5536698688026677,-1.472567153554405,0.09885931558935361,0.6184809965180348,1.0,9/12,33.43%,ANK3;DMD;ATP1B2;ATP1B1;GLRX;ATP1B3;WNK2;FXYD1;NOS1
prerank,neuron remodeling (GO:0016322),-0.5773855396934786,-1.4725571897575866,0.06976744186046512,0.611824040960717,1.0,3/10,4.64%,APP;FARP2;C1QA
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.6530430822767623,1.471829409714133,0.051991150442477874,0.5542160775114013,1.0,17/42,13.14%,CECR2;SMARCC2;MBD3;SMARCA5;ARID1B;SMARCD2;NASP;ACTR5;HNRNPC;MBD2;RBBP4;SMARCA4;SMARCC1;SPTY2D1;RNF8;MTA2;ANP32E
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.6652054515627647,1.471612027828396,0.06568516421291053,0.5511687566429021,1.0,18/32,20.21%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;AAAS;NUP37;NUP85;TPR
prerank,tRNA export from nucleus (GO:0006409),0.6652054515627647,1.471612027828396,0.06568516421291053,0.5511687566429021,1.0,18/32,20.21%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;AAAS;NUP37;NUP85;TPR
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.6690044218217596,1.470814866539448,0.05399325084364454,0.5524745136581627,1.0,9/35,7.87%,AURKB;NEK2;MAPK1;CCT7;ATM;CCT2;TCP1;RTEL1;HNRNPA2B1
prerank,lymphocyte proliferation (GO:0046651),0.7147835112267839,1.4704643712257597,0.0703883495145631,0.5519700784874045,1.0,6/22,11.65%,MS4A1;CD79A;HELLS;RASGRP1;MSN;FLT3
prerank,response to ethanol (GO:0045471),-0.5504214632843177,-1.4699825270959892,0.06746031746031746,0.6142257183169785,1.0,4/14,9.82%,ADCY7;GRIN3A;GOT2;GLRA2
prerank,prostaglandin metabolic process (GO:0006693),-0.45861991888981324,-1.4689159831780234,0.06201550387596899,0.6115634807391271,1.0,7/26,8.41%,HPGDS;TBXAS1;DAGLB;PTGS1;PTGDS;PLAA;PTGR2
prerank,cellular response to inorganic substance (GO:0071241),0.6914755203249929,1.4689028273691007,0.07334963325183375,0.5561650196412049,1.0,9/21,16.28%,AQP1;BLM;DDX11;TIMELESS;FOXO1;DPEP1;KCNC2;MTR;ATRX
prerank,natural killer cell activation (GO:0030101),0.6825065663073968,1.4686510914179793,0.06417736289381563,0.5552815036192732,1.0,5/23,7.76%,CD2;ULBP1;RASGRP1;IL21R;SLAMF7
prerank,regulation of protein localization to nucleus (GO:1900180),0.6547536631825963,1.4669415408049307,0.052338530066815145,0.5600809815746062,1.0,14/43,16.10%,CDK1;GTSE1;PLK1;CARD10;CTNNA1;TFRC;PIN1;PARK7;ORMDL3;CDK5RAP3;LATS1;GSK3B;SIN3A;LIMK2
prerank,steroid hormone biosynthetic process (GO:0120178),0.6550122692562088,1.4666280299317043,0.06936416184971098,0.5593845072285251,1.0,9/29,18.63%,HSD17B3;SRD5A2;TSPO;SRD5A3;DHCR7;STARD3NL;TSPOAP1;MED1;FDXR
prerank,inorganic anion transport (GO:0015698),0.6442176020722585,1.4660780989053341,0.02553191489361702,0.5596590117743702,1.0,5/53,4.27%,SLC4A1;RACGAP1;SLC5A5;ANO10;CLIC5
prerank,positive regulation of chromosome organization (GO:2001252),0.7293069361169863,1.4660549104309155,0.07984293193717278,0.5578097193429622,1.0,6/15,7.30%,RAD21;DDX11;LIG4;PML;FEN1;RTEL1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.6300339718668443,1.4634297582835678,0.0429769392033543,0.5661983102741244,1.0,33/62,22.39%,NUP43;POM121;NDC1;POLR2I;NUP107;POLR2A;NUP42;NUP50;PUM2;H3-3A;NUP214;NUP160;NUP205;SEC13;NUP188;PUM1;DHX9;NUP98;RANBP2;FXR1;NUP210;LIMD1;POLR2K;AAAS;NUP37;POLR2J;ELAVL1;NUP85;AGO2;TPR;NUP93;AGO1;POLR2B
prerank,neuron fate commitment (GO:0048663),-0.5447551551461591,-1.4612863104607199,0.08064516129032258,0.6309913538189337,1.0,3/14,14.45%,TGFBR1;MYT1L;ID2
prerank,cell junction maintenance (GO:0034331),0.7349114559778156,1.4606365507769588,0.08493150684931507,0.5753183299212543,1.0,2/14,1.29%,PRTN3;CD177
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5257318171363479,-1.4598306736458049,0.05603448275862069,0.6296100848488995,1.0,8/15,31.00%,LPL;IL18;CSF1;CD36;AGT;PF4;MAPK9;PLA2G3
prerank,secretion (GO:0046903),-0.5376064439714169,-1.459405004091141,0.08333333333333333,0.6247229493870913,1.0,2/14,3.49%,RIMS1;PRKCI
prerank,regulation of coagulation (GO:0050818),0.7775850991444031,1.458768256231705,0.0898716119828816,0.5809250635372825,1.0,2/11,5.28%,FOXA2;CAV1
prerank,regulation of lymphocyte activation (GO:0051249),0.7444946309673434,1.4578454200800641,0.08368200836820083,0.5827256383312757,1.0,2/12,2.79%,CD19;IKZF3
prerank,protein acetylation (GO:0006473),0.6634216074448077,1.4574171484613965,0.07648401826484018,0.5824250908496461,1.0,12/30,16.99%,ESCO2;NAA40;DSCC1;FOXO1;KAT6A;KAT2B;NAA16;HAT1;ING5;CREBBP;SIRT1;NAT10
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5415104589939049,-1.457357159086123,0.09747292418772563,0.6257917054475199,1.0,4/13,4.89%,CACNB2;CACNA1C;KCNN2;ANK2
prerank,sympathetic nervous system development (GO:0048485),-0.5185379338472438,-1.456831767009406,0.06374501992031872,0.6215452932543437,1.0,7/15,19.01%,NRP2;CTNNB1;NF1;FZD3;SEMA3A;SOX4;SOX11
prerank,negative regulation of cellular senescence (GO:2000773),0.7525334280755913,1.4545996347004195,0.07788595271210014,0.5921600884276168,1.0,6/13,7.47%,FBXO5;TWIST1;RBL1;CDK6;TERF2;AKT3
prerank,protein localization to chromatin (GO:0071168),0.713851768180083,1.453561007622488,0.08801020408163265,0.5943394881964303,1.0,9/18,16.19%,PLK1;RAD21;MCM9;LRWD1;MRNIP;RUVBL2;NIPBL;WAPL;TASOR
prerank,histone H4-K8 acetylation (GO:0043982),0.7171164911550417,1.4531511335135472,0.08524173027989822,0.5921636838003939,1.0,5/15,13.88%,KANSL1;JADE1;KANSL3;HCFC1;KANSL2
prerank,histone H4-K5 acetylation (GO:0043981),0.7171164911550417,1.4531511335135472,0.08524173027989822,0.5921636838003939,1.0,5/15,13.88%,KANSL1;JADE1;KANSL3;HCFC1;KANSL2
prerank,negative regulation of peptidase activity (GO:0010466),-0.3774840484312265,-1.4525318217047318,0.041666666666666664,0.630477861573126,1.0,9/47,17.04%,SPOCK1;LRP1;SERPINE2;TIMP2;SPOCK2;TIMP3;SERPINI1;SERPINE1;CST7
prerank,response to light stimulus (GO:0009416),0.638440252898699,1.4519033503204553,0.05359056806002144,0.5953722690606064,1.0,15/55,11.34%,PCLAF;MEN1;ERCC4;USP1;DTL;USF1;POLD1;MSH6;CPT1B;PRIMPOL;ZRANB3;UBE4B;CDKN2D;ERCC3;CCAR2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.52680061332889,-1.4517236048358004,0.06726457399103139,0.6269270791418655,1.0,7/14,35.95%,DAGLB;SLC5A7;DAGLA;CHAT;NOS1;MOXD1;ACHE
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6897917128515666,1.4516325313945029,0.07891491985203453,0.5944232492576212,1.0,10/20,17.77%,MEN1;PLK1;CDKN2A;NR2F2;IPO7;PTEN;LATS1;IPO5;TFAP4;HEXIM1
prerank,cellular response to light stimulus (GO:0071482),0.6215313126719039,1.4509667551047958,0.045881126173096975,0.5951498675188678,1.0,16/66,14.97%,AURKB;POLK;ERCC4;AQP1;CDC25A;EIF2S1;POLD1;COPS9;PCNA;TAF1;RHNO1;RUVBL2;CREBBP;MYC;CASP9;TP53
prerank,regulation of lymphocyte proliferation (GO:0050670),0.7095482863371663,1.4508478427630038,0.09345794392523364,0.5936443222928359,1.0,4/16,7.52%,IL12A;IKZF3;PTPN22;AHR
prerank,vasoconstriction (GO:0042310),0.7479444276770038,1.4502027641441166,0.08873239436619719,0.5941666267155343,1.0,1/11,0.98%,KEL
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.7754195289159317,1.4501150055893772,0.08057553956834532,0.5925409256877832,1.0,7/10,16.84%,DCLRE1C;TERF2;DCLRE1B;RTEL1;APEX1;TFIP11;RIF1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6497681585416109,1.449937181319875,0.08313817330210772,0.5912978874403404,1.0,11/26,18.12%,KNSTRN;ZFP36L1;EGFR;PDPK1;STAT5B;ZFP36L2;DUSP22;PLCG1;PDE8A;IQGAP1;MED1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.7359134127892442,1.4494854933924177,0.07466666666666667,0.5912753874480338,1.0,3/13,5.98%,PLA2R1;PMAIP1;ATM
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.721755829171329,1.4489409166945164,0.08928571428571429,0.5916343456784166,1.0,3/14,5.66%,ADAMTS7;RFLNB;PTHLH
prerank,midbody abscission (GO:0061952),0.7094183651575494,1.4488551774039615,0.07341772151898734,0.5900730630613006,1.0,2/17,1.19%,CEP55;KIF20A
prerank,positive regulation by host of viral transcription (GO:0043923),0.7183245004721615,1.4486334476592608,0.0858257477243173,0.5890580952454431,1.0,8/15,21.59%,LEF1;NUCKS1;SMARCA4;JUN;CCNT1;TFAP4;CHD1;TAF11
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.4083772924174792,-1.4483448165978596,0.03669724770642202,0.633173843929431,1.0,11/34,16.39%,ANK2;SLC9A1;ZC3H12A;SRI;RYR2;ADRA1A;ATP1B1;SMAD7;ASB3;CALM1;SLC8A1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.7042592351290097,1.4481699645244583,0.08739076154806492,0.5890431107117304,1.0,7/18,12.32%,GINS1;POLA1;POLE;PCNA;LIG1;POLD2;POLD3
prerank,lipid phosphorylation (GO:0046834),-0.5863980723537952,-1.4471721003466913,0.05501618122977346,0.6312787452529094,1.0,6/10,13.69%,DGKH;DGKA;DGKI;DGKZ;DGKQ;DGKB
prerank,nerve growth factor signaling pathway (GO:0038180),0.7677867739085327,1.4471211940137845,0.10300429184549356,0.5913532615603263,1.0,2/10,6.07%,NTF4;KIDINS220
prerank,indolalkylamine catabolic process (GO:0046218),0.7676404395726665,1.4458221224975532,0.08534850640113797,0.5946962800514192,1.0,2/10,3.74%,HAAO;KMO
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.5932941360282993,-1.445355482281028,0.07142857142857142,0.6315112356741347,1.0,4/10,14.64%,IQSEC1;EPB41L4B;ADAM9;MAP4K4
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.6318688956262581,1.4447956958533066,0.059684684684684686,0.5967837302919063,1.0,8/37,9.24%,SKA3;SKA1;SKA2;STMN1;CLASP1;MAPRE3;MARK2;EPHA3
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.6095122409438906,1.4443508481757854,0.019487179487179488,0.5966869771622572,1.0,50/96,20.99%,NUP43;POM121;NDC1;SMG6;DHX38;SMG5;NUP107;SLBP;NUP42;NUP50;UPF2;CPSF2;U2AF1;EIF4A3;NUP214;SRSF3;HNRNPA2B1;NUP160;SRSF4;NCBP1;NUP205;CASC3;RNPS1;U2AF1L4;SEC13;NUP188;THOC3;NUP98;RANBP2;UPF3B;NUP210;THOC5;THOC2;AAAS;SRSF7;THOC7;CDC40;NUP37;DDX39B;POLDIP3;CPSF1;ALKBH5;NCBP2;NUP85;SRSF2;TPR;FYTTD1;SMG7;WDR33;GLE1
prerank,synaptonemal complex assembly (GO:0007130),0.7123179123872606,1.4440599868872317,0.07712418300653595,0.5941130198722524,1.0,3/15,6.09%,RAD21;TRIP13;TEX11
prerank,synaptonemal complex organization (GO:0070193),0.7123179123872606,1.4440599868872317,0.07712418300653595,0.5941130198722524,1.0,3/15,6.09%,RAD21;TRIP13;TEX11
prerank,positive regulation of myelination (GO:0031643),-0.579573358030572,-1.4439387590248218,0.07119741100323625,0.6305598477300196,1.0,6/11,30.45%,TNFRSF1B;CST7;PARD3;TENM4;EGR2;NCMAP
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.6752776741188894,1.4427516284989412,0.08333333333333333,0.597565041757257,1.0,7/22,13.15%,PLA2R1;PMAIP1;RPS20;RPS7;ATM;CDK5RAP3;SPRED2
prerank,DNA packaging (GO:0006323),0.6953587408174452,1.4420395324432023,0.08914728682170543,0.5986422061652239,1.0,7/16,14.97%,CHAF1A;RBBP4;KAT6A;CHAF1B;CDAN1;HAT1;TP53
prerank,oligodendrocyte development (GO:0014003),-0.5192057663620765,-1.441546758678981,0.0784313725490196,0.6327609358646971,1.0,7/15,23.57%,PLP1;EIF2B3;B4GALT5;EIF2B4;EIF2B2;SOX10;CNTNAP1
prerank,regulation of cell projection organization (GO:0031344),-0.5501386624494448,-1.4411493617092792,0.09541984732824428,0.6283575535696838,1.0,4/13,6.20%,TREM2;MACF1;MYO9A;NTNG1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.6601577026218168,1.4406823528729797,0.07727797001153403,0.6022305797075483,1.0,7/32,7.21%,AURKB;NEK2;MAPK1;CCT7;ATM;CCT2;TCP1
prerank,photoreceptor cell development (GO:0042461),-0.5438166926978316,-1.440465325450598,0.08597285067873303,0.6245671071488891,1.0,4/14,14.06%,AHI1;MYO7A;DCX;VEGFA
prerank,regulation of cellular senescence (GO:2000772),0.666246939988266,1.4402538833914091,0.07372175980975029,0.6021805274397616,1.0,11/28,13.30%,HMGA1;FBXO5;TWIST1;RBL1;CGAS;CDK6;CDKN2A;TERF2;AKT3;B2M;ING2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.6291110023736242,1.4402080356770806,0.06073752711496746,0.6004869162551844,1.0,25/48,20.83%,NUP43;POM121;NDC1;NOA1;NUP107;NUP42;NUP50;NUP214;NUP160;ZBTB7A;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;PRKAG2;RUBCNL;AAAS;NUP37;NUP85;PNPT1;TPR;EIF6;PRKAG1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.741669136034897,1.4400263623991074,0.09857142857142857,0.5993379612988626,1.0,6/11,16.05%,FOXM1;SP100;HIPK2;RPS6KA6;TP53;TFAP4
prerank,endocrine system development (GO:0035270),-0.46594280555097356,-1.4393008904620723,0.07608695652173914,0.622744441117781,1.0,10/21,35.68%,TGFBR1;SALL1;NF1;MDK;TG;HOXD3;WNT4;PAX8;GLI2;DKK3
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.5689259069737622,-1.4392602428324697,0.10139860139860139,0.617247884887023,1.0,9/12,23.42%,PPT1;GRN;CLN5;TMEM165;ATP6AP2;TMEM199;CLN6;TMEM9;CCDC115
prerank,acylglycerol homeostasis (GO:0055090),-0.48109185743229815,-1.4388543278151091,0.07142857142857142,0.6129524555812075,1.0,7/20,29.86%,APOE;LPL;SCARB1;IL18;MTLN;MLXIPL;ANGPTL3
prerank,regulation of dendritic spine development (GO:0060998),-0.4879747882425113,-1.437643463204763,0.0684931506849315,0.6118082112536508,1.0,6/19,4.63%,TANC2;CAMK1;APOE;PPFIA2;GRIN3A;PTPRS
prerank,RNA export from nucleus (GO:0006405),0.6049071820498222,1.43635089549694,0.016359918200409,0.612798985306496,1.0,51/100,20.99%,NUP43;POM121;NDC1;SMG6;DHX38;SMG5;NUP107;SLBP;NUP42;NUP50;UPF2;CPSF2;U2AF1;EIF4A3;NUP214;SRSF3;HNRNPA2B1;NUP160;SRSF4;NCBP1;NUP205;CASC3;RNPS1;U2AF1L4;SEC13;NUP188;THOC3;NUP98;RANBP2;UPF3B;NUP210;THOC5;THOC2;AAAS;SRSF7;THOC7;CDC40;NUP37;DDX39B;POLDIP3;CPSF1;ALKBH5;HNRNPA1;NCBP2;NUP85;SRSF2;TPR;FYTTD1;SMG7;WDR33;GLE1
prerank,B cell mediated immunity (GO:0019724),0.7481134699072355,1.4362276882270018,0.08732394366197183,0.6113828848608482,1.0,3/10,10.74%,CD19;CD74;CARD9
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.7562661811886917,1.4361473949945545,0.08985507246376812,0.6098231095992218,1.0,6/10,16.05%,FOXM1;SP100;HIPK2;RPS6KA6;TP53;TFAP4
prerank,vacuolar acidification (GO:0007035),-0.47219047000360703,-1.4349503282671245,0.06217616580310881,0.6152417634373684,1.0,13/21,23.42%,ATP6V0D2;PPT1;GRN;ATP6V0A1;DMXL2;CLN5;TCIRG1;ATP6V1H;ATP6AP2;TMEM199;CLN6;TMEM9;CCDC115
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.520026499312517,-1.4347547717270244,0.08203125,0.6105205535552085,1.0,7/16,16.22%,RASGRF1;SH3BP1;STMN3;ARHGAP44;ALS2;PIK3CB;ARHGAP24
prerank,endochondral bone morphogenesis (GO:0060350),-0.5608767917993516,-1.4345484141625024,0.10247349823321555,0.6058814516709993,1.0,10/11,38.56%,BMPR2;BMPR1B;INPPL1;TRPV4;FGFR3;MEF2C;FOXC1;COL13A1;SCX;BMP4
prerank,tRNA transport (GO:0051031),0.645710578273672,1.4332605665898088,0.07494407158836688,0.6196587540017444,1.0,18/35,20.21%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;AAAS;NUP37;NUP85;TPR
prerank,regulation of B cell activation (GO:0050864),0.6588196481555806,1.433042430747706,0.08799048751486326,0.6186257024623663,1.0,5/25,7.52%,CD19;IKZF3;BANK1;ZFP36L1;AHR
prerank,protein-DNA complex assembly (GO:0065004),0.5984579259547216,1.4329658785769541,0.012048192771084338,0.6170224218371585,1.0,40/116,17.70%,RAD51;HMGB2;CHAF1A;ANP32B;RPA2;SMARCA5;CHD1L;PSMB7;RSF1;PSMD11;MCM6;ORC5;PSMF1;ORC3;NAP1L4;GMNN;PSMC1;H3-3A;ASF1A;SART3;RPA1;ERCC3;SPTY2D1;PSMC3;PSMA4;CHAF1B;PSMC4;PSMD13;PSME1;NAP1L1;PSMB1;RPA3;PSMD8;TCF4;ATRX;MCM3;PSME4;PSMD4;UBA52;DDB2
prerank,protein polymerization (GO:0051258),0.6115178982967958,1.4328049811852466,0.050686378035902854,0.6158202825586666,1.0,8/56,8.54%,DIAPH3;UBE2C;CKAP5;GSN;CENPJ;PIN1;UBE2K;JAK2
prerank,positive regulation of lipid storage (GO:0010884),-0.45929655008832315,-1.4324059287651407,0.0625,0.6073503999665619,1.0,5/21,10.91%,LPL;ZC3H12A;IKBKE;VSTM2A;SCARB1
prerank,tryptophan catabolic process (GO:0006569),0.7382785726916573,1.4323468735452078,0.10818307905686546,0.6159024763296556,1.0,2/11,3.74%,HAAO;KMO
prerank,isotype switching (GO:0045190),0.7636748537631113,1.4322905976135614,0.08391608391608392,0.614248500994543,1.0,6/10,11.39%,BATF;LIG4;MSH6;CCR6;RNF168;RNF8
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5009933084268023,-1.4320992199238864,0.06046511627906977,0.6033211180694795,1.0,10/17,44.41%,CRLS1;LPCAT1;SERAC1;PLA2G12A;PLA2G4A;PLA2G3;LPCAT4;PLA2G5;PLA2G4F;PLA2G2D
prerank,error-free translesion synthesis (GO:0070987),0.6765295344722213,1.4320463600404616,0.0851581508515815,0.6133232476774587,1.0,10/22,14.58%,RPA2;RFC5;POLD1;POLH;PCNA;NPLOC4;RPA1;RFC2;RFC1;RPA3
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3967147274449233,-1.4318847008294688,0.06766917293233082,0.5989761618033986,1.0,16/32,30.06%,APP;TREM2;ARNT;PRKAA2;IGF1;ENO1;PINK1;PFKFB4;PFKFB2;PPARGC1A;HIF1A;BEND3;INSR;PFKFB1;MLXIPL;GAPDHS
prerank,zinc ion transmembrane transport (GO:0071577),-0.46094447690002827,-1.4318697006623649,0.02631578947368421,0.5939808227456692,1.0,10/22,22.61%,SLC39A11;SLC30A4;SLC39A7;SLC39A14;SLC39A8;SLC39A6;SLC39A12;SLC39A3;SLC39A1;SLC30A1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5021713056395234,-1.4316324695882205,0.09502262443438914,0.5897357758346815,1.0,3/17,9.11%,ANK2;SNTA1;SCN1B
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6699750227448732,1.4312258756690828,0.07847800237812129,0.6146479963377063,1.0,4/23,5.54%,IL12A;KLRD1;RASGRP1;RAET1E
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.6611181212961731,1.4311455253452436,0.0779976717112922,0.6130989067317469,1.0,7/29,15.36%,FANCD2;RAD21;TRIP13;TEX11;SIRT7;P3H4;MEI4
prerank,cGMP metabolic process (GO:0046068),0.7313307476033837,1.4305778851684874,0.10013531799729364,0.613599262203922,1.0,3/12,6.74%,NPPC;GUCY1A1;PDE2A
prerank,covalent chromatin modification (GO:0016569),0.7193380645742332,1.4304329682949617,0.08859060402684564,0.6123867953620435,1.0,11/14,23.35%,AURKB;HELLS;MBD2;PARK7;SIRT7;SIRT1;HDAC1;CHD1;HLCS;SETD5;UFL1
prerank,negative regulation of developmental growth (GO:0048640),-0.4119142148350403,-1.4299454806163865,0.08333333333333333,0.5899294483678393,1.0,14/30,27.07%,RTN4;DIP2B;WWC2;PTPRS;MAG;ULK1;DUSP10;CDKL3;ULK2;WWC1;MT3;DCC;NKD1;FGFR3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5050370677426517,-1.4297432827674201,0.07657657657657657,0.5857500625573944,1.0,9/15,25.13%,BMP2K;SNAP91;WASL;TNK2;PIK3CB;SMAP1;HIP1R;AAK1;SCYL2
prerank,positive regulation of intracellular transport (GO:0032388),0.6385898752031194,1.429649460501361,0.07497243660418963,0.6138188412111707,1.0,14/38,15.07%,KIF20B;SPAG5;PCNT;STK11;MLC1;DYNC1H1;PCM1;ACTN2;EIPR1;OAZ1;NUMA1;PGAP1;PDCD10;RIPOR1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.7308299502238453,1.4292078901242415,0.09261744966442953,0.6136998715758331,1.0,7/12,16.83%,BRCA1;RBM15;SMCHD1;PCGF5;HNRNPU;PCGF3;LRIF1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.6031326121875312,1.427863751071577,0.059487179487179485,0.6173907228428687,1.0,20/66,16.25%,CDK1;ECT2;GTSE1;PLK1;CARD10;FLNA;TFRC;CCT7;CCT2;TCP1;EFCAB7;PARK7;ORMDL3;CCT5;CDK5RAP3;PSEN1;BAG3;IPO5;LIMK2;TRIM28
prerank,immunoglobulin mediated immune response (GO:0016064),0.7337239500486523,1.427809551212989,0.09433962264150944,0.6158238245945031,1.0,3/10,10.74%,CD19;CD74;CARD9
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5153524286385508,-1.4239559590173048,0.09322033898305085,0.5976131299785815,1.0,7/16,17.51%,KLK2;KLK3;BMPR2;GSK3A;DDAH1;GPR37L1;SLC2A5
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6658922904817883,1.4232468535845184,0.08051341890315053,0.6325635959678549,1.0,7/24,7.30%,ERCC4;BLM;MSH6;DACH1;TERF2;ZRANB3;RTEL1
prerank,spermatid development (GO:0007286),0.6381897694680395,1.4229158093863061,0.08314606741573034,0.6320410210783411,1.0,8/32,15.34%,CCDC63;CIB1;JAM2;RFX2;RNF8;ING2;BBS4;CEP57
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5030896751766931,-1.4225584939063278,0.0825242718446602,0.5974097404379834,1.0,9/16,25.01%,UPP2;NT5M;DPYD;CRMP1;TET2;NT5C;DPYSL2;DPYSL3;NT5E
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.6530367995273011,1.422431728672779,0.08710801393728224,0.6322224516503885,1.0,14/29,18.99%,PIF1;NOP10;TERF2;ANKRD28;RTEL1;TERF1;RPA1;RFC1;PPP6R3;PPIA;RAD50;PPP6C;DKC1;WRAP53
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5903383735145215,1.4217988608802372,0.028368794326241134,0.6328373623655154,1.0,62/110,23.66%,RPL7;RPL18A;SMG6;RPS20;SMG5;RPL36;RPL14;RPS19;RPS7;EIF3E;RPS4X;RPS18;UPF2;SMG8;RPL23A;EIF4A3;RPL28;RPS14;RPL41;RPLP2;NCBP1;CASC3;RNPS1;RPS27;RPS5;RPS29;RPLP0;RPS11;RPL27A;DCP1A;UPF3B;SMG9;RPS9;RPS15A;HELZ2;RPL12;PYM1;RPL3;GSPT1;UBA52;RPL18;RPL5;RPS6;RPS17;NCBP2;RPS3;RPL21;PPP2CA;RPL23;RPL17;SMG7;RPL24;RPL8;RPL27;DHX34;RPL13A;RPS12;RPS8;RPL15;RPL10;RPS21;SMG1
prerank,muscle cell development (GO:0055001),-0.4245104662921614,-1.4209404296739896,0.06837606837606838,0.5981882609396918,1.0,13/30,16.67%,KDM1A;NEBL;ANK2;IGF1;SGCZ;BIN1;MYOF;DMD;ENG;NRAP;VEGFA;SLC8A1;CXADR
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.697370875670603,1.4207208875330337,0.09923664122137404,0.6354950213510725,1.0,1/17,0.10%,DLGAP5
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.6267543317445561,1.4204599617391542,0.07802197802197802,0.634806054846546,1.0,23/41,21.99%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;ZBTB7A;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;PRKAG2;AAAS;NUP37;NUP85;TPR;EIF6;PRKAG1;NUP93
prerank,regulation of plasminogen activation (GO:0010755),-0.5484219232713352,-1.4194016911923526,0.11610486891385768,0.598403055081729,1.0,5/12,18.05%,PLGRKT;SERPINE2;ENO1;SERPINE1;THBS1
prerank,cell proliferation in forebrain (GO:0021846),0.7496495806032516,1.4182628267652055,0.12482269503546099,0.6418257607323641,1.0,1/10,0.17%,KIF14
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.583036740072902,-1.4181748443867308,0.0958904109589041,0.5969971682268597,1.0,5/10,17.58%,APP;SYNGR1;CAMK2B;SHANK3;DLG4
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6911575698868623,1.417767731089839,0.1111111111111111,0.6420256317285137,1.0,9/15,17.67%,GTSE1;ANP32B;EMD;BAG3;GSK3B;TP53;TCF7L2;XPO4;YWHAE
prerank,signal transduction by p53 class mediator (GO:0072331),0.6347581784154005,1.4174509255006158,0.09122006841505131,0.6415664119504477,1.0,6/30,7.58%,E2F7;PMAIP1;BATF;STK11;MDM4;BOK
prerank,positive regulation of nervous system process (GO:0031646),-0.47874468149669025,-1.417223929307883,0.053811659192825115,0.595318273488629,1.0,8/18,30.45%,RIMS1;RIMS2;TNFRSF1B;CST7;PARD3;TENM4;EGR2;NCMAP
prerank,muscle tissue morphogenesis (GO:0060415),0.6919468882109111,1.4170973443029338,0.10051546391752578,0.6412307381688257,1.0,4/16,12.53%,HEY2;ZFPM1;NOTCH1;EFEMP2
prerank,regulation of DNA binding (GO:0051101),0.6231144531519669,1.4167958189035532,0.06724511930585683,0.6406712151616436,1.0,17/44,16.05%,HMGB2;HJURP;LEF1;E2F1;RSF1;SP100;EDF1;HMGB1;JAK2;ZBTB7A;TXN;SUMO1;JUN;SKI;CEBPG;EGF;TFAP4
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4392723851139302,-1.416070309426564,0.08333333333333333,0.594203954485217,1.0,12/21,31.41%,CACNA1C;ANK2;SRI;DMD;RYR2;CALM1;SLC8A1;ATP1A2;GSTO1;FKBP1B;CAMK2D;CALM2
prerank,positive regulation of double-strand break repair (GO:2000781),0.6226602400441531,1.4155644676029637,0.08030803080308031,0.644074945998948,1.0,7/39,7.23%,RAD51AP1;FOXM1;SMCHD1;DDX11;TIMELESS;ARID2;MRNIP
prerank,telomere maintenance via telomerase (GO:0007004),0.648215392089543,1.4151626298772935,0.09048723897911833,0.6439697051960052,1.0,13/28,18.99%,PIF1;NOP10;TERF2;ANKRD28;RTEL1;TERF1;RPA1;RFC1;PPP6R3;RAD50;PPP6C;DKC1;WRAP53
prerank,mRNA transport (GO:0051028),0.594393140804629,1.4145944648804534,0.026557711950970377,0.6444094182158849,1.0,51/101,20.99%,NUP43;POM121;NDC1;SMG6;DHX38;SMG5;NUP107;SLBP;NUP42;NUP50;UPF2;CPSF2;U2AF1;ZFP36L1;EIF4A3;NUP214;SRSF3;HNRNPA2B1;NUP160;SRSF4;NCBP1;NUP205;CASC3;RNPS1;U2AF1L4;SEC13;NUP188;THOC3;NUP98;RANBP2;UPF3B;NUP210;THOC5;THOC2;AAAS;SRSF7;THOC7;CDC40;NUP37;DDX39B;POLDIP3;CPSF1;ALKBH5;NCBP2;NUP85;SRSF2;TPR;FYTTD1;SMG7;WDR33;GLE1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.5607405191842928,-1.4140675692094415,0.15444015444015444,0.5963596709059785,1.0,5/12,17.37%,HAGH;CNDP2;GSS;CHAC2;OPLAH
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.6711716752540821,1.413803200783291,0.09273182957393483,0.6456532830248873,1.0,3/21,7.77%,TPX2;CLASP1;CIB1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.4907576890611474,-1.41351790335126,0.09950248756218906,0.5930754737557946,1.0,9/17,21.86%,CACNB2;CACNA1C;ANK2;SCN1B;HCN2;SLC8A1;CACNA1G;ATP1A2;SCN3B
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.635233669901707,1.4134332832718466,0.10126582278481013,0.6453573166859804,1.0,17/32,24.20%,CDCA2;ITGA1;PTPA;ANKLE2;PPP2R5A;PIN1;PPP1R15A;CNEP1R1;PPIA;CAMTA1;SPPL3;CALM3;PPP1R15B;PPP1R16B;PRKCD;SMPD1;PTBP1
prerank,cellular response to nitrogen compound (GO:1901699),0.670092855523203,1.4132906561979284,0.10146699266503667,0.6440591095981929,1.0,10/20,22.47%,BLM;DDX11;TIMELESS;PDE12;RIOK3;ROCK2;ATRX;EPG5;ATP2B4;SPIDR
prerank,macromolecule catabolic process (GO:0009057),-0.4230494317537158,-1.4124413076377815,0.05,0.5916487861622002,1.0,12/26,21.45%,CAPN3;PPT1;SH3GLB1;CLN5;IDE;LGMN;CLN8;SIAH1;UVRAG;PIK3R4;CLN6;TRIM24
prerank,response to X-ray (GO:0010165),0.7112981105615191,1.411360432552996,0.09716599190283401,0.6502486963963534,1.0,6/14,13.53%,BLM;LIG4;NUCKS1;ATM;XRCC6;NIPBL
prerank,axonemal dynein complex assembly (GO:0070286),0.6425580942094322,1.4113215503715109,0.08726415094339622,0.648628050000841,1.0,2/28,0.95%,CCDC63;DNAH8
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.6911387198309092,1.4109401236243555,0.10566037735849057,0.6484246611638615,1.0,4/17,7.04%,DHDDS;ALG8;ALG14;NUS1
prerank,actin filament-based transport (GO:0099515),0.6611778759736252,1.4106003528630358,0.10315533980582524,0.6480652512872831,1.0,4/21,3.39%,MYO5C;MYO15A;SYNE2;SUN2
prerank,regulation of neuroblast proliferation (GO:1902692),-0.5245258770580095,-1.4105919634980582,0.1078838174273859,0.592889366167828,1.0,7/15,14.06%,TAFA1;KDM1A;CTNNB1;CX3CR1;NF1;FZD3;VEGFA
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6992866079524688,1.4096807031497944,0.08586525759577279,0.6501654965075251,1.0,3/15,5.39%,IL12A;CCR2;NKAP
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.45382477983507286,-1.40966170923102,0.07534246575342465,0.5912599476529736,1.0,9/27,13.79%,SIRPA;PTPN6;ARRB1;TNFAIP3;ZC3H12A;TLR4;SELENOS;CD200;NCKAP1L
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.718111557403337,1.4091889726721023,0.10822510822510822,0.6504358412387108,1.0,6/11,17.48%,CYP1B1;MAP3K5;PRODH;STK24;PDCD10;ARL6IP5
prerank,positive regulation of dephosphorylation (GO:0035306),0.6474527846130005,1.408398990216128,0.10756501182033097,0.6520183159459367,1.0,15/27,24.20%,CDCA2;PTPA;ANKLE2;PPP2R5A;PIN1;CNEP1R1;PPIA;CAMTA1;SPPL3;CALM3;PPP1R16B;PRKCD;SRC;SMPD1;PTBP1
prerank,nuclear migration (GO:0007097),0.7233064815708311,1.4077831766282844,0.1346938775510204,0.6527705838250749,1.0,7/13,10.90%,SYNE2;SUN2;FBXW11;DYNC1H1;PCM1;PAFAH1B1;SYNE3
prerank,ncRNA export from nucleus (GO:0097064),0.6294479898091747,1.407758184051508,0.08389261744966443,0.6510731693170059,1.0,19/36,20.21%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;AAAS;NUP37;NCBP2;NUP85;TPR
prerank,C-terminal protein amino acid modification (GO:0018410),0.7142763594991853,1.4063192836438192,0.11157601115760112,0.6552491800770727,1.0,3/11,6.05%,AGBL1;LCMT1;AGTPBP1
prerank,diol metabolic process (GO:0034311),-0.47754846944351115,-1.4050828068638055,0.1050228310502283,0.6009201739337273,1.0,8/19,23.91%,HSP90AA1;PTS;SGPP1;CALM1;PRKG2;SPHK2;PLPP3;DEGS2
prerank,peptidyl-lysine modification (GO:0018205),0.5914450041415813,1.4050399475148732,0.029561671763506627,0.6586170202419487,1.0,44/99,19.21%,NUP43;POM121;NDC1;SENP1;SAE1;PLOD3;NUP107;HDAC10;UBE2I;RANGAP1;NUP42;UBA2;NUP50;BCL11A;HDAC6;NUP214;NUP160;NUP205;PIAS3;NUP188;ATP7A;NSMCE2;PARK7;SUMO1;KAT2B;NUP98;RANBP2;NUP210;SIRT7;VPS33B;SUMO2;P3H4;EYA1;PIAS1;NDUFAB1;TRIM28;AAAS;SIRT1;NUP37;TRPM4;HDAC4;SENP6;GCSH;NUP85
prerank,meiosis I (GO:0007127),0.6586882700503875,1.4050360352804725,0.09101654846335698,0.6568443519230088,1.0,5/23,13.30%,MYBL1;SGO1;FOXJ3;PTTG1;ING2
prerank,negative regulation of B cell proliferation (GO:0030889),0.7257764790130344,1.4045221503809748,0.11544011544011544,0.6571840130100591,1.0,6/11,17.59%,BLK;ATM;TNFRSF13B;TYROBP;RC3H1;FCGR2B
prerank,positive regulation of DNA binding (GO:0043388),0.6283509751132405,1.404474075535812,0.09885057471264368,0.6556189374477759,1.0,10/31,15.38%,HMGB2;RB1;TWIST1;EDF1;HMGB1;TXN;PARK7;SKI;CEBPG;EGF
prerank,neural tube development (GO:0021915),0.6968869317106774,1.4044165529726327,0.11198945981554677,0.654059855619401,1.0,1/15,0.26%,STIL
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6388890083138388,1.404322094885161,0.09617612977983778,0.6526563973095378,1.0,7/31,11.98%,UBE2C;CDC20;PLK1;AXIN1;PIN1;FZR1;PTEN
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.6997605959033096,1.40427542713498,0.1121251629726206,0.6510894969856784,1.0,3/14,3.29%,CD177;PHACTR4;FLNA
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5657686411268035,-1.4042452624429775,0.11552346570397112,0.599344506887648,1.0,2/10,2.55%,WHRN;IFT88
prerank,defense response to Gram-negative bacterium (GO:0050829),0.6184968114743002,1.4041242870659703,0.08568329718004339,0.6500232170173537,1.0,5/42,4.77%,HMGB2;RNASE6;AQP1;CAMP;RPS19
prerank,microtubule-based transport (GO:0099111),0.7068360859861328,1.404104442091757,0.10460251046025104,0.6483662788426232,1.0,2/13,7.02%,SPA17;SPEF2
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6644735587554256,1.4028483250193082,0.1175,0.6516265942850821,1.0,10/21,19.38%,CDK1;MAPK1;ZFP36L1;ITGAV;MYC;EGF;MAP2K1;ZFP36L2;PTGER4;LGALS9
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.5930722955780074,1.402680079424592,0.05626326963906582,0.6505554448248325,1.0,21/60,16.37%,CDK1;CCNB1;HEY2;LEF1;PPM1D;CDKN2A;MED30;TNRC6C;TNRC6B;MED31;MECP2;MED8;PTEN;CBFB;PAXIP1;MED14;ATF7IP;TP53;TCF7L2;TRIM28;CDK8
prerank,positive regulation of DNA replication (GO:0045740),0.6900556415170107,1.4022012621106952,0.11492734478203434,0.6508608665433434,1.0,9/16,15.38%,PCNA;ATAD5;FAF1;DNA2;EGFR;DHX9;BRPF3;CTC1;EGF
prerank,positive regulation of immune effector process (GO:0002699),0.6360206638034804,1.401685486323322,0.10470588235294118,0.6513021227854835,1.0,4/27,5.31%,MYB;DHX58;RPS19;CCR2
prerank,intracellular sterol transport (GO:0032366),-0.5414112482865283,-1.4003851807032501,0.1016260162601626,0.6069196134164949,1.0,6/13,15.79%,OSBPL2;ABCA1;OSBP;NPC2;NPC1;SERAC1
prerank,regulation of establishment of cell polarity (GO:2000114),0.6899377265164045,1.399208873029807,0.09759358288770054,0.6601573797715745,1.0,6/16,13.09%,KIF20B;RIPOR2;GSN;CYRIB;ROCK2;RACK1
prerank,triglyceride catabolic process (GO:0019433),-0.47576006398158266,-1.3990201950989272,0.10152284263959391,0.6065162033815031,1.0,7/19,41.14%,LPL;LIPH;FABP4;FABP7;PNPLA3;LIPC;FABP3
prerank,mRNA export from nucleus (GO:0006406),0.5890340716628741,1.3982482974891368,0.027663934426229508,0.6623069496464535,1.0,51/102,20.99%,NUP43;POM121;NDC1;SMG6;DHX38;SMG5;NUP107;SLBP;NUP42;NUP50;UPF2;CPSF2;U2AF1;EIF4A3;NUP214;SRSF3;IWS1;HNRNPA2B1;NUP160;SRSF4;NCBP1;NUP205;CASC3;RNPS1;U2AF1L4;SEC13;NUP188;THOC3;NUP98;RANBP2;UPF3B;NUP210;THOC5;THOC2;AAAS;SRSF7;THOC7;CDC40;NUP37;DDX39B;POLDIP3;CPSF1;ALKBH5;NCBP2;NUP85;SRSF2;TPR;FYTTD1;SMG7;WDR33;GLE1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.6045218412632877,1.3979037001182608,0.07650273224043716,0.6619507475654027,1.0,18/49,15.85%,HMGB2;RBM15;ZFPM1;DPY30;TNRC6C;TNRC6B;H3-3A;KMT2C;CIB1;NFE2;KAT2B;CNOT4;CBFB;KMT2A;RBBP5;KMT2B;RUNX1;SIN3A
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.530946443895413,-1.3971908389697973,0.1003584229390681,0.6074332944164759,1.0,8/12,18.04%,ACLY;ACO2;GLUD1;ACO1;IDH1;IDH3B;IDH3G;IDH3A
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.4821700967068415,-1.3969187273860295,0.11711711711711711,0.6038927714351348,1.0,3/16,1.47%,TREM2;LRP1;APOE
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5745047426065575,-1.394665505346137,0.12121212121212122,0.6066684879077943,1.0,2/10,6.56%,CTNNB1;RYK
prerank,tryptophan metabolic process (GO:0006568),0.7274538525630951,1.3944218396946895,0.11049723756906077,0.6744118557414313,1.0,3/11,10.65%,HAAO;KMO;ATP7A
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.4516045762863557,-1.394154381862971,0.10828025477707007,0.60375754593544,1.0,8/22,15.01%,RAP2A;PDGFD;RAP2C;PDGFC;TOM1L1;VEGFA;MRE11;CALM1
prerank,defense response to bacterium (GO:0042742),0.5819525444712106,1.3940477193683902,0.034308779011099896,0.6741055858417528,1.0,14/105,6.84%,IL12A;HMGB2;RNASE6;PGLYRP1;AQP1;SPN;GBP4;CAMP;PPP1R11;S100A9;RPS19;SLPI;S100A8;GBP2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.6148908074327135,1.392773383145583,0.09050772626931568,0.6778134137920003,1.0,23/41,21.99%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;ZBTB7A;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;PRKAG2;AAAS;NUP37;NUP85;TPR;EIF6;PRKAG1;NUP93
prerank,epithelial structure maintenance (GO:0010669),-0.5583336617558033,-1.391984835791135,0.145985401459854,0.6060623719800939,1.0,4/11,25.90%,STRAP;CXADR;NOD2;RBP4
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.6426019078538445,1.3910319395793418,0.10743801652892562,0.6833309659878536,1.0,9/27,13.15%,PLA2R1;PMAIP1;TWIST1;CD74;CD44;ATM;DYRK1A;YJU2;SPRED2
prerank,nitrogen compound transport (GO:0071705),0.5807278714277411,1.3907461707173394,0.01507537688442211,0.6827232563048431,1.0,33/141,19.08%,CENPF;RHAG;SLC6A12;SLC38A5;AQP1;SLC1A5;NDC1;RAMP1;SLC7A1;SLC6A2;RCN3;PICK1;ABCC2;SLC25A47;SLC16A10;SLC43A2;SLC3A1;CALCRL;SLC52A1;SLC44A1;CHMP1B;VPS33B;ATP11B;SCAMP1;CHMP3;CHMP2B;TMEM30A;HSP90B1;ARL6IP5;SLC22A4;RUFY1;SLC7A14;SEC14L1
prerank,regulation of chemokine production (GO:0032642),-0.38164811581703667,-1.3902811239293544,0.038834951456310676,0.6068668672215733,1.0,8/36,7.24%,APP;TREM2;CSF1R;LPL;AIF1;PYCARD;TLR7;TLR4
prerank,positive regulation of histone methylation (GO:0031062),0.6519229711176344,1.3901472113875937,0.09483793517406963,0.6836071286693822,1.0,11/24,16.94%,MYB;BRCA1;PHF19;PHF1;DNMT1;SMAD4;PAXIP1;KMT2A;JARID2;RIF1;SIRT1
prerank,cellular senescence (GO:0090398),0.6298617822510115,1.3899707645057566,0.10607866507747318,0.6825492773530444,1.0,12/27,19.47%,HMGA1;SMC6;PML;CDKN2A;TERF2;MAPK14;KAT6A;NSMCE2;MAP2K1;SIRT1;CDKN1A;SMC5
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.45166921173998464,-1.388978663108584,0.10989010989010989,0.6063583079500675,1.0,13/20,31.41%,CACNA1C;ANK2;SLC9A1;DMD;RYR2;ATP1B1;CALM1;SLC8A1;ATP1A2;GSTO1;FKBP1B;CAMK2D;CALM2
prerank,regulation of B cell proliferation (GO:0030888),0.6017235625319057,1.388708445744896,0.09565217391304348,0.6860798534095276,1.0,8/44,7.52%,BLK;IKZF3;TNFSF13B;CD38;CD74;TFRC;ATM;AHR
prerank,histone mRNA metabolic process (GO:0008334),0.6348586764549086,1.3884019294786771,0.12266355140186916,0.6855861897898883,1.0,15/27,20.17%,SLBP;SNRPF;ATM;CPSF2;EXOSC10;DCP2;NCBP1;TUT4;ERI1;TUT1;SNRPG;TENT2;NCBP2;XRN1;SNRPB
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.6505284336353456,1.388365018853414,0.12014563106796117,0.6840341651270448,1.0,11/22,19.05%,MEN1;PLK1;CDKN2A;NR2F2;IPO7;PTEN;LATS1;IPO5;TFAP4;HEXIM1;CDKN1A
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.545646954142166,-1.3883175142710793,0.1,0.6037981947581126,1.0,5/11,33.43%,CACNB2;BIN1;CACNB1;CAMK2D;NOS1
prerank,neuron projection extension (GO:1990138),-0.40014805213843585,-1.3873405779987096,0.05,0.6025777052593969,1.0,14/32,22.78%,IMPACT;NRP2;HSP90AA1;SPG11;CTNNB1;USP9X;ULK1;CDK5;SH3GL2;SEMA3A;CDKL3;ULK2;FLRT3;CYFIP1
prerank,tube closure (GO:0060606),0.6159348628822334,1.387181420727077,0.0990990990990991,0.6872346909996825,1.0,5/31,7.70%,STIL;PHACTR4;DEAF1;LMO4;FUZ
prerank,positive regulation of telomerase activity (GO:0051973),0.6244115741344698,1.3848782124835077,0.12114285714285715,0.6949282613357828,1.0,5/33,7.21%,AURKB;NEK2;MAPK1;CCT2;TCP1
prerank,glutathione biosynthetic process (GO:0006750),-0.5607514078984419,-1.3848168346822955,0.15162454873646208,0.6061494316568877,1.0,5/11,17.37%,HAGH;CNDP2;GSS;CHAC2;OPLAH
prerank,primary neural tube formation (GO:0014020),0.6184604703719448,1.3845005642204316,0.10592255125284739,0.6946764694514045,1.0,5/30,7.70%,STIL;PHACTR4;DEAF1;LMO4;FUZ
prerank,renal system development (GO:0072001),0.6030099406851005,1.3841307826114364,0.07995735607675906,0.6944463599921255,1.0,3/52,3.96%,CENPF;LRP4;SULF2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.6084444362739185,1.3837254723689356,0.11662817551963048,0.6943599454873384,1.0,8/33,11.64%,FAM83D;EZH2;TFDP1;DDRGK1;PLCG2;EGFR;RDX;PLCB1
prerank,cGMP biosynthetic process (GO:0006182),0.7315746520854887,1.3836250277533486,0.12184873949579832,0.6930755781711945,1.0,2/10,6.31%,NPPC;GUCY1A1
prerank,response to gamma radiation (GO:0010332),0.6431525410610297,1.382951728053675,0.12261904761904761,0.69424469282725,1.0,9/24,16.40%,FANCD2;MEN1;LIG4;ATM;XRCC6;MYC;TP53;MAP3K20;TMEM109
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5796085541216569,1.3827310900851317,0.054878048780487805,0.6933959266842269,1.0,30/87,19.05%,E2F7;CDKN2C;JADE1;WEE1;RB1;AURKA;FBXO5;PSMB7;PSMD11;PSMF1;RBL1;CDK6;CDKN2A;ZFP36L1;PSMC1;CDKN2D;PSMC3;PSMA4;PTEN;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;ZFP36L2;PSME4;PSMD4;AVEN;BRD7;CDKN1A
prerank,positive regulation of macrophage activation (GO:0043032),-0.47742623002952406,-1.382685457695374,0.11059907834101383,0.6086697465603941,1.0,7/17,19.63%,TREM2;HSPD1;TLR4;TNIP2;TTBK1;THBS1;CCL3
prerank,response to amyloid-beta (GO:1904645),-0.37717775474728277,-1.3811573706406342,0.04938271604938271,0.6093239947409324,1.0,17/44,18.36%,IGF1R;APP;TREM2;LRP1;CASP4;IGF1;ABCC1;GRM5;TLR4;LGMN;CDK5;PRNP;GJA1;CD36;EPHA4;SNX6;ADRB2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5077597887200064,-1.3800016122776093,0.1171875,0.608829372551684,1.0,6/15,13.05%,TRIM27;JMY;ARPC5L;WASHC1;ARPC3;ARPC2
prerank,response to hydroxyurea (GO:0072710),0.7066550179996162,1.3792377207526083,0.1394700139470014,0.7061146150489405,1.0,3/11,4.15%,BLM;DDX11;TIMELESS
prerank,homologous chromosome segregation (GO:0045143),0.665322150304195,1.37832171809003,0.12185929648241206,0.708505134200421,1.0,7/20,20.12%,FANCD2;SGO1;PTTG1;SIRT7;MEI4;CENPC;ZCWPW1
prerank,nucleoside catabolic process (GO:0009164),-0.5439399304681375,-1.3777697940232259,0.12544802867383512,0.6111034652893554,1.0,4/11,6.35%,DERA;UPP2;NT5M;DPYD
prerank,regulation of DNA damage checkpoint (GO:2000001),0.7169482324944377,1.3775108444774322,0.1506849315068493,0.7102820117475173,1.0,5/10,17.17%,RFWD3;RPA2;CCAR2;THOC5;DDX39B
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.4269421538531352,-1.3772800848869635,0.07894736842105263,0.6086195963045455,1.0,12/30,11.28%,NSF;ANK3;MACF1;SEC16A;GGA3;OPTN;GOLGA7;PREPL;VAMP5;VAMP2;GOLGA4;RAB31
prerank,regulation of ATP metabolic process (GO:1903578),0.59707580695839,1.376186318803532,0.08896034297963558,0.7143513466511591,1.0,25/54,20.83%,NUP43;POM121;NDC1;NUP107;ABCD1;NUP42;NUP50;NUP214;NUP160;ZBTB7A;NUP205;SEC13;NUP188;ATP7A;FIS1;NUP98;RANBP2;NUP210;PRKAG2;AAAS;NUP37;NUP85;TPR;EIF6;PRKAG1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.5875479738678622,1.3756780774529564,0.06223175965665236,0.7147144255507042,1.0,21/59,16.37%,CDK1;CCNB1;LEF1;PPM1D;TWIST1;CDKN2A;MED30;SETX;TNRC6C;TNRC6B;MED31;MECP2;MED8;JUN;PTEN;CBFB;MED14;TP53;TCF7L2;TRIM28;CDK8
prerank,regulation of lipase activity (GO:0060191),-0.5200007195090531,-1.3754347605927892,0.14181818181818182,0.6102182584203513,1.0,4/13,11.98%,LPL;PCSK5;PCSK6;LMF1
prerank,mitotic cytokinetic process (GO:1902410),0.6542253681738481,1.3748226088139328,0.11728395061728394,0.7166974730725783,1.0,2/20,1.19%,CEP55;KIF20A
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.6277059684570636,1.3747145444092133,0.11516533637400228,0.7154308298262199,1.0,14/30,17.17%,DDIAS;FBXO5;TWIST1;CD74;CD44;RTEL1;CDKN2D;DYRK1A;CCAR2;YJU2;THOC5;TPT1;SIRT1;DDX39B
prerank,regulation of cellular response to heat (GO:1900034),0.5757935884186312,1.3738179094549154,0.058091286307053944,0.7175125120821082,1.0,32/77,17.67%,RPA2;NUP43;MAPK1;POM121;NDC1;NUP107;NUP42;ATM;NUP50;NUP214;NUP160;NUP205;RPA1;SEC13;NUP188;CCAR2;MLST8;NUP98;RANBP2;NUP210;CREBBP;DNAJC7;BAG1;BAG3;RPA3;GSK3B;DNAJC2;AAAS;SIRT1;DNAJB1;NUP37;YWHAE
prerank,positive regulation of macrophage migration (GO:1905523),-0.4543205227643939,-1.3738158406932568,0.1262135922330097,0.6112701336004386,1.0,11/19,20.08%,TREM2;CSF1R;CMKLR1;AKIRIN1;P2RY12;PTK2;CSF1;MDK;THBS1;CCL3;P2RX4
prerank,cellular response to UV (GO:0034644),0.5856908061035513,1.3734168142445455,0.06646216768916155,0.7174777901706806,1.0,13/76,5.63%,AURKB;POLK;ERCC4;AQP1;CDC25A;EIF2S1;POLD1;COPS9;STK11;PCNA;CHEK1;ACTR5;TAF1
prerank,zinc ion transport (GO:0006829),-0.45262853082805826,-1.373365491059151,0.06896551724137931,0.6086780633186041,1.0,10/21,23.09%,SLC39A11;SLC30A4;SLC39A7;SLC39A14;SLC39A8;SLC39A6;SLC39A3;SLC39A1;SLC30A1;MT3
prerank,nucleic acid metabolic process (GO:0090304),0.5765417087827827,1.3728418352196845,0.07772020725388601,0.7181202420208235,1.0,33/69,22.39%,ANKLE1;DNTT;TOPBP1;POLR2I;POLR2A;FEN1;HNRNPC;HNRNPM;HNRNPL;HNRNPA3;PDE12;HNRNPA2B1;DNA2;DNASE1L1;NCBP1;PCBP2;HNRNPA0;HNRNPR;WDR74;DXO;HNRNPU;RAD50;METTL14;POLR2K;POLR2J;HNRNPA1;NCBP2;DDX54;MMS19;WRN;RBFOX2;WTAP;POLR2B
prerank,fluid transport (GO:0042044),0.7010524857436649,1.3718214649059848,0.12379642365887207,0.720536497395812,1.0,1/12,1.86%,AQP1
prerank,regulation of cell aging (GO:0090342),0.7091888672763986,1.3717858100996505,0.16161616161616163,0.7189728255260444,1.0,1/11,0.50%,FOXM1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.724070842810868,1.371711097823496,0.13024602026049203,0.7175189362720709,1.0,8/10,19.60%,MYB;BRCA1;DNMT1;JARID2;ATRX;RIF1;SIRT1;DNMT3B
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5106034620536626,-1.371205096697744,0.13962264150943396,0.6113328159108685,1.0,3/13,10.50%,GLUL;GOT2;GLUD1
prerank,protein export from nucleus (GO:0006611),0.6217441762914044,1.3710679200517117,0.11862396204033215,0.7184827419660744,1.0,6/27,7.41%,ANKLE1;XPO1;CCHCR1;NUP42;DESI1;NUP214
prerank,regulation of protein dephosphorylation (GO:0035304),0.6123509375041901,1.3709458653566744,0.1087202718006795,0.71726214117742,1.0,20/37,24.20%,CDCA2;PTPA;ANKLE2;PPP1R8;PPP2R5A;PIN1;PPP1R15A;CNEP1R1;PPP6R3;PPP1R2;PPIA;CAMTA1;HSP90B1;SPPL3;PPP1R16A;CALM3;PPP1R16B;PRKCD;SMPD1;PTBP1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.6147949069276686,1.3708152736269494,0.12046783625730995,0.7160992208977159,1.0,4/31,5.02%,HSD17B3;SRD5A2;PYCR3;LSS
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.6301909249125908,1.370775998498005,0.12705882352941175,0.7145691772577765,1.0,10/27,16.89%,RRM2;AK9;RRM1;DUT;RRM2B;NUDT13;NME4;TYMS;AK5;AK6
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.657588466108108,1.3706859794293962,0.125,0.7132291122972708,1.0,7/23,15.39%,CYP1B1;IL7R;OCIAD2;CENPJ;NOTCH1;IL10RA;F2R
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4882968723111357,-1.3703196610805393,0.1214574898785425,0.6101591684035725,1.0,8/16,6.30%,ABCD2;SIRPA;TREM2;APPL2;ADCY7;APOD;PYCARD;ZC3H12A
prerank,sodium ion homeostasis (GO:0055078),0.6532825362990711,1.3692775515439948,0.11288343558282209,0.7173004652672471,1.0,4/21,7.95%,TMPRSS3;SLC12A3;SLC12A1;NEDD4L
prerank,RNA catabolic process (GO:0006401),0.5969459440061146,1.3692410028784938,0.09200438116100766,0.7157570821152982,1.0,14/46,15.99%,SLFN14;RNASE6;LSM6;FEN1;PPP1R8;DCP2;DNA2;NCBP1;LSM2;LSM5;METTL16;DXO;RNASEH2A;ZFP36L2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5922672767884632,1.3687659003966395,0.10314875135722042,0.7160475839230589,1.0,10/48,14.12%,IL12A;CD2;ZFPM1;PTPN22;CCR2;RASGRP1;CYRIB;IL1R1;CEBPG;IL27
prerank,cellular response to hydroxyurea (GO:0072711),0.7217099299639236,1.3685385007310258,0.1316931982633864,0.715221221358285,1.0,3/10,4.15%,BLM;DDX11;TIMELESS
prerank,inositol lipid-mediated signaling (GO:0048017),-0.35608936922017875,-1.3682452909129335,0.0625,0.6121158119974581,1.0,13/50,10.43%,IGF1R;ADAP2;CSF1R;PLCB2;PIK3CD;PIK3R1;IGF1;KCNH1;PI4KA;PIK3C2B;PLCL2;PLCB4;IRS2
prerank,amino acid transport (GO:0006865),0.5863821578374574,1.367917502882975,0.09663409337676439,0.7160574277876769,1.0,8/49,10.11%,SLC6A12;SLC38A5;SLC1A5;SLC7A1;SLC25A47;SLC16A10;SLC43A2;SLC3A1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.41653230537025754,-1.3675010597722532,0.075,0.6106121303134423,1.0,11/24,17.90%,IQSEC1;PIK3R1;PTPRJ;DUSP3;TSC1;FERMT2;PPM1F;VEGFA;MAP4K4;COL16A1;THY1
prerank,regulation of chemotaxis (GO:0050920),-0.38835121948618023,-1.3663830587341155,0.10416666666666667,0.6100370429185841,1.0,13/30,21.11%,TREM2;PTPN2;AIF1;STX4;STX3;P2RY12;ZSWIM6;DUSP3;PPM1F;ZSWIM8;THBS1;P2RX4;EFNB2
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.4464485927013392,-1.3654839777697245,0.09813084112149532,0.60906818088427,1.0,9/18,17.19%,HAVCR2;NAV3;CD34;TNFAIP3;TRIM27;HDAC7;PRNP;ZFP36;KAT5
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.6112593769739391,1.3648062667988903,0.11931818181818182,0.7275281007219649,1.0,4/32,7.77%,TPX2;STMN1;CLASP1;CIB1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.4624010995443596,-1.3644951781755597,0.14224137931034483,0.6080370829823425,1.0,6/17,18.64%,LPL;PCSK5;PCSK6;LMF1;SORT1;APOC1
prerank,regulation of viral entry into host cell (GO:0046596),0.6139570898326786,1.3642671615925066,0.12982456140350876,0.7280038517068287,1.0,9/30,14.47%,TMPRSS4;CD74;SNX3;GSN;LY6E;TRIM11;TRIM68;IFITM3;TRIM5
prerank,neuron maturation (GO:0042551),-0.4606816364073517,-1.3624345123201416,0.09178743961352658,0.61043508783809,1.0,6/18,8.95%,APP;FARP2;C1QA;CLN5;B4GALT5;SRRM4
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6764475349057429,1.3621988367830462,0.15343203230148048,0.7332238703655217,1.0,8/15,20.76%,ZFP36L1;TNRC6C;TNRC6B;CPEB3;CNOT1;ZFP36L2;AGO2;CNOT7
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6764475349057429,1.3621988367830462,0.15343203230148048,0.7332238703655217,1.0,8/15,20.76%,ZFP36L1;TNRC6C;TNRC6B;CPEB3;CNOT1;ZFP36L2;AGO2;CNOT7
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6941436198777968,1.3611561917213468,0.14030261348005502,0.7359436684612086,1.0,2/12,2.25%,IL12A;MAPK1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5168442035261658,-1.3611413180414051,0.1213235294117647,0.6104974297839365,1.0,5/12,13.47%,SNAP47;STX4;STX3;STX2;STX1A
prerank,negative regulation of protein depolymerization (GO:1901880),0.6286276676283721,1.3609857984274338,0.11951219512195121,0.734986063557402,1.0,4/24,10.17%,TPX2;CLASP1;CIB1;LIMA1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.6417948156202943,1.3605890098102127,0.12962962962962962,0.7350023308325673,1.0,4/23,8.71%,HMGB2;CECR2;HMGB1;DNASE1L1
prerank,positive regulation of locomotion (GO:0040017),-0.41645400344436423,-1.3600825472267508,0.09815950920245399,0.6098402770461904,1.0,10/27,12.71%,TREM2;CSF1R;AIF1;STX4;STX3;P2RY12;SPOCK2;AKT2;CFAP20;PPM1F
prerank,maintenance of protein location in nucleus (GO:0051457),0.6479442320718851,1.3598535691017104,0.12437810945273632,0.7364776373273759,1.0,12/20,19.94%,BARD1;SUN2;PML;SP100;RANGAP1;PARK7;CHCHD10;HNRNPU;BBS4;SYNE1;MORC3;TAF3
prerank,diacylglycerol metabolic process (GO:0046339),-0.4166270903066376,-1.3597890289105599,0.07471264367816093,0.6070205446125624,1.0,10/23,18.08%,DGKH;PLA2G15;DGKA;DGKI;DGKZ;DGKQ;DGKB;DGAT1;DAGLA;ANG
prerank,mRNA stabilization (GO:0048255),0.5928653042333457,1.3592188181652394,0.11023622047244094,0.7374075039153923,1.0,21/40,23.67%,E2F1;HNRNPC;BOLL;TAF15;ELAVL4;MAPK14;DHX9;HNRNPA0;MYD88;HNRNPU;PAIP1;ANGEL2;ELAVL1;EIF4ENIF1;THRAP3;SYNCRIP;TENT5D;TARDBP;YBX1;GDNF;CIRBP
prerank,regulation of microtubule depolymerization (GO:0031114),0.629670364751908,1.3589912498341117,0.11288343558282209,0.7366545369534772,1.0,3/25,7.77%,TPX2;CLASP1;CIB1
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.653913547474514,1.358840442974454,0.12826899128268993,0.7356524829028903,1.0,8/18,19.08%,DHX58;NPLOC4;BIRC2;PUM2;PUM1;USP15;GPATCH3;SEC14L1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6623897024833904,1.3583899413225986,0.156,0.7358219345876322,1.0,4/15,10.75%,MAD2L1;FBXO5;RPS7;PARK7
prerank,cardiac muscle cell differentiation (GO:0055007),-0.4462988930062409,-1.358213979132284,0.08387096774193549,0.6077493571048035,1.0,5/21,18.83%,ACVR1;VEGFA;SLC8A1;CXADR;KDM6B
prerank,establishment of vesicle localization (GO:0051650),-0.46020045428857864,-1.3573793428241427,0.08121827411167512,0.6065124474542221,1.0,9/18,16.13%,DNM2;KIF5C;SYNJ1;SPG11;CCDC186;KIF5A;CDK5;RAB11A;SNAPIN
prerank,sulfur amino acid catabolic process (GO:0000098),-0.5542024982738057,-1.3572578013454215,0.13522012578616352,0.6032201295906512,1.0,9/10,44.61%,TXN2;MTRR;ADO;TST;MPST;CBS;GADL1;CTH;BLMH
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6634193395624799,1.357101203908004,0.13986928104575164,0.7397821143734665,1.0,6/16,13.89%,ULBP1;RAET1E;TUBB4B;SLAMF7;TUBB;CEBPG
prerank,regulation of integrin activation (GO:0033623),0.6671857472028708,1.3570979366451916,0.14073071718538566,0.738107505378948,1.0,1/15,0.17%,KIF14
prerank,regulation of mRNA metabolic process (GO:1903311),0.69980940327543,1.3570167185999047,0.14246196403872752,0.7367646170939227,1.0,8/11,20.01%,PTCD2;IWS1;NCBP1;DHX9;SRPK1;SAFB;CDK11B;SLTM
prerank,striated muscle cell development (GO:0055002),0.6594949973008877,1.356596673876406,0.14304812834224598,0.7368726973240568,1.0,2/14,9.26%,TMOD4;FLII
prerank,water transport (GO:0006833),0.702310589837266,1.3565747030927477,0.12745098039215685,0.7353018377460443,1.0,1/12,1.86%,AQP1
prerank,myofibril assembly (GO:0030239),0.591415976188104,1.3565229012613058,0.10176991150442478,0.73387662183925,1.0,6/42,13.95%,TMOD4;CSRP3;CSRP1;FLII;ACTN2;CFLAR
prerank,negative regulation of chemotaxis (GO:0050922),-0.389437946418075,-1.3561026720359735,0.07407407407407407,0.6031811649025397,1.0,12/31,20.67%,PTPN2;AIF1;SEMA3D;SEMA3E;SEMA4C;ROBO1;DUSP3;SEMA4G;SEMA3A;THBS1;SEMA7A;CORO1B
prerank,regulation of phosphate metabolic process (GO:0019220),0.6751601820586961,1.3558753069551155,0.1408083441981747,0.7349255271832688,1.0,8/16,21.10%,BARD1;SMG6;SMG5;PSEN1;CD24;SMG7;MCM7;IKBKB
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.549098921301941,-1.3555858532248006,0.14035087719298245,0.6010265173270869,1.0,6/11,31.42%,HSP90AA1;PTS;CALM1;PRKG2;DHFR;SPR
prerank,melanocyte differentiation (GO:0030318),-0.5370527753681763,-1.3554156565742979,0.14233576642335766,0.5979103011792953,1.0,2/11,4.01%,MITF;LRMDA
prerank,positive regulation of cilium assembly (GO:0045724),0.6482763864659506,1.3529789589799777,0.14687100893997446,0.7454328823414326,1.0,10/18,22.61%,CCDC88A;ARHGAP35;FUZ;TAPT1;HAP1;BBS4;MARK4;SEPTIN9;CROCC;CEP135
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.6053779155878223,1.352177139564562,0.1324354657687991,0.747114830519371,1.0,8/31,17.59%,BLK;SPN;GLMN;ATM;TNFRSF13B;TYROBP;RC3H1;FCGR2B
prerank,positive regulation of response to stimulus (GO:0048584),0.5963387244873914,1.3513847241827146,0.13063063063063063,0.7488296166925036,1.0,12/40,17.59%,ANKLE1;HMGA1;CGAS;CDKN2A;B2M;DHX9;FXR1;MYC;TAF9;TGFB2;SIRT1;FCGR2B
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.684474464890904,1.3503021444291445,0.12834224598930483,0.7515741986477945,1.0,5/13,15.85%,HEY2;TAF1;DDIT3;PSEN1;SIN3A
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5073728531473535,-1.3482929621605575,0.12698412698412698,0.614975534144081,1.0,3/13,10.64%,CLPTM1;ZC3H8;CAMK4
prerank,activation of protein kinase activity (GO:0032147),0.5681034831144248,1.3479075597992172,0.04944500504540868,0.7599325311917552,1.0,31/106,19.61%,TPX2;KIF14;ECT2;CLSPN;BORA;CARD10;CCDC88A;AXIN1;STK11;PRKACA;MARK2;JAK2;PDPK1;TXN;PARK7;MLST8;PIBF1;PPIA;TLR6;STK4;PAK5;PAK2;TGFB2;ADCY8;MAP3K7;TAOK1;MALT1;STK3;TRAF6;MAPKAP1;PRKAR2A
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5369434856586751,-1.3462130785155446,0.13541666666666666,0.6174161722616994,1.0,5/11,17.38%,ACVR1;TGFBR1;SMAD7;TGFBR3;TGFBR2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.6928361515583283,1.3461301378722177,0.1622340425531915,0.7658409825683044,1.0,3/11,12.51%,IL12A;JAK2;CANX
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5793421420859719,1.346071289087787,0.11002178649237472,0.7644132604940534,1.0,17/46,17.67%,ECT2;GTSE1;ANP32B;FLNA;EFCAB7;EMD;DHX9;PSEN1;BAG3;GSK3B;TP53;IPO5;TCF7L2;TRIM28;XPO4;HCLS1;YWHAE
prerank,nuclear transport (GO:0051169),0.6632307626774625,1.3458716531768873,0.15243101182654403,0.7635928567334304,1.0,7/16,17.72%,HMGA1;XPO1;NUP205;NUP98;PSIP1;AAAS;RSRC1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6205340470914481,1.3454416991607214,0.13898704358068315,0.7638518802897493,1.0,5/24,8.28%,ADAMTS7;SOX6;PTHLH;MBOAT2;ZBTB16
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.6956727444422708,1.3452801328572417,0.1623931623931624,0.7628435194054949,1.0,4/11,10.75%,STK26;FYN;UBQLN1;PARK7
prerank,chromatin organization (GO:0006325),0.5644739786387267,1.3450557039997844,0.03614457831325301,0.7621847193340534,1.0,42/132,16.94%,MYB;HMGB2;EZH2;SUV39H1;HIRIP3;SMARCC2;SMARCA5;CHD1L;RB1;DDX11;SMARCD2;RSF1;NPM3;NUCKS1;HDAC10;BAZ2B;RBBP4;TCF7L1;HMGN2;LRWD1;PHF19;BAZ1B;PHF1;SMARCA4;ZBTB7A;SMARCC1;RUVBL2;EHMT1;RUVBL1;KAT2B;MTA2;CDAN1;SETDB2;HCFC1;SATB2;MYC;TADA2A;KDM4C;JARID2;ATRX;BAZ1A;SIRT1
prerank,wound healing (GO:0042060),-0.3241069335299899,-1.3449701808348613,0.08333333333333333,0.6171946821476512,1.0,18/62,15.80%,DST;TGFBR1;MACF1;SMAD3;AHNAK2;IGF1;FUT10;MYOF;NF1;MIA3;ITGB3;SYT7;SCARB1;EPB41L4B;HMOX1;FGF2;DCBLD2;HPSE
prerank,regulation of cellular component size (GO:0032535),0.5988077165172896,1.3448153081870107,0.14170506912442396,0.7615565222289669,1.0,15/30,18.04%,EZR;RIN3;RAB22A;RAP1GAP2;PEX11B;MTPN;LARS1;PPP1R15A;MSN;RDX;PTEN;LAMTOR4;RAC1;PPP1CA;RARG
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.5705958653454299,1.3441945694319084,0.08996897621509824,0.7625088988094029,1.0,23/72,18.41%,POLK;ERCC4;RPA2;XRCC1;RFC5;POLR2I;PRPF19;POLR2A;POLD1;PCNA;LIG1;POLD2;RPA1;ERCC3;RFC2;RFC1;POLD3;RPA3;POLR2K;POLR2J;UBA52;USP7;PPIE
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6978833893598713,1.343959208870981,0.17256011315417255,0.761770427600223,1.0,2/10,7.15%,PHACTR4;NOTCH1
prerank,telomere capping (GO:0016233),0.6593249956381355,1.3432740242572627,0.16454081632653061,0.762969841411287,1.0,8/16,14.98%,DCLRE1C;TERF2;DCLRE1B;TERF1;CTC1;PRKDC;TFIP11;RAD50
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.7114450145340939,1.3431427108127743,0.15173410404624277,0.7618000182486621,1.0,5/10,14.97%,HMGB1;PSMC3;PSMC4;ATF7IP;TP53
prerank,Golgi inheritance (GO:0048313),0.6883858433338207,1.341817296291772,0.16216216216216217,0.7656779810931912,1.0,5/11,14.92%,CDK1;STX5;VRK1;VCPIP1;PDCD10
prerank,neural tube closure (GO:0001843),0.5929666271331807,1.3414692996113244,0.12067039106145251,0.765487926967825,1.0,11/34,19.35%,STIL;PHACTR4;DEAF1;LMO4;FUZ;BBS4;SKI;TGFB2;KDM2B;MTHFD1L;PAX2
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5384371424913308,-1.3412075278664157,0.13541666666666666,0.6246635730031982,1.0,3/11,8.42%,ATG10;APOE;WIPI1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.6123047604558913,1.3408650249124963,0.13099415204678364,0.7663356143816412,1.0,5/29,8.62%,IL12A;KLRD1;RASGRP1;RAET1E;CYRIB
prerank,response to hydrogen peroxide (GO:0042542),0.5874461399943087,1.340817903012613,0.11978021978021978,0.7648963441870356,1.0,14/45,14.92%,ECT2;CYP1B1;STK26;AQP1;FYN;NET1;SETX;HDAC6;MAP3K5;STK24;PARK7;NFE2L2;APTX;PDCD10
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5495930731881168,-1.3400361057439705,0.14634146341463414,0.6246244572350925,1.0,4/11,5.61%,PJA2;TREM2;MFHAS1;TNFAIP3
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.6349627435067193,1.3399095961349405,0.1373283395755306,0.7654291592364899,1.0,5/21,9.42%,ERCC4;RPA2;CHD1L;RPA1;ERCC3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.6349627435067193,1.3399095961349405,0.1373283395755306,0.7654291592364899,1.0,5/21,9.42%,ERCC4;RPA2;CHD1L;RPA1;ERCC3
prerank,prostanoid metabolic process (GO:0006692),-0.4986338735335992,-1.339455885044261,0.140625,0.6227717654872573,1.0,4/13,8.41%,HPGDS;PTGS1;PLAA;PTGR2
prerank,negative regulation of phagocytosis (GO:0050765),0.6466303797564705,1.33891301839211,0.15013054830287206,0.7680281486647769,1.0,8/17,17.59%,PRTN3;CD47;SNX3;HMGB1;PIP4P2;RACK1;APPL1;FCGR2B
prerank,cation transmembrane transport (GO:0098655),0.5907158283882453,1.338838141234643,0.10359869138495092,0.7667383425827423,1.0,4/44,3.20%,RHAG;SLC38A5;SLC7A1;SLC6A5
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.49098821796303144,-1.3386774679416589,0.12048192771084337,0.6212165422770068,1.0,7/14,22.33%,LRP1;AIF1;NDRG4;SERPINE1;PRKG1;CORO1B;TRIB1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.48915696800304753,-1.3385996608067772,0.13716814159292035,0.6180013517345437,1.0,2/15,2.76%,TREM2;LPL
prerank,regulation of cellular component organization (GO:0051128),0.5540759544158673,1.3381860789582936,0.04233870967741935,0.7678149278722867,1.0,25/135,13.59%,MKI67;KIF14;HJURP;RAB33B;CD177;ALKBH4;AURKA;NET1;STK11;TFRC;STON1;STK38L;ARFGAP1;METTL4;RIT2;SOCS2;PARK7;ATF5;BAP1;PACSIN2;HCFC1;ROCK2;STON2;HNRNPU;LATS1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6352332289218587,1.3380875703008785,0.12729498164014688,0.7666078768379739,1.0,8/24,15.39%,CYP1B1;OCIAD2;CENPJ;NOTCH1;JAK2;IL10RA;PIBF1;F2R
prerank,estrogen metabolic process (GO:0008210),0.6450190525800489,1.3380321610079537,0.1483957219251337,0.7651741359455405,1.0,1/15,1.40%,CYP1B1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.5560970055561923,1.3377658041625478,0.026156941649899398,0.7646660837516093,1.0,85/168,22.84%,RPL7;RPL18A;SMG6;RPS20;SMG5;RPL36;RPL14;RPS19;DCPS;RPS7;EIF3E;RPS4X;RPS18;EXOSC8;ATM;UPF2;SMG8;PDE12;ZFP36L1;RPL23A;CSDE1;EIF4A3;DCP1B;RPL28;EXOSC10;DCP2;RPS14;RPL41;RPLP2;NCBP1;CASC3;RNPS1;RPS27;RPS5;PNLDC1;RPS29;RPLP0;RPS11;TUT4;RPL27A;CNOT4;ERI1;DCP1A;UPF3B;SMG9;RPS9;RPS15A;DXO;HELZ2;RPL12;CNOT1;RC3H1;CNOT6;PYM1;SAMD4A;TUT1;RPL3;GSPT1;UBA52;RPL18;TENT2;RPL5;RPS6;RPS17;NCBP2;RPS3;THRAP3;RPL21;XRN1;PPP2CA;RPL23;RPL17;CNOT8;SMG7;CNOT7;RPL24;RPL8;RPL27;DHX34;RPL13A;AGO1;RPS12;RPS8;RPL15;RPL10
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5785984890922556,1.3374395377580912,0.10638297872340426,0.7644062906607678,1.0,9/55,10.93%,HMMR;FMOD;HSPG2;CD44;GALNS;HPSE2;DCN;CEMIP2;OGN
prerank,negative regulation of viral entry into host cell (GO:0046597),0.6703164410985454,1.3373597369992198,0.16666666666666666,0.7630852936977357,1.0,6/12,14.47%,SNX3;GSN;LY6E;TRIM11;IFITM3;TRIM5
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.628869758699216,1.3373481823311668,0.13905683192261184,0.7615248026453697,1.0,1/22,0.93%,LRAT
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6490488287106662,1.3373117916217603,0.14104193138500634,0.7600732526794844,1.0,5/18,13.09%,KIF20B;RIPOR2;CYRIB;ROCK2;RACK1
prerank,histone H2A acetylation (GO:0043968),0.6580258276458265,1.3369214174503496,0.18297331639135958,0.7600485202871493,1.0,7/16,13.29%,NAA40;EPC1;BRD8;YEATS4;RUVBL2;RUVBL1;ING3
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.5447108105128874,-1.3355384715606875,0.1476510067114094,0.6200282696123942,1.0,3/10,25.26%,MBP;MAPK7;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.5447108105128874,-1.3355384715606875,0.1476510067114094,0.6200282696123942,1.0,3/10,25.26%,MBP;MAPK7;KLF4
prerank,response to nitric oxide (GO:0071731),0.678022545517762,1.3353491607117949,0.17757009345794392,0.7651738186339443,1.0,6/13,14.42%,AQP1;FOXO1;DPEP1;TXN;KCNC2;MTR
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.6537434097259626,1.334949737920367,0.15508684863523572,0.7651931508441998,1.0,9/18,16.96%,MAPK1;EZR;SNX3;MTMR2;MSN;RDX;DNAJC13;MAP2K1;CHMP3
prerank,regulation of myelination (GO:0031641),0.6167887214607464,1.3337098073202778,0.1486810551558753,0.7686526575805933,1.0,1/25,0.17%,KIF14
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.613214795256883,1.3336329163663536,0.15808383233532936,0.7673420785588557,1.0,9/24,10.21%,EZH2;PPM1D;SUZ12;EPC1;RBBP4;PHF19;H3-3A;PHF1;DNMT1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.7095443526196972,1.3330076328253322,0.16452074391988555,0.7683209160298499,1.0,7/10,20.97%,STK26;TXN;PARK7;NFE2L2;PDE8A;LRRK2;RIPK1
prerank,positive regulation of DNA recombination (GO:0045911),0.6133240885655955,1.332714586722193,0.15393794749403342,0.7679132090261485,1.0,7/27,12.18%,RAD51AP1;TIMELESS;ARID2;TFRC;MRNIP;KMT5C;PAXIP1
prerank,male meiosis I (GO:0007141),0.6545297732551083,1.3326134856171843,0.16149068322981366,0.766718569271337,1.0,3/16,13.30%,MYBL1;FOXJ3;ING2
prerank,negative regulation of transferase activity (GO:0051348),0.6172841868485093,1.3315203096140877,0.143698468786808,0.7695959195440712,1.0,9/28,14.97%,PIF1;MEN1;ERCC4;FBXO5;TERF1;PARK7;HNRNPU;GSK3B;TP53
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4636888740181223,-1.330135406718992,0.11061946902654868,0.6321634556843642,1.0,4/17,6.72%,NLRP3;HAVCR2;CD86;FCER1G
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.5465066855432922,1.3297727130902637,0.002,0.7751535674659977,1.0,86/417,12.29%,CENPF;DEPDC1;BIRC5;FOXM1;GFI1;MYB;HMGB2;EZH2;RCOR2;MEN1;SUV39H1;BRCA1;SMARCC2;HMGA1;DAP;HEY2;RBM15;DEAF1;LEF1;E2F1;RB1;RIOX1;NIF3L1;RSF1;CBX5;CD38;TWIST1;PML;BCL7A;FBXW11;TIMELESS;PA2G4;HDAC10;UBE2I;MTA3;RPS6KA5;EPC1;CTCF;SCMH1;FOXP1;DACH1;CDKN2A;NR1D1;NKAP;MBD2;FOXO1;PBXIP1;MBD1;ARID4A;GMNN;HDAC6;KLF10;TAF7;NOTCH1;XRCC6;AHR;SFMBT1;SPEN;SAP18;PSPC1;SMARCA4;CIR1;CIPC;ZBTB16;ZBTB7A;NONO;ZNF148;MECP2;PFDN5;TFDP2;NR2F2;KAT6A;ID4;ZEB1;TRIM33;EHMT1;ARID5B;SUMO1;SMAD4;CCAR2;JUN;ATF5;PLCB1;FOXP2;BAP1;SETDB2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5795777343704338,1.3294453360457308,0.13152173913043477,0.775000113792333,1.0,2/45,0.90%,TTK;INHBC
prerank,engulfment of apoptotic cell (GO:0043652),-0.4747322791206927,-1.3290405757641082,0.11836734693877551,0.6319138438630714,1.0,9/15,23.02%,RHOBTB1;XKR6;RHOBTB2;RHOG;RHOH;THBS1;ADGRB1;XKR4;MEGF10
prerank,cellular response to alcohol (GO:0097306),0.5822398913740814,1.328835193545596,0.14872364039955605,0.7761360706699041,1.0,8/42,7.55%,RAD51;BRCA1;BLM;CTNNA1;MAP4K1;MLC1;AHR;GNAI1
prerank,rRNA catabolic process (GO:0016075),0.6519883234591486,1.328591207981716,0.17054263565891473,0.7755881942802159,1.0,3/16,7.55%,SLFN14;EXOSC8;EXOSC10
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.6868906844598871,1.3283208306355356,0.17231638418079095,0.7751935597838828,1.0,2/11,5.36%,BLK;CDKN2A
prerank,endothelial cell proliferation (GO:0001935),-0.44840326736502284,-1.3282253403340398,0.12149532710280374,0.6308549422166317,1.0,7/17,19.61%,BMPR2;CD34;ERN1;HMOX1;ACVRL1;DLG1;BMPER
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.6547790489856669,1.3257154140815586,0.1481958762886598,0.7844026156895891,1.0,9/18,11.87%,NOP10;CCT7;CCT2;TCP1;EXOSC10;DCP2;RUVBL2;RUVBL1;CCT5
prerank,pyruvate metabolic process (GO:0006090),-0.3351399537433766,-1.3241229160901722,0.05084745762711865,0.6392324278614333,1.0,19/52,14.48%,HK2;HK3;GPI;PDHX;HAGH;PFKL;ENO1;ALDOA;LDHA;TPI1;PGM1;PKM;PDHB;SLC16A3;PGAM1;PGAM4;ME1;ALDOC;HOGA1
prerank,positive regulation of cellular senescence (GO:2000774),0.689316769767698,1.3230358445007875,0.1880597014925373,0.7939629630324458,1.0,5/10,16.94%,HMGA1;CGAS;CDKN2A;B2M;SIRT1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5941931831872884,1.3225012318466807,0.15491329479768787,0.7945473452516048,1.0,7/32,17.91%,CD19;CAV1;NPSR1;PDPK1;F2R;PLCG1;SNCA
prerank,regulation of neuron projection arborization (GO:0150011),-0.477970785019001,-1.3223434928736575,0.10330578512396695,0.6408450707887031,1.0,5/15,9.30%,MACF1;MAP3K13;MYO9A;NTNG1;DVL3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7007858834708732,1.3223385849422118,0.16812865497076024,0.7936352505317611,1.0,2/10,7.90%,IL12A;DCN
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5928467153034304,1.3219060551629513,0.13205417607223477,0.7938898193261227,1.0,10/33,12.99%,ECT2;CYP1B1;AQP1;NET1;SETX;HDAC6;MAP3K5;PARK7;SIGMAR1;NFE2L2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.6624718069150191,1.3218585123266977,0.16688918558077437,0.7924497255294156,1.0,4/14,16.28%,BRCA2;TERF2;NABP2;ATRX
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.6521180108376556,1.3218179055188126,0.16514954486345904,0.7910045456337763,1.0,6/16,15.22%,NAA40;KAT2B;NAA16;NAA25;CREBBP;NAA20
prerank,outflow tract septum morphogenesis (GO:0003148),-0.42852124010533943,-1.321297446074779,0.11235955056179775,0.6403869993623609,1.0,7/24,9.23%,ACVR1;NRP2;ZFPM2;BMPR2;ROBO1;SMAD6;ENG
prerank,calcium ion transmembrane transport (GO:0070588),-0.2877888159317106,-1.321286761016164,0.125,0.6370880806383526,1.0,28/86,22.13%,SLC24A3;TRPM3;CACNA1C;TRPC5;MCOLN1;NALCN;SLC8A3;MCUR1;TRPC4;TRPC1;SLC8B1;TMEM165;LETM1;PKD1;MCOLN3;ATP2B3;SPG7;TRPV4;SLC8A1;TRPC3;STOML2;MAIP1;CACNA1G;PMPCA;ORAI1;P2RX4;AFG3L2;SMDT1
prerank,negative regulation of nuclear division (GO:0051784),0.6919650729627558,1.3210460497648042,0.15258855585831063,0.792460494053162,1.0,3/11,5.08%,FBXO5;AURKAIP1;CHEK1
prerank,organic anion transport (GO:0015711),0.5604670605609324,1.3202572574623428,0.08987603305785125,0.7942252215697557,1.0,14/76,12.40%,SLC4A1;RHAG;AQP1;SLC2A8;SLCO4C1;SLC35A2;CYB5RL;SLC35A1;SLCO4A1;LRRC8C;SLC52A1;SLC19A1;ABCC4;SLCO2A1
prerank,positive regulation of embryonic development (GO:0040019),0.634608749911268,1.3188451682692508,0.17700258397932817,0.7986229668675292,1.0,5/19,13.09%,FOXA2;RBM19;NR2C2;PLCB1;RACK1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6884537140308031,1.318776287533187,0.18063583815028902,0.797317477137636,1.0,4/11,12.45%,BARD1;ZFP36L1;NCBP1;ZC3H3
prerank,hematopoietic stem cell differentiation (GO:0060218),0.6846432061236617,1.3187703679724032,0.19444444444444445,0.7957547829991778,1.0,6/10,24.66%,BATF;TP53;HOXB4;LMBR1L;UFL1;MLLT3
prerank,cytosolic transport (GO:0016482),-0.2761668325327579,-1.3186057114772183,0.0,0.6419127503374049,1.0,38/108,20.69%,RAB14;GAK;STX6;STX16;GBF1;WDR91;SNX5;VTI1B;RAB6B;EEA1;LAMP1;VPS13C;TBC1D23;VPS50;ANKRD27;TBC1D10A;PREPL;TRIM27;TBC1D5;SNX16;CLN5;GOSR2;ARL1;WASHC1;YKT6;HOOK2;TBC1D17;GOSR1;SNX6;HOOK3;EPS15;VPS51;SORT1;MYO1D;TBC1D10B;PLEKHJ1;PTPN23;VPS26A
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.6918715713500818,1.3174526963096997,0.18410041841004185,0.7998326061869041,1.0,6/10,17.29%,RUNX3;HMGB1;CBFB;ZBTB7B;RUNX1;SH3RF1
prerank,determination of bilateral symmetry (GO:0009855),0.6102390624385063,1.3173951051452306,0.16686674669867949,0.798482371587772,1.0,2/25,7.15%,STIL;NOTCH1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.6182156852888591,1.316927835814497,0.1687192118226601,0.7988723524620797,1.0,10/22,22.50%,CDKN2C;ANKLE2;CDKN2A;CDKN2D;TP53;DYNLL1;SIRT1;CDKN1A;ROCK1;CDKN1B
prerank,protein kinase A signaling (GO:0010737),0.6782075928073937,1.3164120781905435,0.1922043010752688,0.7994515840771556,1.0,4/12,11.59%,EZR;MYOM1;PRKACA;RDX
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.6635263058675879,1.3163913814911976,0.16212534059945505,0.7979357061560196,1.0,6/13,17.53%,PRPF19;SART3;LSM2;PRPF31;SRSF10;PRPF8
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.3959628838754222,-1.3152717186181129,0.1038961038961039,0.6484491462568244,1.0,8/27,12.13%,RIMS1;RIMS2;SYT1;SYT4;VAMP2;SYT7;SYT9;VAMP7
prerank,sulfate transport (GO:0008272),0.6687255205509899,1.314533428508361,0.16469038208168643,0.8042353146180258,1.0,1/14,0.69%,RACGAP1
prerank,positive regulation of synapse assembly (GO:0051965),-0.3897149918477381,-1.3143567112224273,0.13513513513513514,0.6477185867454567,1.0,9/27,19.25%,PTPRD;SYNDIG1;IL1RAP;CLSTN3;LRRC4B;CLSTN1;CUX2;AGRN;CLSTN2
prerank,positive regulation of programmed cell death (GO:0043068),0.5403745797714921,1.312250006957017,0.012,0.8122880418596208,1.0,69/272,18.19%,TOP2A;ECT2;USP27X;BARD1;CYP1B1;ARHGEF5;PMAIP1;IAPP;E2F1;PDCD2;DAPK2;TIAM1;NET1;PTPA;APAF1;PIDD1;TFPT;TNFSF10;ARHGEF18;PHLDA3;FOXO1;CASP2;FAF1;ATM;ARHGEF3;TRADD;HDAC6;MAP3K5;UBE2Z;HMGB1;BOK;SAP18;TNFAIP8;SOS1;RNPS1;ERCC3;PRR7;PAWR;MAP3K11;MELK;ATF6;CCAR2;JUN;FAS;FGD3;RACK1;ING3;ING5;LATS1;BCL6;PSEN1;HTATIP2;CASP9;STK4;TP53;MAP3K20;MARK4;TFAP4;NLRP2B;SIRT1;ANO6;ARL6IP5;PNMA2;UBA52;SNCA;STK17B;RARG;LRRK2;ARHGEF7
prerank,regulation of biomineral tissue development (GO:0070167),0.603743205268384,1.312197997480979,0.15176470588235294,0.8109168693373999,1.0,5/26,7.15%,HEY2;FBXO5;SGMS2;TWIST1;NOTCH1
prerank,macrophage activation (GO:0042116),-0.36166142063082385,-1.312147833776708,0.09734513274336283,0.6508257313791025,1.0,9/34,10.09%,APP;TREM2;ITGAM;SBNO2;AIF1;C1QA;TLR4;NMI;C5AR1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6245657023935922,1.3119364366976374,0.1814720812182741,0.8104180087001995,1.0,1/19,0.81%,CHRNB4
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.5461980950021935,1.3118475875951188,0.09696969696969697,0.8091880270517567,1.0,21/88,16.92%,CCNF;KIF14;FBXL15;SKP2;PSMB7;PSMD11;FBXW11;PSMF1;FBXO44;PSMC1;FBXO17;PSMC3;PSMA4;FBXL4;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4
prerank,exit from mitosis (GO:0010458),0.6720318231637058,1.3113151892170871,0.18802228412256267,0.8098623044712241,1.0,2/12,5.95%,UBE2C;CLASP1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.3683600501923089,-1.3111980859907149,0.1276595744680851,0.6502918466779483,1.0,14/39,19.28%,SPOCK1;EFNA5;GCNT2;ADAM15;NEXMIF;SEMA3E;CORO1C;CORO2B;PTPRO;RCC2;MAP4K4;JAG1;THBS1;RASA1
prerank,myelination (GO:0042552),-0.3469651433210576,-1.310928716955009,0.04285714285714286,0.6477676941186398,1.0,21/46,23.57%,ABCD2;PLP1;MBP;SCN8A;SLC8A3;PLLP;CMTM8;B4GALT5;NF1;EPB41L3;NFASC;DEGS1;MAL;EIF2B4;ADGRG6;ARHGEF10;TNFRSF21;EIF2B2;PARD3;SOX10;CNTNAP1
prerank,negative regulation of transposition (GO:0010529),0.6549104623565224,1.3108651899719206,0.18324607329842932,0.810075813107628,1.0,4/16,13.34%,MYBL1;UBR2;TUT4;SIRT7
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.3899686539673826,-1.3102389579362979,0.09174311926605505,0.6464727847114982,1.0,15/32,20.32%,ARHGAP6;ADAM15;NEXMIF;APOD;SEMA3E;CLASP2;CORO1C;RCC2;SERPINE1;MAP4K4;ACVRL1;JAG1;THBS1;RASA1;PHLDB2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6093888078701554,1.3100665382085068,0.171021377672209,0.8119212717631527,1.0,9/24,16.94%,DDIAS;CD74;CD44;CDKN2D;CCAR2;ING2;TPT1;TAF9;SIRT1
prerank,prostanoid biosynthetic process (GO:0046457),-0.4734159250033112,-1.3097799353150255,0.14847161572052403,0.6446341379967645,1.0,4/15,5.68%,TBXAS1;DAGLB;PTGS1;PTGDS
prerank,positive regulation of vacuole organization (GO:0044090),-0.5419821671392001,-1.3093141982900953,0.16451612903225807,0.6429353989926267,1.0,4/10,7.95%,PIP4K2B;GRN;SH3GLB1;RAB3GAP2
prerank,negative regulation of cell migration (GO:0030336),-0.26424417747056606,-1.3082037297918685,0.0,0.6429375998905175,1.0,48/137,17.90%,LDLRAD4;MITF;TMEFF2;LRP1;ADARB1;LIMCH1;PTPRG;EVL;SCAI;ADAM15;NAV3;NEXMIF;PTPRK;ARHGAP4;RAP2A;PTPRJ;RAP2B;CLASP2;CORO1C;ROBO1;BST2;AFDN;DUSP3;NF1;MIA3;ENG;ATP1B2;RAP2C;SULF1;DUSP10;FLCN;SINHCAF;RECK;PTPRT;NDRG4;SMAD7;HMOX1;FGF2;SERPINE1;GJA1;ADORA3;ACVRL1;PFN2;EPHA4;JAG1;DAB2IP;MCC;THY1
prerank,DNA strand elongation (GO:0022616),0.6366218195611506,1.3081832801000226,0.17103620474406991,0.8182462375614896,1.0,7/18,16.32%,GINS1;POLA1;DCLRE1B;POLD2;POLD3;RAD50;MCM3
prerank,chromatin remodeling (GO:0006338),0.5540497231123245,1.3081585344703217,0.07959183673469387,0.8167756669834657,1.0,33/100,16.94%,MYB;CECR2;SMARCC2;MBD3;SMARCA5;CHD1L;RB1;ARID1B;SMARCD2;RSF1;NPM3;ACTR5;HNRNPC;MBD2;BAZ2B;RBBP4;BAZ1B;SMARCA4;ZBTB7A;SMARCC1;RUVBL2;RUVBL1;KAT2B;MTA2;HCFC1;SATB2;MYC;TADA2A;KDM4C;JARID2;ATRX;BAZ1A;SIRT1
prerank,regulation of microtubule nucleation (GO:0010968),0.6792480764300647,1.3080886286600784,0.17959770114942528,0.8154797345212764,1.0,5/10,22.05%,CKAP5;MECP2;ARHGEF7;EML2;DCTN1
prerank,arachidonic acid secretion (GO:0050482),-0.5354968300797187,-1.3080676571223384,0.15358361774744028,0.6368858978869992,1.0,8/10,46.48%,ANXA1;DRD2;PNPLA8;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,arachidonate transport (GO:1903963),-0.5354968300797187,-1.3080676571223384,0.15358361774744028,0.6368858978869992,1.0,8/10,46.48%,ANXA1;DRD2;PNPLA8;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,chordate embryonic development (GO:0043009),0.563077266982506,1.308028273237659,0.11914893617021277,0.8141297006559273,1.0,5/55,3.96%,STIL;BRCA1;DEAF1;LIG4;SULF2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.45752039517388443,-1.3076001108110369,0.13705583756345177,0.6349240110361739,1.0,12/17,31.10%,CACNA1C;ATP1A1;ATP1B2;RYR2;ATP1B1;GJA1;SLC8A1;ATP1A2;ATP1A3;FKBP1B;GJC1;GJD3
prerank,axon development (GO:0061564),-0.3012041990067987,-1.307194913221321,0.04,0.6327740662294077,1.0,31/78,24.10%,RTN4;PAK3;APP;ANK3;PLP1;ZDHHC17;CAMSAP2;DSCAML1;NTNG1;RYK;S100B;BAIAP2;MAP1A;CDK5R1;CTNNA2;ACTB;CDK5;GAP43;L1CAM;MAP1S;LLGL1;ADGRB1;SVBP;MAPK8IP3;RAB3A;AFG3L2;PARD3;SLITRK4;BRSK2;DCC;ATL1
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.4530427091987693,-1.3068654895101657,0.14795918367346939,0.6304977529513711,1.0,9/16,31.96%,TREM2;ENO1;FLCN;PINK1;SPHK2;PPARGC1A;ANTKMT;DNAJC30;AK4
prerank,cilium-dependent cell motility (GO:0060285),0.6000185126510391,1.3068496097522528,0.1745049504950495,0.8174920136766122,1.0,2/22,8.10%,DNAH8;CFAP44
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.522580707574176,-1.3061336801304049,0.17045454545454544,0.6295118744470892,1.0,7/12,28.64%,UBASH3B;ANK2;RYR2;ANXA6;FKBP1B;MTLN;PTK2B
prerank,negative regulation of DNA binding (GO:0043392),0.6046647100224891,1.3060200726954025,0.15242494226327943,0.8194352572744752,1.0,10/28,16.05%,HEY2;LEF1;E2F1;RSF1;SP100;JAK2;SUMO1;JUN;SIN3A;TFAP4
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.5663794177270451,1.3056420490185807,0.13130252100840337,0.8195216825507206,1.0,15/60,14.21%,AURKB;NEK2;MAPK1;DSCC1;RFC5;PCNA;CCT7;ATM;CCT2;TCP1;SMOC2;RFC2;CCT5;MYC;CHTF18
prerank,regulation of mitotic spindle assembly (GO:1901673),0.6193191908184059,1.3053082536487026,0.1780821917808219,0.8194939226356756,1.0,8/19,20.21%,CCSAP;PLK1;CHMP1B;HNRNPU;CHMP3;CHMP2B;DRG1;TPR
prerank,glycine metabolic process (GO:0006544),0.669925729524925,1.3049606202240054,0.1906116642958748,0.8194094506942052,1.0,1/12,1.10%,GCAT
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6022814975982611,1.3046819768047793,0.16374269005847952,0.8189953535211381,1.0,4/27,3.20%,SLC38A5;SLC25A12;SLC7A1;SLC6A5
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6388607447807828,1.3040198371972995,0.18396846254927726,0.8203271963496899,1.0,5/14,14.31%,DHX58;PUM2;PUM1;TLR5;USP15
prerank,peptidyl-serine phosphorylation (GO:0018105),0.5406423689752236,1.3037870695379368,0.04623115577889447,0.8198478750862936,1.0,42/153,14.91%,TTK;CDK1;CLSPN;MASTL;PLK1;MAPK1;AURKA;PRKCE;RPS6KA5;MAP4K1;MAPKAPK3;TLK1;TAF1;ATM;CSNK1A1;STK38L;AKT3;PKN2;CSNK1G2;PRKX;MAPK14;PRKCA;PRKACA;STK38;MARK2;MAST2;PDPK1;HIPK2;DYRK1A;VRK1;PRKCB;RPS6KA6;LMTK2;GRK2;ROCK2;PRKDC;LATS1;STK39;CDC7;GSK3B;SGK3;STK4
prerank,histone lysine methylation (GO:0034968),0.585069929138491,1.3037027179373184,0.16455696202531644,0.8186151298184028,1.0,10/33,14.94%,EZH2;MEN1;SUV39H1;WDR5B;DPY30;PAXIP1;SETDB2;KMT2A;RBBP5;KMT2B
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.6556598239467984,1.3034354892655828,0.1755829903978052,0.8182159068919869,1.0,2/13,3.03%,PMAIP1;VDAC2
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.40787239945991677,-1.3033301737458627,0.16666666666666666,0.6345182386104001,1.0,14/25,33.18%,HPRT1;PRPS2;GMPR2;PPAT;AMPD2;DCK;APRT;GART;PRPSAP2;SHMT2;AMPD3;SHMT1;PRPS1;PRPS1L1
prerank,regulation of hormone secretion (GO:0046883),-0.4736041624522823,-1.303127093696374,0.17674418604651163,0.6321429356937228,1.0,5/15,29.80%,VAMP2;SNX6;SOX11;ANXA1;OSM
prerank,regulation of water loss via skin (GO:0033561),0.6426265258822358,1.3026614047124132,0.18,0.8183071714489533,1.0,1/15,1.62%,STMN1
prerank,establishment of skin barrier (GO:0061436),0.6426265258822358,1.3026614047124132,0.18,0.8183071714489533,1.0,1/15,1.62%,STMN1
prerank,histone mRNA catabolic process (GO:0071044),0.6370893602933093,1.302516750052093,0.18880208333333334,0.817366424736546,1.0,8/15,19.63%,ATM;EXOSC10;DCP2;TUT4;ERI1;TUT1;TENT2;XRN1
prerank,histone H3-K9 demethylation (GO:0033169),-0.5016320264222158,-1.3022611450667951,0.17064846416382254,0.631481288722758,1.0,5/11,6.80%,KDM1A;KDM7A;KDM4A;PHF8;KDM4B
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.5089979803302714,-1.3019696134790224,0.15053763440860216,0.6293228636084662,1.0,4/12,19.63%,TREM2;IL18;TTBK1;CCL3
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.6434380747310626,1.3011515756941938,0.16261203585147246,0.8215291255668696,1.0,6/16,12.75%,MYB;BRCA1;DNMT1;SMAD4;PAXIP1;KMT2A
prerank,defense response to protozoan (GO:0042832),0.6740329900669977,1.301101837495933,0.1780250347705146,0.8201871513895462,1.0,4/12,11.92%,GBP4;BATF;GBP2;MYD88
prerank,regulation of intracellular protein transport (GO:0033157),0.5873047251523829,1.300322161510139,0.1674259681093394,0.8218551829603229,1.0,8/32,15.07%,KIF20B;PCNT;PCM1;PTPN14;OAZ1;SIRT7;PDCD10;RIPOR1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6564139217699662,1.300059010316155,0.18659658344283836,0.8214248307429756,1.0,6/14,12.75%,MYB;BRCA1;DNMT1;SMAD4;PAXIP1;KMT2A
prerank,negative regulation of viral life cycle (GO:1903901),0.6345897595445152,1.299024903536568,0.1913499344692005,0.8242082518464239,1.0,7/15,14.47%,SNX3;GSN;LY6E;TRIM11;IFITM3;PPIA;TRIM5
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.6068132670782398,1.2964561966737362,0.19851116625310175,0.8335295049792524,1.0,7/22,19.36%,IL12A;CYRIB;B2M;MAP3K7;MALT1;CD55;TRAF6
prerank,cotranslational protein targeting to membrane (GO:0006613),0.5414973778575638,1.296237946242013,0.09746192893401015,0.8329241934651488,1.0,47/91,22.90%,RPL7;RPL18A;RPS20;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;RPL23A;ARL6IP1;RPL28;RPS14;RPL41;RPLP2;RPS27;RPS5;RPS29;RPLP0;RPS11;RPL27A;RPS9;RPS15A;RPL12;SSR1;RPL3;SEC63;UBA52;RPL18;RPL5;RPS6;RPS17;RPS3;RPL21;RPL23;RPL17;RPL24;RPL8;RPL27;SEC62;RPL13A;RPS12;SSR2;RPS8;RPL15;RPL10;SRP68
prerank,synaptic vesicle membrane organization (GO:0048499),-0.45162991340262343,-1.2958495180195,0.15897435897435896,0.6436189398247025,1.0,8/17,20.50%,SYNGR1;SNAP47;STX4;STX3;STX2;STX1A;SYNGR2;AP3D1
prerank,nuclear export (GO:0051168),0.5477338079379992,1.2957012952002358,0.11031664964249234,0.8335624233818826,1.0,33/80,20.21%,ANKLE1;XPO1;POM121;DHX38;CCHCR1;NUP42;WASHC4;U2AF1;DESI1;EIF4A3;NUP214;SRSF3;SRSF4;NCBP1;CASC3;RNPS1;U2AF1L4;NUP188;THOC3;UPF3B;THOC5;THOC2;XPO4;SRSF7;THOC7;CDC40;DDX39B;POLDIP3;MALT1;HNRNPA1;NCBP2;SRSF2;TPR
prerank,retinoic acid metabolic process (GO:0042573),-0.4720237850692782,-1.2949796734494712,0.16091954022988506,0.6429053997663354,1.0,10/14,49.73%,BCO2;ALDH1A2;CYP26B1;CYP26C1;ALDH1A3;ALDH8A1;CYP2S1;UGT1A7;UGT1A8;UGT1A1
prerank,cilium movement (GO:0003341),0.5479867738516391,1.2941757051263845,0.15783664459161148,0.8385039280204607,1.0,5/48,10.61%,CCDC63;SPA17;CFAP206;SPEF2;CFAP73
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.44282399879604484,-1.293845284837298,0.1346153846153846,0.6431061404964669,1.0,5/18,9.14%,RIMS1;RAP1B;RIMS2;PREPL;RAP1A
prerank,positive regulation of viral life cycle (GO:1903902),0.6053734263151416,1.2932639073378513,0.1928746928746929,0.8409654029901126,1.0,7/22,21.46%,TMPRSS4;CD74;TRIM11;CHMP3;CHMP2B;LGALS9;VPS4A
prerank,homeostasis of number of cells (GO:0048872),0.6575050270630312,1.2920168181434577,0.20680272108843537,0.8446821250746077,1.0,6/12,16.15%,OCIAD2;NOTCH1;NAPEPLD;CARD9;F2R;UBAP2L
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.39623838965311997,-1.2915731929721634,0.14545454545454545,0.6466925295813424,1.0,12/23,31.59%,SMO;PIK3CD;VEGFA;FGF2;GJA1;MDK;SOX8;AGT;WNT5B;SOX9;SIRT6;PAX8
prerank,double-strand break repair via break-induced replication (GO:0000727),0.6561116354219538,1.2914709766318366,0.20861372812920592,0.8454697845538639,1.0,4/12,16.32%,CDC45;MCM6;CDC7;MCM3
prerank,regulation of intracellular signal transduction (GO:1902531),0.5346688918992099,1.2912419774808106,0.002,0.8448789955903142,1.0,110/420,15.21%,TPX2;CDK1;BRIP1;AURKB;ECT2;FAM83D;RACGAP1;BARD1;RAD1;BRCA1;DEPDC1B;ARHGEF5;RMI2;EXO1;RPA2;MBD3;ARHGAP15;CHEK2;ARHGAP11A;BLM;MAPK1;ARHGAP33;AURKA;DAPK2;TIAM1;NET1;AKAP12;EZR;RCN3;TOPBP1;RFC5;RAD9A;ULK4;PML;MAP2K6;PIDD1;AKAP7;PTPN22;ARHGEF18;RBBP8;ARHGDIB;STK11;CHEK1;BRPF1;TAF1;IKBKG;MDM4;ATM;ARHGEF3;TTI1;GPAT3;RBBP4;FAM13A;PDE2A;TRAF3;MOB3B;PIP5K1B;BIRC2;TAF7;PIN1;TAF15;GNAI1;ARHGAP35;MAPK14;RHNO1;ENTPD5;DNA2;PLCG2;HUS1;SOS1;ITGAV;ARHGAP19;EGFR;RPA1;GMIP;PEX5L;RFC2;PDPK1;HIPK2;KAT6A;RIT2;RHOU;STARD8;EHMT1;ARHGAP39;ARHGAP30;TAF6;XIAP;MLST8;TTC5;CRK;MTA2;PTEN;FGD3;TOP3A;ARHGAP9;RAC2;ING2;ARHGAP45;ING5;PRKAG2;TAF2;SGMS1;RPA3;ARHGAP26;STK4;TP53;RAD50;ARHGAP31;BCR
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5664845787187923,1.2905157945582861,0.15122470713525027,0.8463722232089891,1.0,16/46,17.49%,KIF14;ITGB7;ATRNL1;ATRN;LAMA5;LAMC1;LAMB2;LAMB3;ITGAV;NTNG2;ITGA8;NRP1;PARVB;RAC1;PARVA;FN1
prerank,negative regulation of bone remodeling (GO:0046851),-0.5216787841610301,-1.2899519253381837,0.17543859649122806,0.648194397731149,1.0,2/11,5.61%,UBASH3B;TNFAIP3
prerank,histone methylation (GO:0016571),0.5881665016509988,1.2897775809417598,0.1772885283893395,0.847922652045551,1.0,7/26,13.75%,EZH2;SUV39H1;EHMT1;FBL;NSD3;SIRT7;CREBBP
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5413735386935428,1.2891925572009273,0.10214504596527069,0.8489011125023551,1.0,44/87,22.90%,RPL7;RPL18A;RPS20;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;RPL23A;RPL28;RPS14;RPL41;RPLP2;RPS27;RPS5;RPS29;RPLP0;RPS11;RPL27A;RPS9;RPS15A;ZFAND2B;RPL12;RPL3;SEC63;UBA52;RPL18;RPL5;RPS6;RPS17;RPS3;RPL21;RPL23;RPL17;RPL24;RPL8;RPL27;RPL13A;RPS12;RPS8;RPL15;RPL10;SRP68
prerank,regulation of macrophage cytokine production (GO:0010935),0.6402196331725354,1.2888291978032127,0.1880920162381597,0.8487881932545128,1.0,5/13,16.94%,CD74;GPRC5B;PLCG2;TGFB2;SIRT1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.38238831764517034,-1.2888048637035057,0.14965986394557823,0.6486265681759061,1.0,9/27,20.76%,ABCA1;ABCA5;LPL;ITGB3;IL18;CSF1;CD36;AGT;NFKBIA
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.58509295892161,1.2881640934672243,0.17130144605116795,0.849964900195096,1.0,14/36,16.71%,CYP1B1;OCIAD2;CAV1;CENPJ;NOTCH1;JAK2;IL10RA;ADIPOR1;PIGU;EGF;F2R;HGS;JAK3;VHL
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5577693484754105,1.2880928147612152,0.1411637931034483,0.8487469575076951,1.0,16/48,16.94%,BRCA1;CHEK2;E2F1;PML;MSH6;PHLDA3;CASP2;ATM;BOK;HIPK2;PRKDC;CASP9;TP53;TMEM109;CRIP1;SIRT1
prerank,purine-containing compound salvage (GO:0043101),-0.5025271938986785,-1.2874955132849801,0.15658362989323843,0.6494305833668165,1.0,5/12,17.23%,HPRT1;GMPR2;AMPD2;DCK;APRT
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4493766764294985,-1.2861814249412113,0.14795918367346939,0.6471478087407463,1.0,8/16,20.32%,ARHGAP6;APOD;CLASP2;CORO1C;RCC2;ACVRL1;THBS1;PHLDB2
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4493766764294985,-1.2861814249412113,0.14795918367346939,0.6471478087407463,1.0,8/16,20.32%,ARHGAP6;APOD;CLASP2;CORO1C;RCC2;ACVRL1;THBS1;PHLDB2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4907123562503764,-1.2859427281844888,0.17647058823529413,0.6447828768380188,1.0,3/13,13.00%,TREM2;ENO1;PINK1
prerank,ribosomal small subunit assembly (GO:0000028),0.6289541367073765,1.2853548684436396,0.19745222929936307,0.8586350236457734,1.0,6/16,13.52%,RPS19;RPS14;RPS27;MRPS7;RPS5;PRKDC
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.4248776978172795,-1.2848937341960636,0.1651376146788991,0.6451045317007804,1.0,8/19,16.25%,HS6ST3;NDST3;B3GAT3;EXT2;HS6ST2;EXTL3;XYLT2;HS3ST5
prerank,carboxylic acid transport (GO:0046942),0.5586648138720944,1.2845402242542283,0.14393939393939395,0.8604334950149686,1.0,6/55,7.49%,SLC6A12;SLC38A5;SLC1A5;SLC7A1;SLC16A12;SLC16A1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5402848999959141,1.2842857690595497,0.12704918032786885,0.8599050514648571,1.0,21/73,15.39%,ANP32B;DAP;PDCD2;SENP1;APAF1;PIDD1;S100A9;TNFSF10;S100A8;CASP2;TRADD;BOK;JAK2;IFT57;BCL2L13;FAS;F3;RACK1;CFLAR;CASP9;F2R
prerank,positive regulation of organelle assembly (GO:1902117),0.5608435434667871,1.283968534843001,0.15553121577217963,0.8597409840840041,1.0,16/44,20.49%,SPAG5;GPSM2;CCDC88A;ARHGAP35;DYNC1H1;FUZ;TAPT1;NUMA1;BBS4;CNOT1;CNOT6;MARK4;PIP4K2A;G3BP1;PLK4;CROCC
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.5679679027997326,1.2838141612448148,0.1439312567132116,0.8588262949329586,1.0,21/48,18.42%,ATAD2;POLR1B;HMGA1;SMARCA5;ARID1B;DEK;CDCA4;CHEK1;ASF1A;BAZ1B;PHF2;POLR1A;KAT2B;POLR1F;SERTAD2;POLR1C;ELOF1;POLR2K;TAF1C;TAF1D;POLR1G
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.28636727302864873,-1.2832931781886743,0.05,0.6465661967912713,1.0,28/90,18.83%,IGF1R;KDM1A;EBF2;CMKLR1;APPL2;LPIN1;ESRRG;IL4R;ACADL;GNAS;PPARGC1B;MFN2;PRLR;HDAC3;PDGFC;ELOVL6;VEGFA;IL18;EPAS1;GJA1;GRB10;HADH;CD36;ADRB1;KDM3A;PER2;ADRB2;KDM6B
prerank,potassium ion export across plasma membrane (GO:0097623),-0.47932150614965857,-1.2825885372403343,0.19245283018867926,0.6457120969670148,1.0,9/13,51.77%,KCND3;KCNK5;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNA5;KCNE2
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.5006609928135549,-1.2825507800682225,0.2049469964664311,0.6429238456339335,1.0,9/11,41.60%,ITPKB;IP6K1;FGF2;IPMK;IPPK;ITPKC;ITPKA;IP6K2;IP6K3
prerank,negative regulation of B cell activation (GO:0050869),0.6023294676131034,1.282418287950145,0.18976279650436953,0.8633663758586397,1.0,7/21,17.59%,BLK;BANK1;ATM;TNFRSF13B;TYROBP;RC3H1;FCGR2B
prerank,UV-damage excision repair (GO:0070914),0.6610561223851934,1.2818750010025852,0.19281914893617022,0.8642995430867525,1.0,5/12,17.70%,POLA1;ACTR5;POLD3;SIRT1;DDB2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5340090005568464,1.2818556905660488,0.13993871297242083,0.8628409901389177,1.0,18/86,16.39%,TTK;INHBC;MEN1;FBXL15;CCN1;UBE2O;STK11;NOTCH1;JAK2;HIPK2;SMAD4;BMPR1A;ING2;NUMA1;CREBBP;RNF111;BMP3;TGFB2
prerank,organelle assembly (GO:0070925),0.5309961992586856,1.2816064607084343,0.006,0.8624508366524549,1.0,97/385,17.24%,CENPF;CENPE;DLGAP5;CENPA;TMOD4;NEK2;KIF24;CENPW;EMC6;ANLN;TUBGCP6;RCC1;IFT80;EXOC2;ATG13;POC1B;PCNT;FLNA;EIF2S1;EIF2A;HAUS5;WDPCP;HAUS6;CEP83;EXOC4;TUBGCP4;BBIP1;CEP89;RAB1B;GSN;CENPJ;WDR90;DISC1;SSX2IP;ARF4;HDAC6;CSDE1;MAPRE3;NOTCH1;MRPL22;DYNC1H1;FUZ;RP2;OFD1;PTPDC1;RAB8A;CEP250;CFAP44;DBNL;UBQLN1;TMEM237;CYS1;FLII;EDC3;ABLIM3;PCM1;PDE6D;RFX2;TMEM41B;HAUS4;CCDC28B;CEP162;BECN1;AMBRA1;ABCC4;RAB8B;CCDC57;HAUS7;DHX29;SCLT1;RAB43;TUBGCP3;CCDC61;ARL13B;CHMP1B;BBS4;LSM14A;PIBF1;PRRC2C;EXOC5;TP53INP2;MKS1;DYNLL1;RC3H1;LIMD1;ATG101;HGS;DYNLT2B;UBAP2L;PARVA;IFT172;ATG2B;CHMP3;ATP6V0D1;IFT140;BBS9;CHMP2B
prerank,cellular response to interleukin-7 (GO:0098761),0.6189528142101389,1.2814877505170634,0.20280612244897958,0.8599299180336673,1.0,7/17,16.70%,IL2RG;IL7R;SMARCA4;SOCS2;STAT5B;IRS1;JAK3
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.6189528142101389,1.2814877505170634,0.20280612244897958,0.8599299180336673,1.0,7/17,16.70%,IL2RG;IL7R;SMARCA4;SOCS2;STAT5B;IRS1;JAK3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6374877393053249,1.2811432665722005,0.1959544879898862,0.8598354377010781,1.0,1/16,2.11%,CLDN18
prerank,regulation of cholesterol storage (GO:0010885),-0.456615413774762,-1.280595429474467,0.16129032258064516,0.6454765337725664,1.0,4/15,10.91%,TREM2;ABCA1;LPL;SCARB1
prerank,negative regulation of protein metabolic process (GO:0051248),0.5456375714287717,1.2798179679860644,0.16702819956616052,0.8638150548754563,1.0,11/48,9.92%,MAD2L1;IAPP;FLNA;AZIN1;SNX3;MDM4;PIN1;ITGAV;VBP1;EGFR;PFDN5
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.6302798008025807,1.2790047213142803,0.21348314606741572,0.8657608615812402,1.0,8/14,18.78%,HNRNPC;BOLL;ELAVL4;MAPK14;HNRNPA0;MYD88;ANGEL2;ELAVL1
prerank,negative regulation of catabolic process (GO:0009895),0.5527674691300248,1.2784637863896402,0.1613958560523446,0.8664614183518632,1.0,7/47,9.19%,MAD2L1;FLNA;AZIN1;SNX3;MDM4;PIN1;EGFR
prerank,actin filament polymerization (GO:0030041),0.5834047751485167,1.2782633297036656,0.1914648212226067,0.8658183222376864,1.0,3/29,8.54%,DIAPH3;GSN;JAK2
prerank,regulation of neuron migration (GO:2001222),0.5991519070858979,1.2781717285483827,0.18321513002364065,0.8646788148527735,1.0,2/26,3.78%,KIF20B;ULK4
prerank,negative regulation of cartilage development (GO:0061037),0.6426189153174996,1.277992765380793,0.208731241473397,0.863874659185977,1.0,2/13,5.66%,ADAMTS7;PTHLH
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5780059548489773,1.277769155276098,0.20141342756183744,0.8633297063544257,1.0,15/29,23.13%,LSM6;DCPS;EXOSC8;DCP1B;DCP2;LSM2;EDC3;LSM5;DCP1A;LSM7;CNOT6;CNOT8;CNOT7;DIS3;LSM3
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.45665855540464534,-1.2775568388721137,0.1717557251908397,0.6507932827983355,1.0,6/14,17.04%,TREM2;GRN;IGF1;TNFRSF1B;CD200;CST7
prerank,regulation of neuroinflammatory response (GO:0150077),-0.4379959248703372,-1.2769250786847737,0.16062176165803108,0.6497493226946799,1.0,6/19,14.74%,TREM2;IGF1;TNFRSF1B;CD200;IL18;DAGLA
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.619070625177704,1.2768326552463751,0.19125,0.8642735830227609,1.0,7/19,17.19%,POLR2I;POLR2A;TERF2;TERF1;ATRX;POLR2K;POLR2J
prerank,regulation of DNA recombination at telomere (GO:0072695),0.619070625177704,1.2768326552463751,0.19125,0.8642735830227609,1.0,7/19,17.19%,POLR2I;POLR2A;TERF2;TERF1;ATRX;POLR2K;POLR2J
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.6427733879300043,1.2766324993418905,0.20533333333333334,0.8635560470100536,1.0,9/15,19.42%,NOP10;CCT7;CCT2;TCP1;RUVBL2;RUVBL1;CCT5;DKC1;CCT6A
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5348490291948804,-1.2761646733114094,0.18006430868167203,0.6491252079484877,1.0,3/10,4.87%,HK2;HK3;PFKL
prerank,regulation of cellular localization (GO:0060341),0.5491684003468102,1.2754957711094577,0.16757344940152338,0.8667981079023636,1.0,7/46,7.64%,BLK;FOXA2;SPAG5;MAD1L1;NR1D1;GSN;DYNC1H1
prerank,positive regulation of chromatin organization (GO:1905269),0.6490537754482686,1.275494555271262,0.2219215155615697,0.8652911442374138,1.0,8/12,24.79%,TERF2;H3-3A;TERF1;SIN3A;ATRX;UBE2N;MIER1;TINF2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.576505970028724,1.274700939831936,0.17727272727272728,0.8669669494938287,1.0,17/33,21.82%,SLBP;SNRPF;CPSF2;SETX;NCBP1;CSTF3;SCAF8;SNRPG;PCF11;CPSF1;CLP1;TTF2;NCBP2;SNRPB;CPSF7;WDR33;PAPOLA
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5140605942695046,-1.2744980750913173,0.20202020202020202,0.6507290829899218,1.0,3/11,12.47%,MERTK;SELENOS;AXL
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.4254585095650752,-1.2743378171913147,0.14948453608247422,0.6483003763246749,1.0,5/19,14.50%,HSPD1;TLR7;MAVS;TLR4;CHUK
prerank,negative regulation of DNA replication (GO:0008156),0.6448980030216366,1.2740374256380511,0.22010869565217392,0.8682726784615489,1.0,5/13,15.66%,S100A11;GMNN;TERF1;CDAN1;WAPL
prerank,positive regulation of protein sumoylation (GO:0033235),0.6547641529200796,1.2739001167225275,0.2182890855457227,0.8673172140325677,1.0,5/10,17.98%,SAE1;UBA2;PIAS3;PIAS1;HDAC4
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.3722182677087706,-1.273612115899974,0.1111111111111111,0.6477102533730376,1.0,12/36,11.28%,NSF;ANK3;MACF1;GGA3;OPTN;GOLGA7;PREPL;AFDN;VAMP5;VAMP2;GOLGA4;RAB31
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.6717176892292287,1.2726242905326934,0.21726618705035972,0.8711603566370753,1.0,8/11,19.42%,CCT7;CCT2;TCP1;TERF1;CCT5;DKC1;WRAP53;CCT6A
prerank,histone H2B ubiquitination (GO:0033523),-0.5200682089315352,-1.272271295313198,0.19243986254295534,0.6487787043823823,1.0,4/10,5.78%,WAC;UBE2E1;CTR9;DTX3L
prerank,protein localization to mitochondrion (GO:0070585),-0.5206847646244392,-1.2722609983014168,0.21453287197231835,0.6460136919770227,1.0,5/11,19.57%,HK2;RALA;PINK1;MAIP1;COX18
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6737083689287803,1.271909838185266,0.21304347826086956,0.8726293746662198,1.0,5/10,23.11%,OXSR1;CCR2;STK39;ADAM10;ADAM17
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5920324076248704,1.2707208157284946,0.18347509113001215,0.874676556162242,1.0,9/23,19.40%,PMAIP1;E2F1;YWHAH;TFDP1;TFDP2;PPP3CC;TP53;YWHAE;CASP8
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5920324076248704,1.2707208157284946,0.18347509113001215,0.874676556162242,1.0,9/23,19.40%,PMAIP1;E2F1;YWHAH;TFDP1;TFDP2;PPP3CC;TP53;YWHAE;CASP8
prerank,hepaticobiliary system development (GO:0061008),0.5964008722909472,1.2701998699932915,0.19777503090234858,0.8753892946953182,1.0,12/20,20.79%,PHF2;ARID5B;CDK5RAP3;NIPBL;CEBPG;PRKCSH;XBP1;NKX2-8;PROX1;PKD2;MET;CITED2
prerank,oligosaccharide metabolic process (GO:0009311),-0.3378884515139881,-1.2701383864642097,0.0975609756097561,0.6490487772141152,1.0,18/46,23.53%,MANBA;ST8SIA1;MAN2B1;ST3GAL6;ST6GALNAC4;ST6GAL2;ST6GALNAC6;ST3GAL4;MAN2C1;ST8SIA5;MAN2B2;GLA;ST6GALNAC3;ST8SIA3;MAN1B1;GAL3ST4;B3GALT5;B3GALT2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5711400947012231,1.2700820056584083,0.17972350230414746,0.8743912979086421,1.0,12/31,19.40%,PMAIP1;E2F1;YWHAH;TFDP1;BOK;TFDP2;CHCHD10;PPP3CC;GSK3B;TP53;YWHAE;CASP8
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6365447155488075,1.2699811641051342,0.20234986945169714,0.8733257905337549,1.0,3/15,11.99%,HAAO;KMO;FAH
prerank,methylguanosine-cap decapping (GO:0110156),0.657699127434666,1.2699280692734507,0.2231638418079096,0.8720715152117257,1.0,5/10,12.28%,DCPS;DCP1B;DCP2;EDC3;DCP1A
prerank,negative regulation of wound healing (GO:0061045),-0.38612953213424095,-1.2693709828954598,0.15267175572519084,0.6484205274188128,1.0,9/28,14.35%,SERPINE2;APOE;SLC12A2;CD34;CLASP2;TFPI;ALOX5;FGF2;SERPINE1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5134121676229887,-1.2686555280866347,0.20860927152317882,0.6475672214048133,1.0,2/10,2.29%,SALL1;BASP1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.5006785162970717,-1.2684268259999703,0.17391304347826086,0.6455039778025815,1.0,4/10,20.15%,CD84;SLC8B1;SARAF;STIM1
prerank,vesicle transport along microtubule (GO:0047496),0.5956367575594278,1.2682671995603356,0.20848938826466917,0.8777410956828378,1.0,10/23,19.28%,NDE1;FBXW11;DYNC1H1;PAFAH1B1;KIF13A;HAP1;KIFAP3;FYCO1;CLN3;TRAK2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6503626974765573,1.2680283892682822,0.2231638418079096,0.8758107385108204,1.0,5/11,21.45%,IL2RG;IL2RA;STAT5B;JAK3;SYK
prerank,cellular response to interleukin-2 (GO:0071352),0.6503626974765573,1.2680283892682822,0.2231638418079096,0.8758107385108204,1.0,5/11,21.45%,IL2RG;IL2RA;STAT5B;JAK3;SYK
prerank,macrophage activation involved in immune response (GO:0002281),-0.4678956137516399,-1.2677476066632638,0.20610687022900764,0.644746244970845,1.0,5/13,7.89%,TREM2;SBNO2;GRN;CX3CR1;NMI
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.4578846882427928,-1.2676846591344928,0.1918819188191882,0.6422634122495475,1.0,9/13,37.72%,LTBP1;FSTL1;FBN1;GREM2;CD46;NBL1;CHRDL1;GREM1;BMP2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.5762129839641063,1.2672044462678331,0.18906605922551253,0.8778278764718354,1.0,9/32,21.84%,CD19;NPSR1;PDPK1;HAP1;F2R;PLCG1;SNCA;PKD2;CALM3
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4778619416347184,-1.2663546788436295,0.15384615384615385,0.6434259209478053,1.0,6/13,18.74%,ABCA1;LPL;CDH13;FCER1G;CD36;CD81
prerank,histone acetylation (GO:0016573),0.5381357106596827,1.2661744771314267,0.15527950310559005,0.8805661935698761,1.0,26/69,18.55%,JADE1;NAA40;BRCA2;LEF1;EPC1;BRD8;BRD1;BRPF1;YEATS4;KAT6A;RUVBL2;RUVBL1;TAF6;BRPF3;KAT2B;HAT1;ING3;ING5;CREBBP;TADA2A;TADA3;YEATS2;TAF9;MAP3K7;PHF20;PHF20L1
prerank,in utero embryonic development (GO:0001701),0.5864991067116732,1.266093819239012,0.21529411764705883,0.879426675282014,1.0,2/25,3.65%,STIL;LIG4
prerank,peptidyl-serine modification (GO:0018209),0.5244693875811302,1.2656517563058454,0.06726907630522089,0.8797482058092749,1.0,42/166,14.91%,TTK;CDK1;CLSPN;MASTL;PLK1;MAPK1;AURKA;PRKCE;RPS6KA5;MAP4K1;MAPKAPK3;TLK1;TAF1;ATM;CSNK1A1;STK38L;AKT3;PKN2;CSNK1G2;PRKX;MAPK14;PRKCA;PRKACA;STK38;MARK2;MAST2;PDPK1;HIPK2;DYRK1A;VRK1;PRKCB;RPS6KA6;LMTK2;GRK2;ROCK2;PRKDC;LATS1;STK39;CDC7;GSK3B;SGK3;STK4
prerank,RNA transport (GO:0050658),0.5367701722679511,1.265579742012795,0.14933058702368693,0.8785395027000228,1.0,31/71,20.21%,CKAP5;POM121;DHX38;SLBP;U2AF1;ZFP36L1;EIF4A3;NUP214;SRSF3;HNRNPA2B1;SRSF4;NCBP1;CASC3;RNPS1;U2AF1L4;NUP188;THOC3;UPF3B;THOC5;FLOT1;THOC2;SRSF7;THOC7;CDC40;DDX39B;POLDIP3;HNRNPA1;NCBP2;SRSF2;PNPT1;TPR
prerank,epiboly involved in wound healing (GO:0090505),0.6072903569893036,1.2655146058230262,0.2249357326478149,0.8773515448928506,1.0,6/16,14.92%,FLNA;CCN1;CD44;ARHGAP35;TOR1A;PDCD10
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5820165322348672,1.2647340407984722,0.20963855421686747,0.877732850321871,1.0,7/23,14.62%,MEN1;STK11;HIPK2;SMAD4;ING2;CREBBP;RNF111
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5820165322348672,1.2647340407984722,0.20963855421686747,0.877732850321871,1.0,7/23,14.62%,MEN1;STK11;HIPK2;SMAD4;ING2;CREBBP;RNF111
prerank,neutrophil migration (GO:1990266),0.5376061219451214,1.2639693009015358,0.15287958115183245,0.8792913682914015,1.0,5/58,5.77%,PRTN3;CD177;PECAM1;S100A9;S100A8
prerank,rRNA 3'-end processing (GO:0031125),0.6760821700382021,1.2634691044322959,0.23066104078762306,0.8799833431117422,1.0,4/10,11.85%,ERI2;EXOSC8;EXOSC10;ERI1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.5410987031206649,1.2629192718818678,0.14654282765737875,0.8808609211277209,1.0,30/73,18.42%,EZH2;POLR1B;SMARCA5;GLMN;PPM1D;DEK;SUZ12;EPC1;CTCF;RBBP4;HDAC6;PHF19;H3-3A;BAZ1B;PHF1;PHF2;POLR1A;MECP2;DNMT1;KAT2B;POLR1F;POLR1C;JARID2;TASOR;POLR2K;TAF1C;TDG;HDAC4;TAF1D;POLR1G
prerank,negative regulation of binding (GO:0051100),0.5301853512326836,1.262071285728692,0.13524590163934427,0.8828941941993149,1.0,27/81,19.05%,AURKB;LEF1;E2F1;AURKA;DDX11;RSF1;ZFPM1;SLPI;SP100;CAV1;DISC1;PIN1;JAK2;PARK7;SUMO1;JUN;RACK1;TFIP11;GSK3B;WAPL;TFAP4;STYX;PEX14;PPP1CA;LRRK2;GNL3L;CDKN1A
prerank,response to unfolded protein (GO:0006986),-0.3332283942185705,-1.261852825999047,0.08,0.6527066739333184,1.0,14/48,19.82%,HSP90AA1;STT3B;HSPD1;OPTN;ERN1;TM7SF3;TOR1B;HSPH1;ERP44;PRKN;HSPA5;DAB2IP;DNAJC4;HSPA13
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.4424450592245551,-1.261788828158156,0.178743961352657,0.650190521842787,1.0,11/16,31.41%,CACNA1C;ANK2;DMD;RYR2;CALM1;SLC8A1;ATP1A2;GSTO1;FKBP1B;CAMK2D;CALM2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6009567928656511,1.2617740962189383,0.19828641370869032,0.8826717431541223,1.0,6/22,14.59%,MASTL;PTPA;PPP1R11;PPP1R15A;ROCK2;GSK3B
prerank,peptide catabolic process (GO:0043171),-0.39843262305344707,-1.261270280513864,0.17032967032967034,0.6489194551534381,1.0,7/23,10.33%,XPNPEP1;CPQ;NPEPPS;ANPEP;IDE;ECE1;GGT5
prerank,negative regulation of histone modification (GO:0031057),0.6248108360976566,1.2604796971526662,0.20105124835742444,0.8867071276387044,1.0,5/14,17.91%,BRCA1;TWIST1;TAF7;JARID2;SNCA
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.518394224791928,1.2601971729456065,0.009,0.8864014376198778,1.0,116/497,16.25%,CENPF;DEPDC1;BIRC5;FOXM1;GFI1;MYB;HMGB2;EZH2;RCOR2;MEN1;SUV39H1;BRCA1;SMARCC2;HMGA1;DAP;HEY2;RBM15;DEAF1;LEF1;E2F1;RB1;RIOX1;RSF1;CBX5;CD38;S100A11;TWIST1;PML;BCL7A;FBXW11;TIMELESS;PA2G4;HDAC10;UBE2I;MTA3;RPS6KA5;EPC1;CTCF;SCMH1;FOXP1;DACH1;CDKN2A;NR1D1;NKAP;MBD2;FOXO1;PBXIP1;MBD1;ARID4A;GMNN;HDAC6;KLF10;TAF7;NOTCH1;XRCC6;EIF4A3;AHR;SFMBT1;SPEN;SAP18;PSPC1;SMARCA4;CIR1;CIPC;ZBTB16;TERF1;ZBTB7A;NONO;ZNF148;MECP2;PFDN5;TFDP2;CPEB3;NR2F2;KAT6A;ID4;ZEB1;TRIM33;EHMT1;ARID5B;SUMO1;SMAD4;CCAR2;TYMS;JUN;ATF5;PLCB1;IGF2BP3;CDAN1;FOXP2;BAP1;SETDB2;ZBTB33;FXR1;SP3;RACK1;NIPBL;DDIT3;LSM14A;BCL6;GSK3B;CNOT1;YEATS2;LIMS1;ATF7IP;TP53;LIMD1;POU2F1;JARID2;WAPL;SIN3A;TCF7L2;SAMD4A;TFAP4;FOXK2;TRIM28
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5291473299396975,-1.2601127183817116,0.1986970684039088,0.6493795259964333,1.0,6/10,25.69%,GALNT3;POGLUT1;GALNT1;POGLUT3;GALNT2;MGAT5B
prerank,regulation of transposition (GO:0010528),0.6524620706083438,1.2595635246604187,0.22829131652661064,0.8875637704104731,1.0,3/13,13.34%,MYBL1;UBR2;SIRT7
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.44505701795420805,-1.258470492562179,0.1867704280155642,0.6511241950531209,1.0,8/15,13.78%,SRPRA;SPCS2;ZFAND2A;RAB3GAP2;RYR2;SEC61G;SEC61A1;SRPRB
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6509708723162528,1.2580689955704036,0.22237960339943344,0.8922467924116053,1.0,8/12,19.42%,CCT7;CCT2;TCP1;CCT5;DKC1;GNL3L;WRAP53;CCT6A
prerank,positive regulation of microtubule polymerization (GO:0031116),0.566469181206562,1.2579761718048954,0.19534883720930232,0.891166727204993,1.0,12/28,22.05%,CKAP5;CDK5RAP2;CLASP1;MECP2;SLAIN2;NUMA1;RAC1;DRG1;RPS3;MET;MAPT;DCTN1
prerank,regulation of multicellular organism growth (GO:0040014),-0.4571369592386982,-1.2578932451567213,0.1572052401746725,0.6499814807286924,1.0,3/15,7.51%,APP;IGF1;PPIB
prerank,response to UV-B (GO:0010224),0.6534760757508127,1.257694578745897,0.21060171919770773,0.8908423532018391,1.0,2/12,4.80%,IL12A;STK11
prerank,apical junction assembly (GO:0043297),0.5417940491620097,1.2576600478672486,0.19553666312433582,0.8895371060221443,1.0,6/53,8.93%,ECT2;CLDN18;PECAM1;CTNNA1;PKN2;STRN
prerank,negative regulation of proteolysis (GO:0045861),-0.37009655242559103,-1.2573234757931864,0.1391304347826087,0.6490497962905736,1.0,11/34,17.04%,SERPINE2;TIMP2;CAMK2N1;TIMP3;BAG6;CLN8;CDK5;PRNP;DNAJC1;EPHA4;CST7
prerank,positive regulation of phagocytosis (GO:0050766),-0.32138713619060644,-1.2570780248510878,0.0759493670886076,0.6471329874377401,1.0,9/47,6.72%,MERTK;SIRPA;TREM2;APPL2;CD300LF;IL15RA;PTPRJ;PYCARD;FCER1G
prerank,regulation of fibrinolysis (GO:0051917),0.6430962407807108,1.2565112048587663,0.22164276401564537,0.8929115549477864,1.0,2/13,3.70%,FAP;USF1
prerank,regulation of T cell chemotaxis (GO:0010819),0.6562555805833437,1.2553863858244554,0.2332859174964438,0.896139129689775,1.0,5/11,23.11%,OXSR1;CCR2;STK39;ADAM10;ADAM17
prerank,regulation of phosphorylation (GO:0042325),0.5232136507164349,1.2540639404382161,0.1219758064516129,0.9001903013632347,1.0,49/120,21.99%,BARD1;CDKN2C;NUP43;POM121;NDC1;CCDC88A;GLMN;ANKLE2;PML;NUP107;CDKN2A;NUP42;CCDC88C;NUP50;PIN1;NUP214;NUP160;ZBTB7A;EGFR;CDKN2D;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;NRP1;PRKAG2;PSEN1;DYNLL1;EGF;SLAMF8;CD24;AAAS;SIRT1;NUP37;FN1;CDKN1A;NUP85;PPP2CA;TPR;ILK;EIF6;PRKAG1;MCM7;ROCK1;IKBKB;CADM4;NUP93
prerank,transepithelial transport (GO:0070633),-0.4425626417766938,-1.2535089929692882,0.18691588785046728,0.6545722084521842,1.0,11/15,36.84%,SLC12A2;SLC1A2;ABCC1;SLC1A3;CXADR;GPLD1;SLC1A1;SLC26A6;SLC23A1;SLC23A2;BEST1
prerank,regulation of cellular response to stress (GO:0080135),0.518698079388984,1.2530974758180626,0.13636363636363635,0.9028112988277448,1.0,46/115,20.21%,RPA2;NUP43;MAPK1;POM121;NDC1;NUP107;CRHBP;ABCD1;NUP42;MBTPS2;ARMT1;ATM;NUP50;NUP214;NUP160;NUP205;RPA1;SEC13;AMFR;NUP188;CCAR2;MLST8;NUP98;RANBP2;NUP210;ROCK2;ING2;CREBBP;DNAJC7;BAG1;BAG3;CASP9;RPA3;GSK3B;DNAJC2;AAAS;SIRT1;DNAJB1;NUP37;ADCY8;YWHAE;CLN3;NUP85;NPAS2;PNPT1;TPR
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.560428528579966,1.2524311258555016,0.2308584686774942,0.9041956812198078,1.0,15/31,23.13%,LSM6;DCPS;EXOSC8;DCP1B;DCP2;LSM2;EDC3;LSM5;DCP1A;LSM7;CNOT6;CNOT8;CNOT7;DIS3;LSM3
prerank,primary alcohol metabolic process (GO:0034308),0.5897080717689478,1.252179185582692,0.22328931572629052,0.9037672570855146,1.0,5/25,14.52%,LRAT;CYP1B1;NAPEPLD;RDH10;GPD2
prerank,apoptotic cell clearance (GO:0043277),-0.3581489090407361,-1.2520246813041689,0.15,0.6560195699881232,1.0,14/30,19.93%,TREM2;LRP1;RHOBTB1;XKR6;RHOBTB2;ITGB3;SCARB1;RHOG;TGM2;RHOH;RARA;THBS1;ADGRB1;XKR4
prerank,positive regulation of cell aging (GO:0090343),0.6509863114163341,1.2514736423159223,0.25370919881305637,0.9052802892843019,1.0,5/11,16.94%,HMGA1;CGAS;CDKN2A;B2M;SIRT1
prerank,microtubule bundle formation (GO:0001578),0.5450086007257694,1.249739075997914,0.1828193832599119,0.9109765279482485,1.0,5/42,5.95%,KIF20A;PLK1;CDK5RAP2;CFAP206;CLASP1
prerank,protein import into peroxisome membrane (GO:0045046),0.5824298614921363,1.2496623255970143,0.22727272727272727,0.9098357408453233,1.0,9/22,12.03%,PEX26;ABCD1;ACBD5;PEX11B;PXMP4;GDAP1;PEX2;RAB8B;FIS1
prerank,transition metal ion homeostasis (GO:0055076),0.5675992695844474,1.2491290384737355,0.21096543504171633,0.9106118058224211,1.0,6/28,11.30%,TFR2;CUTC;HEPH;CYBRD1;B2M;XIAP
prerank,epithelial cell differentiation (GO:0030855),0.5259748476931115,1.2486478248002255,0.16391752577319588,0.911241344371561,1.0,5/88,5.60%,E2F7;CDK1;E2F8;PCNA;EDF1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5029714125417359,-1.2482224149856556,0.21708185053380782,0.6638695390725331,1.0,5/11,9.10%,EGLN1;OGFOD1;P4HA1;P3H2;EGLN3
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5596516750307223,1.2473733803096734,0.20914285714285713,0.9152137074750029,1.0,10/31,18.68%,MEN1;RIOX1;TWIST1;CDK6;NOTCH1;SKI;LIMD1;TRPM4;SUFU;CRIM1
prerank,regulation of dephosphorylation (GO:0035303),0.6375831397466807,1.247271310644142,0.22996057818659657,0.9141372475568641,1.0,8/15,23.20%,SMG6;SMG5;MTMR2;CDK5RAP3;PPP1R16A;SMG7;PPP1R16B;SRC
prerank,thyroid hormone generation (GO:0006590),0.6521477150986177,1.2469967070011712,0.2441860465116279,0.9138402270778415,1.0,3/10,18.19%,SLC5A5;CTSK;FOXE1
prerank,mRNA metabolic process (GO:0016071),0.5240643732438709,1.2467331528871344,0.14504596527068436,0.9134386461604282,1.0,38/90,20.20%,SLFN14;LSM6;AURKAIP1;SCAF11;SLBP;SNRPF;U2AF1;DCP2;HNRNPA2B1;PRKACA;SRSF4;NCBP1;LSM2;NONO;CSTF3;PCBP2;HNRNPA0;LSM5;METTL16;KIN;PRMT9;HNRNPR;DXO;PCBP3;TP53;ZFP36L2;SRSF7;TCERG1;SNRPG;PCF11;PRPF8;ALKBH5;HIPK3;NCBP2;SRSF2;SF3A2;SNRPB;PNPT1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5166411207888864,1.2461371007910962,0.11740890688259109,0.9143717585636092,1.0,42/108,21.45%,PMAIP1;ANP32B;DAP;PDCD2;SENP1;APAF1;PIDD1;S100A9;TNFSF10;S100A8;CASP2;GSN;TRADD;MAP3K5;HMGB1;BOK;JAK2;PRR7;CARD9;IFT57;BCL2L13;FAS;FIS1;F3;RACK1;UACA;MYC;CFLAR;CASP9;F2R;SIRT1;ARL6IP5;SNCA;MALT1;RPS3;GRAMD4;LGALS9;CASP8;DAPK1;RIPK1;MAPT;SYK
prerank,neuromuscular process (GO:0050905),0.6244260329299633,1.2458973438841372,0.23753280839895013,0.9139619676264924,1.0,7/16,22.05%,AGTPBP1;KCNA1;PAFAH1B1;TIFAB;CLN3;NRXN1;DCTN1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5731129513219468,1.2456481470785707,0.20567375886524822,0.913514647240314,1.0,4/26,5.31%,CYP1B1;BRCA1;SULF2;CCR2
prerank,regulation of gastrulation (GO:0010470),0.6142242765972895,1.2455642304175145,0.23521320495185694,0.912393751174358,1.0,4/14,14.47%,FOXA2;CLASP1;RACK1;DAG1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6457416761620154,1.2454482781365621,0.225531914893617,0.9114312848219038,1.0,2/12,7.90%,IL12A;DCN
prerank,kidney development (GO:0001822),0.5338846643079725,1.2452520388082489,0.17801047120418848,0.9108040120821198,1.0,5/65,8.28%,CENPF;LRP4;SULF2;PRKX;ZBTB16
prerank,plasma membrane repair (GO:0001778),-0.4624604286817634,-1.2451916913589558,0.20553359683794467,0.6694157724087001,1.0,7/13,29.16%,AHNAK2;MYOF;SYT7;RAB3A;ANXA6;DYSF;SYT11
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3868374181760365,-1.245178010844113,0.19879518072289157,0.6667877686202609,1.0,8/23,16.95%,HAVCR2;VSIR;CD274;ZC3H12A;TLR4;AXL;PRNP;RARA
prerank,histone modification (GO:0016570),0.5209157117440326,1.2447108756351688,0.13171225937183384,0.9117467130261984,1.0,33/109,19.37%,AURKB;UHRF1;EZH2;RCOR2;CCNA2;INCENP;HDAC10;MTA3;RPS6KA5;BRD8;HDAC6;EYA3;BAZ1B;SIN3B;KAT6A;RUVBL2;EHMT1;PARK7;RUVBL1;TAF6;NSD3;MTA2;SIRT7;CREBBP;EYA1;SIN3A;USP21;SIRT1;HDAC4;PHF20;PHF20L1;HDAC1;TBL1XR1
prerank,positive regulation of secretion (GO:0051047),0.6438832293500071,1.2439464037574322,0.25323741007194245,0.9134613258311013,1.0,1/11,1.86%,AQP1
prerank,negative regulation of cell cycle (GO:0045786),0.5243997067081341,1.243531163483325,0.18041237113402062,0.9137513984338039,1.0,20/73,17.77%,MAD2L1;MEN1;PLK1;RB1;NPPC;CDK6;CDKN2A;GMNN;RUNX3;HPGD;NR2F2;IPO7;TAF6;PTEN;LATS1;IPO5;ANGEL2;TFAP4;NLRP2B;HEXIM1
prerank,response to molecule of bacterial origin (GO:0002237),0.5197183061932343,1.2434230393340708,0.16718266253869968,0.9127417549034822,1.0,17/69,17.91%,IL12A;HMGB2;PTPN22;S100A9;MAPKAPK3;SLPI;FOXP1;S100A8;JAK2;CYRIB;HNRNPA0;OTUD5;F2R;TNFRSF11A;CD24;FCGR2B;SNCA
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5921501150460929,1.2430623158151828,0.22682926829268293,0.912814738646243,1.0,5/21,9.87%,MASTL;PTPA;PPP1R11;PPP1R8;PPP1R15A
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5895366844168108,1.242939440001109,0.21878862793572312,0.9118905808279743,1.0,4/21,10.14%,CHST3;CSGALNACT2;DCN;CHST12
prerank,cellular response to interleukin-4 (GO:0071353),0.6558383009525012,1.242382508764616,0.2535612535612536,0.9126952532117281,1.0,3/10,17.05%,LEF1;JAK3;XBP1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.5139732243808647,1.242047080212428,0.10854271356783919,0.9126336714128159,1.0,41/144,17.67%,KIF20B;ECT2;GTSE1;PMAIP1;ANP32B;E2F1;C2CD5;ATG13;FYN;PCNT;FLNA;SAE1;YWHAH;TFDP1;UBL5;CIB1;EFCAB7;ABLIM3;TFDP2;PCM1;RHOU;EMD;FIS1;OAZ1;BAP1;RAC2;PSEN1;BAG3;ARIH2;PPP3CC;GSK3B;PDCD10;TP53;RIPOR1;IPO5;TCF7L2;TRIM28;XPO4;TMEM30A;HCLS1;YWHAE
prerank,cilium assembly (GO:0060271),0.5148530972569085,1.2418869136163422,0.039,0.9118595186072156,1.0,93/297,18.70%,CDK1;NEK2;KIF24;CKAP5;PLK1;CDK5RAP2;IFT80;EXOC2;CEP152;NDE1;POC1B;PCNT;CFAP206;FLNA;HAUS5;WDPCP;HAUS6;CEP83;CEP192;EXOC4;TNPO1;BBIP1;TUBB4B;ODF2;CEP89;GSN;CLASP1;CENPJ;WDR90;DISC1;CEP72;SSX2IP;ARF4;HDAC6;CEP76;NOTCH1;DYNC1H1;ALMS1;FUZ;RP2;OFD1;PTPDC1;RAB8A;CEP250;CFAP44;PRKACA;NEDD1;GORAB;CEP70;TMEM237;CYS1;TBC1D32;ABLIM3;NINL;PCM1;PDE6D;RFX2;PAFAH1B1;HAUS4;CCDC28B;TUBB;CEP162;IFT57;ABCC4;RAB8B;CCDC57;HAUS7;SCLT1;ARL13B;BBS4;PIBF1;EXOC5;MKS1;CNTRL;DYNLL1;CEP57;KIFAP3;DYNLT2B;SDCCAG8;MARK4;PARVA;IFT172;ATP6V0D1;IFT140;BBS9;C2CD3;YWHAE;HAUS3;TXNDC15;ATAT1;FAM161A;BBOF1;CEP63
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5352145497271232,1.2410038493844595,0.1759656652360515,0.9140654393624263,1.0,17/55,20.97%,FOXM1;CYP1B1;BRCA1;DCXR;ARF4;MAPK14;GRB2;DHRS4;RAC2;MPV17;TP53;RAC1;SNCA;CDKN1A;PAX2;EIF6;RIPK1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.579109047561657,1.240788394991289,0.21497584541062803,0.9134800070888341,1.0,3/24,3.96%,CYP1B1;BRCA1;SULF2
prerank,histone H3-K4 trimethylation (GO:0080182),-0.5083943437353969,-1.240701499371011,0.19424460431654678,0.6768453313689506,1.0,7/11,23.64%,KMT2D;CTR9;SETD1B;PRDM9;TET2;OGT;BEND3
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5793235126751493,1.2396443557029806,0.21919431279620852,0.9168017684690327,1.0,7/23,15.38%,PLK1;MAPK1;AXIN1;UBE2K;S1PR2;PRKAG2;EGF
prerank,regulation of protein catabolic process (GO:0042176),0.5176733978896425,1.239159394331837,0.15587044534412955,0.9173570331667777,1.0,16/99,9.19%,MAD2L1;FAM83D;BARD1;CHEK2;DTL;FLNA;AXIN1;AZIN1;SNX3;FOXO1;FAF1;MDM4;STX5;PIN1;NEDD4L;EGFR
prerank,cellular response to pH (GO:0071467),-0.4246177551762401,-1.238579232024367,0.1963470319634703,0.6801018232795686,1.0,8/17,22.72%,IMPACT;MCOLN1;SLC9A1;RAB11FIP5;GPLD1;HYAL1;PKD2L1;CHP1
prerank,innate immune response in mucosa (GO:0002227),0.6568778443222373,1.2382220722617618,0.2526002971768202,0.919840375343595,1.0,1/10,3.69%,CAMP
prerank,modulation by host of symbiont process (GO:0051851),0.55658098960208,1.238185312036825,0.2273781902552204,0.9185364972884738,1.0,14/31,23.92%,AQP1;LEF1;NUCKS1;SMARCA4;NAPEPLD;CARD9;JUN;CCNT1;TFAP4;HDAC1;CHD1;TAF11;TARDBP;HMGA2
prerank,positive regulation of apoptotic process (GO:0043065),0.5114987745508716,1.2381143299422663,0.04,0.9173860445697042,1.0,68/293,18.19%,TOP2A;ECT2;USP27X;BARD1;CYP1B1;ARHGEF5;PMAIP1;IAPP;E2F1;PDCD2;DAPK2;FAP;TIAM1;NET1;PTPA;APAF1;PIDD1;TFPT;TNFSF10;ARHGEF18;PHLDA3;FOXO1;CASP2;FAF1;ATM;ARHGEF3;TRADD;MAP3K5;UBE2Z;HMGB1;BOK;SAP18;TNFAIP8;SOS1;RNPS1;ERCC3;PRR7;PAWR;MAP3K11;MELK;ATF6;CCAR2;JUN;FAS;FGD3;RACK1;ING3;ING5;DDIT3;LATS1;BCL6;PSEN1;CASP9;STK4;TP53;MAP3K20;TFAP4;TGFB2;NLRP2B;SIRT1;ANO6;ARL6IP5;PNMA2;UBA52;SNCA;STK17B;RARG;ARHGEF7
prerank,heme biosynthetic process (GO:0006783),0.5890171734231827,1.2378941616435992,0.23501199040767387,0.9168817577308649,1.0,13/22,28.48%,ALAS2;ABCB10;TSPO;NFE2L1;COX10;PPOX;UROS;FXN;CPOX;PGRMC1;COX15;ALAS1;ATP5IF1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.48994494451431714,-1.2377204367515982,0.1889763779527559,0.6799229644023188,1.0,6/13,13.76%,MGLL;ABHD12;ABHD16A;ABHD6;MOGAT3;DGAT1
prerank,steroid metabolic process (GO:0008202),0.5178735055324011,1.2374068560791651,0.16615067079463364,0.9174075556732131,1.0,10/72,12.97%,HSD17B3;SRD5A2;CYP1B1;LSS;CYP2A6;GBA2;TSPO;CYP27A1;CYP46A1;DHRS4
prerank,mucosal immune response (GO:0002385),0.6043345734822216,1.2363547062461866,0.2655217965653897,0.9202399110073215,1.0,1/15,3.69%,CAMP
prerank,cytoplasmic translation (GO:0002181),0.5190232771235745,1.2362668651419728,0.150460593654043,0.9191854986837097,1.0,45/91,22.84%,RPL7;RPL18A;RPS20;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;RPL23A;RPL28;RPS14;RPL41;RPS27;RPS5;RPS29;RPLP0;RPS11;TMA7;RPL27A;RPS9;RPS15A;RPL12;RPL22L1;ZC3H15;RPL3;GSPT1;UBA52;RPL18;DRG1;RPL5;RPS6;RPS17;RPS3;RPL21;RPL23;RPL17;RPL24;RPL8;RPL27;RPL13A;RPS12;RPS8;RPL15;RPL10
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5940721330734889,1.236251572973843,0.23595505617977527,0.9178309375022837,1.0,12/20,22.08%,TNRC6C;TNRC6B;CNOT1;LIMD1;CNOT6;AGO2;HELZ;CNOT8;EIF6;CNOT7;CELF1;AGO1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5249484817384773,1.2357825674899892,0.17181069958847736,0.9183243821208942,1.0,19/72,19.12%,SHCBP1;MAPK1;POLR2I;POLR2A;FLRT2;HNRNPM;SETX;GRB2;NCBP1;FGF9;SPRED2;CEP57;FGFR1;FIBP;POLR2K;POLR2J;KIF16B;HNRNPA1;NCBP2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5650362756497622,1.2356348262741819,0.21120186697782964,0.9175084042732508,1.0,9/27,19.05%,AQP1;E2F1;LIG4;CD74;CDK6;DHX9;MYC;FN1;CDKN1A
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6187212834981175,1.2349839003586636,0.25668449197860965,0.9187358345104737,1.0,4/15,12.37%,NTF4;GRB2;SOS1;HAP1
prerank,regulation of membrane repolarization (GO:0060306),0.6263914687812442,1.234859599886978,0.2506775067750677,0.9178528786777762,1.0,4/13,17.67%,CAV1;NEDD4L;KCNJ2;YWHAE
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.45555680488496303,-1.2344210008122374,0.19183673469387755,0.6864506319213043,1.0,7/14,25.01%,UPP2;NT5M;DPYD;UMPS;NT5C;DHODH;NT5E
prerank,negative regulation of axonogenesis (GO:0050771),-0.3685234826825169,-1.2343988074255663,0.16176470588235295,0.6838309469106727,1.0,15/27,25.51%,RTN4;RUFY3;DIP2B;GDI1;PTPRS;MAG;ULK1;EFNB3;THY1;CDKL3;ULK2;MT3;MCF2;DCC;OMG
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.622985319546467,1.2338857932801701,0.23435419440745672,0.9205401777897089,1.0,4/13,10.75%,BARD1;SP100;RANGAP1;PARK7
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.6448675595174707,1.23366774967231,0.2556497175141243,0.9199522908932463,1.0,5/10,19.08%,DHX58;NPLOC4;RIOK3;GPATCH3;SEC14L1
prerank,actin filament bundle organization (GO:0061572),0.5427862873492224,1.2336023011438273,0.21892816419612315,0.9188165842820698,1.0,7/33,13.46%,RFLNB;EZR;NEDD9;SHROOM2;LIMA1;PAWR;ADD2
prerank,regulation of myoblast fusion (GO:1901739),0.6370740824397504,1.233368400936215,0.26884779516358465,0.9183644810481003,1.0,4/11,13.95%,RIPOR2;MAPK14;FLOT1;CFLAR
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.6346673109390001,1.2325619807736503,0.2546916890080429,0.9203323437356348,1.0,5/12,23.23%,POU2AF1;MFNG;FCGR2B;GPR183;DOCK10
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3827926397710939,-1.231852710515625,0.1610738255033557,0.6885496011493696,1.0,7/25,12.14%,CTSS;ANK3;ANK2;DMD;COX17;ATP1B2;ATP1B1
prerank,regulation of epithelial cell migration (GO:0010632),-0.3181049522083679,-1.2311267155136085,0.13793103448275862,0.6879169647795105,1.0,24/51,22.87%,RTN4;GLUL;MACF1;PTPRG;EVL;RREB1;BMPR2;ENPP2;PFN1;CLASP2;CORO1C;DUSP10;PPM1F;RAB11A;PTK2;PFN2;DAB2IP;MCC;BMPER;PTPN23;CEACAM1;HYAL1;HIF1A;CAPN7
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.645277641267189,1.2310224932029852,0.2571022727272727,0.925074822811162,1.0,5/11,11.88%,EZR;MTMR2;MSN;RDX;EIPR1
prerank,amide transport (GO:0042886),0.571978423177779,1.230769303582217,0.23452380952380952,0.9247515339224801,1.0,5/26,11.15%,SLC38A5;ABCA13;SLC14A2;TAP1;SLC19A1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.633952773239717,1.2298784951913129,0.2591549295774648,0.927013687009571,1.0,3/12,10.74%,RASGRP1;PAEP;CARD9
prerank,tRNA modification (GO:0006400),-0.299360138343564,-1.2298128426090467,0.14285714285714285,0.6889498959922333,1.0,31/62,27.76%,PUS10;PUS7;ANKRD16;TRMT1;DTWD2;NSUN2;DUS2;WDR4;QTRT1;ELP5;TRIT1;TYW5;TRMT61B;MTO1;METTL2A;METTL2B;TPRKB;METTL1;FTSJ1;THADA;THUMPD1;ALKBH1;TRMT10A;TRMT12;LCMT2;THUMPD2;GTPBP3;TRMT9B;TRMT13;BCDIN3D;DTWD1
prerank,positive regulation of binding (GO:0051099),0.5156567629481065,1.2291163912431595,0.17568947906026558,0.9287882157024917,1.0,27/84,15.90%,HMGB2;MEN1;STMN1;DDX11;TIAM1;EPB41;CAV1;EDF1;TAF1;GMNN;PIN1;HMGB1;NCBP1;TXN;HIPK2;AMFR;B2M;DHX9;FLOT1;ADD2;SKI;CEBPG;PSEN1;GSK3B;STK4;EGF;TCF7L2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.4854493904062259,-1.228923140896388,0.22695035460992907,0.6886837179067345,1.0,5/12,13.39%,RIMS1;RIMS2;SYT1;SYT7;UNC13A
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6335493506734522,1.2288263757091766,0.24346629986244842,0.9286045466594436,1.0,3/11,16.74%,STMN1;NRP1;RAC1
prerank,filopodium assembly (GO:0046847),0.5988448614769537,1.228777350058121,0.24932614555256064,0.9274072027851612,1.0,5/16,12.54%,PPP1R9B;EZR;FGD6;FGD3;S1PR2
prerank,T cell homeostasis (GO:0043029),0.6504761942656718,1.2284929697420295,0.2528409090909091,0.9272667211510051,1.0,4/10,16.70%,PMAIP1;PPP2R3C;FAS;JAK3
prerank,regulation of presynapse organization (GO:0099174),-0.41873982792014447,-1.2283082728005292,0.20454545454545456,0.6851025442673007,1.0,3/18,2.36%,APP;LRFN5;PTPRD
prerank,regulation of presynapse assembly (GO:1905606),-0.41873982792014447,-1.2283082728005292,0.20454545454545456,0.6851025442673007,1.0,3/18,2.36%,APP;LRFN5;PTPRD
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6001110666353532,1.2282871091605974,0.2471626733921816,0.9267445971269868,1.0,6/18,9.71%,STMN1;RIPOR2;ARHGAP35;TNFAIP1;CUL3;HEG1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5264866081426849,1.2275266225529746,0.21922246220302377,0.9285615153602571,1.0,14/49,16.74%,KIF14;IAPP;MEFV;LCMT1;PMEPA1;HDAC6;HMGB1;RIOK3;PARK7;TFIP11;GSK3B;AIDA;NLRC3;NLRP2B
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5858632801810114,1.2274594919467507,0.2384428223844282,0.9274642696510409,1.0,3/22,2.74%,TNFRSF18;FANCA;IL2RA
prerank,cellular response to interleukin-6 (GO:0071354),-0.3740077970176733,-1.2270502133851595,0.13071895424836602,0.6861874958904887,1.0,8/26,12.38%,SBNO2;CTR9;ST3GAL6;RELA;SELPLG;SPI1;PTPRT;STAT3
prerank,sensory organ development (GO:0007423),0.5326113807018571,1.2267471349794523,0.21382289416846653,0.9291214737505775,1.0,11/51,16.39%,NTF4;SMCHD1;PBX4;PBX3;SHROOM2;SALL2;HIPK2;ATF6;SMG9;PBX2;TGFB2
prerank,mononuclear cell differentiation (GO:1903131),0.5684668303264861,1.2266724161919178,0.23393939393939395,0.9280212960064665,1.0,2/24,1.15%,BLK;LY6D
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.5321250396959887,1.2264980787628537,0.21548821548821548,0.9273183535242774,1.0,11/37,14.97%,PMAIP1;S100A9;RPS7;CAV1;S100A8;BOK;BECN1;FIS1;RACK1;DDIT3;TP53
prerank,histone H3 acetylation (GO:0043966),0.5380132977939902,1.22644441311619,0.23406593406593407,0.9261799700833818,1.0,15/40,17.72%,JADE1;BRCA2;LEF1;BRD1;BRPF1;KAT6A;BRPF3;KAT2B;ING5;PHF14;TADA2A;TADA3;YEATS2;TAF9;MAP3K7
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5455914585066244,1.2262841213871307,0.2184782608695652,0.9254457726960009,1.0,12/40,13.59%,XPO1;GLMN;PML;AXIN1;RPS7;TAF1;DESI1;HIPK2;RAD23A;PTEN;CDK5RAP3;LATS1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6363086294736462,1.2258504427842756,0.25770308123249297,0.9258837104283107,1.0,4/11,13.69%,CAV1;NEDD4L;ACTN2;STK39
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.4574621711558988,-1.2254271504785608,0.1956521739130435,0.6878150280172104,1.0,13/14,54.29%,ECE1;CORIN;ENPEP;RASL10B;AVPR2;ACE;ACE2;OXTR;EDN3;EDN2;AVPR1A;AGTR1;EDN1
prerank,eosinophil chemotaxis (GO:0048245),-0.4655462187289757,-1.2247118507356847,0.2054263565891473,0.6847446147480477,1.0,5/14,33.03%,CCL4;CCL3;CCL13;CCL2;CCL5
prerank,eosinophil migration (GO:0072677),-0.4655462187289757,-1.2247118507356847,0.2054263565891473,0.6847446147480477,1.0,5/14,33.03%,CCL4;CCL3;CCL13;CCL2;CCL5
prerank,pancreas development (GO:0031016),0.6124348639939646,1.2246518097007757,0.25,0.9292375948274852,1.0,1/12,0.89%,NKX6-1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.5102084916418275,1.2244506386131715,0.031,0.9286484461839545,1.0,82/314,17.88%,CCNF;BUB1B;KIF14;CDK1;UBE2C;AURKB;MAD2L1;CCNB1;CDC20;PLK1;FBXL15;SKP2;RB1;AURKA;FBXO5;PSMB7;PSMD11;PML;CDC23;FBXW11;CDC27;PSMF1;TAF1;FAF1;NPLOC4;FBXO44;PSMC1;ANAPC7;FBXO45;BIRC2;SPSB3;UBE2K;UBE4B;NEDD4L;FAF2;DNAJC18;FBXO17;UBQLN1;TNFAIP1;CUL3;PTTG1;PSMC3;PCBP2;DERL2;AMFR;RAD23A;UBR2;PSMA4;SPSB4;TRIM3;FZR1;FBXL4;PSMC4;ARRB2;PCNP;BUB3;NFE2L2;PSMD13;SPOP;PSME1;DDIT3;RHBDD2;DCAF11;ZFAND2B;PSMB1;RBCK1;ARMC8;PSMD8;YOD1;PSME4;DNAJB9;KLHL22;PSMD4;SIRT1;RNF103-CHMP3;UBXN1;RNF4;HSP90B1;UBA52;FAM8A1;SYVN1;FEM1C
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.6405045055302787,1.2241406326010658,0.2384937238493724,0.9284554944196893,1.0,3/11,11.59%,BLK;PRKCA;RDX
prerank,neurotrophin signaling pathway (GO:0038179),0.5862628359401886,1.223160482759554,0.2777085927770859,0.9311104380825771,1.0,5/21,12.37%,NTF4;KIDINS220;GRB2;SOS1;HAP1
prerank,macrophage chemotaxis (GO:0048246),-0.4988026986619323,-1.2230730324269194,0.21794871794871795,0.6866456937953397,1.0,5/10,33.03%,EDNRB;CCL3;CXCL17;CCL2;CCL5
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6420361687239731,1.222725857219629,0.27323943661971833,0.9301623183399735,1.0,1/10,8.02%,CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6420361687239731,1.222725857219629,0.27323943661971833,0.9301623183399735,1.0,1/10,8.02%,CEP250
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.27331756494137716,-1.2225656376106755,0.0,0.6854897737634212,1.0,44/118,22.48%,TANC2;PAK3;RUFY3;EFNA5;TNIK;LARP4;EGLN1;PPFIA2;HECW1;CTNNB1;RAP2A;KNDC1;TNFAIP3;CLASP2;CDH2;FMNL2;INF2;NF1;CDK5R1;STRIP1;POGLUT1;ARHGAP44;SPARC;FERMT2;CDK5;HMOX1;WTIP;FGF2;ZMYM6;VASH1;EPHA4;ABI2;SHANK3;MYO19;CFL1;BMPER;KIF1A;ZDHHC15;PHLDB2;CAPZB;SH3D19;TSPAN12;CEACAM1;LZTS1
prerank,mesenchyme development (GO:0060485),-0.4305997918814056,-1.2225497361254016,0.20481927710843373,0.6830048748583517,1.0,2/15,3.18%,TGFBR1;BMPR2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5641673407247535,1.2216236103691498,0.24644549763033174,0.9335437998461907,1.0,5/26,8.09%,RRM2;RRM1;ALG8;RRM2B;ST3GAL2
prerank,positive regulation of protein import (GO:1904591),0.5407072162382544,1.2215767102842858,0.22606689734717417,0.9323720978733153,1.0,9/30,17.45%,ECT2;ARHGEF5;FLNA;EFCAB7;PSEN1;BAG3;IPO5;TRIM28;HCLS1
prerank,negative regulation of developmental process (GO:0051093),0.5113246544309813,1.221518273183893,0.2,0.9312564817021514,1.0,10/69,7.70%,FOXM1;ANP32B;HEY2;SUZ12;TFRC;CDK6;BCL11A;NOTCH1;SFMBT1;FUZ
prerank,response to interleukin-4 (GO:0070670),0.6504542533336253,1.2207530798878692,0.26406926406926406,0.9330677318760511,1.0,3/10,17.05%,LEF1;JAK3;XBP1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.5754198094012329,1.220156515084904,0.24969400244798043,0.9341517405613347,1.0,1/22,0.14%,SHCBP1
prerank,regulation of glucose import (GO:0046324),-0.36188968046606235,-1.2200219504399314,0.1643835616438356,0.687201208935815,1.0,10/30,15.09%,APPL2;PRKCI;PIK3R1;IGF1;AKT2;IRS2;GSK3A;SELENOS;RHOQ;GRB10
prerank,extracellular transport (GO:0006858),0.6027680213133144,1.219377232693976,0.25745257452574527,0.9359259778043317,1.0,2/13,7.02%,SPA17;SPEF2
prerank,lymphocyte chemotaxis (GO:0048247),-0.3457747277338634,-1.2192977955745166,0.14728682170542637,0.6867198119892414,1.0,11/34,33.03%,SLC12A2;PIK3CD;CCL15;CH25H;CCL4;CCL3;CCL14;CYP7B1;CCL13;CCL2;CCL5
prerank,regulation of protein kinase activity (GO:0045859),0.5112349796080825,1.2192133762485746,0.16464646464646465,0.93520564317394,1.0,26/106,17.93%,CENPE;ECT2;RB1;CCN1;MMD2;SMG8;MAPRE3;MMD;TAF7;XRCC6;MRNIP;CEP85;TAB1;SNX9;PDPK1;PARK7;RELN;PRKAG2;ADCYAP1;PPIA;DTNBP1;TARBP2;PAK2;SIRT1;SNCA;IQGAP1
prerank,microtubule anchoring at centrosome (GO:0034454),0.6439791247955855,1.2187477706493852,0.2580195258019526,0.9357525180534816,1.0,4/10,13.42%,NIN;NINL;PCM1;BBS4
prerank,cardiac ventricle development (GO:0003231),0.5856475143682719,1.2186236864398172,0.24390243902439024,0.9348805272491161,1.0,4/20,7.15%,HEY2;MDM4;PDE2A;NOTCH1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6042627603348608,1.218369619137154,0.2696929238985314,0.9345479613523996,1.0,8/15,22.19%,TNRC6C;TNRC6B;CPEB3;CNOT1;EIF4ENIF1;AGO2;CNOT7;TENT4A
prerank,positive regulation of macroautophagy (GO:0016239),-0.3210600970051927,-1.2182593688517664,0.14457831325301204,0.6868482421891096,1.0,16/48,19.06%,WAC;SCOC;SPTLC1;PIP4K2B;PRKAA2;OPTN;GNAI3;SH3GLB1;RAB3GAP2;IRGM;PINK1;SESN3;UVRAG;TSC2;ADRB2;VPS13D
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.40905278197538725,-1.218185925732747,0.18691588785046728,0.6844988934007942,1.0,6/19,15.82%,PATJ;PRKCI;ERBIN;DLG2;LRRC7;DLG1
prerank,regulation of actin filament-based movement (GO:1903115),-0.49950095285366847,-1.2181085321102298,0.24342105263157895,0.6822212888541042,1.0,2/10,7.62%,ANK2;SRI
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.45719429906601106,-1.217240841274187,0.20408163265306123,0.6822664278948891,1.0,7/13,32.73%,SYNGR1;SHISA6;GRIK2;RAB3A;SHISA7;SLC8A2;PPFIA3
prerank,cellular response to interleukin-12 (GO:0071349),0.5237393938811422,1.21681251318199,0.2281081081081081,0.9396244543914402,1.0,13/48,16.43%,IL12A;LMNB1;CD47;CNN2;TCP1;HNRNPA2B1;JAK2;MSN;RPLP0;PLCB1;PPIA;PAK2;MTAP
prerank,nucleoside salvage (GO:0043174),0.6224076859792205,1.2162790269481623,0.27285714285714285,0.9404255739430178,1.0,2/10,3.25%,TK1;UCK2
prerank,sprouting angiogenesis (GO:0002040),0.5226388700058506,1.215721645394345,0.2235294117647059,0.9413891704239123,1.0,3/51,4.65%,E2F7;E2F8;PGF
prerank,base conversion or substitution editing (GO:0016553),0.632102669418175,1.2154387813591525,0.28304597701149425,0.9412098151777418,1.0,1/11,0.80%,ADAD1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.6342465530634228,1.2153708742647464,0.2768595041322314,0.9401447249670818,1.0,1/10,0.73%,IL12A
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.52691465772788,1.2153281304731283,0.21008403361344538,0.9389793357773277,1.0,17/59,15.76%,CDK1;CIT;MAPK1;OXSR1;CHEK1;TAF1;PRKCA;MARK2;PDPK1;HIPK2;DYRK1A;LMTK2;ROCK2;PRKDC;STK39;GSK3B;MAP2K1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6039796079764427,1.2146079442370092,0.25637755102040816,0.9406038780164072,1.0,1/16,0.73%,IL12A
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.5447320543859541,1.2140195988988185,0.21899441340782122,0.9416582332296759,1.0,9/35,14.63%,MASTL;ITGA1;PTPA;PPP1R11;PPP1R15A;PPP6R3;PPP1R2;GSK3B;PPP1R12A
prerank,phospholipid biosynthetic process (GO:0008654),0.5427697027735864,1.2132724675986433,0.242152466367713,0.9433978016125973,1.0,12/36,18.69%,DHDDS;SGMS2;AGPAT4;PCYT2;NUS1;IDI1;AGPAT3;SGMS1;FDPS;SRD5A3;FAR1;CLN3
prerank,gene expression (GO:0010467),0.5003489628926693,1.212865252104861,0.053,0.9436590074881711,1.0,131/348,21.40%,MRPL36;ADAD1;NR4A2;NUP43;RPL7;POM121;E2F1;RPL18A;NDC1;SMG6;RPS20;DHX38;MRPL18;RBM3;POLR2I;SMG5;NUP107;RPL36;RPL14;POLR2A;SLBP;EPC1;RPS19;RPS7;NUP42;RPS4X;HNRNPL;RPS18;MRPL10;NUP50;UPF2;PTMA;CPSF2;SETX;U2AF1;RPL23A;DNAJB11;EIF4A3;NUP214;SRSF3;RPL28;ELAVL4;HNRNPA2B1;MRPL37;RPS14;RPL41;TSPAN33;RPLP2;NUP160;SRSF4;NCBP1;NUP205;CASC3;RNPS1;RPS27;U2AF1L4;MRPL51;MRPS7;MRPL43;SEC13;RPS5;DHPS;RBMS2;NUP188;RPS29;RPLP0;RPS11;MRPS17;IGF2BP3;RPL27A;THOC3;NUP98;RANBP2;UPF3B;NUP210;RPS9;RPS15A;THOC5;HNRNPU;PRPF4;TFIP11;MRPL24;RPL12;THOC2;DARS1;SNRNP40;POLR2K;AAAS;SRSF7;THOC7;CDC40;NUP37;RPL3;DDX39B;POLR2J;POLDIP3;CPSF1;GSPT1;CLP1;RPL18;DRG1;TSPAN5;DKC1;ALKBH5;YARS2;NKX2-8;RPL5;RPS6;RPS17;NCBP2;NUP85;RPS3;DDX54;RPL21;AGO2;SRSF2;GOLPH3;SRBD1;RPL23;RPL17;TPR;FYTTD1;SMG7;SYNCRIP;MMS19;WDR33;GLE1;RSL24D1;RPL24;RPL8;RPL27
prerank,regulation of macrophage activation (GO:0043030),-0.3542669468088505,-1.2127382704205778,0.20930232558139536,0.6922366583294833,1.0,11/30,20.41%,PJA2;LRFN5;MFHAS1;HSPD1;ZC3H12A;TLR4;TNIP2;CD200;IL31RA;THBS1;MYO18A
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6113897565151963,1.2126975037820782,0.2733516483516483,0.9430420763617255,1.0,1/13,0.73%,IL12A
prerank,regulation of lipid kinase activity (GO:0043550),0.6395152800243844,1.2124884143787107,0.28870292887029286,0.9425626771925758,1.0,3/11,5.70%,RB1;RBL1;PPP2R5A
prerank,axonal transport (GO:0098930),0.5370338176672819,1.2121631617455866,0.24689966178128522,0.9425336019142885,1.0,8/36,14.43%,KIF4A;BLOC1S4;FBXW11;DYNC1H1;PAFAH1B1;AP3M2;HAP1;DTNBP1
prerank,actomyosin structure organization (GO:0031032),0.5060632047739433,1.2116536178046986,0.18969072164948453,0.9432582040768867,1.0,14/75,13.07%,CIT;TMOD4;ALKBH4;CSRP3;EPB41;SORBS1;MYH10;CSRP1;FLII;TNFAIP1;CUL3;ACTN2;FAM171A1;ROCK2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5428904673839806,1.2112142867992612,0.24717832957110608,0.943735863223104,1.0,9/35,13.52%,HMGB2;ZFPM1;ABCB10;BRD1;CDK6;ZFP36L1;MAPK14;STAT5B;PRKDC
prerank,cellular response to dsRNA (GO:0071359),0.6058778579131978,1.2111671080539574,0.27549668874172184,0.9426137198698522,1.0,7/15,17.78%,CGAS;CAV1;PDE12;RIOK3;DHX9;FLOT1;COLEC12
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5248056693566404,1.2110675173263128,0.238562091503268,0.9417249544102859,1.0,12/46,16.43%,IL12A;LMNB1;CNN2;TCP1;HNRNPA2B1;JAK2;MSN;RPLP0;PLCB1;PPIA;PAK2;MTAP
prerank,organic substance transport (GO:0071702),0.5054684766913558,1.2108684800137193,0.1577350859453994,0.9411485939802137,1.0,26/121,19.16%,CENPF;ABCA13;NDC1;RAMP1;SLC6A2;RCN3;ABCD1;TAP1;PICK1;ABCA2;NME4;ABCA7;CALCRL;SLC19A1;ATP8A1;SLCO2A1;CHMP1B;VPS33B;SCAMP1;CHMP3;CHMP2B;HSP90B1;ARL6IP5;SLC22A4;RUFY1;DISP1
prerank,regulation of cellular metabolic process (GO:0031323),0.5194993325537448,1.2105584218267837,0.24809575625680086,0.9411509266222452,1.0,9/45,14.69%,FOXM1;CYP1B1;PANK2;AGPAT1;ARF4;ABCA2;FASN;FLOT1;MPV17
prerank,inhibitory synapse assembly (GO:1904862),-0.4775749719700703,-1.2105045850750062,0.23469387755102042,0.6954447532747904,1.0,5/11,14.67%,GABRB3;GABRG2;GABRA2;LGI2;GABRA1
prerank,vesicle transport along actin filament (GO:0030050),0.5734287077592009,1.2103696582718282,0.2642679900744417,0.9405630633024842,1.0,2/19,2.63%,MYO5C;MYO15A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.34422245219800346,-1.2103685521694376,0.18095238095238095,0.69336016514534,1.0,15/35,28.30%,BMP2K;MKLN1;SNAP91;PPT1;TNK2;PIK3CB;SMAP1;SERPINE1;APOC1;HIP1R;ARF1;AAK1;VTN;PICALM;ARF6
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.2779976624474423,-1.2102724704017611,0.15384615384615385,0.6911829213220638,1.0,25/78,15.82%,NUMB;TREM2;LRP1;SQSTM1;DPP10;BCL2L1;VTI1B;STX4;PRKCI;STX3;PIK3R1;ZDHHC5;AR;MMP14;ZDHHC8;VAMP8;RHOG;ACTB;CLIP3;CDK5;PTPN9;AP2M1;RHOQ;PPFIA1;DLG1
prerank,regulation of ERAD pathway (GO:1904292),-0.48124124793084166,-1.2098300710627279,0.21232876712328766,0.6899262106166573,1.0,5/11,16.72%,USP19;RNF185;BAG6;ATXN3;TMEM259
prerank,epithelial cell migration (GO:0010631),0.5337820332326721,1.2098141856999192,0.25111607142857145,0.9414300169374221,1.0,7/37,13.01%,CYP1B1;ANLN;FAP;PKN2;PRKX;DPP4;NRP1
prerank,retinal metabolic process (GO:0042574),0.6099929757602919,1.2096466460951807,0.276797829036635,0.9408320446377575,1.0,2/12,13.06%,CYP1B1;RDH10
prerank,modification-dependent protein catabolic process (GO:0019941),0.5050952077499858,1.2094262082874785,0.0980980980980981,0.9403744770674595,1.0,55/193,18.62%,BUB1B;UBE2C;AURKB;MAD2L1;UHRF1;CDC20;PLK1;AURKA;DTL;PSMD11;PPP1R11;CDC23;UBE2I;CDC27;PSMF1;TAF1;NPLOC4;ANAPC7;FBXO45;BIRC6;UBE2K;UBE4B;UBE3B;NEDD4L;UBQLN1;CUL3;LONP1;KCTD21;PTTG1;AMFR;UBE3C;RNF168;MIB1;RNF8;SPSB4;CNOT4;FZR1;FBXL4;BUB3;FBXO11;PSMD13;ARIH2;RNF20;RNF111;RC3H1;MYLIP;UBE2R2;XBP1;RNF19A;UBA52;SYVN1;FEM1C;UBE2G1;RBBP6;RNF43
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.5552446547575715,1.2090822672183195,0.25378346915017463,0.9404433656863513,1.0,3/26,9.29%,CYP1B1;DDAH2;ABCA2
prerank,plasma membrane invagination (GO:0099024),0.5541466917420413,1.2090613392106104,0.25471698113207547,0.9392091296630034,1.0,5/29,7.99%,AURKB;ALKBH4;SNX33;GSN;SNX9
prerank,atrial septum development (GO:0003283),0.6101337845976602,1.2089803477923016,0.26766304347826086,0.9382320287280692,1.0,3/13,5.92%,HEY2;ZFPM1;MDM4
prerank,connective tissue development (GO:0061448),0.5299622066734936,1.2086540761404276,0.25257142857142856,0.9382170768411805,1.0,8/35,10.86%,SOX6;CD44;SULF2;DDRGK1;ZBTB16;PGRMC2;ATP7A;ARID5B
prerank,nucleus organization (GO:0006997),0.5295206849629338,1.2082880459234335,0.21244635193133046,0.9383311646777522,1.0,14/47,17.24%,CEP55;NDC1;REEP4;SUN2;RPS19;NUP205;IRAG2;TOR1A;NUP98;CHMP1B;NUMA1;SYNE1;CHMP3;CHMP2B
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5062201508371558,1.2080219043599303,0.20291363163371487,0.938079740081025,1.0,11/72,11.17%,TPX2;STMN1;IAPP;CLASP1;CIB1;CYRIB;VBP1;PFDN5;LIMA1;DYRK1A;SMAD4
prerank,aortic valve morphogenesis (GO:0003180),0.5370977923207298,1.2071326445126451,0.2722095671981777,0.9403256339147132,1.0,7/30,15.60%,HEY2;RB1;TWIST1;NOTCH1;SLIT3;ROCK2;ELN
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5031929218357771,-1.2071154264797626,0.2525597269624573,0.6949436057089833,1.0,5/10,27.62%,CD34;RAP1A;TMEM100;CEACAM1;KDR
prerank,response to thyroid hormone (GO:0097066),-0.453685607896238,-1.2063992541318838,0.20689655172413793,0.6943312817535421,1.0,3/13,0.68%,CTSS;LMO2;CTSB
prerank,peptide biosynthetic process (GO:0043043),0.49619508205596863,1.2061284920298765,0.14529058116232466,0.9430205363117117,1.0,60/153,22.84%,MRPL36;RPL7;RHD;RPL18A;RPS20;MRPL18;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;MRPL10;RPL23A;RPL28;MRPL37;RPS14;RPL41;RPLP2;RPS27;MRPL51;MRPS7;MRPL43;RPS5;DHPS;RPS29;RPLP0;RPS11;MRPS17;IGF2BP3;RPL27A;RPS9;RPS15A;MRPL24;RPL12;PCSK1;DARS1;RPL3;GSPT1;RPL18;YARS2;RPL5;RPS6;RPS17;RPS3;RPL21;AGO2;SRBD1;RPL23;RPL17;RSL24D1;RPL24;RPL8;RPL27;RPL13A;MRPS12;RPS12;RPS8;RPL15;RPL10
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.34078337772516915,-1.2055008240735428,0.17857142857142858,0.6943591585182929,1.0,15/31,20.24%,TANC2;PPFIA2;CDK5R1;ARHGAP44;CUX2;CDK5;CAMK2B;LRP8;EPHA4;ABI2;SHANK3;CAPRIN1;CFL1;KIF1A;ZDHHC15
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6426590431797952,1.2049911972490102,0.2857142857142857,0.9464017163447037,1.0,3/10,11.60%,FAP;NOTCH1;DPP4
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.601270697932292,1.2049331703620767,0.2768595041322314,0.9453221397009182,1.0,1/13,0.72%,GFI1
prerank,carbohydrate transport (GO:0008643),0.6339804336110574,1.2046137270005,0.2782485875706215,0.9453012788465361,1.0,1/11,1.86%,AQP1
prerank,protein targeting to ER (GO:0045047),0.5029240419047943,1.2039014252088005,0.1744421906693712,0.9469363206634912,1.0,48/99,22.90%,RPL7;RPL18A;RPS20;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;RPL23A;RPL28;SPCS1;RPS14;RPL41;RPLP2;RPS27;GET3;RPS5;RPS29;RPLP0;RPS11;RPL27A;RPS9;RPS15A;ZFAND2B;RPL12;RPL3;SEC63;UBA52;RPL18;RPL5;RPS6;RPS17;RPS3;RPL21;RPL23;RPL17;SPCS3;RPL24;RPL8;RPL27;SEC62;RPL13A;RPS12;RPS8;RPL15;RPL10;SRP68
prerank,negative regulation of secretion (GO:0051048),0.6405119015160498,1.2038612341974544,0.2716927453769559,0.9458220661382524,1.0,4/10,15.38%,ERBB3;CD74;TIFAB;EGF
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3506840251422241,-1.2037681653819972,0.16101694915254236,0.6968265093818005,1.0,7/29,17.58%,APP;SYNGR1;APOE;SHISA6;GRIK2;CAMK2B;DLG4
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6109718501053596,1.2035975305909008,0.2722298221614227,0.9455383762298505,1.0,7/13,20.76%,TNRC6C;TNRC6B;CPEB3;CNOT1;EIF4ENIF1;AGO2;CNOT7
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.6524196147366772,1.2034066422802474,0.29464285714285715,0.9449935960229092,1.0,7/10,19.42%,CCT7;CCT2;TCP1;CCT5;DKC1;WRAP53;CCT6A
prerank,positive regulation of neuron differentiation (GO:0045666),0.5408616134903587,1.2030044673721865,0.21155943293347873,0.9453211855837951,1.0,10/40,16.04%,ECT2;GPRC5B;MMD2;TCF3;MMD;ZEB1;NRCAM;SIN3A;TCF4;FGFR1
prerank,negative regulation of mRNA processing (GO:0050686),0.5938383770656924,1.202568789170015,0.2626788036410923,0.9457501223896332,1.0,6/15,16.59%,BARD1;SAP18;SRSF4;RNPS1;SRSF10;SRSF7
prerank,hexose biosynthetic process (GO:0019319),-0.3201750146344095,-1.2024401351140424,0.1827956989247312,0.6979768856265165,1.0,18/42,23.15%,GPI;GOT2;ENO1;ALDOA;AKR1B1;ATF4;TPI1;PGM1;PGAM1;G6PC3;SLC25A11;ALDOC;SLC39A14;PER2;ENO2;CRY1;PPARGC1A;ENO3
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5450475081212098,1.2010832783087046,0.26450116009280744,0.9504207325915477,1.0,13/29,18.96%,MEN1;LEF1;TCF7L1;SMARCA4;TLE4;RUVBL1;BCL9L;CREBBP;MYC;RBBP5;TCF7L2;TLE3;HDAC1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.5047654412636177,1.2009738417698737,0.20408163265306123,0.9495712847821007,1.0,22/87,19.12%,SHCBP1;MAPK1;POLR2I;CD44;POLR2A;FLRT2;HNRNPM;SETX;ZFP36L1;GRB2;NCBP1;FGF9;SPRED2;CEP57;ZFP36L2;FGFR1;FIBP;POLR2K;POLR2J;KIF16B;HNRNPA1;NCBP2
prerank,actin-myosin filament sliding (GO:0033275),0.5366560558201188,1.2005598844329586,0.24330357142857142,0.9486658669888896,1.0,6/38,16.42%,DES;MYL1;MYBPC1;ACTN2;TPM4;VIM
prerank,muscle filament sliding (GO:0030049),0.5366560558201188,1.2005598844329586,0.24330357142857142,0.9486658669888896,1.0,6/38,16.42%,DES;MYL1;MYBPC1;ACTN2;TPM4;VIM
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.393134474873092,-1.2000634780405808,0.21608040201005024,0.7019248118677675,1.0,6/21,10.36%,TREM2;LRP1;APOE;PLTP;ZDHHC8;GPS2
prerank,peptide cross-linking (GO:0018149),0.5524582022708258,1.1997577837980875,0.24555160142348753,0.9505812158757557,1.0,4/25,17.71%,EPB42;ABCA7;FN1;F13A1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.47470275677473195,-1.1991626969907767,0.23674911660777384,0.7019260276042372,1.0,5/11,25.11%,CSNK1E;CSNK1D;RSPO3;WNT5B;NKD1
prerank,regulation of protein binding (GO:0043393),0.4958792144497049,1.198532840110852,0.19736842105263158,0.9542898876514466,1.0,43/114,21.03%,AURKB;MEN1;PLK1;AURKA;DDX11;TIAM1;ZFPM1;EPB41;SLPI;CAV1;TAF1;DISC1;PIN1;PRKACA;MARK2;HIPK2;AMFR;PARK7;B2M;CRK;RACK1;FLOT1;ADD2;TFIP11;PSEN1;GSK3B;STK4;TCF7L2;STYX;PEX14;LDLRAP1;SPPL3;PPP1CA;HDAC4;LRRK2;GNL3L;CDKN1A;STK3;AKTIP;PPP2CA;PRMT7;BTBD1;ROCK1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.620135331475503,1.1982583302281264,0.2875536480686695,0.9540949608383158,1.0,1/10,1.40%,CYP1B1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5214187321213694,1.197339411636175,0.2423580786026201,0.9563814568003616,1.0,22/44,23.77%,FTO;ZFP36L1;TNRC6C;TNRC6B;CPEB3;PUM1;METTL16;ROCK2;CNOT1;METTL14;RC3H1;ZFP36L2;EIF4ENIF1;AGO2;CNOT8;PNPT1;PRR5L;CNOT7;ROCK1;CELF1;ZC3HAV1;MEX3D
prerank,peroxisomal membrane transport (GO:0015919),0.5452302923687424,1.1972775104272355,0.2598331346841478,0.9553470253823233,1.0,12/27,18.79%,PEX26;ABCD1;ACBD5;PEX11B;PXMP4;GDAP1;PEX2;RAB8B;FIS1;PEX14;ATAD1;ABCD4
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5882627083735172,1.197107551389162,0.2794871794871795,0.9546908906377247,1.0,4/16,14.56%,DDIAS;CDKN2D;CCAR2;TPT1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5560844118490932,1.1965047403843487,0.26976744186046514,0.9557452560026231,1.0,6/25,13.52%,HMGB2;ABCB10;BRD1;MAPK14;STAT5B;PRKDC
prerank,determination of left/right symmetry (GO:0007368),0.5304221365039022,1.1964882841220548,0.26905829596412556,0.9545280046221425,1.0,3/37,7.93%,STIL;NOTCH1;OFD1
prerank,negative regulation of phosphatase activity (GO:0010923),0.5598124138428678,1.1958688166699243,0.25670945157526254,0.9556233263193906,1.0,7/25,16.39%,MASTL;PTPA;PPP1R11;PPP1R15A;PPP1R35;GSK3B;TGFB2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.5812538865158235,1.1953162380737195,0.2653333333333333,0.9565694547565317,1.0,12/16,26.09%,DCPS;SNRPC;SNRNP200;CWC15;PSIP1;SART1;NCBP2;WBP11;RBM22;DDX23;SFSWAP;PRPF39
prerank,regulation of cell development (GO:0060284),0.5376439799597568,1.195029278746982,0.2630992196209587,0.9563699413496585,1.0,4/36,5.78%,HMGB2;HEY2;RPS19;FOXO1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5579522660600048,1.1947018096434383,0.26855123674911663,0.9563951785443779,1.0,6/25,17.91%,CD19;NPSR1;PDPK1;F2R;PLCG1;SNCA
prerank,regulation of cell morphogenesis (GO:0022604),-0.34773478693057935,-1.1946051242601254,0.2032520325203252,0.7117700376396486,1.0,11/30,14.37%,EFNA5;MACF1;MYO9A;LARP4;NTNG1;FMNL2;STRIP1;SPARC;FERMT2;WTIP;ZMYM6
prerank,bicellular tight junction assembly (GO:0070830),0.5237364007041576,1.1944412946009553,0.2508108108108108,0.9561603159927281,1.0,3/46,2.61%,ECT2;CLDN18;PECAM1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.5103998773471046,1.1941125115007285,0.21487603305785125,0.9562663161412249,1.0,20/65,17.74%,AURKB;AURKA;PSMB7;PSMD11;PSMF1;CHEK1;PSMC1;NABP2;PSMC3;PSMA4;PSMC4;CDK5RAP3;PSMD13;PSME1;PABIR1;PSMB1;PSMD8;PSME4;PSMD4;AVEN
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4285609224486814,-1.1935653124813277,0.2594142259414226,0.7120228590973251,1.0,7/14,26.84%,ANK3;SLC9A1;DMD;ATP1B1;GLRX;CHP1;WNK2
prerank,regulation of glycolytic process (GO:0006110),0.5065643023989276,1.1933213882153189,0.23474663908996898,0.9580997586322416,1.0,28/68,21.99%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;ENTPD5;NUP160;ZBTB7A;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;PRKAG2;PSEN1;AAAS;NUP37;HDAC4;NUP85;ZBTB20;TPR;EIF6;PRKAG1;CBFA2T3;NUP93
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.4896152504174338,-1.1932552790274544,0.26666666666666666,0.7105309302988733,1.0,5/10,14.06%,KDM1A;CTNNB1;CX3CR1;FZD3;VEGFA
prerank,positive regulation of calcium ion import (GO:0090280),-0.4568975761680771,-1.1931774058128934,0.23272727272727273,0.7083533265194832,1.0,8/12,49.07%,CCL3;SPHK2;CCL2;PDGFRB;CXCL12;STC1;RAMP3;ATP2A1
prerank,epithelial to mesenchymal transition (GO:0001837),0.5212265485318417,1.1927224351739318,0.24494142705005326,0.9592004986916599,1.0,12/47,16.39%,FAM83D;HEY2;LEF1;NOTCH1;ROCK2;HNRNPAB;GSK3B;LIMS1;FGFR1;TASOR;TRIM28;TGFB2
prerank,negative regulation of bone mineralization (GO:0030502),0.6017219462858433,1.1926337529623618,0.29476584022038566,0.9582746214012482,1.0,1/13,1.49%,RFLNB
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.5457234846711096,1.1926104519771108,0.2646370023419204,0.9571084438268049,1.0,12/29,23.67%,E2F1;TAF15;HNRNPU;PAIP1;ELAVL1;EIF4ENIF1;THRAP3;TENT5D;DHX34;YBX1;GDNF;CIRBP
prerank,regulation of monocyte differentiation (GO:0045655),0.605055892589938,1.192153232269938,0.2878179384203481,0.9576388391807605,1.0,5/14,13.88%,CD74;FOXP1;CDK6;ZFP36L1;MYC
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5568151055646795,1.1918601083265181,0.27146464646464646,0.9575011149445886,1.0,7/21,20.56%,MEFV;FYN;BIRC2;DELE1;USP50;EPHA7;AIM2
prerank,cellular response to reactive oxygen species (GO:0034614),0.5116826928474139,1.1918577499658594,0.22082018927444794,0.9562381524199683,1.0,24/59,23.15%,ECT2;CYP1B1;AQP1;MAPK1;NET1;SETX;HDAC6;MAP3K5;EGFR;PARK7;JUN;NFE2L2;MPV17;ERCC6L2;SIRT1;RPS3;PAX2;PKD2;RIPK1;MAPT;PLEKHA1;PXN;OSER1;PRKCD
prerank,zymogen activation (GO:0031638),-0.350035738217331,-1.191658132292889,0.16666666666666666,0.7101511458302059,1.0,8/39,11.45%,ASPH;KLK2;KLK3;VSIR;TBC1D10A;MMP14;PLAU;LGMN
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.5152004927409404,1.1915319205809978,0.2508004268943437,0.9562596617027337,1.0,19/52,19.88%,PMAIP1;E2F1;ATG13;SAE1;YWHAH;TFDP1;UBL5;ABLIM3;TFDP2;RHOU;BAP1;RAC2;ARIH2;PPP3CC;TP53;YWHAE;CASP8;SREBF2;HPS4
prerank,organelle fusion (GO:0048284),-0.3830204722715877,-1.1914577018077344,0.2131979695431472,0.7082762884421872,1.0,12/22,28.35%,EEA1;STX4;MFN2;MIEF1;MIGA2;MFF;SPG7;VPS11;AFG3L2;USP30;MFN1;MIEF2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.6047333105429947,1.191355766278991,0.29093369418132614,0.9556823767871877,1.0,3/12,14.72%,EZH2;ASXL1;CNOT1
prerank,regulation of interleukin-12 production (GO:0032655),0.5124128134754828,1.1912182267694278,0.2418655097613883,0.9549855996378444,1.0,10/47,13.80%,MEFV;CD47;IL16;FOXP1;HMGB1;MAPK14;PLCG2;MAST2;PLCB1;PIBF1
prerank,vasculogenesis (GO:0001570),0.5395780345050804,1.1902102937826151,0.27304550758459745,0.9575999278691185,1.0,5/32,7.15%,HEY2;GLMN;CAV1;CCM2;NOTCH1
prerank,regulation of peptidase activity (GO:0052547),0.5718792812803861,1.190113176465654,0.27383863080684595,0.9567178692400897,1.0,3/19,5.28%,NRDC;RCN3;CAV1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5983461109262724,1.189997133930658,0.2987551867219917,0.9558936672730785,1.0,2/12,3.25%,TK1;UCK2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5638529248561426,1.1895794244367228,0.2920245398773006,0.9562494516105707,1.0,6/19,16.74%,DAPK2;CD74;RIPOR2;RAC2;MCU;RAC1
prerank,plasma membrane organization (GO:0007009),-0.3013197874916518,-1.1895491473002915,0.18604651162790697,0.7114245261297544,1.0,18/61,15.44%,ABCD2;NSF;ANK3;OSBPL2;STX4;AHNAK2;ANK2;BIN1;STX2;MYOF;BIN3;SYT7;EPB41L3;TLCD2;SERP1;PLSCR4;DEGS1;PACSIN1
prerank,intestinal lipid absorption (GO:0098856),0.6071254027919001,1.1887223355966083,0.28444444444444444,0.9583864105326013,1.0,2/11,10.17%,CEL;LIMA1
prerank,regulation of synapse assembly (GO:0051963),-0.3188498473919451,-1.1884779564844539,0.17721518987341772,0.7118971473196078,1.0,9/46,11.79%,APP;LRFN5;PTPRD;SYNDIG1;IL1RAP;CLSTN3;LRRC4B;CLSTN1;CUX2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.616649431412934,1.1882330787048925,0.298050139275766,0.9590652402489416,1.0,8/11,24.45%,DNMT1;SETDB2;ATF7IP;TASOR;TRIM28;SETDB1;TPR;RESF1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.342386709586288,-1.188220757227128,0.208955223880597,0.7101468018091766,1.0,9/30,14.48%,CACNA1C;SCN1A;ANK2;ATP1A1;SNTA1;SCN1B;RYR2;FGF12;GJA1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6275383745249072,1.1881121404031458,0.3103932584269663,0.9582634379096722,1.0,4/10,17.91%,BRCA1;TAF7;SIRT1;SNCA
prerank,RNA 3'-end processing (GO:0031123),0.5109367566628722,1.188079792468102,0.22210743801652894,0.9571490858950857,1.0,35/69,22.19%,DHX38;CPSF2;U2AF1;EIF4A3;SRSF3;SRSF4;NCBP1;CASC3;RNPS1;U2AF1L4;CSTF3;TUT4;RPRD1B;THOC3;UPF3B;THOC5;THOC2;SRSF7;THOC7;CDC40;TUT1;DDX39B;POLDIP3;PCF11;CPSF1;CLP1;TENT2;NCBP2;SRSF2;CPSF7;PNPT1;WDR33;RPRD2;PAPOLA;TENT4A
prerank,protein modification by small protein conjugation (GO:0032446),0.493760919733644,1.188075404406474,0.065,0.9559215580667976,1.0,102/361,17.78%,CCNF;UBE2C;UBE2T;UHRF1;TRIM58;BARD1;RFWD3;RNF26;PLK1;BRCA1;FBXL15;MEFV;NUP43;POM121;NDC1;SAE1;NUP107;CDC23;FBXW11;MKRN1;UBE2I;CDC27;PCNA;RANGAP1;NUP42;UBA2;NUP50;BCL11A;TRAIP;MSL2;ANAPC7;FBXO45;UBE2Z;DDRGK1;NUP214;BIRC6;UBE2K;NEDD4L;TRIM11;RNF157;RAD18;NUP160;KLHL9;NUP205;TNFAIP1;ASB1;CUL3;PIAS3;TRIM47;CBLL1;AMFR;TRIM33;NUP188;TRIM44;NSMCE2;SUMO1;UBR2;RNF168;RTF1;MIB1;RNF8;SPSB4;PEX2;CNOT4;EIPR1;TRIM68;ARRB2;PCNP;NUP98;RANBP2;CDK5RAP3;RNF152;CUL9;NUP210;FBXO11;NFE2L2;RACK1;PRKDC;NFX1;SUMO2;ARIH2;RNF20;TRIM5;RNF111;VCPIP1;EYA1;PIAS1;MYLIP;TRIM28;UBE2R2;AAAS;VHL;SIRT1;RNF103-CHMP3;NUP37;TRPM4;PEX14;CAND2;UBA52;UBE2M;USP7;SYVN1
prerank,regulation of nervous system process (GO:0031644),-0.40622461081817074,-1.1879124901048514,0.2072072072072072,0.7086910244741566,1.0,5/18,9.57%,APP;DLGAP4;HTR2C;SLC8A3;DLGAP2
prerank,negative regulation of interferon-beta production (GO:0032688),-0.4982276301309906,-1.187792359113103,0.26851851851851855,0.7066710492231145,1.0,3/10,5.04%,SIRPA;PTPRS;PYCARD
prerank,positive regulation of B cell proliferation (GO:0030890),0.5367490838900867,1.1869418536321419,0.2830409356725146,0.9589900282530763,1.0,4/29,5.04%,TNFSF13B;CD38;CD74;TFRC
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5181497171243837,1.186796314739121,0.24917309812568908,0.9582965704971816,1.0,8/42,16.77%,RBM15;OXSR1;CCR2;GPR75;CIB1;STK39;GPR35;CCL25
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5578348838937401,1.1864706041302098,0.29277566539923955,0.9583407140969349,1.0,3/19,7.93%,SPA17;SPEF2;OFD1
prerank,ganglion development (GO:0061548),-0.47833319409445185,-1.1861082331996105,0.25245901639344265,0.7089394165223833,1.0,4/11,15.00%,NRP2;CTNNB1;FZD3;SEMA3A
prerank,neuron apoptotic process (GO:0051402),0.5686878087711824,1.1855203644167882,0.27895392278953923,0.9608062470418363,1.0,3/19,3.65%,CIT;ERBB3;LIG4
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.4669869555874614,-1.1851307312589412,0.24302788844621515,0.7091323913884984,1.0,5/12,27.55%,ZC3H12A;STAT3;LIN28B;BCDIN3D;ZC3H10
prerank,digestive tract development (GO:0048565),-0.34105333577362085,-1.184844908661317,0.1893939393939394,0.7076692737626981,1.0,9/33,20.58%,SALL1;SMO;PCSK5;CLMP;PKD1;GLI3;EDNRB;PKDCC;CCDC39
prerank,regulation of mononuclear cell migration (GO:0071675),-0.3657621746583116,-1.1845961205178994,0.2037037037037037,0.7059922220127124,1.0,5/23,2.95%,CSF1R;CMKLR1;STK10;AKIRIN1;AIF1
prerank,positive regulation of cell junction assembly (GO:1901890),-0.30576267744220326,-1.1841788193609248,0.13333333333333333,0.7048312416635211,1.0,19/56,20.71%,CNTNAP2;PTPRD;SYNDIG1;PTPRJ;IL1RAP;CLSTN3;LRRC4B;CLSTN1;TSC1;CUX2;FERMT2;PPM1F;NPHP1;VEGFA;MAP4K4;COL16A1;THY1;CLSTN2;AGT
prerank,mRNA catabolic process (GO:0006402),0.5250847011827583,1.1835100781933885,0.26019845644983464,0.9674299850056105,1.0,17/44,22.08%,SLFN14;LSM6;PDE12;EXOSC10;DCP2;LSM2;TUT4;LSM5;METTL16;DXO;RC3H1;ZFP36L2;THRAP3;XRN1;PNPT1;DHX34;AGO1
prerank,embryonic organ development (GO:0048568),0.507742662686692,1.1830530405974067,0.23329798515376457,0.9679368299694806,1.0,6/61,3.81%,STIL;HEY2;TEAD4;PBX4;ZFPM1;PBX3
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5783885041269056,1.1829023165331594,0.2811296534017972,0.9672641877719319,1.0,1/17,0.89%,NKX6-1
prerank,cardiac atrium morphogenesis (GO:0003209),0.5787009705754618,1.18282599797178,0.28552971576227393,0.9663008545853597,1.0,3/16,7.15%,HEY2;ZFPM1;NOTCH1
prerank,neurogenesis (GO:0022008),0.5295278185703183,1.1823432396831095,0.25573770491803277,0.9669624913103011,1.0,14/43,21.48%,CIT;CDK5RAP2;WDR62;CDK6;HAP1;METTL14;LPAR1;THOC2;TGFB2;CXCR4;TRAK2;BTBD1;MAPT;BTBD2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.5485548045151913,1.1815592444016298,0.2703349282296651,0.9687497659559328,1.0,9/25,22.94%,HEY2;RB1;TWIST1;ZBTB7A;PARK7;SIN3A;TRAF6;NIBAN2;NSD1
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5643016739659051,1.1811271875139246,0.2948885976408912,0.9692297005656677,1.0,7/17,24.16%,PANK2;CAV1;ADIPOR1;PRKAG2;EIF6;PPARD;PRKAB2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.523579589261858,1.180148492414128,0.26216814159292035,0.971807220570138,1.0,5/36,5.78%,FOXM1;MEN1;EZR;PTPN22;FOXO1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.4908402283749699,-1.1801164402587243,0.2549019607843137,0.7139684235514155,1.0,3/10,25.26%,SH2B3;MAPK7;KLF4
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.4653232411052581,-1.1797768102090134,0.25704225352112675,0.7126070058101894,1.0,1/11,0.60%,TREM2
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.25127747660464506,-1.1794508470231149,0.05263157894736842,0.7110877101822806,1.0,26/92,14.64%,RTN4;IQSEC1;ANXA3;NRP2;RREB1;GPI;BMPR2;ENPP2;PFN1;PIK3CD;PRKD1;GRN;CLASP2;ZC3H12A;ANGPT1;ITGB3;SCARB1;EPB41L4B;SPARC;PPM1F;PIK3CB;RAB11A;ADAM9;VEGFA;FGF2;MAP4K4
prerank,regulation of hippo signaling (GO:0035330),0.5720682638591975,1.1792510526872697,0.2948717948717949,0.9740991173853897,1.0,3/17,8.10%,CIT;MOB3B;MAPK14
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.4863738337536377,-1.1784512575548027,0.27241379310344827,0.7115479547798377,1.0,4/10,9.40%,APOE;ABCA1;PRKACB;ZDHHC8
prerank,positive regulation of neutrophil migration (GO:1902624),0.5620961422721232,1.1774933275589117,0.3079754601226994,0.9795541126338955,1.0,6/18,16.74%,DAPK2;CD74;RIPOR2;RAC2;MCU;RAC1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.579077773711332,1.177421438734276,0.30809399477806787,0.9785595448152942,1.0,3/14,5.33%,PISD;CHKB;PCYT2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.38702175823961704,-1.1772068837103988,0.21578947368421053,0.7126385696395261,1.0,11/21,16.25%,HS6ST3;NDST3;HS3ST4;B3GAT3;EXT2;SULF1;HS6ST2;EXTL3;XYLT2;HPSE;HS3ST5
prerank,regulation of organelle assembly (GO:1902115),0.5040683280588595,1.1767103643130628,0.2474120082815735,0.9801058629662268,1.0,25/73,19.50%,STIL;CDKL1;TBC1D1;EZR;TBC1D22B;CEP295;EVI5;RAB1B;GSN;CENPJ;CEP76;ALMS1;MSN;RDX;NPRL3;DYNLT2B;SDCCAG8;RAB5A;IFT140;ADPRH;RNF4;SENP6;STAM;RABEP2;SGSM3
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.44812376824117606,-1.1764699144493533,0.25793650793650796,0.7123915781680641,1.0,6/12,25.46%,PARP6;PARP16;PARP2;TNKS2;PARP3;TNKS
prerank,positive regulation of protein maturation (GO:1903319),0.6101405742514787,1.1758809345442478,0.31540697674418605,0.9821139685064733,1.0,2/11,14.79%,TFR2;CCBE1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.45914075036640556,-1.175517439945704,0.2706766917293233,0.7126931592642569,1.0,3/12,0.68%,CTSS;LMO2;CTSB
prerank,regulation of synapse maturation (GO:0090128),0.6217717441799906,1.1755016271167507,0.30354609929078014,0.9823515153399114,1.0,2/10,11.03%,CDC20;RELN
prerank,nucleotide biosynthetic process (GO:0009165),0.5622621690018021,1.1751523609978287,0.2972292191435768,0.9825461232511645,1.0,3/18,5.88%,RRM2;RRM1;RRM2B
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.5326338572562533,1.1751493510963655,0.29107981220657275,0.9813072365145188,1.0,10/25,20.75%,FBXL15;CCN1;UBE2O;NOTCH1;SMAD4;BMPR1A;NUMA1;ACVR2B;RBPJ;SMAD2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5563706410418688,1.1748669184515872,0.28793774319066145,0.9811408840125085,1.0,8/18,26.29%,AQP1;ZFP36L1;HNRNPU;ZFP36L2;PCK2;KLF9;BCL2L11;UBE2L3
prerank,second-messenger-mediated signaling (GO:0019932),0.4934349724067445,1.1744488705398648,0.22816032887975335,0.9815539968487269,1.0,21/82,18.13%,CXCR5;PPP1R9B;SAMD14;DDAH2;RCAN3;CCR2;GUCY1A1;INPP5A;PLCG2;NUDT4;PDPK1;CCR6;BTK;CHRM3;DGKD;MCU;PLCG1;TRPM4;MCTP1;CXCR4;LRRK2
prerank,regulation of platelet aggregation (GO:0090330),0.5709171127994688,1.1743214121904761,0.2975420439844761,0.9808060256187031,1.0,2/17,8.22%,BLK;PRKCA
prerank,regulation of cytokine production (GO:0001817),0.49127991483155775,1.1742279664723507,0.19919110212335692,0.9798973561571652,1.0,21/126,11.66%,ERMAP;RNF26;PLA2R1;POLA1;CD47;GLMN;BATF;PPP1R11;CCN4;RPS6KA5;FOXP1;AGPAT1;CCR2;TRAF3;NFAM1;MAPK14;MAST2;ASB1;BTN3A3;CARD9;IGF2BP3
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4907969682200573,1.1738715959089967,0.22484599589322382,0.9800243185488309,1.0,20/85,16.46%,UHRF1;RAB33B;DEAF1;CDK6;NR1D1;ZFP36L1;RUNX3;TGFA;LAMC1;EGFR;B2M;MTSS1;PEX2;FGF9;PRKDC;MYC;LIMS1;TCF7L2;TGFB2;NLRC3
prerank,regulation of striated muscle contraction (GO:0006942),-0.35750211986849495,-1.1732935866923468,0.2265625,0.7166840515134045,1.0,10/27,20.08%,ANK2;SLC8A3;SRI;DMD;RYR2;SMAD7;ASB3;CALM1;ATP1A2;P2RX4
prerank,regulation of cartilage development (GO:0061035),0.5667930246656059,1.1732874594897582,0.29156327543424315,0.9810616502226716,1.0,5/18,11.80%,SOX6;PTHLH;MBOAT2;ZBTB16;TAPT1
prerank,action potential (GO:0001508),-0.30626009227854056,-1.1731124776698105,0.14285714285714285,0.7149403137278659,1.0,11/44,11.05%,ANK3;SCN8A;GNA15;SCN1A;KCND2;GNA14;SRI;SCN9A;DMD;SCN3A;KCNA2
prerank,phospholipid catabolic process (GO:0009395),-0.3657820243625933,-1.1724165853648545,0.23076923076923078,0.7146172338504656,1.0,6/24,14.95%,GPCPD1;ABHD12;ENPP2;GDE1;PLBD2;SMPDL3A
prerank,regulation of cell size (GO:0008361),0.5494579727494704,1.1722502120633052,0.3162393162393162,0.9838441004290209,1.0,10/23,18.04%,EZR;RAP1GAP2;MTPN;LARS1;MSN;RDX;PTEN;LAMTOR4;RAC1;RARG
prerank,regulation of myeloid cell differentiation (GO:0045637),0.49856673212233255,1.1719829938057191,0.25823591923485656,0.9836013607213553,1.0,20/62,15.85%,RBM15;ZFPM1;CDK6;DPY30;TNRC6C;TNRC6B;H3-3A;KMT2C;ZBTB16;NFE2;KAT2B;CNOT4;PRKCB;CBFB;KMT2A;CREBBP;RBBP5;KMT2B;RUNX1;SIN3A
prerank,apical protein localization (GO:0045176),-0.4861814141093274,-1.1714227038240035,0.29430379746835444,0.7151517005694561,1.0,6/10,15.60%,ATP8B1;SHROOM3;INSC;ACTB;GOPC;MAL
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.563873923355452,1.170815909382028,0.3091364205256571,0.9869724569850683,1.0,6/17,16.74%,DAPK2;CD74;RIPOR2;RAC2;MCU;RAC1
prerank,regulation of autophagosome assembly (GO:2000785),-0.3238997186418124,-1.170699321584372,0.16296296296296298,0.7151539620866133,1.0,8/33,7.95%,TBC1D14;IFT88;TBC1D12;PIP4K2B;FEZ2;FEZ1;SH3GLB1;RAB3GAP2
prerank,regulation of apoptotic process (GO:0042981),0.48173681307854405,1.170539347322632,0.029,0.9867794413150701,1.0,150/676,18.32%,TOP2A;KIF14;CDK1;STIL;BIRC5;ECT2;MAD2L1;USP27X;BARD1;CYP1B1;PLK1;ARHGEF5;STK26;PMAIP1;ANP32B;AQP1;IAPP;LEF1;E2F1;SKP2;DDAH2;PDCD2;IKZF3;DAPK2;TIAM1;NET1;FLNA;SLK;CD38;PTPA;CD74;ANKLE2;CD44;GLS2;APAF1;PIDD1;TFPT;PA2G4;TNFSF10;ARHGEF18;UBE2O;PHLDA3;TFRC;FOXO1;CASP2;FAF1;ATM;ARHGEF3;LCMT1;TRADD;DPEP1;PTMA;SETX;ARF4;BIRC2;ARL6IP1;MAP3K5;UBE2Z;DDRGK1;PIM2;HMGB1;BIRC6;BOK;PIM3;SAP18;CIB1;TNFAIP8;RNF157;ERC1;JAK2;SOS1;ZBTB7A;EGFR;RNPS1;ERCC3;PIM1;PRR7;ACTN2;SOCS2;PAWR;MAP3K11;MELK;PARK7;SIGMAR1;ATF6;XIAP;CCAR2;JUN;ATF5;IFT57;FLT3;FAS;MYD88;NAA16;TOMM70;FGD3;APEX1;FBXO11;RACK1;ANP32E;ING3;ING5;BEX2;ACTN4;PRKDC;LATS1;GLO1;CREBBP;MYC;BCL6;CFLAR;PSEN1;BAG1;BAG3;PPIA;MYDGF;HTATIP2;CASP9;TPT1;GSK3B;STK4;PDCD10;TP53;MAP3K20;TFAP4;PAK2;TAF9;ARHGDIA;STEAP3;JAK3;VHL;NLRP2B;SIRT1;XBP1;SH3RF1;HSP90B1;ANO6;ARL6IP5;PNMA2;UBA52;AVEN;NDRG1;SNCA;STK17B;RARG;RBM25;MED1;ARHGEF7;MALT1;ADAM10
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5363170279232291,1.1702634541122434,0.3130034522439586,0.9866466403925103,1.0,7/27,9.08%,SMG6;SMG5;DACH1;ATM;TERF2;NABP2;SMOC2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4984593293321568,1.1696249108810093,0.2489539748953975,0.9879448124255092,1.0,6/63,5.04%,IL12A;SLC7A1;TNFSF13B;CD38;CD74;TFRC
prerank,negative regulation of histone acetylation (GO:0035067),0.611196455319304,1.168953402607375,0.30520393811533053,0.9894319808341021,1.0,5/11,17.91%,BRCA1;TAF7;SIN3A;SIRT1;SNCA
prerank,neutral amino acid transport (GO:0015804),0.5326496673973711,1.1686836016353817,0.3037825059101655,0.9891998088413861,1.0,2/28,2.20%,SLC38A5;SLC1A5
prerank,cellular copper ion homeostasis (GO:0006878),-0.43000140570918155,-1.1685970191331296,0.2450592885375494,0.7185329480667522,1.0,7/14,21.87%,APP;SLC31A2;PRNP;COX19;CCDC22;MT2A;ARF1
prerank,ncRNA catabolic process (GO:0034661),0.5308686375590254,1.1685664238391225,0.2878612716763006,0.9884232159747259,1.0,8/28,19.63%,SLFN14;EXOSC8;EXOSC10;TUT4;RBM7;DIS3L;ZCCHC8;XRN1
prerank,tight junction assembly (GO:0120192),0.5096719338585154,1.1684450943858027,0.28525641025641024,0.9876328748943647,1.0,3/49,2.61%,ECT2;CLDN18;PECAM1
prerank,mesenchymal cell development (GO:0014031),0.5683190155731248,1.1683960336211305,0.29419191919191917,0.9866230123534535,1.0,5/18,11.80%,HEY2;PEF1;NOTCH1;TCOF1;TAPT1
prerank,apoptotic process (GO:0006915),0.4791427292570617,1.1681066108617377,0.16816816816816818,0.9865440683721078,1.0,51/203,15.68%,CIT;CD2;JADE1;ESPL1;PMAIP1;DAP;IAPP;IL2RA;TCHP;DAPK2;ERBB3;FAP;PRKCE;LIG4;APAF1;PIDD1;BRAT1;STK11;CHEK1;CYFIP2;IKBKG;FOXO1;CASP2;TRADD;TRAIP;PAEP;AHR;BOK;CIB1;ZBTB16;JAK2;RFK;ERCC3;TNFAIP1;PPP1R15A;PAWR;MELK;IFT57;BCL2L13;FAS;MYD88;RNF152;FXR1;MAGI3;MYC;CFLAR;PPIA;CASP9;STK4;PLAGL1;PAK5
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3726628217365171,-1.1679843767983837,0.24528301886792453,0.7178333745307224,1.0,6/23,8.33%,NLRP3;PPM1A;RELA;ZC3H12A;NMI;SPI1
prerank,cellular response to organic cyclic compound (GO:0071407),0.48148036383016596,1.1679773127485247,0.19698492462311556,0.985765688956564,1.0,22/141,10.65%,RAD51;SLC5A5;CYP1B1;BRCA1;AQP1;BLM;CTNNA1;EZR;HCN3;CRHBP;TAF1;PDE12;ZFP36L1;PDE2A;AHR;GNAI1;EGFR;P2RY1;EGR1;RIOK3;RUVBL2;MSN
prerank,positive regulation of developmental growth (GO:0048639),-0.31427379491979895,-1.167761481609906,0.1694915254237288,0.716180094966251,1.0,11/49,10.34%,RIMS1;RUFY3;RIMS2;MACF1;MAP3K13;SYT1;PPIB;LIMK1;PLAA;SYT4;GOLGA4
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.38493792816294226,-1.1674994148297673,0.22346368715083798,0.7146076896347919,1.0,12/20,28.30%,FHOD1;FMNL2;STRIP1;NCKAP1L;RHOQ;FHOD3;DLG1;LLGL1;PLEK;FMNL3;LLGL2;ARF6
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.5470331135538549,1.1674909376796114,0.2915129151291513,0.9864491762783312,1.0,4/20,10.75%,RB1;TWIST1;DDRGK1;PARK7
prerank,spliceosomal snRNP assembly (GO:0000387),0.5091454157858718,1.1673500452911556,0.29180327868852457,0.9857351709655312,1.0,15/38,20.49%,PRPF19;GEMIN8;SNRPF;SNRPC;SART3;LSM2;PRPF31;CLNS1A;SRSF10;SART1;GEMIN7;SNRPG;PRPF8;SNRPB;PRMT7
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5908712247532151,1.1673082198033513,0.3063660477453581,0.984680523085513,1.0,6/12,19.02%,STMN1;DYRK1A;SNCA;ARHGEF7;TBCD;EML2
prerank,response to sterol (GO:0036314),-0.45776162014122224,-1.1671399747439168,0.2891156462585034,0.7132795649748322,1.0,6/11,19.79%,TGFBR1;CCR5;TGFBR2;INSIG1;CCL3;PMVK
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6132671249277928,1.16708125464029,0.301521438450899,0.9843390907992794,1.0,4/11,13.34%,DDX11;SMARCA4;NOL11;SIRT7
prerank,positive regulation of lymphocyte activation (GO:0051251),0.5329734613907449,1.1669034024645892,0.30202140309155767,0.983804430058875,1.0,7/28,14.45%,IL12A;CD47;CCR2;XRCC6;CYRIB;PRKDC;TYROBP
prerank,transport along microtubule (GO:0010970),-0.44534690554493367,-1.1665518504705215,0.24187725631768953,0.7126470010952634,1.0,4/13,12.15%,APP;SPG11;COPG2;CLIP3
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4583535863912672,-1.16594283373295,0.2867132867132867,0.7120929232303188,1.0,9/12,22.64%,SEC61A2;SGTA;SEC61G;SEC61A1;SGTB;HSPA5;CHMP4B;CHMP4A;SEC61B
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3412308856793337,-1.1658001923889902,0.19008264462809918,0.7102922151285047,1.0,13/33,15.44%,DNM2;OPHN1;GAK;SYNJ1;SYNJ2;SNAP91;DNM3;SYT1;VAMP2;CDK5;STX1A;PIP5K1C;PACSIN1
prerank,regulation of cation channel activity (GO:2001257),-0.2550271992380626,-1.1650433242164775,0.06666666666666667,0.7099942946905239,1.0,22/89,15.82%,CTSS;APP;ANK3;CACNB2;GRIA1;GRIA4;KCNAB1;ANK2;DLG2;MINK1;SHISA6;CACNG7;DMD;CACNG2;VAMP2;FGF12;CACNB4;LRRC7;CALM1;JPH4;CAMK2B;DLG1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.4961321919349547,1.1649903651209108,0.253125,0.9899012025726796,1.0,19/61,16.94%,PSMB7;PSMD11;PSMF1;PANK2;AZIN1;CAV1;PSMC1;PSMC3;PSMA4;PSMC4;OAZ1;PSMD13;PSME1;PRKAG2;PSMB1;PSMD8;PSME4;PSMD4;SIRT1
prerank,lipoprotein transport (GO:0042953),-0.48609040575993867,-1.164197742814802,0.27906976744186046,0.7100861559987716,1.0,5/10,20.32%,LRP1;ZDHHC17;MIA3;CD36;UNC119B
prerank,sensory perception of taste (GO:0050909),-0.46669004611653986,-1.1634353249552891,0.303951367781155,0.7099656508346667,1.0,4/10,34.38%,CD36;PKD2L1;ASIC1;PKD1L3
prerank,positive regulation of vascular permeability (GO:0043117),0.5981801895656722,1.1626604156198905,0.3149171270718232,0.997697672539111,1.0,3/12,6.74%,FGFBP3;TJP3;PDE2A
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5010277920561224,1.1626412117385532,0.2674897119341564,0.9965641042698253,1.0,26/70,22.52%,KIF14;ITGB7;RB1;ATRNL1;ATRN;LAMA5;LAMC1;LAMB2;LAMB3;ITGAV;NTNG2;RELN;ARL13B;ITGA8;NRP1;PARVB;RAC1;PARVA;FN1;TBCD;PROX1;ILK;EFNA1;ITGA4;ACTN1;PXN
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5037123647733981,1.1626158823365518,0.2713833157338965,0.9954586955901017,1.0,2/51,0.92%,KIF20B;NTF4
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5265127620754524,1.1615901520837608,0.31381733021077285,0.9981342703774236,1.0,6/29,13.15%,FOXA2;VASN;FUZ;ADIPOR1;PTEN;SPRED2
prerank,negative regulation of transport (GO:0051051),0.5011603641766267,1.1614332525414943,0.28324324324324324,0.9975184151309137,1.0,16/51,17.91%,PRTN3;ERBB3;SNX33;SNX3;MTMR2;ITGAV;EPHA3;ABCA7;PIP4P2;PTEN;RACK1;EGF;ARL6IP5;FCGR2B;MCTP1;SNCA
prerank,L-amino acid transport (GO:0015807),0.5283065787977219,1.1613259069445097,0.3261904761904762,0.9967160510560477,1.0,3/28,2.84%,SLC38A5;SLC25A12;SLC7A1
prerank,protein localization to vacuole (GO:0072665),-0.4585538880876977,-1.1611872961104464,0.28185328185328185,0.7140369958755856,1.0,7/13,18.74%,RTN4;RNF128;MFSD1;SH3GLB1;GLMP;LAMTOR5;CD81
prerank,mitochondrial fission (GO:0000266),-0.4147738579104875,-1.161110101079101,0.27692307692307694,0.7121203827087043,1.0,7/16,16.71%,DNM2;DNM3;DNM1L;MIEF1;PRKN;MFF;MTFR1L
prerank,B cell differentiation (GO:0030183),0.508700029931966,1.160982046509936,0.279651795429815,0.996782083460976,1.0,17/46,23.11%,MS4A1;CD79A;TCF3;CD79B;NFAM1;PLCG2;ZBTB7A;FLT3;CEBPG;DNAJB9;JAK3;SYVN1;HDAC4;NHEJ1;ITGA4;HDAC9;ADAM17
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.4781245443143446,1.1608100142593885,0.029,0.9962052235618422,1.0,162/807,16.25%,CENPF;DEPDC1;E2F7;BIRC5;AURKB;E2F8;FOXM1;UHRF1;GFI1;NKX6-1;MYB;HMGB2;EZH2;RCOR2;MEN1;PLK1;SUV39H1;BRCA1;SMARCC2;NR4A2;HMGA1;DAP;HEY2;RBM15;DEAF1;LEF1;E2F1;UXT;RB1;RIOX1;RSF1;FLNA;ELK4;CBX5;CD38;EZR;TWIST1;ZFPM1;MCPH1;PML;BCL7A;FBXW11;TIMELESS;PA2G4;HDAC10;UBE2I;MTA3;RPS6KA5;EPC1;CTCF;SCMH1;FOXP1;ETS2;DACH1;SP100;CAV1;CDKN2A;NR1D1;NKAP;TAF1;MBD2;FOXO1;MDM4;E2F6;BCL11A;PBXIP1;MBD1;TCF3;ARID4A;GMNN;RUNX3;HDAC6;PDE2A;KLF10;TAF7;NOTCH1;XRCC6;HMGB1;AHR;SFMBT1;SPEN;SAP18;MAX;PSPC1;NEDD4L;SMARCA4;CIR1;CIPC;RPS14;ZBTB16;ETV6;NCOA5;ZBTB7A;SIN3B;NONO;ZNF148;MECP2;PFDN5;TFDP2;CPEB3;ZBTB32;IRF2BPL;NR2C2;NR2F2;KAT6A;ID4;ZEB1;TRIM33;CUX1;MXI1;EHMT1;ARID5B;SUMO1;RTF1;SMAD4;CCAR2;PEX2;JUN;ATF5;PLCB1;MTA2;FOXP2;ZNF25;CBFB;RNF2;BAP1;SETDB2;PRDM6;HCFC1;ZBTB33;SP3;ZBTB7B;HNRNPU;SIRT7;NIPBL;DDIT3;CREBBP;SKI;MYC;BCL6;NFX1;PSEN1;POU6F1;CNOT1;YEATS2;LIMS1;ATF7IP;MOSPD1;TP53;LRRFIP1;RUNX1;LIMD1;IRF8;POU2F1;JARID2;SIN3A;TCF7L2;HIVEP1;TFAP4;DUSP22;FOXK2;TRIM28
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.597607389964926,1.1603948728161353,0.336986301369863,0.9966288422572178,1.0,1/11,1.81%,NR4A2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.48645150490637934,-1.1597212540872763,0.30514705882352944,0.7137651722803322,1.0,3/10,15.01%,CACNB2;SRI;CALM1
prerank,regulation of interferon-gamma production (GO:0032649),0.4927160776665682,1.1591166603395946,0.26687435098650053,1.0,1.0,13/71,14.12%,IL12A;CD2;CD47;ZFPM1;PTPN22;CCR2;RASGRP1;HMGB1;CYRIB;IL1R1;DDIT3;CEBPG;IL27
prerank,protein modification by small protein removal (GO:0070646),0.48061496228019684,1.1582757780849682,0.162,1.0,1.0,86/252,21.36%,CDK1;CLSPN;USP27X;BARD1;CDC20;CCNA2;BRCA1;CDC25A;SKP2;USP1;SENP1;PSMB7;BABAM1;PSMD11;TFPT;ABRAXAS1;PSMF1;SNX3;ACTR5;INO80D;IKBKG;MDM4;USP38;TRAF3;PSMC1;BIRC2;DESI2;DESI1;TAB1;USP48;USP31;ASXL1;PSMC3;RAD23A;TOR1A;PSMA4;RUVBL1;SMAD4;BECN1;KAT2B;PTEN;PSMC4;BAP1;ARRB2;HCFC1;UCHL5;USP14;PSMD13;PSME1;MYC;USP24;USP15;PSMB1;VCPIP1;TADA3;TP53;OTUD5;HGS;PSMD8;USP50;YOD1;FOXK2;PSME4;USP21;USP25;PSMD4;USP40;UBA52;USP7;DDB2;MAP3K7;SENP6;STAM;TRAF6;COPS3;USP34;ACTL6A;KEAP1;SMAD2;INO80E;RIPK1;MDM2;OTUD7A;USP47;USP46;COPS2
prerank,skeletal system morphogenesis (GO:0048705),0.4984766045646933,1.1580427122346935,0.27850877192982454,1.0,1.0,9/42,16.04%,RAB33B;RFLNB;SPEF2;FUZ;HHIP;SKI;ANKRD11;HOXB4;FGFR1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.28070279894520067,-1.1579064248534163,0.17142857142857143,0.7162052282463546,1.0,17/72,11.59%,RIMS1;APP;RIMS2;SQSTM1;STX4;SLC8A3;SYT1;KCTD13;CACNG7;CACNG2;VAMP2;SHANK2;CLSTN3;GRIK2;LGMN;CLSTN1;ADRA1A
prerank,anion transmembrane transport (GO:0098656),0.49712242126475925,1.1578366192808507,0.28335056876938985,1.0,1.0,17/67,18.00%,SLC38A5;SLC25A21;SLC25A12;SLC7A1;SLC6A5;SLC16A12;SLC35A2;SLC35A1;LRRC8B;LRRC8C;SLC19A1;SLC25A22;SLC35C2;SLC25A13;SFXN1;ARL6IP5;SLC35B1
prerank,regulation of microtubule polymerization (GO:0031113),0.5088370217823792,1.157520929627269,0.2883771929824561,1.0,1.0,18/40,22.93%,CDK5RAP2;STMN1;CLASP1;MAPRE3;GBA2;DYRK1A;SLAIN2;NUMA1;RAC1;DRG1;SNCA;TBCD;EML2;RPS3;MET;MAPT;DCTN1;CAMSAP1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5681678301489269,1.1566614469313408,0.31681877444589307,1.0,1.0,2/17,2.65%,CCNE1;PDCD2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5606119334956017,1.1564300645690841,0.3220125786163522,1.0,1.0,6/17,22.04%,ITGA1;PTPA;PPP1R15A;PPP1R12A;CALM3;PPP1R15B
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.44289332802489095,-1.1563924043398022,0.2783882783882784,0.718181629642585,1.0,4/13,18.61%,HSP90AA1;PTS;CALM1;PRKG2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5355722457222182,1.1562475500686875,0.3087885985748218,1.0,1.0,6/27,7.07%,MAPK1;FBXW11;IKBKG;CCDC88C;CCM2;MAP3K5
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.265235491198418,-1.1560078062561712,0.20833333333333334,0.717121131907125,1.0,22/80,13.84%,STX6;TBC1D14;STX16;GBF1;SNX5;VTI1B;RAB6B;TBC1D23;VPS50;TMED9;TBC1D10A;PREPL;TRIM27;SGSM2;TBC1D5;CLN5;GOSR2;ARL1;WASHC1;YKT6;TBC1D17;GOSR1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.585752564896274,1.1557971140244874,0.32439678284182305,1.0,1.0,6/13,19.48%,NKAP;RUNX3;CBFB;ZBTB7B;RUNX1;PNP
prerank,negative regulation of protein catabolic process (GO:0042177),0.5091216729375988,1.1555684577736818,0.28824833702882485,1.0,1.0,9/40,13.00%,MAD2L1;FLNA;AZIN1;SNX3;MDM4;PIN1;EGFR;CDK5RAP3;NELL1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.562826544455749,1.155427931100021,0.31155778894472363,1.0,1.0,3/17,4.25%,UBASH3A;EZR;PTPN22
prerank,import into nucleus (GO:0051170),0.4833187086931018,1.1552965661714212,0.262448132780083,1.0,1.0,32/73,22.65%,POM121;NUP107;GEMIN8;BACH2;TNPO1;SNRPF;IPO13;NUP50;NUP214;SEC13;IPO7;NUP188;RANBP6;RPAIN;HTATIP2;E2F3;APPL1;IPO5;GEMIN7;KPNB1;SNRPG;HNRNPA1;EIF4ENIF1;NUP85;MMP12;SNRPB;TPR;TNPO2;TNPO3;SYK;NUP93;PHB2
prerank,negative regulation of histone methylation (GO:0031061),0.6004418435862174,1.1550894645241763,0.32816901408450705,1.0,1.0,5/10,19.60%,BRCA1;PHF1;DNMT1;JARID2;DNMT3B
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5778314129345685,1.1550811662556237,0.32669322709163345,1.0,1.0,2/12,1.91%,RFWD3;RPA2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5358664975492011,1.1550154845046419,0.3216867469879518,0.9994985640681405,1.0,7/24,17.90%,SDHAF4;COQ10B;COX10;GFPT2;MYC;SLC25A13;NDUFS1
prerank,positive regulation of chemotaxis (GO:0050921),-0.3045928567502838,-1.154701926104796,0.20454545454545456,0.7185329905976255,1.0,14/43,20.08%,TREM2;AIF1;STX4;PRKD1;STX3;P2RY12;CDH13;LGMN;PPM1F;VEGFA;FGF2;MDK;THBS1;P2RX4
prerank,lipoprotein localization (GO:0044872),-0.46156186455134685,-1.1543940903702579,0.2743055555555556,0.7172485220218224,1.0,6/11,24.55%,LRP1;ZDHHC17;MIA3;CD36;UNC119B;ZDHHC3
prerank,intracellular cholesterol transport (GO:0032367),-0.4377033464370505,-1.1541386935566473,0.2773109243697479,0.7158730830255603,1.0,6/15,15.79%,OSBPL2;ABCA1;OSBP;NPC2;NPC1;SERAC1
prerank,ion transport (GO:0006811),0.4839996505958196,1.1539002957619728,0.2388663967611336,1.0,1.0,11/111,7.26%,SLC4A1;CHRNB4;SLC12A3;SLC5A5;P2RX1;VDAC2;ANO10;KCNN4;SLC12A7;SLC12A1;TSPO
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3063551393591002,-1.1537559104791033,0.17475728155339806,0.7148185608037844,1.0,13/39,18.51%,BMP2K;EPN2;MAML1;PRKCI;ROBO1;MAML3;POGLUT1;STAT3;ZMIZ1;TSPAN14;TM2D3;JAG1;NEPRO
prerank,positive regulation of protein transport (GO:0051222),0.4898164117789839,1.153745739120683,0.2801235839340886,1.0,1.0,13/67,15.07%,KIF20B;ARHGEF5;PCNT;EZR;MYOM1;MYH10;PCM1;CNST;OAZ1;RACK1;PPIA;PDCD10;RIPOR1
prerank,lysine metabolic process (GO:0006553),0.5867224069646335,1.1535001874251118,0.31866666666666665,1.0,1.0,1/12,1.71%,SLC25A21
prerank,lysine catabolic process (GO:0006554),0.5867224069646335,1.1535001874251118,0.31866666666666665,1.0,1.0,1/12,1.71%,SLC25A21
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6008657513633939,1.153467931325475,0.3309659090909091,0.9994806005262616,1.0,2/10,3.54%,PMAIP1;PRKCE
prerank,regulation of mast cell activation (GO:0033003),-0.46136532427127447,-1.1533701737837256,0.29896907216494845,0.7135965119250965,1.0,2/10,2.50%,CD84;CD300LF
prerank,heme catabolic process (GO:0042167),-0.42652156367911404,-1.1533008801875093,0.29959514170040485,0.7096104978053129,1.0,5/14,20.75%,ABCC1;HMOX2;SLCO2B1;HMOX1;BLVRA
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.42652156367911404,-1.1533008801875093,0.29959514170040485,0.7096104978053129,1.0,5/14,20.75%,ABCC1;HMOX2;SLCO2B1;HMOX1;BLVRA
prerank,protein deubiquitination (GO:0016579),0.47817040849058734,1.1525735985195846,0.169,1.0,1.0,69/242,17.72%,CDK1;CLSPN;USP27X;BARD1;CDC20;CCNA2;BRCA1;CDC25A;SKP2;USP1;PSMB7;BABAM1;PSMD11;TFPT;ABRAXAS1;PSMF1;SNX3;ACTR5;INO80D;IKBKG;MDM4;USP38;TRAF3;PSMC1;BIRC2;DESI2;TAB1;USP48;USP31;ASXL1;PSMC3;RAD23A;PSMA4;RUVBL1;SMAD4;BECN1;KAT2B;PTEN;PSMC4;BAP1;ARRB2;HCFC1;UCHL5;USP14;SPATA2;PSMD13;PSME1;MYC;USP24;USP15;PSMB1;VCPIP1;TADA3;TP53;OTUD5;HGS;PSMD8;USP50;YOD1;FOXK2;PSME4;USP21;USP25;PSMD4;USP40;UBA52;USP7;DDB2;MAP3K7
prerank,regulation of extracellular matrix organization (GO:1903053),0.5761641560819664,1.1525649414048125,0.3393548387096774,1.0,1.0,5/15,15.17%,RB1;FAP;NOTCH1;EFEMP2;RUNX1
prerank,regulation of mast cell degranulation (GO:0043304),0.5753588261674827,1.1523802921027415,0.3436293436293436,0.9999475529419419,1.0,1/14,0.41%,BLK
prerank,protein monoubiquitination (GO:0006513),0.5197204257157901,1.1523241629471754,0.3018867924528302,0.9989720753728154,1.0,10/36,16.77%,UBE2T;UHRF1;DTL;UBE2O;RAD18;CUL3;FANCL;RNF20;UBE2R2;KLHL22
prerank,regulation of cell population proliferation (GO:0042127),0.4769570155642408,1.1520072781645496,0.058,0.998973803294338,1.0,125/691,17.11%,PRC1;KIF20B;SHCBP1;KIF14;TTK;E2F7;CDKN3;BIRC5;PRTN3;FOXM1;UHRF1;HMGB2;EZH2;RAB33B;TIPIN;MEN1;CYP1B1;CDKN2C;HMGA1;ITGA1;PPP1R9B;LEF1;CD47;FBXO5;IL7R;CCDC88A;ERBB3;GLMN;TIAM1;S100A11;PPM1D;PML;TIMELESS;ARID2;COPS9;PGF;CTCF;STK11;TFRC;CDK6;CDKN2A;CRKL;PTHLH;RPS4X;MDM4;RBBP4;ZFP36L1;TGFA;BIRC2;KLF10;CDC25B;NOTCH1;XRCC6;TSPO;DDRGK1;PIM2;BIRC6;BOK;FUZ;CIB1;JAK2;ITGAV;STRN;EGFR;CDKN2D;CAPN1;CUL3;MECP2;DHPS;DERL2;PTPN14;XIAP;JUN;FGF9;ATF5;KAT2B;RPRD1B;DPP4;FLT3;PTEN;BAP1;S1PR2;PDS5B;BMPR1A;STAT5B;RPS9;RPS15A;ING5;PRKDC;SLURP1;TMEM115;SKI;MYC;BCL6;NAP1L1;CDC7;IRS1;SGK3;KDM4C;LIMS1;ADAMTS1;PDCD10;TP53;JUNB;RUNX1;EGF;F2R;PIAS1;PTPRU;ELN;HGS;MAP2K1;TNFRSF11A;CNOT6;TCF7L2;FGFR1;TFAP4;DUSP22;TGFB2;ACER3;VHL;SIRT1;SSR1;XBP1;TRPM4
prerank,T cell differentiation in thymus (GO:0033077),0.57569206966899,1.1516624393144868,0.3155149934810952,0.9990307453832066,1.0,4/14,15.99%,LIG4;ZFP36L1;CCR6;ZFP36L2
prerank,positive regulation of immune system process (GO:0002684),0.5610292600359947,1.1506942628858625,0.32349165596919127,1.0,1.0,1/16,0.75%,TNFRSF18
prerank,intraciliary retrograde transport (GO:0035721),-0.443056544226551,-1.1506628407172808,0.28832116788321166,0.7147999299957135,1.0,6/12,19.88%,DYNC2H1;IFT43;DYNC2I1;WDR35;DYNC2I2;WDR19
prerank,erythrocyte development (GO:0048821),0.6132773859489814,1.1505114687925186,0.332398316970547,1.0,1.0,3/10,9.12%,ALAS2;ABCB10;ZBTB7A
prerank,regulation of programmed cell death (GO:0043067),0.47886564520218056,1.1505029961815494,0.1963927855711423,0.9999700407324877,1.0,50/161,20.97%,BIRC5;STK26;PMAIP1;ANP32B;SKP2;IKZF3;DAPK2;SLK;GLS2;APAF1;PIDD1;DCPS;CASP2;ATM;LCMT1;BIRC2;JAK2;ZBTB7A;ACTN2;IFT57;FLT3;FAS;TOMM70;APEX1;FBXO11;ANP32E;BEX2;ACTN4;CREBBP;BCL6;HTATIP2;TPT1;TP53;MARK4;ACER3;STEAP3;JAK3;SIRT1;NDRG1;RARG;RBM25;LRRK2;MALT1;RPS3;PAX2;ALK;DAPK1;BNIP3;WRN;RIPK1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.3883849743798122,-1.1504219637768351,0.27601809954751133,0.7133676274419576,1.0,5/17,5.77%,RTN4;APOE;GGA3;IGF1;BIN1
prerank,brain morphogenesis (GO:0048854),0.5840090775171762,1.150394494177798,0.3401920438957476,0.9992106732989571,1.0,5/12,13.42%,FBXW11;SPEF2;PAFAH1B1;PTEN;BBS4
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.5352089748157237,1.150210673644445,0.30105017502917153,0.9987550064732872,1.0,13/27,21.91%,TNRC6B;PUM2;EGFR;PUM1;DHX9;FXR1;TP53;LIMD1;MAP2K1;EIF4ENIF1;AGO2;RIPK1;EIF4E2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.47372210783045965,1.1501981470048517,0.195,0.9976350622727321,1.0,38/175,16.94%,TNFRSF18;ADAMTS7;EDARADD;BRCA1;TNFSF13B;PSMB7;PSMD11;CRHBP;TANK;PSMF1;NR1D1;TRADD;ZFP36L1;TRAF3;PSMC1;GBP2;BIRC2;CIB1;JAK2;PSMC3;TNFRSF13B;PSMA4;DHX9;PSMC4;NFE2L2;PSMD13;PSME1;ACTN4;PSMB1;LIMS1;TP53;PSMD8;TNFRSF11A;ZFP36L2;PSME4;CCL25;PSMD4;SIRT1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5477993539946029,1.1500314642149014,0.31064356435643564,0.9970590802865181,1.0,8/20,15.40%,ERBB3;CASP2;BOK;ITGAV;FAS;CASP9;GSK3B;APPL1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4883660305514121,1.1500212502150455,0.28439425051334705,0.9959311104192111,1.0,20/86,16.39%,KIF14;FOXM1;ARHGEF18;ARHGDIB;MMD2;RASGRP1;CRKL;DENND4C;NOTCH1;ARFGAP1;GRB2;JAK2;STARD8;RDX;ARHGEF28;DENND1A;PDCD10;BCR;ARHGDIA;TGFB2
prerank,phagolysosome assembly (GO:0001845),-0.4390055997461367,-1.149833450987333,0.289198606271777,0.7128217169444439,1.0,3/12,10.80%,RAB14;RAB20;SYT7
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5986152643088448,1.1493375229683587,0.3274336283185841,0.997379029266783,1.0,2/10,8.28%,SOX6;ZBTB16
prerank,regulation of neuron differentiation (GO:0045664),0.49181423452450534,1.149227926262585,0.2792607802874743,0.9965944075075261,1.0,17/76,18.13%,ECT2;NTF4;CDK5RAP2;TIAM1;GPRC5B;MMD2;YWHAH;TCF3;MMD;ZEB1;CDK5RAP3;NRCAM;SIN3A;TCF4;FGFR1;MED1;LRRK2
prerank,regulation of focal adhesion assembly (GO:0051893),-0.29103423297888487,-1.1489108680437845,0.2127659574468085,0.7131457355501546,1.0,22/54,18.05%,ARHGAP6;EFNA5;LIMCH1;MACF1;APOD;PTPRJ;SLC9A1;CLASP2;CORO1C;LDB1;DUSP3;TSC1;FERMT2;RCC2;PPM1F;PTK2;VEGFA;MAP4K4;ACVRL1;COL16A1;THY1;THBS1
prerank,leukocyte tethering or rolling (GO:0050901),0.5656959514671982,1.1488923602110046,0.3227931488801054,0.9966439557591582,1.0,8/17,22.30%,SPN;ITGB7;JAM2;ADD2;GOLPH3;GCNT1;ROCK1;ITGA4
prerank,ncRNA transcription (GO:0098781),0.5797136137506165,1.1488030372338778,0.33819628647214856,0.995793953743896,1.0,7/13,20.58%,BRF1;SNAPC3;NIFK;SIRT7;POLR1G;RPAP2;SPIN1
prerank,regulation of keratinocyte migration (GO:0051547),-0.44999694666533874,-1.1485449207790401,0.3024054982817869,0.7120929232303188,1.0,4/12,14.64%,IQSEC1;EPB41L4B;ADAM9;MAP4K4
prerank,peptidyl-threonine modification (GO:0018210),0.49103289759126373,1.1482669675859642,0.2897196261682243,0.996601516403602,1.0,17/66,15.76%,CDK1;CIT;MAPK1;OXSR1;CHEK1;TAF1;PRKCA;MARK2;PDPK1;HIPK2;DYRK1A;LMTK2;ROCK2;PRKDC;STK39;GSK3B;MAP2K1
prerank,response to interleukin-6 (GO:0070741),0.6027162329511497,1.148226067833569,0.32865168539325845,0.9956010179326962,1.0,1/10,0.77%,FOXA2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.5849903181656013,1.1477684766604555,0.3263888888888889,0.9961356402236069,1.0,2/12,10.58%,CCR2;IL1R1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.37483202531880827,-1.147723091902449,0.2611111111111111,0.712208260952932,1.0,5/21,9.31%,ARHGAP25;RASAL3;LZTR1;MFN2;SH3BP1
prerank,protein phosphorylation (GO:0006468),0.47357555001358526,1.1476178516099602,0.096,0.9955048600120311,1.0,112/479,16.39%,TTK;CDK1;BIRC5;AURKB;BLK;CLSPN;CIT;NEK2;MASTL;CCNA2;INCENP;CCNE1;PLK1;STK26;CHEK2;MAPK1;CDKL1;AURKA;OXSR1;DAPK2;FYN;SLK;PRKCE;HASPIN;MAP2K6;RSKR;ERG;RPS6KA5;MAP4K1;STK11;MAPKAPK3;CHEK1;CDK6;GRK6;TLK1;GMFG;TAF1;SIK2;ATM;RUNX3;CSNK1A1;STK38L;MAP3K5;CDC25B;PIM2;CDK17;AKT3;PKN2;BIRC6;CSNK1G2;PIM3;MAP3K1;BAZ1B;MAP4K2;PRKX;HCST;MAPK14;PRKCA;PRKACA;ERC1;STK38;PICK1;MARK2;JAK2;LMTK3;MAST2;STK24;EGFR;EPHA3;PIM1;PDPK1;MAP4K5;CDK19;HIPK2;TESK2;MAP3K11;MELK;DYRK1A;VRK1;BTK;RELN;FLT3;CCNT1;PRKCB;RPS6KA6;BMPR1A;LMTK2;GRK2;ROCK2;PRKDC;PRKAG2;LATS1;CDK16;STK39;FAM20A;NRBP1;HTATIP2;CDC7;USP15;GSK3B;SGK3;STK4;MAP3K20;BCR;PAK5;MAP2K1;MARK4;FGFR1;LIMK2;PAK2;CDK8;TGFB2
prerank,positive regulation of heart rate (GO:0010460),-0.3973433098301909,-1.1473808619150876,0.2623762376237624,0.7110687162491609,1.0,5/17,21.86%,RYR2;ADRA1A;ADRA1B;ADRB1;SCN3B
prerank,regulation of cellular pH (GO:0030641),0.5201965753601653,1.1473387626106144,0.31733021077283374,0.9953970891621265,1.0,8/29,19.26%,SLC4A1;SLC9A8;SLC9A9;ATP6AP1;ATP5F1B;CLN3;SLC9A7;SLC9A6
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.26441098989219564,-1.1472055928996456,0.08695652173913043,0.7095202690913279,1.0,23/87,15.57%,ACVR1;ITGB5;TGFBR1;GCNT2;APPL2;F11R;NLK;PTPRK;SMAD1;SMAD3;ZFYVE9;USP9X;SMAD6;ZMIZ2;ENG;LPXN;FERMT2;SMAD7;ZMIZ1;ADAM9;PTK2;TGFBR3;ACVRL1
prerank,defense response to fungus (GO:0050832),0.5454600807304197,1.1469695749608255,0.3153034300791557,0.9956420653990593,1.0,4/17,10.74%,S100A9;S100A8;PLCG2;CARD9
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5422768941191849,1.146538973506671,0.3124231242312423,0.9960796595369171,1.0,5/24,10.65%,CD177;PECAM1;EZR;GFUS;MSN
prerank,positive regulation of cell adhesion (GO:0045785),0.4804532128609302,1.1463895603898329,0.29132231404958675,0.9954736364979867,1.0,10/74,8.84%,IL12A;TNFRSF18;ECM2;CD47;PPP3CA;ATM;CIB1;PRKCA;JAK2;ITGAV
prerank,sarcomere organization (GO:0045214),0.5197296651780476,1.1463511402794344,0.3130128956623681,0.9944721329040612,1.0,3/27,10.21%,CSRP3;CSRP1;ACTN2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.47282603957828395,1.1463225886273918,0.20804020100502513,0.9934304951039886,1.0,37/170,14.55%,TCF19;TRIM58;TMPRSS4;AFF3;MEFV;AFF1;CTCF;FOXP1;CDK6;NKAP;PTHLH;ZFP36L1;ZUP1;PIN1;MTMR2;AHR;NOVA2;TRIM11;SART3;PCBP2;TRIM44;ZNF462;PRDM10;ATXN7L3B;UBAP2;IGF2BP3;NPAT;TRIM68;PRDM6;NELL1;ROCK2;FLOT1;MYC;PSEN1;HNRNPAB;TRIM5;PCBP3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4274486039238188,-1.1453019935365487,0.29850746268656714,0.7124467582232283,1.0,7/13,28.98%,SEC16A;EDEM2;BCAP31;CD81;EDEM1;SAR1A;SORL1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.47891624120466164,1.1449497105365765,0.2637474541751528,0.9974384978775823,1.0,25/94,16.41%,CYP1B1;BRCA1;PMAIP1;CHEK2;E2F1;ITPR1;PML;APAF1;MSH6;STK11;CASP2;ATM;MAP3K5;PRODH;BOK;STK24;CUL3;PPP1R15A;HIPK2;PRKDC;DDIT3;CASP9;TP53;CD24;CRIP1
prerank,nuclear envelope organization (GO:0006998),0.5426622288940169,1.14437022008479,0.311639549436796,0.9984952511801748,1.0,5/20,10.92%,NEMP1;REEP4;SUN2;EMD;TOR1A
prerank,organic acid transport (GO:0015849),0.48071890812691953,1.143828083852634,0.2676200204290092,0.9993608226581978,1.0,13/94,11.68%,SLC6A12;SLC38A5;SLC1A5;SLC7A1;SLC16A1;ABCC2;SLC25A47;SLC16A10;SLC43A2;SLC3A1;SLC19A1;STARD5;ABCC4
prerank,nuclear pore complex assembly (GO:0051292),0.6083901972198342,1.1437692951562193,0.3238231098430813,0.9984553884990396,1.0,5/10,12.33%,NDC1;NUP107;NUP205;AHCTF1;NUP98
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5744651276948143,1.1431295502561645,0.34506089309878213,0.9996514336244415,1.0,5/13,23.15%,CD177;TYROBP;MAPT;SYK;PRKCD
prerank,steroid biosynthetic process (GO:0006694),0.4841544468756576,1.1430652628365447,0.291044776119403,0.9987497908141112,1.0,9/56,13.57%,HSD17B3;LBR;SRD5A2;LSS;OSBPL3;CYP27A1;SLC27A2;CYP46A1;PRKAG2
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.3219986951008216,-1.1427667763739062,0.27007299270072993,0.7170733763434607,1.0,15/33,20.52%,PTPRG;APOE;EVL;CORO1C;KRIT1;DUSP10;VASH1;ACVRL1;PFN2;DAB2IP;MCC;THBS1;ADGRB1;PTPN23;SVBP
prerank,organophosphate catabolic process (GO:0046434),-0.446593685130388,-1.1425305068228147,0.32666666666666666,0.7156669459639231,1.0,3/11,10.34%,ABHD12;ENPP2;PLBD2
prerank,macrophage differentiation (GO:0030225),-0.4305623494739964,-1.1424149293902974,0.27309236947791166,0.7139390480767278,1.0,5/13,18.86%,CSF1R;VEGFA;CSF1;IL31RA;CDC42
prerank,negative regulation of protein binding (GO:0032091),0.4779040767242411,1.1423830652893976,0.27586206896551724,1.0,1.0,20/71,19.05%,AURKB;AURKA;DDX11;ZFPM1;SLPI;CAV1;DISC1;PIN1;PARK7;B2M;ARRB2;RACK1;TFIP11;GSK3B;STYX;PEX14;PPP1CA;LRRK2;GNL3L;CDKN1A
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.45787821720025107,-1.1423771489752226,0.30685920577617326,0.7120246623800952,1.0,9/11,54.24%,PLA2G7;AGT;PLA2G3;LIPC;PLA2G5;ABCG1;PLA2G10;APOA2;AGTR1
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2746073390928571,-1.1422395151587181,0.16666666666666666,0.7104018447903144,1.0,19/75,12.72%,CSF1R;DGKH;SYNJ1;PLA2G15;GPCPD1;ABHD12;PLCB2;PLA2G7;GDE1;PIGB;HDHD5;PIGN;ABHD6;CRLS1;AGK;PIGX;PIGP;ABHD3;PLA2G6
prerank,regulation of Golgi organization (GO:1903358),0.5632435075561693,1.1419393701810687,0.34220532319391633,1.0,1.0,7/17,18.96%,RAB33B;MAPK1;STX5;ARMH3;PDCD10;MAP2K1;PDE4DIP
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4922622448554109,1.141900795438799,0.2829581993569132,0.9996181223720293,1.0,7/56,12.63%,TTK;INHBC;PMEPA1;PIN1;SMAD4;SNX25;BMPR1A
prerank,negative regulation of potassium ion transport (GO:0043267),0.579250022219857,1.1418253206009479,0.33469945355191255,0.9987574536963311,1.0,4/13,13.69%,CAV1;NEDD4L;ACTN2;STK39
prerank,RNA destabilization (GO:0050779),0.5582993180342192,1.1418170043955689,0.33033419023136246,0.9976534315936204,1.0,11/18,25.27%,ZC3H18;FTO;PUM1;METTL16;ROCK2;DXO;METTL14;ROCK1;CELF1;MEX3D;GIGYF2
prerank,regulation of organelle organization (GO:0033043),0.48160321530925587,1.1417155325744426,0.28891149542217703,0.9968888280177927,1.0,27/80,19.75%,RAB33B;ARHGEF5;PISD;MAPK1;EZR;S100A9;S100A8;STX5;PDE2A;ARL6IP1;MARK2;MSN;RDX;FIS1;ARMH3;SIRT7;DIAPH1;PDCD10;TBC1D25;MTM1;PAK2;LMAN1;TAOK1;CLN3;PDE4DIP;SAR1B;GOLPH3
prerank,modulation by symbiont of entry into host (GO:0052372),0.5555818243502774,1.1416488435799237,0.33377837116154874,0.9960321348077348,1.0,4/16,14.47%,EXOC2;CAV1;TRIM68;TRIM5
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.4235487096960635,-1.1416001712466977,0.31153846153846154,0.7100481176909988,1.0,5/14,9.31%,OPHN1;MYO9A;PATJ;RAP2A;SH3BP1
prerank,response to axon injury (GO:0048678),-0.40093018081313064,-1.141485085032073,0.2796208530805687,0.7083214754041735,1.0,10/18,28.92%,TREM2;APOD;P2RY12;GAP43;P2RX4;MAPK8IP3;DPYSL3;FLRT3;DHFR;MORN4
prerank,non-motile cilium assembly (GO:1905515),0.5236104196221478,1.1411063416451306,0.33408833522083803,0.9969467660462883,1.0,11/30,13.80%,CEP89;DISC1;FUZ;CEP250;GORAB;TBC1D32;PCM1;IFT57;ARL13B;BBS4;PIBF1
prerank,actin polymerization or depolymerization (GO:0008154),0.4937555055567193,1.1409672647454714,0.3064687168610817,0.9963605617917061,1.0,5/50,9.26%,DIAPH3;GSN;JAK2;CFL2;FLII
prerank,response to lipid (GO:0033993),0.47371607543599054,1.1406605400672318,0.25688073394495414,0.9963560140762603,1.0,23/105,18.04%,IL12A;HMGB2;ALPL;PTPN22;S100A9;MAPKAPK3;SLPI;FOXP1;S100A8;FOXO1;JAK2;CDKN2D;ABCA2;ASXL1;SOCS2;HNRNPA0;STAT5B;OTUD5;F2R;TNFRSF11A;RXRB;SNCA;RARG
prerank,regulation of protein metabolic process (GO:0051246),0.4975119231652572,1.1404159875800928,0.32461873638344224,0.9961474214805391,1.0,10/44,15.64%,FAM83D;CHEK2;FAF1;TRAF3;NEDD4L;MTPN;ABCA7;ROCK2;SPOP;HGS
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5943065663657717,1.1400047202863735,0.3380681818181818,0.996537591982182,1.0,2/11,7.52%,KLRD1;AHR
prerank,positive regulation of histone acetylation (GO:0035066),0.5335720425025052,1.1389544996700849,0.3293124246079614,0.999297107588274,1.0,8/23,19.01%,BRCA1;RPS6KA5;RUVBL2;SMAD4;PAXIP1;TADA2A;GLYR1;BRD7
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4766543709220823,1.1388978358356239,0.31360332294911736,0.9983989164882402,1.0,20/67,19.13%,ECM2;FLNA;NEDD9;PLEKHA2;CDK6;CRKL;CIB1;JAK2;CRK;NRP1;RSU1;GSK3B;LIMS1;TRIOBP;RAC1;CCL25;UTRN;FN1;ARHGEF7;S100A10
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5784524129056485,1.1384510784360473,0.3516483516483517,0.9988984382692067,1.0,6/13,16.94%,TWIST1;CD74;CD44;DYRK1A;YJU2;SIRT1
prerank,regulation of histone modification (GO:0031056),-0.4319803526211841,-1.1383649829486922,0.2857142857142857,0.7142570829583776,1.0,4/13,10.18%,PARG;AKAP8L;MTHFR;FLCN
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5953729479532319,1.1381816641428941,0.3564493758668516,0.9987588302996393,1.0,4/10,12.75%,BRCA1;CHEK1;SMAD4;KMT2A
prerank,motile cilium assembly (GO:0044458),-0.44332523669548046,-1.1378898196984604,0.3263157894736842,0.7134033675574454,1.0,7/12,35.08%,E2F4;SPATA6;BBS5;CCDC39;DNAAF3;CCDC40;RSPH9
prerank,peptidyl-arginine modification (GO:0018195),0.564447542427017,1.137844483883517,0.33646112600536193,0.9988706212791026,1.0,6/15,21.42%,ART3;KRTCAP2;PARK7;NDUFAF5;PRMT7;PADI4
prerank,calcium ion import into cytosol (GO:1902656),0.5620165198033489,1.1377506805591837,0.34810951760104303,0.9981068613233416,1.0,1/15,1.22%,MS4A1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5017263837021799,1.1375613661493116,0.30293159609120524,0.9976717988043005,1.0,18/46,21.74%,RB1;NRDC;MAP2K6;STK11;ACOT11;NR1D1;NOTCH1;LAMA4;NOVA2;ACOT13;DDIT3;LGR4;ADAMTS5;TLE3;ACVR2B;RBPJ;PLCL1;NR1H3
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.47340846113186347,1.1374146242952068,0.2439516129032258,0.9971040420936577,1.0,33/140,15.42%,ECT2;FOXM1;RACGAP1;DEPDC1B;ARHGEF5;ARHGAP15;ARHGAP11A;ARHGAP33;TIAM1;NET1;ARHGEF18;ARHGDIB;ARHGEF3;FAM13A;ARHGAP35;CYRIB;SOS1;ITGAV;ARHGAP19;GMIP;RHOU;STARD8;ARHGAP39;RELN;ARHGAP30;FGD3;ARHGAP9;RAC2;ARHGAP45;ARHGAP26;ARHGAP31;BCR;FAM13B
prerank,cell chemotaxis (GO:0060326),0.49294055030604145,1.137405365179588,0.3068062827225131,0.996032598662589,1.0,12/60,17.65%,HMGB2;CXCR5;LEF1;CCR2;CCR6;ARRB2;NRP1;LPAR1;ELMO2;CCL25;PARVA;CXCR4
prerank,protein targeting to peroxisome (GO:0006625),0.5148218276221956,1.1371824489085058,0.3204225352112676,0.9957416864171612,1.0,9/29,12.03%,PEX26;ABCD1;ACBD5;PEX11B;PXMP4;GDAP1;PEX2;RAB8B;FIS1
prerank,regulation of stem cell proliferation (GO:0072091),0.5437635655983729,1.1368923799273127,0.3337595907928389,0.9957378928682067,1.0,2/17,6.62%,HMGB2;ZFP36L1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.5409347079079562,1.136850738467646,0.3309002433090024,0.9947645886769227,1.0,8/19,16.39%,HEY2;ZFPM1;MDM4;NOTCH1;SMAD4;SLIT3;BMPR1A;TGFB2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.40484527004122706,-1.1367033681811833,0.30472103004291845,0.714211498264084,1.0,2/15,0.96%,IGF1R;TEC
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5759163975653354,1.1365165347018267,0.34776725304465494,0.9949187977652668,1.0,8/13,23.11%,HMGB1;AKT3;PDPK1;FGFR1;PLCG1;APLN;ITGA4;ADAM17
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.46686250757055986,-1.13638255724376,0.3333333333333333,0.7130488705838063,1.0,3/10,6.35%,UPP2;NT5M;DPYD
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.4858985749130659,1.136113215085203,0.29265770423991727,0.995347202155434,1.0,4/69,3.65%,KIF14;NTF4;ERBB3;LIG4
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.39764302672346963,-1.135534260946219,0.2775330396475771,0.7134738619154206,1.0,4/16,15.99%,RELA;ALOX5;ST3GAL4;MDK
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.4487882917573668,-1.1352476558078066,0.3114754098360656,0.7122031771965635,1.0,5/10,12.80%,PADI2;APOD;WASL;MIA3;CD200
prerank,actin filament network formation (GO:0051639),-0.450037458606636,-1.134973216264198,0.31475409836065577,0.7110017107170076,1.0,3/11,15.32%,FHOD1;SPIRE1;FHOD3
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5102081851119822,1.1344737122247373,0.31662870159453305,1.0,1.0,12/34,20.48%,FLNA;NEDD9;CRKL;CIB1;CRK;NRP1;LIMS1;TRIOBP;RAC1;ARHGEF7;S100A10;ILK
prerank,tRNA processing (GO:0008033),-0.26407712869536526,-1.1343672522077657,0.16981132075471697,0.710638511268986,1.0,35/61,37.12%,ANKRD16;SARS1;TRMT1;DTWD2;NSUN2;WDR4;QTRT1;ELP5;TRIT1;TYW5;TSEN15;METTL1;FTSJ1;THUMPD1;TRMT10B;RPP21;RTRAF;FAM98B;TRMT10A;LCMT2;ELAC2;TRMT9B;DDX1;DTWD1;RPP40;NSUN6;POP5;CTU2;AARS2;TSEN54;POP7;THG1L;QTRT2;TRMT61A;CTU1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.42634904724809747,-1.1334311493668292,0.2727272727272727,0.7111768570251653,1.0,7/13,46.23%,NAXD;PARP16;NAXE;NAPRT;NUDT12;NAMPT;PARP10
prerank,alcohol catabolic process (GO:0046164),0.5893397916009877,1.1332418939096407,0.34411764705882353,1.0,1.0,4/10,15.32%,CEL;CYP27A1;CYP46A1;SRD5A3
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.38616506845015036,-1.1330435472655234,0.28365384615384615,0.7102102280671757,1.0,3/17,9.80%,ANK3;KCNAB1;VAMP2
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.3841325149285,-1.1329717284890108,0.2857142857142857,0.7084239489036561,1.0,8/19,18.05%,CSF1R;CMKLR1;AKIRIN1;MPP1;PTK2;CSF1;MDK;THBS1
prerank,positive regulation of cellular process (GO:0048522),0.4676980545338372,1.1324724987834356,0.09,1.0,1.0,105/565,17.78%,PRC1;KIF20B;KIF14;TTK;BIRC5;PRTN3;FOXM1;ANKLE1;IL12A;TNFRSF18;EZH2;SPAG5;TIPIN;IL2RG;LEF1;CD47;FBXO5;IL7R;ERBB3;TIAM1;PPP3CA;SMC6;PA2G4;S100A9;BRAT1;COPS9;PGF;RPS19;DDX49;CHEK1;MLC1;AGPAT1;CAV1;CRKL;PTHLH;RPS4X;S100A8;FAF1;ATM;CSPP1;ZFP36L1;TGFA;CDC25B;NOTCH1;PRODH;DDRGK1;H3-3A;DYNC1H1;CIB1;PRKCA;RAD18;MTPN;ITGAV;NCBP1;EGFR;CAPN1;CUL3;MECP2;PRR7;DHPS;DERL2;ABCA7;RAD23A;FGF9;RPRD1B;DPP4;FLT3;FASN;PTEN;HCFC1;S1PR2;FXR1;RPS9;RPS15A;FLOT1;NUMA1;ACTN4;MYC;NAP1L1;PABIR1;CDC7;IRS1;KDM4C;PDCD10;EGF;F2R;TNFRSF11A;CNOT6;FGFR1;TGFB2;ACER3;VHL;CAPN10;RAC1;KLHL22;SIRT1;CYBA;SSR1;XBP1;TRPM4;HCLS1;FN1;FCGR2B;KITLG;COLEC12
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5145009553199066,1.132463731854666,0.33413461538461536,1.0,1.0,7/26,11.91%,CCNB1;CDC25B;PKN2;PRKCA;SMOC2;CUL3;CCDC57
prerank,serine family amino acid biosynthetic process (GO:0009070),0.581614766734495,1.132405900206085,0.3543417366946779,1.0,1.0,4/12,17.51%,SERINC5;SERINC3;SEPHS1;PHGDH
prerank,Golgi to lysosome transport (GO:0090160),-0.4597370671354364,-1.1322317703503164,0.3288135593220339,0.7084400312377847,1.0,2/11,3.56%,GAK;LAMP1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.3731248531715972,-1.1320365192439739,0.2616279069767442,0.7070559643167524,1.0,16/22,41.34%,ROBO1;MIA3;VEGFA;FGF2;GPLD1;EFNB2;KDR;SRF;NR4A1;EGR3;ID1;EMP2;GREM1;EPHB4;CDH5;SLIT2
prerank,amino acid import across plasma membrane (GO:0089718),0.5338192266664981,1.1320140416217648,0.3457382953181273,1.0,1.0,3/24,3.20%,SLC1A5;SLC7A1;SLC6A5
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.47077985884597323,1.1320062798539632,0.2735562310030395,1.0,1.0,30/104,18.23%,MUC19;PSMB7;FYN;PSMD11;FBXW11;RPS6KA5;PSMF1;KLRD1;IKBKG;PSMC1;TAB1;PRKACA;PLCG2;TAB3;PDPK1;PSMC3;CARD9;PSMA4;PSMC4;PSMD13;PSME1;CREBBP;TYROBP;PSMB1;PSMD8;PAK2;PSME4;PSMD4;MAP3K7;MALT1
prerank,cellular response to lectin (GO:1990858),0.47077985884597323,1.1320062798539632,0.2735562310030395,1.0,1.0,30/104,18.23%,MUC19;PSMB7;FYN;PSMD11;FBXW11;RPS6KA5;PSMF1;KLRD1;IKBKG;PSMC1;TAB1;PRKACA;PLCG2;TAB3;PDPK1;PSMC3;CARD9;PSMA4;PSMC4;PSMD13;PSME1;CREBBP;TYROBP;PSMB1;PSMD8;PAK2;PSME4;PSMD4;MAP3K7;MALT1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5748167837333775,1.1319904435363177,0.3373333333333333,1.0,1.0,3/13,11.17%,HEY2;NOTCH1;SMAD4
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.47076839130047476,1.1318884147652395,0.2768762677484787,0.9999893333301223,1.0,30/105,18.23%,MUC19;PSMB7;FYN;PSMD11;FBXW11;RPS6KA5;PSMF1;KLRD1;IKBKG;PSMC1;TAB1;PRKACA;PLCG2;TAB3;PDPK1;PSMC3;CARD9;PSMA4;PSMC4;PSMD13;PSME1;CREBBP;TYROBP;PSMB1;PSMD8;PAK2;PSME4;PSMD4;MAP3K7;MALT1
prerank,rRNA modification (GO:0000154),0.5340059229601718,1.1316521123979133,0.3383084577114428,0.9998093312110955,1.0,9/21,17.99%,ZCCHC4;NOP10;TFB1M;TFB2M;FBL;NSUN3;DIMT1;NAT10;DKC1
prerank,negative regulation of lipid storage (GO:0010888),-0.3862364372843858,-1.130919764203333,0.29545454545454547,0.7080607837862687,1.0,3/19,1.79%,TREM2;PTPN2;ABCA1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5734625925263162,1.1308216209147781,0.3577981651376147,1.0,1.0,5/13,16.35%,CD74;AGPAT1;TRIM44;DHX9;TAF9
prerank,small GTPase mediated signal transduction (GO:0007264),0.4722006725251387,1.1304879137064803,0.2787878787878788,1.0,1.0,35/103,19.84%,CCNA2;RRAD;ARHGAP33;RB1;CCDC88A;GRAP2;TIAM1;NTN1;ARHGEF18;RASGRP1;CDKN2A;CRKL;CCDC88C;MAPK14;GRB2;SOS1;DNMT1;RIT2;PARK7;ARHGAP30;JUN;PLD2;PLD1;TP53;ARHGAP31;BCR;USP50;TRIM28;RAC1;RASSF1;SETDB1;CDKN1A;KSR1;ARHGAP1;G3BP1
prerank,cellular response to interleukin-15 (GO:0071350),0.582256621301695,1.1304308863851715,0.3417890520694259,0.999914189787181,1.0,5/13,16.70%,IL2RG;GRB2;PLCB1;STAT5B;JAK3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.582256621301695,1.1304308863851715,0.3417890520694259,0.999914189787181,1.0,5/13,16.70%,IL2RG;GRB2;PLCB1;STAT5B;JAK3
prerank,detection of calcium ion (GO:0005513),-0.43111668469437214,-1.130428532561183,0.3064516129032258,0.7073915947938446,1.0,7/13,33.95%,SYT1;RYR2;CALM1;STIM1;KCNMB2;CALM2;KCNMB4
prerank,negative regulation of TORC1 signaling (GO:1904262),0.5704766586859489,1.1303205453579328,0.35190217391304346,0.9992447912616467,1.0,4/13,12.60%,STK11;ATM;SZT2;RNF152
prerank,supramolecular fiber organization (GO:0097435),0.46608689580369866,1.1303108726103182,0.171,0.9982005871502275,1.0,46/334,11.42%,KIF18B;KIF14;KIF2C;MYO5C;TMOD4;SPTA1;KIF24;KIF18A;CKAP5;CYP1B1;STMN1;DES;TUBGCP6;IAPP;PPP1R9B;SAMD14;MYO15A;CCDC88A;SLK;HSPG2;PLOD3;CRTAP;TUBGCP4;GSN;CENPJ;CCDC88C;COL1A2;RND3;PIN1;SHROOM2;H3-3A;DYNC1H1;CIB1;COL4A4;TSPAN33;LAMB3;FLII;PCM1;WHAMM;KIF2A;ATP7A;SHROOM4;B2M;SLAIN2;GGA1;TLL2
prerank,insulin receptor signaling pathway (GO:0008286),-0.2802856569434555,-1.1302429370639493,0.13333333333333333,0.7060336175541546,1.0,22/69,15.09%,IGF1R;BCAR3;PTPN2;ATP6V1B2;ATP6V1C1;ATP6V0D2;PIK3R1;ATP6V0A1;ATP6V0B;AKT2;BAIAP2;IDE;SH2B2;TCIRG1;GAB1;IRS2;GSK3A;ATP6V1H;ATP6V1A;RHOQ;SLC39A14;GRB10
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.46773281174042713,1.1299723772051748,0.203,0.9983723463272819,1.0,94/241,20.83%,RBM15;LSM6;DHX38;POLR2I;SNRNP25;PRPF19;POLR2A;IK;SNRPF;HNRNPC;SNRPC;HNRNPM;HNRNPL;HNRNPA3;CPSF2;CRNKL1;PPIL3;U2AF1;SNRNP200;UBL5;EIF4A3;SRSF3;SPEN;TXNL4A;RNPC3;HNRNPA2B1;PSPC1;NOVA2;SART3;SRSF4;NCBP1;PRPF38A;LSM2;SNRNP35;RALY;NONO;CASC3;RNPS1;U2AF1L4;PPWD1;SRRT;CSTF3;RBM19;PCBP2;PRPF31;DHX9;HNRNPA0;LSM5;U2SURP;UPF3B;ZMAT2;HNRNPR;CWC15;HNRNPU;SF3B5;PRPF4;TFIP11;SRRM2;PDCD7;LSM7;METTL14;SRSF10;SART1;GEMIN7;DNAJC8;SNRNP40;ESS2;POLR2K;SRSF7;CDC40;DDX39B;POLR2J;SNRPG;GCFC2;PCF11;CPSF1;PRPF8;RSRC1;CLP1;PPIE;HNRNPA1;PPIH;ELAVL1;NCBP2;ZCCHC8;SRSF2;SF3A2;SNRNP48;SNRPB;CPSF7;PPIL1;RBM4B;SYNCRIP;WDR33
prerank,positive regulation of chemokine production (GO:0032722),-0.29673339303297,-1.1294657651607638,0.19736842105263158,0.7062093261703806,1.0,9/44,7.24%,APP;CSF1R;MBP;LPL;AIF1;PYCARD;TLR7;MAVS;TLR4
prerank,negative regulation of reproductive process (GO:2000242),0.5478195971446918,1.129132119288481,0.34974093264248707,1.0,1.0,3/17,6.98%,NPPC;ARHGDIB;PAEP
prerank,rRNA methylation (GO:0031167),0.5379033246476593,1.1288137350519452,0.3463892288861689,1.0,1.0,9/22,15.24%,ZCCHC4;TFB1M;TFB2M;EMG1;METTL15;FBL;METTL16;NSUN3;DIMT1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4824121861850342,1.128616071583498,0.32055378061767836,1.0,1.0,11/52,13.32%,MBNL3;RBM15;HNRNPL;SAP18;NOVA2;ZBTB7A;RNPS1;RBFOX3;RBM7;FXR1;HNRNPU
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5208225914394062,1.1284422175384894,0.3479289940828402,0.9996014120381057,1.0,6/26,10.93%,FMOD;ST3GAL1;SLC35D2;ST3GAL2;B3GNT2;OGN
prerank,histone H3-K4 methylation (GO:0051568),0.5254149869079935,1.128342961963779,0.3365500603136309,0.9988926366372626,1.0,8/26,14.94%,MEN1;WDR5B;DPY30;KMT2C;PAXIP1;KMT2A;RBBP5;KMT2B
prerank,gluconeogenesis (GO:0006094),-0.3096901854851384,-1.1282006541287772,0.24,0.7075480134311507,1.0,17/39,23.15%,GPI;GOT2;ENO1;ALDOA;ATF4;TPI1;PGM1;PGAM1;G6PC3;SLC25A11;ALDOC;SLC39A14;PER2;ENO2;CRY1;PPARGC1A;ENO3
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.4378768991155705,-1.1280677165847905,0.32971014492753625,0.7060116711953315,1.0,8/12,33.18%,HPRT1;PRPS2;PPAT;AMPD2;GART;PRPSAP2;PRPS1;PRPS1L1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5740418710394051,1.1280528294152565,0.34459459459459457,0.9989263935464588,1.0,7/13,20.33%,TXN;PARK7;NFE2L2;RACK1;PDE8A;LRRK2;MET
prerank,peripheral nervous system development (GO:0007422),0.5287113766378376,1.1277843388238427,0.33495736906211937,0.9988299108476273,1.0,3/23,9.64%,NTF4;ERBB3;PMP22
prerank,regulation of T cell cytokine production (GO:0002724),0.552044329228914,1.1276686423111748,0.34441489361702127,0.9981591906012833,1.0,7/15,19.36%,CCR2;B2M;TRPM4;MAP3K7;MALT1;CD55;TRAF6
prerank,protein autoubiquitination (GO:0051865),0.4863646482969045,1.1275378692511462,0.2949117341640706,0.997596537602153,1.0,25/61,24.33%,UBE2T;UHRF1;BRCA1;RNF157;RAD18;RNF141;CUL3;AMFR;RNF8;CNOT4;TRIM68;NFX1;RNF115;SH3RF1;RNF4;TRIM37;DDB2;TRAF6;RNF213;MDM2;LRSAM1;UHRF2;OBI1;ITCH;RNF41
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3245337828493897,-1.1275180701021992,0.27906976744186046,0.7055130276636229,1.0,18/34,27.41%,TREM2;CD300LF;MFHAS1;PTPRS;TNFAIP3;CD300A;TLR4;GPS2;GPR108;LY96;DAB2IP;TICAM1;CACTIN;TICAM2;SMPDL3B;LYN;TYRO3;CD14
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.46926007361576433,1.1272045132387958,0.28672032193158953,0.9977603215996408,1.0,39/122,17.26%,ZCCHC4;RBM3;ABCB10;PCNA;EIF3E;ATAD5;SLC25A37;RPS4X;FAF1;SORBS1;EIF4A3;NIBAN1;DNA2;JAK2;MTPN;SMOC2;EGFR;CPEB3;DHX9;BRPF3;CTC1;UPF3B;FXR1;PRKDC;MYC;IRS1;PLD1;METTL14;EGF;PYM1;SAMD4A;EEF2;TGFB2;VIM;SIRT1;NAT10;XBP1;LARP4B;POLDIP3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3969627131485121,-1.1269271928180646,0.2747747747747748,0.7051448761134537,1.0,13/17,41.34%,ROBO1;MIA3;VEGFA;FGF2;GPLD1;EFNB2;KDR;SRF;NR4A1;EGR3;GREM1;EPHB4;SLIT2
prerank,mitochondrial translational termination (GO:0070126),0.4725310652250376,1.1268508596597449,0.2976554536187564,0.9979421309377378,1.0,21/88,17.25%,MRPL36;AURKAIP1;MRPL18;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;MRPL24;MRPL48;MRPS10;MTRF1L;MRPS34;MRPL38
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.46768656116644763,1.1259639614490284,0.24473420260782347,1.0,1.0,41/163,17.72%,CD19;BLK;ERMAP;MS4A1;CD79A;GRAP2;PSMB7;FYN;CD38;PSMD11;FBXW11;PTPN22;PSMF1;IKBKG;CD79B;PSMC1;NFAM1;PLCG2;BTN3A3;PDPK1;PSMC3;BTK;PSMA4;PRKCB;PSMC4;PRAM1;DENND1B;PSMD13;PSME1;THEMIS;PSMB1;RBCK1;RC3H1;PSMD8;PAK2;PSME4;PLCG1;PIK3CA;PSMD4;SPPL3;MAP3K7
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.45831763967357186,-1.1259607389142392,0.31690140845070425,0.7057430094192487,1.0,6/11,54.17%,RTP4;PKD2L1;PKD1L3;LPO;RTP2;TAS1R3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.500709380537905,1.1258931644018983,0.33771929824561403,0.9991915504752759,1.0,16/47,19.38%,FOXM1;MAPK1;ULK4;RASGRP1;FOXO1;EGFR;CARD9;FAS;MYC;PPIA;PDCD10;MAP2K1;TGFB2;ARL6IP5;TAOK1;LGALS9
prerank,regulation of interferon-beta production (GO:0032648),-0.30258389287624937,-1.125199715125981,0.26666666666666666,0.7058491436779674,1.0,11/46,7.87%,SIRPA;HSP90AA1;POLR3C;PTPRS;PYCARD;TLR7;RNF135;POLR3A;MAVS;TLR4;IRF1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5026131093541326,1.1247130120907636,0.3337222870478413,1.0,1.0,8/28,17.45%,ECT2;FLNA;EFCAB7;PSEN1;BAG3;IPO5;TRIM28;HCLS1
prerank,positive regulation of cell population proliferation (GO:0008284),0.4674042267523593,1.1241666976527547,0.133,1.0,1.0,74/423,17.70%,PRC1;KIF20B;KIF14;TTK;BIRC5;PRTN3;FOXM1;EZH2;TIPIN;AQP1;LEF1;E2F1;CD47;FBXO5;IL7R;ERBB3;TIAM1;CCN1;LIG4;CD74;CCN4;COPS9;PGF;FOXP1;CDK6;CRKL;PTHLH;RPS4X;TGFA;CDC25B;NOTCH1;DDRGK1;CIB1;LAMC1;ITGAV;EGFR;CAPN1;CUL3;PIM1;MECP2;DHPS;DERL2;DHX9;FGF9;RPRD1B;DPP4;FLT3;PTEN;S1PR2;BMPR1A;RPS9;RPS15A;HNRNPU;MYC;NAP1L1;CDC7;IRS1;KDM4C;PDCD10;EGF;F2R;TNFRSF11A;CNOT6;TCF7L2;FGFR1;TGFB2;ACER3;SIRT1;SSR1;XBP1;TRPM4;HCLS1;FN1;KITLG
prerank,negative regulation of metabolic process (GO:0009892),0.4919259007049992,1.1237422046777457,0.3193548387096774,1.0,1.0,20/54,21.74%,RB1;NRDC;MAP2K6;STK11;ACOT11;NR1D1;NOTCH1;LAMA4;NOVA2;ACOT13;FIS1;ZDHHC7;DDIT3;LGR4;ADAMTS5;TLE3;ACVR2B;RBPJ;PLCL1;NR1H3
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5806221034105594,1.1236745797008603,0.35802469135802467,1.0,1.0,5/11,15.26%,PUM2;PUM1;DHX9;FXR1;LIMD1
prerank,regulation of platelet activation (GO:0010543),0.5311048604656997,1.123637474538654,0.34554334554334554,1.0,1.0,1/21,0.41%,BLK
prerank,plasma membrane tubulation (GO:0097320),0.5636731069993078,1.123436751078981,0.356951871657754,1.0,1.0,4/13,12.41%,SNX33;SNX9;WHAMM;PACSIN2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.4959781406403146,1.1234285354413116,0.3247767857142857,1.0,1.0,2/39,1.86%,BLK;TFR2
prerank,global genome nucleotide-excision repair (GO:0070911),0.5191198114714544,1.1233806918429479,0.3297997644287397,0.9996576313255143,1.0,6/26,17.70%,ERCC4;CHD1L;ERCC3;RNF111;UBA52;DDB2
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.36105475045225277,-1.1231252268802692,0.2736842105263158,0.7071746574943724,1.0,8/20,20.01%,ECHS1;ACADSB;HIBCH;ACAD8;ALDH6A1;ACAT1;BCKDHA;SLC25A44
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.36105475045225277,-1.1231252268802692,0.2736842105263158,0.7071746574943724,1.0,8/20,20.01%,ECHS1;ACADSB;HIBCH;ACAD8;ALDH6A1;ACAT1;BCKDHA;SLC25A44
prerank,glycosphingolipid metabolic process (GO:0006687),-0.3093187501860484,-1.1230481124460627,0.23863636363636365,0.7055017522207389,1.0,15/42,21.65%,HEXB;CTSA;PSAP;ST8SIA1;LARGE1;ST6GALNAC6;B4GALNT1;GALC;ST8SIA5;CERK;GLA;ST6GALNAC3;CLN6;ST8SIA3;GLB1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.32422640218309956,-1.122789392452861,0.23134328358208955,0.7043173857765679,1.0,11/32,22.78%,RREB1;AKIRIN1;ENPP2;PIK3R1;CORO1C;ARPC2;ABI2;TWF2;CDC42;CORO1B;CYFIP1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5256873275677401,1.1227755384927693,0.35128518971848227,1.0,1.0,6/22,11.85%,ERI2;KRI1;EXOSC8;EXOSC10;URB1;ERI1
prerank,lymphocyte differentiation (GO:0030098),0.4754313933787098,1.122605609937785,0.30991735537190085,1.0,1.0,15/68,17.98%,LY6D;MS4A1;CD79A;PTPN22;TCF3;CD79B;NFAM1;PLCG2;ZBTB7A;FLT3;CEBPG;DNAJB9;JAK3;LMBR1L;HDAC4
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.47012599602501937,-1.122489987071769,0.33451957295373663,0.7032607781467747,1.0,6/10,20.98%,TREM2;CD68;TLR4;MIA3;CD36;TICAM1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.3649304940693442,-1.1223871520173396,0.30049261083743845,0.7017049171908544,1.0,12/20,36.86%,SEMA3D;SEMA3E;SEMA4C;SEMA4G;SEMA3A;SEMA7A;SEMA4D;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.39492080827450304,-1.1223203963483337,0.31932773109243695,0.7000517290941316,1.0,11/16,40.23%,PTPRJ;PDGFD;PDGFC;PLAT;FER;PDGFRA;PTPN1;PDGFRB;BCAR1;PDGFA;RGS14
prerank,negative regulation of vascular permeability (GO:0043116),-0.4351798108507972,-1.1222839972115386,0.32452830188679244,0.6983331060007095,1.0,6/12,14.06%,PTPRJ;ANGPT1;FERMT2;SH3GL2;DDAH1;VEGFA
prerank,protein destabilization (GO:0031648),0.503244005739173,1.1222115194163356,0.3423728813559322,1.0,1.0,11/32,17.91%,PLK1;FBXW11;NR1D1;GSN;CCDC88C;CUL3;RAD23A;PEX2;CREBBP;SIRT1;SNCA
prerank,mitochondrial translational elongation (GO:0070125),0.4703403734603231,1.1220373527075629,0.300921187308086,1.0,1.0,20/88,17.25%,MRPL36;AURKAIP1;MRPL18;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;MRPL24;MRPL48;MRPS10;MRPS34;MRPL38
prerank,positive regulation of leukocyte migration (GO:0002687),0.5147550730146014,1.121913615763945,0.33141542002301494,0.9996341387110077,1.0,1/27,0.75%,TNFRSF18
prerank,regulation of response to stress (GO:0080134),0.5859629194046142,1.1218267122527126,0.3553370786516854,0.9988761838661442,1.0,2/10,5.16%,CRHBP;MLC1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5207160568449188,1.1218072189915786,0.3392434988179669,0.9978985070570551,1.0,5/29,10.57%,IL12A;CCR2;HMGB1;JAM2;CCR6
prerank,actin crosslink formation (GO:0051764),0.5511515483530671,1.1214608928972305,0.35684647302904565,0.9981137284591891,1.0,2/12,3.41%,FLNA;GAS2L3
prerank,B cell activation (GO:0042113),0.48167283952290735,1.121345223712463,0.32676348547717843,0.9974687733169655,1.0,25/68,23.11%,MS4A1;CD79A;BANK1;RASGRP1;TCF3;CD79B;NFAM1;PLCG2;FCRL1;ZBTB7A;BTK;FLT3;PRKCB;CEBPG;DNAJB9;JAK3;HDAC4;MALT1;CASP8;NHEJ1;GPR183;ITGA4;HDAC9;PHB2;ADAM17
prerank,regulation of protein autophosphorylation (GO:0031952),-0.31969276203965374,-1.1212621735066637,0.23300970873786409,0.6991702032834659,1.0,12/36,15.01%,IMPACT;PPP2R5C;RAP2A;PDGFD;ENG;RAP2C;PDGFC;MVP;TOM1L1;VEGFA;MRE11;CALM1
prerank,regulation of intracellular pH (GO:0051453),0.4960814561220794,1.1206782921264258,0.33748584371460927,0.9988136208483417,1.0,8/34,19.26%,SLC4A1;SLC9A8;SLC9A9;ATP5F1B;LRRK2;CLN3;SLC9A7;SLC9A6
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.4456838838200497,-1.120301163658336,0.30625,0.6997784033082348,1.0,5/11,20.08%,TREM2;CDH13;CCL4;CCL3;P2RX4
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.5003977539442639,1.120256565287124,0.34967320261437906,0.9992750245351243,1.0,7/37,10.95%,RNASE6;PPP1R8;ENTPD3;ENTPD5;DNASE1L1;NCBP1;NUDT9
prerank,negative regulation of defense response to virus (GO:0050687),0.5934377501629263,1.1201764429621144,0.35704125177809387,0.9985108798244868,1.0,4/10,18.88%,RNF26;PCBP2;TARBP2;PPM1B
prerank,smoothened signaling pathway (GO:0007224),0.5083559024539589,1.1199270766099165,0.34891676168757124,0.9983307243713712,1.0,1/32,0.26%,STIL
prerank,regulation of mRNA stability (GO:0043488),0.4648158947811339,1.1198668615721517,0.2688821752265861,0.9974937357033884,1.0,65/145,26.60%,XPO1;E2F1;PSMB7;PSMD11;PSMF1;TNPO1;EXOSC8;FTO;PDE12;ZFP36L1;PSMC1;PUM2;TAF15;NUP214;DCP2;PRKCA;PSMC3;PSMA4;PUM1;IGF2BP3;PSMC4;DCP1A;APEX1;METTL16;FXR1;ROCK2;PSMD13;HNRNPU;PSME1;PAIP1;PSMB1;METTL14;RC3H1;PSMD8;SAMD4A;ZFP36L2;PSME4;VIM;PSMD4;UBA52;ELAVL1;EIF4ENIF1;THRAP3;XRN1;ROCK1;TENT5D;CELF1;PSME2;DIS3;PRKCD;YBX1;GDNF;CIRBP;NPM1;MEX3D;PSME3;PSMD6;GIGYF2;FASTKD1;SET;YWHAZ;KHSRP;PSMA1;PSMD9;CARHSP1
prerank,protein localization to lysosome (GO:0061462),-0.3378955952054386,-1.1193931172772411,0.28125,0.7003525916436454,1.0,9/28,14.08%,RTN4;GGA3;RNF128;MFSD1;SNX16;SCARB2;GLMP;LAMTOR5;NAGPA
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5042054969388892,1.1193658258904464,0.36764705882352944,0.9981137751088877,1.0,9/32,16.94%,PMAIP1;PML;STK11;PHLDA3;BOK;HIPK2;TP53;TMEM109;SIRT1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3510497484935304,-1.1193307066287022,0.2786885245901639,0.6987586145362891,1.0,7/24,14.82%,NUMB;BCL2L1;GDI1;LZTFL1;AP2M1;RHOQ;PPFIA1
prerank,response to cholesterol (GO:0070723),-0.38331932900725335,-1.1188700453685354,0.2764227642276423,0.6980912094329816,1.0,9/17,19.79%,TGFBR1;SMO;OSBPL7;CCR5;GRAMD1B;TGFBR2;GPLD1;CCL3;PMVK
prerank,negative regulation of hippo signaling (GO:0035331),0.5768267891840143,1.1187378429245896,0.36363636363636365,0.999265092252947,1.0,2/12,8.10%,CIT;MAPK14
prerank,nucleocytoplasmic transport (GO:0006913),0.49744690972103955,1.1182828772671776,0.3388338833883388,0.9998575492260489,1.0,16/40,20.17%,XPO1;GEMIN8;BACH2;SNRPF;NCBP1;NUP205;NUP98;HTATIP2;GEMIN7;AAAS;SNRPG;RSRC1;MALT1;HNRNPA1;NCBP2;SNRPB
prerank,protein import (GO:0017038),0.465794892504259,1.118256714832725,0.30390143737166325,0.9989116598706453,1.0,38/84,23.66%,PEX26;POM121;NUP107;SNX33;ABCD1;TNPO1;IPO13;ACBD5;NUP50;NUP214;PEX11B;PXMP4;SEC13;IPO7;NUP188;GDAP1;RANBP6;PEX2;RAB8B;FIS1;RPAIN;E2F3;APPL1;IPO5;KPNB1;PEX14;ATAD1;EIF4ENIF1;NUP85;MMP12;TPR;TNPO2;TNPO3;SYK;NUP93;PHB2;PEX3;IPO8
prerank,cilium organization (GO:0044782),0.4623280344670415,1.1181460224187811,0.24624624624624625,0.9982669638194082,1.0,59/210,18.31%,KIF24;TSGA10IP;IFT80;EXOC2;RTTN;POC1B;PCNT;FLNA;WDPCP;CEP83;MNS1;EXOC4;BBIP1;ODF2;CEP89;GSN;CENPJ;WDR90;DISC1;SSX2IP;ARF4;HDAC6;NOTCH1;FUZ;RP2;OFD1;PTPDC1;RAB8A;CEP250;CFAP44;TMEM237;CYS1;ABLIM3;PCM1;PDE6D;RFX2;CCDC28B;CEP162;ABCC4;RAB8B;CCDC57;SCLT1;ARL13B;BBS4;PIBF1;EXOC5;MKS1;DYNLL1;KIFAP3;DYNLT2B;MARK4;PARVA;IFT172;ATP6V0D1;IFT140;BBS9;TXNDC15;ATAT1;FAM161A
prerank,xenobiotic transport (GO:0042908),-0.38623724377258745,-1.118030027678527,0.27358490566037735,0.6984583164944438,1.0,3/17,6.29%,ABCC5;ABCC3;ABCC1
prerank,positive regulation of kinase activity (GO:0033674),0.46620852083555653,1.1179652259927664,0.30792377131394183,0.9978578660197408,1.0,18/107,13.65%,CENPE;ERBB3;CCN1;LMO4;CD74;MMD2;MAPRE3;MMD;XRCC6;MRNIP;SNX9;EGFR;EPHA3;RELN;FLT3;LMTK2;PRKAG2;ADCYAP1
prerank,activation of phospholipase C activity (GO:0007202),0.5098940644924533,1.1171405901514815,0.36921296296296297,0.9997382660954093,1.0,3/29,3.43%,NTF4;S1PR4;HTR2A
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5677965238773682,1.1167778080807624,0.3860845839017735,0.9999587340650911,1.0,5/12,17.78%,CGAS;CAV1;DHX9;FLOT1;COLEC12
prerank,"DNA-templated transcription, termination (GO:0006353)",0.4776963450562076,1.1165764638041307,0.3395638629283489,0.9996098715977303,1.0,27/68,21.82%,POLR1B;POLR2A;SLBP;SNRPF;CPSF2;SETX;NCBP1;POLR1A;ERCC3;CSTF3;POLR1F;POLR1C;POLR2K;SCAF8;SNRPG;PCF11;CPSF1;TAF1C;CLP1;TTF2;TAF1D;POLR1G;NCBP2;SNRPB;CPSF7;WDR33;PAPOLA
prerank,regulation of cell adhesion (GO:0030155),0.46437489173053453,1.116468528272054,0.2806484295845998,0.9989500627054853,1.0,16/129,9.97%,KIF14;IL12A;TNFRSF18;SPN;ERBB3;PPP3CA;RIPOR2;CYTIP;ARHGDIB;PPP1CB;ATM;PRKX;PRKCA;PLXNA2;ITGAV;CBLL1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.3815096887653643,-1.1156918238889981,0.3094170403587444,0.7026470364598958,1.0,5/17,12.30%,ZDHHC17;PCSK6;FSTL1;SULF1;DOK5
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.485125558024562,1.115638388758209,0.34378378378378377,1.0,1.0,6/49,13.80%,IL12A;TNFRSF18;JAK2;PARP14;FLT3;PIBF1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.4501160925677171,-1.1151626841701046,0.31333333333333335,0.7021007241511742,1.0,5/11,18.05%,CD34;CD200;ATP6AP2;CD46;THBS1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.48075548977053745,1.1148136654258318,0.31901181525241673,1.0,1.0,18/52,15.98%,LSM6;DCPS;EXOSC8;PDE12;DCP1B;DCP2;LSM2;EDC3;PNLDC1;TUT4;CNOT4;LSM5;DCP1A;CNOT1;LSM7;RC3H1;CNOT6;SAMD4A
prerank,extracellular matrix assembly (GO:0085029),0.5236176644184816,1.1144120233802033,0.35377358490566035,1.0,1.0,6/23,12.53%,HAS1;LAMB2;LAMB3;NTNG2;ATP7A;EFEMP2
prerank,epithelial cell-cell adhesion (GO:0090136),-0.45887959919807497,-1.1137823129945024,0.34507042253521125,0.7038472983763546,1.0,2/11,9.20%,ITGB5;JUP
prerank,regulation of histone acetylation (GO:0035065),0.5024935324125152,1.1137009377380025,0.35545556805399325,1.0,1.0,13/33,19.01%,BRCA1;RPS6KA5;CHEK1;TAF7;IWS1;RUVBL2;PARK7;PAXIP1;KMT2A;TADA2A;GLYR1;SNCA;BRD7
prerank,regulation of cell differentiation (GO:0045595),0.46130143699454673,1.1136789431555796,0.28413654618473894,1.0,1.0,31/148,16.71%,HEMGN;NTF4;CDK5RAP2;ANP32B;HEY2;PDCD2;TIAM1;PA2G4;SUZ12;CDK6;NR1D1;PTHLH;CLASP1;YWHAH;ZFP36L1;MBOAT2;RUNX3;BIRC2;PRKACA;EPHA3;PRKCB;CBFB;CDK5RAP3;CREBBP;BCL6;DAG1;RUNX1;ST7;FGFR1;CD24;VHL
prerank,positive regulation of dendrite extension (GO:1903861),-0.39127674906715115,-1.1136520375363532,0.2955665024630542,0.7024317404204881,1.0,6/17,13.39%,RIMS1;RIMS2;SYT1;PLAA;SYT4;UNC13A
prerank,negative regulation of intracellular protein transport (GO:0090317),0.5230208931896501,1.1135979983877786,0.35279805352798055,1.0,1.0,7/22,18.66%,BARD1;SP100;RANGAP1;PARK7;LMAN1;LRRK2;SUFU
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.4608676792303134,1.1129663657858258,0.221,1.0,1.0,100/264,20.83%,RBM15;LSM6;DHX38;POLR2I;SNRNP25;PRPF19;GEMIN8;POLR2A;SCAF11;IK;DCPS;SNRPF;HNRNPC;SNRPC;HNRNPM;HNRNPL;HNRNPA3;CPSF2;CRNKL1;PPIL3;U2AF1;SNRNP200;UBL5;EIF4A3;SRSF3;SPEN;TXNL4A;RNPC3;HNRNPA2B1;PSPC1;NOVA2;SART3;SRSF4;NCBP1;PRPF38A;LSM2;SNRNP35;RALY;NONO;CASC3;RNPS1;U2AF1L4;PPWD1;SRRT;CSTF3;RBM19;PCBP2;PRPF31;DHX9;HNRNPA0;LSM5;U2SURP;UPF3B;ZMAT2;HNRNPR;CWC15;HNRNPU;SF3B5;PRPF4;TFIP11;CLNS1A;SRRM2;PDCD7;LSM7;METTL14;SRSF10;SART1;GEMIN7;DNAJC8;SNRNP40;ESS2;POLR2K;SRSF7;CDC40;SRPK1;DDX39B;POLR2J;SNRPG;GCFC2;PCF11;CPSF1;PRPF8;RSRC1;CLP1;PPIE;HNRNPA1;PPIH;ELAVL1;NCBP2;ZCCHC8;SRSF2;SF3A2;SNRNP48;SNRPB;CPSF7;PPIL1;RBM4B;PRMT7;SYNCRIP;WDR33
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3588044203991847,-1.1126502397908253,0.3048780487804878,0.7015814349043739,1.0,13/22,35.76%,GOLGA7;ZDHHC8;CLIP3;ZDHHC24;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;ZDHHC4;ZDHHC23;ZDHHC22;ZDHHC1;GOLGA7B
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3588044203991847,-1.1126502397908253,0.3048780487804878,0.7015814349043739,1.0,13/22,35.76%,GOLGA7;ZDHHC8;CLIP3;ZDHHC24;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;ZDHHC4;ZDHHC23;ZDHHC22;ZDHHC1;GOLGA7B
prerank,sodium ion transport (GO:0006814),0.4712479200626353,1.1124063305499914,0.3129459734964322,1.0,1.0,8/85,7.95%,SLC6A12;SLC12A3;SLC5A5;SLC6A2;SLC6A5;HCN3;SLC12A1;NEDD4L
prerank,regulation of dendrite extension (GO:1903859),-0.3912683565051255,-1.1122561048040787,0.30319148936170215,0.7008449799113767,1.0,6/18,13.39%,RIMS1;RIMS2;SYT1;PLAA;SYT4;UNC13A
prerank,T cell proliferation (GO:0042098),0.5747478156730361,1.1121655795668621,0.3755047106325707,1.0,1.0,3/13,16.94%,RASGRP1;MSN;LMBR1L
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2349871149218022,-1.1121234852093893,0.2,0.6994697600322378,1.0,28/128,17.82%,ACVR1;ITGB5;TGFBR1;GCNT2;APPL2;F11R;NLK;PTPRK;SMAD1;BMPR2;SMAD3;ZFYVE9;USP9X;SMAD6;ZMIZ2;BMPR1B;ENG;LPXN;FERMT2;SMAD7;ZMIZ1;ADAM9;PTK2;TGFBR3;ACVRL1;TGFBR2;BMP6;SMURF2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.502709567968429,1.1120198868419215,0.3548387096774194,1.0,1.0,4/29,5.28%,PMAIP1;PML;TNFSF10;CAV1
prerank,regulation of protein sumoylation (GO:0033233),0.5265713584036492,1.1118310800049014,0.3602080624187256,1.0,1.0,8/17,18.74%,SAE1;UBA2;PIAS3;EGR1;PARK7;PIAS1;HDAC4;GNL3L
prerank,"transcription, DNA-templated (GO:0006351)",0.46462490879109825,1.1110485923879534,0.239,1.0,1.0,62/207,19.94%,PAX5;PMF1;TRIP13;NR4A2;GTF3C5;DEAF1;E2F1;SMARCA5;RSF1;GTF2E1;DEK;POLR2I;POLR2A;EPC1;TAF1;MBD1;PTMA;SETX;IRF9;BRF1;TFDP1;TAF7;TAF15;IWS1;TFB2M;GTF2A1;NCBP1;SNAPC3;RNPS1;ERCC3;KLF13;BTF3;RTF1;TAF6;NELFA;CCNT1;CBFB;ARRB2;TEFM;ZBTB7B;TAF2;NFX1;POLR1C;GMEB2;CCNK;TP53;NELFB;TAF9;POLR2K;PIR;MLLT1;XBP1;POLR2J;TAF1C;DRG1;TTF2;NKX2-8;HIPK3;NCBP2;NCOA6;GTF2A2;TAF3
prerank,pre-replicative complex assembly (GO:0036388),0.4747394723061189,1.11065281039865,0.34018499486125386,1.0,1.0,19/64,17.60%,PSMB7;PSMD11;MCM6;ORC5;PSMF1;ORC3;GMNN;PSMC1;PSMC3;PSMA4;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;MCM3;PSME4;PSMD4;UBA52
prerank,cellular response to increased oxygen levels (GO:0036295),0.5772874966378398,1.110533944528692,0.37042459736456806,1.0,1.0,5/11,17.11%,CAV1;FOXO1;FAS;ATP6AP1;ATP6V0D1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.26535235411082414,-1.1105024946099782,0.18181818181818182,0.7017627424131476,1.0,44/107,27.96%,SLC24A3;TPCN2;HTR2C;ANK2;SLC8A3;ATP2B2;ATP13A1;SLC8B1;TMEM165;CCL15;RYR2;ATP1B1;SLC39A7;SLC41A1;SLC39A14;MT1B;MT1G;MT1E;MT1A;MT1H;MT1F;MT1M;MT1X;ATP2B3;TRPV4;SLC8A1;SLC39A8;STOML2;SLC39A6;MT2A;CCL3;SLC39A12;STIM1;SLC30A1;CHERP;MT3;CD40;CCR1;RMDN3;CCL14;ATP13A4;CHRNA7;STIM2;ATP2C1
prerank,regulation of cholesterol efflux (GO:0010874),-0.3249084872676216,-1.1092005860246126,0.2517482517482518,0.7031359676322179,1.0,7/30,10.36%,TREM2;LRP1;APOE;ABCA5;PLTP;ZDHHC8;GPS2
prerank,protein localization to nucleus (GO:0034504),0.4640370857569146,1.109014762948264,0.3065989847715736,1.0,1.0,40/102,21.99%,PLK1;POM121;PML;NUP107;TNPO1;IPO13;NUP50;GBP2;NUP214;ZBTB7A;SEC13;IPO7;NUP188;ABCA7;TOR1A;RANBP6;CNEP1R1;RPAIN;CHCHD10;HNRNPU;BBS4;INTS13;NOL8;E2F3;APPL1;IPO5;KPNB1;YWHAE;MORC3;EIF4ENIF1;NUP85;MMP12;TAF3;TPR;TNPO2;WRN;MDM2;TNPO3;SYK;NUP93
prerank,regulation of protein kinase C signaling (GO:0090036),0.5507406618753867,1.1089638314955002,0.37632978723404253,1.0,1.0,4/14,14.77%,ULK4;GPD1L;DGKD;ADGRV1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.5682182961412686,1.1088779550133085,0.3788300835654596,1.0,1.0,4/12,23.93%,CCR2;CARD9;ZBTB1;PRKCQ
prerank,cellular response to virus (GO:0098586),0.501608730663537,1.1085347019740452,0.3649122807017544,1.0,1.0,5/30,12.08%,IL12A;POU2AF1;MAPK14;RIOK3;TOMM70
prerank,protein insertion into membrane (GO:0051205),-0.31617268371449364,-1.1082297194183524,0.2689075630252101,0.703805076343554,1.0,16/32,24.61%,APP;SGTA;VAMP2;SEC61G;HMOX1;STX1A;TRAM1;SERP1;PRNP;RTP4;MAIP1;GET4;COX18;SEC61B;REEP1;GET1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3620039570441245,-1.108229289100044,0.2692307692307692,0.702071566303299,1.0,10/20,22.13%,SLC8A3;MCUR1;SLC8B1;LETM1;SPG7;STOML2;MAIP1;PMPCA;AFG3L2;SMDT1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5383269029655744,1.1080657261568905,0.3671875,1.0,1.0,8/18,22.30%,SPN;ITGB7;JAM2;ADD2;GOLPH3;GCNT1;ROCK1;ITGA4
prerank,positive regulation of translation (GO:0045727),0.4613532015112863,1.107790524418572,0.3285859613428281,1.0,1.0,31/94,20.88%,ZCCHC4;RBM3;JMJD4;EIF3E;RPS4X;BOLL;MPV17L2;EIF4A3;NIBAN1;CPEB3;DHX9;UPF3B;FXR1;RPS9;PRKDC;EIF5A2;PLD1;METTL14;PYM1;SAMD4A;EEF2;VIM;TRUB2;NAT10;LARP4B;POLDIP3;ELAVL1;RPL5;AGO2;EIF6;EIF2B5
prerank,glutathione metabolic process (GO:0006749),-0.3089064628754429,-1.1077036223150531,0.23423423423423423,0.7017974742059415,1.0,9/38,17.37%,HPGDS;CTNS;HAGH;CNDP2;GGT5;GSS;CHAC2;GPX1;OPLAH
prerank,regulation of actin nucleation (GO:0051125),0.5682813338865065,1.1073535059434496,0.356353591160221,1.0,1.0,3/12,10.19%,GSN;PICK1;WHAMM
prerank,protein K48-linked ubiquitination (GO:0070936),0.48242691550906974,1.1070128161729398,0.34,1.0,1.0,15/54,18.21%,UBE2C;UBE2T;SKP2;UBE2K;NEDD4L;CUL3;AMFR;RNF8;RNF152;ARIH2;RNF115;UBE2R2;RNF4;SYVN1;UBE2G1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5217777242872074,1.106608768770431,0.36342042755344417,1.0,1.0,5/24,9.89%,ALAS2;ABCB10;TSPO;NFE2L1;COX10
prerank,regulation of superoxide anion generation (GO:0032928),0.5463780168879866,1.106429483654564,0.37681159420289856,1.0,1.0,1/14,1.29%,CD177
prerank,negative regulation of calcium ion transport (GO:0051926),-0.3954397943790867,-1.106183154243821,0.33047210300429186,0.7038382540539126,1.0,10/15,44.89%,TRIM27;ATP1A2;CBARP;SLC30A1;PACSIN3;ADRA2A;NOS1;PLN;EPO;STC1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5657138975393071,1.1060357222702222,0.37904269081500647,1.0,1.0,5/13,16.70%,IL7R;JAK2;PIGU;EGF;JAK3
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5420087988100118,1.105776336802339,0.36936936936936937,1.0,1.0,3/16,16.39%,SOX6;HOXB4;TGFB2
prerank,negative regulation of programmed cell death (GO:0043069),0.45568695299650985,1.1054461696864957,0.208,1.0,1.0,89/355,21.33%,KIF14;CDK1;STIL;BIRC5;MAD2L1;BARD1;PLK1;AQP1;LEF1;DDAH2;FLNA;CD38;CD74;ANKLE2;CD44;PIDD1;PA2G4;UBE2O;DCPS;TFRC;FOXO1;CASP2;DPEP1;PTMA;SETX;ARF4;BIRC2;ARL6IP1;UBE2Z;DDRGK1;PIM2;BIRC6;PIM3;CIB1;TNFAIP8;RNF157;ERC1;EGFR;PIM1;SOCS2;PARK7;XIAP;ATF5;FAS;MYD88;NAA16;PRKDC;GLO1;MYC;CFLAR;PSEN1;BAG1;BAG3;MYDGF;HTATIP2;TPT1;GSK3B;PDCD10;TP53;PAK2;TAF9;ARHGDIA;VHL;SIRT1;XBP1;SH3RF1;HSP90B1;UBA52;AVEN;SNCA;MED1;MALT1;ADAM10;CLN3;HDAC1;HIPK3;PAX2;TRAF6;GOLPH3;DSTYK;ARAF;MET;CITED2;BNIP3;RIPK1;DNAJC3;IKBKB;USP47;RPS6KA3
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4725187629318821,1.1053057749057764,0.32644628099173556,1.0,1.0,22/73,17.70%,MYB;PDCD2;PSMB7;PSMD11;PSMF1;TCF3;PSMC1;PSMC3;PSMA4;CBFB;PSMC4;KMT2A;PSMD13;PSME1;PRKDC;PSMB1;METTL14;RUNX1;PSMD8;PSME4;PSMD4;KITLG
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5180712493012222,1.1050736266098868,0.3632019115890084,1.0,1.0,10/24,20.53%,MAP2K6;IKBKG;TAB1;UBE2V1;TAB3;UBA52;MAP3K7;TRAF6;CASP8;UBE2N
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5794533426478896,1.104549110107588,0.390625,1.0,1.0,5/11,14.80%,ARID1B;CDCA4;CHEK1;SERTAD2;ELOF1
prerank,histone H2A monoubiquitination (GO:0035518),0.5343097928655475,1.1041876438181792,0.3756345177664975,1.0,1.0,7/17,18.10%,PCGF5;RNF168;RNF2;PCGF3;TRIM37;DDB2;KDM2B
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5801687425916843,1.1041231604720962,0.36524300441826213,1.0,1.0,3/10,8.95%,EMC6;EMC10;EMC3
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3832381685288091,-1.1031347919738654,0.2903225806451613,0.7097388939860906,1.0,6/17,15.99%,SERPINE2;PTPRZ1;BIN1;TNFRSF1B;ID2;MDK
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4650362930262333,1.103021712427851,0.34074823053589487,1.0,1.0,31/101,19.40%,UHRF1;PLK1;ZCCHC4;AURKAIP1;EZR;RBM3;FBXW11;CYFIP2;EIF3E;RPS4X;FAF1;EIF4A3;NIBAN1;CPEB3;MSN;RDX;UPF3B;FXR1;PRKDC;PLD1;METTL14;PYM1;SAMD4A;EEF2;VIM;NAT10;LARP4B;POLDIP3;ELAVL1;RPL5;CASP8
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.3865447415696366,-1.1026394579509295,0.3059360730593607,0.7092455092704242,1.0,8/15,35.06%,ATF3;ZC3H12A;ZFAND1;MKNK2;GSTO1;GSTO2;PPIF;DHX36
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4670041767146555,1.1025577266668503,0.3498452012383901,1.0,1.0,22/72,16.74%,STMN1;NET1;RIPOR2;ARHGEF18;LPAR4;ARHGDIB;ARHGEF3;ARHGAP35;TNFAIP1;CUL3;HEG1;RIT2;STARD8;ARHGEF28;NRP1;PDCD10;BCR;F2R;LPAR1;GPR35;ARHGDIA;RAC1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5279435186450826,1.1024885519462095,0.35910878112712974,1.0,1.0,10/16,29.47%,RBM3;NCBP1;NUP98;DAZAP1;THRAP3;NCL;CIRBP;PRDX6;TRA2A;SNW1
prerank,positive regulation of transmembrane transport (GO:0034764),0.5508333149289452,1.1023171698529028,0.37935656836461124,1.0,1.0,4/13,17.46%,C2CD5;AZIN1;ACSL5;ANO6
prerank,protein localization to cilium (GO:0061512),-0.31815708886326177,-1.1020983427212339,0.25,0.7088537403572728,1.0,15/32,27.21%,TULP3;ZNF423;ARL6;WDR35;INVS;TCTN1;CSNK1D;RABEP1;WDR19;TULP2;SNX10;ARL3;TCTN2;BBS1;TUB
prerank,anterograde axonal transport (GO:0008089),0.48751864180382287,1.102007868085356,0.3552036199095023,1.0,1.0,2/37,3.51%,KIF4A;BLOC1S4
prerank,dendritic cell chemotaxis (GO:0002407),0.5476967040310782,1.1016805783054402,0.3780821917808219,1.0,1.0,6/14,22.24%,CCR2;HMGB1;CCR6;TRPM4;CXCR4;GPR183
prerank,regulation of B cell differentiation (GO:0045577),0.5339649696618703,1.1016160983665826,0.36772486772486773,1.0,1.0,7/17,17.05%,IKZF3;ZFP36L1;PPP2R3C;BTK;SLAMF8;ZFP36L2;XBP1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5602378979060563,1.1013120952261153,0.38873626373626374,1.0,1.0,4/13,7.57%,SMUG1;DUT;MBD4;NEIL1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.524170126016891,1.1011400095088064,0.3690773067331671,1.0,1.0,5/19,15.53%,FOXA2;NOTCH1;FLOT1;DENND6A;PTPRU
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5862136993559777,1.1010200258210412,0.3864306784660767,1.0,1.0,5/10,28.49%,TYROBP;CD24;FN1;LAPTM4B;HSP90AB1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2658966472590502,-1.1007365458708624,0.2,0.7105423291413937,1.0,33/75,26.00%,PAK3;APP;OPHN1;ANK3;ZDHHC17;DSCAML1;MINK1;NTNG1;RYK;S100B;BAIAP2;MAP1A;MAP6;MEF2A;CTNNA2;ACTB;CDK5;FARP1;MAP1S;LLGL1;TMEM106B;ADGRB1;RAB3A;AFG3L2;CELSR2;PARD3;SLITRK4;BRSK2;DCC;ATL1;DVL1;KLF7;SLITRK3
prerank,protein-containing complex subunit organization (GO:0043933),0.4639881555211152,1.1003578062795643,0.3152064451158107,1.0,1.0,33/109,18.59%,KNTC1;CARD10;FANCA;NDC1;CD74;PML;NAPG;TUBGCP4;IKBKG;MDM4;KPNA3;SNX9;LAMC1;ZW10;NUP205;NDUFAF1;NIFK;FAS;MAGI1;NUP98;KMT2A;CHCHD10;ADD2;CREBBP;TP53;KIFAP3;FANCC;TFAP4;DARS1;PEX14;EPRS1;PPIH;SLC2A1
prerank,glycerol metabolic process (GO:0006071),-0.45276129261485676,-1.1002899837192863,0.31493506493506496,0.7099884168390477,1.0,7/10,37.02%,COQ2;TPI1;COQ3;ANGPTL3;TKFC;PDXP;GK5
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3357543313720886,-1.1002615562786322,0.25595238095238093,0.7083245409489938,1.0,4/26,5.29%,RIMS1;APP;RIMS2;SLC8A3
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5522658940559589,1.1001727419760536,0.3728129205921938,1.0,1.0,3/14,14.92%,CARD10;NOTCH1;PDCD10
prerank,regulation of acute inflammatory response (GO:0002673),-0.3644773979052426,-1.100013898757314,0.30303030303030304,0.7072764314703867,1.0,10/18,51.55%,NLRP3;PTGES;OSM;OSMR;IL6;PLA2G2D;GSTP1;KLKB1;F12;DNASE1
prerank,necroptotic process (GO:0070266),-0.38886924821476543,-1.0998498880228487,0.32158590308370044,0.7060010115471652,1.0,9/16,27.41%,ITPK1;DNM1L;TLR4;LY96;TICAM1;IPMK;TICAM2;MLKL;CD14
prerank,rRNA transcription (GO:0009303),0.5370940280130928,1.0998228058102115,0.38980891719745225,1.0,1.0,7/17,20.58%,GTF3C5;BRF1;NIFK;TCOF1;SIRT7;POLR1G;SPIN1
prerank,regulation of immune response (GO:0050776),0.456915311587664,1.0996754994972107,0.30522088353413657,1.0,1.0,20/135,11.30%,CD19;ICAM4;ULBP1;SPN;ITGB7;DHX58;PTPN22;KLRD1;FOXP1;RAET1E;COL1A2;TRAF3;BIRC2;AHR;SLAMF7;HCST;TREML1;PILRA;B2M;XIAP
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5496221093651156,1.0994129380885629,0.38294993234100133,1.0,1.0,1/14,0.97%,MYB
prerank,protein localization to phagophore assembly site (GO:0034497),0.5724604953643306,1.098454192939355,0.3877840909090909,1.0,1.0,2/11,3.98%,ATG13;STX17
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5105149915081715,1.0984142695183867,0.3701067615658363,1.0,1.0,11/26,20.53%,MAP2K6;IKBKG;TAB1;UBE2V1;TAB3;TIFA;UBA52;MAP3K7;TRAF6;CASP8;UBE2N
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.4004820961373828,-1.0977997721965271,0.31797235023041476,0.709316848985633,1.0,9/15,29.53%,SMAD1;ITGA5;PKM;VEGFA;FGF2;BMPER;KLF4;JMJD8;TJP1
prerank,regulation of protein localization to centrosome (GO:1904779),0.5834219770307367,1.0976346360204463,0.3974358974358974,1.0,1.0,4/10,15.93%,CEP72;CEP250;GSK3B;MARK4
prerank,regulation of interleukin-17 production (GO:0032660),0.5024240858818744,1.0973681236163808,0.38461538461538464,1.0,1.0,5/31,13.56%,IL12A;CARD9;MYD88;ZBTB7B;DDIT3
prerank,protein import into nucleus (GO:0006606),0.4620256862181329,1.0973429437369713,0.3449001051524711,1.0,1.0,28/66,22.65%,POM121;NUP107;TNPO1;IPO13;NUP50;KPNA3;NUP214;SEC13;IPO7;NUP188;RANBP6;RANBP2;RPAIN;E2F3;APPL1;IPO5;KPNB1;EIF4ENIF1;NUP85;MMP12;RPL23;TPR;TNPO2;TNPO3;SYK;NUP93;KPNA4;PHB2
prerank,protein K63-linked deubiquitination (GO:0070536),0.4948961189783619,1.0973329285100695,0.3722794959908362,1.0,1.0,9/31,17.64%,USP27X;BABAM1;ABRAXAS1;SPATA2;OTUD5;USP50;YOD1;USP25;USP7
prerank,glycoprotein metabolic process (GO:0009100),-0.27132815273318495,-1.0971717941400818,0.2857142857142857,0.7092349696246768,1.0,23/53,22.77%,MANBA;ST8SIA1;MAN1C1;NGLY1;MAN2A2;GANAB;STT3B;MAN2B1;LARGE1;PCSK6;B4GALT5;ERP44;ST6GALNAC6;ST3GAL4;B4GALT7;HPSE;ST8SIA5;ST6GALNAC3;AGA;ST8SIA3;MAN1B1;GAL3ST4;HIF1A
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.38063218070585725,-1.0969984555976182,0.3056768558951965,0.7079676117370797,1.0,8/16,20.64%,ST8SIA1;ST6GALNAC4;LARGE1;ST6GALNAC6;B4GALNT1;ST8SIA5;ST6GALNAC3;ST8SIA3
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.5572060958168017,1.0969381040286834,0.363265306122449,1.0,1.0,6/13,20.17%,CPSF2;NCBP1;TUT1;CPSF1;NCBP2;CPSF7
prerank,glutamate receptor signaling pathway (GO:0007215),-0.29651178209010437,-1.09687907212981,0.30927835051546393,0.7065984123648139,1.0,9/37,14.74%,APP;DAGLB;GRIA4;GRIN3A;GRM5;CDK5R1;GRIK2;GRM8;DAGLA
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5516099817794837,1.096817271384782,0.3788487282463186,1.0,1.0,4/13,7.15%,SAE1;UBA2;DESI2;DESI1
prerank,pore complex assembly (GO:0046931),0.5321699034427891,1.0965970072154108,0.3707440100882724,1.0,1.0,10/19,21.99%,NDC1;NUP107;TSPAN33;NUP205;AHCTF1;NUP98;ANO6;ADAM10;TPR;NUP93
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4654416931764287,1.096448391783628,0.3391572456320658,1.0,1.0,14/74,14.47%,FOXA2;EZH2;LEF1;TIAM1;VASN;TWIST1;CLASP1;EPHA3;SMAD4;ADIPOR1;PTEN;BCL9L;SPRED2;DAG1
prerank,vascular transport (GO:0010232),0.46192709252966385,1.0962096618242763,0.34183673469387754,1.0,1.0,15/81,12.41%,SLC38A5;SLC5A5;SLC1A5;SLC7A1;SLC2A4;SLC16A12;TFRC;LRP3;SLC16A1;ABCC2;ABCA2;SLC19A1;ATP8A1;ABCC4;SLC44A1
prerank,alpha-amino acid metabolic process (GO:1901605),0.4769926227536256,1.0960109365040387,0.38146551724137934,1.0,1.0,12/45,17.21%,SLC25A12;PYCR3;DDAH2;KMO;GLS2;DPEP1;RIMKLB;ATP7A;SLC25A13;KYAT3;ASS1;NAALAD2
prerank,positive regulation of ion transport (GO:0043270),-0.2876330931989017,-1.0959423109176847,0.3125,0.7072374547749558,1.0,17/48,22.25%,ANK3;CACNB2;CNKSR3;ANK2;SCN1B;FHL1;VAMP8;VAMP7;CCL4;DLG1;WFS1;CCL3;ORAI1;P2RX4;RAB3B;SCN3B;AHCYL1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5682155401414506,1.0957216433610888,0.3768913342503439,1.0,1.0,7/12,17.77%,RNF168;RNF8;NELFA;HNRNPU;NELFB;TCERG1;HEXIM1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.507045234738327,1.0953388267983084,0.3786057692307692,1.0,1.0,7/23,16.74%,DAPK2;CD74;RIPOR2;DPP4;RAC2;MCU;RAC1
prerank,RNA modification (GO:0009451),-0.2803753546262292,-1.0953012995021696,0.2631578947368421,0.7072471712033913,1.0,22/54,18.52%,ADARB1;ADAR;PUS7;ANKRD16;TRMT1;DTWD2;NSUN2;NSUN4;JMJD6;WDR4;QTRT1;ELP5;TRIT1;TYW5;NOP2;METTL1;FTSJ1;MEPCE;THUMPD1;FTSJ3;ALKBH1;PARN
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5647907533480814,1.0949466737689852,0.3935309973045822,1.0,1.0,4/12,13.42%,NIN;NINL;PCM1;BBS4
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.49614897284342585,1.0948935511753213,0.36155606407322655,1.0,1.0,9/33,20.97%,LEF1;CD74;ZFP36L1;PRKCA;RUNX1;HCLS1;TRAF6;CASP8;RIPK1
prerank,response to organic cyclic compound (GO:0014070),0.469056329905675,1.0947404739111513,0.3657754010695187,1.0,1.0,7/52,12.73%,CYP1B1;ALPL;PMAIP1;CDKN2D;ABCA2;SOCS2;STAT5B
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.34591877014933087,-1.0942766412050315,0.296969696969697,0.7082708299947668,1.0,11/21,24.15%,RAP1GDS1;SLC8A3;MCUR1;SLC8B1;LETM1;TGM2;BCAP31;MAIP1;AFG3L2;SMDT1;ANXA6
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.4369235909153585,-1.0942125299994794,0.3472222222222222,0.7067464203102489,1.0,3/11,5.23%,IGF1R;PIK3R1;IGF1
prerank,nucleic acid-templated transcription (GO:0097659),0.4865201452139207,1.0941902754220312,0.3590859630032644,1.0,1.0,7/42,9.41%,NR4A2;E2F1;POLR2I;POLR2A;EPC1;PTMA;RNPS1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.5524974941962819,1.094189417357023,0.3992197659297789,1.0,1.0,8/14,26.30%,FASTKD5;TFB1M;TFB2M;TEFM;PNPT1;TFAM;FASTKD1;FOXO3
prerank,amino acid transmembrane transport (GO:0003333),0.47810349189258966,1.0938085799362598,0.37404580152671757,1.0,1.0,3/45,2.84%,SLC38A5;SLC25A12;SLC7A1
prerank,epithelium development (GO:0060429),0.4529009662557858,1.0933342479383656,0.3346814964610718,1.0,1.0,5/107,4.98%,CDK1;STIL;RCN3;TIMELESS;PCNA
prerank,glycogen biosynthetic process (GO:0005978),0.569818220454471,1.0926470013302476,0.38865836791147995,1.0,1.0,2/12,5.37%,PGM2;NR1D1
prerank,glucan biosynthetic process (GO:0009250),0.569818220454471,1.0926470013302476,0.38865836791147995,1.0,1.0,2/12,5.37%,PGM2;NR1D1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.45058029132950195,1.0926437497968804,0.064,1.0,1.0,317/1645,16.28%,CENPF;DEPDC1;E2F7;BRIP1;BIRC5;PAX5;E2F8;FOXM1;E2F2;GFI1;FOXA2;RRM2;NKX6-1;VAX2;MYB;HMGB2;EZH2;RCOR2;SPIB;MYBL1;MEN1;CCNE1;ATAD2;SUV39H1;CDC45;RAD21;CDK5RAP2;BRCA1;DMRTA1;SPIN4;SMARCC2;NR4A2;HMGA1;SOX6;CHEK2;DAP;POLA1;HEY2;BLM;RBM15;BRCA2;MYRFL;DEAF1;LEF1;E2F1;SMARCA5;UXT;NSD2;RB1;FBXO5;TEAD4;RIOX1;ARID1B;IKZF3;PBX4;NIF3L1;LIN9;SMARCD2;BATF;RSF1;ELK4;CBX5;CD38;TWIST1;DEK;CD74;USF1;HMGB3;PBX3;PML;AXIN1;NUP107;BCL7A;FBXW11;POLR2A;TIMELESS;PA2G4;NUCKS1;HDAC10;ERG;BACH2;UBE2I;MTA3;LCORL;RPS6KA5;EPC1;CTCF;RBBP8;BRD9;SCMH1;PCNA;FOXP1;ETS2;DACH1;BRPF1;ACTR5;SP100;CDKN2A;NR1D1;NKAP;MED30;HOMEZ;EDF1;MBD2;NFXL1;FOXO1;LIN54;FOXJ3;MDM4;ATF7;BAZ2B;KDM3B;E2F6;ZBTB26;YWHAH;BCL11A;PBXIP1;MBD1;EBF1;TCF7L1;TCF3;ARID4A;GMNN;ZFP41;IRF9;RUNX3;HDAC6;TFDP1;TGFA;MAPRE3;EBF3;PHF19;KLF10;BRD4;MAP3K5;TAF7;NOTCH1;MED31;TAF15;XRCC6;PIM2;HMGB1;PCBD2;CDK17;MLF2;AHR;CAMTA2;SFMBT1;ZNF326;BAZ1B;SPEN;SAP18;ILF2;MAX;PSPC1;DMTF1;PHF1;PHF2;SMARCA4;UBE2V1;CIR1;YEATS4;MAPK14;CIPC;SEC14L2;ZBTB16;PCGF5;RLF;ERC1;E2F5;METTL4;NCOA7;ETV6;PLAG1;NFE2L1;NRF1;ZBTB7A;EGFR;FLI1;ABCA2;NONO;ZNF148;PIAS3;MECP2;SP110;SRRT;KLF13;EGR1;PFDN5;IFRD1;TFDP2;SMARCC1;HIRA;SALL2;ZBTB32;MYNN;SPTY2D1;IRF2BPL;NR2C2;RFX2;HIPK2;NR2F2;KAT6A;ID4;ZEB1;TRIM33;TSHZ1;DBX2;CUX1;MXI1;NFYC;TRIM44;RUVBL2;DYRK1A;EHMT1;ARID5B;SUMO1;NFE2;RUVBL1;SMAD4;ATF6;MED8;CCAR2;TYMS;DHX9;JUN;ATF5;PLCB1;NSD3;CRK;CCNT1;PRKCB;NPAT;NAA16;FOXP2;ZNF25;CBFB;BAP1;SETDB2;HCFC1;RAI1;SATB2;ZBTB33;STAT5B;KMT2A;SP3;NFE2L2;ZBTB7B;ING2;HIVEP2;ING5;CC2D1A;REXO4;NIPBL;SP140;DDIT3;CDK16;PSIP1;CREBBP;MYC;CEBPG;BCL6;PHF14;GABPA;NFX1;PSEN1;MED14;POU6F1;HNRNPAB;ZNF112;TADA2A;HTATIP2;RNF20;TP53INP2;CAMTA1;PBX2;RNF111;E2F3;GMEB2;CCNK;KDM4C;ELF1;TADA3;YEATS2;LIMS1;ATF7IP;DNAJC2;KMT2B;TP53;JUNB;LRRFIP1;GPATCH3;GON4L;RUNX1;LIMD1;IRF8;EGF;F2R;HOXB4;POU2F1;PIAS1;SRSF10;PLAGL1;JARID2;MAP2K1;SIN3A;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;PURG;RFX7;FOXK2;TRIM28;RFX4;ATRX
prerank,Notch signaling involved in heart development (GO:0061314),0.5639872990029438,1.0925968719105166,0.38247566063977745,1.0,1.0,2/11,7.15%,HEY2;NOTCH1
prerank,protein import into peroxisome matrix (GO:0016558),0.55590697541683,1.0924256536124013,0.3821478382147838,1.0,1.0,4/12,17.48%,PEX26;PEX5L;PEX2;PEX14
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.466600998268725,1.092282960467202,0.36119711042311664,1.0,1.0,31/69,22.87%,GTF2E1;POLR2I;POLR2A;INTS4;INTS9;GTF2A1;NCBP1;NABP2;SNAPC3;SRRT;INTS1;TAF6;INTS14;RPRD1B;CCNT1;INTS13;CCNK;POU2F1;TAF9;POLR2K;POLR2J;POU2F2;NCBP2;SNAPC5;GTF2A2;RPAP2;INTS12;RPRD2;TAF11;POLR2B;INTS11
prerank,regulation of blood coagulation (GO:0030193),0.5134546200373178,1.0921228231582416,0.3933253873659118,1.0,1.0,3/27,5.28%,FOXA2;FAP;CAV1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.49980825037563803,1.091870918825511,0.3785450061652281,1.0,1.0,9/26,18.14%,GFI1;BIRC2;LRRC14;FLOT1;TLR5;APPL1;LGR4;NLRP2B;FLOT2
prerank,translation (GO:0006412),0.4502464322055011,1.091695489447593,0.282,1.0,1.0,80/208,23.52%,MRPL36;RPL7;VARS1;RPL18A;RPS20;MRPL18;NOA1;RPL36;RPL14;GATC;MRPL47;RPS19;RPS7;RPS4X;MRPL16;RPS18;MRPL10;RPL23A;EEF1B2;RPL28;MRPL37;PPA2;RPS14;RPL41;RPLP2;LARS1;RPS27;MRPL51;MRPS7;MRPL43;RPS5;DHPS;RPS29;RPLP0;RPS11;MRPS17;IGF2BP3;TMA7;RPL27A;GFM2;RPS9;RPS15A;MRPL24;RPL12;RPL22L1;ZC3H15;EEF2;DARS1;MRPS34;RPL3;GSPT1;UBA52;EPRS1;RPL18;DRG1;YARS2;RPL5;RPS6;RPS17;RPS3;RPL21;AGO2;PTCD3;SRBD1;RPL23;RPL17;RSL24D1;RPL24;RPL8;RPL27;RPL13A;TRMT112;MRPS12;RPS12;RPS8;RPL15;RPL10;ABCE1;KARS1;RPS21
prerank,activation of protein kinase A activity (GO:0034199),-0.39251835312429617,-1.0916829801040417,0.34156378600823045,0.7115332344502862,1.0,4/16,4.85%,PRKACB;PRKAR1A;ADCY7;ADCY2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.5067524440660796,1.091186790020169,0.39976415094339623,1.0,1.0,3/25,8.84%,CD2;ITGB7;ITGAV
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.5643449834337323,1.0907518426017595,0.3883357041251778,1.0,1.0,5/11,16.94%,CD74;CD44;ING2;TAF9;SIRT1
prerank,mRNA processing (GO:0006397),0.45083202262416044,1.0902742731352486,0.267,1.0,1.0,111/287,20.93%,RBM15;LSM6;AURKAIP1;DHX38;POLR2I;SNRNP25;PRPF19;POLR2A;SCAF11;IK;SNRPF;HNRNPC;SNRPC;HNRNPM;HNRNPL;HNRNPA3;CPSF2;CMTR2;CRNKL1;PPIL3;U2AF1;SNRNP200;UBL5;EIF4A3;SRSF3;SPEN;TXNL4A;RNPC3;HNRNPA2B1;PSPC1;NOVA2;PRKACA;SART3;SRSF4;NCBP1;PRPF38A;LSM2;SNRNP35;RALY;NONO;CASC3;RNPS1;ERCC3;U2AF1L4;PPWD1;SRRT;CSTF3;RBM19;PCBP2;PRPF31;DHX9;RPRD1B;HNRNPA0;THOC3;LSM5;U2SURP;UPF3B;KIN;ZMAT2;PRMT9;HNRNPR;THOC5;CWC15;HNRNPU;SF3B5;PRPF4;TFIP11;SRRM2;PDCD7;LSM7;METTL14;THOC2;SRSF10;SART1;GEMIN7;DNAJC8;SNRNP40;ESS2;POLR2K;SRSF7;THOC7;CDC40;TCERG1;DDX39B;POLR2J;POLDIP3;SNRPG;GCFC2;PCF11;CPSF1;PRPF8;RSRC1;CLP1;PPIE;ALKBH5;HNRNPA1;PPIH;ELAVL1;NCBP2;ZCCHC8;SRSF2;SF3A2;SNRNP48;SNRPB;CPSF7;PPIL1;RNMT;RBM4B;SYNCRIP;WDR33;RPRD2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5696913043658003,1.0901530092516096,0.3903448275862069,1.0,1.0,5/11,11.79%,GSN;PRR7;PARK7;CAAP1;FAS
prerank,protein K63-linked ubiquitination (GO:0070534),0.4936968353764482,1.090112141154396,0.37513751375137516,1.0,1.0,20/41,24.59%,UBE2T;PRPF19;UBE2O;TRAF3;UBE2V1;RNF168;RNF8;RNF152;ARIH2;TRIM5;RNF115;TRAF3IP2;RNF4;UBE2G1;TRAF6;UBE2N;HECTD1;NEDD4;ITCH;UBE2S
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5590136805138185,1.0898198972045694,0.3890449438202247,1.0,1.0,1/11,0.60%,E2F2
prerank,mRNA methylation (GO:0080009),0.5339036040820007,1.0897341051909688,0.39453125,1.0,1.0,7/15,22.24%,CBLL1;METTL8;METTL16;VIRMA;METTL14;WTAP;TRMT10C
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.35482512816595074,-1.0897292220436847,0.30049261083743845,0.7129400191999491,1.0,8/20,33.69%,HPGDS;GSTO1;GSTA3;MGST1;AKR1A1;GSTA4;GSTO2;GSTZ1
prerank,glutathione derivative metabolic process (GO:1901685),-0.35482512816595074,-1.0897292220436847,0.30049261083743845,0.7129400191999491,1.0,8/20,33.69%,HPGDS;GSTO1;GSTA3;MGST1;AKR1A1;GSTA4;GSTO2;GSTZ1
prerank,protein complex oligomerization (GO:0051259),0.4484430181660898,1.0897169647302891,0.37104994903160043,1.0,1.0,15/85,14.01%,ECT2;POLQ;MS4A1;BLM;CUTC;ATL2;BOK;MPP2;LRRC8C;TIFA;CARD9;KCNC2;ZNHIT6;MICU1;MCU
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.5589351015415078,1.0896605501551513,0.38633193863319387,1.0,1.0,5/12,16.94%,CD74;CD44;ING2;TAF9;SIRT1
prerank,regulation of endothelial cell migration (GO:0010594),-0.24293663987460418,-1.0896241821739048,0.2916666666666667,0.7115212784816874,1.0,30/85,20.71%,ANXA3;GLUL;NRP2;APOE;GPI;BMPR2;PIK3CD;PRKD1;GRN;ZC3H12A;KRIT1;ANGPT1;NF1;SH3BP1;ITGB3;SCARB1;SPARC;PIK3CB;PTK2;VEGFA;FGF2;VASH1;ACVRL1;DAB2IP;GPLD1;THBS1;BMPER;ADGRB1;SVBP;AGT
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.2770249572762586,-1.0895165582575943,0.28125,0.7101161928311621,1.0,13/51,12.60%,VWC2L;SMAD1;BMPR2;SPART;SMAD6;FSTL1;BMPR1B;UBE2D1;SKIL;LEMD2;FBN1;SMAD7;GREM2
prerank,nuclear pore organization (GO:0006999),0.549507619407735,1.089170267315631,0.38107752956636004,1.0,1.0,5/14,12.33%,NDC1;NUP107;NUP205;AHCTF1;NUP98
prerank,negative regulation of cell differentiation (GO:0045596),0.4520508192126976,1.0890672248291497,0.317,1.0,1.0,34/181,17.11%,FOXA2;ADAMTS7;MYB;MEN1;ANP32B;E2F1;RB1;RIOX1;VASN;TWIST1;ZFPM1;SUZ12;CDK6;CAV1;PTHLH;FOXO1;LRP3;NOTCH1;ZBTB16;ITGAV;EGFR;ASXL1;ADIPOR1;PTEN;SPRED2;HNRNPU;SKI;ADGRV1;METTL14;LIMD1;NELFB;ZFP36L2;SIRT1;TRPM4
prerank,myeloid leukocyte differentiation (GO:0002573),0.4569642936302639,1.0888495426611215,0.36628511966701355,1.0,1.0,18/65,19.40%,PRTN3;LEF1;E2F1;BATF;DEK;PML;FOXP1;MAPK14;THOC5;GLO1;TYROBP;RUNX1;TNFRSF11A;PIR;SIRT1;CDKN1A;LGALS9;CASP8
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.49021714456293447,1.0887562865945961,0.36202830188679247,1.0,1.0,7/29,17.70%,RPA2;CHD1L;RPA1;ERCC3;RPA3;UBA52;DDB2
prerank,ribosome assembly (GO:0042255),0.4663004431880788,1.0886549792548428,0.36324324324324325,1.0,1.0,20/47,23.75%,EIF2A;RPS19;RPL23A;MPV17L2;MRPL22;RPS14;RPS27;MRPS7;RPS5;RPLP0;DHX29;RPL3;RPL5;EIF6;RSL24D1;RPL24;EFL1;RPL10;MRPL20;NPM1
prerank,neurotransmitter transport (GO:0006836),-0.2619064015813816,-1.0884221149429307,0.3793103448275862,0.7113272507981295,1.0,27/73,27.39%,RIMS1;GLUL;SYNJ1;PPFIA2;SLC1A2;GABRA2;SYT1;SLC17A6;VAMP2;SLC1A3;GAD2;UNC13A;STX1A;SLC5A7;PPFIA1;SNAPIN;ATP1A2;RAB3A;STXBP1;PTPRN2;PDZD11;CPLX1;SLC32A1;DVL1;SNAP25;SLC38A1;SLC1A1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.473363031692496,1.0879034792874183,0.3653217011995638,1.0,1.0,13/49,14.97%,PMAIP1;DAPK2;S100A9;CAV1;S100A8;BOK;UBQLN1;BECN1;FIS1;RACK1;DDIT3;SGMS1;TP53
prerank,response to purine-containing compound (GO:0014074),-0.37946969998858104,-1.0877012917105888,0.3490566037735849,0.711505984843716,1.0,8/17,29.80%,RYR2;DGKQ;TRPC3;P2RX4;VGF;NDUFS4;ABCC9;TRPM2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.37132916261443677,-1.0876728895734638,0.34972677595628415,0.7099428842109036,1.0,7/20,14.17%,TGFBR1;HSP90AA1;WASHC1;PRKN;PINK1;ZMIZ1;EPAS1
prerank,positive regulation of proteolysis (GO:0045862),0.47198476822916835,1.0875919449581097,0.3711558854718982,1.0,1.0,9/55,7.99%,PLK1;NRDC;AURKAIP1;RCN3;FBXW11;SNX33;TANK;CYFIP2;SNX9
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.47944303028228297,1.0875096561815816,0.36332958380202474,1.0,1.0,8/38,14.59%,BRCA1;PMAIP1;TNFSF10;SP100;TRADD;FAS;CFLAR;GSK3B
prerank,serine family amino acid metabolic process (GO:0009069),-0.39584627130913325,-1.0870968780848977,0.3217391304347826,0.7096496321137025,1.0,11/16,42.90%,SARS1;CDO1;PSPH;SHMT2;SHMT1;SEPHS2;SRR;CBS;THNSL2;CTH;DAO
prerank,transport across blood-brain barrier (GO:0150104),0.4572047882839495,1.086770971331695,0.3622448979591837,1.0,1.0,15/83,12.41%,SLC38A5;SLC5A5;SLC1A5;SLC7A1;SLC2A4;SLC16A12;TFRC;LRP3;SLC16A1;ABCC2;ABCA2;SLC19A1;ATP8A1;ABCC4;SLC44A1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.46949297826731606,1.0867583148037874,0.36219640971488914,1.0,1.0,15/50,16.92%,PSMB7;PSMD11;PSMF1;AZIN1;PSMC1;PSMC3;PSMA4;PSMC4;OAZ1;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4
prerank,response to metal ion (GO:0010038),0.45887161821508016,1.0863926216321633,0.36354166666666665,1.0,1.0,19/67,17.91%,TFR2;SLC25A12;HAAO;PPP3CA;CAV1;PEF1;NEDD4L;PPP2CB;SEC31A;SLC25A13;ANXA11;ATP5F1D;GPHN;HVCN1;CRIP1;SLC30A5;NDRG1;PPP1CA;SNCA
prerank,male gonad development (GO:0008584),0.4838341563031989,1.0858509551418605,0.38018433179723504,1.0,1.0,6/34,17.70%,SRD5A2;CSDE1;FGF9;ING2;TGFB2;KITLG
prerank,aortic valve development (GO:0003176),0.4752578604861264,1.085798079373035,0.37919463087248323,1.0,1.0,7/34,15.60%,HEY2;RB1;TWIST1;NOTCH1;SLIT3;ROCK2;ELN
prerank,regulation of JUN kinase activity (GO:0043506),0.48007764363315986,1.0857718538463503,0.3839080459770115,1.0,1.0,12/33,21.40%,ARHGEF5;PTPN22;MAP3K5;MAP3K11;TLR6;AIDA;TNFRSF11A;MAP3K7;HIPK3;RPS3;TRAF6;SASH1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5156634198483084,1.0849387541973632,0.38125,1.0,1.0,3/22,7.77%,NTF4;KIDINS220;CIB1
prerank,cellular response to osmotic stress (GO:0071470),0.5077267379657228,1.0848519177807636,0.38902743142144636,1.0,1.0,3/21,6.62%,AQP1;OXSR1;ZFP36L1
prerank,brain development (GO:0007420),0.45008788418819756,1.0844026483233602,0.3470824949698189,1.0,1.0,23/136,14.60%,CENPF;CDK5RAP2;SOX6;PBX4;HSPG2;UTP3;PBX3;FBXW11;SPEF2;SHROOM2;PAFAH1B1;SHROOM4;RELN;PTEN;HAP1;CDK5RAP3;SMG9;MDGA1;BBS4;NIPBL;POU6F1;ADGRL3;PBX2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.40103611970020614,-1.0843855154350968,0.3652173913043478,0.7146680402125475,1.0,10/13,35.42%,APP;SQSTM1;LGMN;SHANK3;AKAP5;SHISA7;CHRNA7;ADCY1;EIF2AK4;EPHB2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3826734226993954,-1.0842093714029744,0.33181818181818185,0.7134591111865414,1.0,9/16,27.19%,TMEM50B;VPS36;LEPROTL1;TMEM50A;CHMP7;LEPROT;CHMP4B;CHMP4A;VPS28
prerank,response to tumor necrosis factor (GO:0034612),0.4494759698763211,1.0841381504721226,0.372829417773238,1.0,1.0,20/91,19.40%,ADAMTS7;BRCA1;AFF3;CRHBP;TANK;NR1D1;TRADD;ZFP36L1;GBP2;CIB1;JAK2;DHX9;NFE2L2;TNFRSF11A;ZFP36L2;CCL25;SIRT1;ADAM10;RPS3;CASP8
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.3542431810220582,-1.0835791576816582,0.3333333333333333,0.7134958128657215,1.0,7/22,14.06%,PJA2;MFHAS1;MINK1;ZC3H12A;SPI1;NCF1;VEGFA
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5139362599911289,1.0834972351517433,0.4127979924717691,1.0,1.0,11/20,23.78%,PPIL3;PIN1;PPWD1;PPIG;PPIA;PPIE;PPIH;PPIL1;FKBP1A;CWC27;NKTR
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.506327461690133,1.0834754804855455,0.38895558223289317,1.0,1.0,4/23,12.59%,SLC12A3;SLC12A7;SLC12A1;SLC12A6
prerank,regulation of Notch signaling pathway (GO:0008593),-0.2470602170269193,-1.0833438361214738,0.28125,0.7124540750656055,1.0,22/76,18.51%,BMP2K;EPN2;PRAG1;MAML1;GALNT11;PRKCI;ARRDC1;ARRB1;YTHDF2;MMP14;MAML3;POGLUT1;STAT3;ZMIZ1;TSPAN15;FBXW7;TSPAN14;TM2D3;JAG1;CD46;LLGL1;NEPRO
prerank,pentose-phosphate shunt (GO:0006098),0.5609124092110618,1.0831302811617103,0.4102209944751381,1.0,1.0,2/11,4.01%,PGM2;H6PD
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.36096116556862906,-1.082383979305192,0.37640449438202245,0.7116474103947829,1.0,11/20,30.06%,APP;ARNT;PRKAA2;IGF1;PFKFB4;PFKFB2;HIF1A;INSR;PFKFB1;MLXIPL;GAPDHS
prerank,positive regulation of glycolytic process (GO:0045821),-0.36096116556862906,-1.082383979305192,0.37640449438202245,0.7116474103947829,1.0,11/20,30.06%,APP;ARNT;PRKAA2;IGF1;PFKFB4;PFKFB2;HIF1A;INSR;PFKFB1;MLXIPL;GAPDHS
prerank,generation of neurons (GO:0048699),0.4494374443148559,1.0823520295431586,0.322,1.0,1.0,32/190,17.29%,CIT;RACGAP1;VAX2;HMGB2;NR4A2;HEY2;NIF3L1;CDK6;DISC1;RUNX3;PIN1;IER2;MYEF2;MARK2;MTPN;PAFAH1B1;DNER;RELN;NRP1;MDGA1;FGF13;NRCAM;ADGRL3;RUNX1;THOC2;MAP2K1;SDCCAG8;LRP12;FGFR1;TGFB2;RAC1;SH3RF1
prerank,regulation of fibroblast proliferation (GO:0048145),0.47314921128799575,1.0823483116473496,0.37882096069869,1.0,1.0,15/45,19.05%,AQP1;E2F1;LIG4;CD74;CDK6;EMD;DHX9;PEX2;SKI;MYC;TP53;NLRC3;FN1;MORC3;CDKN1A
prerank,positive regulation of protein binding (GO:0032092),0.4642543653778294,1.0823033921039913,0.3700534759358289,1.0,1.0,21/56,19.69%,MEN1;TIAM1;EPB41;CAV1;TAF1;PIN1;PPP2CB;HIPK2;AMFR;B2M;FLOT1;ADD2;PSEN1;GSK3B;STK4;TCF7L2;SPPL3;LRRK2;STK3;AKTIP;PPP2CA
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4910052762317701,1.0818825993437498,0.3923739237392374,1.0,1.0,7/26,17.28%,FOXA2;NR1D1;PIM3;BAIAP3;CDK16;TRPM4;ADCY8
prerank,snRNA transcription (GO:0009301),0.4625473392724015,1.0813551805514527,0.37731958762886597,1.0,1.0,31/70,22.87%,GTF2E1;POLR2I;POLR2A;INTS4;INTS9;GTF2A1;NCBP1;NABP2;SNAPC3;SRRT;INTS1;TAF6;INTS14;RPRD1B;CCNT1;INTS13;CCNK;POU2F1;TAF9;POLR2K;POLR2J;POU2F2;NCBP2;SNAPC5;GTF2A2;RPAP2;INTS12;RPRD2;TAF11;POLR2B;INTS11
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.29945895780139287,-1.0810771523835712,0.28865979381443296,0.7131775726265436,1.0,8/41,8.52%,CTSS;ANK3;KCNMA1;KCNN2;ANK2;KCNJ6;GABBR1;GABBR2
prerank,regulation of cytoplasmic transport (GO:1903649),0.5649557383747797,1.0808394144504263,0.4,1.0,1.0,6/11,18.13%,MAPK1;DNAJC13;MAP2K1;CHMP3;USP7;LRRK2
prerank,translational termination (GO:0006415),0.45072588343743347,1.0807540842385617,0.37055837563451777,1.0,1.0,22/95,17.50%,MRPL36;AURKAIP1;MRPL18;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;MRPL24;MRPL48;MRPS10;MTRF1L;MRPS34;MRPL38;GSPT1
prerank,negative regulation of neuron projection development (GO:0010977),-0.2784197350110105,-1.0804982684144586,0.35714285714285715,0.7130192914608842,1.0,22/56,17.93%,RTN4;SPOCK1;RUFY3;GAK;APOE;STMN2;PRAG1;GDI1;HDAC2;PTPRS;MAG;EFNB3;PTPRO;FKBP4;PTPN9;PAQR3;CBFA2T2;SEMA3A;TRPV4;EPHA4;THY1;CRMP1
prerank,negative regulation of secretion by cell (GO:1903531),0.4778429674767384,1.0803765600684514,0.38641425389755013,1.0,1.0,3/38,7.15%,IL12A;STXBP6;NOTCH1
prerank,mRNA 3'-end processing (GO:0031124),0.4559980964920514,1.0803518181902843,0.3847715736040609,1.0,1.0,33/78,20.93%,DHX38;SLBP;CPSF2;U2AF1;EIF4A3;SRSF3;SRSF4;NCBP1;CASC3;RNPS1;U2AF1L4;CSTF3;RPRD1B;THOC3;UPF3B;THOC5;THOC2;SRSF7;THOC7;CDC40;TUT1;SCAF8;DDX39B;POLDIP3;PCF11;CPSF1;CLP1;TENT2;NCBP2;SRSF2;CPSF7;WDR33;RPRD2
prerank,regulation of glucose transmembrane transport (GO:0010827),0.5261099545874168,1.0802698349919932,0.39668367346938777,1.0,1.0,5/18,18.59%,C2CD5;PRKCB;PRKAG2;APPL1;SLC2A1
prerank,vascular process in circulatory system (GO:0003018),0.5334422813608726,1.0801130226824995,0.38294993234100133,1.0,1.0,5/13,24.01%,ROCK2;ROCK1;GCLM;GCLC;ITGB1BP1
prerank,regulation of tube diameter (GO:0035296),0.5334422813608726,1.0801130226824995,0.38294993234100133,1.0,1.0,5/13,24.01%,ROCK2;ROCK1;GCLM;GCLC;ITGB1BP1
prerank,regulation of stem cell differentiation (GO:2000736),0.45663014301322835,1.0797215582881836,0.36826042726347913,1.0,1.0,25/89,16.92%,MYB;PSMB7;PSMD11;PSMF1;TCF3;PSMC1;NOTCH1;PSMC3;PSMA4;CBFB;PSMC4;BMPR1A;KMT2A;PSMD13;HNRNPU;PSME1;PRKDC;PSMB1;RUNX1;NELFB;HOXB4;PSMD8;ZFP36L2;PSME4;PSMD4
prerank,respiratory electron transport chain (GO:0022904),0.5407171565313752,1.0794492717660853,0.3815261044176707,1.0,1.0,9/14,24.49%,SLC25A12;SLC25A22;SLC25A13;GPD2;NDUFA5;ETFRF1;ETFDH;ETFA;ETFB
prerank,angiogenesis involved in wound healing (GO:0060055),-0.43663931796192357,-1.0792993283269057,0.3602693602693603,0.7141977357364243,1.0,7/11,29.94%,CD34;ITGB3;VEGFA;HPSE;NDNF;KDR;SRF
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3890107159737586,-1.0786760507643953,0.34977578475336324,0.7142185533940492,1.0,4/17,4.85%,PRKACB;PRKAR1A;ADCY7;ADCY2
prerank,nuclear membrane organization (GO:0071763),0.5125668326103662,1.0784819689165523,0.4088669950738916,1.0,1.0,4/19,10.92%,PLK1;NEMP1;EMD;TOR1A
prerank,negative regulation of response to stimulus (GO:0048585),0.46225419149503083,1.078236803594512,0.3862212943632568,1.0,1.0,9/60,7.63%,FOXA2;FBXO5;ERBB3;TWIST1;RBL1;CDK6;TERF2;AKT3;PIM3
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.4489774223285314,1.0782258083737009,0.281,1.0,1.0,85/341,17.88%,BUB1B;KIF14;UBE2C;AURKB;MAD2L1;UHRF1;CDC20;PLK1;SKP2;AURKA;DTL;PSMB7;PSMD11;PML;PPP1R11;CDC23;FBXW11;UBE2I;CDC27;PSMF1;TAF1;FAF1;NPLOC4;PSMC1;ANAPC7;FBXO45;BIRC2;SPSB3;BIRC6;UBE2K;UBE4B;UBE3B;NEDD4L;UBQLN1;TNFAIP1;CUL3;KCTD21;PTTG1;PSMC3;PCBP2;AMFR;UBE3C;RAD23A;PSMA4;RNF168;MIB1;RNF8;SPSB4;TRIM3;CNOT4;FZR1;FBXL4;PSMC4;ARRB2;PCNP;BUB3;FBXO11;NFE2L2;PSMD13;SPOP;PSME1;DDIT3;DCAF11;ARIH2;RNF20;ZFAND2B;PSMB1;RNF111;RBCK1;RC3H1;ARMC8;PSMD8;MYLIP;PSME4;RNF115;UBE2R2;KLHL22;PSMD4;SIRT1;XBP1;UBXN1;RNF4;RNF19A;SYVN1;FEM1C
prerank,protein-containing complex assembly (GO:0065003),0.44575546905300306,1.0776977114364228,0.315,1.0,1.0,84/259,19.40%,KNTC1;F5;MEN1;CARD10;MEFV;BLM;FANCA;LEF1;TIAM1;CD74;PML;AXIN1;NAPG;TUBGCP4;IKBKG;RAB1B;MDM4;TRADD;STX5;TCF7L1;ANKRD28;PEF1;CSNK1A1;TGFA;KPNA3;TRAPPC9;BOK;SMARCA4;SNX9;SEC24B;DBNL;LAMC1;TSPAN33;ZW10;SEC24A;TLE4;NDUFAF1;CUL3;SEC13;NIFK;TRAPPC4;BET1;RUVBL1;DHX9;FAS;MAGI1;SEC31A;BCL9L;ZNHIT6;KMT2A;PPP6R3;CHCHD10;ADD2;CREBBP;MYC;MCU;RBBP5;GSK3B;TP53;PPP6C;CNIH1;KIFAP3;FANCC;TCF7L2;TFAP4;DARS1;LMAN1;GORASP1;ADCY8;ANO6;PEX14;FN1;CAND2;EPRS1;LRRK2;ADAM10;TLE3;PPIH;SLC2A1;PDE4DIP;HDAC1;SAR1B;TRAPPC3;CASP8
prerank,mRNA destabilization (GO:0061157),0.48073020989666554,1.0776171095113043,0.3979706877113867,1.0,1.0,13/38,15.99%,DCPS;FTO;PDE12;ZFP36L1;CPEB3;TUT4;PUM1;METTL16;ROCK2;CNOT1;METTL14;RC3H1;ZFP36L2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.49336430838806833,1.0773365445963659,0.38610478359908884,1.0,1.0,8/30,11.03%,MMD2;RASGRP1;CRKL;NOTCH1;GRB2;JAK2;ITGAV;RELN
prerank,positive regulation of cell development (GO:0010720),0.48795855921670905,1.077166178668582,0.3821138211382114,1.0,1.0,9/31,22.57%,NKX6-1;LIG4;SPEN;NAP1L1;TYROBP;ATP6AP1;MME;NUMBL;NIBAN2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5061264864870038,1.0769606755384762,0.4056372549019608,1.0,1.0,7/21,18.13%,PMAIP1;BOK;PARK7;DDIT3;XBP1;SYVN1;LRRK2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3866622270987575,-1.076787100775342,0.36475409836065575,0.7174979257381908,1.0,5/16,17.87%,DAGLB;SLC27A1;SCARB1;CTDNEP1;GPLD1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5475931849986752,1.0765281984384398,0.4180790960451977,1.0,1.0,5/11,16.47%,NOVA2;PCBP2;IGF2BP3;PCBP3;ZNF445
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.5314787483741462,1.0758571394900098,0.41310160427807485,1.0,1.0,5/14,12.43%,RPL7;DDX18;URB1;NIFK;ZNHIT6
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.5746137314282029,1.0753376312348426,0.40482954545454547,1.0,1.0,2/10,10.21%,CFL2;ACTN2
prerank,cell junction organization (GO:0034330),-0.2573749102068698,-1.0753330240768864,0.24390243902439024,0.7193473163262466,1.0,17/71,9.31%,PAK3;APP;OPHN1;FBLIM1;MYO9A;CAPZA1;PPFIA2;PRKCI;VASP;SMAD3;APBB2;C1QA;SLC8A3;SEMA3E;GRM5;TJP2;SH3BP1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4456401815288199,1.0752202877721964,0.25,1.0,1.0,103/476,16.25%,FOXM1;FOXA2;MYB;HMGB2;MYBL1;ATAD2;CDK5RAP2;BRCA1;SMARCC2;HMGA1;CHEK2;HEY2;BLM;BRCA2;MYRFL;DEAF1;LEF1;E2F1;ARID1B;PBX4;NIF3L1;RSF1;CD38;CD74;PML;AXIN1;FBXW11;EPC1;CTCF;ETS2;BRPF1;SP100;NR1D1;MED30;EDF1;FOXO1;YWHAH;TCF3;RUNX3;MAPRE3;EBF3;BRD4;MAP3K5;NOTCH1;TAF15;XRCC6;PIM2;PCBD2;AHR;ILF2;SMARCA4;UBE2V1;YEATS4;SEC14L2;ZBTB16;RLF;EGFR;FLI1;EGR1;SMARCC1;HIPK2;NR2F2;KAT6A;TRIM44;DYRK1A;NFE2;SMAD4;JUN;ATF5;PLCB1;NSD3;NPAT;NAA16;HCFC1;RAI1;KMT2A;SP3;ING2;ING5;DDIT3;CREBBP;MYC;PSEN1;MED14;HNRNPAB;RNF20;TP53INP2;RNF111;ELF1;TADA3;ATF7IP;DNAJC2;KMT2B;TP53;GPATCH3;RUNX1;EGF;F2R;MAP2K1;TCF4;TFAP4;FOXK2;TRIM28
prerank,positive regulation of metabolic process (GO:0009893),-0.2507204505402772,-1.074952009502905,0.3333333333333333,0.7186554922910893,1.0,30/103,18.83%,IGF1R;KDM1A;EBF2;CMKLR1;APPL2;LPIN1;ESRRG;ACLY;IL4R;ACACA;ACADL;GNAS;PPARGC1B;MFN2;PRLR;HDAC3;PDGFC;ELOVL6;VEGFA;IL18;EPAS1;GJA1;GRB10;HADH;CD36;ADRB1;KDM3A;PER2;ADRB2;KDM6B
prerank,endocytic recycling (GO:0032456),-0.2836984717455004,-1.074557015626114,0.28421052631578947,0.7179802783975766,1.0,18/50,20.69%,RAB14;STX6;VPS39;EHD4;ACAP2;RAB11FIP3;VPS50;ANKRD27;SNX27;CMTM6;WASHC1;CCDC22;EPS15;VPS51;VPS26C;ENTR1;PTPN23;VPS26A
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.45857476743092085,1.0744753390738984,0.39622641509433965,1.0,1.0,16/70,16.39%,IL12A;ERBB3;CASP2;TRADD;BOK;CIB1;JAK2;ITGAV;PDPK1;FAS;DELE1;BAG3;CASP9;GSK3B;APPL1;TGFB2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4228066148525111,-1.0741350267355778,0.34532374100719426,0.7174159553740312,1.0,6/12,15.82%,CACNA1C;BIN1;CTNNA3;JUP;RYR2;DLG1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.49300959600769634,1.073986786296072,0.39246658566221143,1.0,1.0,4/21,10.75%,BRCA1;ABCD1;HDAC6;PARK7
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.4436998164843638,1.0737325555415704,0.229,1.0,1.0,145/572,20.81%,E2F7;AURKB;E2F8;FOXM1;UHRF1;GFI1;NKX6-1;MYB;EZH2;MEN1;PLK1;SUV39H1;NR4A2;HEY2;DEAF1;E2F1;UXT;RB1;ELK4;CBX5;EZR;TWIST1;ZFPM1;MCPH1;HDAC10;UBE2I;MTA3;EPC1;CTCF;FOXP1;ETS2;DACH1;SP100;CAV1;NR1D1;NKAP;TAF1;MBD2;MDM4;E2F6;BCL11A;TCF3;RUNX3;PDE2A;KLF10;TAF7;NOTCH1;HMGB1;SPEN;MAX;NEDD4L;SMARCA4;CIR1;RPS14;ZBTB16;ETV6;NCOA5;ZBTB7A;SIN3B;ZNF148;MECP2;CPEB3;ZBTB32;IRF2BPL;NR2C2;NR2F2;ID4;ZEB1;TRIM33;CUX1;MXI1;ARID5B;SUMO1;RTF1;SMAD4;PEX2;JUN;MTA2;FOXP2;ZNF25;CBFB;RNF2;PRDM6;HCFC1;ZBTB7B;HNRNPU;SIRT7;CC2D1A;NIPBL;DDIT3;CREBBP;SKI;MYC;BCL6;NFX1;PSEN1;BAG3;POU6F1;CNOT1;YEATS2;MOSPD1;TP53;LRRFIP1;RUNX1;IRF8;SIN3A;TCF7L2;HIVEP1;DUSP22;ATRX;NFATC3;VHL;RIF1;TCERG1;SIRT1;DNAJB1;TRIM37;UBA52;HEXIM1;SNCA;HDAC4;RARG;KDM2B;MED1;FOXE1;DPF2;SUFU;PROX1;HDAC1;GATAD2B;TRAF6;TBL1XR1;SREBF2;DNMT3B;HDAC8;ZBTB18;TAF3;RPL23;TPR;ACVR2B;RBPJ;PPARD;SMAD2;CITED2;GATAD2A
prerank,keratan sulfate catabolic process (GO:0042340),0.5569107397969311,1.072713833952194,0.41260744985673353,1.0,1.0,3/11,10.93%,FMOD;GALNS;OGN
prerank,aspartate family amino acid metabolic process (GO:0009066),0.5134638504121799,1.072467006266264,0.4105793450881612,1.0,1.0,6/18,17.21%,SLC25A12;MSRA;SMS;SLC25A13;ASS1;NAALAD2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.47994472212044215,1.0722144679783343,0.40266963292547275,1.0,1.0,6/36,10.59%,GFI1;CD74;AGPAT1;UBE2K;PARP14;TRIM44
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3210794538950382,-1.071702730120663,0.2620689655172414,0.7215901415981815,1.0,6/27,9.73%,CACNA1C;ANK2;SRI;CTNNA3;JUP;RYR2
prerank,negative regulation of macrophage activation (GO:0043031),-0.3642539773897482,-1.0715079316556495,0.3700440528634361,0.7205135248298704,1.0,6/16,17.90%,LRFN5;GRN;ZC3H12A;CD200;CST7;IL31RA
prerank,regulation of immunoglobulin production (GO:0002637),-0.34426769898384113,-1.0711499410903678,0.3431952662721893,0.7198636207417096,1.0,3/23,3.48%,GPI;CD86;STX4
prerank,negative regulation of cell development (GO:0010721),0.49987656754249654,1.0708758480574885,0.3914081145584726,1.0,1.0,6/25,14.59%,RFLNB;PTHLH;NOTCH1;PCM1;B2M;GSK3B
prerank,regulation of urine volume (GO:0035809),-0.4444066370601992,-1.0708419942059086,0.39570552147239263,0.7190595508494557,1.0,7/10,45.38%,NPR3;HAS2;NPR1;TFAP2B;HYAL2;ADCY6;ADM
prerank,regulation of hemopoiesis (GO:1903706),0.5541873206391992,1.0708052326719593,0.41522988505747127,1.0,1.0,6/10,25.74%,PRKCB;CBFB;CREBBP;RUNX1;PURB;PTN
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4934621663618803,1.07043565854726,0.4,1.0,1.0,5/29,10.75%,PLK1;FBXO5;AXIN1;PIN1;PARK7
prerank,membrane lipid catabolic process (GO:0046466),0.5487751828448449,1.0701032092777505,0.39825581395348836,1.0,1.0,1/10,1.40%,CYP1B1
prerank,negative regulation of catalytic activity (GO:0043086),0.4997779554134474,1.0693304437175377,0.4,1.0,1.0,8/24,18.69%,HDAC6;NOTCH1;CCAR2;PPP1R12A;TP53;NOSIP;SIRT1;CLN3
prerank,regulation of protein acetylation (GO:1901983),0.5428416534613877,1.0686758203303024,0.42935528120713307,1.0,1.0,6/12,18.31%,CEP295;PARK7;GSK3B;SIRT1;TAOK1;FAM161A
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5389250038525637,1.0685157484667807,0.4099722991689751,1.0,1.0,3/11,10.75%,FYN;ABCD1;PARK7
prerank,regulation of lymphocyte migration (GO:2000401),0.5693761356713255,1.0684623713197225,0.41761363636363635,1.0,1.0,4/10,10.65%,SPN;JAM2;CCR6;MSN
prerank,nuclear body organization (GO:0030575),0.5523216459346333,1.0683568266035008,0.4217032967032967,1.0,1.0,6/12,23.07%,PML;HIPK2;USP50;WRAP53;AFF2;ZPR1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.29010247096213754,-1.0678625298315676,0.2857142857142857,0.724686852320946,1.0,9/48,12.96%,TREM2;PTPN2;RFFL;PADI2;YTHDF2;ROBO1;SH2B3;GPS2;CARD16
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.44381691881996055,1.0677258224303177,0.3756294058408862,1.0,1.0,25/114,16.92%,TNFRSF18;EDARADD;TNFSF13B;PSMB7;PSMD11;PSMF1;TRADD;TRAF3;PSMC1;BIRC2;JAK2;PSMC3;TNFRSF13B;PSMA4;PSMC4;PSMD13;PSME1;ACTN4;PSMB1;LIMS1;TP53;PSMD8;TNFRSF11A;PSME4;PSMD4
prerank,heart looping (GO:0001947),0.4747382685128898,1.0674847476121332,0.3946784922394678,1.0,1.0,4/40,13.42%,STIL;NOTCH1;SETDB2;BBS4
prerank,synapse organization (GO:0050808),-0.23172830854713009,-1.0674207838456296,0.1,0.7242050330190314,1.0,32/125,16.00%,PAK3;APP;ANK3;LRFN5;CACNB2;PTPRD;PPFIA2;LRRC4;DNM3;APBB2;PTPRS;C1QA;SLC8A3;SEMA3E;SPOCK2;NTNG1;CX3CR1;RYK;CDH2;C1QC;GRM5;PDZRN3;SHANK2;C5AR1;LRRC4B;CDK5;UNC13A;CACNB4;PPFIA1;FARP1;L1CAM;AGRN
prerank,protein autophosphorylation (GO:0046777),0.4435487352998934,1.0673235945661204,0.36947791164658633,1.0,1.0,33/157,14.91%,AURKB;NEK2;STK26;CHEK2;AURKA;OXSR1;DAPK2;SLK;MAP4K1;STK11;MAPKAPK3;TAF1;SIK2;ATM;PIM2;PIM3;PRKX;MARK2;JAK2;STK24;EGFR;PIM1;PDPK1;MAP3K11;MELK;DYRK1A;VRK1;FLT3;LMTK2;STK39;HTATIP2;GSK3B;STK4
prerank,aggrephagy (GO:0035973),0.497195428139805,1.067225250785088,0.41935483870967744,1.0,1.0,11/27,17.60%,PCNT;ACBD5;HDAC6;DYNC1H1;UBE2V1;UBQLN1;PARK7;ARL13B;DYNLL1;VIM;UBA52
prerank,protein deacylation (GO:0035601),0.49801219233913524,1.0671674186899487,0.4019370460048426,1.0,1.0,10/23,18.96%,ABHD17A;HDAC10;HDAC6;LYPLA1;ABHD17B;SIRT7;SIN3A;SIRT1;HDAC4;HDAC1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.48336557285293374,1.067039704208365,0.39864864864864863,1.0,1.0,6/33,13.52%,HMGB2;ABCB10;BRD1;MAPK14;STAT5B;PRKDC
prerank,regulation of acrosome reaction (GO:0060046),0.5496584138021781,1.0670226064377197,0.4197707736389685,1.0,1.0,2/10,19.27%,PLCB1;GLRA1
prerank,positive regulation of transferase activity (GO:0051347),0.4449331567751638,1.0666199737818638,0.3691073219658977,1.0,1.0,20/142,9.82%,AURKB;NEK2;PLK1;MAPK1;DSCC1;ERBB3;LMO4;CD74;RFC5;AXIN1;UBE2I;PCNA;SERINC5;CCT2;PIN1;TCP1;HNRNPA2B1;EGFR;EPHA3;RFC2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.44691566873501803,1.0665321098881166,0.3941908713692946,1.0,1.0,29/80,21.45%,PMAIP1;AQP1;CD44;TNFSF10;DPEP1;ARL6IP1;MAP3K5;HMGB1;CDKN2D;CARD9;XIAP;FIS1;DELE1;UACA;MYC;F2R;SIRT1;SH3RF1;ARL6IP5;YWHAE;SNCA;MALT1;GRAMD4;PAX2;DAPK1;EPHA7;USP47;RPS6KA3;SYK
prerank,phosphorylation (GO:0016310),0.4409325092659196,1.0664691703558673,0.296,1.0,1.0,126/385,21.45%,CDK1;BIRC5;AURKB;NEK2;CCNE1;PLK1;STK26;CHEK2;MAPK1;CDKL1;AURKA;OXSR1;DAPK2;FYN;PRKCE;HASPIN;RSKR;ERG;RPS6KA5;MAP4K1;PANK2;STK11;CHEK1;CDK6;GRK6;TLK1;GMFG;TAF1;SIK2;ATM;RUNX3;CSNK1A1;STK38L;MAP3K5;CDC25B;PIM2;CDK17;AKT3;PKN2;BIRC6;CSNK1G2;PIM3;MAP3K1;MAP4K2;HCST;PRKCA;PRKACA;STK38;PICK1;MARK2;JAK2;LMTK3;MAST2;STK24;PIM1;PDPK1;MAP4K5;CDK19;HIPK2;TESK2;MAP3K11;MELK;DYRK1A;VRK1;BTK;FGGY;CCNT1;PRKCB;BMPR1A;LMTK2;GRK2;ROCK2;DGKD;PRKDC;PRKAG2;LATS1;CDK16;STK39;FAM20A;NRBP1;GSK3B;SGK3;STK4;MAP3K20;BCR;LIMD1;PAK5;MAP2K1;MARK4;FGFR1;LIMK2;PAK2;CDK8;TGFB2;JAK3;PIK3CA;SRPK1;PGK1;FAM20B;MORC3;STK17B;TAOK1;LRRK2;ADAM10;CREB1;NIM1K;HIPK3;STK3;NADK;CDK11B;PRKD2;ALK;DAPK1;PLK4;EPHA7;MARK1;ACVR2B;ILK;PRKAG1;ROCK1;IKBKB;TYK2;DGKE;COPS2;SYK;GRK3
prerank,ribosomal small subunit biogenesis (GO:0042274),0.46413339400271075,1.0662779817827976,0.41414141414141414,1.0,1.0,11/39,12.67%,LSM6;RPS19;RPS7;RPS14;NOL11;RPS27;EMG1;MRPS7;RPS5;RIOK3;SRFBP1
prerank,keratan sulfate metabolic process (GO:0042339),0.4825866600235137,1.0660927517722396,0.4009163802978236,1.0,1.0,7/31,10.93%,FMOD;GALNS;ST3GAL1;SLC35D2;ST3GAL2;B3GNT2;OGN
prerank,positive regulation of nervous system development (GO:0051962),-0.3004492186527362,-1.0658430877325578,0.36,0.7266662115639871,1.0,10/42,11.79%,NUMB;PTPRD;SYNDIG1;CX3CR1;IL1RAP;CLSTN3;LRRC4B;TGM2;CLSTN1;CUX2
prerank,positive regulation of mRNA processing (GO:0050685),0.49886145762611606,1.0652584264518485,0.4146039603960396,1.0,1.0,9/21,23.67%,RBM3;NCBP1;NUP98;DAZAP1;NCBP2;THRAP3;LEO1;NCL;CIRBP
prerank,modulation by symbiont of host process (GO:0044003),0.5448800223021351,1.065026149292217,0.39204545454545453,1.0,1.0,4/10,17.60%,B2M;HGS;PGK1;UBA52
prerank,artery development (GO:0060840),-0.3452184004371832,-1.0643701227251186,0.3693181818181818,0.7287688356248075,1.0,8/23,15.57%,TGFBR1;BMPR2;ROBO1;NF1;ENG;SMAD7;VEGFA;ACVRL1
prerank,mesoderm development (GO:0007498),0.5115431185822437,1.064366105319934,0.4316185696361355,1.0,1.0,3/18,11.00%,IKZF3;JAK2;BTK
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5590223747841235,1.064201750776621,0.4246771879483501,1.0,1.0,6/10,23.07%,PRKCE;NEDD4L;STK39;HECW2;NEDD4;OSR1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5422538448718016,1.0633755417270876,0.42533333333333334,1.0,1.0,3/13,11.64%,RAMP1;ABCA2;PLCB1
prerank,organophosphate ester transport (GO:0015748),-0.3302837813746023,-1.0631405313368,0.33544303797468356,0.7302079170866366,1.0,8/24,13.32%,OSBPL2;PLTP;PRELID2;SCP2;MTTP;SCARB1;PITPNB;NPC2
prerank,response to progesterone (GO:0032570),0.5134580880306746,1.063038070264299,0.4175392670157068,1.0,1.0,2/18,5.28%,CATSPERB;CAV1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.43827609909078574,1.0623758082707433,0.338,1.0,1.0,73/260,18.31%,KIF24;STK26;IFT80;EXOC2;PPP1R9B;CCDC88A;POC1B;PCNT;NTN1;FLNA;EZR;WDPCP;CEP83;EXOC4;BBIP1;CEP89;GSN;CENPJ;WDR90;DISC1;SSX2IP;ARF4;HDAC6;NOTCH1;FXYD5;FUZ;RP2;OFD1;PTPDC1;RAB8A;CEP250;CFAP44;FGD6;TMEM237;CYS1;ABLIM3;PMP22;PCM1;PDE6D;RFX2;WHAMM;ACTN2;CCDC28B;MTSS1;CEP162;ABCC4;RAB8B;CCDC57;FGD3;SCLT1;S1PR2;ARL13B;EMP1;NRP1;BBS4;PIBF1;EXOC5;MKS1;PARVB;DYNLL1;DYNLT2B;RAC1;PARVA;IFT172;ATP6V0D1;IFT140;BBS9;ANO6;TXNDC15;ARHGEF7;ATAT1;ABLIM2;FAM161A
prerank,skeletal muscle tissue development (GO:0007519),0.4758192058616287,1.0623108286701224,0.42081447963800905,1.0,1.0,7/32,21.08%,CSRP3;CAV1;CAV2;SKI;CFLAR;ZBTB18;SVIL
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3302842743094401,-1.0619921677797752,0.34591194968553457,0.7314164819281922,1.0,8/28,18.07%,PTPN2;APPL2;PTPRE;PIP4K2B;GSK3A;GRB10;TSC2;SLC27A4
prerank,cellular sodium ion homeostasis (GO:0006883),0.5240135534901783,1.0617523824466526,0.4143790849673203,1.0,1.0,2/15,7.95%,TMPRSS3;NEDD4L
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5096492698533669,1.061284140530301,0.40993788819875776,1.0,1.0,6/20,20.13%,FGFBP3;SULF2;SMOC2;APLN;PRKD2;DSTYK
prerank,negative regulation of protein transport (GO:0051224),0.4910882829941934,1.0609204743599099,0.3859223300970874,1.0,1.0,2/25,4.60%,IL12A;SNX3
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.3982738557966077,-1.060820988631851,0.3849056603773585,0.7328435245899624,1.0,6/13,31.64%,ZFYVE28;ZGPAT;SNX6;SOCS5;ERRFI1;CHMP6
prerank,establishment of endothelial barrier (GO:0061028),0.4839753827424157,1.0602713963131112,0.4177362893815636,1.0,1.0,7/29,11.59%,PECAM1;EZR;TJP3;RAB1B;PDE2A;MSN;RDX
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4626520276915216,1.0599619768016175,0.41657579062159217,1.0,1.0,18/47,24.33%,CD177;DCXR;MAPK14;GRB2;PLCG2;DHRS4;TLR6;TYROBP;TP53;CYBA;CDKN1A;RAB27A;RIPK1;MAPT;SYK;PRKCD;SLC5A3;RNF41
prerank,mitochondrial translation (GO:0032543),0.4441218156126696,1.0599077448729077,0.4034552845528455,1.0,1.0,23/104,17.25%,MRPL36;AURKAIP1;MRPL18;NOA1;GATC;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;MRPL24;MRPL48;MRPS10;MTRF1L;MRPS34;MRPL38
prerank,mitochondrial gene expression (GO:0140053),0.4654196801458712,1.0596810314870007,0.4192139737991266,1.0,1.0,11/42,12.35%,FASTKD5;NOA1;GATC;MRPL47;MRPL16;TFB2M;MRPL51;MRPS7;MRPS17;GFM2;TEFM
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.4859158851400765,1.0595149528834444,0.40898617511520735,1.0,1.0,7/29,15.17%,BRCA1;AXIN1;DDRGK1;CBFB;LATS1;CNOT1;RUNX1
prerank,neuromuscular synaptic transmission (GO:0007274),0.5132309048723129,1.059347573785357,0.4421052631578947,1.0,1.0,2/18,8.39%,CHRNB4;ERC1
prerank,hexose transmembrane transport (GO:0008645),0.5079004864283344,1.0586534757499924,0.43034825870646765,1.0,1.0,7/21,24.04%,SLC2A4;SLC2A8;SLC2A12;SLC2A3;SLC2A1;PPARD;SLC5A3
prerank,atrioventricular valve development (GO:0003171),0.5223220886111962,1.0581261735181788,0.41005291005291006,1.0,1.0,6/14,16.39%,ZFPM1;MDM4;NOTCH1;SLIT3;BMPR1A;TGFB2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3011758110936899,-1.058006516425364,0.33116883116883117,0.7381319705544908,1.0,14/29,32.56%,PTPN2;PTPN6;YTHDF2;MAVS;RNASEL;CDC37;ZBP1;USP18;CACTIN;MUL1;TTLL12;WNT5A;ISG15;PTPN1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.4937426890970047,1.0579148294566316,0.4123456790123457,1.0,1.0,9/23,21.40%,ARHGEF5;MAP3K5;MAP3K11;TLR6;TNFRSF11A;MAP3K7;RPS3;TRAF6;SASH1
prerank,regulation of receptor recycling (GO:0001919),-0.37580511165331065,-1.0578140493044237,0.3835616438356164,0.7370484367076686,1.0,3/16,8.75%,NSF;OPTN;ECE1
prerank,positive regulation of leukocyte activation (GO:0002696),0.5166764236142493,1.0577058863897812,0.4120667522464698,1.0,1.0,1/18,0.99%,CD2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5355536452585573,1.057037039389129,0.42799461641991926,1.0,1.0,5/14,19.36%,CARD10;TLR6;MAP3K7;MALT1;TRAF6
prerank,N-terminal protein amino acid modification (GO:0031365),0.541588979469577,1.0568993551299088,0.4379263301500682,1.0,1.0,3/14,12.05%,NAA40;METAP2;NAA16
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.470642146772559,1.0568426539701958,0.4118918918918919,1.0,1.0,9/40,16.39%,EZH2;LEF1;TIAM1;TWIST1;NOTCH1;SMAD4;BCL9L;TCF7L2;TGFB2
prerank,DNA methylation (GO:0006306),0.4901290302378539,1.0563172784017554,0.4108433734939759,1.0,1.0,10/23,20.81%,PPM1D;HELLS;PICK1;METTL4;DNMT1;EHMT1;ATF7IP;ATRX;DNMT3B;GATAD2A
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.49775784010755597,1.0562790609384256,0.4251497005988024,1.0,1.0,5/24,9.79%,CGAS;PDE2A;GNAI1;RNF157;PEX5L
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.44259430403907063,1.056202170911093,0.39487179487179486,1.0,1.0,35/84,25.64%,MBNL3;RBM15;RBM3;HNRNPL;SRSF3;SAP18;NOVA2;SRSF4;NCBP1;ZBTB7A;RNPS1;RBFOX3;NUP98;METTL16;RBM7;FXR1;HNRNPU;DAZAP1;SRSF10;SRSF7;SRPK1;RBM25;HNRNPA1;THRAP3;CELF1;RBFOX2;WTAP;NCL;CIRBP;HNRNPK;PTBP1;NSRP1;SFSWAP;YTHDC1;KHDRBS3
prerank,negative regulation of organelle assembly (GO:1902116),0.4771860716343803,1.0559601843556756,0.42777155655095184,1.0,1.0,10/35,18.13%,CDK5RAP2;BRCA1;TCHP;SMAD4;KAT2B;MDM1;MTM1;LIMK2;TRIM37;LRRK2
prerank,positive regulation of protein metabolic process (GO:0051247),0.4426772165193401,1.0557763432782357,0.4148073022312373,1.0,1.0,21/110,14.59%,UHRF1;BARD1;TFR2;DTL;AXIN1;ABCB10;RASGRP1;SLC25A37;FOXO1;RAB1B;STX5;PAEP;NEDD4L;MTPN;ABCA2;CARD9;FZR1;OAZ1;ROCK2;PSEN1;GSK3B
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5453654532745386,1.0556754624899316,0.4113573407202216,1.0,1.0,3/11,10.21%,SNX33;NEDD4L;ACTN2
prerank,response to alcohol (GO:0097305),-0.3207294280625081,-1.0553910549632848,0.3310344827586207,0.7415824416249638,1.0,8/27,19.79%,TGFBR1;GRIN3A;GOT2;CCR5;TGFBR3;TGFBR2;CCL3;PMVK
prerank,negative regulation of signaling (GO:0023057),-0.32011824311843873,-1.0552761529036716,0.3878787878787879,0.7402351818423474,1.0,3/25,5.24%,ACVR1;UBASH3B;OPTN
prerank,negative regulation of autophagy (GO:0010507),-0.26643586002023034,-1.0552322257209574,0.29411764705882354,0.7387440040408733,1.0,15/54,13.03%,CTSA;TREM2;TBC1D14;KDM4A;SNRNP70;HGF;MCL1;FOXK1;EIF4G3;TSC1;GOLGA2;WASHC1;STAT3;PINK1;ZKSCAN3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.355726254852303,-1.054656965287805,0.37433155080213903,0.7386103643492092,1.0,5/19,5.77%,RTN4;APOE;GGA3;IGF1;BIN1
prerank,regulation of osteoblast differentiation (GO:0045667),0.44487565532299433,1.0546395245321636,0.4227226202661208,1.0,1.0,11/82,8.22%,HEMGN;MEN1;FBXO5;RIOX1;CCN1;TWIST1;CCN4;CDK6;LRP3;NOTCH1;PRKACA
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.23590273060721034,-1.0546380745506396,0.34782608695652173,0.7370772183763122,1.0,39/91,23.42%,APP;NDFIP1;FTH1;CUL1;HMOX2;SLC11A2;SLC31A2;ACO1;HMOX1;SLC39A7;ISCU;FTL;ATP6V1A;PRNP;SLC39A14;MT1B;MT1G;MT1E;MT1A;MT1H;MT1F;MT1M;MT1X;TMEM199;COX19;SLC39A8;CCDC22;BMP6;SLC39A6;MT2A;SLC39A12;SLC22A17;GLRX3;ARF1;NUBP1;FRRS1;SLC30A1;MT3;CCDC115
prerank,mRNA modification (GO:0016556),0.5028885548124111,1.0545936996014529,0.422029702970297,1.0,1.0,11/22,23.85%,CBLL1;PUS3;METTL8;METTL16;VIRMA;METTL14;TRUB2;DKC1;WTAP;TRMT10C;TRUB1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.48470065373288934,1.0545145784867949,0.4230769230769231,1.0,1.0,4/27,10.14%,CHST3;CSGALNACT2;DCN;CHST12
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4677770247942919,1.0544003839727056,0.42560175054704596,1.0,1.0,8/37,15.38%,PLK1;MAPK1;AXIN1;UBE2K;S1PR2;SPRED2;PRKAG2;EGF
prerank,regulation of interleukin-1 production (GO:0032652),0.526954924479461,1.0542803936895737,0.43826322930800543,1.0,1.0,3/15,7.33%,MEFV;FOXP1;HMGB1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4517293404736074,1.054264593979542,0.4105480868665977,1.0,1.0,19/70,16.92%,MYB;PSMB7;PSMD11;PSMF1;TCF3;PSMC1;PSMC3;PSMA4;CBFB;PSMC4;KMT2A;PSMD13;PSME1;PRKDC;PSMB1;RUNX1;PSMD8;PSME4;PSMD4
prerank,positive regulation of phosphatase activity (GO:0010922),0.4965121435316328,1.0540590540267687,0.43253012048192774,1.0,1.0,3/21,9.87%,ITGA1;PTPA;PPP1R15A
prerank,regulation of defense response to virus (GO:0050688),0.5327776729307456,1.0530966711109457,0.44516129032258067,1.0,1.0,4/14,11.45%,RNF26;TRAF3;PCBP2;DHX9
prerank,calcium-mediated signaling (GO:0019722),0.44133943052812336,1.052689171219608,0.41260162601626016,1.0,1.0,23/93,18.13%,CXCR5;PPP1R9B;SAMD14;PPP3CA;RCAN3;CCR2;PRKACA;PLCG2;NUDT4;EGFR;PDPK1;CCR6;BTK;FIS1;CHRM3;MCU;PPP3CC;STIMATE;PLCG1;TRPM4;MCTP1;CXCR4;LRRK2
prerank,translational elongation (GO:0006414),0.4401510084907419,1.0525754735586734,0.4131979695431472,1.0,1.0,23/101,17.25%,MRPL36;AURKAIP1;MRPL18;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;EEF1B2;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;RACK1;MRPL24;MRPL48;MRPS10;EEF2;MRPS34;MRPL38
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.45067781836965093,-1.0525579187469274,0.3968253968253968,0.7406991435369796,1.0,4/10,15.09%,APPL2;GSK3A;SELENOS;GRB10
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.4527901633926621,1.0522456552379955,0.4145021645021645,1.0,1.0,8/57,9.53%,MRPL36;XPO1;RPL7;RPL14;RPS19;RPS7;URB2;EMG1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.3501486142022688,-1.052040312417182,0.35,0.7403524229571766,1.0,7/19,14.35%,CAMKK2;DNM1L;HTRA2;GSK3A;PRKN;PINK1;FBXW7
prerank,regulation of cell growth (GO:0001558),0.43520620915466146,1.0519312018700668,0.377,1.0,1.0,40/204,16.94%,KIF14;RAB33B;CDKN2C;JADE1;PPP1R9B;RB1;TCHP;NET1;PML;S100A9;BRAT1;STK11;DDX49;TFRC;CDKN2A;S100A8;H3-3A;CIB1;SMARCA4;MTPN;NCBP1;EGFR;CDKN2D;DERL2;SOCS2;SMAD4;CCAR2;SLIT3;BAP1;RACK1;SERTAD2;BCL6;PABIR1;SGK3;TP53;PAK5;NDRG3;TGFB2;KLHL22;SIRT1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.4678879524119097,1.051926099091723,0.42081949058693247,1.0,1.0,9/36,15.38%,CCR2;TAF1;HDAC6;TGFA;JAK2;PARK7;RELN;NRP1;EGF
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.4963871614382496,1.0518737066796744,0.4315403422982885,1.0,1.0,9/20,25.56%,PRKCE;NEDD4L;ACTN2;STK39;YWHAE;HECW2;NEDD4;OSR1;CAB39
prerank,stem cell differentiation (GO:0048863),0.4697704692822624,1.051476582346095,0.4320441988950276,1.0,1.0,17/39,26.05%,BATF;PSMD11;PUM1;TP53;NELFB;HOXB4;JARID2;TGFB2;LMBR1L;PAX2;FGFR2;OSR1;UFL1;MTF2;HMGA2;MLLT3;SETD2
prerank,copper ion transport (GO:0006825),0.5565778079129233,1.05120616367644,0.4435028248587571,1.0,1.0,5/11,17.18%,CUTC;ATP7A;STEAP2;STEAP3;ATOX1
prerank,RNA stabilization (GO:0043489),0.4760834262726197,1.0509336168557588,0.42032332563510394,1.0,1.0,15/33,24.74%,E2F1;TRDMT1;TAF15;HNRNPU;PAIP1;DKC1;TENT2;ELAVL1;EIF4ENIF1;THRAP3;TENT5D;YBX1;GDNF;CIRBP;ZCCHC17
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4482616899590869,1.0507180891321823,0.42217484008528783,1.0,1.0,21/57,21.45%,PMAIP1;MEFV;FYN;TNFSF10;CYFIP2;MAP3K5;HMGB1;CARD9;FIS1;UACA;MYC;F2R;USP50;SIRT1;ARL6IP5;MALT1;GRAMD4;CASP8;DAPK1;AIM2;SYK
prerank,regulation of leukocyte migration (GO:0002685),0.5096620218264427,1.0503092499682478,0.4444444444444444,1.0,1.0,1/16,0.75%,TNFRSF18
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5574626237108092,1.0495894653451563,0.42937062937062936,1.0,1.0,1/11,1.98%,SOX6
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.28927044949439196,-1.0490281856987724,0.3786407766990291,0.7463413038918469,1.0,11/39,15.91%,PIK3CD;PIP4K2B;ITPKB;PIK3R1;IP6K1;PI4KA;PIK3C2B;SOCS7;PIK3CB;TMEM150A;TTC7B
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5326313039474044,1.0487196299725974,0.4470108695652174,1.0,1.0,5/13,14.80%,ARID1B;CDCA4;CHEK1;SERTAD2;ELOF1
prerank,positive regulation of actin nucleation (GO:0051127),0.5470362391399473,1.0485167371430002,0.43919885550786836,1.0,1.0,3/11,14.64%,GSN;WHAMM;BRK1
prerank,cellular response to organonitrogen compound (GO:0071417),0.4348080977066018,1.0483840583036783,0.4101010101010101,1.0,1.0,25/99,19.97%,SLC5A5;BRCA1;AQP1;CTNNA1;EZR;HCN3;CRHBP;TAF1;ZFP36L1;PDE2A;AHR;LARS1;P2RY1;EGR1;CPEB3;LAMTOR4;DIAPH1;LAMTOR3;IPO5;XBP1;HSP90B1;GLRA1;GABRB2;GOLPH3;PKD2
prerank,RNA metabolic process (GO:0016070),0.4322105928166782,1.048287312356524,0.4259818731117825,1.0,1.0,47/127,22.39%,ADAD1;RNASE6;RBM3;POLR2I;POLR2A;PPP1R8;HNRNPC;HNRNPM;HNRNPL;HNRNPA3;SETX;FTO;ELAVL4;HNRNPA2B1;NCBP1;RBMS2;PCBP2;DHX9;HNRNPA0;HNRNPR;WDR74;HNRNPU;PRPF4;TFIP11;PCBP3;RNASEH2A;METTL14;SNRNP40;POLR2K;RNASE1;DDX39B;POLR2J;CLP1;DKC1;TENT2;HNRNPA1;NCBP2;DDX54;AGO2;PNPT1;SYNCRIP;PAPOLA;RBFOX2;RNASEH2B;AGO1;WTAP;POLR2B
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.50411932677358,1.0482651606871873,0.4298469387755102,1.0,1.0,7/19,21.80%,IL12A;DCN;SMOC2;CCBE1;CADM4;ADAMTS3;SEMA6A
prerank,regulation of cell motility (GO:2000145),0.43411288392996206,1.0481765681500554,0.40524193548387094,1.0,1.0,22/121,15.38%,KIF14;ERBB3;NTN1;FLNA;SLK;TWIST1;LMO4;AMOTL2;CDK6;PIN1;PKN2;PRKX;PLXNA2;CYRIB;EGFR;KIF2A;FGF9;CRK;ROCK2;DIAPH1;SGK3;EGF
prerank,magnesium ion transport (GO:0015693),0.5334939354190589,1.0481383011151395,0.4415041782729805,1.0,1.0,7/12,23.48%,MAGT1;TUSC3;NIPAL4;NIPA2;NIPAL3;MMGT1;CNNM4
prerank,positive regulation of lyase activity (GO:0051349),-0.3920939142065692,-1.0479895361766702,0.4103585657370518,0.7473336582727,1.0,6/14,24.38%,CACNA1C;NF1;ISCU;ORAI1;STIM1;AKAP5
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5269115516102529,1.0478283640490431,0.4409340659340659,1.0,1.0,4/14,18.32%,OXSR1;CCR2;STK39;ADAM10
prerank,negative regulation of apoptotic process (GO:0043066),0.43371625064762737,1.0476799016073235,0.341,1.0,1.0,87/444,18.32%,KIF14;CDK1;STIL;BIRC5;MAD2L1;NTF4;BARD1;PLK1;NR4A2;AQP1;MAPK1;LEF1;DDAH2;RB1;ERBB3;FLNA;CD38;LIG4;CD74;ANKLE2;CD44;PIDD1;PA2G4;UBE2O;TFRC;CAV1;FOXO1;CASP2;DPEP1;PTMA;SETX;ARF4;BIRC2;ARL6IP1;NOTCH1;UBE2Z;DDRGK1;PIM2;BIRC6;PIM3;CIB1;PRKCA;TNFAIP8;RNF157;ERC1;EGFR;CDKN2D;PIM1;SOCS2;PARK7;XIAP;ATF5;FAS;MYD88;NAA16;PRKDC;GLO1;MYC;CFLAR;PSEN1;BAG1;BAG3;MYDGF;HTATIP2;TPT1;GSK3B;PDCD10;TP53;F2R;PAK2;TAF9;ARHGDIA;VHL;PIK3CA;SIRT1;XBP1;SH3RF1;HCLS1;HSP90B1;UBA52;YWHAE;AVEN;SNCA;KDM2B;MED1;MALT1;ADAM10
prerank,lipid oxidation (GO:0034440),-0.40247972155180756,-1.047475622723222,0.37404580152671757,0.7470808752730952,1.0,2/12,8.60%,PLA2G7;ALOX5
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5638905060714343,1.0474384884711885,0.447178002894356,1.0,1.0,4/10,19.38%,KLRD1;ARRB2;FCGR2B;LGALS9
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.49855244061169923,1.0468899075556304,0.4283965728274174,1.0,1.0,6/20,21.45%,STMN1;RNF157;GRK2;SNCA;MET;GRK3
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.44492206860000727,1.0467737924881173,0.4194915254237288,1.0,1.0,15/55,16.20%,PMAIP1;PML;S100A9;TNFSF10;CAV1;S100A8;BOK;BECN1;FAS;FIS1;RACK1;ING5;DDIT3;TP53;PAK2
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3256335011890515,-1.0466988581511671,0.31788079470198677,0.747504305859639,1.0,8/27,10.36%,TREM2;LRP1;APOE;ABCA5;PLTP;SCP2;ZDHHC8;GPS2
prerank,RNA methylation (GO:0001510),0.4473836440685257,1.0465394402207846,0.45010615711252655,1.0,1.0,16/60,15.24%,RBM15;ZCCHC4;TRMO;TRDMT1;TFB1M;TFB2M;TRMT5;CBLL1;METTL8;TYW3;FBL;METTL16;VIRMA;NSUN3;METTL14;DIMT1
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.3543782975050037,-1.0458991619680558,0.3868312757201646,0.7480217349201,1.0,9/16,27.40%,ACLY;PPT1;ACACA;PPT2;ACAT1;MLYCD;GCDH;PPCS;SCD
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4892255674836636,1.0456977337361757,0.42048192771084336,1.0,1.0,4/25,9.89%,CSGALNACT2;HAS1;EXT1;B3GNT2
prerank,pharyngeal system development (GO:0060037),-0.3759862378674911,-1.0454099603145552,0.38596491228070173,0.7476225337602339,1.0,2/15,3.18%,TGFBR1;BMPR2
prerank,regulation of neuron projection development (GO:0010975),-0.2244025036481311,-1.0449711860289586,0.3333333333333333,0.7471518845207096,1.0,57/163,20.24%,TANC2;PAK3;SPOCK1;RUFY3;GAK;CAMSAP2;CAMK1;APOE;STMN2;PRAG1;PPFIA2;PRKCI;PRKD1;KNDC1;HDAC2;PTPRS;MBOAT1;NTNG1;CDH2;MAG;SCN1B;RAP1A;CDK5R1;ATP1B2;ARHGAP44;PTPRO;FES;GSK3A;NDRG4;CTNNA2;SCARB2;CDK5;SERPINI1;FKBP4;PTPN9;CAMK2G;PAQR3;CBFA2T2;LRRC7;SEMA3A;CAMK2B;TRPV4;MDK;EPHA4;ABI2;SHANK3;DAB2IP;NCS1;RTN4IP1;CRMP1;TWF2;RAPGEF1;PLXNB3;CFL1;ABL2;KIF1A;ZDHHC15
prerank,regulation of cardiac conduction (GO:1903779),-0.26745721810426626,-1.044502554488489,0.29411764705882354,0.7467117683489997,1.0,32/54,38.25%,ITPR2;ASPH;ANK2;SLC8A3;ATP2B2;ATP1A1;TRPC1;ATP1B2;RYR2;ATP1B1;ATP2B3;SLC8A1;ITPR3;ATP1A2;STIM1;AGT;AHCYL1;ATP1A3;ATP1B3;FKBP1B;ABCC9;SLC8A2;FXYD1;NPR2;NOS1;ATP2A3;CORIN;ATP2B1;DMPK;FXYD2;FXYD6;NPR1
prerank,regulation of histone methylation (GO:0031060),-0.38977132408191906,-1.0443750535808893,0.38257575757575757,0.7454692859703693,1.0,4/13,17.28%,CTR9;MTHFR;CHTOP;PIH1D1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.519027876996304,1.0443069986291527,0.4402035623409669,1.0,1.0,3/15,7.99%,NRDC;SNX33;SNX9
prerank,regulation of protein kinase A signaling (GO:0010738),0.4958529796108938,1.0436345235583342,0.442643391521197,1.0,1.0,3/20,4.22%,IAPP;AKAP12;AKAP7
prerank,ceramide catabolic process (GO:0046514),-0.377487776868572,-1.0435550262099724,0.38721804511278196,0.7459918790835695,1.0,1/14,0.15%,HEXB
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5515351080666595,1.0432242136687593,0.4588744588744589,1.0,1.0,6/10,23.07%,PRKCE;NEDD4L;STK39;HECW2;NEDD4;OSR1
prerank,chloride transport (GO:0006821),0.44856015990592124,1.0429785868259185,0.4298969072164949,1.0,1.0,11/74,12.59%,SLC4A1;SLC12A3;ANO10;CLIC5;SLC12A7;SLC12A1;GABRA4;CLIC1;GABRA5;ANO3;SLC12A6
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.43193893962848057,1.0429584477114613,0.299,1.0,1.0,202/834,20.79%,DLGAP5;CKAP2;E2F7;E2F8;FOXM1;E2F2;UHRF1;FOXA2;NKX6-1;MYB;HMGB2;SPIB;POU2AF1;MYBL1;MEN1;ATAD2;BRCA1;NR4A2;TFR2;HMGA1;HEY2;LEF1;E2F1;SMARCA5;SENP1;SMARCD2;RSF1;ELK4;PPP3CA;CCN1;TWIST1;ZFPM1;CSRP3;BCLAF3;USF1;ERG;RPS6KA5;EPC1;RBL1;BRD8;NR1D1;MED30;IKBKG;FOXO1;FOXJ3;ATM;KANSL3;TCF3;BCL2L12;SETX;ARF4;TFDP1;KLF10;BRD4;TAF7;NOTCH1;PIN1;XRCC6;DDRGK1;HMGB1;AHR;CAMTA2;KMT2C;MAX;DCN;SMARCA4;YEATS4;SSBP3;GABPB2;GABPB1;PCGF5;RLF;EFCAB7;E2F5;IER2;NCOA7;PLAG1;NRF1;EGFR;ASXL1;EGR1;TFDP2;SALL2;IRF2BPL;NR2C2;HIPK2;PSMC3;NR2F2;KAT6A;RUVBL2;PARK7;ZNF462;PRDM10;SMAD4;ATF6;TAF6;MLLT10;DHX9;JUN;ATF5;KAT2B;RPRD1B;CCNT1;NPAT;PELP1;PAXIP1;NFATC2IP;BCL9L;APEX1;HCFC1;SATB2;BMPR1A;STAT5B;KMT2A;SP3;NFE2L2;HNRNPU;SIRT7;BEX1;HELZ2;PRKDC;DDIT3;CEBPZ;ADCYAP1;CREBBP;SKI;MYC;CEBPG;GABPA;MED14;MYDGF;HTATIP2;PBX2;RNF111;PPP1R12A;E2F3;CCNK;ELF1;SS18;MOSPD1;TP53;JUNB;RUNX1;IRF8;HOXB4;POU2F1;PLAGL1;SIN3A;TCF7L2;TCF4;HIVEP1;FOXK2;RFX4;ATRX;TAF9;CDK8;TGFB2;NFATC3;TCERG1;SIRT1;XBP1;TMF1;APLN;RNF4;RXRB;MLXIP;HCLS1;GLYR1;UBA52;ZBED4;POU2F2;HDAC4;RARG;MED1;CREB1;DPF2;NKX2-8;PROX1;HDAC1;PAX2;TRAF6;TBL1XR1;THRAP3;NPAS2;SREBF2;AGO2;NCOA6;HDAC8;ZBTB18;MMP12;PRKD2;PKD2;NCOA2;MET;MED13;FIZ1;RBPJ;PRDM4;PHF10;PPARD;SMAD2;CITED2
prerank,lipid droplet organization (GO:0034389),-0.33035641061305226,-1.0427770739274451,0.3567251461988304,0.7463546418172576,1.0,4/22,9.70%,CDS1;AUP1;CDS2;ZFYVE1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3776465398165124,-1.0427202328353025,0.36538461538461536,0.7449192994589416,1.0,4/14,12.96%,PTPN2;RFFL;GPS2;CARD16
prerank,positive regulation of viral transcription (GO:0050434),0.4866976522711919,1.0426082359119113,0.4287396937573616,1.0,1.0,9/25,17.19%,RSF1;POLR2I;POLR2A;NELFA;DHX9;CCNT1;NELFB;POLR2K;POLR2J
prerank,Notch signaling pathway (GO:0007219),0.4519574936629163,1.0424501963032469,0.4354166666666667,1.0,1.0,8/59,14.04%,DLGAP5;HEY2;NOTCH1;MIB1;KAT2B;CREBBP;MYC;PSEN1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5196405846181998,1.0420117382484615,0.42370572207084467,1.0,1.0,1/13,1.11%,CHST3
prerank,ether lipid metabolic process (GO:0046485),-0.3796113354081711,-1.0418550262740218,0.42735042735042733,0.7455685107237656,1.0,8/14,24.04%,PLA2G7;DHRS7B;GNPAT;NCEH1;PLA2G6;TMEM86B;AGMO;PEDS1
prerank,skeletal system development (GO:0001501),0.43326501968259185,1.0416510696334889,0.42326980942828485,1.0,1.0,23/148,12.76%,RAB33B;RFLNB;ALPL;SOX6;DEAF1;TEAD4;CD44;SULF2;HAPLN2;ETS2;EXT1;PTHLH;COL1A2;SPEF2;DDRGK1;SLC10A7;ZBTB16;ATP7A;DYM;TCOF1;BPNT2;PAPSS2;HHIP
prerank,monocyte differentiation (GO:0030224),-0.4357346193087776,-1.0416468887516674,0.4271523178807947,0.744585689821882,1.0,5/10,17.90%,CSF1R;PDE1B;VEGFA;MT1G;IL31RA
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.4676196813991276,1.0416249897813652,0.4451901565995526,1.0,1.0,8/36,14.11%,NR4A2;RB1;DAPK2;BCL2L12;FAS;ING5;SGMS1;PPIA
prerank,actin filament bundle assembly (GO:0051017),0.46125370393046916,1.0415877082322682,0.43314285714285716,1.0,1.0,8/33,17.46%,EZR;NEDD9;SHROOM2;LIMA1;PAWR;ADD2;CALD1;HSP90B1
prerank,determination of heart left/right asymmetry (GO:0061371),0.46119515398752026,1.0413255995851527,0.42668136714443217,1.0,1.0,4/43,13.42%,STIL;NOTCH1;SETDB2;BBS4
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4707212004987526,1.0410628527139918,0.4447004608294931,1.0,1.0,6/30,16.29%,CHST3;CSGALNACT2;DCN;CHST12;ARSB;CHSY1
prerank,positive regulation of histone modification (GO:0031058),0.4704616825502632,1.0410498846874974,0.43537414965986393,1.0,1.0,12/33,20.53%,BRCA1;RPS6KA5;SART3;RUVBL2;PAXIP1;ZBTB7B;ING2;NIPBL;TADA2A;GLYR1;BRD7;UBE2N
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.5290704590600493,1.0405949332248254,0.43156424581005587,1.0,1.0,5/11,21.47%,TAF7;JAK2;SIRT1;XBP1;CIITA
prerank,transcription by RNA polymerase II (GO:0006366),0.4330268500666558,1.0405709195922306,0.4174174174174174,1.0,1.0,105/305,22.91%,PAX5;E2F2;PMF1;TRIP13;NR4A2;DEAF1;TEAD4;GTF2E1;DEK;POLR2I;POLR2A;HDAC10;SLBP;INTS4;SNRPF;NR1D1;INTS9;TAF1;MBD1;CPSF2;SETX;IRF9;TFDP1;TAF7;NOTCH1;TAF15;IWS1;GTF2A1;NCBP1;NABP2;SNAPC3;ERCC3;SRRT;KLF13;CSTF3;BTF3;NR2C2;INTS1;RTF1;TAF6;INTS14;NELFA;KAT2B;RPRD1B;CCNT1;CBFB;ARRB2;ZBTB7B;TAF2;CREBBP;INTS13;NRBP1;NFX1;E2F3;GMEB2;CCNK;ELOF1;NELFB;POU2F1;TAF9;POLR2K;PIR;MLLT1;XBP1;SCAF8;POLR2J;SNRPG;RXRB;PCF11;CPSF1;TAF1C;CLP1;POU2F2;RARG;MED1;TTF2;NKX2-8;HDAC1;NCBP2;TBL1XR1;PRRX1;SNAPC5;GTF2A2;TAF3;SNRPB;CPSF7;RPAP2;NRBF2;RNMT;RBPJ;INTS12;PPARD;WDR33;RPRD2;COPS2;TAF11;NR1H3;PAPOLA;MED23;POLR2B;HDAC9;ELP4;INTS11;RXRG;ZBTB1
prerank,regulation of postsynapse organization (GO:0099175),-0.31323417066085385,-1.0402962640856788,0.36486486486486486,0.7464648846968918,1.0,13/28,20.24%,TANC2;PPFIA2;CDK5R1;ARHGAP44;CDK5;EPHA4;ABI2;SHANK3;ABHD17C;ARHGAP22;CFL1;KIF1A;ZDHHC15
prerank,endothelial cell development (GO:0001885),0.4770232812378288,1.0402446008840496,0.4451073985680191,1.0,1.0,5/25,11.59%,PECAM1;EZR;PDE2A;MSN;RDX
prerank,membrane repolarization (GO:0086009),-0.3803149108230249,-1.0400627724295124,0.3991769547325103,0.7454842730260631,1.0,5/15,18.68%,ATP1A1;ATP1B2;ATP1B1;KCND3;ATP1A2
prerank,regulation of mRNA catabolic process (GO:0061013),0.43308421470172465,1.0399705034886593,0.4161616161616162,1.0,1.0,38/121,20.76%,XPO1;PSMB7;PSMD11;PSMF1;TNPO1;EXOSC8;ZFP36L1;PSMC1;PUM2;NUP214;DCP2;PRKCA;PSMC3;PSMA4;PUM1;IGF2BP3;PSMC4;DCP1A;APEX1;FXR1;PSMD13;PSME1;PSMB1;CNOT1;RC3H1;PSMD8;SAMD4A;ZFP36L2;PSME4;VIM;PSMD4;UBA52;ELAVL1;XRN1;CNOT8;PNPT1;PRR5L;CNOT7
prerank,cytoskeleton organization (GO:0007010),0.43653181150732395,1.0398866794909654,0.4313131313131313,1.0,1.0,22/114,15.68%,DIAPH3;CECR2;DES;WDPCP;NEDD9;CNN2;ANK1;RND3;PPP2R3C;MAST2;FGD6;RHOU;SYNE3;PDZD8;FGD3;PACSIN2;PLD2;RAC2;PALLD;DIAPH1;LIMD1;PAK5
prerank,transcription by RNA polymerase I (GO:0006360),0.47485393335814774,1.0391841623273088,0.4662857142857143,1.0,1.0,11/34,18.42%,POLR1B;TAF1;POLR1A;ERCC3;TCOF1;POLR1F;POLR1C;POLR2K;TAF1C;TAF1D;POLR1G
prerank,protein autoprocessing (GO:0016540),0.5160200236527106,1.038703727047883,0.438058748403576,1.0,1.0,3/17,11.27%,MYRFL;PIDD1;FAM111A
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.4479423121236746,1.038637048730168,0.4278131634819533,1.0,1.0,15/53,16.92%,PSMB7;PSMD11;PSMF1;AZIN1;PSMC1;PSMC3;PSMA4;PSMC4;OAZ1;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4
prerank,mesenchymal cell differentiation (GO:0048762),0.4517939334887179,1.0385279189057135,0.45215562565720296,1.0,1.0,11/51,16.39%,FAM83D;HEY2;LEF1;NOTCH1;ROCK2;HNRNPAB;GSK3B;LIMS1;FGFR1;TRIM28;TGFB2
prerank,RNA processing (GO:0006396),0.429114800332095,1.0374196548103622,0.426,1.0,1.0,58/176,20.17%,ADAD1;PPP1R9B;FASTKD5;LSM6;AURKAIP1;RBM3;SNRNP25;SCAF11;SNRPF;HNRNPC;HNRNPL;SETX;U2AF1;ELAVL4;RNPC3;HNRNPA2B1;PRKACA;SRSF4;NCBP1;SNRNP35;NONO;RNPS1;CSTF3;RBMS2;TUT4;CCAR2;HNRNPA0;LSM5;YJU2;KIN;PRMT9;HNRNPR;PPIG;HNRNPU;PRPF4;TFIP11;PDCD7;SNRNP40;SRSF7;TUT1;SRPK1;TCERG1;DDX39B;SNRPG;PRPF8;RSRC1;CLP1;DKC1;TENT2;ALKBH5;NCBP2;DDX54;ZCCHC8;PPP2CA;SRSF2;SF3A2;SNRNP48;SNRPB
prerank,positive regulation of interleukin-2 production (GO:0032743),0.48369716720086287,1.0373015089762694,0.45539906103286387,1.0,1.0,10/25,19.97%,GLMN;CCR2;PLCG2;RUNX1;MAP3K7;MALT1;RPS3;TRAF6;PNP;PRKD2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5186662904486212,1.037028564709816,0.44823066841415465,1.0,1.0,3/15,10.14%,CSGALNACT2;DCN;CHST12
prerank,negative regulation of dephosphorylation (GO:0035305),0.503448648586393,1.036975523536009,0.4401008827238335,1.0,1.0,4/18,10.26%,PTPA;PPP1R8;PPP1R15A;PPP1R35
prerank,innate immune response (GO:0045087),0.4255681354138204,1.0369655355842988,0.416,1.0,1.0,30/217,12.01%,BLK;TRIM58;RNASE6;PGLYRP1;MEFV;SKP2;TRIM59;FYN;DHX58;CD74;CAMP;PML;KLRD1;ANKHD1;SLPI;SP100;IKBKG;SERINC5;SERINC3;HMGB1;TRIM11;PLCG2;TREML1;TIFA;CARD9;BTK;B2M;CLPB;MYD88;TRIM68
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.42467708770446516,-1.0355054985811996,0.42662116040955633,0.7550702624086956,1.0,3/10,14.25%,PRKAR1A;CD274;PRNP
prerank,positive regulation of establishment of protein localization (GO:1904951),0.4920766420485774,1.035467942209443,0.44029850746268656,1.0,1.0,9/19,19.42%,CEP295;CCT7;CENPJ;CCT2;TCP1;CCT5;DKC1;WRAP53;CCT6A
prerank,regulation of phagocytosis (GO:0050764),0.44469754259056743,1.0352176938732875,0.43649946638207043,1.0,1.0,8/53,13.09%,PRTN3;IL2RG;CD47;SNX3;ITGAV;ABCA7;PIP4P2;RACK1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5135580215902534,1.0349301582704833,0.44414535666218036,1.0,1.0,2/15,3.54%,PMAIP1;PRKCE
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4771954122261975,1.0348144154233998,0.45730994152046783,1.0,1.0,1/27,0.38%,CD19
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.43215193918900374,-1.034268691787334,0.4178082191780822,0.7567205082100072,1.0,7/10,24.56%,ARNT;ITGA5;ITGB3;GRB10;HIF1A;MT3;VTN
prerank,negative regulation of phosphorylation (GO:0042326),0.44159953644489797,1.0339527669255795,0.4466321243523316,1.0,1.0,31/85,23.03%,MEN1;CDKN2C;ANKLE2;CDKN2A;CRKL;NIBAN1;CIB1;IBTK;CDKN2D;PARK7;PTEN;CDK5RAP3;HNRNPU;PRKDC;PPIA;DYNLL1;FKBP8;SIRT1;PTPN13;HDAC4;LRRK2;CDKN1A;PRR5L;ROCK1;CBFA2T3;MAPT;CADM4;PPP1R15B;NTRK3;CDKN1B;TARDBP
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.4085927387449024,-1.0339117912483309,0.42142857142857143,0.7546157261316998,1.0,3/12,12.57%,EFNA5;CORO1C;RCC2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.4085927387449024,-1.0339117912483309,0.42142857142857143,0.7546157261316998,1.0,3/12,12.57%,EFNA5;CORO1C;RCC2
prerank,cardiac muscle cell development (GO:0055013),0.5017153031464606,1.0337888070535055,0.45165238678090575,1.0,1.0,2/20,3.63%,HEY2;CSRP3
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4858134644251968,1.033437048866071,0.44095477386934673,1.0,1.0,5/21,21.03%,HEY2;NOTCH1;ROCK2;TRPM4;ROCK1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5287941114665117,1.0332609214371686,0.4649243466299862,1.0,1.0,6/12,19.49%,H6PD;MBTPS2;SEC14L2;ABCA2;KPNB1;SREBF2
prerank,protein polyubiquitination (GO:0000209),0.42851128611793743,1.0332359923498087,0.406,1.0,1.0,72/297,18.56%,CCNF;UBE2C;UBE2T;BARD1;RNF26;BRCA1;FBXL15;SKP2;DTL;PSMB7;PSMD11;PRPF19;CDC23;FBXW11;MKRN1;CDC27;UBE2O;PSMF1;TAF1;FBXO44;TRAF3;PSMC1;ANAPC7;BIRC2;UBE2K;UBE4B;UBE3B;NEDD4L;UBE2V1;FBXO17;CUL3;PSMC3;AMFR;UBE3C;UBR2;PSMA4;RNF168;RNF8;TRIM3;FZR1;TRIM68;FBXL4;CBFB;PSMC4;RNF152;FBXO11;PSMD13;SPOP;PSME1;ARIH2;RNF20;TRIM5;PSMB1;RBCK1;HECTD2;RC3H1;PSMD8;MYLIP;PSME4;RNF115;TRAF3IP2;UBE2R2;PSMD4;RNF4;HERC6;RNF19A;UBA52;DDB2;SYVN1;UBE2G1;FBXW8;RBBP6
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4288901966124588,1.0332239192401733,0.4537223340040241,1.0,1.0,36/136,20.56%,GFI1;FOXA2;MEN1;CYP1B1;DAP;RB1;FLNA;SP100;CDKN2A;TAF1;TRAF3;LRRC14;PIM1;SUMO1;RNF2;PAXIP1;ARRB2;CDK5RAP3;DDIT3;CEBPG;RBCK1;TCF7L2;NLRC3;COMMD6;NLRP2B;SIRT1;PEX14;TRIM37;USP7;HDAC4;SUFU;PROX1;TAF3;PKD2;KEAP1;AIM2
prerank,long-term memory (GO:0007616),0.4988407847013593,1.0332088627015446,0.4529262086513995,1.0,1.0,2/19,3.16%,NTF4;SLC2A4
prerank,cellular response to ketone (GO:1901655),0.4701389599966768,1.0332054868706824,0.4657375145180023,1.0,1.0,14/35,23.20%,AQP1;MAP4K1;DCPS;AHR;GNAI1;MSN;ROCK2;ADCY8;PTGER4;GOLPH3;PCK2;GNB1;KLF9;SRC
prerank,secondary palate development (GO:0062009),0.5132600244634812,1.0326973750603574,0.44921875,1.0,1.0,4/14,20.75%,LEF1;SMAD4;TGFB2;SMAD2
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5539154859652893,1.032621511205051,0.47262247838616717,1.0,1.0,6/11,19.42%,CCT7;CCT2;TCP1;CCT5;DKC1;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5539154859652893,1.032621511205051,0.47262247838616717,1.0,1.0,6/11,19.42%,CCT7;CCT2;TCP1;CCT5;DKC1;CCT6A
prerank,thymus development (GO:0048538),-0.3846131065743652,-1.0321125722934763,0.4223826714801444,0.757726898196823,1.0,1/13,0.54%,TGFBR1
prerank,positive regulation of cyclase activity (GO:0031281),-0.37873831968287336,-1.0318690295395936,0.43373493975903615,0.7567445568738691,1.0,6/14,24.38%,CACNA1C;NF1;MAPK8;ORAI1;STIM1;AKAP5
prerank,embryonic digestive tract development (GO:0048566),-0.3488553090229127,-1.0315144467510866,0.4155251141552511,0.7560861114755804,1.0,6/18,19.01%,SALL1;PCSK5;GLI3;ID2;PKDCC;SOX11
prerank,dendrite morphogenesis (GO:0048813),-0.29266507612075804,-1.0313124545284502,0.3865546218487395,0.7550773321138946,1.0,17/35,27.59%,PAK3;PHACTR1;MINK1;WASL;MAP6;MEF2A;CTNNA2;FARP1;SHANK3;DLG4;CDC42;TMEM106B;CELSR2;DVL1;KLF7;ABITRAM;CHRNA7
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.5257220732218182,1.030858132084448,0.45241379310344826,1.0,1.0,5/12,18.96%,FOXP1;SMARCA4;ZBTB7A;SIRT1;HDAC1
prerank,adherens junction organization (GO:0034332),-0.28362483930021093,-1.0307363104306078,0.37254901960784315,0.7549702303443077,1.0,18/48,19.51%,CDH11;CDH8;CTNNB1;CTNND1;CDH13;CDH2;CDH12;AFDN;JUP;ACTB;FERMT2;SMAD7;NECTIN4;CADM2;PIP5K1C;CADM1;ANG;CSK
prerank,protein deacetylation (GO:0006476),0.4563456454647568,1.0306597489881466,0.4552486187845304,1.0,1.0,13/41,19.37%,RCOR2;FLNA;HDAC10;MTA3;HDAC6;SIN3B;MTA2;SIRT7;SIN3A;SIRT1;HDAC4;HDAC1;TBL1XR1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.43077886774175717,1.0302457920820054,0.4387550200803213,1.0,1.0,53/166,22.87%,E2F2;NR4A2;POLR1B;SMARCA5;TEAD4;RSF1;GTF2E1;POLR2I;POLR2A;HDAC10;NR1D1;TAF1;BRF1;TAF7;NOTCH1;TAF15;TFB1M;TFB2M;GTF2A1;POLR1A;ERCC3;NR2C2;TAF6;KAT2B;POLR1F;TAF2;CREBBP;NRBP1;POLR1C;E2F3;TAF9;POLR2K;POLR2J;RXRB;TAF1C;RARG;MED1;TAF1D;POLR1G;HDAC1;TBL1XR1;NCOA6;GTF2A2;TAF3;NRBF2;RBPJ;PPARD;TAF11;NR1H3;MED23;POLR2B;HDAC9;RXRG
prerank,regulation of neuron death (GO:1901214),0.4336590895658378,1.030189882388534,0.44726166328600403,1.0,1.0,11/82,10.81%,KIF14;FYN;EIF2S1;IKBKG;INPP5A;GPR75;MAP3K5;NENF;EGR1;PARK7;SIGMAR1
prerank,negative regulation of protein processing (GO:0010955),-0.3956225072069638,-1.0298010932741892,0.4115384615384615,0.7558785623375897,1.0,5/12,25.29%,SERPINE2;PRNP;SERPINE1;THBS1;GAS1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4373558047398855,1.0295887676126054,0.45846477392218715,1.0,1.0,15/65,17.82%,SUV39H1;PMAIP1;AQP1;TWIST1;TBL2;MDM4;ZFP36L1;PICK1;UBQLN1;HIPK2;MYC;TP53;SIRT1;PGK1;NDRG1
prerank,presynapse assembly (GO:0099054),0.5046009170077674,1.0295145256123615,0.4662337662337662,1.0,1.0,4/16,11.98%,CEL;LRP4;BSN;PTEN
prerank,rRNA metabolic process (GO:0016072),0.4225322477589508,1.0288943283138956,0.443,1.0,1.0,57/160,23.10%,SLFN14;RPL7;RPL18A;UTP3;RPL36;RPL14;RPS19;DDX49;RPS7;HELQ;EXOSC8;RPL23A;RPL28;EXOSC10;RPS14;RPL41;NOL11;RPLP2;RPS27;EMG1;NIFK;UTP6;RPLP0;FBL;RPL27A;PELP1;WDR74;RPS9;NOL8;RPL12;NOP58;POP4;RPL3;UBA52;RPL18;DKC1;PES1;MPHOSPH6;RPL5;RPS6;RPS17;DIS3L;DDX54;RPL21;XRN1;RPL23;RPL17;RPL24;MAPT;RPL8;RPL27;RPL13A;DIS3;RPL15;RPL10;RPF1;NOP14
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4291793178573906,-1.0288919810076722,0.4172661870503597,0.7566093142728415,1.0,4/10,17.47%,RC3H2;ZC3H12A;SMAD7;NFKBID
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.42851230370994925,1.0283707350978948,0.413,1.0,1.0,69/366,15.55%,ESCO2;MYB;EZH2;CCNA2;MYBL1;SPIN4;HMGA1;SOX6;CHEK2;BRCA2;E2F1;DSCC1;NSD2;RB1;FBXO5;CCDC88A;EIF2A;RBM3;PML;NUP107;ORC5;POLR2A;NUCKS1;HDAC10;RPS6KA5;ACTR5;ORC3;EDF1;NFXL1;LIN54;ATF7;TCF7L1;TCF3;GMNN;RUNX3;PHF19;NOTCH1;MLF2;AHR;PSPC1;DMTF1;PHF1;UBE2V1;ERC1;PLAG1;MTPN;NONO;SRRT;PFDN5;SPTY2D1;PUM3;NR2C2;NFYC;TCOF1;CCAR2;ATF5;NSD3;HCFC1;SP3;ING2;REXO4;DDIT3;CREBBP;NFX1;RNF20;TP53;GON4L;LIMD1;SRSF10
prerank,positive regulation of receptor internalization (GO:0002092),-0.3228544447002396,-1.028368917610986,0.4444444444444444,0.7564327837820921,1.0,5/22,8.49%,AHI1;CD63;ARRB1;TBC1D5;ANGPT1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.408492574485786,-1.0280956754728638,0.3857677902621723,0.7556188208680624,1.0,7/11,31.39%,UQCRC2;UQCRQ;UQCRFS1;UQCRB;CYCS;UQCR11;UQCC3
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.4246158311798131,1.027605154203998,0.354,1.0,1.0,234/1082,17.60%,CKAP2;E2F7;E2F8;FOXM1;E2F2;UHRF1;FOXA2;NKX6-1;MYB;HMGB2;SPIB;POU2AF1;MYBL1;MEN1;ATAD2;CDK5RAP2;BRCA1;SMARCC2;NR4A2;TFR2;HMGA1;CHEK2;HEY2;BLM;BRCA2;MYRFL;DEAF1;LEF1;E2F1;SMARCA5;SENP1;ARID1B;PBX4;NIF3L1;SMARCD2;RSF1;ELK4;CD38;PPP3CA;CCN1;TWIST1;ZFPM1;CSRP3;BCLAF3;CD74;USF1;PML;AXIN1;FBXW11;ERG;RPS6KA5;EPC1;CTCF;RBL1;CDCA4;BRD8;ETS2;CHEK1;BRPF1;SP100;NR1D1;MED30;EDF1;IKBKG;FOXO1;FOXJ3;ATM;YWHAH;KANSL3;TCF3;BCL2L12;SETX;ARF4;RUNX3;TFDP1;MAPRE3;EBF3;KLF10;BRD4;MAP3K5;TAF7;NOTCH1;PIN1;TAF15;XRCC6;DDRGK1;PIM2;HMGB1;PCBD2;AHR;CAMTA2;ASF1A;KMT2C;ILF2;MAX;DCN;SMARCA4;UBE2V1;YEATS4;SSBP3;SEC14L2;GABPB2;GABPB1;ZBTB16;PCGF5;RLF;EFCAB7;E2F5;IER2;NCOA7;PLAG1;NRF1;EGFR;FLI1;ASXL1;EGR1;TFDP2;SMARCC1;SALL2;IRF2BPL;NR2C2;HIPK2;PSMC3;NR2F2;KAT6A;TRIM44;RUVBL2;DYRK1A;PARK7;ZNF462;PRDM10;NFE2;SMAD4;ATF6;TAF6;MLLT10;DHX9;JUN;ATF5;KAT2B;RPRD1B;PLCB1;NSD3;CCNT1;NPAT;PELP1;NAA16;NFATC2IP;BCL9L;APEX1;HCFC1;RAI1;SATB2;BMPR1A;STAT5B;KMT2A;SP3;NFE2L2;CHCHD10;THOC5;ING2;HNRNPU;SIRT7;ING5;BEX1;HELZ2;PRKDC;DDIT3;CEBPZ;SERTAD2;ADCYAP1;CREBBP;SKI;MYC;CEBPG;GABPA;PSEN1;MED14;MYDGF;HNRNPAB;HTATIP2;RNF20;TP53INP2;PBX2;RNF111;PPP1R12A;E2F3;CCNK;ELOF1;ELF1;TADA3;SS18;ATF7IP;DNAJC2;KMT2B;MOSPD1;TP53;JUNB;GPATCH3;RUNX1;IRF8;EGF;F2R;HOXB4;POU2F1;PLAGL1;MAP2K1;SIN3A;TCF7L2;TCF4;HIVEP1;TFAP4;FOXK2;TRIM28;RFX4;ATRX;TAF9;CDK8;NFATC3;VHL;USP21;TCERG1;SIRT1;XBP1;SCAF8;TMF1;DDX39B;RNF4;RXRB;MLXIP;HCLS1;GLYR1;CAND2;UBA52
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4465123654569373,1.027386298723177,0.44610458911419426,1.0,1.0,11/52,9.84%,CNPY4;GPSM2;PRKCE;EPB41;SORBS1;GNAI1;CIB1;EFCAB7;EGFR;EPHA3;PDPK1
prerank,mammary gland epithelium development (GO:0061180),-0.3804888463066225,-1.0273579528410153,0.43656716417910446,0.7559484120480868,1.0,4/14,14.45%,CSF1R;ERBB4;AKT2;ID2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5234207047969645,1.0272958150493563,0.4530612244897959,1.0,1.0,7/13,23.35%,DDRGK1;PPP1R15A;ABCA7;RACK1;DNAJB9;PPP1R15B;UFL1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.507326830643299,1.0272267242281137,0.461038961038961,1.0,1.0,1/15,0.72%,SLFN14
prerank,organelle disassembly (GO:1903008),0.4611514227331421,1.0264928955395805,0.4638009049773756,1.0,1.0,5/33,12.25%,CDK1;STX5;DDRGK1;VRK1;GFM2
prerank,negative regulation of type I interferon production (GO:0032480),-0.27437615733276133,-1.0263863901613375,0.38144329896907214,0.7568638418092987,1.0,11/40,11.38%,SIRPA;HAVCR2;PTPRS;PYCARD;TNFAIP3;RNF135;IKBKE;UBA7;MAVS;TRIM25;TRAF3IP1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.4158713569258251,-1.025998719384555,0.4326923076923077,0.7563166877648473,1.0,4/10,22.23%,SERPINE2;SH2B3;PRKG1;CEACAM1
prerank,cell differentiation in spinal cord (GO:0021515),0.534450381089087,1.0254813072176494,0.46096096096096095,1.0,1.0,2/10,13.03%,SOX6;MDGA1
prerank,"wound healing, spreading of cells (GO:0044319)",0.46891921599885694,1.0252224641704586,0.44351961950059454,1.0,1.0,6/24,14.92%,FLNA;CCN1;CD44;ARHGAP35;TOR1A;PDCD10
prerank,nitric oxide mediated signal transduction (GO:0007263),0.4952415166300681,1.0248774734660946,0.46153846153846156,1.0,1.0,3/16,11.12%,DDAH2;GUCY1A1;KCNC2
prerank,histone deacetylation (GO:0016575),0.45345915586126656,1.0246091253178062,0.48148148148148145,1.0,1.0,14/43,19.79%,RCOR2;ELK4;HDAC10;MTA3;HDAC6;SIN3B;MTA2;SIRT7;SIN3A;SIRT1;HDAC4;HDAC1;TBL1XR1;HDAC8
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4602494033592626,1.0245805380190036,0.4532130777903044,1.0,1.0,5/33,8.05%,PYCR3;DDAH2;GLS2;PRODH;RIMKLB
prerank,protein ubiquitination (GO:0016567),0.4252948096956249,1.0244383863854813,0.433,1.0,1.0,113/471,17.78%,CCNF;UBE2C;UBE2T;UHRF1;TRIM58;BARD1;RFWD3;RNF26;PLK1;BRCA1;FBXL15;MEFV;SKP2;DTL;PSMB7;PSMD11;PRPF19;CDC23;FBXW11;MKRN1;CDC27;UBE2O;PSMF1;PCNA;TAF1;TRAIP;FBXO44;MSL2;PSMC1;ANAPC7;FBXO45;BIRC2;UBE2Z;BIRC6;UBE2K;UBE4B;UBE3B;NEDD4L;UBE2V1;TRIM11;RNF157;RAD18;FBXO17;KLHL9;RNF141;TNFAIP1;ASB1;CUL3;TRIM47;CBLL1;PSMC3;AMFR;UBE3C;TRIM33;TRIM44;UBR2;PSMA4;RNF168;RTF1;MIB1;RNF8;SPSB4;PEX2;TRIM3;CNOT4;EIPR1;TRIM68;FBXL4;CBFB;PSMC4;ARRB2;PCNP;RNF152;CUL9;FBXO11;NFE2L2;RACK1;PSMD13;SPOP;PSME1;PRKDC;NFX1;ARIH2;FANCL;RNF20;TRIM5;PSMB1;RNF111;RBCK1;VCPIP1;HECTD2;RC3H1;PSMD8;MYLIP;PSME4;RNF115;UBE2R2;VHL;KLHL22;PSMD4;SIRT1;RNF103-CHMP3;SH3RF1;RNF4;HERC6;RNF19A;PEX14;TRIM37;CAND2;UBA52;USP7;DDB2;SYVN1
prerank,axon extension (GO:0048675),-0.32159754855987394,-1.0244120590748187,0.3898305084745763,0.7587621154545243,1.0,7/23,15.00%,NRP2;HSP90AA1;SPG11;USP9X;ULK1;CDK5;SEMA3A
prerank,positive regulation of T cell migration (GO:2000406),0.49206042967614017,1.024053038983356,0.47081218274111675,1.0,1.0,3/20,5.31%,SPN;OXSR1;CCR2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.28774047356408333,-1.0234358635833685,0.45263157894736844,0.7597958354023725,1.0,18/39,33.41%,PRKCI;TNFAIP3;KRIT1;ANGPT1;TNIP2;SERPINE1;ECSCR;THBS1;MAPK7;PDCD4;CD40;NDNF;RGCC;KDR;ICAM1;CCL2;PAK4;TEK
prerank,embryonic limb morphogenesis (GO:0030326),0.4563282493684638,1.023431779761809,0.4577226606538895,1.0,1.0,13/34,23.09%,AFF3;TWIST1;WDPCP;NIPBL;CREBBP;SKI;MAP3K20;TGFB2;RARG;HDAC1;MEGF8;OSR1;INTU
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.3298720045591681,-1.0231548517919236,0.39908256880733944,0.7589428604157926,1.0,6/20,14.82%,NUMB;BCL2L1;LZTFL1;AP2M1;RHOQ;PPFIA1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.303339537992348,-1.02274297751831,0.38028169014084506,0.7585247763395018,1.0,10/31,15.82%,OPHN1;MYO9A;PRKCI;RAP2A;ERBIN;DLG2;SH3BP1;PDCD6IP;LRRC7;DLG1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.42220392468565776,1.0222463000076114,0.351,1.0,1.0,392/1667,20.81%,CKAP2;E2F7;CDK1;BRIP1;PAX5;AURKB;E2F8;FOXM1;E2F2;UHRF1;GFI1;FOXA2;NKX6-1;VAX2;MYB;HMGB2;EZH2;CCNB1;RCOR2;SPIB;POU2AF1;MYBL1;MEN1;PLK1;ATAD2;SUV39H1;RAD21;BRCA1;DMRTA1;SMARCC2;NR4A2;TFR2;HMGA1;SOX6;HEY2;DEAF1;LEF1;E2F1;SMARCA5;UXT;RB1;SENP1;TEAD4;ARID1B;IKZF3;PBX4;LIN9;SMARCD2;BATF;RSF1;ELK4;CBX5;EZR;PPM1D;PPP3CA;CCN1;TWIST1;ZFPM1;MCPH1;DEK;CSRP3;BCLAF3;USF1;HMGB3;PBX3;NUCKS1;HDAC10;ERG;BACH2;UBE2I;MTA3;LCORL;RPS6KA5;EPC1;CTCF;RBL1;RBBP8;BRD8;BRD9;FOXP1;ETS2;DACH1;SP100;CAV1;CDKN2A;NR1D1;NKAP;MED30;HOMEZ;TAF1;MBD2;IKBKG;FOXO1;FOXJ3;MDM4;ATF7;ATM;BAZ2B;KDM3B;E2F6;ZBTB26;BCL11A;KANSL3;EBF1;TCF7L1;TCF3;ARID4A;BCL2L12;SETX;ZFP41;IRF9;ARF4;RUNX3;PDE2A;TNRC6C;TFDP1;TGFA;TNRC6B;EBF3;KLF10;BRD4;TAF7;NOTCH1;MED31;PIN1;XRCC6;DDRGK1;HMGB1;AHR;CAMTA2;KMT2C;BAZ1B;SPEN;SAP18;MAX;DCN;DMTF1;PHF2;NEDD4L;SMARCA4;CIR1;YEATS4;MAPK14;SSBP3;GABPB2;GABPB1;RPS14;ZBTB16;PCGF5;RLF;EFCAB7;E2F5;IER2;NCOA7;ETV6;PLAG1;NCOA5;NFE2L1;NRF1;ZBTB7A;EGFR;FLI1;SIN3B;ABCA2;ZNF148;ASXL1;PIAS3;MECP2;SP110;KLF13;EGR1;IFRD1;TFDP2;CPEB3;SMARCC1;HIRA;SALL2;ZBTB32;MYNN;IRF2BPL;NR2C2;RFX2;HIPK2;PSMC3;NR2F2;KAT6A;ID4;ZEB1;TRIM33;TSHZ1;DBX2;CUX1;MXI1;NFYC;RUVBL2;PARK7;ZNF462;PRDM10;ARID5B;SUMO1;NFE2;RUVBL1;RTF1;SMAD4;ATF6;MED8;TAF6;MLLT10;DHX9;PEX2;JUN;ATF5;KAT2B;RPRD1B;CRK;MTA2;CCNT1;PRKCB;NPAT;PELP1;PTEN;FOXP2;ZNF25;CBFB;RNF2;NFATC2IP;PRDM6;BCL9L;APEX1;HCFC1;RAI1;SATB2;BMPR1A;ZBTB33;STAT5B;KMT2A;SP3;NFE2L2;ZBTB7B;HNRNPU;HIVEP2;SIRT7;CC2D1A;BEX1;HELZ2;PRKDC;NIPBL;SP140;DDIT3;CEBPZ;ADCYAP1;PSIP1;CREBBP;SKI;MYC;CEBPG;BCL6;PHF14;GABPA;NFX1;PSEN1;MED14;MYDGF;POU6F1;ZNF112;TADA2A;HTATIP2;CAMTA1;PBX2;RNF111;PPP1R12A;CNOT1;E2F3;GMEB2;CCNK;KDM4C;ELF1;TADA3;SS18;YEATS2;MOSPD1;TP53;JUNB;LRRFIP1;RUNX1;IRF8;HOXB4;POU2F1;PIAS1;PLAGL1;SIN3A;TCF7L2;TCF4;HIVEP1;TFAP4;ZNF23;PURG;DUSP22;RFX7;FOXK2;TRIM28;RFX4;ATRX;TAF9;CDK8;ZNF445;BAZ1A;NFATC3;PCGF3;VHL;RIF1;TCERG1;SIRT1;SMARCAL1;DNAJB1;XBP1;TMF1;RNF4;RXRB;MLXIP;HCLS1;TRIM37;GLYR1;UBA52;HEXIM1;ZBED4;ZNF467;SNCA;POU2F2;HDAC4;RARG;KDM2B;MED1;REPIN1;FOXE1;ZBTB34;PHF20;CREB1;ZNF740;DPF2;RFX1;PHF20L1;SUFU;GMEB1;NKX2-8;PROX1;HDAC1;GATAD2B;BRD7;CDKN1A;SAFB;ARID3B;ZBTB20;PAX2;TRAF6;TBL1XR1;THRAP3;NPAS2;SREBF2;ELP3;DNMT3B;PRRX1;ZHX3;AGO2;NCOA6;HDAC8;ZBTB18;ZFX;MMP12;TAF3;PRKD2;PKD2;SLTM;RPL23;ACTL6A;BRD3;MYT1;TPR;RPAP2;NCOA2;MET;ACVR2B;KDM2A;MED13;FIZ1;RBPJ;PRDM4;PHF10;PPARD;SMAD2;CITED2;GATAD2A
prerank,atrial septum morphogenesis (GO:0060413),0.5381164334436304,1.022237705444586,0.45652173913043476,1.0,1.0,2/10,3.56%,HEY2;ZFPM1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.42558247866052157,1.022234210309014,0.445,1.0,1.0,67/348,16.94%,CENPE;TTK;INHBC;NTF4;PLK1;MAPK1;PECAM1;CCN1;CD74;CD44;AXIN1;BRAT1;RPS6KA5;PGF;TFRC;CAV1;BANK1;MMD2;RASGRP1;CRKL;HDAC6;MAPRE3;MMD;PIN1;XRCC6;MRNIP;DDRGK1;NIBAN1;UBE2K;CIB1;SNX9;PLCG2;JAK2;EGFR;P2RY1;TXN;PARK7;RELN;SMAD4;WDFY2;FGF9;FAS;S1PR2;BMPR1A;FXR1;NRP1;ROCK2;RACK1;FLOT1;PRKAG2;LATS1;ADCYAP1;FAM20A;PPIA;MYDGF;STK4;PDCD10;TP53;RAD50;EGF;BMP3;LIMK2;PAK2;TGFB2;RAC1;PDE8A;SIRT1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.32268769641263567,-1.022120988964301,0.375,0.7586646063860537,1.0,8/22,25.00%,CACNB2;SRI;DMD;GNB5;CACNB4;STAC2;CBARP;CACNB1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.5031970268823923,1.0220581678209977,0.45103092783505155,1.0,1.0,8/17,20.17%,NCBP1;CPEB3;CCNT1;ZC3H3;VIRMA;RNF20;NCBP2;CPSF7
prerank,positive regulation of cell cycle (GO:0045787),0.4319777958165393,1.021809731379082,0.4704016913319239,1.0,1.0,22/62,23.11%,CCNB1;CCNYL1;CHEK1;MAPRE3;CDC25B;PKN2;PRKCA;SMOC2;EGFR;RAD23A;CCDC57;HCFC1;RPS15A;TGFB2;PROX1;PKD2;CCND3;CITED2;MDM2;CDKN1B;FGFR2;ADAM17
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.42838932584785583,1.0217858051248994,0.47474747474747475,1.0,1.0,34/109,18.23%,MAPK1;GRAP2;PSMB7;PPP3CA;PSMD11;FBXW11;PSMF1;IKBKG;PSMC1;MAP3K1;TAB1;GRB2;PLCG2;SOS1;TAB3;PDPK1;PSMC3;BTK;PSMA4;JUN;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PAK2;PSME4;PLCG1;NFATC3;RAC1;PIK3CA;PSMD4;MAP3K7;MALT1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.39672432568412536,-1.0213522694418216,0.42105263157894735,0.7589740131216278,1.0,5/12,27.28%,MTTP;DGAT1;APOC1;SOAT2;ACSL3
prerank,positive regulation of ruffle assembly (GO:1900029),-0.384050700435557,-1.0210884335387844,0.39928057553956836,0.7581681135774,1.0,3/13,15.26%,PFN1;P2RY12;EPS8
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.31590546602663083,-1.0207945113605454,0.4470588235294118,0.7574426842165969,1.0,4/23,5.23%,APP;ARNT;PRKAA2;IGF1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.2780910664403413,-1.0205135210284724,0.40869565217391307,0.7565895513607619,1.0,9/37,16.78%,TENM2;PTPRD;FAT4;CD164;TENM1;NECTIN4;CADM1;CXADR;ITGAL
prerank,Fc receptor signaling pathway (GO:0038093),0.42790763862172443,1.0202960960234426,0.4682139253279516,1.0,1.0,34/110,18.23%,MAPK1;GRAP2;PSMB7;PPP3CA;PSMD11;FBXW11;PSMF1;IKBKG;PSMC1;MAP3K1;TAB1;GRB2;PLCG2;SOS1;TAB3;PDPK1;PSMC3;BTK;PSMA4;JUN;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PAK2;PSME4;PLCG1;NFATC3;RAC1;PIK3CA;PSMD4;MAP3K7;MALT1
prerank,myeloid dendritic cell activation (GO:0001773),0.5111058906046069,1.020050661088222,0.45544554455445546,1.0,1.0,2/12,7.33%,BATF;HMGB1
prerank,substantia nigra development (GO:0021762),-0.27546974961281295,-1.0199260344768641,0.40145985401459855,0.7565867005847594,1.0,17/37,19.70%,PLP1;MBP;SEC16A;PADI2;BASP1;COX6B1;CNP;SUDS3;GLUD1;ACTB;CKB;NDUFS3;CALM1;HSPA5;TTBK1;CDC42;NDRG2
prerank,cellular lipid catabolic process (GO:0044242),0.46647256597804043,1.0198402524260204,0.45754716981132076,1.0,1.0,5/27,10.99%,CYP1B1;CEL;ACBD5;NUDT19;PLBD1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4878258581849471,1.0196944877175214,0.4875,1.0,1.0,7/21,19.97%,KCNN4;FOXP1;IKBKG;NFAM1;PRKCB;RPS3;PRKD2
prerank,neuron migration (GO:0001764),0.44849256005609905,1.0188290272301166,0.48442534908700324,1.0,1.0,18/48,20.31%,NR4A2;DISC1;MARK2;PAFAH1B1;DNER;RELN;NRP1;MDGA1;FGF13;NRCAM;ADGRL3;SDCCAG8;LRP12;FGFR1;RAC1;SH3RF1;ELP3;MARK1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5056937897227379,1.0176780432026704,0.4624505928853755,1.0,1.0,3/16,10.65%,ABCD1;PDE12;ATP7A
prerank,positive regulation of RNA splicing (GO:0033120),0.4606932087630423,1.0176656898052268,0.47330960854092524,1.0,1.0,13/29,24.63%,RBM3;POLR2A;SETX;NCBP1;DYRK1A;NUP98;DAZAP1;HNRNPLL;THRAP3;ZPR1;NCL;CIRBP;RBM22
prerank,protein secretion (GO:0009306),-0.2618958484157031,-1.0176344335077891,0.4230769230769231,0.7609491657152008,1.0,17/56,14.80%,RIMS2;TMEM167A;ABCA1;WLS;PCSK5;MON1A;TANGO2;COPG2;MIA3;MTTP;CYB5R4;PDIA4;RAB12;CAMK2G;OLFM2;NAGPA;PTPRN
prerank,regulation of protein transport (GO:0051223),-0.2972181514600346,-1.0175247535250205,0.3693181818181818,0.7597166152602164,1.0,14/27,32.56%,NDFIP1;STXBP5L;NDFIP2;PPM1F;STXBP5;DNAJC1;LLGL1;CHP1;RHBDF2;GAPVD1;LLGL2;P3H1;RHBDF1;PTPN1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.2802314120860664,-1.017403840595688,0.4074074074074074,0.7585506940419671,1.0,7/38,9.20%,CACNB2;CACNA1C;ANK2;BIN1;CTNNA3;SCN1B;JUP
prerank,mitochondrial fusion (GO:0008053),-0.34075379750736723,-1.0173292756334456,0.4,0.7572776551828828,1.0,10/18,28.35%,MFN2;MIEF1;MIGA2;MFF;SPG7;STOML2;AFG3L2;USP30;MFN1;MIEF2
prerank,cellular macromolecule catabolic process (GO:0044265),0.44106923435558215,1.0171707762853033,0.4692556634304207,1.0,1.0,7/49,8.88%,RNASE6;CHEK2;PPP1R8;FBXO44;FBXO17;DNASE1L1;NCBP1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.45252686699845973,1.0170398881785307,0.48256467941507314,1.0,1.0,5/33,5.73%,UBASH3A;EZR;PTPN22;KCNN4;IKBKG
prerank,gonad development (GO:0008406),0.44113919890496267,1.0169649081248395,0.47125140924464487,1.0,1.0,7/41,17.70%,SRD5A2;NUP107;CSDE1;NR2F2;FGF9;TGFB2;KITLG
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.44889242674455315,1.0167482120550655,0.47026431718061673,1.0,1.0,7/39,13.51%,MYO5C;MYO15A;NDE1;FBXW11;PAFAH1B1;HAP1;ACTN4
prerank,T cell activation (GO:0042110),0.43772452226684117,1.016136541171301,0.4672897196261682,1.0,1.0,6/69,5.36%,CD2;PPP3CA;CD74;CD44;PTPN22;RASGRP1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3529051992880312,-1.0156021313769188,0.3891402714932127,0.7600477030679524,1.0,2/18,0.73%,RIMS1;RIMS2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.43095469759204674,1.0153118988160492,0.47963340122199594,1.0,1.0,9/98,8.51%,CDK1;UHRF1;CCNB1;DCXR;AGPAT1;RAB1B;MAPK14;GRB2;PICK1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.355290357003914,-1.014633121500895,0.424390243902439,0.7609103945471556,1.0,6/18,18.50%,CDH8;NAPA;SLC17A6;GRIK2;UNC13A;GRIK4
prerank,sulfur compound transport (GO:0072348),0.47314043259301,1.0146141672408127,0.4666666666666667,1.0,1.0,1/27,0.69%,RACGAP1
prerank,negative regulation of cell communication (GO:0010648),-0.32622686596298966,-1.014458451430343,0.37823834196891193,0.7598826398948444,1.0,2/21,0.65%,ACVR1;UBASH3B
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.47543996852178366,1.014062814294977,0.4851720047449585,1.0,1.0,10/27,18.55%,BRD8;KAT6A;RUVBL2;RUVBL1;TAF6;KAT2B;CREBBP;ATAT1;PHF20;PHF20L1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.2689753216457763,-1.0140410902200887,0.4056603773584906,0.7594594632336753,1.0,9/40,7.05%,BCL2L1;GHITM;HGF;PYCARD;PLAUR;FAM162A;IGF1;DNM1L;MLLT11
prerank,gliogenesis (GO:0042063),0.510219731599756,1.013764060363415,0.48370273794002605,1.0,1.0,5/15,19.35%,CDK6;RELN;METTL14;TGFB2;PAX2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4647720376972932,1.0137231326558052,0.46768507638072854,1.0,1.0,7/26,18.96%,BRCA1;FOXP1;SMARCA4;ZBTB7A;CNOT1;SIRT1;HDAC1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3144082748243359,-1.0135672305478534,0.38028169014084506,0.7592445247544279,1.0,8/25,16.67%,CACNA1C;ANK2;CTNNA3;JUP;RYR2;CALM1;DLG1;CXADR
prerank,negative regulation of immune effector process (GO:0002698),0.5091840919724213,1.0127832959522374,0.44718792866941015,1.0,1.0,6/13,19.21%,CD47;RPS19;RC3H1;APPL1;SLAMF8;CD55
prerank,canonical Wnt signaling pathway (GO:0060070),0.4303762429399723,1.0127449067129208,0.4812889812889813,1.0,1.0,14/68,18.13%,NR4A2;LEF1;AXIN1;CAV1;TCF7L1;CSNK1A1;PTEN;BCL9L;GSK3B;TCF7L2;RAB5A;PPP1CA;RARG;LRRK2
prerank,regulation of endocytosis (GO:0030100),0.430819528527987,1.012694608501161,0.45846477392218715,1.0,1.0,18/61,18.53%,CD177;TFR2;SNX33;STON1;MTMR2;ARFGAP1;NEDD4L;EPHA3;CBLL1;RIT2;ABCA7;PACSIN2;FLOT1;STON2;RAB5A;MCTP1;SNCA;RUFY1
prerank,regulation of complement activation (GO:0030449),0.4483819959517171,1.011842845390005,0.462819089900111,1.0,1.0,1/40,0.38%,CD19
prerank,maturation of SSU-rRNA (GO:0030490),0.44660611759870644,1.011767663534999,0.4711864406779661,1.0,1.0,12/34,19.58%,LSM6;UTP3;RPS19;NOL10;RPS14;NOL11;RIOK3;UTP6;SRFBP1;NAT10;RIOK1;HELB
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.48358116760924674,1.011683225577854,0.4823815309842041,1.0,1.0,9/21,23.93%,PRTN3;PSEN1;DAG1;SPPL3;ADAM10;ERAP1;ADAM17;MYH9;PRKCQ
prerank,motor neuron axon guidance (GO:0008045),0.5050950551738596,1.0112506519222688,0.47299077733860345,1.0,1.0,5/15,16.74%,NTN1;SLIT1;TMEFF1;RAC2;RAC1
prerank,ear morphogenesis (GO:0042471),0.48302787240473094,1.0112065040469358,0.4634760705289673,1.0,1.0,6/20,23.07%,TWIST1;TIFAB;NIPBL;PAX2;FGFR2;OSR1
prerank,oogenesis (GO:0048477),0.5010736999322523,1.0107569084653103,0.46082337317397076,1.0,1.0,1/15,1.66%,TRIP13
prerank,rRNA processing (GO:0006364),0.4150736979881952,1.0102563956524215,0.476,1.0,1.0,63/172,23.10%,RPL7;RPL18A;LSM6;UTP3;RPL36;RPL14;RPS19;DDX49;RPS7;HELQ;EXOSC8;RPL23A;RPL28;EXOSC10;TFB1M;RPS14;RPL41;NOL11;RPLP2;RPS27;EMG1;RIOK3;UTP6;RPLP0;FBL;RPL27A;ERI1;PELP1;SRFBP1;WDR74;RPS9;PRKDC;NOL8;NSA2;RPL12;NOP58;SART1;POP4;NAT10;RPL3;UBA52;RPL18;DKC1;PES1;RIOK1;MPHOSPH6;RPL5;RPS6;RPS17;DDX54;RPL21;RPL23;RPL17;EIF6;RPL24;RPL8;RPL27;RPL13A;DIS3;RPL15;RPL10;RPF1;NOP14
prerank,RNA splicing (GO:0008380),0.4218896472838841,1.0097352708573173,0.48024316109422494,1.0,1.0,34/95,20.60%,PPP1R9B;LSM6;SNRNP25;SCAF11;SNRPF;HNRNPC;U2AF1;TXNL4A;RNPC3;SRSF4;NCBP1;SNRNP35;NONO;RNPS1;CCAR2;YJU2;PPIG;PRPF4;PDCD7;SRSF10;SNRNP40;SRSF7;SRPK1;TCERG1;DDX39B;SNRPG;PRPF8;RSRC1;NCBP2;PPP2CA;SRSF2;SNRNP48;SNRPB;SYNCRIP
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.47658002861220033,1.0094562743694433,0.46192259675405745,1.0,1.0,8/19,23.29%,PML;PHLDA3;HIPK2;TP53;TMEM109;SIRT1;AEN;HIPK1
prerank,sensory perception (GO:0007600),-0.2659296019087104,-1.009391131573505,0.42105263157894735,0.7681617456585809,1.0,27/45,40.00%,WHRN;GNAS;MYO7A;SCN9A;TTC8;C5AR1;KCNA2;PCDH15;NIPSNAP1;CDH23;PENK;P2RX4;PTGES;CHRNA7;GNAL;NTSR2;CHRNA4;CCL2;OPRL1;OPRK1;CLRN1;USH2A;PNOC;ALOXE3;PDYN;KCNK4;CHRNB2
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4506474136835452,1.0092922159939806,0.4884742041712404,1.0,1.0,10/38,16.94%,PHLPP2;PHLDA3;BANK1;CIB1;PTEN;ARRB2;RACK1;DDIT3;DAG1;SIRT1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.4555622152295403,1.0092025809609748,0.45774647887323944,1.0,1.0,7/30,14.59%,BRCA1;TNFSF10;TRADD;PARK7;FAS;CFLAR;GSK3B
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.3160986778886381,-1.0090046638021681,0.42771084337349397,0.7676758354310576,1.0,10/22,27.19%,MVB12B;PLAA;VPS36;TOM1L1;UBAP1L;PTPN23;VPS37C;RNF126;UBAP1;VPS28
prerank,cGMP-mediated signaling (GO:0019934),0.5119461450040069,1.008908306830631,0.47619047619047616,1.0,1.0,3/13,11.12%,AQP1;PDE2A;KCNC2
prerank,actin filament organization (GO:0007015),0.41198708743019935,1.008741025437291,0.4879759519038076,1.0,1.0,16/151,10.76%,MYO5C;TMOD4;SPTA1;RFLNB;PPP1R9B;SAMD14;MYO15A;FLNA;GAS2L3;NEDD9;GSN;RND3;SHROOM2;FLII;WHAMM;SHROOM4
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4787504559351027,1.008450042263511,0.4728395061728395,1.0,1.0,7/20,19.01%,BRCA1;RPS6KA5;RUVBL2;PAXIP1;TADA2A;GLYR1;BRD7
prerank,skeletal muscle organ development (GO:0060538),0.464172231413931,1.00829520254416,0.4642857142857143,1.0,1.0,7/26,21.08%,CSRP3;CAV1;FXR1;CFLAR;DISP1;ZBTB18;SVIL
prerank,regulation of T cell activation (GO:0050863),0.4345774649122242,1.008117402065744,0.4781659388646288,1.0,1.0,5/42,8.62%,CD2;CD47;PTPN22;CCR2;CYRIB
prerank,response to cadmium ion (GO:0046686),0.455012457649345,1.0080746217837444,0.4722550177095632,1.0,1.0,5/26,11.47%,MAPK1;HAAO;EGFR;SUMO1;JUN
prerank,signal peptide processing (GO:0006465),-0.40312440589172915,-1.0079647140907593,0.4666666666666667,0.7687425636005795,1.0,4/11,8.26%,PCSK5;SPCS2;HM13;CLN5
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3668273767470485,-1.0078578951871187,0.4462809917355372,0.7675412493909062,1.0,7/15,31.76%,PTPN2;YTHDF2;USP18;CACTIN;MUL1;TTLL12;ISG15
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4591772433904101,1.0076983726263287,0.4748283752860412,1.0,1.0,1/29,0.38%,CD19
prerank,regulation of wound healing (GO:0061041),0.45209536568738296,1.0075966967284795,0.48148148148148145,1.0,1.0,5/42,11.74%,FOXA2;PRKCE;CAV1;INSL3;CRK
prerank,NIK/NF-kappaB signaling (GO:0038061),0.42605191499429895,1.0073410592579395,0.4794238683127572,1.0,1.0,20/72,19.36%,CARD10;PSMB7;PSMD11;FBXW11;PSMF1;PSMC1;BIRC2;PSMC3;PSMA4;PSMC4;PSMD13;PSME1;TLR6;PSMB1;PSMD8;PSME4;PSMD4;MAP3K7;MALT1;TRAF6
prerank,lung epithelium development (GO:0060428),0.5196193533984009,1.0073358942841126,0.47050359712230216,1.0,1.0,1/10,3.54%,RCN3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.5188508611446521,1.007250449341166,0.4904891304347826,1.0,1.0,7/13,17.77%,RNF168;RNF8;NELFA;HNRNPU;NELFB;TCERG1;HEXIM1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.38163027556546114,-1.0069855999992838,0.4423076923076923,0.768243888277606,1.0,6/13,28.98%,SEC16A;CD81;INSIG1;BRSK2;SAR1A;SORL1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.30962711153082123,-1.0066296390918836,0.40522875816993464,0.767686729372368,1.0,13/26,32.25%,APP;ZFYVE28;ZGPAT;NCF1;FBXW7;SNX6;NCK2;SOCS5;ERRFI1;HBEGF;CHMP6;BTC;ADRA2A
prerank,response to exogenous dsRNA (GO:0043330),0.4803275410067944,1.006588841416572,0.4769038701622971,1.0,1.0,5/18,17.78%,CGAS;CAV1;DHX9;FLOT1;COLEC12
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.43449120162904253,1.0065385948619747,0.4814004376367615,1.0,1.0,9/44,15.83%,LBR;SRD5A2;OSBPL3;CYP27A1;SLC27A2;PARK7;CYP46A1;PRKAG2;DHCR7
prerank,positive regulation of cell death (GO:0010942),0.43255565036432136,1.0062060938350323,0.47193347193347196,1.0,1.0,20/59,22.50%,FYN;EIF2S1;FAF1;MAP3K5;PRODH;PRR7;EGR1;HTATIP2;TYROBP;GSK3B;MARK4;FCGR2B;SNCA;RARG;LRRK2;BNIP3;RIPK1;MAPT;CELF1;CDKN1B
prerank,regulation of receptor internalization (GO:0002090),-0.279387705019555,-1.0061115692979843,0.4636363636363636,0.7675365335330799,1.0,7/35,8.49%,MKLN1;AHI1;ATXN2;CD63;ARRB1;TBC1D5;ANGPT1
prerank,response to ketone (GO:1901654),0.46273661636123475,1.0057612147948203,0.46772228989037756,1.0,1.0,6/24,21.74%,CATSPERB;CAV1;SLIT3;TGFB2;ABHD2;NR1H3
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.43371528283073585,1.0056240288782625,0.4916317991631799,1.0,1.0,16/55,17.74%,AURKA;PSMB7;PSMD11;PSMF1;PSMC1;PSMC3;PSMA4;ATF5;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4;AVEN
prerank,respiratory tube development (GO:0030323),-0.30034690730279795,-1.0055768979382242,0.40397350993377484,0.7674843445557638,1.0,16/28,38.56%,PCSK5;BAG6;NPHP3;VEGFA;FGF2;LOXL3;CCDC39;RBP4;PDPN;ITGA3;CCDC40;ABCA3;GLI2;WNT7B;FGF7;BMP4
prerank,regulation of amyloid-beta formation (GO:1902003),-0.27737707956090485,-1.0046076197823997,0.4247787610619469,0.7686194036316715,1.0,10/34,16.29%,RTN4;APOE;GGA3;RELA;IGF1;BIN1;GSK3A;CASP3;PRNP;EPHA4
prerank,positive chemotaxis (GO:0050918),-0.3534366825196417,-1.0044986180312814,0.42990654205607476,0.7674290927753362,1.0,5/17,18.89%,PTPRJ;ANGPT1;VEGFA;TSC2;PLXNB3
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.42419652257581086,-1.0043355170816435,0.43884892086330934,0.7663515572615258,1.0,6/10,14.67%,GABRG2;GABRG3;GABRA2;GABRA3;GABRG1;GABRA1
prerank,regulation of actin filament depolymerization (GO:0030834),0.5182033276684231,1.0041642091235068,0.47368421052631576,1.0,1.0,4/12,16.78%,MTPN;CFL2;LIMA1;PIK3CA
prerank,L-glutamate transmembrane transport (GO:0015813),0.5272430362968371,1.0036866367457125,0.4711964549483013,1.0,1.0,4/10,17.48%,SLC25A12;SLC25A22;SLC25A13;ARL6IP5
prerank,regulation of humoral immune response (GO:0002920),0.43890195736959553,1.0031903425399316,0.4747252747252747,1.0,1.0,1/44,0.38%,CD19
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.35390411764362256,-1.0031382875244366,0.4409090909090909,0.7679829164520054,1.0,9/17,40.12%,GPLD1;APOC1;SORL1;IL1B;ADRA2A;PDE3B;PRKAA1;MFSD2A;HCAR2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5190547124702827,1.0029581718649143,0.5006821282401092,1.0,1.0,6/12,22.99%,NUP214;PTPN14;SIRT7;AAAS;TPR;NEDD4
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5146174997581507,1.0022347842520767,0.4842681258549932,1.0,1.0,4/12,16.94%,BRCA1;PIBF1;WDTC1;SIRT1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.43479832075160046,1.0019515591749648,0.4747583243823845,1.0,1.0,4/47,5.28%,GFI1;BRCA1;FYN;CAV1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.47291626379658,1.0011520991795009,0.48481012658227846,1.0,1.0,4/18,13.69%,CAV1;NEDD4L;SLC43A2;STK39
prerank,BMP signaling pathway (GO:0030509),-0.2485185694619126,-1.0011293974646818,0.46,0.7718054171396408,1.0,11/62,15.57%,ACVR1;SMAD1;BMPR2;SMAD3;USP9X;SMAD6;BMPR1B;ENG;SMAD7;TGFBR3;ACVRL1
prerank,negative regulation of T cell activation (GO:0050868),0.4492998538006286,1.0011073691234234,0.49050279329608937,1.0,1.0,4/35,4.25%,SPN;GLMN;RIPOR2;PTPN22
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.41360474463332547,1.0010821106792864,0.5035105315947843,1.0,1.0,50/166,19.97%,ZCCHC4;DDAH2;RBM3;ABCB10;PCNA;EIF3E;NR1D1;ATAD5;SLC25A37;RPS4X;FAF1;SORBS1;EIF4A3;NIBAN1;DNA2;SMOC2;EGFR;EGR1;CPEB3;ATP7A;PARK7;DHX9;BRPF3;CTC1;CNEP1R1;UPF3B;FXR1;PRKDC;MYC;TLR6;ELOVL5;IRS1;PLD1;METTL14;EGF;APPL1;ASS1;PYM1;SAMD4A;EEF2;VIM;SIRT1;NAT10;LARP4B;POLDIP3;SNCA;ELAVL1;RPL5;PRKD2;PKD2
prerank,positive regulation of transport (GO:0051050),0.416928326589284,1.0005863157378676,0.49337410805300713,1.0,1.0,20/85,17.91%,SPAG5;TFR2;IL2RG;C2CD5;CD47;MLC1;BOK;DYNC1H1;NEDD4L;CBLL1;ABCA7;KMT2A;CHCHD10;FLOT1;NUMA1;GSK3B;CAPN10;CYBA;FCGR2B;SNCA
prerank,neurotransmitter uptake (GO:0001504),-0.38210597750421965,-1.000428974726788,0.45454545454545453,0.7721510012350429,1.0,6/12,32.28%,GLUL;SLC1A3;ATP1A2;SNAP25;SLC38A1;SLC1A6
prerank,receptor clustering (GO:0043113),0.4567737857843189,0.9998471675629973,0.4700352526439483,1.0,1.0,13/27,27.47%,ITGB7;LRP4;FLNA;PICK1;NRXN2;NRXN1;DLG3;ITGA4;ITGB1BP1;DNAJA3;PTN;NLGN1;SAV1
prerank,proteoglycan biosynthetic process (GO:0030166),-0.29173171342609644,-0.9994868105127765,0.4222222222222222,0.7730609356938327,1.0,11/31,13.34%,NDST3;BMPR2;CHST8;IGF1;B3GAT3;BMPR1B;EXT2;CHST11;EXTL3;XYLT2;B4GALT7
prerank,positive regulation of interferon-beta production (GO:0032728),-0.3000571769174972,-0.9993501088368746,0.4146341463414634,0.7719462456147981,1.0,8/33,7.87%,HSP90AA1;POLR3C;TLR7;RNF135;POLR3A;MAVS;TLR4;IRF1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5361947622649426,0.9992942177424511,0.5065123010130246,1.0,1.0,5/10,23.20%,ABCD1;DCN;RACK1;LRRK2;SRC
prerank,snRNA metabolic process (GO:0016073),0.48050011850317575,0.9990914481299666,0.4916129032258065,1.0,1.0,8/17,22.87%,INTS4;INTS9;INTS1;RBM7;TUT1;ZCCHC8;INTS12;INTS11
prerank,regulation of intracellular transport (GO:0032386),0.43645566375447853,0.9990150366522432,0.47586980920314254,1.0,1.0,14/38,22.78%,SPAG5;MLC1;NUP214;DYNC1H1;HAP1;RAB11B;NUMA1;DYNLT2B;AAAS;CAPN10;LRRK2;INPP5F;NEFH;ATPSCKMT
prerank,cellular response to estradiol stimulus (GO:0071392),0.4814365129026687,0.9990027650766466,0.48427672955974843,1.0,1.0,3/18,10.60%,CRHBP;EGFR;RUVBL2
prerank,central nervous system neuron development (GO:0021954),0.49066805790142815,0.9987995492976465,0.4838709677419355,1.0,1.0,4/15,11.98%,GBA2;ARHGAP35;ATP7A;PTEN
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.2843351575337401,-0.9987693393395787,0.45,0.771912064903368,1.0,4/34,3.48%,LACC1;GPI;CD86;STX4
prerank,regulation of transferase activity (GO:0051338),0.4864752057946198,0.9986905048686824,0.49355670103092786,1.0,1.0,4/17,15.88%,SMG6;ATM;NABP2;SLAMF8
prerank,triglyceride homeostasis (GO:0070328),-0.3007716980915974,-0.9985425953842779,0.48366013071895425,0.7710624087378879,1.0,11/26,37.24%,APOE;LPL;SCARB1;IL18;MTLN;FITM2;MLXIPL;ANGPTL3;DGAT2;C1QTNF3;LIPC
prerank,response to glucagon (GO:0033762),-0.3418012095037753,-0.9983324144959322,0.46226415094339623,0.7701738032093278,1.0,4/19,4.85%,PRKACB;PRKAR1A;ADCY7;ADCY2
prerank,regulation of lipid storage (GO:0010883),-0.3118985389067323,-0.9982840292127486,0.44559585492227977,0.7688513848542559,1.0,6/22,9.89%,PTPN2;LPL;ZC3H12A;IKBKE;VSTM2A;ITGB3
prerank,response to interferon-gamma (GO:0034341),0.42340227107287437,0.9982476657597844,0.5120167189132706,1.0,1.0,18/67,21.76%,MEFV;CD47;GBP4;CD74;SP100;PDE12;GBP2;IFITM3;IRF8;CCL25;EPRS1;SNCA;LGALS9;DAPK1;SYNCRIP;GAPDH;CIITA;RPL13A
prerank,positive regulation of organelle organization (GO:0010638),-0.28993466061320006,-0.9978055128922948,0.4715447154471545,0.7687308941990051,1.0,9/32,9.33%,TREM2;SYNJ1;SORBS3;TMED9;AKT2;SHCBP1L;RAB3GAP2;IRGM;HTRA2
prerank,lipid translocation (GO:0034204),0.46727596635984103,0.9977040190156505,0.4642857142857143,1.0,1.0,9/21,20.69%,ATP11C;ATP8B4;ABCA7;RFT1;ATP8A1;ATP11B;TMEM30A;ATP11A;ATP8B2
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.4684649737036839,0.9973592956881778,0.4830097087378641,1.0,1.0,5/21,17.87%,AXIN1;CAV1;CSNK1A1;GSK3B;PPP1CA
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3747904064867966,-0.9968213925209733,0.45188284518828453,0.7697414587421756,1.0,7/14,18.05%,CSF1R;CMKLR1;AKIRIN1;PTK2;CSF1;MDK;THBS1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4882341313637844,0.9967860182089343,0.484,1.0,1.0,1/15,1.11%,CHST3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.37675380995253727,-0.9967426479682716,0.462406015037594,0.7685302574314703,1.0,4/13,10.19%,IRAK2;UNC93B1;TLR7;TNIP2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5314402761516319,0.996583301156597,0.4971671388101983,1.0,1.0,2/10,8.38%,PDE2A;RNF157
prerank,pyroptosis (GO:0070269),-0.35761612294268974,-0.995961890564571,0.46332046332046334,0.768931135716519,1.0,2/15,2.91%,TREM2;CASP4
prerank,regulation of neurogenesis (GO:0050767),0.4330950284723657,0.9944444795395734,0.5106382978723404,1.0,1.0,7/55,11.13%,HMGB2;HEY2;LIG4;NOTCH1;SPEN;PCM1;B2M
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4566515761497206,0.994347411383489,0.5074626865671642,1.0,1.0,10/32,18.42%,POLR1B;TAF1;POLR1A;ERCC3;POLR1F;POLR1C;POLR2K;TAF1C;TAF1D;POLR1G
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4432327811447522,0.9942628994116285,0.49563318777292575,1.0,1.0,3/40,3.43%,NTF4;S1PR4;HTR2A
prerank,positive regulation of MAP kinase activity (GO:0043406),0.42474339446096243,0.9935323635646839,0.5125786163522013,1.0,1.0,17/66,19.36%,EZH2;ARHGEF5;RASGRP1;MAP3K5;EGFR;MAP3K11;FLT3;TLR6;PDCD10;EGF;TNFRSF11A;FGFR1;CD24;MAP3K7;LRRK2;RPS3;TRAF6
prerank,regulation of trans-synaptic signaling (GO:0099177),0.44680166363287205,0.9933928667060744,0.4797219003476246,1.0,1.0,13/33,27.42%,NTF4;CEL;RELN;BCR;BTBD9;CACNA1B;GRIK5;GRIK3;PXK;BDNF;ABR;NLGN2;NLGN1
prerank,O-glycan processing (GO:0016266),0.43303321891826635,0.9932657380881533,0.4994675186368477,1.0,1.0,6/54,9.89%,MUC19;GALNT10;GXYLT1;ST3GAL1;ST3GAL2;B3GNT2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4384201641489087,0.9930261559239872,0.5107991360691144,1.0,1.0,9/48,17.91%,CD19;NPSR1;PRKACA;PDPK1;JPH1;DIAPH1;F2R;PLCG1;SNCA
prerank,regulation of membrane depolarization (GO:0003254),0.472064028643171,0.9922421863813798,0.48280254777070064,1.0,1.0,3/18,7.95%,ABCD1;GPD1L;NEDD4L
prerank,cellular component assembly (GO:0022607),0.41012734732726236,0.9922020900790475,0.54,1.0,1.0,57/253,17.66%,KNTC1;CHAF1A;RAD21;TRIP13;CARD10;FANCA;CFAP206;FLNA;EZR;CD74;PML;HAS1;NEDD9;NAPG;TUBGCP4;IKBKG;MDM4;GSN;TEX11;RBBP4;KPNA3;ARL6IP1;SHROOM2;SNX9;LAMC1;ZW10;BSN;NDUFAF1;NIFK;LIMA1;PAWR;RHOU;CHAF1B;FAS;CDAN1;MAGI1;KMT2A;CHCHD10;RAC2;ADD2;CREBBP;P3H4;VCPIP1;LIMS1;PDCD10;TP53;PARVB;KIFAP3;FANCC;RTN3;TFAP4;DARS1;RAC1;PARVA;CALD1;PEX14;EPRS1
prerank,potassium ion homeostasis (GO:0055075),0.4619485675887291,0.9921422012060236,0.49818621523579204,1.0,1.0,5/23,13.00%,SLC12A3;SLC12A7;SLC12A1;SLC12A6;KCNJ2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5115552745442643,0.9920235862901516,0.5034387895460798,1.0,1.0,8/12,25.76%,DNMT1;SETDB2;ATF7IP;TASOR;TRIM28;SETDB1;RESF1;TET1
prerank,cellular respiration (GO:0045333),0.43449149470112064,0.9917845452645999,0.5059978189749182,1.0,1.0,15/41,24.49%,SDHAF4;NDUFS8;COQ10B;ME3;COX10;SLC25A13;ATP5F1D;NDUFA5;MDH2;NDUFS1;ETFRF1;UQCRH;ETFDH;ETFA;ETFB
prerank,L-serine metabolic process (GO:0006563),0.5240626211864767,0.9917346276735284,0.5,1.0,1.0,2/10,5.97%,SERINC5;SERINC3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.48065234085924236,0.991713260976151,0.48249027237354086,1.0,1.0,8/16,19.71%,CAV1;PARP14;ADIPOR1;PIBF1;HGS;VHL;PPP2CA;INPP5F
prerank,monocarboxylic acid transport (GO:0015718),0.4297169201011629,0.9915444866619474,0.5076086956521739,1.0,1.0,7/51,12.40%,SLC6A12;SLC16A12;SLC16A1;ABCC2;STARD5;ABCC4;SLCO2A1
prerank,negative regulation of cellular component movement (GO:0051271),0.4926536529997434,0.9913971998134331,0.4961038961038961,1.0,1.0,3/15,11.74%,SP100;PIN1;CRK
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4319002672570268,0.9913924069376564,0.5080213903743316,1.0,1.0,16/48,21.55%,FLNA;NEDD9;CRKL;CIB1;CUX1;CRK;NRP1;PRKDC;LIMS1;TRIOBP;RAC1;ARHGEF7;FBXW8;S100A10;ILK;CAPRIN2
prerank,protein K48-linked deubiquitination (GO:0071108),0.4627147342105767,0.9911509065646629,0.48936170212765956,1.0,1.0,10/23,22.23%,USP27X;BAP1;VCPIP1;OTUD5;USP50;YOD1;USP25;USP34;OTUD7A;MINDY2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4802217935538171,0.9908026289251792,0.492772667542707,1.0,1.0,6/17,17.37%,EMC6;EMC10;EMC3;GET3;EMC1;CAMLG
prerank,neuronal action potential (GO:0019228),-0.3145914680846626,-0.9905994325553727,0.44565217391304346,0.7806214839759726,1.0,6/22,11.05%,ANK3;SCN8A;SCN1A;SCN9A;SCN3A;KCNA2
prerank,negative regulation of immune system process (GO:0002683),-0.3489353681782947,-0.9905896107789154,0.4434389140271493,0.779211320098016,1.0,13/16,48.00%,CD200;HMOX1;PDCD1;HOXA7;LYN;SOX9;COL3A1;IL17D;ADTRP;FOXP3;FADD;FCRLB;SPINK5
prerank,negative regulation of cell activation (GO:0050866),-0.3736097040234557,-0.9899666475425376,0.452755905511811,0.7793912767128667,1.0,2/14,1.47%,TREM2;APOE
prerank,snRNA processing (GO:0016180),0.4817341175004881,0.9893787784953695,0.4883116883116883,1.0,1.0,7/16,22.87%,INTS4;INTS9;INTS1;INTS14;TUT1;INTS12;INTS11
prerank,positive regulation of vasoconstriction (GO:0045907),0.49298377009060657,0.9892285025986398,0.4731034482758621,1.0,1.0,3/13,17.11%,CAV1;F2R;TRPM4
prerank,cellular response to mechanical stimulus (GO:0071260),0.4328411516442501,0.9892233968952606,0.5005452562704471,1.0,1.0,10/46,13.26%,AQP1;CHEK1;CNN2;CASP2;PDE2A;MAP3K1;FAS;MYD88;TMEM150C;TLR5
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4062948906772067,0.9889096113092708,0.552,1.0,1.0,113/532,17.72%,BIRC5;PRTN3;IL12A;TNFRSF18;LMNB1;EDARADD;IL2RG;IL7R;IL2RA;GRAP2;TNFSF13B;PSMB7;FYN;IL18RAP;BATF;TWIST1;PSMD11;PML;CD44;FBXW11;IL16;RPS6KA5;PSMF1;SP100;CCR2;IL21R;CNN2;CRKL;LAMA5;IKBKG;FOXO1;TRADD;COL1A2;IRF9;TRAF3;PSMC1;GBP2;BIRC2;GPR75;TCP1;HNRNPA2B1;TAB1;SMARCA4;UBE2V1;PRKACA;GRB2;JAK2;IL20RA;SOS1;TAB3;XAF1;IL17RA;PIM1;EGR1;PSMC3;ZEB1;SOCS2;IL22;RHOU;IL1R1;MSN;TNFRSF13B;RPLP0;PSMA4;B2M;SMAD4;IL10RA;PLCB1;FLT3;CRK;MYD88;ADIPOR1;TRIM68;PSMC4;CANX;F3;STAT5B;PSMD13;PSME1;ACTN4;IFITM3;MYC;BCL6;PPIA;IL27;TRIM5;PSMB1;IRS1;LIMS1;TP53;JUNB;IRF8;APPL1;POU2F1;GPR35;PSMD8;TNFRSF11A;PAK2;PSME4;VIM;MTAP;TRAF3IP2;JAK3;MAOA;CCL25;PIK3CA;PSMD4;SIRT1;HSP90B1;FN1;UBA52;F13A1;MAP3K7
prerank,gene silencing by miRNA (GO:0035195),0.4490686449735715,0.9886861861323091,0.4994192799070848,1.0,1.0,14/32,22.08%,ZC3H7A;TNRC6C;TNRC6B;PUM2;PUM1;CNOT1;LIMD1;TARBP2;CNOT6;AGO2;CNOT8;EIF6;CNOT7;AGO1
prerank,positive regulation of reproductive process (GO:2000243),-0.2991171463767033,-0.9883167514723578,0.43884892086330934,0.7820002622868134,1.0,7/31,19.35%,LHFPL2;CFAP69;PRDM9;PGAM4;VEGFA;SMURF2;TACR3
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.40975631608182944,0.9882841271657953,0.5195979899497487,1.0,1.0,26/124,16.74%,BLK;STMN1;TSGA10IP;PPP1R9B;SAMD14;RB1;BLOC1S4;WDPCP;MNS1;FRY;MAP4;ODF2;HMGB1;FRYL;LIMA1;TOR1A;VAPA;RAB35;ADCYAP1;CDK16;DTNBP1;GSK3B;KIFAP3;MARK4;LRP12;RAC1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.5144730420262027,0.9880778338372594,0.5047879616963065,1.0,1.0,3/11,16.39%,HEY2;BMPR1A;TGFB2
prerank,protein oxidation (GO:0018158),0.5120135712928466,0.9878752763650976,0.49442896935933145,1.0,1.0,2/11,13.20%,CHCHD4;SUMF1
prerank,negative regulation of translation (GO:0017148),0.41721415704153436,0.9874121115394398,0.5195876288659794,1.0,1.0,36/87,25.27%,EIF3E;FTO;EIF4EBP3;EIF4A3;CPEB3;PUM1;TYMS;IGF2BP3;METTL16;FXR1;ROCK2;RACK1;LSM14A;CNOT1;METTL14;SAMD4A;EPRS1;EIF4ENIF1;RPS3;AGO2;DAPK1;CNOT8;TPR;SYNCRIP;CNOT7;ROCK1;GAPDH;CELF1;RPL13A;EIF4E2;YBX1;NCL;MEX3D;DAPK3;EIF2AK2;GIGYF2
prerank,positive regulation of protein catabolic process (GO:0045732),0.42037223930135564,0.9865143699551333,0.5241521068859198,1.0,1.0,15/84,12.14%,BARD1;NRDC;DTL;EZR;AXIN1;SNX33;FOXO1;FAF1;STX5;NEDD4L;SNX9;MSN;RDX;FZR1;OAZ1
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.31911665730127153,-0.9864534246251763,0.5078534031413613,0.7850241453256812,1.0,8/19,17.90%,PTPRJ;TSC1;FERMT2;PPM1F;VEGFA;MAP4K4;COL16A1;THY1
prerank,negative regulation of cellular protein localization (GO:1903828),0.4450503563914541,0.9861886232020711,0.5011415525114156,1.0,1.0,10/34,16.60%,CTNNA1;RIPOR2;SNX33;NEDD4L;ACTN2;ROCK2;LATS1;GSK3B;SIN3A;ANKRD13A
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.4156401350413438,0.9858680530720793,0.52,1.0,1.0,24/80,18.93%,ZCCHC4;RBM3;EIF3E;RPS4X;EIF4A3;NIBAN1;ABCA2;CPEB3;UPF3B;FXR1;ROCK2;RACK1;PRKDC;PLD1;METTL14;PYM1;SAMD4A;EEF2;VIM;NAT10;LARP4B;POLDIP3;ELAVL1;RPL5
prerank,positive regulation of cell migration (GO:0030335),0.41209683546474923,0.985746186601039,0.545,1.0,1.0,29/253,8.37%,KIF20B;GTSE1;ARHGEF39;TNFRSF18;LEF1;PECAM1;FBXO5;SYNE2;TIAM1;S100A11;SUN2;PPP3CA;CCN1;PRKCE;CCN4;NEDD9;CAV1;CCR2;CRKL;CLASP1;ATM;TRADD;HDAC6;NOTCH1;DDRGK1;CIB1;PRKCA;INSL3;PLCG2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.32403451292597185,-0.98544690072695,0.49246231155778897,0.7860755853573311,1.0,6/21,15.99%,KDM1A;CTNNB1;CX3CR1;FZD3;VEGFA;MDK
prerank,regulation of oxidoreductase activity (GO:0051341),0.5004692376156459,0.9853207335022592,0.5140056022408963,1.0,1.0,5/13,21.03%,HDAC6;ATP7A;SZT2;SLAMF8;SIRT4
prerank,DNA alkylation (GO:0006305),0.46999555584832137,0.985222171600208,0.47890818858560796,1.0,1.0,8/19,20.81%,PPM1D;HELLS;DNMT1;EHMT1;ATF7IP;ATRX;DNMT3B;GATAD2A
prerank,DNA methylation or demethylation (GO:0044728),0.46999555584832137,0.985222171600208,0.47890818858560796,1.0,1.0,8/19,20.81%,PPM1D;HELLS;DNMT1;EHMT1;ATF7IP;ATRX;DNMT3B;GATAD2A
prerank,positive regulation of dendrite development (GO:1900006),-0.407037608061694,-0.985168951674342,0.47619047619047616,0.7853465737191464,1.0,5/10,20.24%,PACSIN1;LRP8;DAB2IP;VLDLR;ZDHHC15
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.47305809987874003,0.9851529851446259,0.49875,1.0,1.0,2/20,5.93%,PLA2R1;GSN
prerank,regulation of immune effector process (GO:0002697),0.43448564779717436,0.9845183614775972,0.49667405764966743,1.0,1.0,1/41,0.38%,CD19
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.34226734512018564,-0.9840231815393251,0.4444444444444444,0.7866512627431664,1.0,4/18,3.74%,MANBA;NGLY1;DERA;STT3B
prerank,regulation of pH (GO:0006885),-0.3811003497552571,-0.983996558228716,0.4612794612794613,0.7853000418421867,1.0,2/11,5.58%,LACC1;SLC9A1
prerank,osteoclast differentiation (GO:0030316),-0.3118164745270645,-0.9837648768004421,0.4729064039408867,0.7844862627992284,1.0,4/22,2.71%,TREM2;CSF1R;FARP2;SBNO2
prerank,selective autophagy (GO:0061912),0.4217860936897211,0.9832277225495074,0.5132275132275133,1.0,1.0,17/56,17.60%,ATG13;PCNT;ACBD5;ATM;HDAC6;DDRGK1;DYNC1H1;UBE2V1;UBQLN1;PARK7;BECN1;AMBRA1;ARL13B;DYNLL1;VIM;ATG2B;UBA52
prerank,smooth muscle tissue development (GO:0048745),-0.40376686599196876,-0.9832227663906278,0.48881789137380194,0.7844332833638498,1.0,3/10,9.23%,SMO;NF1;ENG
prerank,blood vessel diameter maintenance (GO:0097746),0.44001140339113753,0.9829841445786666,0.49829351535836175,1.0,1.0,1/34,0.98%,KEL
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.22335586292434345,-0.982319652098164,0.5185185185185185,0.7851478759440187,1.0,21/77,18.05%,ACVR1;TGFBR1;BCL2L1;GHITM;RELA;HGF;PLAUR;MCL1;IGF1;CX3CR1;AR;PRKN;BCL2L2;PINK1;NDUFS3;NOC2L;QARS1;ACAA2;GPX1;PIH1D1;THBS1
prerank,regulation of developmental growth (GO:0048638),-0.2938821998162333,-0.9821605455908939,0.4589041095890411,0.7841160236196011,1.0,4/29,5.23%,DNM2;APP;APOE;IGF1
prerank,negative regulation of gene expression (GO:0010629),0.40765368474265157,0.9820933161949258,0.56,1.0,1.0,91/302,22.08%,SLFN14;EZH2;HEY2;RB1;AURKA;LSM6;PPM1D;HELLS;PPP1R11;PTPN22;SUZ12;RPS6KA5;EPC1;RBL1;FOXP1;CRKL;TAF1;TERF2;RBBP4;TNRC6C;LRP3;TNRC6B;PHF19;NOTCH1;EIF4A3;DDRGK1;H3-3A;DCP2;PHF1;ABCC2;LSM2;ZNF148;ASB1;PARP14;MECP2;CPEB3;DNMT1;PARK7;TYMS;KAT2B;IGF2BP3;LSM5;SETDB2;METTL16;BMPR1A;FXR1;ROCK2;RACK1;DXO;LSM14A;PSEN1;CNOT1;PDCD10;RUNX1;JARID2;MAP2K1;LGR4;SAMD4A;ZFP36L2;TASOR;TGFB2;VHL;SIRT1;CNPY2;APLN;FCGR2B;EPRS1;FLOT2;ADAM10;PTGER4;SETDB1;EIF4ENIF1;HDAC1;RPS3;LGALS9;DNMT3B;AGO2;DAPK1;CNOT8;PNPT1;SYNCRIP;PTBP2;CNOT7;CITED2;GAPDH;MAPT;CELF1;RPL13A;EIF4E2;AGO1;ATP2B4
prerank,negative regulation of viral release from host cell (GO:1902187),0.4938840061038052,0.9818278108461628,0.5068681318681318,1.0,1.0,5/13,16.96%,PML;TRIM11;TRIM5;TRIM28;CHMP3
prerank,regulation of filopodium assembly (GO:0051489),-0.2668030493418753,-0.9816295931026242,0.44,0.7839853625135959,1.0,12/38,16.00%,TENM2;ARAP1;RALA;PIK3R1;WASL;ARHGAP44;TENM1;GAP43;FXR2;MYO10;RHOQ;AGRN
prerank,embryonic organ morphogenesis (GO:0048562),-0.263927661387521,-0.9815114289203458,0.47368421052631576,0.7828672682420431,1.0,17/42,30.02%,ACVR1;DSCAML1;RYR2;FBN1;DYNC2I1;ID2;EFEMP1;SOX11;HOXC4;HOXD4;HOXA3;RBP4;HOXD3;HOXC9;HOXA9;HOXB9;PDGFRA
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.3291200583035652,-0.9814178592724849,0.45549738219895286,0.7816694204425759,1.0,5/20,18.36%,ADRA1A;LMBRD2;ADRA1B;ADRB1;ADRB2
prerank,histone monoubiquitination (GO:0010390),0.45704073581712445,0.981375056983867,0.5060096153846154,1.0,1.0,7/24,18.10%,UHRF1;RNF168;RNF2;RNF20;TRIM37;DDB2;KDM2B
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.4868572033025353,0.9808803099750114,0.5062814070351759,1.0,1.0,5/17,14.89%,S100A11;CCN4;FGF9;NRP1;ADAMTS1
prerank,regulation of mRNA processing (GO:0050684),0.43451673251786777,0.9807954382009023,0.5290763968072976,1.0,1.0,16/32,25.64%,PTCD2;ZFP36L1;SRSF3;IWS1;NCBP1;DHX9;METTL16;SRSF10;SRPK1;SAFB;CDK11B;SLTM;PAPOLA;HNRNPK;YTHDC1;KHDRBS3
prerank,regulation of astrocyte differentiation (GO:0048710),-0.3814760157907885,-0.980205430297411,0.463519313304721,0.7833130032055735,1.0,4/12,16.29%,SERPINE2;BIN1;ID2;EPHA4
prerank,peptidyl-methionine modification (GO:0018206),0.50311272688047,0.9801168937854821,0.5069252077562327,1.0,1.0,4/12,15.22%,METAP2;NAA16;NAA25;NAA20
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.42873190172678954,0.9800265794689637,0.5197802197802198,1.0,1.0,7/41,15.53%,FOXA2;CD47;CD44;MAGI1;FLOT1;DENND6A;PTPRU
prerank,regulation of transport (GO:0051049),-0.2893464703550707,-0.9797523547264432,0.4444444444444444,0.7830312551122238,1.0,15/36,22.34%,MBTPS1;REEP5;MYO6;VAMP2;FES;ACTB;PRKN;CDK5;PINK1;RAB11A;ICA1L;YRDC;POFUT2;LEPR;WWC1
prerank,stress-activated MAPK cascade (GO:0051403),0.4167395278402787,0.9795829703257267,0.5247108307045215,1.0,1.0,21/61,21.10%,MAPK1;FBXW11;CRKL;IKBKG;CCM2;ZFP36L1;MAP3K5;MAP4K2;TAB1;UBE2V1;MAPK14;TAB3;MAP3K11;MAP3K20;UBA52;MAP3K7;PTGER4;TRAF6;LGALS9;UBE2N;IKBKB
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.3567373364588851,-0.9795694015326302,0.4605809128630705,0.7820733061750387,1.0,8/15,38.62%,SMO;VEGFA;SOX8;AGT;SOX9;PAX8;BMP4;LHX1
prerank,proteasome assembly (GO:0043248),0.5166297506972517,0.9792967452582032,0.5223665223665224,1.0,1.0,6/11,23.31%,PSMD11;POMP;PSMD13;PSMD4;PSMG1;PSMG2
prerank,dendritic spine morphogenesis (GO:0060997),-0.34535308745633087,-0.9791584037736724,0.4808510638297872,0.78170087193129,1.0,5/15,18.86%,PAK3;WASL;SHANK3;DLG4;CDC42
prerank,COPII-coated vesicle budding (GO:0090114),0.41026024527358523,0.9788345687917029,0.5287356321839081,1.0,1.0,26/68,21.61%,F5;SEC23B;RAB1B;STX5;ANKRD28;PEF1;TGFA;TRAPPC9;SEC24B;SEC24A;CUL3;SEC13;TRAPPC4;BET1;VAPA;SEC31A;PPP6R3;PPP6C;CNIH1;LMAN1;GORASP1;SAR1B;TRAPPC3;SCAP;TMED10;TRAPPC10
prerank,regulation of protein localization to cell periphery (GO:1904375),0.468526818875708,0.9786411275618958,0.5038659793814433,1.0,1.0,7/18,21.46%,PLK1;ABCA2;ZDHHC7;APPL1;LDLRAP1;CLN3;VPS4A
prerank,cellular response to fatty acid (GO:0071398),-0.3801475073723443,-0.9784324744127779,0.4664179104477612,0.7821732609703693,1.0,2/12,6.30%,LPL;ZC3H12A
prerank,cartilage development (GO:0051216),0.4198976016710306,0.9783115792966488,0.5363735070575462,1.0,1.0,7/49,10.65%,SOX6;CD44;SULF2;RUNX3;DDRGK1;ZBTB16;ATP7A
prerank,negative regulation of cellular process (GO:0048523),0.4046872753494963,0.9782905877268068,0.591,1.0,1.0,94/521,16.94%,E2F7;CDKN3;PRTN3;FOXM1;MYBL1;MEN1;CYP1B1;CDKN2C;JADE1;ANP32B;HMGA1;ITGA1;BLM;PPP1R9B;SPN;RB1;FBXO5;TCHP;ERBB3;GLMN;S100A11;PPM1D;CCN1;PML;CCN4;RIPOR2;SUZ12;ARID2;SNX3;CTCF;ARHGDIB;STK11;CDK6;SP100;CDKN2A;PTHLH;MDM4;RBBP4;GMNN;PDE12;RUNX3;KLF10;NOTCH1;PIM2;FUZ;CIB1;SMARCA4;HPGD;RAD18;PLXNA2;JAK2;STRN;JAM2;CDKN2D;CBLL1;PIP4P2;PARK7;UBR2;SMAD4;PTPN14;TAF6;CCAR2;ATF5;BECN1;KAT2B;SLIT3;PTEN;BAP1;PDS5B;RACK1;SIRT7;ING5;SERTAD2;SLURP1;TMEM115;SKI;MYC;BCL6;ADAMTS1;TP53;TGFBI;F2R;PTPRU;HGS;MAP2K1;TFAP4;NDRG3;ARHGDIA;TGFB2;TMEM109;VHL;NLRP2B;PDE8A;SIRT1
prerank,phospholipid transport (GO:0015914),-0.25392009228409934,-0.9782207701562592,0.4411764705882353,0.7812994354119067,1.0,15/52,13.32%,APOE;ATP8A2;OSBPL2;ABCA1;ATP9A;ATP8B1;PLTP;PRELID2;ABCC1;SCP2;MTTP;SCARB1;PITPNB;SCARB2;NPC2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.3713315826412569,-0.977983610865762,0.48134328358208955,0.7805060789685354,1.0,5/13,17.38%,CTNNB1;SEMA3E;ENG;VEGFA;TGFBR2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.2916697503248408,-0.977878517486486,0.45652173913043476,0.7793745778779919,1.0,9/24,16.87%,APOE;PSMD14;CTSC;UBE3A;NUB1;PKD1;PINK1;EPHA4;GPX1
prerank,regulation of establishment of protein localization (GO:0070201),-0.35432834931704565,-0.9778622697433265,0.45787545787545786,0.7780476413188588,1.0,4/14,8.21%,CTSD;TREM2;CORO2B;PTP4A3
prerank,metal ion export (GO:0070839),-0.2958736291964593,-0.9776858090483314,0.5,0.7771102358902039,1.0,8/31,25.59%,SLC9A1;ATP1A1;ATP1B2;ATP1B1;KCND3;ATP1A2;ATP1A3;ATP1B3
prerank,histone H2A ubiquitination (GO:0033522),0.48264302407405824,0.977362725811986,0.5268542199488491,1.0,1.0,7/17,18.10%,UBR2;RNF168;RNF8;RNF2;TRIM37;DDB2;KDM2B
prerank,positive regulation of ATPase activity (GO:0032781),0.42798667206674673,0.9769725942520937,0.5268346111719606,1.0,1.0,8/41,17.04%,UHRF1;MSH6;DNAJB11;AHSA1;DHX9;HNRNPU;DYNLL1;DNAJB1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.45099288166713936,0.9769305526106465,0.5040556199304751,1.0,1.0,4/27,9.73%,SLFN14;RNASE6;PDE12;CSTF3
prerank,cellular response to hypoxia (GO:0071456),0.40576862414387355,0.9768610435867001,0.5331325301204819,1.0,1.0,31/126,17.82%,SUV39H1;PMAIP1;AQP1;PSMB7;TWIST1;PSMD11;TBL2;PSMF1;MDM4;ZFP36L1;PSMC1;UBQLN1;HIPK2;PSMC3;PSMA4;PSMC4;PSMD13;PSME1;CREBBP;MYC;PSMB1;TP53;LIMD1;PSMD8;PSME4;VHL;PSMD4;SIRT1;PGK1;UBA52;NDRG1
prerank,negative regulation of nervous system development (GO:0051961),0.47951929996221965,0.9762390330271294,0.5115384615384615,1.0,1.0,4/17,11.67%,NOTCH1;PCM1;B2M;SLIT1
prerank,positive regulation of growth (GO:0045927),0.41444405004301965,0.9761740841799127,0.5245046923879041,1.0,1.0,19/64,23.11%,S100A9;BRAT1;DDX49;S100A8;H3-3A;CIB1;MTPN;NCBP1;EGFR;DERL2;PLCB1;PABIR1;TGFB2;KLHL22;ADAM10;USP47;RPS6KA3;ZPR1;ADAM17
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.42530447903068136,0.9759055223089257,0.5328947368421053,1.0,1.0,15/45,23.20%,RPS6KA5;TGFA;GRB2;SOS1;EGFR;PDPK1;DGKD;EGF;PLCG1;PIK3CA;IQGAP1;KIF16B;PTPN11;ADAM17;SRC
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4847970597138879,0.9756870150892465,0.5079155672823219,1.0,1.0,3/14,8.37%,CD74;GPRC5B;PLCG2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.42044487374188255,0.9754434815500992,0.5143769968051118,1.0,1.0,16/50,21.33%,AQP1;CD44;DPEP1;BCL2L12;ARL6IP1;CDKN2D;PARK7;XIAP;CAAP1;PAK2;SH3RF1;YWHAE;SNCA;PAX2;USP47;RPS6KA3
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.46150327937481617,0.9754248288859256,0.5283018867924528,1.0,1.0,8/21,20.52%,TWIST1;MED30;SETX;JUN;PAXIP1;MED14;MED1;MED13
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.45772801836051785,0.9748312167810593,0.5017626321974148,1.0,1.0,3/22,4.25%,UBASH3A;EZR;PTPN22
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4694486646608438,0.9744905386744721,0.5138339920948617,1.0,1.0,7/17,23.11%,CCNYL1;MAPRE3;EGFR;PROX1;PKD2;CCND3;ADAM17
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.24823770297527684,-0.9744815418394255,0.4090909090909091,0.7834386698911169,1.0,15/69,10.43%,IGF1R;CSF1R;PIK3R5;PLCB2;MYO16;PIK3CD;PIK3R1;IGF1;KCNH1;PI4KA;PIK3C2B;NF1;PLCL2;PLCB4;IRS2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4664903679415775,0.9744654087780605,0.5074626865671642,1.0,1.0,1/19,1.71%,SLC25A21
prerank,sphingolipid catabolic process (GO:0030149),-0.3450438293269067,-0.9740285503934987,0.44081632653061226,0.7831113817966028,1.0,7/15,30.63%,ENPP2;PPT1;SMPDL3A;GLA;ACER2;SMPD2;SGPL1
prerank,positive regulation of gene expression (GO:0010628),0.4035013263270969,0.973800696654352,0.613,1.0,1.0,123/442,22.33%,PLA2R1;BRCA1;TFR2;POLR1B;HEY2;MAPK1;LEF1;E2F1;SMARCA5;ZCCHC4;GLMN;BATF;EZR;TWIST1;RBM3;DEK;CD74;POLR2A;PTPN22;CTCF;TFRC;AGPAT1;RPS7;EIF3E;RPS4X;GSN;ATM;TERF2;MYOM1;SETX;EPHX2;PDE2A;TNRC6C;LRP3;TNRC6B;NOTCH1;NFAM1;EIF4A3;DDRGK1;NIBAN1;BAZ1B;ELAVL4;PHF2;MAPK14;PLCG2;EGFR;POLR1A;EGR1;CPEB3;DNMT1;MSN;DYRK1A;CARD9;PARK7;FGF9;KAT2B;RDX;MYD88;POLR1F;HCFC1;UPF3B;F3;FXR1;NFE2L2;ROCK2;ZBTB7B;FLOT1;PRKDC;MYC;GABPA;PSEN1;POLR1C;TLR6;DTNBP1;TYROBP;GSK3B;TADA3;LIMS1;PDCD10;PLD1;TP53;METTL14;EGF;HGS;MAP2K1;PYM1;SAMD4A;EEF2;VIM;POLR2K;NAT10;LARP4B;POLDIP3;FN1;TAF1C;MED1;TAF1D;POLR1G;PTGER4;ELAVL1;RPL5;HNRNPLL;RPS3;LGALS9;DNMT3B;AGO2;RPL23;RAB27A;RBPJ;EIF6;CITED2;PRKAG1;RIPK1;ROCK1;GAPDH;CELF1;CALCOCO1;FGR;AGO1;ACTG1;TENT4A;MED23;NTRK3
prerank,myeloid cell development (GO:0061515),0.48396928835059605,0.9737991810055661,0.5277777777777778,1.0,1.0,3/18,5.05%,ALAS2;ABCB10;FOXP1
prerank,positive regulation of protein acetylation (GO:1901985),-0.3679533931359127,-0.9737927501356585,0.4842105263157895,0.7822650921774086,1.0,3/12,4.49%,DIP2B;CAMK1;PRKAA2
prerank,positive regulation of cytokine production (GO:0001819),0.4030810694627441,0.9736716334195245,0.591,1.0,1.0,54/292,15.40%,IL12A;CD2;POU2AF1;CYP1B1;PLA2R1;BRCA1;GLMN;BATF;DHX58;TWIST1;ZFPM1;CD74;SULF2;IL16;PTPN22;FOXP1;CGAS;AGPAT1;CCR2;RASGRP1;PAEP;NFAM1;XRCC6;HMGB1;MAPK14;PLCG2;CYRIB;IL17RA;EGR1;IL1R1;CARD9;PARK7;DHX9;PLCB1;MYD88;F3;ROCK2;ZBTB7B;FLOT1;TLR5;PRKDC;DDIT3;CREBBP;PIBF1;CEBPG;IL27;POLR1C;TLR6;TYROBP;CCBE1;LRRFIP1;RUNX1;F2R;APPL1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.5095122626679477,0.9732709939863329,0.5177304964539007,1.0,1.0,4/10,16.35%,RUVBL2;RUVBL1;ZNHIT6;TAF9
prerank,glucose transmembrane transport (GO:1904659),0.4743833831596225,0.9725920178850426,0.5254452926208651,1.0,1.0,6/18,24.04%,SLC2A4;SLC2A8;SLC2A3;SLC2A1;PPARD;SLC5A3
prerank,regulation of viral transcription (GO:0046782),0.4274693102833039,0.972536043659093,0.5032679738562091,1.0,1.0,13/39,17.77%,RSF1;POLR2I;POLR2A;TRIM11;NELFA;DHX9;CCNT1;IFITM3;NELFB;TARBP2;POLR2K;POLR2J;HEXIM1
prerank,regulation of cholesterol transport (GO:0032374),0.4580067844797048,0.9724401466942947,0.5245098039215687,1.0,1.0,4/20,9.29%,ABCA13;NUS1;TSPO;ABCA2
prerank,detection of mechanical stimulus (GO:0050982),-0.3270704120735777,-0.97226435465275,0.44324324324324327,0.7846557929213547,1.0,9/19,24.12%,CTNNB1;CDH2;JUP;PKD1;PTK2;PIEZO2;PKD2L1;PKD1L2;PKD2L2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.377724894647229,-0.9722015999617406,0.4812286689419795,0.7834650827905688,1.0,4/12,11.49%,TMEFF2;HDAC2;AR;SELENOS
prerank,epidermis development (GO:0008544),0.4175613109427021,0.9719430781854489,0.5293501048218029,1.0,1.0,4/56,12.90%,NTF4;PTHLH;LAMB3;EMP1
prerank,negative regulation of endocytosis (GO:0045806),0.4523068310727024,0.9715013055616768,0.5294117647058824,1.0,1.0,9/24,23.02%,SNX33;CAV1;MTMR2;EPHA3;ABCA7;RAC1;MCTP1;NR1H3;LRSAM1
prerank,basement membrane organization (GO:0071711),0.4912695743908942,0.9714274348828943,0.5274151436031331,1.0,1.0,5/14,10.78%,FLRT2;LAMB2;LAMB3;NTNG2;NID1
prerank,response to histamine (GO:0034776),-0.3985926937949307,-0.9714195049451342,0.49310344827586206,0.7839936571579996,1.0,2/10,2.99%,GABRB3;GABRG2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.32098310497683835,-0.9708524904730101,0.5,0.7840982543902952,1.0,7/22,22.43%,ANK2;SLC9A1;RYR2;ATP1B1;CALM1;STAC2;GSTO1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.445233176201681,0.9706399415376655,0.5229357798165137,1.0,1.0,8/30,16.97%,MAGT1;ALG8;STT3A;MGAT2;FUT8;OST4;TUSC3;LMAN1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4408431672112806,0.9699179905582195,0.5197294250281849,1.0,1.0,8/30,14.14%,ATG13;SAE1;UBL5;ABLIM3;RHOU;BAP1;RAC2;ARIH2
prerank,peptidyl-asparagine modification (GO:0018196),0.44317683416587506,0.9698686371898444,0.5234285714285715,1.0,1.0,8/31,16.97%,MAGT1;ALG8;STT3A;MGAT2;FUT8;OST4;TUSC3;LMAN1
prerank,peptidyl-tyrosine modification (GO:0018212),0.4162395200593707,0.9697869503932112,0.5421052631578948,1.0,1.0,10/56,11.65%,BLK;FYN;TPST1;JAK2;EGFR;EPHA3;DYRK1A;BTK;RELN;FLT3
prerank,cellular response to unfolded protein (GO:0034620),-0.29210640870367843,-0.969698254207683,0.5231788079470199,0.7856316192854158,1.0,8/26,19.82%,HSPD1;OPTN;ERN1;TM7SF3;PRKN;HSPA5;DAB2IP;HSPA13
prerank,regulation of cilium assembly (GO:1902017),0.4192654634072589,0.9691970498605639,0.543455497382199,1.0,1.0,20/62,21.66%,CDKL1;TBC1D1;CCDC88A;TCHP;TBC1D22B;EVI5;ARHGAP35;FUZ;TAPT1;BBS4;DYNLT2B;SDCCAG8;MARK4;LIMK2;IFT140;RABEP2;SGSM3;CROCC;TBC1D15;EVI5L
prerank,endosome organization (GO:0007032),0.42552750758840596,0.9690109496102314,0.5393743257820928,1.0,1.0,13/41,20.46%,RNF26;SNX33;SNX3;TMCC1;WASHC4;RAB22A;DNAJC13;PI4K2B;VPS33B;USP50;CHMP2B;AKTIP;RAB27A
prerank,Wnt signaling pathway (GO:0016055),0.4045482897126813,0.9687923313125687,0.5635808748728383,1.0,1.0,21/92,20.25%,NR4A2;LEF1;AXIN1;SNX3;NXN;CCDC88C;TCF7L1;CSNK1A1;CSNK1G2;PLCG2;STRN;PTEN;BCL9L;GSK3B;TCF7L2;CD24;UBA52;RARG;LRRK2;USP34;DIXDC1
prerank,negative regulation of protein modification process (GO:0031400),0.4077862153423051,0.96877270941295,0.5512295081967213,1.0,1.0,28/79,23.03%,MEN1;XRCC1;PTPA;CRTAP;PPP1R8;CRKL;NIBAN1;CIB1;IBTK;PPP1R15A;PARK7;PTEN;CDK5RAP3;PRKDC;PPIA;GSK3B;FKBP8;SIRT1;PTPN13;LRRK2;PRR5L;MAPT;CADM4;PPP1R15B;ATP2B4;PPP1R16B;NTRK3;TARDBP
prerank,post-translational protein modification (GO:0043687),0.40367472407288846,0.9682403452311736,0.602,1.0,1.0,73/332,18.89%,CCNF;ESCO2;F5;MEN1;FBXL15;FN3KRP;DSCC1;SKP2;DTL;PSMB7;CCN1;PSMD11;FBXW11;PSMF1;LRRC41;RAB1B;FBXO44;PSMC1;ASB7;STT3A;SPSB3;RAB8A;ZBTB16;FBXO17;LAMC1;LAMB2;KLHL9;ASB1;CUL3;PSMC3;SOCS2;DCAF17;PSMA4;SPSB4;DCAF7;FBXL4;PSMC4;RAB11B;CUL9;FBXO11;PSMD13;SUMF1;PSME1;RAB2A;DCAF11;PSMB1;RBBP5;PRKCSH;CHML;PRSS23;PSMD8;WDTC1;DCAF8;ASB8;PSME4;RAB5A;DCAF5;VHL;KLHL22;PSMD4;SCG3;DCAF4;HSP90B1;FN1;UBE2M;DDB2;FEM1C;SDC2;SUMF2;ADAM10;FBXW8;CKAP4;ICMT
prerank,protein methylation (GO:0006479),0.42301893036952254,0.967513736684444,0.5456521739130434,1.0,1.0,14/40,22.94%,EZH2;LCMT1;EHMT1;NSD3;GSPT1;PRMT3;RAB6A;ICMT;SNRPB;PRMT7;TRMT112;EEF1AKMT2;ATPSCKMT;NSD1
prerank,protein homooligomerization (GO:0051260),0.3964295195647997,0.9670632432260583,0.5579053373615307,1.0,1.0,14/114,11.13%,ECT2;POLQ;TK1;BLM;SLC1A5;ATL2;CBR4;ACOT13;MPP2;TIFA;CARD9;SIGMAR1;KCNC2;B2M
prerank,regulation of protein import into nucleus (GO:0042306),0.42621249523706756,0.9670374603032948,0.5218855218855218,1.0,1.0,10/36,20.21%,ECT2;FLNA;EFCAB7;PSEN1;BAG3;IPO5;TRIM28;HCLS1;SUFU;TPR
prerank,stress granule assembly (GO:0034063),0.4606173600048554,0.9666699888532431,0.5049627791563276,1.0,1.0,11/20,25.60%,EIF2S1;CSDE1;DYNC1H1;LSM14A;PRRC2C;UBAP2L;G3BP1;MAPT;ATXN2L;CIRBP;RPS23
prerank,positive regulation of immune response (GO:0050778),0.412596237991224,0.9666419066214685,0.5424430641821946,1.0,1.0,13/64,20.37%,MYB;CD177;CD74;RIOK3;DHX9;TGFB2;SIRT1;CYBA;XBP1;FCGR2B;LGALS9;IFI35;POLR3B
prerank,organelle organization (GO:0006996),0.40067170370154703,0.9663599506396551,0.606,1.0,1.0,65/388,14.32%,DIAPH3;KIF4A;CDCA8;CEP55;CENPW;CECR2;DES;TSGA10IP;PTCD2;ATP8B4;LIG4;WDPCP;MNS1;STX17;NEDD9;ATL2;TMCC1;ABCD1;CAV1;CNN2;ODF2;CLASP1;AGTPBP1;ANK1;NPLOC4;CSNK1A1;TFB1M;FAF2;GABPB1;TFB2M;PEX11B;ZW10;BLZF1;MAST2;NRF1;FGD6;CAV2;LONP1;IRAG2;RHOU;ATP7A;PARK7;DYM;SYNE3;TOR1A;HPS3;PDZD8;PEX2;VAPA;FGD3;SEC31A;PACSIN2;PLD2;RAB43;HCFC1;PI4K2B;CHCHD10;CHMP1B;NUMA1;PALLD;MYC;RAB2A;GABPA;PPIA;DIAPH1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5087430517267695,0.9656776095304216,0.5273775216138329,1.0,1.0,4/10,21.34%,MAPK1;FAS;MAP2K1;NBR1
prerank,regulation of T cell mediated immunity (GO:0002709),0.5081301495975658,0.9655673331363869,0.5260930888575458,1.0,1.0,4/10,22.91%,CCR2;HMGB1;TRPM4;ZBTB1
prerank,membrane assembly (GO:0071709),-0.2726200019289057,-0.9655236066216847,0.5,0.794183223894572,1.0,8/34,7.66%,ANK3;GAK;PTPRD;UBXN2A;STX4;SPAST;UBXN2B;STX2
prerank,blood vessel morphogenesis (GO:0048514),0.4136752037853183,0.9651008548289083,0.5512820512820513,1.0,1.0,13/54,21.85%,CYP1B1;HEY2;GLMN;CAV1;CCM2;AGGF1;NRP1;CCBE1;COL4A1;PROX1;RBPJ;SYK;EGFL7
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4987512804191941,0.9649476650581292,0.5310810810810811,1.0,1.0,1/13,1.29%,CD177
prerank,cell-cell junction organization (GO:0045216),0.4127081033656005,0.9645776944631634,0.5491209927611168,1.0,1.0,14/79,16.39%,PRTN3;CD177;SDK1;CTNNA1;TJP3;CDH18;CDH24;NECTIN1;GJA4;LIMS1;F2R;CTNND2;CDH4;TGFB2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.3812674796048405,-0.9645540887014945,0.5102739726027398,0.795242618779102,1.0,3/11,12.51%,RC3H2;ZC3H12A;SMAD7
prerank,regulation of calcium ion transport (GO:0051924),-0.24852443124629606,-0.9641030628888674,0.5272727272727272,0.7950771239485951,1.0,16/54,20.15%,CD84;CACNB2;CTNNB1;ANK2;PLPP4;SRI;SLC8B1;CAMK2G;CCL4;CAMK2B;SARAF;WFS1;CCL3;ORAI1;P2RX4;STIM1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.33062630777359364,-0.9637108727250101,0.4708994708994709,0.7946990451975078,1.0,5/19,6.30%,NLRP3;IGF1;TNFAIP3;CX3CR1;ZC3H12A
prerank,cytoplasmic microtubule organization (GO:0031122),0.4140371497154871,0.9634757512415857,0.5505376344086022,1.0,1.0,13/54,13.42%,TUBGCP6;CCDC88A;SLK;EZR;TUBGCP4;CLASP1;CCDC88C;DYNC1H1;CIB1;PCM1;SLAIN2;TUBGCP3;NUMA1
prerank,regulation of hydrolase activity (GO:0051336),0.40717932257255374,0.9633701618539123,0.5414078674948241,1.0,1.0,15/71,13.58%,ARHGEF5;ARHGAP15;FBXW11;CAV1;PLXNA2;FGD6;EPHA3;PAFAH1B1;CFAP73;RDX;CRK;FGD3;CDK5RAP3;ARHGAP9;ADAP1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3989260190370073,0.9630888790109127,0.6076076076076076,1.0,1.0,36/199,16.29%,FOXA2;HEY2;BRCA2;RB1;NRDC;LRP4;VASN;MAP2K6;PPP1R11;CRHBP;RPS6KA5;RPS19;ARHGDIB;STK11;ACOT11;NR1D1;PAEP;NOTCH1;LAMA4;SFMBT1;NOVA2;ACOT13;EGFR;ASB1;RPS6KA6;ADIPOR1;PTEN;TIFAB;ROCK2;SPRED2;DDIT3;GSK3B;F2R;SLAMF8;LGR4;CHSY1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.45779743805930323,0.9630169857585306,0.5321782178217822,1.0,1.0,5/20,18.63%,TSPO;CYP46A1;STARD3NL;TSPOAP1;FDXR
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4858482221790805,0.9625979086849263,0.5311258278145695,1.0,1.0,3/14,13.15%,CAV1;ZEB1;SPRED2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4704537701296763,0.9625514526936099,0.5264516129032258,1.0,1.0,6/15,16.74%,MEFV;MYD88;TLR6;USP50;NLRC3;NLRP2B
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.23761332701464674,-0.9623135723276045,0.5925925925925926,0.7966992562721256,1.0,18/72,14.29%,IGF1R;TREM2;PTPN6;PIK3R5;PIK3CD;FLT1;PIK3R1;HGF;IGF1;PDGFD;PDGFC;GAB1;IRS2;PIK3CB;NCF1;PTK2;IL18;FGF2
prerank,cytoplasmic translational initiation (GO:0002183),-0.32980161993292145,-0.9622668213755388,0.4838709677419355,0.7954233733212163,1.0,5/17,9.54%,EIF4A2;EIF2B3;MCTS1;EIF3M;RBM4
prerank,negative regulation of neuron death (GO:1901215),0.4062836731182684,0.9621570469016405,0.5588235294117647,1.0,1.0,6/93,6.33%,KIF14;NTF4;ERBB3;LIG4;IKBKG;INPP5A
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2299664983467658,-0.9615928919341022,0.5483870967741935,0.7956879919537897,1.0,12/76,11.59%,CMKLR1;C3AR1;GNA15;HTR2C;P2RY12;CX3CR1;GRM5;GNA14;GPR157;C5AR1;TGM2;ADRA1A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4352329589851264,0.9615357802441377,0.5272108843537415,1.0,1.0,4/32,7.77%,CARD10;NOTCH1;AKT3;CIB1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4008331838772653,0.9614347951702749,0.5422680412371134,1.0,1.0,17/76,17.64%,GFI1;CYP1B1;DAP;CDKN2A;FAF1;TRAF3;LRRC14;ARRB2;CDK5RAP3;DDIT3;RBCK1;NLRC3;COMMD6;NLRP2B;SIRT1;TRIM37;USP7
prerank,organelle transport along microtubule (GO:0072384),0.43130186954099964,0.9612990645279925,0.5222857142857142,1.0,1.0,10/31,21.27%,UXT;NDE1;FBXW11;PAFAH1B1;HAP1;PEX14;RAB6A;CLN3;TRAK2;MAPT
prerank,negative regulation of interleukin-12 production (GO:0032695),0.4675314595495455,0.961270653505405,0.5173333333333333,1.0,1.0,3/14,16.70%,MEFV;PIBF1;JAK3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.48176106598639873,0.9612363509792552,0.5223274695534507,1.0,1.0,6/14,20.17%,CPSF2;NCBP1;TUT1;CPSF1;NCBP2;CPSF7
prerank,regulation of feeding behavior (GO:0060259),0.49775076659919987,0.9608303899355157,0.5226960110041265,1.0,1.0,1/11,3.13%,AGRP
prerank,ribosome biogenesis (GO:0042254),0.39480956251111177,0.9604904379055094,0.592,1.0,1.0,61/187,23.39%,MRPL36;XPO1;RPL7;RPL18A;EIF2A;UTP3;RPL36;RPL14;RPS19;DDX49;RPS7;HELQ;EXOSC8;RPL23A;MRPL22;RPL28;EXOSC10;URB2;RPS14;RPL41;NOL11;RPLP2;RPS27;EMG1;UTP6;RPLP0;FBL;RPL27A;PELP1;DHX29;WDR74;RPS9;NOL8;RPL12;NOP58;POP4;RPL3;UBA52;RPL18;DKC1;PES1;RIOK1;MPHOSPH6;RPL5;RPS6;RPS17;DDX54;RPL21;RPL23;RPL17;EIF6;RPL24;RPL8;RPL27;RPL13A;DIS3;RPL15;RPL10;RPF1;NOP14;ABCE1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4546220433006763,0.9604089301824301,0.5331724969843185,1.0,1.0,4/21,11.99%,CEL;ACBD5;NUDT19;FAH
prerank,insulin secretion (GO:0030073),-0.3196422460681242,-0.9600352266235764,0.46464646464646464,0.7980764123844002,1.0,6/19,16.64%,RIMS2;SELENOT;CYB5R4;CAMK2G;PTPRN;RAB11FIP5
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.35058016901720024,-0.9595583839934261,0.4977168949771689,0.7978691173929885,1.0,8/16,16.50%,GBF1;SEC16A;ANK2;UBAC2;MIA3;RYR2;BCAP31;HSPA5
prerank,electron transport chain (GO:0022900),-0.3436176720850155,-0.9592365607842016,0.5064377682403434,0.7973692221639381,1.0,7/15,26.63%,POR;SDHB;UQCRFS1;SDHA;PDIA5;PPARGC1A;NDOR1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.43292047883357954,0.9589932298769368,0.5329608938547487,1.0,1.0,10/33,15.17%,AXIN1;HDAC6;DDRGK1;H3-3A;PARK7;TRIM68;CBFB;LATS1;KDM4C;RUNX1
prerank,P-body assembly (GO:0033962),0.4813695489380085,0.9587806702045943,0.5326842837273992,1.0,1.0,7/12,23.13%,DYNC1H1;EDC3;LSM14A;RC3H1;LIMD1;EIF4ENIF1;LSM3
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.4925666640093668,0.9585998560895351,0.5349162011173184,1.0,1.0,3/12,7.33%,CD74;FOXP1;HMGB1
prerank,proteasomal protein catabolic process (GO:0010498),0.40124844679444066,0.9584527346134174,0.611,1.0,1.0,51/201,18.21%,KIF14;PMAIP1;SKP2;PSMB7;RCN3;PSMD11;PML;PRPF19;FBXW11;PSMF1;NR1D1;FAF1;FBXO44;PSMC1;FBXO45;BIRC2;SPSB3;UBE2K;UBE4B;NEDD4L;TNFAIP1;CUL3;PSMC3;PCBP2;RAD23A;PSMA4;SPSB4;TRIM3;PSMC4;ARRB2;PCNP;NFE2L2;PSMD13;SPOP;PSME1;DDIT3;DCAF11;ZFAND2B;PSMB1;RBCK1;ARMC8;PSMD8;PSME4;KLHL22;PSMD4;SIRT1;UBXN1;RNF4;SYVN1;FEM1C;UBE2G1
prerank,establishment of protein localization to organelle (GO:0072594),0.403135865812991,0.9581006776303799,0.5577523413111343,1.0,1.0,28/72,23.66%,NEURL1B;POM121;NUP107;TNPO1;IPO13;NUP50;NUP214;SEC13;IPO7;NUP188;RANBP6;IL10RA;RPAIN;E2F3;APPL1;IPO5;KPNB1;EIF4ENIF1;NUP85;MMP12;TPR;TNPO2;TNPO3;SYK;NUP93;PHB2;LRSAM1;IPO8
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.48291404049116615,0.9579282653032037,0.5423956931359354,1.0,1.0,4/13,19.24%,PALM;CCR2;ADGRV1;GRM3
prerank,smooth muscle cell differentiation (GO:0051145),0.4962666134451409,0.9573280525377519,0.5518672199170125,1.0,1.0,2/12,13.54%,HEY2;TMEM204
prerank,mitochondrion localization (GO:0051646),0.4576719060011912,0.956856138286027,0.5406451612903226,1.0,1.0,8/19,22.50%,BRAT1;MARK2;HAP1;MTM1;LRRK2;TRAK2;MARK1;ATCAY
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4666311029900468,0.9565542491142093,0.5412844036697247,1.0,1.0,6/16,16.94%,FTO;PIM1;NAPEPLD;ZBTB7B;HNRNPU;SIRT1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.29942373266690636,-0.9564768836232677,0.5182926829268293,0.8028453317993554,1.0,7/25,10.55%,FBXL17;NGLY1;CLPP;RNF185;AUP1;ZER1;BAG6
prerank,membrane protein proteolysis (GO:0033619),0.42912558630824565,0.9563351279060687,0.5228031145717463,1.0,1.0,9/37,19.36%,PRTN3;NAPSA;MBTPS2;PSEN1;DAG1;SPPL3;ADAM10;ERAP1;TRAF6
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4124893380242573,0.9562729419399154,0.5428881650380022,1.0,1.0,10/45,15.34%,PML;CD44;SP100;IRF9;GBP2;JAK2;B2M;TRIM68;TRIM5;IRF8
prerank,glucose import (GO:0046323),0.4854258970383873,0.9561584142175445,0.5291607396870555,1.0,1.0,4/13,18.59%,SLC2A4;ZDHHC7;SLC2A3;SLC2A1
prerank,cellular protein modification process (GO:0006464),0.3955968505605703,0.9560606518466072,0.722,1.0,1.0,232/983,18.39%,CCNF;CDK1;BIRC5;AURKB;EPB42;NEK2;F5;MEN1;CCNE1;PLK1;STK26;FBXL15;CHEK2;MAPK1;FN3KRP;CDKL1;SKP2;AURKA;ART3;OXSR1;DTL;DAPK2;CEL;PSMB7;FYN;PIGH;PPM1D;PTPRA;PPP3CA;CCN1;PRKCE;PSMD11;HASPIN;FBXW11;PTPN22;RSKR;ERG;JMJD4;UBE2I;RPS6KA5;MAP4K1;PSMF1;LRRC41;PPP2R5E;STK11;CHEK1;CDK6;GRK6;TLK1;GMFG;PPP1CB;TAF1;SIK2;PPP2R5A;MSRA;RAB1B;ATM;LCMT1;FBXO44;ARF4;RUNX3;CSNK1A1;PSMC1;MPI;STK38L;ASB7;STT3A;NUS1;MAP3K5;CDC25B;UBL5;MTMR2;PIM2;METAP2;ST3GAL1;SPSB3;CDK17;AKT3;PKN2;BIRC6;CSNK1G2;PIM3;MAP3K1;MAP4K2;TAB1;RAB8A;SLC35A1;HCST;ST3GAL2;PRKCA;PRKACA;ZBTB16;STK38;FBXO17;LAMC1;LAMB2;PICK1;MARK2;JAK2;LMTK3;KLHL9;ST8SIA4;MAST2;ENGASE;STK24;ASB1;CUL3;PIM1;SEPHS1;PARP14;PPP2CB;PDPK1;MAP4K5;B3GNT2;ATG4B;CDK19;HIPK2;PSMC3;TESK2;SOCS2;MAP3K11;DCAF17;ABCA7;PIGT;MELK;DYRK1A;PARK7;VRK1;BTK;PSMA4;PTPN7;PTPN14;PPP1CC;SPSB4;DCAF7;MTMR6;CCNT1;PRKCB;PTEN;FBXL4;PHKA2;PSMC4;BAP1;RAB11B;BMPR1A;LMTK2;CUL9;FBXO11;GRK2;ROCK2;PSMD13;SUMF1;CHRM3;SIRT7;PSME1;PRKDC;PRKAG2;LATS1;CDK16;STK39;PGAP1;RAB2A;FAM20A;NRBP1;DCAF11;PPP3CC;PIGU;PSMB1;RBBP5;GSK3B;PPP1R12A;PRKCSH;SGK3;CHML;STK4;PRSS23;NTAQ1;PTPN5;MAP3K20;BCR;PPP6C;MTM1;ST3GAL5;PTPRU;PSMD8;PAK5;MAP2K1;WDTC1;PMM2;PPP2R5D;MARK4;DCAF8;FGFR1;TRIOBP;LIMK2;PAK2;ASB8;PSME4;CDK8;TGFB2;RAB5A;DCAF5;JAK3;VHL;KLHL22;USP25;SRPK1;DUSP12;PSMD4;SIRT1;SCG3;ADPRH;DCAF4;HSP90B1;FN1;UBA52;UBE2M;DDB2;F13A1;PTPN13;PPP1CA;FEM1C;SDC2;FAM20B;MORC3;STK17B;TAOK1;LRRK2;ILKAP;SUMF2;ADAM10;CREB1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3756373295786989,-0.9559009147131932,0.5107142857142857,0.8029233065788028,1.0,3/12,9.89%,ABCA1;ABCA5;ITGB3
prerank,regulation of endopeptidase activity (GO:0052548),-0.24784080037124556,-0.9558810387173596,0.5128205128205128,0.8016187348199344,1.0,10/59,15.54%,SPOCK1;SERPINE2;TIMP2;VSIR;SPOCK2;TIMP3;SERPINI1;SERPINE1;PSMB8;APH1A
prerank,positive regulation of behavior (GO:0048520),0.5026767427179193,0.9556687023654585,0.5300859598853869,1.0,1.0,1/10,3.13%,AGRP
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.45161114108208444,0.9556609577717291,0.5307402760351317,1.0,1.0,8/22,20.52%,MED30;PSMC3;PSMC4;PAXIP1;MED14;TP53;MED1;MED13
prerank,metal ion homeostasis (GO:0055065),0.4227269341718509,0.9556575779041041,0.5433333333333333,1.0,1.0,8/40,13.98%,SLC12A3;CAV1;SLC12A7;SLC12A1;KCNA1;TMTC2;SLC12A6;FAM20A
prerank,positive regulation of interleukin-12 production (GO:0032735),0.43033109452047064,0.9556271673790327,0.5449374288964732,1.0,1.0,5/31,11.64%,IL16;HMGB1;MAPK14;PLCG2;PLCB1
prerank,tRNA aminoacylation (GO:0043039),-0.2583491197199449,-0.9555867667067225,0.5625,0.8009957722674709,1.0,12/37,12.86%,IARS2;CARS1;WARS2;SARS1;NARS1;AIMP1;FARSA;IARS1;HARS2;HARS1;QRSL1;TARS1
prerank,response to estrogen (GO:0043627),0.42769413798114503,0.9553526276677428,0.5466052934407365,1.0,1.0,6/31,16.34%,BRCA1;CRHBP;CAV1;PELP1;RBBP5;CD24
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4165636137313642,0.955334660784551,0.5542553191489362,1.0,1.0,13/49,21.45%,CD2;CD74;HMGB1;PARK7;MYD88;F3;TLR5;DDIT3;F2R;LGALS9;PRKD2;RIPK1;SYK
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.4347638894077431,0.9551872622956373,0.5409836065573771,1.0,1.0,10/26,22.05%,CDK5RAP2;CLASP1;SLAIN2;NUMA1;RAC1;DRG1;RPS3;MET;MAPT;DCTN1
prerank,cardiolipin metabolic process (GO:0032048),-0.3603898092551934,-0.9546202632618176,0.493006993006993,0.8019515151126864,1.0,7/13,27.24%,SLC27A1;CRLS1;PLA2G6;PGS1;PLSCR3;TAMM41;PLA2G4A
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5090001803508364,0.9544975749821918,0.544055944055944,1.0,1.0,4/11,20.97%,EGFR;TP53;MAP2K1;RIPK1
prerank,positive regulation of protein deacetylation (GO:0090312),0.4748895647055119,0.9543351445265511,0.5191040843214756,1.0,1.0,4/14,13.53%,DYRK1A;ZBTB7B;ING2;NIPBL
prerank,secondary alcohol biosynthetic process (GO:1902653),0.4296897702699018,0.954155492402937,0.5420560747663551,1.0,1.0,6/30,15.83%,LBR;LSS;IDI1;NSDHL;FDPS;DHCR7
prerank,regulation of gene expression (GO:0010468),0.3932132366264711,0.9535332765866167,0.727,1.0,1.0,163/903,15.76%,MBNL3;TCF19;TRIM58;TMPRSS4;MYB;EZH2;ERMAP;MYBL1;BRCA1;SPIN4;AFF3;HMGA1;SOX6;CHEK2;MEFV;HEY2;BRCA2;MAPK1;LEF1;E2F1;NSD2;RB1;AURKA;GLMN;AFF1;EZR;TWIST1;CD74;PML;NUP107;POLR2A;CCN4;PTPN22;HDAC10;RPS6KA5;CTCF;RBL1;TFRC;FOXP1;ZC3H7A;ACTR5;CDK6;RPS7;NKAP;CRKL;EDF1;TAF1;PTHLH;NFXL1;HNRNPL;LIN54;GSN;ATF7;ATM;TERF2;MYOM1;TCF7L1;TCF3;ZFP36L1;RUNX3;HDAC6;EPHX2;PDE2A;TRAF3;TNRC6C;LRP3;TNRC6B;PHF19;ZUP1;PUM2;NOTCH1;PIN1;DDRGK1;MLF2;AHR;ZNF326;PSPC1;DMTF1;PHF1;NOVA2;UBE2V1;TRIM11;MAPK14;PLCG2;ERC1;METTL4;SART3;PLAG1;CLK4;ABCC2;NONO;ZNF148;PARP14;MECP2;SRRT;BTN3A3;EGR1;PFDN5;SPTY2D1;NR2C2;DNMT1;PCBP2;RBM38;NFYC;TRIM44;MSN;PARK7;ZNF462;PRDM10;PUM1;ATXN7L3B;UBAP2;CCAR2;FGF9;ATF5;RDX;IGF2BP3;NSD3;MYD88;NPAT;TRIM68;SETDB2;PRDM6;METTL16;HCFC1;F3;BMPR1A;SP3;NFE2L2;NELL1;ROCK2;RACK1;ZBTB7B;ING2;REXO4;DDIT3;CREBBP;MYC;BCL6;GABPA;NFX1;PSEN1;HNRNPAB;TLR6;RNF20;DTNBP1;TYROBP;TRIM5;PCBP3;GSK3B;TADA3;LIMS1;PDCD10;TP53;RC3H1;GON4L;RUNX1;LIMD1;EGF;SRSF10;AHNAK;HGS;MAP2K1
prerank,cation transport (GO:0006812),0.39497948767393826,0.9533853076545786,0.6036036036036037,1.0,1.0,13/167,9.21%,RHAG;SLC38A5;SLC12A3;SLC5A5;AQP1;SLC7A1;ANO10;KCNN4;TAF7;TRPM7;NEDD4L;KCNA1;KCNJ3
prerank,positive regulation of cellular component movement (GO:0051272),0.4404223423415934,0.9533424724937438,0.535671100362757,1.0,1.0,4/24,4.80%,NTN1;TWIST1;RPS19;STK11
prerank,endoplasmic reticulum organization (GO:0007029),-0.22291673527735048,-0.9529446664015805,0.5517241379310345,0.8046562548827156,1.0,18/72,14.25%,RTN4;APP;GAK;SEC16A;REEP3;TOR1B;DNM1L;REEP5;SGTA;MIA3;VAMP2;SEC61G;SEC61A1;HMOX1;STX1A;TRAM1;SERP1;PRNP
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4684715477388797,0.9529320200536532,0.546772068511199,1.0,1.0,6/17,16.94%,TWIST1;CD74;CD44;DYRK1A;YJU2;SIRT1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.41625505345807756,0.9513591341221389,0.5463917525773195,1.0,1.0,14/37,20.02%,PML;RPS7;TAF1;DDRGK1;HIPK2;PARK7;CCAR2;UCHL5;TAF9;UBXN1;CAMLG;USP7;RPL5;RPL23
prerank,cell-cell junction assembly (GO:0007043),-0.22122525668200618,-0.9512291999188752,0.5581395348837209,0.8075908869485573,1.0,17/63,15.97%,CDH11;CDH8;PATJ;CTNNB1;CTNND1;CDH2;CLDN11;CDH12;JUP;FLCN;EPB41L3;ACTB;SMAD7;GJA1;PIP5K1C;TLN2;TRPV4
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3059427174320761,-0.9511696272057679,0.5480225988700564,0.8063681197091371,1.0,5/23,6.30%,NLRP3;IGF1;TNFAIP3;CX3CR1;ZC3H12A
prerank,regulation of type I interferon production (GO:0032479),0.40605853190473284,0.9510879934963421,0.5747950819672131,1.0,1.0,21/84,16.99%,RNF26;POLA1;DHX58;PTPN22;CGAS;NPLOC4;TRAF3;PIN1;XRCC6;PCBP2;DHX9;MYD88;PRKDC;CREBBP;POLR1C;LRRFIP1;GPATCH3;OTUD5;IRF8;POLR2K;NLRX1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.36694705461261645,-0.9508354617633468,0.501779359430605,0.8058387070521414,1.0,6/12,31.59%,SMO;VEGFA;SOX8;AGT;SOX9;PAX8
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.47748369910112143,0.9505221733193686,0.5303430079155673,1.0,1.0,5/14,12.22%,SEC23B;SEC24B;SEC24A;SEC13;SEC31A
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.28321054936054024,-0.9500759466544576,0.5244755244755245,0.8063305643511376,1.0,11/26,18.86%,FHOD1;ASAP3;PFN1;SLC9A1;LIMK1;TSC1;PRKN;PFN2;SHANK3;PLEK;CDC42
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.43345829957857174,0.9496531261447029,0.5310668229777257,1.0,1.0,10/27,19.36%,MAP3K1;TAB1;TAB3;BTK;MYD88;TLR5;TLR6;UBA52;MAP3K7;TRAF6
prerank,protein-containing complex disassembly (GO:0032984),0.40932470300272,0.9495626081857023,0.5665236051502146,1.0,1.0,18/54,21.46%,AXIN1;STX17;CAV1;CSNK1A1;LIX1;UBQLN1;VPS16;MYC;VPS33B;GSK3B;RUBCNL;PYM1;CHMP3;EPG5;PPP1CA;CLN3;RPL23;VPS4A
prerank,ribonucleoprotein complex assembly (GO:0022618),0.3951202125812494,0.9494878067043518,0.596579476861167,1.0,1.0,45/132,21.50%,EIF4B;PRPF19;GEMIN8;SCAF11;RPS19;SNRPF;SNRPC;SETX;CRNKL1;RPL23A;SNRNP200;TXNL4A;RPS14;SART3;NCBP1;RPS27;MRPS7;RPS5;RPLP0;DHX9;DHX29;PRKDC;CLNS1A;LUC7L2;SRSF10;SART1;TARBP2;GEMIN7;SRPK1;RPL3;DDX39B;SNRPG;GCFC2;CLP1;EIF2D;RPL5;SF3A2;SNRPB;CPSF7;PRMT7;EIF6;RSL24D1;RPL24;KHDC4;CELF1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3883088331825891,-0.9489545345899606,0.5111111111111111,0.8077375466858648,1.0,4/10,9.31%,OPHN1;MYO9A;RAP2A;SH3BP1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.47774090082971354,0.9488249832565916,0.5237449118046132,1.0,1.0,4/13,14.45%,SNX33;GPD1L;ABCA7;TYROBP
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4318829269195897,0.9487714125779234,0.5331781140861467,1.0,1.0,5/27,13.93%,PISD;CHKB;PCYT2;NAPEPLD;SELENOI
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.47805761583893697,0.9483639834369393,0.5548302872062664,1.0,1.0,7/13,26.59%,JAK2;CANX;IL27;TYK2;IL6ST;JAK1;OAS2
prerank,MAPK cascade (GO:0000165),0.3937883534044538,0.9483278105265537,0.647,1.0,1.0,67/295,18.13%,CDK1;SPTA1;MEN1;MAPK1;IL2RG;IL2RA;ERBB3;PSMB7;FYN;ABHD17A;PTPRA;PSMD11;FBXW11;PSMF1;RASGRP1;GFRA2;PPP1CB;IKBKG;CCM2;SETX;ZFP36L1;PSMC1;TGFA;MAP3K5;GRB2;JAK2;SOS1;ITGAV;LYPLA1;EGFR;CUL3;PDE6D;ACTN2;PSMC3;RIT2;ABHD17B;PSMA4;PTPN7;PPP1CC;FGF9;FLT3;PSMC4;FGF13;PSMD13;PSME1;MYC;GFRA1;PSMB1;IRS1;LAMTOR3;MAP3K20;SPTAN1;EGF;PSMD8;MAP2K1;ZFP36L2;FGFR1;PSME4;JAK3;PIK3CA;PSMD4;UBA52;YWHAE;KITLG;MAP3K7;TAOK1;LRRK2
prerank,regulation of neurotransmitter transport (GO:0051588),0.47072304109239305,0.9480986885698034,0.5346666666666666,1.0,1.0,1/16,0.81%,CHRNB4
prerank,organelle fission (GO:0048285),-0.2959609560389582,-0.9480001984739171,0.48404255319148937,0.8086078325075163,1.0,9/24,16.71%,DNM2;DNM3;CORO1C;DNM1L;PEX19;MIEF1;PRKN;MFF;MTFR1L
prerank,import into cell (GO:0098657),0.4202958147531169,0.9478896145887309,0.5722222222222222,1.0,1.0,8/41,13.93%,NEURL1B;SLC7A1;SLC12A7;LRRC8C;SLC19A1;IL10RA;SLC12A6;SLC29A1
prerank,Ras protein signal transduction (GO:0007265),0.3928707676073208,0.9475482977295677,0.6144578313253012,1.0,1.0,41/137,19.84%,CCNA2;GPSM2;PHACTR4;RB1;GRAP2;TIAM1;NTN1;ARHGDIB;RASGRP1;CDKN2A;CRKL;ARHGEF3;COL1A2;MAPK14;DBNL;GRB2;SOS1;DNMT1;RIT2;PARK7;JUN;CDC42EP3;ROCK2;RAC2;BRK1;PLD1;TP53;RIPOR1;USP50;TRIM28;ARHGDIA;RAC1;KPNB1;RASSF1;SETDB1;CDC42EP1;CDKN1A;KSR1;SGSM3;ARHGAP1;G3BP1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4078640246083591,0.9470637329706127,0.5676251331203408,1.0,1.0,6/57,13.80%,IL12A;TNFRSF18;JAK2;PARP14;FLT3;PIBF1
prerank,muscle contraction (GO:0006936),0.3929475382056618,0.9470055534844695,0.5873493975903614,1.0,1.0,17/126,17.45%,TMOD4;DES;ITGA1;SSPN;MYL1;MYOM1;SORBS1;SNTB1;MYBPC1;GNAO1;ACTN2;EMD;ROCK2;TPM4;VIM;CALD1;UTRN
prerank,phospholipid dephosphorylation (GO:0046839),0.42198943792143767,0.9469209794272798,0.5517241379310345,1.0,1.0,9/37,15.29%,PLPPR3;MTMR12;EPHX2;MTMR2;PIP4P2;MTMR6;PTEN;PLPPR4;MTM1
prerank,transition metal ion transport (GO:0000041),0.4273746598335522,0.9466857315486263,0.5488636363636363,1.0,1.0,4/35,5.04%,TFR2;CUTC;HEPH;TFRC
prerank,microvillus organization (GO:0032528),0.4695117886899245,0.9462952910196005,0.5345744680851063,1.0,1.0,3/13,7.33%,STK26;EZR;FXYD5
prerank,regulation of cellular component biogenesis (GO:0044087),0.42103723596160586,0.9462407184928016,0.5722160970231532,1.0,1.0,9/39,13.59%,HJURP;EZR;NOTCH1;SPTY2D1;MSN;RDX;HCFC1;ROCK2;LATS1
prerank,iron ion transmembrane transport (GO:0034755),-0.39504496265458455,-0.9462121894010069,0.5152542372881356,0.8115468061916237,1.0,4/10,16.69%,ABCC5;SLC11A2;SLC39A14;SLC39A8
prerank,embryonic heart tube morphogenesis (GO:0003143),0.41945606087101156,0.9460244035839972,0.5683060109289617,1.0,1.0,1/44,0.26%,STIL
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4052523630206362,0.945751864624046,0.5923632610939112,1.0,1.0,19/73,22.33%,NTF4;CD44;AXIN1;TFRC;CAV1;HDAC6;EGFR;TXN;PARK7;LATS1;STK4;PDCD10;HCLS1;SNCA;PRKD2;ARAF;CAPRIN2;ATP2B4;NTRK3
prerank,autophagosome assembly (GO:0000045),0.4084777748794607,0.9457390185539188,0.5638859556494192,1.0,1.0,12/52,16.90%,EMC6;ATG13;STX17;RAB1B;UBQLN1;TMEM41B;BECN1;AMBRA1;RAB43;TP53INP2;ATG101;ATG2B
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.4356450000538031,0.945676590398891,0.5439229843561973,1.0,1.0,5/25,10.23%,PML;PSMF1;RPS7;TAF1;HIPK2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.4686065823439668,0.9455061431463349,0.560880829015544,1.0,1.0,3/15,11.60%,FAP;CLASP1;DPP4
prerank,ATP transport (GO:0015867),0.4991181096134393,0.9452548727808772,0.5433526011560693,1.0,1.0,1/10,2.56%,CD47
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.3491969903719976,-0.9450802899268937,0.5078125,0.8131139911934712,1.0,8/13,26.25%,UBAC2;OS9;EDEM2;BCAP31;ERLEC1;UBE2G2;BRSK2;EDEM1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.4795678003683346,0.9450375147282114,0.5063649222065064,1.0,1.0,4/11,14.97%,MBTPS2;ATF6;DDIT3;TP53
prerank,renal filtration (GO:0097205),0.4944132300568076,0.9450269824163225,0.5440340909090909,1.0,1.0,2/10,3.96%,TBC1D8B;SULF2
prerank,termination of RNA polymerase I transcription (GO:0006363),0.43417960241120757,0.9448010212024682,0.5654205607476636,1.0,1.0,9/30,18.42%,POLR1B;POLR1A;ERCC3;POLR1F;POLR1C;POLR2K;TAF1C;TAF1D;POLR1G
prerank,apoptotic mitochondrial changes (GO:0008637),-0.26964448412282205,-0.9444037386821644,0.6141732283464567,0.8133914863592098,1.0,5/32,6.51%,HK2;ERBB4;BCL2L1;HSPD1;DNM1L
prerank,protein maturation (GO:0051604),0.39701000137565745,0.944123337902011,0.5896130346232179,1.0,1.0,22/95,19.90%,TMPRSS4;KEL;NAA40;CIAO2A;CPM;CASP2;DNAJB11;METAP2;TSPAN33;PITRM1;NAA16;F3;PSEN1;PCSK1;NDUFAB1;CPD;TSPAN5;ADAM10;CLN3;GCSH;PCSK7;MME
prerank,cellular response to interleukin-1 (GO:0071347),0.39051766660604315,0.9441105693813927,0.6222444889779559,1.0,1.0,32/143,17.72%,ADAMTS7;CD47;PSMB7;PSMD11;FBXW11;TANK;RPS6KA5;PSMF1;NR1D1;IKBKG;PSMC1;GBP2;TAB1;UBE2V1;TAB3;EGR1;PSMC3;IL1R1;PSMA4;PLCB1;MYD88;PSMC4;PSMD13;PSME1;PSMB1;RC3H1;PSMD8;PSME4;CCL25;PSMD4;UBA52;MAP3K7
prerank,positive regulation of inflammatory response (GO:0050729),0.40056098629174275,0.9440834502859001,0.602880658436214,1.0,1.0,13/86,11.45%,CD47;CCN4;IL16;S100A9;RPS19;GPRC5B;CCR2;S100A8;TRADD;PDE2A;IL17RA;NAPEPLD;DHX9
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.3885339826932024,-0.9440607083808289,0.49310344827586206,0.8115407884439046,1.0,4/10,20.11%,NSMAF;SIRT3;PLA2G6;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.3885339826932024,-0.9440607083808289,0.49310344827586206,0.8115407884439046,1.0,4/10,20.11%,NSMAF;SIRT3;PLA2G6;SPHK2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3984959553070813,0.9439447940970204,0.5590717299578059,1.0,1.0,21/61,19.38%,F5;RAB1B;STX5;ANKRD28;PEF1;TGFA;TRAPPC9;SEC24B;SEC24A;CUL3;SEC13;TRAPPC4;BET1;SEC31A;PPP6R3;PPP6C;CNIH1;LMAN1;GORASP1;SAR1B;TRAPPC3
prerank,vesicle coating (GO:0006901),0.3984959553070813,0.9439447940970204,0.5590717299578059,1.0,1.0,21/61,19.38%,F5;RAB1B;STX5;ANKRD28;PEF1;TGFA;TRAPPC9;SEC24B;SEC24A;CUL3;SEC13;TRAPPC4;BET1;SEC31A;PPP6R3;PPP6C;CNIH1;LMAN1;GORASP1;SAR1B;TRAPPC3
prerank,COPII vesicle coating (GO:0048208),0.3984959553070813,0.9439447940970204,0.5590717299578059,1.0,1.0,21/61,19.38%,F5;RAB1B;STX5;ANKRD28;PEF1;TGFA;TRAPPC9;SEC24B;SEC24A;CUL3;SEC13;TRAPPC4;BET1;SEC31A;PPP6R3;PPP6C;CNIH1;LMAN1;GORASP1;SAR1B;TRAPPC3
prerank,regulation of chromatin binding (GO:0035561),0.4913794643931744,0.9432283847584785,0.5287517531556802,1.0,1.0,6/10,26.52%,DDX11;GMNN;WAPL;BTAF1;MED25;PARP9
prerank,negative regulation of cyclase activity (GO:0031280),0.4761138826393456,0.9432181301981031,0.5579514824797843,1.0,1.0,4/14,19.24%,PALM;CCR2;ADGRV1;GRM3
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4685043493538249,0.9428706189009396,0.5357142857142857,1.0,1.0,3/15,16.39%,BRCA1;FGFR1;TGFB2
prerank,eye development (GO:0001654),0.4079361179778375,0.9428054252418121,0.5711229946524065,1.0,1.0,11/54,16.39%,PBX4;PBX3;SHROOM2;SALL2;HIPK2;ATF6;SMG9;NIPBL;SKI;PBX2;TGFB2
prerank,activation of protein kinase B activity (GO:0032148),0.4243917586353482,0.9421497689150923,0.5395033860045146,1.0,1.0,6/29,14.11%,CCDC88A;PDPK1;TXN;PARK7;MLST8;PPIA
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.24015737042035845,-0.9421123101124953,0.6612903225806451,0.8148899768824154,1.0,19/52,18.05%,SRPRA;ERN1;WIPI1;ADD1;ZBTB17;HDGF;GSK3A;HYOU1;GOSR2;TATDN2;EXTL3;TSPYL2;SRPRB;PARP16;SERP1;EXTL2;LMNA;HSPA5;WFS1
prerank,cellular protein catabolic process (GO:0044257),0.40594963688184593,0.9420554726452335,0.5836820083682008,1.0,1.0,16/59,21.09%,ADAMTS7;PISD;CHEK2;FAP;CLTC;LONP1;AP2B1;CTSK;CTSO;MYLIP;UBE2G1;MALT1;CASP8;BNIP3;RIPK1;MDM2
prerank,positive regulation of hormone secretion (GO:0046887),0.4456667606078901,0.9419963237447727,0.5506493506493506,1.0,1.0,1/17,1.86%,TFR2
prerank,phosphatidylserine metabolic process (GO:0006658),-0.27378357504721607,-0.9417943636276777,0.5538461538461539,0.814367698921711,1.0,7/32,11.45%,PLA2G15;ABHD12;SLC27A1;MBOAT1;ABHD16A;OSBPL10;PTDSS2
prerank,sodium-independent organic anion transport (GO:0043252),0.48739681637341387,0.9415876510486336,0.5579710144927537,1.0,1.0,6/10,25.16%,SLCO4C1;SLCO4A1;SLCO2A1;SLCO3A1;SLCO5A1;SLCO1C1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.4109655095064287,0.9411330302319424,0.5573419078242229,1.0,1.0,13/44,21.33%,AQP1;CD44;DPEP1;ARL6IP1;CDKN2D;XIAP;SH3RF1;YWHAE;SNCA;CAST;PAX2;USP47;RPS6KA3
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.4189547408857434,0.941099442574663,0.5388127853881278,1.0,1.0,12/36,22.08%,LEF1;PPP3CA;TNRC6C;TNRC6B;GNAO1;PLCB1;PLCB3;TCF7L2;MAP3K7;AGO2;GNB1;AGO1
prerank,lipid biosynthetic process (GO:0008610),0.3897335615139675,0.9409557086301243,0.6016597510373444,1.0,1.0,14/77,18.63%,HSD17B3;SRD5A2;LSS;AGPAT4;PCYT2;CBR4;AGPAT3;ACSL5;PDSS2;NDUFAB1;ELOVL4;XBP1;AGPS;FDXR
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5021168546660763,0.9409428389572274,0.5679886685552408,1.0,1.0,4/10,21.59%,PPP3CA;PPP3CC;NFATC3;ADGRB2
prerank,calcineurin-mediated signaling (GO:0097720),0.5021168546660763,0.9409428389572274,0.5679886685552408,1.0,1.0,4/10,21.59%,PPP3CA;PPP3CC;NFATC3;ADGRB2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.43778148873663114,0.9407872346760918,0.5343980343980343,1.0,1.0,5/23,11.28%,CCDC88A;TUBA1C;CCDC88C;TUBA1B;TUBB
prerank,neuron development (GO:0048666),0.390016190810372,0.9407674540433285,0.6217303822937625,1.0,1.0,30/141,17.18%,BLK;STMN1;PPP1R9B;SAMD14;RB1;PBX4;BLOC1S4;PBX3;FRY;MAP4;RUNX3;GBA2;HMGB1;TDP2;FRYL;ATP7A;TOR1A;VAPA;RAB35;ADCYAP1;CDK16;DTNBP1;GSK3B;PBX2;RUNX1;THOC2;LRP12;TGFB2;XBP1;LGI4
prerank,cellular response to hormone stimulus (GO:0032870),0.39958468157943294,0.9407009902670632,0.5802469135802469,1.0,1.0,11/69,12.73%,SLC5A5;RAMP1;CRHBP;BRD8;CAV1;ZFP36L1;SOCS2;RDX;SLIT3;PELP1;STAT5B
prerank,visual system development (GO:0150063),0.4187906469539199,0.9403460154147049,0.5618729096989966,1.0,1.0,8/37,16.39%,PBX4;PBX3;SALL2;HIPK2;ATF6;SMG9;PBX2;TGFB2
prerank,muscle organ development (GO:0007517),-0.24013251996181215,-0.9398800394442106,0.5555555555555556,0.8175021476695287,1.0,12/54,11.88%,SGCD;CAPN3;SGCE;SPEG;IGF1;LARGE1;FKTN;SRI;VAMP5;DMD;FHL1;MEF2A
prerank,regulation of protein localization to cell surface (GO:2000008),0.42078799899934854,0.9395068537523539,0.5534308211473565,1.0,1.0,10/33,15.38%,SNX33;GPD1L;NEDD4L;ABCA2;ACTN2;ABCA7;TOR1A;RAB11B;TYROBP;EGF
prerank,positive regulation of cartilage development (GO:0061036),0.45762772575885,0.9392646488743337,0.5427461139896373,1.0,1.0,3/17,11.80%,SOX6;ZBTB16;TAPT1
prerank,cellular response to drug (GO:0035690),0.43319365627338385,0.9385450822802927,0.5436081242532855,1.0,1.0,10/25,25.09%,CRHBP;TFRC;DPEP1;MYC;TP53;SLAMF8;AIM2;PPM1E;RBM22;PDE4B
prerank,regulation of response to biotic stimulus (GO:0002831),0.4225146448561992,0.9381514784063856,0.5755053507728894,1.0,1.0,12/28,19.40%,DHX58;PTPN22;FOXP1;TRAF3;BIRC2;XIAP;TRIM5;APPL1;FCGR2B;ERAP1;CD55;CASP8
prerank,intermediate filament organization (GO:0045109),0.46126431427346165,0.938086084935754,0.5347938144329897,1.0,1.0,3/17,16.42%,DES;MTM1;VIM
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.422559976737231,0.9380829748631884,0.5620689655172414,1.0,1.0,6/29,10.27%,KRI1;UTP3;RPS19;NOL10;RPS14;UTP6
prerank,positive regulation of insulin secretion (GO:0032024),0.4129492350174918,0.9379106473892777,0.5479603087100331,1.0,1.0,7/36,17.28%,BLK;BAIAP3;MCU;TCF7L2;CAPN10;TRPM4;ADCY8
prerank,cellular response to cytokine stimulus (GO:0071345),0.38636594181743217,0.9378128823285066,0.719,1.0,1.0,81/416,17.75%,BIRC5;PRTN3;IL12A;ADAMTS7;BRCA1;IL2RG;LEF1;CD47;GBP4;IL2RA;GRAP2;OXSR1;FYN;BATF;TWIST1;CRHBP;RIPOR2;IL16;TANK;CCR2;NR1D1;CRKL;LAMA5;FOXO1;TRADD;COL1A2;PDE12;ZFP36L1;PDE2A;GBP2;UBE2K;CIB1;PRKACA;GRB2;JAK2;IL20RA;SOS1;PIM1;EGR1;ZEB1;SOCS2;IL22;RHOU;IL1R1;PTPN7;PTPN14;DHX9;IL10RA;FLT3;CRK;F3;STAT5B;NFE2L2;HNRNPU;STK39;MYC;BCL6;GSK3B;TP53;JUNB;PTPN5;RC3H1;IRF8;POU2F1;ZFP36L2;VIM;JAK3;MAOA;CCL25;PIK3CA;SIRT1;XBP1;HCLS1;HSP90B1;FN1;UBA52;LDLRAP1;CXCR4;EPRS1;F13A1;PTPN13
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.35007149216332323,-0.937660770932876,0.5166666666666667,0.8215304613183014,1.0,3/15,9.53%,HDAC2;EDA;ROGDI
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.49219368023618904,0.9367969084021935,0.5842391304347826,1.0,1.0,5/11,19.38%,RUNX3;HMGB1;CBFB;RUNX1;LGALS9
prerank,carboxylic acid transmembrane transport (GO:1905039),0.41431916445479083,0.9367939659145407,0.5837053571428571,1.0,1.0,4/40,11.15%,SLC38A5;SLC25A21;SLC16A1;SLC19A1
prerank,response to chemokine (GO:1990868),0.4797217164159713,0.9365548223868662,0.5445026178010471,1.0,1.0,2/13,4.12%,OXSR1;RIPOR2
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.386609841678115,0.9364487672151618,0.6125126135216953,1.0,1.0,28/124,17.72%,LEF1;PSMB7;TIAM1;PPP3CA;PSMD11;PSMF1;CCDC88C;TNRC6C;PSMC1;TNRC6B;CLTC;GNAO1;PSMC3;PSMA4;PLCB1;PSMC4;ARRB2;AP2B1;PLCB3;PSMD13;PSME1;PSMB1;PSMD8;TCF7L2;PSME4;RAC1;PSMD4;MAP3K7
prerank,calcium ion import (GO:0070509),0.4314819282525756,0.9357034997492818,0.5512820512820513,1.0,1.0,5/28,14.01%,MS4A1;CACNA1I;MICU3;MICU1;MCU
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3900306087058429,0.9355144650736378,0.698,1.0,1.0,58/327,15.55%,MYB;EZH2;MYBL1;SPIN4;HMGA1;SOX6;CHEK2;BRCA2;E2F1;NSD2;RB1;NIF3L1;PML;NUP107;POLR2A;HDAC10;RPS6KA5;ACTR5;EDF1;NFXL1;LIN54;ATF7;TCF7L1;TCF3;RUNX3;PHF19;NOTCH1;MLF2;AHR;PSPC1;DMTF1;PHF1;UBE2V1;ERC1;PLAG1;RALY;NONO;SRRT;PFDN5;SPTY2D1;NR2C2;NFYC;CCAR2;ATF5;NSD3;HCFC1;SP3;ING2;REXO4;ACTN4;DDIT3;CREBBP;NFX1;RNF20;TP53;GON4L;LIMD1;SRSF10
prerank,phosphate ion transport (GO:0006817),-0.32948360156388656,-0.9353463887628028,0.5260869565217391,0.8256769814567229,1.0,4/16,21.48%,SLC25A3;SLC25A11;SLC37A1;SLC37A2
prerank,neuron projection development (GO:0031175),0.3902946184959901,0.9351596484134451,0.6653306613226453,1.0,1.0,25/168,14.77%,KIF20B;BLK;NTF4;STMN1;PPP1R9B;SAMD14;RB1;BLOC1S4;FRY;MAP4;HMGB1;DBNL;FRYL;MARK2;ATP7A;TOR1A;VASH2;PTEN;VAPA;RAB35;ADCYAP1;CDK16;DTNBP1;GSK3B;ADGRV1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4507282882303653,0.9342216464066827,0.548306148055207,1.0,1.0,6/18,13.00%,EZR;FAF1;MSN;RDX;CDK5RAP3;NELL1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.32939716533797525,-0.933847380824432,0.5019607843137255,0.8278638847248504,1.0,3/14,12.14%,ANK2;ATP1B2;ATP1B1
prerank,microvillus assembly (GO:0030033),0.4585574861771926,0.933580837470954,0.5496083550913838,1.0,1.0,3/14,7.33%,STK26;EZR;FXYD5
prerank,gland development (GO:0048732),0.40019997323181483,0.9333887270029142,0.5985324947589099,1.0,1.0,18/59,22.91%,EZR;CAV1;ARHGAP35;PHF2;MSN;ARID5B;CDK5RAP3;CEBPG;PRKCSH;XBP1;FOXE1;NKX2-8;PROX1;PKD2;MET;CITED2;FGFR2;ZBTB1
prerank,female gamete generation (GO:0007292),0.42503259696075657,0.9330315041999274,0.578215527230591,1.0,1.0,2/29,4.56%,TRIP13;MCM9
prerank,negative regulation of growth (GO:0045926),0.38676352434243466,0.9325047037919155,0.6062437059415912,1.0,1.0,23/121,16.94%,TMPRSS4;CDKN2C;JADE1;PPP1R9B;RB1;TCHP;PML;STK11;CDKN2A;NOTCH1;SMARCA4;CDKN2D;SMAD4;CCAR2;SLIT3;RACK1;ING5;SERTAD2;BCL6;TP53;NDRG3;TGFB2;SIRT1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.48217877303629253,0.932226053506436,0.5589812332439679,1.0,1.0,3/13,13.19%,TPST1;BPNT2;SULT6B1
prerank,regulation of proteolysis (GO:0030162),0.4086691563204984,0.9320766030663575,0.5755627009646302,1.0,1.0,7/48,6.75%,PLK1;AURKAIP1;FBXW11;CYFIP2;CAV1;HDAC6;TRAF3
prerank,protein localization to cell junction (GO:1902414),0.44232735254081484,0.9320051006118903,0.5588235294117647,1.0,1.0,6/22,16.20%,TJP3;ARHGEF18;BSN;HEG1;NECTIN1;PAK2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.464489278978819,0.9318595696524428,0.5567010309278351,1.0,1.0,3/15,12.62%,IL16;PGF;F3
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3956274668131008,0.9313231132890881,0.592173017507724,1.0,1.0,16/75,17.77%,MEN1;PLK1;RB1;CDKN2A;STK38;PKIG;HEG1;NR2F2;IPO7;PTEN;CDK5RAP3;LATS1;IPO5;TFAP4;SIRT1;HEXIM1
prerank,sterol metabolic process (GO:0016125),0.39232515108793253,0.930992971713294,0.5853658536585366,1.0,1.0,14/60,21.22%,LBR;CYP1B1;OSBPL5;GBA2;CYP27A1;CYP46A1;PRKAG2;NSDHL;DHCR7;LDLRAP1;FDXR;PPARD;OSBPL1A;SCAP
prerank,positive regulation of sodium ion transport (GO:0010765),-0.36360817119799105,-0.9308264850729535,0.552901023890785,0.833719199831303,1.0,3/12,9.11%,ANK3;CNKSR3;SCN1B
prerank,sterol biosynthetic process (GO:0016126),0.417380916621264,0.9307719340146262,0.5729047072330654,1.0,1.0,7/33,15.83%,LBR;LSS;IDI1;PRKAG2;NSDHL;FDPS;DHCR7
prerank,mitochondrial transport (GO:0006839),0.39866744579739966,0.9305038154528781,0.5804721030042919,1.0,1.0,13/53,14.50%,PMAIP1;ABCB10;TOMM34;TMEM14C;SLC25A16;TSPO;PITRM1;TIMM9;GDAP1;FIS1;TOMM70;TIMM23;SLC25A13
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4139491158048072,0.9301318633046803,0.584061135371179,1.0,1.0,12/38,19.88%,ATG13;SAE1;UBL5;ABLIM3;RHOU;BAP1;RAC2;ARIH2;LMAN1;LRRK2;SREBF2;HPS4
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3928970626161946,0.9299665300444374,0.6082995951417004,1.0,1.0,14/95,10.93%,CHST3;FMOD;HSPG2;CSGALNACT2;HAS1;EXT1;ST3GAL1;DCN;SLC35D2;ST3GAL2;SLC10A7;B3GNT2;CHST12;OGN
prerank,negative regulation of transmembrane transport (GO:0034763),-0.3926704335690906,-0.9296067427193471,0.5397350993377483,0.8353034232720551,1.0,4/10,18.05%,AKT2;CTTNBP2NL;IRS2;THBS1
prerank,positive regulation of vasculature development (GO:1904018),0.3897172135558702,0.9292022451441487,0.6131013306038895,1.0,1.0,19/94,17.05%,CYP1B1;BRCA1;AQP1;TWIST1;EMC10;PGF;PRKCA;SMOC2;PDPK1;HIPK2;VASH2;PRKCB;F3;AGGF1;MYDGF;RUNX1;PLCG1;SIRT1;XBP1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.421761977992554,0.92868092718739,0.5741573033707865,1.0,1.0,7/30,16.74%,NET1;LPAR4;ARHGEF3;F2R;LPAR1;GPR35;RAC1
prerank,glycoprotein biosynthetic process (GO:0009101),-0.2295778608767175,-0.928056363074127,0.6785714285714286,0.8377546411618823,1.0,30/79,24.16%,GCNT2;ST8SIA1;BMPR2;CHST8;COG7;ST3GAL6;IGF1;LARGE1;FUT10;B4GALT5;BMPR1B;ALG5;B3GALNT2;ST3GAL4;CHST11;MGAT1;GOLGA2;B4GALT7;SERP1;NPC1;ST8SIA5;TMEM106A;ALG1;ST8SIA3;DAD1;GAL3ST4;B3GALT5;DDOST;B3GALT2;COG3
prerank,positive regulation of bone resorption (GO:0045780),0.4849657721887771,0.927896053022774,0.5726744186046512,1.0,1.0,5/11,21.45%,PRKCA;TNFRSF11A;ATP6AP1;PLEKHM1;SYK
prerank,fatty acid elongation (GO:0030497),0.47075471880162945,0.9273667718660797,0.5597826086956522,1.0,1.0,4/13,16.26%,HACD4;ABCD1;ELOVL5;ELOVL4
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.47621137278058234,0.9273333560203653,0.576978417266187,1.0,1.0,3/12,9.92%,IAPP;VBP1;PFDN5
prerank,dendritic cell migration (GO:0036336),0.4499876408885339,0.9273162638982141,0.5610079575596817,1.0,1.0,5/16,17.65%,CCR2;HMGB1;CCR6;TRPM4;CXCR4
prerank,positive regulation of hydrolase activity (GO:0051345),0.3891793863275991,0.9270806342379097,0.6381909547738693,1.0,1.0,13/137,9.31%,ECT2;PRTN3;HMGB2;EZH2;ARHGAP11A;NET1;RCN3;RASGRP1;EVI5;PIN1;SNX9;LARS1;CAV2
prerank,ovarian follicle development (GO:0001541),-0.3402206962707601,-0.9270568297820359,0.5019011406844106,0.8387122005700418,1.0,4/13,21.74%,VEGFA;EIF2B4;ANG;EIF2B2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.2855666005292345,-0.9268821677410992,0.5664335664335665,0.8377610028134749,1.0,8/28,10.55%,ERO1A;CASP4;QRICH1;ERN1;ATF4;TMEM117;SELENOK;BAG6
prerank,response to iron ion (GO:0010039),0.471156021476587,0.9267150335888018,0.5635036496350365,1.0,1.0,3/12,17.91%,TFR2;B2M;SNCA
prerank,response to glucocorticoid (GO:0051384),0.42280754468929505,0.9265425561516246,0.5817757009345794,1.0,1.0,5/26,15.99%,ZFP36L1;SLIT3;HNRNPU;PDCD7;ZFP36L2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.4946031320523626,0.9261075814972641,0.5569620253164557,1.0,1.0,4/10,20.49%,PCGF5;MECP2;PCGF3;PRMT7
prerank,regulation of cellular component movement (GO:0051270),0.40525063120169547,0.9261045703193251,0.6096256684491979,1.0,1.0,20/49,23.97%,ERBB3;RPS19;CDK6;SP100;HDAC6;PKN2;ZSWIM4;EGFR;ROCK2;ACTN4;DIAPH1;EGF;MEMO1;INPP5F;ROCK1;CADM4;ARHGAP18;ACTN1;ADAM17;DAPK3
prerank,activation of adenylate cyclase activity (GO:0007190),-0.2568515577270992,-0.926057169434149,0.5922330097087378,0.8384457516295892,1.0,9/35,20.98%,ADCY7;ADCY2;CAP2;LGR5;ADORA3;ADRB1;ADRB2;ADCY5;EDNRA
prerank,cobalamin metabolic process (GO:0009235),-0.32354133116274186,-0.9254499269958971,0.5691056910569106,0.83851144393346,1.0,7/17,28.86%,MMADHC;ABCC1;MMUT;MTRR;TCN2;LMBRD1;CD320
prerank,regulation of glucose metabolic process (GO:0010906),0.4123578078524566,0.9254100152036846,0.583427922814983,1.0,1.0,9/34,17.64%,PMAIP1;ADIPOR1;SIRT7;SDHAF3;IRS1;RUBCNL;FOXK2;SIRT1;USP7
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3826982489049396,0.9253357820534481,0.6346346346346347,1.0,1.0,41/161,19.33%,JADE1;PSMB7;LRP4;PSMD11;AXIN1;PSMF1;STK11;CAV1;CCDC88C;CSNK1A1;PSMC1;FUZ;TLE4;CUL3;PFDN5;PSMC3;AMFR;RUVBL2;EMD;PSMA4;PSMC4;TMEM131L;PSMD13;PSME1;DDIT3;LATS1;PSMB1;GSK3B;STK4;LIMD1;PTPRU;PSMD8;TCF7L2;PSME4;PSMD4;LMBR1L;TMEM170B;AMER2;TLE3;HDAC1;STK3
prerank,C4-dicarboxylate transport (GO:0015740),0.4669851464606126,0.9252583963621134,0.5708502024291497,1.0,1.0,3/14,14.50%,SLC25A12;SLC25A22;SLC25A13
prerank,lymphocyte mediated immunity (GO:0002449),0.4758861226534749,0.9251175330325698,0.5697050938337802,1.0,1.0,5/12,27.63%,KLRD1;BTN3A3;CD55;MYO1G;MSH2
prerank,development of primary male sexual characteristics (GO:0046546),0.41096389776845305,0.9249231947643158,0.5963302752293578,1.0,1.0,5/34,17.70%,SRD5A2;CSDE1;FGF9;TGFB2;KITLG
prerank,regulation of myoblast differentiation (GO:0045661),0.41673859557525994,0.9248188733459274,0.5835214446952596,1.0,1.0,5/32,11.64%,RIPOR2;ZFP36L1;NOTCH1;MAPK14;PLCB1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4329970980460346,0.924405093878305,0.5712468193384224,1.0,1.0,4/20,8.28%,CDK6;ZFP36L1;CIB1;ZBTB16
prerank,tRNA wobble base modification (GO:0002097),-0.33923308341070024,-0.9243688998209522,0.5607843137254902,0.8397939383867956,1.0,10/14,39.31%,MTO1;ALKBH1;DPH3;GTPBP3;TRMT9B;CTU2;CTU1;MOCS3;ADAT2;KTI12
prerank,positive regulation of hemostasis (GO:1900048),-0.3784598544351159,-0.9243592273428046,0.5704918032786885,0.8371263363473066,1.0,4/10,18.05%,ST3GAL4;SERPINE1;HPSE;THBS1
prerank,positive regulation of coagulation (GO:0050820),-0.3784598544351159,-0.9243592273428046,0.5704918032786885,0.8371263363473066,1.0,4/10,18.05%,ST3GAL4;SERPINE1;HPSE;THBS1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.29094311424656816,-0.9239974986637398,0.5625,0.8366659864153264,1.0,9/24,18.86%,TENM2;ARAP1;RALA;PIK3R1;WASL;TENM1;RHOQ;AGRN;CDC42
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4453839104753232,0.9237936078811897,0.571072319201995,1.0,1.0,5/19,21.59%,PPP3CA;INPP5A;PPP3CC;NFATC3;ADGRB2
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2823613438377658,-0.9236551370720669,0.5555555555555556,0.8361585549297128,1.0,7/26,15.08%,GAK;SNAP91;SIGLEC1;CLTB;AP2S1;AP2M1;PIP5K1C
prerank,negative regulation of cellular metabolic process (GO:0031324),0.40402894769393316,0.9235649420082415,0.5892255892255892,1.0,1.0,5/37,9.29%,BRCA1;RIN3;MTMR2;ITGAV;ABCA2
prerank,regulation of steroid metabolic process (GO:0019218),0.4328047856424157,0.923458981589389,0.5840597758405978,1.0,1.0,4/23,10.05%,PANK2;EPHX2;ABCA2;FMO5
prerank,establishment of protein localization to membrane (GO:0090150),-0.21996968950654808,-0.9228294126955696,0.6486486486486487,0.8368333337033691,1.0,21/66,24.55%,RAB3IP;PRKCI;GOLGA7;AFDN;MYO1C;RAB3GAP2;RABGEF1;NCF1;RAB11A;RTP4;NPC1;ARL6;ZDHHC24;ZDHHC20;COX18;ZDHHC15;MICALL1;PARD3;VPS37C;REEP1;ZDHHC3
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4855422416569524,0.9224975468197463,0.5728155339805825,1.0,1.0,3/11,14.97%,FAP;BOK;TP53
prerank,cholesterol biosynthetic process (GO:0006695),0.41443558304252315,0.9222345820454763,0.5916955017301038,1.0,1.0,6/31,15.83%,LBR;LSS;IDI1;NSDHL;FDPS;DHCR7
prerank,regulation of tau-protein kinase activity (GO:1902947),0.48318924776352123,0.9221139423443507,0.5653409090909091,1.0,1.0,2/10,9.86%,RB1;EGR1
prerank,positive regulation of glucose import (GO:0046326),-0.29815789460994907,-0.9211616049891542,0.6040609137055838,0.8394470356084904,1.0,6/21,14.51%,PRKCI;PIK3R1;IGF1;AKT2;IRS2;RHOQ
prerank,maturation of 5.8S rRNA (GO:0000460),0.44515497376767127,0.9208512929991051,0.5802310654685494,1.0,1.0,8/17,23.00%,EXOSC10;URB1;PRKDC;NSA2;PES1;MPHOSPH6;EIF6;RPF1
prerank,mitochondrial transcription (GO:0006390),0.4908461219715802,0.9207091671654036,0.5960729312762973,1.0,1.0,3/10,12.35%,TFB1M;TFB2M;TEFM
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.44106436479421157,0.9203373789503593,0.589058524173028,1.0,1.0,5/18,17.59%,PMAIP1;BOK;DDIT3;XBP1;FCGR2B
prerank,regulation of phosphatase activity (GO:0010921),0.4387296768900922,0.9202747008834676,0.5823244552058111,1.0,1.0,6/24,17.46%,PTPA;PPP1R35;CDK5RAP3;PPP6R3;PPP1R2;HSP90B1
prerank,regulation of vasculogenesis (GO:2001212),0.45792789561202735,0.920257058696514,0.582562747688243,1.0,1.0,1/14,2.10%,HEY2
prerank,regulation of cellular protein localization (GO:1903827),-0.2470682964478942,-0.9197428407423566,0.5753424657534246,0.841416851499763,1.0,12/45,16.64%,KDM1A;CSNK1E;GBF1;HSP90AA1;CTNNB1;PRKAA2;MAP1A;DVL3;GPC3;PPM1F;GPC5;RAB11FIP5
prerank,sodium ion transmembrane transport (GO:0035725),0.38622744602703385,0.9197324078602451,0.6470588235294118,1.0,1.0,6/84,6.86%,SLC6A12;SLC12A3;SLC6A2;SLC6A5;HCN3;SLC12A1
prerank,regulation of primary metabolic process (GO:0080090),0.38027642979424225,0.9197069642115131,0.6539618856569709,1.0,1.0,39/126,20.75%,PSMB7;PSMD11;PSMF1;AZIN1;LSS;NR1D1;EDF1;PSMC1;SIN3B;IDI1;PSMC3;NFYC;ABCA7;PSMA4;FASN;ADIPOR1;PSMC4;OAZ1;ROCK2;PSMD13;BBS4;PSME1;HELZ2;CREBBP;PSMB1;RUBCNL;FDPS;PSMD8;DHCR7;SIN3A;PSME4;PSMD4;MED1;CERS2;TBL1XR1;SREBF2;NCOA6;NCOA2;PPARD
prerank,cAMP biosynthetic process (GO:0006171),-0.3816934887142606,-0.9194570922066931,0.5936395759717314,0.8407627312817169,1.0,2/10,4.85%,ADCY7;ADCY2
prerank,myeloid cell differentiation (GO:0030099),0.40328957727827264,0.9194477498072666,0.5933476394849786,1.0,1.0,12/47,17.45%,ALAS2;ZFPM1;RPS19;PRKX;RPS14;ZBTB16;JAK2;HIPK2;KAT6A;RUNX1;JAK3;HCLS1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.2962800272691644,-0.9193863756915915,0.5900900900900901,0.839551873099138,1.0,7/20,19.51%,NUMB;BCL2L1;AP2M1;RHOQ;PPFIA1;PKDCC;CSK
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.22212612910338564,-0.9192349877950605,0.6590909090909091,0.8385805504338563,1.0,15/63,13.03%,TREM2;TBC1D14;TIMP2;KDM4A;HGF;MCL1;ATRAID;TIMP3;FOXK1;EIF4G3;GSK3A;GOLGA2;WASHC1;STAT3;ZKSCAN3
prerank,negative regulation of cilium assembly (GO:1902018),0.47447824502731717,0.9189326399006535,0.5714285714285714,1.0,1.0,2/12,4.87%,TCHP;MAP4
prerank,regulation of neuron apoptotic process (GO:0043523),0.3867118245100283,0.9188769911709839,0.6277890466531441,1.0,1.0,4/96,3.65%,KIF14;NTF4;ERBB3;LIG4
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4553473951078021,0.9188250798370965,0.5862516212710766,1.0,1.0,3/15,6.96%,REEP4;ATL2;ARL6IP1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.31814010597598885,-0.9187904301158838,0.5601851851851852,0.8382990214733972,1.0,7/17,35.96%,ADRA1A;ADRA1B;ADRB1;ADRB2;ADRA2A;DRD2;GPR101
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.2656933797614439,-0.9187448455120857,0.5982142857142857,0.8370930454205543,1.0,22/35,35.91%,CSF1R;F11R;SEMA3E;BAIAP2;FES;CDK5;MDK;CDC42;ABL2;RAPGEF3;HRAS;PTK2B;HCK;TJP1;TRPM2;PDGFRA;NOTCH2;ABI3;TEK;STAP1;PHPT1;BAIAP2L2
prerank,cellular response to gamma radiation (GO:0071480),0.44385252472523884,0.9186848227406322,0.5806045340050378,1.0,1.0,8/17,24.22%,ATM;XRCC6;TP53;MAP3K20;TMEM109;WRN;MDM2;TLK2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.33185749180351376,-0.918350335793975,0.5475113122171946,0.8366639783782073,1.0,4/15,14.74%,DAGLB;GRM5;GRM8;DAGLA
prerank,heterochromatin organization (GO:0070828),0.46738549642947474,0.9181194718295147,0.5706521739130435,1.0,1.0,6/14,23.92%,SMCHD1;SETDB2;SIRT1;SETDB1;SETD7;HMGA2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.42448387481646194,0.9179054986689812,0.5731132075471698,1.0,1.0,10/27,21.65%,CCDC88A;ULK4;DISC1;NTNG2;PTEN;PSEN1;GSK3B;FCGR2B;MARK1;BRSK1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.2892398816670728,-0.9177002750161235,0.5629139072847682,0.836907766355689,1.0,11/24,33.41%,TNFAIP3;KRIT1;ANGPT1;TNIP2;SERPINE1;MAPK7;NDNF;KDR;ICAM1;PAK4;TEK
prerank,'de novo' posttranslational protein folding (GO:0051084),0.41259531786872616,0.9174042497850616,0.5956221198156681,1.0,1.0,15/30,26.80%,CHCHD4;CCT2;DNAJC18;ENTPD5;DNAJC7;BAG1;SDF2;DNAJB4;DNAJB1;DNAJB12;DNAJB14;HSPE1;HSPA9;UGGT1;ST13
prerank,ERBB signaling pathway (GO:0038127),0.39391770795369035,0.9171060747712,0.6269592476489029,1.0,1.0,15/64,18.37%,MAPK1;ERBB3;RPS6KA5;TGFA;PRKCA;GRB2;SOS1;EGFR;PDPK1;DGKD;EGF;PLCG1;PIK3CA;IQGAP1;KIF16B
prerank,regulation of inclusion body assembly (GO:0090083),-0.36657446414002626,-0.9171024489627357,0.5576923076923077,0.8370243316547367,1.0,2/11,5.07%,SNCAIP;DNAJB6
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.4784621349217815,0.9168813770633949,0.5667574931880109,1.0,1.0,1/11,1.29%,CD177
prerank,response to interleukin-1 (GO:0070555),0.382850139572671,0.9160816406672533,0.6487046632124353,1.0,1.0,16/73,19.38%,ADAMTS7;CD47;TANK;NR1D1;GBP2;PRKCA;IL1R1;MYD88;RC3H1;TNFRSF11A;TAF9;CCL25;SNCA;HDAC4;TRAF6;LGALS9
prerank,positive regulation of viral process (GO:0048524),0.39526071003816776,0.9156518784426394,0.6168421052631579,1.0,1.0,18/60,18.59%,RSF1;POLR2I;POLR2A;PDE12;PKN2;RAD23A;NELFA;DHX9;CCNT1;PPIA;STAU1;NELFB;TARBP2;POLR2K;SRPK1;POLR2J;PPIE;PPIH
prerank,regulation of viral release from host cell (GO:1902186),0.42763462126004415,0.915541143221266,0.5809284818067754,1.0,1.0,13/21,29.37%,PML;TRIM11;TRIM5;TRIM28;CHMP3;CHMP2B;VPS4A;TRIM35;TSG101;TRIM62;TRIM21;VPS37B;TRIM13
prerank,cellular response to leucine starvation (GO:1990253),-0.37898227165802345,-0.9153558849652733,0.5442622950819672,0.8398442483853505,1.0,5/10,21.52%,IMPACT;RRAGD;SESN3;GCN1;SESN2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.24281162093430186,-0.9151136729390135,0.6619718309859155,0.8391114972621883,1.0,13/46,17.36%,SIRPA;PTPN2;CNKSR3;CAMK2N1;TLR4;TIMP3;DUSP3;DUSP10;FLCN;DLG1;SPRED1;DAB2IP;RANBP9
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.40997072974654863,0.9147555650778485,0.5912653975363942,1.0,1.0,1/34,0.38%,CD19
prerank,pulmonary valve morphogenesis (GO:0003184),0.4431348142456246,0.914691353099542,0.5728770595690748,1.0,1.0,2/17,7.15%,HEY2;NOTCH1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4354951445406528,0.9142529341605159,0.5774473358116481,1.0,1.0,10/20,23.22%,MBTPS2;EPHX2;SEC14L2;ABCA2;FMO5;KPNB1;LDLRAP1;SREBF2;TTC39B;LPCAT3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.38895077643862525,0.914252678944167,0.612603305785124,1.0,1.0,19/67,16.96%,PSMB7;PSMD11;PSMF1;IKBKG;PSMC1;TAP1;ITGAV;PSMC3;PSMA4;B2M;PSMC4;PSMD13;PSME1;PSMB1;CYBB;PSMD8;PSME4;PSMD4;CYBA
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.3836249548996467,0.9135375490023265,0.6360887096774194,1.0,1.0,25/94,17.72%,PSMB7;PSMD11;FBXW11;RPS6KA5;PSMF1;IKBKG;PSMC1;TAB1;UBE2V1;TAB3;EGR1;PSMC3;IL1R1;PSMA4;PLCB1;MYD88;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4;UBA52;MAP3K7
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.39891507225039247,0.9133630191380101,0.5959271168274384,1.0,1.0,8/46,15.90%,IL12A;CCN4;FOXP1;XRCC6;OGN;PRKDC;ELN;TCF7L2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3869977023817132,0.9132723722534105,0.6088794926004228,1.0,1.0,18/59,21.10%,TANK;IKBKG;TRADD;BIRC2;TAB1;ERC1;TAB3;TIFA;ROCK2;RBCK1;NLRC3;UBA52;MAP3K7;NKIRAS1;TRAF6;RIPK1;ROCK1;IKBKB
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.45998990960742125,0.9123272559538235,0.5760111576011158,1.0,1.0,5/11,22.60%,ABCA2;ABCA7;AGO2;NECAB1;SOAT1
prerank,negative regulation of cell population proliferation (GO:0008285),0.37860278667019226,0.9123203432689306,0.754,1.0,1.0,60/351,16.71%,E2F7;CDKN3;IL12A;MEN1;CYP1B1;CDKN2C;HMGA1;ITGA1;E2F1;GLMN;FAP;S100A11;PPM1D;PML;ARID2;CTCF;STK11;CDK6;CDKN2A;PTHLH;MDM4;RBBP4;RUNX3;TFDP1;KLF10;NOTCH1;PIM2;FUZ;CIB1;JAK2;STRN;CDKN2D;EMD;OGN;B2M;PTPN14;MTSS1;PEX2;ATF5;KAT2B;PTEN;BAP1;PDS5B;NELL1;ING5;SLURP1;TMEM115;SKI;MYC;E2F3;ADAMTS1;TP53;F2R;PTPRU;HGS;MAP2K1;TFAP4;TGFB2;NLRC3;VHL
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3832327964337882,0.9121751422510572,0.633130081300813,1.0,1.0,15/98,9.96%,PMAIP1;CNPY4;E2F1;C2CD5;FYN;PRKCE;YWHAH;SORBS1;TFDP1;CIB1;EFCAB7;EGFR;EPHA3;PDPK1;TFDP2
prerank,protein targeting (GO:0006605),-0.196742840106435,-0.9121307758493825,1.0,0.8445289944518255,1.0,48/118,27.21%,SRPRA;RAB3IP;TOMM40;PRKCI;DNAJC19;SPCS2;AP4S1;ZFAND2A;GOLGA7;LAMP2;MFN2;MYO1C;FUT10;RABGEF1;TIMM17A;PEX19;SEC61G;GIPC1;SEC61A1;BCAP31;NCF1;SRPRB;CDC37;LONP2;RTP4;ARL6;MFF;ZDHHC24;AIP;PEX1;ZDHHC20;SRP14;TIMM22;TIMM10B;ZDHHC15;FBXO7;MICALL1;PARD3;VPS37C;TIMM13;ZDHHC3;TOMM7;TOMM22;KIF13B;EDEM1;ZDHHC12;TIMM8B;PEX16
prerank,retinoid metabolic process (GO:0001523),0.3880670181016247,0.9116097712900674,0.6213991769547325,1.0,1.0,3/71,3.43%,LRAT;CYP1B1;HSPG2
prerank,regulation of microglial cell activation (GO:1903978),-0.33005630045156376,-0.9113986513788007,0.5619834710743802,0.8448794384432947,1.0,5/15,19.63%,TREM2;GRN;TTBK1;CST7;CCL3
prerank,erythrocyte differentiation (GO:0030218),0.40789437803910183,0.9113118528124431,0.6010869565217392,1.0,1.0,12/44,18.12%,ALAS2;ZFPM1;RPS19;ABCB10;RPS14;JAK2;HIPK2;CDK5RAP3;CEBPG;JAK3;HCLS1;MED1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.472238108728134,0.9110766266587621,0.5957767722473605,1.0,1.0,3/10,13.56%,EIF2S1;NFE2L2;DDIT3
prerank,fatty acid transport (GO:0015908),-0.3111520281848128,-0.9110000328121991,0.5665236051502146,0.8445399297082093,1.0,3/17,5.46%,APOE;SLC27A1;GOT2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3766930004964446,0.9106567121367726,0.725,1.0,1.0,66/234,21.10%,NKX6-1;ARHGEF5;IL18RAP;PIDD1;S100A9;RPS6KA5;TFRC;CAV1;TAF1;MBTPS2;IKBKG;S100A8;TRADD;TCF3;TFDP1;NFAM1;DDRGK1;CIB1;TAB1;SMARCA4;UBE2V1;PLCG2;ERC1;MTPN;TAB3;ZBTB7A;HIPK2;CARD9;PARK7;ARID5B;BTK;RELN;DHX9;PRKCB;MYD88;PTEN;TRIM68;FLOT1;BEX1;DDIT3;CEBPG;CFLAR;PPIA;TLR6;TRIM5;RBCK1;TNFRSF11A;ADCY8;HCLS1;TRIM37;UBA52;MAP3K7;HDAC4;FLOT2;MALT1;RPS3;STK3;TRAF6;LGALS9;PRKD2;ALK;UBE2N;AIM2;SLCO3A1;RIPK1;IKBKB
prerank,regulation of interleukin-13 production (GO:0032656),0.46345290255651567,0.9104723401451789,0.5881542699724518,1.0,1.0,1/13,2.33%,LEF1
prerank,early endosome to late endosome transport (GO:0045022),-0.29926198093165596,-0.9104580136058065,0.5692307692307692,0.844548916904605,1.0,7/20,20.28%,WDR91;EEA1;ANKRD27;SNX16;HOOK2;HOOK3;PTPN23
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.46626729123775973,0.9099423831564402,0.5915300546448088,1.0,1.0,5/12,22.88%,SORBS1;ZBTB7B;IRS1;SIRT1;PTPN11
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3990406364344035,0.9099270428197145,0.6087420042643923,1.0,1.0,6/51,10.57%,IL12A;MAPK1;PGF;CCR2;HMGB1;CCR6
prerank,regulation of cellular protein metabolic process (GO:0032268),0.39308444456512426,0.9092342274565948,0.5978021978021978,1.0,1.0,6/47,10.87%,UHRF1;EIF2A;RBM3;MTPN;PUM3;TCOF1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3801332535860601,0.9091445697341446,0.6636455186304129,1.0,1.0,40/138,22.87%,E2F2;NR4A2;TEAD4;GTF2E1;POLR2I;POLR2A;HDAC10;NR1D1;TAF1;TAF7;NOTCH1;TAF15;GTF2A1;ERCC3;NR2C2;TAF6;KAT2B;TAF2;CREBBP;NRBP1;E2F3;TAF9;POLR2K;POLR2J;RXRB;RARG;MED1;HDAC1;TBL1XR1;GTF2A2;TAF3;NRBF2;RBPJ;PPARD;TAF11;NR1H3;MED23;POLR2B;HDAC9;RXRG
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4680087879207877,0.9080981466530282,0.5817174515235457,1.0,1.0,4/11,16.71%,CAV1;ADIPOR1;HGS;VHL
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.3739003163478466,-0.9080764067439054,0.5476190476190477,0.8487630376981314,1.0,6/10,21.73%,NAGK;GNE;NPL;GNPDA1;GNPDA2;AMDHD2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.37669946121574416,-0.9074714137388494,0.5714285714285714,0.8488643654759432,1.0,3/10,10.18%,DIP2B;PRKAA2;FLCN
prerank,histone deubiquitination (GO:0016578),-0.31207667447867393,-0.9068510215400253,0.5806451612903226,0.8490571230443795,1.0,8/18,23.93%,ENY2;USP3;USP22;KAT2A;USP49;ATXN7;TRRAP;TAF10
prerank,positive regulation of axon extension (GO:0045773),-0.2921970467806764,-0.9067168286209986,0.6081871345029239,0.8480373059445181,1.0,9/22,20.27%,RUFY3;MACF1;MAP3K13;LIMK1;GOLGA4;VEGFA;L1CAM;TWF2;SEMA7A
prerank,regulation of adaptive immune response (GO:0002819),-0.3068463712347229,-0.9063702712937153,0.5733333333333334,0.8475506580224992,1.0,4/18,7.87%,ADCY7;PYCARD;TRIM27;IRF1
prerank,negative regulation of response to wounding (GO:1903035),-0.29164532309359914,-0.9059675396942338,0.5882352941176471,0.8471943019112713,1.0,6/19,16.29%,PTPRS;ALOX5;FGF2;SERPINE1;MDK;EPHA4
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.44322097873767996,0.9054775636453452,0.5875,1.0,1.0,4/19,13.19%,TPST1;BPNT2;PAPSS2;SULT6B1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4703421575033482,0.9052420950227974,0.6142270861833106,1.0,1.0,3/11,11.17%,FOXO1;NOTCH1;SMAD4
prerank,positive regulation of interleukin-6 production (GO:0032755),0.38370907547139343,0.9050827641537874,0.6273291925465838,1.0,1.0,16/68,17.97%,POU2AF1;TWIST1;CD74;IL16;HMGB1;PLCG2;IL17RA;CARD9;DHX9;MYD88;TLR6;TYROBP;F2R;CYBA;XBP1;POU2F2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.4451462573133983,0.9049364199241441,0.5768156424581006,1.0,1.0,5/15,22.74%,TWIST1;EIF4A3;NIPBL;MTHFD1L;FGFR2
prerank,cellular response to amino acid stimulus (GO:0071230),0.4032884938296348,0.9046867848793696,0.6052036199095022,1.0,1.0,11/33,20.72%,FYN;LARS1;CPEB3;UBR2;LAMTOR4;LAMTOR3;IPO5;KLHL22;XBP1;GLRA1;RRAGB
prerank,activation of GTPase activity (GO:0090630),0.38164398205700606,0.9046308172257459,0.6514690982776089,1.0,1.0,9/89,5.61%,ECT2;ARHGEF5;TBC1D1;TIAM1;TBC1D8B;TBC1D22B;RASGRP1;RANGAP1;EVI5
prerank,tetrapyrrole metabolic process (GO:0033013),-0.31383489243024315,-0.9046307932877564,0.6008771929824561,0.8490062650224951,1.0,7/18,28.86%,MMADHC;ABCC1;MMUT;MTRR;TCN2;LMBRD1;CD320
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.26989547162892336,-0.9043461679273951,0.5826086956521739,0.8483569772131565,1.0,3/27,1.89%,C3AR1;GNA15;HTR2C
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.47795491474875007,0.9042265191256527,0.5819209039548022,1.0,1.0,3/10,15.73%,CLTC;AP2B1;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.47795491474875007,0.9042265191256527,0.5819209039548022,1.0,1.0,3/10,15.73%,CLTC;AP2B1;MYLIP
prerank,regulation of isotype switching (GO:0045191),0.43818766185364433,0.9039296802784301,0.5801324503311258,1.0,1.0,4/14,16.84%,TFRC;KMT5C;PAXIP1;RIF1
prerank,regulation of kinase activity (GO:0043549),0.37940717583371375,0.9037443302219647,0.6724313326551373,1.0,1.0,26/89,22.74%,ECT2;RB1;ERBB3;LMO4;CD74;RBL1;SMG8;EGFR;EPHA3;FLT3;LMTK2;HNRNPU;RAD50;SLAMF8;FGFR1;ALK;EPHA7;DSTYK;MET;MAPT;EPHA10;FGR;NTRK3;DDR2;CDKN1B;FGFR2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.2803151028225608,-0.9034463483903207,0.6011904761904762,0.8491104234063632,1.0,7/27,18.07%,PTPN2;PTPRE;PIP4K2B;GSK3A;GRB10;TSC2;SLC27A4
prerank,regulation of sensory perception of pain (GO:0051930),-0.37126797996438143,-0.9028399043888533,0.5827814569536424,0.8491727336974106,1.0,4/11,21.99%,MGLL;ZFHX2;CCL3;TMEM100
prerank,ncRNA processing (GO:0034470),0.37105911897113675,0.9027990681420588,0.7077077077077077,1.0,1.0,67/200,23.10%,RPL7;RPL18A;UTP3;RPL36;RPL14;INTS4;RPS19;DDX49;RPS7;INTS9;HELQ;EXOSC8;RPL23A;RPL28;EXOSC10;HNRNPA2B1;RPS14;RPL41;NOL11;RPLP2;RPS27;EMG1;SRRT;UTP6;INTS1;RPLP0;TUT4;FBL;RPL27A;PELP1;WDR74;RPS9;NOL8;RPL12;NOP58;TARBP2;POP4;TUT1;RPL3;UBA52;RPL18;DKC1;PES1;MPHOSPH6;RPL5;RPS6;RPS17;DDX54;ZCCHC8;RPL21;AGO2;RPL23;RPL17;INTS12;SMAD2;RPL24;RPL8;RPL27;RPL13A;AGO1;DIS3;RPP30;RPL15;RPL10;INTS11;RPF1;NOP14
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.24506614102864357,-0.9027855592807924,0.7241379310344828,0.8479987532836276,1.0,9/40,14.35%,AHI1;PPT1;CD63;ARRB1;WASL;TBC1D5;ANGPT1;VEGFA;SERPINE1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.4339676461201917,0.9026710602452003,0.5805626598465473,1.0,1.0,4/19,12.32%,POLD1;POLD2;TYMS;POLD3
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.41845783086179106,0.9026191281669443,0.6030444964871194,1.0,1.0,8/26,18.13%,FYN;TXN;PARK7;NFE2L2;PPIA;PDE8A;SIRT1;LRRK2
prerank,long-chain fatty acid metabolic process (GO:0001676),0.38314347467958576,0.902364968516582,0.6367432150313153,1.0,1.0,11/64,15.06%,CYP1B1;ABCD1;EPHX2;HPGD;ACOT2;SLC27A2;LTA4H;CPT1A;ACSL5;ELOVL5;CPT2
prerank,protein lipidation (GO:0006497),-0.22846591938818084,-0.9022414646227979,0.7692307692307693,0.84790482486558,1.0,26/59,28.86%,GLUL;ZDHHC17;ATG10;ZDHHC13;ZDHHC5;PIGB;PIGN;WIPI1;ZDHHC8;SELENOK;PIGP;MPPE1;GPLD1;ZDHHC16;ZDHHC20;PIGC;ZDHHC15;PIGG;WDR45;PGAP4;ZDHHC3;ZDHHC12;DPM3;PIGQ;PIGZ;HHAT
prerank,negative regulation of cellular component organization (GO:0051129),0.3819911751997881,0.9022310366710197,0.6642487046632124,1.0,1.0,17/74,17.62%,IAPP;FAP;SNX33;LCMT1;TERF2;HDAC6;MTMR2;RTEL1;EPHA3;RIOK3;ABCA7;RDX;TFIP11;GSK3B;AIDA;DNAJB1;MCTP1
prerank,regulation of MAPK cascade (GO:0043408),0.3762968799747673,0.9021137640024786,0.6946946946946947,1.0,1.0,34/157,18.06%,FAM83D;ARHGEF5;IAPP;MAPK1;CCN1;CD74;ULK4;CAV1;RASGRP1;HMGB1;PLCG2;EGFR;CAV2;RIT2;ABCA7;FLT3;FAS;ROCK2;MYDGF;TRIM5;DAG1;STK4;EGF;F2R;LPAR1;PAK5;MAP2K1;FGFR1;STYX;PAK2;CD24;FN1;IQGAP1;TAOK1
prerank,regulation of microtubule-based process (GO:0032886),0.3959914062983357,0.9019203361616438,0.620958751393534,1.0,1.0,15/36,22.26%,AURKA;CLASP1;HDAC6;MARK2;EPHA3;ATF5;DIAPH1;GSK3B;MARK4;TAOK1;MEMO1;ROCK1;MAPT;KLHL42;PHLDB1
prerank,cellular protein metabolic process (GO:0044267),0.3740098962256336,0.9018693120025753,0.778,1.0,1.0,107/396,22.28%,MRPL36;F5;MEN1;NAPSA;CHEK2;RPL7;RPL18A;RPS20;MRPL18;PIGH;CCN1;RPL36;RPL14;L2HGDH;UBE2I;RPS19;RPS7;RPS4X;MSRA;RPS18;MRPL10;LCMT1;RPL23A;UBL5;ST3GAL1;RPL28;SPCS1;SLC35A1;MRPL37;RPS14;RPL41;STK38;LAMC1;LAMB2;RPLP2;ST8SIA4;TMEM208;RPS27;SEPHS1;MRPL51;MRPS7;MRPL43;RPS5;DHPS;RPS29;LTA4H;RPLP0;RPS11;MRPS17;IGF2BP3;RPL27A;PHKA2;BAP1;FBXO11;RPS9;RPS15A;CHRM3;PRKDC;MRPL24;PSEN1;RPL12;PRKCSH;PRSS23;NTAQ1;DARS1;USP25;DUSP12;RPL3;SCG3;ADPRH;HSP90B1;FN1;GSPT1;UBA52;SPPL3;UBE2M;RPL18;SDC2;UBE2G1;ADAM10;CKAP4;FDXR;YARS2;ICMT;RPL5;RPS6;RPS17;RPS3;RPL21;AGO2;SRBD1;RPL23;RPL17;ARAF;SPCS3;RIPK1;DNAJC3;RSL24D1;RPL24;RPL8;RPL27;PADI4;RPL13A;IGFBP7;MRPS12;RPS12;NEDD8
prerank,cellular response to growth factor stimulus (GO:0071363),0.37211866165187263,0.9015228363669947,0.6963927855711423,1.0,1.0,28/151,16.79%,KNSTRN;ADAMTS7;SOX6;CD44;HAS1;CRKL;KIDINS220;SETX;ZFP36L1;PDE2A;NOTCH1;CIB1;MAPK14;EGFR;PDPK1;EMD;SMAD4;BMPR1A;STAT5B;NRP1;RACK1;RAB35;LIMS1;APPL1;ZFP36L2;DUSP22;PLCG1;PDE8A
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4072224700361338,0.9014921401036522,0.6208853575482406,1.0,1.0,5/34,9.44%,E2F1;ZFPM1;FOXO1;LRP3;ASXL1
prerank,clathrin coat assembly (GO:0048268),-0.31740682438435397,-0.9008890715961784,0.6387665198237885,0.8496318490663032,1.0,9/15,30.78%,CLTB;AP2S1;NSG1;EPS15;HIP1R;PICALM;NSG2;CALY;SGIP1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.41823858585635443,0.9007334349789851,0.601684717208183,1.0,1.0,9/24,23.16%,ZFP36L1;CBFB;CTSK;ROCK2;NUMA1;RUNX1;MED1;ROCK1;NCOA3
prerank,spliceosomal complex assembly (GO:0000245),0.3957845183480463,0.9005788520454063,0.6216216216216216,1.0,1.0,16/46,21.50%,PRPF19;SCAF11;SETX;CRNKL1;SNRNP200;TXNL4A;NCBP1;LUC7L2;SRSF10;SRPK1;DDX39B;SNRPG;GCFC2;SF3A2;KHDC4;CELF1
prerank,regulation of cilium movement (GO:0003352),0.48465045243923965,0.9003359105782557,0.6080476900149031,1.0,1.0,1/10,3.22%,CFAP206
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4174153660504452,0.9001498604813658,0.6062424969987995,1.0,1.0,6/24,16.47%,PTPN22;CGAS;TRIM44;TOMM70;SIN3A;TRAF3IP2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.44640442321709756,0.9001471991402631,0.5994659546061415,1.0,1.0,5/14,21.45%,PTPN22;CCR2;CD55;LGALS9;SYK
prerank,embryonic digit morphogenesis (GO:0042733),0.4363271469054812,0.899986037907753,0.6050632911392405,1.0,1.0,7/18,23.09%,TWIST1;WDPCP;CREBBP;MAP3K20;HDAC1;OSR1;INTU
prerank,heart morphogenesis (GO:0003007),0.3904408253799407,0.8997006821553796,0.6181818181818182,1.0,1.0,8/50,16.39%,HEY2;ZFPM1;FLRT2;MDM4;NOTCH1;BMPR1A;NIPBL;TGFB2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.38222365519172935,0.8993420362342148,0.6625641025641026,1.0,1.0,24/78,21.71%,CDC20;PLK1;CAV1;TAF1;CSNK1A1;DDRGK1;UBQLN1;SUMO1;RAD23A;FZR1;NFE2L2;RACK1;SUMO2;ARIH2;PABIR1;GSK3B;PIAS1;RNF19A;LRRK2;KEAP1;MDM2;CBFA2T3;UBQLN2;HECTD1
prerank,mammary gland development (GO:0030879),0.4239096330210114,0.8991320679310743,0.5909090909090909,1.0,1.0,5/21,17.20%,CAV1;ARHGAP35;JAK2;ZBTB7B;APLN
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.37244985098457806,0.8982602060768703,0.6858585858585858,1.0,1.0,26/113,19.26%,ERCC4;RPA2;CHD1L;TFRC;FAF1;ATM;TERF1;RPA1;ERCC3;PSMC3;PARK7;SUMO1;MYD88;PSMC4;RACK1;TLR6;RPA3;GSK3B;BRK1;TP53;USP50;DDB2;SNCA;GNL3L;SLF1;RPS3
prerank,defense response to symbiont (GO:0140546),0.37853622694580635,0.898118696368557,0.6541200406917599,1.0,1.0,8/92,6.58%,RNASE6;PMAIP1;SKP2;FLNA;CGAS;SERINC5;SERINC3;PDE12
prerank,vesicle organization (GO:0016050),0.3937024530829322,0.8980219771448712,0.6333333333333333,1.0,1.0,13/46,19.43%,RNF26;SNX33;CAV1;WASHC4;RAB22A;CAV2;DNAJC13;PI4K2B;VPS33B;USP50;CHMP2B;SAR1B;AKTIP
prerank,potassium ion import across plasma membrane (GO:1990573),0.39427120140335353,0.8976746157347325,0.6188389923329682,1.0,1.0,6/41,13.00%,SLC12A3;SLC12A7;SLC12A1;KCNJ3;SLC12A6;KCNJ2
prerank,membrane depolarization during action potential (GO:0086010),-0.27376815293764956,-0.8973706373449749,0.624113475177305,0.8564741667350095,1.0,10/26,18.68%,SCN8A;CACNA1C;SCN1A;SCN9A;SCN3A;SCN1B;HCN2;SLC8A1;CACNA1G;ATP1A2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.22511990981606267,-0.8972835130079301,0.7111111111111111,0.85535624372598,1.0,17/57,19.82%,APP;DLGAP4;GRIA1;GRIA4;DLG2;MINK1;SHISA6;CACNG7;CACNG2;DLGAP2;LRRC7;CAMK2B;DLG1;DLGAP3;DLG4;GSG1L;PRRT1
prerank,primary miRNA processing (GO:0031053),-0.36639682898954906,-0.8972789791296607,0.5899053627760252,0.8540595793618865,1.0,3/10,4.32%,SMAD1;PUS10;SMAD3
prerank,cellular response to metal ion (GO:0071248),0.372331481957152,0.8969896789904303,0.6824596774193549,1.0,1.0,15/123,11.47%,ECT2;SLFN14;TFR2;AQP1;MAPK1;CRHBP;SYT8;DPEP1;PLCG2;KCNA1;EGFR;SUMO1;B2M;SYT3;JUN
prerank,glutamine family amino acid catabolic process (GO:0009065),0.448568711975163,0.8967872129819182,0.5967078189300411,1.0,1.0,2/13,7.18%,GLS2;PRODH
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.394379647440161,0.8963639802145148,0.600896860986547,1.0,1.0,4/35,10.29%,IL12A;CAV1;CAV2;NR2F2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.319004333098532,-0.8963566204940696,0.5983263598326359,0.8547882374672455,1.0,6/15,16.18%,ABHD12;GOT2;ABHD16A;GGT5;HOGA1;CHAC2
prerank,heart development (GO:0007507),-0.21044921881498505,-0.8958222306549265,1.0,0.8547147163754846,1.0,39/150,18.83%,ACVR1;ADAP2;TGFBR1;ERBB4;CACNA1C;SGCD;SALL1;ZFPM2;BMPR2;NDUFV2;PCSK5;SGCZ;ECE1;NF1;PKD1;FBN1;GPC3;NDRG4;TCF25;MEF2A;FGF12;MICAL2;PTK2;KAT2A;VEGFA;ID2;PDLIM2;TGFBR3;SOX4;ACVRL1;TSC2;LDB3;CXADR;PDLIM4;TGFBR2;PDLIM1;ZDHHC16;CHD7;KDM6B
prerank,axonal transport of mitochondrion (GO:0019896),-0.3519326923057541,-0.8957683400569577,0.5732484076433121,0.8535626535298025,1.0,3/11,8.48%,ACTR10;SPAST;SYBU
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.4514179368608918,0.8957272882887258,0.5964467005076142,1.0,1.0,5/15,15.40%,IL17RA;CARD9;MYD88;TLR6;APPL1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3760865132619577,0.895361344275483,0.6673448626653102,1.0,1.0,19/95,14.62%,MEN1;VASN;STK11;CAV1;PMEPA1;PIN1;ZBTB7A;PDPK1;HIPK2;TRIM33;SMAD4;SNX25;BCL9L;SPRED2;ING2;LATS1;CREBBP;SKI;RNF111
prerank,regulation of defense response to virus by host (GO:0050691),0.4073949261572413,0.895077750945617,0.6241217798594848,1.0,1.0,8/30,16.47%,PTPN22;CGAS;TRIM44;DHX9;TOMM70;TARBP2;SIN3A;TRAF3IP2
prerank,cellular response to chemokine (GO:1990869),0.3895114914611568,0.8950321131865266,0.6275565123789021,1.0,1.0,7/46,16.77%,OXSR1;RIPOR2;CCR2;GPR75;STK39;GPR35;CCL25
prerank,acute-phase response (GO:0006953),0.4537157466726691,0.8949794963033423,0.5862068965517241,1.0,1.0,1/12,10.39%,IL22
prerank,positive regulation of B cell activation (GO:0050871),0.38518036344592643,0.894847005669546,0.6267529665587918,1.0,1.0,10/50,17.05%,TNFSF13B;CD38;CD74;TFRC;PPP2R3C;BTK;KMT5C;PAXIP1;RIF1;XBP1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.2988947494951604,-0.8947678283831859,0.5794871794871795,0.8545935529643052,1.0,11/19,29.01%,ITGAM;TLR4;NMI;LY96;TIRAP;ITGB2;TICAM2;PIK3AP1;SCIMP;CD14;TNIP3
prerank,negative regulation by host of viral transcription (GO:0043922),0.45606333280188743,0.8947271684711827,0.6066481994459834,1.0,1.0,6/12,23.92%,PSMC3;JUN;TFAP4;HDAC1;TARDBP;HMGA2
prerank,phospholipid translocation (GO:0045332),0.40556834549641874,0.8946622040992387,0.5990510083036773,1.0,1.0,9/28,20.69%,ATP11C;ATP8B4;ABCA7;ATP8A1;ATP11B;TMEM30A;ANO6;ATP11A;ATP8B2
prerank,regulation of T cell proliferation (GO:0042129),0.38306831095608324,0.8946222664434387,0.6524453694068678,1.0,1.0,4/61,5.04%,SPN;SLC7A1;GLMN;TFRC
prerank,leukotriene metabolic process (GO:0006691),0.4333433406374328,0.8942672421419854,0.6080910240202275,1.0,1.0,4/19,13.05%,DPEP2;DPEP1;LTA4H;ABCC10
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.2690599869037389,-0.893898235096743,0.6149068322981367,0.8553810580252548,1.0,9/23,28.66%,UBASH3B;PSEN2;ANK2;PRNP;ATP1A2;CBARP;CACNB1;PTK2B;CAMK2D
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3819620171544411,0.8936820480740358,0.667017913593256,1.0,1.0,15/63,17.29%,PML;TNFSF10;SP100;CAV1;TRADD;BCL2L12;BIRC6;ITGAV;PARK7;FAS;CFLAR;TCF7L2;FGFR1;PAK2;SH3RF1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.382693543185251,0.8934766792152761,0.6432264736297828,1.0,1.0,13/62,16.74%,NET1;LPAR4;MMD2;RASGRP1;CRKL;ARHGEF3;NOTCH1;GRB2;JAK2;F2R;LPAR1;GPR35;RAC1
prerank,negative regulation of receptor internalization (GO:0002091),0.4391736758140412,0.8930747714453354,0.5680555555555555,1.0,1.0,4/12,21.60%,RIN3;MTMR2;ANKRD13A;UBQLN2
prerank,regulation of dendrite development (GO:0050773),-0.24921627438145233,-0.8930656915242589,0.7052631578947368,0.8559765395930858,1.0,14/37,24.33%,CAMSAP2;TNIK;HECW1;RAP2A;KNDC1;PACSIN1;LRP8;DAB2IP;RTN4IP1;VLDLR;ZDHHC15;LZTS1;DCC;SEMA4D
prerank,negative regulation of T cell proliferation (GO:0042130),0.4173597259894537,0.8929179532960567,0.6313309776207303,1.0,1.0,2/28,3.02%,SPN;GLMN
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.4323360143077788,0.8923177711966265,0.5992366412213741,1.0,1.0,8/18,23.11%,HMGB1;AKT3;PDPK1;FGFR1;PLCG1;APLN;ITGA4;ADAM17
prerank,cellular component maintenance (GO:0043954),0.45389243487514563,0.8918101649835394,0.6046831955922864,1.0,1.0,3/12,8.51%,FYN;MTMR2;PICK1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.42885366537094594,0.8908625262919818,0.6229299363057325,1.0,1.0,6/18,21.12%,CCR2;CACNG5;RELN;CACNG8;NRXN1;CACNG4
prerank,defense response to tumor cell (GO:0002357),-0.37053509114326394,-0.8907368937275408,0.5947712418300654,0.8600424773127433,1.0,6/10,33.91%,SPI1;PRDX2;KLF4;RBMS3;ABI3;DLEC1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4414292125947248,0.890603933904385,0.6219667943805874,1.0,1.0,3/16,11.64%,RIPOR2;MAPK14;PLCB1
prerank,carnitine metabolic process (GO:0009437),0.4600376741461647,0.8901607025454976,0.5997304582210242,1.0,1.0,4/12,15.06%,ACADM;CPT1B;CPT1A;CPT2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.37642335877589644,0.889979752758784,0.6912820512820513,1.0,1.0,11/85,17.34%,BIRC5;RIPOR2;CLIC5;TIMM9;NIPBL;ADGRV1;EYA1;CCDC50;LRTOMT;HOMER2;TSPEAR
prerank,regulation of insulin secretion (GO:0050796),0.36952804347876017,0.8899252334504484,0.6944162436548224,1.0,1.0,14/101,16.72%,BLK;FOXA2;ITPR1;NR1D1;PRKCA;PICK1;KCNC2;DPP4;EIPR1;CDK16;MCU;IRS1;TCF7L2;CAPN10
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.404970269238854,0.88947714373705,0.6341463414634146,1.0,1.0,4/27,7.95%,GPD1L;YWHAH;FXYD5;NEDD4L
prerank,protein localization to cell-cell junction (GO:0150105),0.4388742794441163,0.8893347421995372,0.5931558935361216,1.0,1.0,2/15,4.46%,TJP3;ARHGEF18
prerank,positive regulation of neurogenesis (GO:0050769),-0.21738541857978932,-0.8892315228432811,0.725,0.8622464660427585,1.0,21/68,20.44%,NUMB;KDM1A;PTPRD;PLXNA4;CTNNB1;CX3CR1;ROBO1;MAP6;FZD3;TGM2;TIAM2;CUX2;VEGFA;PLXNA1;SHANK3;CAPRIN1;PLXNB3;SOX11;CDKL3;SOX8;TRIM32
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.3185289444471153,-0.8892118439298429,0.5874439461883408,0.8609979411975832,1.0,3/16,7.69%,PADI2;PPARGC1B;AR
prerank,alpha-amino acid catabolic process (GO:1901606),0.4081220115893151,0.8887003355173356,0.6431095406360424,1.0,1.0,4/29,11.99%,HAAO;KMO;PRODH;FAH
prerank,polyamine metabolic process (GO:0006595),0.44937829909166654,0.8885500900606813,0.6175675675675676,1.0,1.0,4/13,12.57%,HDAC10;HDAC6;DHPS;SMS
prerank,sensory perception of sound (GO:0007605),0.37641934712185976,0.8885049199394892,0.6922290388548057,1.0,1.0,11/88,17.34%,BIRC5;RIPOR2;CLIC5;TIMM9;NIPBL;ADGRV1;EYA1;CCDC50;LRTOMT;HOMER2;TSPEAR
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.3198627444575271,-0.888155618955799,0.5900900900900901,0.8620310692468787,1.0,7/16,22.93%,GPR137C;RRAGD;FLCN;LAMTOR5;PIH1D1;SIK3;CLEC16A
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3769857188791053,0.887876766624698,0.6659772492244054,1.0,1.0,27/72,24.82%,CD74;AGPAT1;IKBKG;TRADD;BIRC2;JAK2;TRIM44;SUMO1;CBFB;SPATA2;RACK1;CFLAR;RBCK1;ELF1;RUNX1;PIAS1;CD24;CASP8;RIPK1;IKBKB;SYK;PTPN11;HIPK1;ABCE1;VRK2;MADD;IFNGR1
prerank,regulation of transmembrane transport (GO:0034762),0.40401072795931703,0.8868684748530304,0.6436651583710408,1.0,1.0,8/31,18.69%,NEDD4L;KCNJ3;PIM1;PRKCB;KCNJ2;SNCA;SLC2A1;KCNJ10
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4061192919612391,0.8867639352394282,0.6177156177156177,1.0,1.0,10/28,20.53%,MAP2K6;IKBKG;TAB1;UBE2V1;TAB3;UBA52;MAP3K7;TRAF6;CASP8;UBE2N
prerank,endoderm development (GO:0007492),0.44545869674159344,0.8861966717226187,0.5953360768175583,1.0,1.0,2/13,18.37%,LAMC1;KIF16B
prerank,autophagosome organization (GO:1905037),0.3841286388448497,0.8861647780349738,0.6475583864118896,1.0,1.0,11/50,16.90%,EMC6;ATG13;RAB1B;UBQLN1;TMEM41B;BECN1;AMBRA1;RAB43;TP53INP2;ATG101;ATG2B
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.44066342226007504,0.8856582499695822,0.6182519280205655,1.0,1.0,3/16,6.71%,PIGH;PIGF;PIGA
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4428627377332542,0.8846417156689648,0.6222826086956522,1.0,1.0,4/13,13.32%,PIM1;NAPEPLD;ZBTB7B;HNRNPU
prerank,entry into host (GO:0044409),0.4507404073001967,0.8842200717112115,0.6344370860927152,1.0,1.0,8/13,26.00%,GRB2;ITGAV;CBLL1;PPIA;CXCR4;MET;SRC;CBL
prerank,negative regulation of cell junction assembly (GO:1901889),-0.271667663729114,-0.8841334831231639,0.6370370370370371,0.8697960884946159,1.0,8/25,20.32%,ARHGAP6;APOD;CLASP2;CORO1C;RCC2;ACVRL1;THBS1;PHLDB2
prerank,N-glycan processing (GO:0006491),-0.2999288245746211,-0.8840160094733295,0.6358974358974359,0.8686890382930861,1.0,4/18,3.24%,ST8SIA1;MAN1C1;MAN2A2;GANAB
prerank,camera-type eye development (GO:0043010),0.407371268443596,0.8837695818362925,0.6203592814371257,1.0,1.0,3/25,13.77%,CYP1B1;SHROOM2;SKI
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.4160313674740774,0.8834874362997326,0.605830164765526,1.0,1.0,7/20,23.11%,CCNYL1;MAPRE3;EGFR;PROX1;PKD2;CCND3;ADAM17
prerank,membrane lipid biosynthetic process (GO:0046467),0.3731689795901582,0.8834311854948452,0.6496350364963503,1.0,1.0,16/58,20.14%,SGMS2;HACD4;PRKD3;CSNK1G2;ST3GAL2;VAPA;CERS4;SGMS1;ELOVL5;ELOVL4;CERS6;ACER3;GBGT1;CERS2;PRKD2;ST8SIA6
prerank,negative regulation of translational initiation (GO:0045947),0.44903072632974705,0.8831480840591429,0.6160108548168249,1.0,1.0,5/13,24.68%,EIF3E;EIF4EBP3;AGO2;TPR;EIF2AK1
prerank,Golgi to endosome transport (GO:0006895),-0.31946154350948885,-0.8831259144484216,0.6218487394957983,0.8693827063442605,1.0,6/16,17.73%,RAB14;GBF1;VPS13C;WIPI1;EPS15;SORT1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.37022498849769375,0.8828900456012653,0.6866125760649088,1.0,1.0,21/102,17.66%,NR4A2;C2CD5;SLC2A4;USF1;CRHBP;CAV1;FOXO1;DENND4C;SORBS1;ZFP36L1;RAB8A;PRKACA;PDPK1;KAT2B;RAB8B;PRKDC;IRS1;CAPN10;XBP1;ADCY8;EPRS1
prerank,regulation of activated T cell proliferation (GO:0046006),-0.26077598074705066,-0.882832328618179,0.6124031007751938,0.8687197972312767,1.0,6/30,14.25%,PRKAR1A;CD274;PYCARD;IGF1;IL18;PRNP
prerank,protein modification process (GO:0036211),0.3745494541219478,0.8826094302093698,0.6612410986775178,1.0,1.0,22/76,18.89%,PIGH;UBE2I;MSRA;LCMT1;UBL5;ST3GAL1;SLC35A1;STK38;ST8SIA4;SEPHS1;PHKA2;BAP1;FBXO11;CHRM3;PRKDC;NTAQ1;USP25;DUSP12;ADPRH;UBA52;UBE2M;ICMT
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.38435305813919085,0.8822889966768243,0.6626506024096386,1.0,1.0,13/47,20.48%,FLNA;NEDD9;CRKL;CIB1;CRK;NRP1;ACTN4;LIMS1;TRIOBP;RAC1;ARHGEF7;S100A10;ILK
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.23620690674514677,-0.8820051150799721,0.7307692307692307,0.86935724945184,1.0,14/42,16.54%,IARS2;CARS1;WARS2;SARS1;NARS1;AIMP1;FARSA;IARS1;HARS2;HARS1;NARS2;TARS1;QARS1;TARS3
prerank,regulation of regulated secretory pathway (GO:1903305),-0.25660298557531336,-0.8819808455513809,0.6272727272727273,0.868115653717141,1.0,9/34,16.30%,RIMS1;RIMS2;SYT1;PREPL;SYT4;SYT7;SYT9;SNAPIN;SYT6
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.36615933800932315,0.881556865302943,0.7191574724172518,1.0,1.0,45/149,21.10%,IL18RAP;PIDD1;S100A9;RPS6KA5;TFRC;CAV1;IKBKG;S100A8;TRADD;DDRGK1;CIB1;TAB1;UBE2V1;ERC1;MTPN;TAB3;ZBTB7A;CARD9;BTK;DHX9;PRKCB;MYD88;TRIM68;FLOT1;CFLAR;PPIA;TLR6;TRIM5;RBCK1;TNFRSF11A;TRIM37;UBA52;MAP3K7;FLOT2;MALT1;RPS3;TRAF6;LGALS9;PRKD2;ALK;UBE2N;AIM2;SLCO3A1;RIPK1;IKBKB
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.41230248022669946,0.8814677354050067,0.6236162361623616,1.0,1.0,4/23,16.20%,EPHX2;HPGD;LTA4H;GSTM1
prerank,glycogen metabolic process (GO:0005977),0.4128369493936331,0.8814506222645772,0.6258992805755396,1.0,1.0,6/27,15.37%,PGM2;NR1D1;PHKA2;PRKAG2;GSK3B;GBE1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4011772020008863,0.8813262422431819,0.6133177570093458,1.0,1.0,12/30,21.95%,FOXP1;HDAC6;H3-3A;SMARCA4;ZBTB7A;PARK7;TRIM68;KDM4C;SIRT1;HDAC1;NCOA2;RNF6
prerank,regulation of tissue remodeling (GO:0034103),-0.2856064554586933,-0.8811294360166622,0.6544502617801047,0.8687183963683665,1.0,5/18,22.23%,SYT7;IL18;MDK;LEPR;CEACAM1
prerank,postsynaptic membrane organization (GO:0001941),0.4239525433968533,0.8810198082995784,0.6261089987325729,1.0,1.0,5/17,18.91%,CEL;LRP4;NRXN2;GPHN;NRXN1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.21856055615431214,-0.8807736326305639,0.6530612244897959,0.8682534059466026,1.0,19/59,24.44%,OSBPL2;ACLY;LPL;ACACA;OSBPL9;OSBPL7;ALOX5;SCP2;OSBP;OSBPL6;CH25H;HOGA1;LIPH;PER2;CYP39A1;MLYCD;AMACR;OXSM;MCAT
prerank,membrane lipid metabolic process (GO:0006643),0.41283055442806227,0.8807286518297325,0.61090458488228,1.0,1.0,1/22,1.40%,CYP1B1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.37137416531728135,0.8804637727584724,0.6757322175732218,1.0,1.0,15/73,17.59%,BLK;MAPK1;FYN;PRKCE;CYFIP2;GRB2;PLCG2;CRK;PLD2;BRK1;ELMO2;PLCG1;RAC1;PIK3CA;FCGR2B
prerank,proteolysis (GO:0006508),0.36254900456849476,0.8802413827603907,0.788,1.0,1.0,53/252,21.09%,PRTN3;TMPRSS4;TMPRSS3;ADAMTS7;KEL;NAPSA;SENP1;FAP;FBXO3;CPA6;CPM;CASP2;CTSE;DESI2;DESI1;METAP2;SPCS1;PITRM1;CAPN1;LONP1;ATG4B;VASH2;FAM111A;DPP4;PSMC4;CTSK;CTSO;F3;MMP19;PSEN1;PCSK1;ADGRV1;CPD;VHL;CAPN10;USP25;NAALAD2;SPPL3;MALT1;SENP6;ADAM10;ERAP1;RNPEP;SUFU;CLN3;PCSK7;CASP8;MMP12;MME;SPCS3;PRCP;CAPN15;MDM2
prerank,mitochondrial genome maintenance (GO:0000002),0.46487332545341575,0.8800488657193648,0.628099173553719,1.0,1.0,4/11,14.69%,AKT3;LONP1;TOP3A;MPV17
prerank,protein N-linked glycosylation (GO:0006487),0.37612984253495946,0.8799214711250106,0.6750261233019854,1.0,1.0,15/66,16.97%,MAGT1;KRTCAP2;ALG8;ALG14;STT3A;MGAT2;ST3GAL1;ENTPD5;FUT8;OST4;GFPT2;SRD5A3;PMM2;TUSC3;LMAN1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.36578235868991377,0.8797867628552838,0.7191919191919192,1.0,1.0,16/121,13.80%,IL12A;TNFRSF18;PECAM1;ERBB3;CD74;CD44;NEDD9;GPRC5B;BANK1;PLCG2;JAK2;PARP14;RELN;FLT3;NRP1;PIBF1
prerank,regulation of RNA metabolic process (GO:0051252),0.36937697950403353,0.8796483539815251,0.6564482029598309,1.0,1.0,17/59,21.50%,MBNL3;HNRNPL;ZNF326;NOVA2;METTL4;CLK4;PCBP2;RBM38;IGF2BP3;PCBP3;RC3H1;AHNAK;MED1;HNRNPLL;AFF2;PTBP2;CELF1
prerank,aminoglycan metabolic process (GO:0006022),-0.36293952918689054,-0.8794165856827495,0.5966666666666667,0.8699610904230514,1.0,6/10,32.37%,B3GAT3;XYLT2;B4GALT7;CLN6;CHST9;B3GALT6
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.2572973389313468,-0.8793612678920836,0.6546762589928058,0.8688221675896102,1.0,5/30,7.24%,CD274;CD34;HSPD1;PYCARD;TLR4
prerank,regulation of endocytic recycling (GO:2001135),0.4509066153427187,0.8793155500794643,0.5909090909090909,1.0,1.0,6/11,23.72%,ACTN2;EIPR1;RAB11B;ARHGAP1;INPP5F;EHD1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.43704176896428776,0.8792957447336842,0.6082887700534759,1.0,1.0,3/14,10.74%,RASGRP1;PAEP;CARD9
prerank,protein stabilization (GO:0050821),0.3645048644563752,0.8791426812182036,0.7444889779559118,1.0,1.0,46/168,20.39%,GTSE1;USP27X;CHEK2;TSPAN1;FLNA;FKBPL;CRTAP;NAPG;CCT7;RPS7;TAF1;MDM4;CCT2;PIN1;TCP1;PIM2;TRIM44;PARK7;SUMO1;CCT5;PTEN;NAA16;HCFC1;FLOT1;BAG1;BAG3;TYROBP;ATF7IP;STK4;PDCD10;TAF9;VHL;PARVA;CAMLG;USP7;SYVN1;MORC3;FLOT2;CREB1;RPL5;CDKN1A;STK3;CCT6A;HPS4;RPL23;NCLN
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4527007938153106,0.8791122923677094,0.631578947368421,1.0,1.0,4/12,18.63%,TSPO;STARD3NL;TSPOAP1;FDXR
prerank,regulation of lipid metabolic process (GO:0019216),0.36629862548866854,0.8788959083903647,0.6848609680741503,1.0,1.0,26/88,20.75%,PANK2;LSS;CAV1;NR1D1;EDF1;SIN3B;IDI1;NFYC;ABCA7;FASN;ADIPOR1;BBS4;HELZ2;PRKAG2;CREBBP;RUBCNL;FDPS;DHCR7;SIN3A;MED1;CERS2;TBL1XR1;SREBF2;NCOA6;NCOA2;PPARD
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.4648559353132988,0.8787300341304363,0.599713055954089,1.0,1.0,4/10,23.32%,NCBP1;CPEB3;NCBP2;LEO1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4529559609547769,0.878472841709693,0.6141843971631206,1.0,1.0,3/10,19.08%,PTPN22;AIDA;HIPK3
prerank,respiratory chain complex IV assembly (GO:0008535),0.40732848124771925,0.8783138297059062,0.6257668711656442,1.0,1.0,3/21,9.89%,PET100;COA6;COX10
prerank,protein homotrimerization (GO:0070207),0.43373476031828156,0.8779399051368152,0.6085219707057257,1.0,1.0,4/14,20.20%,SLC1A5;SIGMAR1;DISP1;PNPT1
prerank,protein trimerization (GO:0070206),0.43373476031828156,0.8779399051368152,0.6085219707057257,1.0,1.0,4/14,20.20%,SLC1A5;SIGMAR1;DISP1;PNPT1
prerank,phospholipid homeostasis (GO:0055091),0.45064293902155983,0.8776526600031251,0.6075418994413407,1.0,1.0,1/11,3.54%,RCN3
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.40566167841902717,0.8776416491052123,0.6424314660309892,1.0,1.0,6/26,18.88%,RNF26;DHX58;PCBP2;NLRC3;TRAFD1;PPM1B
prerank,cytosolic calcium ion transport (GO:0060401),-0.2574375472843209,-0.8774959078478004,0.6713286713286714,0.8717013444483164,1.0,11/28,22.13%,CACNA1C;MCUR1;RYR2;ADRA1A;ATP2B3;JPH4;SLC8A1;ITPR3;MAIP1;AFG3L2;SMDT1
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.29994384365220483,-0.8767906706622988,0.6502463054187192,0.8719730996951107,1.0,4/18,7.89%,SBNO2;PYCARD;FCER1G;NMI
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3714187845333272,0.8766212631502035,0.6649537512846866,1.0,1.0,19/70,16.96%,PSMB7;PSMD11;PSMF1;IKBKG;PSMC1;TAP1;ITGAV;PSMC3;PSMA4;B2M;PSMC4;PSMD13;PSME1;PSMB1;CYBB;PSMD8;PSME4;PSMD4;CYBA
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.44630413661356794,0.8765355044547165,0.6280653950953679,1.0,1.0,4/13,16.94%,SORBS1;ZBTB7B;IRS1;SIRT1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.3701692987907277,0.8760973587467188,0.6480908152734778,1.0,1.0,11/69,14.45%,CD2;SPN;TWIST1;CCR2;RASGRP1;HMGB1;PLCG2;JAK2;DHX9;PSEN1;TYROBP
prerank,neutrophil degranulation (GO:0043312),0.3623944279328273,0.8760105343972182,0.852,1.0,1.0,94/425,18.61%,PRTN3;RAB44;MS4A3;CHRNB4;CD177;P2RX1;PGLYRP1;PGM2;ABCA13;MAPK1;CD47;PECAM1;CLEC12A;MAGT1;ATP8B4;PSMB7;S100A11;PSMD11;CAMP;CD44;GALNS;APAF1;PA2G4;S100A9;SLPI;FRMPD3;CNN2;GMFG;TUBB4B;S100A8;GSN;CCT2;NFAM1;XRCC6;HMGB1;DYNC1H1;ILF2;SLCO4C1;MAPK14;FAF2;DBNL;DNASE1L1;ITGAV;KCMF1;CAPN1;IMPDH2;IRAG2;SLC27A2;PSMC3;LTA4H;ORMDL3;B2M;TUBB;ATP8A1;VAPA;CRACR2A;DNAJC13;ARHGAP9;PSMD13;ARHGAP45;ARSB;PSEN1;PPIA;ATP11B;DIAPH1;COMMD9;TYROBP;PSMB1;SCAMP1;LAMTOR3;PLD1;DYNLL1;ARMC8;SPTAN1;GCA;CYBB;HVCN1;NBEAL2;PDXK;EEF2;SLC2A3;RAC1;GLIPR1;KPNB1;CYBA;CANT1;TMEM30A;ANO6;IQGAP1;ADAM10;FUCA1;PPIE;RAB6A;CKAP4
prerank,homotypic cell-cell adhesion (GO:0034109),-0.23733056157300247,-0.8758819785409623,0.6981132075471698,0.8726271899788264,1.0,17/39,26.01%,UBASH3B;FERMT3;P2RY12;GNAS;RAP2B;TJP2;ITGB3;ACTB;PIK3CB;METAP1;MEGF11;PLEK;STXBP1;PLPP3;MEGF10;MYL12A;TYRO3
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.29907743670232156,-0.8752393312689286,0.6243654822335025,0.8727788955415003,1.0,5/18,15.54%,APOE;PSEN2;ADAM19;NSG1;APH1A
prerank,regulation of interleukin-8 production (GO:0032677),0.3720625619992831,0.8745502747823423,0.675954592363261,1.0,1.0,11/69,15.39%,CD2;CD74;PTPN22;HMGB1;PARK7;MYD88;F3;TLR5;DDIT3;TLR6;F2R
prerank,histone H3 deacetylation (GO:0070932),0.4355335555295259,0.8737045237416613,0.6191099476439791,1.0,1.0,8/15,22.55%,ELK4;SIRT7;SIRT1;HDAC4;HDAC1;HDAC8;SMARCAD1;HDAC9
prerank,amyloid fibril formation (GO:1990000),0.3834339979501043,0.8736286592728391,0.656554712892741,1.0,1.0,16/51,21.27%,IAPP;HSPG2;GSN;H3-3A;TSPAN33;B2M;GGA1;TGFBI;UBA52;GGA2;SNCA;TSPAN5;ADAM10;RIPK1;MDM2;MAPT
prerank,neutrophil activation involved in immune response (GO:0002283),0.36137234502636406,0.8734075152333922,0.859,1.0,1.0,94/428,18.61%,PRTN3;RAB44;MS4A3;CHRNB4;CD177;P2RX1;PGLYRP1;PGM2;ABCA13;MAPK1;CD47;PECAM1;CLEC12A;MAGT1;ATP8B4;PSMB7;S100A11;PSMD11;CAMP;CD44;GALNS;APAF1;PA2G4;S100A9;SLPI;FRMPD3;CNN2;GMFG;TUBB4B;S100A8;GSN;CCT2;NFAM1;XRCC6;HMGB1;DYNC1H1;ILF2;SLCO4C1;MAPK14;FAF2;DBNL;DNASE1L1;ITGAV;KCMF1;CAPN1;IMPDH2;IRAG2;SLC27A2;PSMC3;LTA4H;ORMDL3;B2M;TUBB;ATP8A1;VAPA;CRACR2A;DNAJC13;ARHGAP9;PSMD13;ARHGAP45;ARSB;PSEN1;PPIA;ATP11B;DIAPH1;COMMD9;TYROBP;PSMB1;SCAMP1;LAMTOR3;PLD1;DYNLL1;ARMC8;SPTAN1;GCA;CYBB;HVCN1;NBEAL2;PDXK;EEF2;SLC2A3;RAC1;GLIPR1;KPNB1;CYBA;CANT1;TMEM30A;ANO6;IQGAP1;ADAM10;FUCA1;PPIE;RAB6A;CKAP4
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3898100670210023,0.8733987176695789,0.6326767091541136,1.0,1.0,9/31,19.91%,PEX26;CHCHD4;DNAJC15;PEX2;TOMM70;TIMM23;GRPEL2;PEX14;TOMM40L
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.3949034111087324,0.8732010179789058,0.6316410861865407,1.0,1.0,7/30,16.94%,BATF;TNFRSF13B;FLT3;PRRC2C;TP53;HOXB4;LMBR1L
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.40350175478673544,0.873092069854199,0.6351829988193625,1.0,1.0,4/27,8.62%,CD47;CD44;CCR2;CYRIB
prerank,mesonephros development (GO:0001823),0.44641192408396374,0.8729235306001195,0.6040462427745664,1.0,1.0,3/11,23.07%,ZBTB16;PAX2;OSR1
prerank,maturation of LSU-rRNA (GO:0000470),0.4015595133605842,0.8729058273881515,0.6325088339222615,1.0,1.0,6/26,14.43%,RPL7;DDX18;URB1;NIFK;ZNHIT6;NSA2
prerank,cardiac conduction system development (GO:0003161),0.4061280632253367,0.8728338644765394,0.6405693950177936,1.0,1.0,3/24,12.63%,HEY2;SMAD4;BMPR1A
prerank,regulation of RNA splicing (GO:0043484),0.36621513450802884,0.8725490131154497,0.6818652849740933,1.0,1.0,27/69,25.88%,MBNL3;POLR2A;HNRNPL;SETX;SRSF3;ZNF326;METTL4;CLK4;RBM38;DYRK1A;METTL16;SRSF10;AHNAK;SRPK1;HNRNPLL;AFF2;PTBP2;CELF1;ZPR1;HNRNPK;CLK2;PTBP1;RBM22;HNRNPH1;YTHDC1;KHDRBS3;HNRNPH3
prerank,neutrophil mediated immunity (GO:0002446),0.36090517674656203,0.8724414800885261,0.862,1.0,1.0,95/432,18.61%,PRTN3;RAB44;MS4A3;CHRNB4;CD177;P2RX1;PGLYRP1;PGM2;ABCA13;MAPK1;CD47;PECAM1;CLEC12A;MAGT1;ATP8B4;PSMB7;S100A11;PSMD11;CAMP;CD44;GALNS;APAF1;PA2G4;S100A9;SLPI;FRMPD3;CNN2;GMFG;TUBB4B;S100A8;GSN;CCT2;NFAM1;XRCC6;HMGB1;DYNC1H1;ILF2;SLCO4C1;MAPK14;FAF2;DBNL;DNASE1L1;ITGAV;KCMF1;CAPN1;IMPDH2;IRAG2;SLC27A2;PSMC3;CARD9;LTA4H;ORMDL3;B2M;TUBB;ATP8A1;VAPA;CRACR2A;DNAJC13;ARHGAP9;PSMD13;ARHGAP45;ARSB;PSEN1;PPIA;ATP11B;DIAPH1;COMMD9;TYROBP;PSMB1;SCAMP1;LAMTOR3;PLD1;DYNLL1;ARMC8;SPTAN1;GCA;CYBB;HVCN1;NBEAL2;PDXK;EEF2;SLC2A3;RAC1;GLIPR1;KPNB1;CYBA;CANT1;TMEM30A;ANO6;IQGAP1;ADAM10;FUCA1;PPIE;RAB6A;CKAP4
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.42597205378298225,0.8720731338732403,0.5978260869565217,1.0,1.0,4/14,16.84%,TFRC;KMT5C;PAXIP1;RIF1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.453693149286236,0.8719451681593139,0.616551724137931,1.0,1.0,6/11,27.73%,BIRC2;CASP8;RIPK1;SLC25A4;ARHGEF2;NUPR1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.3121613925265593,-0.8718899795027719,0.5867768595041323,0.8787824562422392,1.0,3/15,6.98%,WHRN;SCN1A;COL11A1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.3683679615450124,0.87173352098335,0.7170385395537525,1.0,1.0,24/93,22.94%,NTF4;CD44;AXIN1;TFRC;CAV1;GPD1L;HDAC6;EGFR;TXN;PARK7;PTEN;RACK1;LATS1;STK4;PDCD10;NLRP2B;HCLS1;SNCA;PRKD2;ARAF;CAPRIN2;ATP2B4;NTRK3;NSD1
prerank,catecholamine metabolic process (GO:0006584),-0.33119408412463874,-0.8716184585776735,0.6239669421487604,0.8780930304993503,1.0,3/14,12.27%,SNCAIP;RNF180;PRKN
prerank,UV protection (GO:0009650),0.463493199374208,0.8713154893438543,0.640117994100295,1.0,1.0,1/10,4.82%,FEN1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4608328743020317,0.8712768894729432,0.6244784422809457,1.0,1.0,4/10,15.39%,PRKD3;PICK1;DGKD;F2R
prerank,regulation of macrophage differentiation (GO:0045649),-0.30438062581950287,-0.8712284971145944,0.6144578313253012,0.8775872134060275,1.0,4/15,14.45%,PTPN2;C1QC;CSF1;ID2
prerank,neuron differentiation (GO:0030182),0.3592414095366965,0.871078264923345,0.7442326980942828,1.0,1.0,13/165,9.42%,FOXA2;VAX2;NR4A2;PBX4;NIF3L1;PBX3;RUNX3;PIN1;TDP2;IER2;MYEF2;MTPN;ERCC3
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.39631599846172605,0.870757408135348,0.6375291375291375,1.0,1.0,9/29,21.10%,TANK;IKBKG;TRAF3;BIRC2;TLR6;UBA52;CASP8;RIPK1;IKBKB
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.3403819609596279,-0.8706907317051557,0.6307692307692307,0.877496377819851,1.0,4/13,16.39%,ANK3;SRI;CALM1;SLC8A1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.43142541690414377,0.870552853984173,0.6263440860215054,1.0,1.0,5/15,16.94%,CD74;CD44;ING2;TAF9;SIRT1
prerank,regulation of ion transmembrane transport (GO:0034765),0.39528746727150843,0.8701558594774328,0.6465909090909091,1.0,1.0,9/33,23.60%,NEDD4L;KCNJ3;KCNJ2;CHRM3;ANO6;YWHAE;KCNJ10;NEDD4;WNK3
prerank,AMP metabolic process (GO:0046033),0.4392425551437324,0.8701373577198172,0.6195054945054945,1.0,1.0,3/13,16.87%,AK9;ADSL;AK3
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.36650905252568444,-0.8700890738542074,0.6265060240963856,0.8775427037723684,1.0,3/10,12.79%,IMPACT;ENG;MVP
prerank,ruffle organization (GO:0031529),-0.3137997646642329,-0.8698771537881793,0.6053811659192825,0.8767091889875525,1.0,6/16,22.78%,CSF1R;AIF1;ARFIP2;PLEK;CORO1B;CYFIP1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.2841035842511105,-0.8698539339418261,0.6288659793814433,0.8754664122411845,1.0,7/21,18.05%,CSF1R;CMKLR1;AKIRIN1;PTK2;CSF1;MDK;THBS1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4105105723129637,0.8693117050718524,0.6288916562889165,1.0,1.0,7/20,19.36%,IL1R1;B2M;DENND1B;MAP3K7;MALT1;CD55;TRAF6
prerank,calcium ion transport into cytosol (GO:0060402),0.41450881451765176,0.8690738778543231,0.6349009900990099,1.0,1.0,1/21,1.22%,MS4A1
prerank,external encapsulating structure organization (GO:0045229),0.3605888878276257,0.8686709754333302,0.775,1.0,1.0,35/205,17.49%,ADAMTS7;ICAM4;ITGA1;ECM2;ITGB7;CD47;PECAM1;HSPG2;CD44;LAMA5;COL1A2;LAMA4;DCN;COL4A4;LAMC1;LAMB2;LAMB3;ITGAV;SMOC2;JAM2;ATP7A;NID1;BSG;ITGA8;COL23A1;MMP19;DAG1;ADAMTS1;TGFBI;ELN;ST7;ADAMTSL3;ADAMTS5;COL4A1;FN1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.36323521814634624,0.8680959281964999,0.6854508196721312,1.0,1.0,18/85,16.92%,PSMB7;TIAM1;PSMD11;PSMF1;PSMC1;CLTC;PSMC3;PSMA4;PSMC4;ARRB2;AP2B1;PSMD13;PSME1;PSMB1;PSMD8;PSME4;RAC1;PSMD4
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.43646265232114884,0.8676894908516496,0.6287978863936592,1.0,1.0,2/13,5.06%,ALG8;ALG14
prerank,microtubule anchoring (GO:0034453),0.4537359442061776,0.8673821305130345,0.6288515406162465,1.0,1.0,4/12,17.48%,CLASP1;PCM1;DAG1;PEX14
prerank,regulation of p38MAPK cascade (GO:1900744),0.391409126988565,0.8673217989222336,0.6640625,1.0,1.0,5/35,5.36%,EZR;ULK4;EMC10;PTPN22;RASGRP1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.417835227881109,0.8673017009472662,0.6397435897435897,1.0,1.0,7/18,22.65%,SUV39H1;EHMT1;KMT2A;KMT2B;ASH1L;SETD7;EEF1AKMT2
prerank,carboxylic acid catabolic process (GO:0046395),-0.3358130732430865,-0.8671874560964185,0.625,0.880033114514277,1.0,7/12,29.60%,NAGK;NPL;GNPDA1;GNPDA2;AMDHD2;IL4I1;RENBP
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.39190624648469796,0.8671520943720429,0.6471277842907386,1.0,1.0,8/30,18.79%,HACD4;ABCD1;ACOT2;SLC27A2;PEX2;ELOVL5;ELOVL4;ABCD4
prerank,T cell activation involved in immune response (GO:0002286),0.4355560297731837,0.8670216061054207,0.6141078838174274,1.0,1.0,1/12,3.68%,CD74
prerank,protein O-linked mannosylation (GO:0035269),-0.2884556214055376,-0.8668311614644343,0.6428571428571429,0.8795640113156115,1.0,3/18,6.81%,CRPPA;LARGE1;FKTN
prerank,positive regulation of defense response (GO:0031349),0.3628657178601826,0.8665972399002387,0.7002032520325203,1.0,1.0,13/89,11.45%,CD47;CCN4;IL16;S100A9;GPRC5B;CCR2;S100A8;TRADD;PDE2A;IL17RA;RIOK3;NAPEPLD;DHX9
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.37591950215925335,0.8663118462502781,0.6630434782608695,1.0,1.0,14/48,23.11%,NUS1;HMGB1;AKT3;CIB1;MAPK14;PRKCA;PDPK1;FGFR1;PLCG1;SIRT1;ATP5F1B;PRKD2;HDAC9;ADAM17
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.45168317778189565,0.8662428739026731,0.6248236953455572,1.0,1.0,3/11,14.76%,ATL2;ARL6IP1;VCPIP1
prerank,cellular response to glucose stimulus (GO:0071333),-0.2557265988904763,-0.8658200460803555,0.6985294117647058,0.8804070713252106,1.0,8/30,16.64%,IGF1R;SELENOT;PRKAA2;ERN1;PTPRN;SLC39A14;SOX4;RAB11FIP5
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.41284084523741055,0.8651692201166562,0.6313065976714101,1.0,1.0,2/18,9.74%,PMAIP1;ALKBH7
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.37002967539905685,0.8645821641521698,0.704312114989733,1.0,1.0,23/75,23.11%,HMGB2;EMC10;PGF;HMGB1;AKT3;PRKCA;PDPK1;VASH2;F3;AGGF1;NRP1;MYDGF;EGF;FGFR1;PLCG1;SIRT1;APLN;PROX1;PRKD2;EGFL7;PPP1R16B;ITGA4;ADAM17
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4008849349962553,0.8644936324477658,0.6543504171632897,1.0,1.0,7/25,16.74%,RIN3;MTMR2;ITGAV;ABCA2;PSEN1;ANKRD13A;RAC1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3583363560693645,-0.8644586459129877,0.6265822784810127,0.8820400329212369,1.0,5/10,33.94%,IL18;RARA;SPHK2;IRF4;PRKCZ
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.45299935656253226,0.8643536788501436,0.605301914580265,1.0,1.0,5/10,20.79%,JUN;BAG3;VHL;DNAJB1;CITED2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.36329629200930014,0.8643319286198404,0.7005181347150259,1.0,1.0,13/76,12.48%,BRCA1;SAE1;AXIN1;TANK;CAV1;UBA2;BIRC2;UBQLN1;CUL3;PIAS3;XIAP;PAXIP1;CDK5RAP3
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.28950735220713686,-0.8642520154001228,0.650887573964497,0.8812028759033351,1.0,6/22,15.99%,PTPRK;PRKD1;SRSF6;EPB41L4B;ZFP36;MDK
prerank,negative regulation of macroautophagy (GO:0016242),-0.2679728712489426,-0.8640294708519431,0.7005347593582888,0.8803397662654768,1.0,11/26,27.68%,FEZ2;FEZ1;TSC1;PINK1;TSC2;CHMP4B;CHMP4A;LZTS1;CLEC16A;SEC22B;RUBCN
prerank,response to cytokine (GO:0034097),0.361221245966749,0.863524499082245,0.765295887662989,1.0,1.0,32/141,19.90%,FOXA2;AFF3;MEFV;LEF1;CD74;PML;MAPKAPK3;SP100;PRKCA;JAK2;XAF1;IL1R1;PTPN7;PTPN14;FLT3;MYD88;IFITM3;PTPN5;TNFRSF11A;TAF9;JAK3;HCLS1;LDLRAP1;CXCR4;PTPN13;SNCA;HDAC4;ADAM10;TRAF6;LGALS9;CASP8;MME
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.3175816293137324,-0.8635040772636369,0.6206896551724138,0.8802135796451507,1.0,1/15,0.14%,ACVR1
prerank,regulation of establishment of planar polarity (GO:0090175),0.3607762948968811,0.8632524807172376,0.7048008171603677,1.0,1.0,18/88,16.92%,PSMB7;TIAM1;PSMD11;PSMF1;PSMC1;CLTC;PSMC3;PSMA4;PSMC4;ARRB2;AP2B1;PSMD13;PSME1;PSMB1;PSMD8;PSME4;RAC1;PSMD4
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.27458640014788716,-0.8632186311953994,0.6748768472906403,0.8796155248673467,1.0,4/20,7.83%,ACLY;PPT1;ACACA;PPT2
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.25924059899001195,-0.8630893254407779,0.68,0.8786432530718713,1.0,3/28,1.47%,APP;SQSTM1;APOE
prerank,positive regulation of peptidase activity (GO:0010952),0.41694910724862505,0.8628139736134378,0.6491228070175439,1.0,1.0,4/20,13.47%,RCN3;TANK;DDRGK1;PSME1
prerank,glycolipid metabolic process (GO:0006664),-0.22006055382095352,-0.8625859611786103,0.782608695652174,0.8784983485778995,1.0,12/47,18.91%,HEXB;CTSA;PSAP;ST3GAL6;ST6GALNAC4;ST6GALNAC6;ST3GAL4;B4GALNT1;GALC;CERK;GLA;ST6GALNAC3
prerank,mitochondrion distribution (GO:0048311),0.43948329473419634,0.8622917136006975,0.6352288488210819,1.0,1.0,7/12,25.70%,HAP1;MTM1;LRRK2;TRAK2;MAPT;ATCAY;TRAK1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.2607431003312899,-0.862240855167872,0.6486486486486487,0.878033170992006,1.0,13/26,31.77%,BCL2L1;MCL1;HTRA2;PPP2R1B;IL1A;UNC5B;EYA2;MAPK7;BCL2;PF4;RET;INHBA;IL1B
prerank,protein localization to cell surface (GO:0034394),0.3964158283722957,0.8619646854202729,0.658273381294964,1.0,1.0,6/26,17.84%,CD177;FLNA;GGA1;PIGU;PTPRU;GGA2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3559948751698428,0.8619324969699674,0.7710843373493976,1.0,1.0,42/152,21.57%,DEPDC1B;PSMB7;PSMD11;SULF2;AXIN1;PSMF1;GPRC5B;CAV1;DISC1;PSMC1;PIN1;CSNK1G2;SMARCA4;EGFR;PSMC3;PSMA4;RUVBL1;XIAP;CCAR2;PSMC4;PSMD13;LRRK1;PSME1;SKI;PSMB1;EGF;PSMD8;LGR4;PSME4;PSMD4;TRPM4;PTK7;LRRK2;PPM1B;TBL1XR1;USP34;RSPO2;ILK;SPIN1;USP47;CAPRIN2;ZEB2
prerank,regulation of biosynthetic process (GO:0009889),-0.33899569507331967,-0.8617388353042772,0.6678082191780822,0.8778765734653701,1.0,5/11,34.04%,ALOX5;SPHK2;MID1IP1;THRSP;SLC25A33
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.39148733928821133,0.8617282045490915,0.6386946386946387,1.0,1.0,8/28,18.99%,SMCHD1;MRNIP;KMT5C;SIRT7;PRKDC;TFIP11;RIF1;WRAP53
prerank,histone ubiquitination (GO:0016574),0.4041771796797066,0.8611796329577368,0.6332518337408313,1.0,1.0,4/21,14.30%,UHRF1;UBR2;RNF8;RNF20
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.41649535482493616,0.8608231040580091,0.6430317848410758,1.0,1.0,5/18,11.59%,EZR;FAF1;ABCA2;MSN;RDX
prerank,bile acid biosynthetic process (GO:0006699),-0.2650876159045819,-0.8604964588526116,0.6962025316455697,0.8792198922263244,1.0,7/24,12.44%,OSBPL2;OSBPL9;OSBPL7;SCP2;OSBP;OSBPL6;CH25H
prerank,sulfur compound catabolic process (GO:0044273),0.38499046429981104,0.8604924921308011,0.6641137855579868,1.0,1.0,6/38,13.73%,FMOD;GALNS;DPEP1;DCN;OGN;ARSB
prerank,positive regulation of protein modification process (GO:0031401),0.35810885537550685,0.8604679554510188,0.7847847847847848,1.0,1.0,58/203,23.41%,CDCA2;PECAM1;RAMP1;PTPA;CCN1;CD74;ANKLE2;AXIN1;BRAT1;PGF;CEP295;TFRC;RASGRP1;CRKL;PPP2R5A;PIN1;NIBAN1;CIB1;EGFR;P2RY1;TXN;DYRK1A;WDFY2;FGF9;FAS;CNEP1R1;FXR1;ROCK2;RACK1;FLOT1;FAM20A;PPIA;MYDGF;CAMTA1;STK4;LIMK2;RAC1;PDE8A;SIRT1;SPPL3;TAOK1;LRRK2;FAM161A;AKTIP;SVIP;CCND3;ILK;UBE2N;SLCO3A1;RIPK1;CALM3;PPP1R16B;EFNA1;NTRK3;ASPSCR1;ADAM17;PRKCD;C3
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.35656126695232293,0.8602229180247153,0.7279116465863453,1.0,1.0,5/110,5.66%,ADGRD1;S1PR4;IAPP;RAMP1;PTHLH
prerank,response to zinc ion (GO:0010043),-0.26781649896074955,-0.8596878774472893,0.6463414634146342,0.879666155329624,1.0,12/25,20.08%,GLRA2;SLC30A4;MT1B;MT1G;MT1E;MT1A;MT1H;MT1F;MT1M;MT1X;MT2A;P2RX4
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.24986153661624236,-0.85965291423794,0.7191780821917808,0.8784931512704169,1.0,5/29,7.83%,ACLY;PPT1;ACACA;ELOVL7;PPT2
prerank,negative regulation of lyase activity (GO:0051350),0.42261028977541815,0.8594163080341528,0.6466753585397653,1.0,1.0,4/16,19.24%,PALM;CCR2;ADGRV1;GRM3
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.41188931083293057,0.859327289057863,0.6435768261964736,1.0,1.0,4/18,15.17%,RB1;CLASP1;EFEMP2;RUNX1
prerank,positive regulation of isotype switching (GO:0045830),0.41731665182853017,0.8590555491730412,0.628,1.0,1.0,4/15,16.84%,TFRC;KMT5C;PAXIP1;RIF1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.35675418948398646,0.8589110299518676,0.761,1.0,1.0,45/186,19.33%,JADE1;PSMB7;LRP4;PSMD11;AXIN1;PSMF1;STK11;NXN;CAV1;CCDC88C;CSNK1A1;PSMC1;FUZ;TLE4;CUL3;HMGXB4;PFDN5;PSMC3;AMFR;RUVBL2;EMD;PSMA4;PSMC4;TMEM131L;RACK1;PSMD13;PSME1;DDIT3;LATS1;PSMB1;GSK3B;STK4;LIMD1;PTPRU;PSMD8;TCF7L2;PSME4;PSMD4;LMBR1L;TMEM170B;AMER2;TLE3;RNF43;HDAC1;STK3
prerank,substrate-dependent cell migration (GO:0006929),0.4320032671699631,0.8578595304235267,0.6293333333333333,1.0,1.0,3/14,13.01%,NTN1;ANKS1A;NRP1
prerank,regulation of GTPase activity (GO:0043087),0.35515789003006953,0.8577433695858686,0.7787787787787788,1.0,1.0,28/177,15.39%,ECT2;PRTN3;EZH2;ARHGEF5;ARHGAP15;ARHGAP11A;NET1;RASGRP1;EVI5;PIN1;SNX9;PLXNA2;LARS1;FGD6;EPHA3;CAV2;GMIP;RDX;CRK;FGD3;ARHGAP9;RACK1;RSU1;ADAP1;ADCYAP1;GSK3B;LIMS1;F2R
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.35459590977103,0.8573558404514736,0.7757757757757757,1.0,1.0,17/152,15.97%,ADGRD1;S1PR4;VIPR2;IAPP;RAMP1;AKAP12;PTHLH;PDE2A;GNAI1;INSL3;GNAO1;CALCRL;S1PR2;ADCYAP1;ADGRL3;LPAR1;LGR4
prerank,anterior/posterior axis specification (GO:0009948),0.4250592269126573,0.8569710792184181,0.6589986468200271,1.0,1.0,3/15,16.19%,DDIT3;SKI;TASOR
prerank,phosphate ion transmembrane transport (GO:0035435),-0.3295375142709118,-0.8569254858097421,0.6714801444043321,0.8829816280610273,1.0,4/12,21.48%,SLC25A3;SLC25A11;SLC37A1;SLC37A2
prerank,icosanoid metabolic process (GO:0006690),0.3792517993816952,0.8568432990310806,0.6663043478260869,1.0,1.0,7/40,13.14%,CYP1B1;DPEP2;DPEP1;HPGD;LTA4H;ABCC10;PON3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.37965024384805923,0.8560538242883627,0.6685022026431718,1.0,1.0,12/37,22.50%,DNMT1;JUN;FGF9;PTEN;EFEMP2;BMPR1A;ADAMTS1;APLN;LDLRAP1;CDKN1A;MEF2D;CDKN1B
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.39614513330850004,0.8560046912026622,0.6694411414982164,1.0,1.0,9/26,25.68%,BRCA1;ADIPOR1;PRKAG2;ELOVL5;WDTC1;EIF6;NR1H3;PRKAB2;NR1H2
prerank,regulation of heart contraction (GO:0008016),-0.21078163506237274,-0.8558263868461928,0.6,0.8840286113007773,1.0,24/90,20.71%,ITPR2;ASPH;ANK2;SLC8A3;ATP2B2;ATP1A1;TRPC1;CELF2;SRI;ATP1B2;RYR2;GSK3A;ATP1B1;SMAD7;ASB3;ADORA3;CALM1;ATP2B3;SLC8A1;ITPR3;ATP1A2;P2RX4;STIM1;AGT
prerank,negative regulation of stem cell differentiation (GO:2000737),0.43919564068667444,0.855711385145254,0.640218878248974,1.0,1.0,4/12,15.99%,NOTCH1;HNRNPU;NELFB;ZFP36L2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.31927246020359484,-0.8551193188566721,0.6575342465753424,0.8842788696092445,1.0,5/13,19.70%,ENTPD7;GNAI3;RHOQ;RAN;GTPBP1
prerank,endothelial cell migration (GO:0043542),0.3786523043524831,0.8549498795019468,0.6518353726362626,1.0,1.0,5/37,13.01%,CYP1B1;FAP;PRKX;DPP4;NRP1
prerank,cardiac muscle cell contraction (GO:0086003),-0.2915956004040623,-0.8546666204448733,0.6715686274509803,0.8839585851015473,1.0,7/19,21.86%,CACNA1C;SCN1A;ATP1A1;SCN1B;FGF12;CACNA1G;SCN3B
prerank,extracellular structure organization (GO:0043062),0.35472203274023567,0.8539472010461275,0.7987987987987988,1.0,1.0,35/204,17.49%,ADAMTS7;ICAM4;ITGA1;ECM2;ITGB7;CD47;PECAM1;HSPG2;CD44;LAMA5;COL1A2;LAMA4;DCN;COL4A4;LAMC1;LAMB2;LAMB3;ITGAV;SMOC2;JAM2;ATP7A;NID1;BSG;ITGA8;COL23A1;MMP19;DAG1;ADAMTS1;TGFBI;ELN;ST7;ADAMTSL3;ADAMTS5;COL4A1;FN1
prerank,intracellular protein transmembrane transport (GO:0065002),0.37179294845917055,0.8533566672594123,0.6722595078299777,1.0,1.0,11/42,17.48%,PEX26;C2CD5;CHCHD4;DNAJC15;PEX2;TOMM70;TIMM23;GRPEL2;ZFAND2B;SEC63;PEX14
prerank,adipose tissue development (GO:0060612),0.4374909354461546,0.8532886890865139,0.6257142857142857,1.0,1.0,3/11,17.05%,PGRMC2;ARID5B;XBP1
prerank,carnitine shuttle (GO:0006853),0.4377554832433225,0.8531542852137297,0.639943741209564,1.0,1.0,4/11,15.06%,CPT1B;CPT1A;PRKAG2;CPT2
prerank,skeletal muscle contraction (GO:0003009),0.41184931356993926,0.8528806965797564,0.6500638569604087,1.0,1.0,1/19,4.08%,CCDC78
prerank,myelin assembly (GO:0032288),0.44122032371319514,0.8524118757683707,0.617816091954023,1.0,1.0,2/10,9.64%,ABCA2;PMP22
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.29612671384545786,-0.8520892714965032,0.6960352422907489,0.8881400731261138,1.0,11/17,36.65%,DGKQ;SMAD7;CALM1;SPRED1;SPRED3;PARD3;CALM2;DDIT4;SPRY2;SIRT2;PPEF2
prerank,regulation of metal ion transport (GO:0010959),0.4153395520534596,0.8520488267154246,0.6361290322580645,1.0,1.0,2/16,4.45%,IL16;EPB41
prerank,acute inflammatory response (GO:0002526),0.40083118293446324,0.8520049562845559,0.6521739130434783,1.0,1.0,3/23,17.46%,IL22;F3;ANO6
prerank,cellular response to catecholamine stimulus (GO:0071870),0.40055048741969446,0.8518258435965977,0.6510791366906474,1.0,1.0,7/23,22.08%,MAPK1;PRKACA;GABPA;SNCA;LRRK2;GNB1;ATP2B4
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4276024642949646,0.851491170496866,0.6609498680738787,1.0,1.0,1/13,2.29%,CACNA1I
prerank,cardiac muscle tissue development (GO:0048738),0.36789869956124444,0.8513475413297033,0.6923076923076923,1.0,1.0,6/50,12.63%,HEY2;ZFPM1;CSRP3;NOTCH1;SMAD4;BMPR1A
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.43422795070422304,0.8513079591643917,0.6510344827586206,1.0,1.0,5/13,22.60%,KPNA3;RANBP2;IPO5;KPNB1;KPNA4
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.2727854896906269,-0.8512637768289866,0.6958762886597938,0.8886077518743619,1.0,6/22,13.91%,MAN1C1;EDEM3;RNF185;OS9;EDEM2;RNF139
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.3819553677524441,0.8511847305169334,0.6727898966704937,1.0,1.0,4/33,12.53%,IL12A;OGN;PTEN;EFEMP2
prerank,defense response to virus (GO:0051607),0.3582090000802278,0.851030723349902,0.72920892494929,1.0,1.0,13/100,14.47%,RNASE6;PMAIP1;SKP2;FLNA;CGAS;SERINC5;SERINC3;PDE12;CLPB;MYD88;NT5C3A;IFITM3;TRIM5
prerank,T cell receptor signaling pathway (GO:0050852),0.35394543923105587,0.8509789234079259,0.7740963855421686,1.0,1.0,38/138,21.10%,ERMAP;GRAP2;PSMB7;FYN;PSMD11;FBXW11;PTPN22;PSMF1;IKBKG;PSMC1;PLCG2;BTN3A3;PDPK1;PSMC3;PSMA4;PSMC4;PRAM1;DENND1B;PSMD13;PSME1;THEMIS;PSMB1;RBCK1;RC3H1;PSMD8;PAK2;PSME4;PLCG1;PIK3CA;PSMD4;SPPL3;MAP3K7;MALT1;TRAF6;PRKD2;UBE2N;EIF2B5;IKBKB
prerank,histone H3-K36 demethylation (GO:0070544),-0.35288958842557094,-0.8508099207800031,0.6442953020134228,0.8882955091733387,1.0,4/10,6.80%,KDM7A;KDM4A;PHF8;KDM4B
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.2882747368096825,-0.850759241899583,0.6801801801801802,0.8871427408270101,1.0,6/17,25.41%,ATP1A1;AR;TFPI;ATP1A2;ATP1A3;URI1
prerank,dendritic spine organization (GO:0097061),-0.2508117231588403,-0.8506779709142712,0.782051282051282,0.8860506525681393,1.0,3/26,0.60%,IGF1R;PAK3;TREM2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.42429388745771524,0.8505311257391461,0.6502732240437158,1.0,1.0,5/15,17.78%,NPLOC4;FAF2;DERL2;HSP90B1;SYVN1
prerank,chemical homeostasis (GO:0048878),0.3623828258175471,0.8505083473873805,0.6817702845100105,1.0,1.0,3/61,7.95%,SLC4A1;USF1;NEDD4L
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3930177117134194,0.8501705077442863,0.66388557806913,1.0,1.0,11/26,26.85%,CIB1;PLCG2;CAMTA1;GSK3B;STIMATE;HOMER2;SPPL3;ATP2B4;PTBP1;DYRK2;AKAP6
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.2769034573452054,-0.8490174813805333,0.6349206349206349,0.8884218781523922,1.0,9/20,24.47%,MBTPS1;PSEN2;RELA;HM13;ADAM9;APH1A;SPPL2B;APH1B;SPPL2A
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.39998016694980343,0.8489219833744688,0.6501809408926418,1.0,1.0,8/23,19.71%,MTMR12;MTMR2;PIP4P2;MTMR6;PTEN;MTM1;OCRL;INPP5F
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.38532097249680736,0.848696343282929,0.6728538283062645,1.0,1.0,9/30,21.10%,TANK;IKBKG;TRAF3;BIRC2;TLR6;UBA52;CASP8;RIPK1;IKBKB
prerank,lamellipodium assembly (GO:0030032),0.38849538761315244,0.8483646180845642,0.6595744680851063,1.0,1.0,12/26,25.83%,CCDC88A;ABLIM3;WHAMM;PARVB;RAC1;ARHGEF7;ABLIM2;GOLPH3;VCL;SRGAP2;ABLIM1;ARHGEF6
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.2555388912964937,-0.8483195542495054,0.7,0.8885846710509805,1.0,14/27,33.72%,CACNB2;ANK2;DMD;CACNB4;CALM1;JPH4;SELENON;CACNB1;FKBP1B;CAMK2D;CALM2;ADRA2A;NOS1;JPH3
prerank,response to estradiol (GO:0032355),0.3784042272647592,0.8481149713432126,0.6609392898052692,1.0,1.0,5/31,12.73%,CRHBP;EGFR;SOCS2;RUVBL2;STAT5B
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4027639195475293,0.8476289566842728,0.6458598726114649,1.0,1.0,2/20,4.25%,PRKCE;PTPN22
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3828378628267274,0.8472377204256282,0.6797312430011199,1.0,1.0,6/35,9.71%,STMN1;RIPOR2;ARHGAP35;TNFAIP1;CUL3;HEG1
prerank,renal absorption (GO:0070293),0.44036102701659996,0.8471468941227651,0.6362339514978602,1.0,1.0,1/10,5.93%,GSN
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.37145120604612825,0.8469688879697104,0.6805708013172338,1.0,1.0,12/38,22.61%,DHX58;PUM2;PRKCA;RIOK3;PUM1;DHX9;USP15;CYBA;IFI35;POLR3B;SASH1;AKIRIN2
prerank,ketone body metabolic process (GO:1902224),0.4441447433938781,0.8467011513492654,0.6486880466472303,1.0,1.0,2/10,9.66%,ACSS3;BDH1
prerank,regulation of T cell migration (GO:2000404),0.4121685864458636,0.8466539915044085,0.6604477611940298,1.0,1.0,3/18,10.57%,SPN;RIPOR2;CCR6
prerank,cell projection assembly (GO:0030031),0.39356325852316837,0.8462259463883915,0.6578313253012048,1.0,1.0,6/22,16.79%,GSN;RHOU;RAC2;PARVB;RAC1;PARVA
prerank,cellular response to ATP (GO:0071318),0.41815489156996205,0.8461952377918919,0.6394101876675603,1.0,1.0,3/14,17.46%,TAF1;P2RY1;HSP90B1
prerank,regulation of response to external stimulus (GO:0032101),0.35153357779897837,0.8460103471968418,0.770392749244713,1.0,1.0,32/121,21.86%,FOXA2;DHX58;PTPN22;FOXP1;CAV1;CCR2;TRAF3;BIRC2;BRD4;METAP2;JAK2;CYRIB;STK24;IL1R1;PARK7;XIAP;MYD88;USP14;SPATA2;BCL6;TRIM5;F2R;APPL1;FCGR2B;CXCR4;ERAP1;CD55;CASP8;NMT2;CELF1;AKNA;FGR
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.2890732344845558,-0.8459602948637605,0.6836734693877551,0.8922166067573483,1.0,6/19,15.06%,TGFBR1;ERBB4;ZFPM2;FGF2;VGLL4;TGFBR3
prerank,regulation of sodium ion transport (GO:0002028),-0.243107387537849,-0.8459535168143967,0.7739130434782608,0.8909839254740602,1.0,9/34,15.82%,NKAIN2;ANK3;CNKSR3;ATP1A1;SNTA1;SCN1B;FGF12;PER1;DLG1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.37587571237124506,0.8458233889399531,0.6741321388577828,1.0,1.0,5/35,8.81%,AQP1;PDE7B;PDE2A;AHR;NUDT4
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.23809019210624127,-0.8457503640919484,0.7815126050420168,0.8901306758774293,1.0,8/35,11.77%,NRP2;FARP2;PLXNA4;SEMA3D;SEMA3E;SEMA4C;SH3BP1;SEMA4G
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3960531757129826,0.8455261246502909,0.6556776556776557,1.0,1.0,7/22,25.99%,CHD1L;ERCC3;UBA52;DDB2;XPA;PARP1;RBX1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4164138533915978,0.8454989151136588,0.6469816272965879,1.0,1.0,4/16,15.99%,ZFP36L1;CPEB3;RC3H1;ZFP36L2
prerank,ventricular septum development (GO:0003281),0.374934475841203,0.8451390148255584,0.6867335562987736,1.0,1.0,8/37,12.63%,HEY2;ZFPM1;MDM4;PDE2A;NOTCH1;SMAD4;SLIT3;BMPR1A
prerank,positive regulation of blood coagulation (GO:0030194),0.41915658461580196,0.8448375083218983,0.6484771573604061,1.0,1.0,6/17,23.94%,USF1;F3;F2R;ANO6;APOH;ENPP4
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4186452593838394,0.8448352144103318,0.6420911528150134,1.0,1.0,3/14,16.94%,PMAIP1;IRS1;SIRT1
prerank,positive regulation of biosynthetic process (GO:0009891),0.3692579674504826,0.8445677911481276,0.6951219512195121,1.0,1.0,12/40,21.03%,SORBS1;PLCG2;MTPN;TLR6;RUNX1;F2R;VIM;CYBA;CREB1;ZBTB20;RAB27A;SIRT4
prerank,protein targeting to lysosome (GO:0006622),-0.2736094145690829,-0.844520587783101,0.6903553299492385,0.8913891271333017,1.0,5/20,14.08%,GGA3;LAMP2;SNX16;SCARB2;NAGPA
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.36799652275682465,0.8441718721397391,0.6901408450704225,1.0,1.0,11/48,19.06%,NPPC;PANK2;GUCY1A1;SLC25A16;IMPDH2;PAPSS2;DCAKD;ADSL;AK5;ADCY8;PANK1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.311679472929016,-0.8437675665820464,0.6807692307692308,0.8916793480362577,1.0,7/14,31.65%,PRKCI;ECSCR;THBS1;PDCD4;CD40;RGCC;CCL2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.35719893396810787,0.8435275271976227,0.7337461300309598,1.0,1.0,15/76,20.07%,SPAG5;GPSM2;PRKCE;SYNPO2;DYNC1H1;SNX9;CFL2;CDC42EP3;NRP1;NUMA1;KATNBL1;HCLS1;CDC42EP1;PROX1;PLK4
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.3558726212879896,-0.8430588841908228,0.6355140186915887,0.8919834846180055,1.0,2/10,5.92%,TSNAX;TSN
prerank,megakaryocyte differentiation (GO:0030219),0.43373673774484117,0.8430334118676581,0.6356050069541029,1.0,1.0,1/11,3.56%,ZFPM1
prerank,epithelial tube morphogenesis (GO:0060562),-0.241317609279812,-0.8427058864763369,0.7327586206896551,0.8913919552029048,1.0,5/32,10.26%,ACVR1;CSF1R;CTNNB1;RYR2;PKD1
prerank,positive regulation of catalytic activity (GO:0043085),0.3766830768522839,0.8426714990747576,0.6941045606229144,1.0,1.0,7/37,14.04%,PHACTR4;MSH6;CAV1;CIB1;MAPK14;ATP7A;PSEN1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.376522918945248,0.8425497274688745,0.6759156492785794,1.0,1.0,12/39,23.60%,GPD1L;YWHAH;FXYD5;NEDD4L;CHRM3;STK39;UTRN;YWHAE;RIPK1;PHB2;NEDD4;WNK3
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.4416311071056344,0.8424193297932673,0.6444759206798867,1.0,1.0,5/10,24.49%,ACADM;IVD;ETFDH;ETFA;ETFB
prerank,heart contraction (GO:0060047),-0.23507026632703687,-0.842378535294534,0.6666666666666666,0.8908314353116747,1.0,9/41,18.68%,SGCD;SGCZ;DMD;SCN1B;RYR2;ATP1B1;SLC8A1;GPX1;ATP1A2
prerank,regulation of microtubule-based movement (GO:0060632),0.44002562496960845,0.8421980806385079,0.6620111731843575,1.0,1.0,4/11,21.43%,HDAC6;HAP1;DYNLT2B;NEFH
prerank,cranial nerve development (GO:0021545),0.4304743118102464,0.842102384363918,0.6638537271448663,1.0,1.0,3/11,19.35%,ERBB3;TIFAB;PAX2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.2658772654734232,-0.8410851796191532,0.6950354609929078,0.8922330998685233,1.0,7/26,15.82%,KCNAB1;ANK2;ATP1B2;VAMP2;FHL1;ATP1B1;DLG1
prerank,amide biosynthetic process (GO:0043604),0.36030742278278594,0.84036946352751,0.6875664187035069,1.0,1.0,9/47,16.35%,RHD;SGMS2;NMRAL1;CERS4;SGMS1;PCSK1;ASL;ASS1;CERS6
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.4245233484346736,0.8403618529333379,0.6666666666666666,1.0,1.0,3/14,19.36%,TYROBP;ATP6AP1;TRAF6
prerank,positive regulation of protein ubiquitination (GO:0031398),0.35665259737432914,0.8401818006942477,0.7316821465428277,1.0,1.0,13/80,12.48%,PLK1;BRCA1;AXIN1;CAV1;PEF1;BIRC2;PIN1;UBQLN1;CUL3;XIAP;SPSB4;PAXIP1;CDK5RAP3
prerank,negative regulation of cholesterol transport (GO:0032375),0.437986956116055,0.8400768045525552,0.6757532281205165,1.0,1.0,2/10,19.49%,ABCA2;SREBF2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.4287793998715836,0.8397091460798826,0.654054054054054,1.0,1.0,7/12,22.79%,ABCA2;ABCA7;ROCK2;FLOT2;ROCK1;TMED10;FKBP1A
prerank,cellular response to glucose starvation (GO:0042149),0.3695055411821199,0.8394086112986834,0.6902944383860414,1.0,1.0,14/41,22.67%,PMAIP1;TBL2;SIK2;PICK1;SZT2;BECN1;PRKAG2;TP53;XBP1;HNRNPA1;NIM1K;PRKAG1;BRSK1;MYBBP1A
prerank,cholesterol metabolic process (GO:0008203),0.3540052674170439,0.8394016798932575,0.7172774869109948,1.0,1.0,15/68,21.22%,LBR;CEL;LSS;OSBPL5;GBA2;IDI1;CYP27A1;CYP46A1;NSDHL;FDPS;DHCR7;LDLRAP1;PPARD;OSBPL1A;SCAP
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.42174783675503746,0.8390620031573446,0.6631016042780749,1.0,1.0,5/14,16.59%,SAP18;SRSF4;RNPS1;SRSF10;SRSF7
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.39630848970514676,0.8389467693609913,0.6560196560196561,1.0,1.0,4/20,16.31%,TMPRSS3;NEDD4L;KCNJ2;ATP6AP1
prerank,JNK cascade (GO:0007254),0.3693908070453658,0.8383097913641473,0.6808510638297872,1.0,1.0,13/40,20.53%,CRKL;IKBKG;MAP3K5;MAP4K2;TAB1;UBE2V1;TAB3;MAP3K11;UBA52;MAP3K7;PTGER4;TRAF6;UBE2N
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.26376337401933075,-0.8375185390275726,0.75,0.8980445554745632,1.0,6/24,15.00%,SEMA3D;SEMA3E;SEMA4C;SEMA4G;VEGFA;SEMA3A
prerank,Rho protein signal transduction (GO:0007266),0.3606047905589084,0.8373608387398028,0.711558854718982,1.0,1.0,13/53,21.03%,PHACTR4;NTN1;ARHGDIB;ARHGEF3;COL1A2;RHOU;CDC42EP3;ROCK2;RIPOR1;ARHGDIA;CDC42EP1;ARHGAP1;ROCK1
prerank,neutrophil activation (GO:0042119),-0.3344218549132032,-0.8372966410875803,0.6777777777777778,0.8972745371631614,1.0,2/12,6.72%,KMT2E;FCER1G
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.40833178402501796,0.8369714453216551,0.6706989247311828,1.0,1.0,3/15,15.99%,ZFP36L1;HNRNPU;ZFP36L2
prerank,response to insulin (GO:0032868),0.35239562574962463,0.8367131566176856,0.7274590163934426,1.0,1.0,18/80,17.66%,C2CD5;SLC2A4;USF1;FOXO1;DENND4C;SORBS1;ZFP36L1;RAB8A;PDPK1;KAT2B;RAB8B;ZBTB7B;PRKDC;IRS1;CAPN10;SIRT1;XBP1;EPRS1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.35649098246074884,0.8364365544623372,0.7349272349272349,1.0,1.0,12/67,16.70%,BLK;FYN;JAK2;EGFR;EPHA3;DYRK1A;BTK;RELN;FLT3;PIBF1;FGFR1;JAK3
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.40474175734887546,0.836275253283225,0.6632390745501285,1.0,1.0,5/17,22.50%,PTEN;EFEMP2;APLN;CDKN1A;CDKN1B
prerank,cellular response to starvation (GO:0009267),0.3493477655593944,0.8361138408805309,0.8116817724068479,1.0,1.0,38/147,20.91%,STK26;PMAIP1;DAP;MAPK1;EIF2S1;TBL2;SIK2;FOXO1;KLF10;MAP3K5;PICK1;LARS1;STK24;SEC13;SZT2;MLST8;BECN1;FAS;RNF152;ATP6V0E1;PRKAG2;LAMTOR4;LAMTOR3;TP53;RIPOR1;NPRL3;SIRT1;XBP1;ATP6V0D1;LRRK2;HNRNPA1;NIM1K;CDKN1A;SREBF2;RRAGB;WDR45B;PRKAG1;WRN
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4060468578082785,0.8360970461709833,0.664572864321608,1.0,1.0,3/17,12.63%,HEY2;NOTCH1;BMPR1A
prerank,negative regulation of chemokine production (GO:0032682),0.4157614280248833,0.835103656908365,0.6358768406961178,1.0,1.0,1/14,2.08%,MEFV
prerank,coenzyme A biosynthetic process (GO:0015937),0.4382203635168793,0.8347385443196923,0.6638537271448663,1.0,1.0,4/11,19.06%,PANK2;SLC25A16;DCAKD;PANK1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4382203635168793,0.8347385443196923,0.6638537271448663,1.0,1.0,4/11,19.06%,PANK2;SLC25A16;DCAKD;PANK1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4382203635168793,0.8347385443196923,0.6638537271448663,1.0,1.0,4/11,19.06%,PANK2;SLC25A16;DCAKD;PANK1
prerank,camera-type eye morphogenesis (GO:0048593),0.4389687510276926,0.8345369814182211,0.6662030598052852,1.0,1.0,3/10,18.10%,SHROOM2;SKI;KDM2B
prerank,response to retinoic acid (GO:0032526),0.3557702834900394,0.8344353204538885,0.7313746065057712,1.0,1.0,11/59,19.35%,AQP1;ATM;SETX;EPHA3;CDKN2D;ASXL1;PTK7;RXRB;RARG;CREB1;PAX2
prerank,response to lipopolysaccharide (GO:0032496),0.34596372218362337,0.8342821244111199,0.7863590772316951,1.0,1.0,13/138,8.54%,GFI1;IL12A;HMGB2;PTPN22;S100A9;MAPKAPK3;SLPI;FOXP1;NR1D1;S100A8;HMGB1;MAPK14;JAK2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.40943795423924034,0.834125301075686,0.6605504587155964,1.0,1.0,1/16,1.57%,BRCA1
prerank,organophosphate biosynthetic process (GO:0090407),-0.23139182426165866,-0.8340733036521522,0.7352941176470589,0.9024559467746355,1.0,9/37,14.29%,AGPAT5;ITPKB;MBOAT1;IP6K1;GNPAT;TPI1;MOCS2;LPCAT1;FGF2
prerank,negative regulation by host of viral process (GO:0044793),0.4419801329349364,0.834073066718303,0.6632653061224489,1.0,1.0,3/10,14.75%,PSMC3;VAPA;CCNK
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4339528651618795,0.8334468507263303,0.6753782668500687,1.0,1.0,2/12,10.14%,DCN;CHST12
prerank,positive regulation of catabolic process (GO:0009896),0.35554284235118483,0.8330897955532311,0.7278415015641293,1.0,1.0,8/65,12.14%,BARD1;DTL;AXIN1;FOXO1;STX5;NEDD4L;FZR1;OAZ1
prerank,dicarboxylic acid transport (GO:0006835),0.38024664989627005,0.8327542414539338,0.6690058479532164,1.0,1.0,6/28,17.48%,SLC25A12;ABCC2;SLC19A1;SLC25A22;SLC25A13;ARL6IP5
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.313866301584398,-0.8325464418235892,0.6926070038910506,0.9042129743783087,1.0,4/13,10.43%,IGF1;AKT2;PHKG2;IRS2
prerank,ether lipid biosynthetic process (GO:0008611),-0.3419329388728188,-0.8324765984898294,0.6802721088435374,0.9030902375091384,1.0,7/10,35.93%,DHRS7B;GNPAT;CHPT1;PEDS1;PLA2G4A;PEX7;PLA2G4C
prerank,focal adhesion assembly (GO:0048041),0.40038353679832095,0.8323707870079989,0.6473489519112207,1.0,1.0,8/21,23.20%,SORBS1;WHAMM;ACTN2;TESK2;BCR;ARHGEF7;ACTN1;SRC
prerank,negative regulation of protein polymerization (GO:0032272),0.3832350084120381,0.8322884842809826,0.6778443113772455,1.0,1.0,9/27,23.15%,STMN1;CYRIB;DYRK1A;SNCA;TBCD;EML2;SSH2;TWF1;PRKCD
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.35161072960729134,0.8322355268227009,0.7103092783505155,1.0,1.0,11/73,14.45%,CD2;SPN;TWIST1;CCR2;RASGRP1;HMGB1;PLCG2;JAK2;DHX9;PSEN1;TYROBP
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3926880714914314,0.8320543626431328,0.6844660194174758,1.0,1.0,3/22,7.99%,NRDC;SNX33;SNX9
prerank,cellular iron ion homeostasis (GO:0006879),0.35290296561287765,0.8319386809157218,0.7054429028815368,1.0,1.0,5/55,5.04%,TFR2;HEPH;ALAS2;CYBRD1;TFRC
prerank,acidic amino acid transport (GO:0015800),0.40609598412038594,0.8319136446151781,0.6627906976744186,1.0,1.0,4/17,17.48%,SLC25A12;SLC25A22;SLC25A13;ARL6IP5
prerank,positive regulation of TOR signaling (GO:0032008),-0.23130682444329467,-0.8316016438846277,0.7222222222222222,0.9035452601002532,1.0,10/40,14.32%,TREM2;GPR137C;RRAGD;HDAC3;WDR59;FLCN;FNIP1;LAMTOR5;NCKAP1L;RRAGC
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.3656586932761307,0.8315168142917321,0.7018498367791077,1.0,1.0,12/39,23.60%,PRKCE;GPD1L;YWHAH;FXYD5;NEDD4L;FGF13;STK39;UTRN;HECW2;NEDD4;OSR1;WNK3
prerank,regulation of ossification (GO:0030278),0.3679420394650024,0.8312511236258632,0.6901565995525727,1.0,1.0,5/36,8.28%,LRP4;SGMS2;TWIST1;NOTCH1;ZBTB16
prerank,cortical cytoskeleton organization (GO:0030865),-0.2292960646028104,-0.8311159443759204,0.8214285714285714,0.9033372516564029,1.0,18/41,23.44%,FHOD1;RHOBTB1;FMNL2;RHOBTB2;STRIP1;RHOG;EPB41L3;NCKAP1L;RHOQ;RHOH;FHOD3;DLG1;TRPV4;LLGL1;PLEK;RHOC;FMNL3;RHOF
prerank,regulation of phospholipase activity (GO:0010517),0.43856719640285124,0.8310447904940529,0.6642120765832106,1.0,1.0,5/10,22.74%,RASGRP1;PDPK1;FGFR1;SNCA;FGFR2
prerank,regulation of muscle contraction (GO:0006937),0.3789809209973737,0.8309260736851952,0.6753554502369669,1.0,1.0,3/26,8.88%,CAV1;PPP1R12B;KCNA1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.30547730881882906,-0.8309045999404917,0.6833333333333333,0.9024792992141589,1.0,5/15,17.87%,SLC27A1;SCARB1;CTDNEP1;FBXW7;GPLD1
prerank,positive regulation of response to external stimulus (GO:0032103),0.3448330044530927,0.8306900802061687,0.7941767068273092,1.0,1.0,18/128,11.45%,CD47;DHX58;USF1;CCN4;IL16;S100A9;GPRC5B;CCR2;S100A8;TRADD;PDE2A;PUM2;PRKCA;IL17RA;RIOK3;NAPEPLD;PUM1;DHX9
prerank,glucan catabolic process (GO:0009251),0.4123297628083628,0.8306207878477044,0.6815789473684211,1.0,1.0,2/15,12.06%,PGM2;PHKA2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.42153461991533303,0.8303712502150874,0.6617050067658998,1.0,1.0,8/13,26.20%,CNOT1;RC3H1;CNOT8;PNPT1;PRR5L;CNOT7;ZC3HAV1;KHSRP
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.28627384252558064,-0.830319557644316,0.6894977168949772,0.9023871084413903,1.0,5/18,8.48%,HEATR1;PHF8;WDR75;DHX33;ATF4
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.29721265851281764,-0.8302199701311057,0.6880733944954128,0.9013323977651014,1.0,2/16,3.68%,VSIR;CD274
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.40532160016332397,0.8301450230620477,0.6760374832663989,1.0,1.0,8/15,27.42%,HAP1;CNTNAP4;BAIAP3;CLN3;USP46;SYN3;NLGN2;NLGN1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.35264103420976306,0.8300160904853425,0.7383177570093458,1.0,1.0,10/71,12.38%,ADAMTS7;PMAIP1;FAP;PRPF19;NR1D1;FBXO44;HDAC6;LONP1;CTSK;CTSO
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3695493305235614,0.8299268550599919,0.6863636363636364,1.0,1.0,4/33,9.62%,CARD10;NOTCH1;HMGB1;MECP2
prerank,positive regulation of cell motility (GO:2000147),0.3476148484492391,0.8295799454601147,0.838,1.0,1.0,31/205,15.51%,GTSE1;ARHGEF39;LEF1;PECAM1;SYNE2;TIAM1;NTN1;SUN2;PPP3CA;CCN1;TWIST1;NEDD9;CAV1;ATM;TRADD;NOTCH1;DDRGK1;CIB1;PRKCA;EGFR;CBLL1;RDX;F3;ROCK2;RACK1;ACTN4;PDCD10;RIPOR1;EGF;F2R;SPAG9
prerank,homocysteine metabolic process (GO:0050667),-0.3323894250418016,-0.8289982641811636,0.6885813148788927,0.9026078721439836,1.0,4/11,14.43%,MTHFR;MMUT;MTRR;NOX4
prerank,regulation of peptide hormone secretion (GO:0090276),0.34655641081197963,0.8289178742384097,0.7088477366255144,1.0,1.0,8/67,11.88%,TFR2;ITPR1;CRHBP;PRKCA;PICK1;KCNC2;DPP4;EIPR1
prerank,toxin transport (GO:1901998),0.4385879965116133,0.8287717661233889,0.6597796143250688,1.0,1.0,2/10,18.32%,ANTXR2;ADAM10
prerank,regulation of protein polymerization (GO:0032271),-0.2291907105110263,-0.8286705104074197,0.7363636363636363,0.9020481730652754,1.0,10/35,19.56%,PAK3;CAMSAP2;HSP90AA1;PFN1;COTL1;PFN2;TTBK1;ARL2;RASA1;CTTN
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3470255938264816,0.8284482813578252,0.8016032064128257,1.0,1.0,22/140,19.21%,S1PR4;CXCR5;IAPP;LPAR4;CAV1;CCR2;HMGB1;P2RY1;CCR6;FIS1;ADCYAP1;JPH1;F2R;LPAR1;GPR35;CD24;TRPM4;ADCY8;SPPL3;CXCR4;PTGER4;CD55
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.2848692496918296,-0.8283800898482182,0.708994708994709,0.9014447320646476,1.0,10/19,29.80%,PTPRJ;GRM5;RYR2;BCAP31;PRNP;FKBP1B;KDR;VCAM1;ADGRL1;TRPM2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.36155764323330775,0.8282274859487805,0.7138157894736842,1.0,1.0,6/41,11.03%,ERBB3;FYN;NEDD9;GPRC5B;TGFA;RELN
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.2362043252069585,-0.8278769105911226,0.7678571428571429,0.9011922475332783,1.0,4/35,7.01%,CDH11;CDH8;CDH13;CDH12
prerank,inorganic anion transmembrane transport (GO:0098661),0.3611048018913212,0.827644156995592,0.7357894736842105,1.0,1.0,8/63,12.59%,SLC12A3;SLC5A5;SLC12A7;SLC12A1;GABRA4;GABRA5;ANO3;SLC12A6
prerank,muscle cell migration (GO:0014812),-0.34493173498911045,-0.8275502835916315,0.7151702786377709,0.9005156852949044,1.0,4/10,23.52%,ITGB3;AAMP;MEGF10;PLAT
prerank,hippo signaling (GO:0035329),0.3886077005623095,0.8274108664380592,0.6839565741857659,1.0,1.0,10/26,20.15%,TEAD4;AMOTL2;LATS1;MOB1A;STK4;YWHAE;AMOTL1;MOB1B;STK3;NPHP4
prerank,cellular response to interferon-gamma (GO:0071346),0.3445824629516818,0.8273455535557017,0.7563710499490316,1.0,1.0,21/88,21.76%,CD47;GBP4;PML;CD44;SP100;IRF9;PDE12;GBP2;JAK2;B2M;TRIM68;TRIM5;IRF8;CCL25;EPRS1;LGALS9;DAPK1;SYNCRIP;GAPDH;CIITA;RPL13A
prerank,negative regulation of cell adhesion (GO:0007162),0.350378988160752,0.8271039326682484,0.7402464065708418,1.0,1.0,8/72,9.97%,CYP1B1;SPN;ERBB3;RIPOR2;ARHGDIB;NOTCH1;PLXNA2;CBLL1
prerank,regulation of cytoskeleton organization (GO:0051493),0.3435801379221254,0.8268293896705171,0.7872340425531915,1.0,1.0,23/108,18.69%,ARHGEF5;MAPK1;CCDC88A;EZR;S100A9;S100A8;CLASP1;RND3;ARHGAP35;MARK2;EPHA3;MLST8;CRK;ROCK2;RAC2;DIAPH1;GSK3B;PAK2;RAC1;KATNBL1;IQGAP1;TAOK1;CLN3
prerank,positive regulation of GTPase activity (GO:0043547),0.3442694769621832,0.8264797693001978,0.8308308308308309,1.0,1.0,19/188,9.52%,ECT2;PRTN3;EZH2;ARHGEF5;ARHGAP11A;TBC1D1;TIAM1;NET1;TBC1D8B;TBC1D22B;RASGRP1;RANGAP1;EVI5;PIN1;SNX9;RAP1GAP2;LARS1;CAV2;GMIP
prerank,dermatan sulfate metabolic process (GO:0030205),0.4266019809592297,0.8264468847267734,0.6884353741496598,1.0,1.0,2/13,10.14%,DCN;CHST12
prerank,protein tetramerization (GO:0051262),0.35430010429165426,0.826417188406117,0.7489583333333333,1.0,1.0,12/67,20.17%,MS4A1;TK1;CUTC;CBR4;ACOT13;B2M;KCNJ2;TRPM4;SNCA;PKD2;KCNC1;CPSF7
prerank,receptor catabolic process (GO:0032801),0.38218400093378696,0.826381695556594,0.680672268907563,1.0,1.0,7/24,18.62%,CLTC;BECN1;SNX25;AP2B1;MYLIP;KIF16B;RNF43
prerank,nucleotide metabolic process (GO:0009117),-0.2634895942099127,-0.82629275111097,0.7357142857142858,0.9017118921631813,1.0,15/23,35.35%,CMPK1;ME1;NMNAT3;DCK;NMNAT1;FHIT;DCTD;AK1;NMNAT2;AK7;GUK1;ENPP3;AK4;AK8;NME2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.28208563345213344,-0.8256598886687944,0.7741935483870968,0.9016360656619729,1.0,8/19,27.59%,APP;TMEM106A;MAPK8;WFS1;KLF2;MAPK7;KLF4;CHRNA7
prerank,negative regulation of MAPK cascade (GO:0043409),0.3471565143813663,0.8251362599124282,0.7609805924412666,1.0,1.0,15/87,14.47%,FOXM1;EZR;CAV1;FOXO1;PIN1;STK38;ABCA7;SMAD4;RPS6KA6;PTEN;CDK5RAP3;SPRED2;MYC;PPIA;DAG1
prerank,pinocytosis (GO:0006907),0.43577018156313674,0.8250673703377178,0.6671469740634006,1.0,1.0,2/10,4.96%,SNX33;MAPKAPK3
prerank,monosaccharide transmembrane transport (GO:0015749),0.4091524004619176,0.8249910983311368,0.6901041666666666,1.0,1.0,2/16,10.96%,SLC2A8;SLC2A12
prerank,regulation of vesicle-mediated transport (GO:0060627),0.34663104837621667,0.8243563699761869,0.7640449438202247,1.0,1.0,23/91,18.53%,RAB33B;CD177;MAPK1;STON1;ARFGAP1;RAB8A;LGI3;ITGAV;RIT2;RAB8B;DNAJC13;HAP1;PACSIN2;RAB11B;NRP1;STON2;PLD1;MAP2K1;RAB5A;CHMP3;USP7;LRRK2;RUFY1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3993614666918583,0.824229376244759,0.65625,1.0,1.0,5/18,18.96%,SOX6;NOTCH1;XBP1;HDAC4;HDAC1
prerank,cellular response to sterol (GO:0036315),-0.32229841845959806,-0.8239600127472908,0.690566037735849,0.9037001657045098,1.0,5/13,18.98%,SMO;OSBPL7;GRAMD1B;GPLD1;INSIG1
prerank,extracellular matrix organization (GO:0030198),0.341720715484118,0.8236826334567041,0.895,1.0,1.0,47/276,17.49%,ADAMTS7;ICAM4;CYP1B1;ITGA1;ECM2;ITGB7;CD47;PECAM1;HSPG2;CD44;PLOD3;HAS1;FLRT2;CRTAP;LAMA5;GSN;COL1A2;LAMA4;DCN;COL4A4;LAMC1;LAMB2;LAMB3;ITGAV;SMOC2;JAM2;CAPN1;ATP7A;NID1;TLL2;BSG;CTSK;ITGA8;FLOT1;COL23A1;MMP19;DAG1;P3H4;ADAMTS1;TGFBI;ELN;ST7;TGFB2;ADAMTSL3;ADAMTS5;COL4A1;FN1
prerank,chondrocyte differentiation (GO:0002062),0.3652911098027545,0.8235071873997561,0.6872852233676976,1.0,1.0,3/32,6.66%,SOX6;SULF2;RUNX3
prerank,melanosome localization (GO:0032400),0.3827713606730612,0.8231884734656862,0.6850490196078431,1.0,1.0,9/21,24.62%,SHROOM2;RAB11B;BBS4;VPS33B;MREG;RAB27A;RAB27B;BBS7;BBS2
prerank,steroid catabolic process (GO:0006706),0.4213195818151476,0.8225651673488329,0.6929955290611028,1.0,1.0,1/10,6.13%,YWHAH
prerank,epidermal cell differentiation (GO:0009913),-0.22661646049137713,-0.8224847587068919,0.8556701030927835,0.9054035692494335,1.0,7/41,16.45%,CTNNB1;HDAC2;ST14;CASP3;ADAM9;ERCC2;JAG1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3436453520596897,0.822396625481233,0.806060606060606,1.0,1.0,26/116,23.64%,VIPR2;IAPP;RAMP1;FYN;PTHLH;DPEP1;NPSR1;MAPK14;PRKACA;INSL3;PLCG2;CALCRL;ADCYAP1;PLCG1;ADCY8;FCGR2B;CREB1;PTGER4;PRKAR2A;SYK;ADCY9;FGR;GNB1;ADAM17;SRC;MYH9
prerank,presynapse organization (GO:0099172),-0.33919824322760905,-0.8217906009519814,0.650887573964497,0.9055452263856584,1.0,5/10,37.65%,C5AR1;DVL1;LRRTM3;WNT5A;WNT7A
prerank,positive regulation of angiogenesis (GO:0045766),0.3425585510320008,0.8215986207379704,0.7850655903128153,1.0,1.0,19/108,17.05%,CYP1B1;BRCA1;AQP1;TWIST1;EMC10;PGF;PRKCA;SMOC2;PDPK1;HIPK2;VASH2;PRKCB;F3;AGGF1;MYDGF;RUNX1;PLCG1;SIRT1;XBP1
prerank,negative regulation of protein secretion (GO:0050709),0.3611224163706105,0.8213053095260024,0.7064116985376828,1.0,1.0,1/38,0.73%,IL12A
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.34806717789240704,0.821177752729122,0.765495867768595,1.0,1.0,19/74,17.60%,PSMB7;PSMD11;PSMF1;PSMC1;NOTCH1;PSMC3;PSMA4;PSMC4;NFE2L2;PSMD13;PSME1;CREBBP;PSMB1;LIMD1;PSMD8;PSME4;VHL;PSMD4;UBA52
prerank,ncRNA 3'-end processing (GO:0043628),0.4116775777934547,0.8211418991076168,0.6839237057220708,1.0,1.0,5/14,20.66%,INTS14;ERI1;TRNT1;PTCD1;INTS12
prerank,detection of visible light (GO:0009584),0.4051290638220285,0.8209017972150024,0.6645326504481434,1.0,1.0,1/16,8.02%,CEP250
prerank,protein processing (GO:0016485),0.345690799219392,0.8206553575879121,0.7810590631364562,1.0,1.0,21/102,20.43%,TMPRSS4;KEL;MYRFL;PIDD1;CPM;CASP2;METAP2;SPCS1;PITRM1;TMEM208;FAM111A;F3;PSEN1;PCSK1;CPD;SPPL3;ADAM10;CLN3;PCSK7;MME;SPCS3
prerank,positive regulation of lymphocyte migration (GO:2000403),0.42652000783559285,0.8204422162645572,0.6861626248216833,1.0,1.0,2/12,9.15%,SPN;JAM2
prerank,receptor metabolic process (GO:0043112),0.3478168011504751,0.8200012362818391,0.7354211663066955,1.0,1.0,15/53,18.37%,RAMP1;TFRC;CAV1;CLTC;GRB2;CALCRL;BECN1;SNX25;ARRB2;RAB11B;LMTK2;GRK2;LDLRAP1;SNCA;KIF16B
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3573400321596527,0.8199419887526925,0.727854855923159,1.0,1.0,11/53,13.47%,XPO1;GLMN;PSMF1;DESI1;DDRGK1;PRKACA;PSMC3;RAD23A;UCHL5;USP14;PSME1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3422999673760588,0.8199271950737042,0.8062563067608476,1.0,1.0,11/117,8.37%,VIPR2;IAPP;RAMP1;FYN;PTHLH;DPEP1;NPSR1;MAPK14;PRKACA;INSL3;PLCG2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3833150443321598,0.8195774375742815,0.6983372921615202,1.0,1.0,4/24,12.03%,C2CD5;FYN;CIB1;FIS1
prerank,positive regulation of developmental process (GO:0051094),0.3378279167137095,0.819057013752125,0.8142570281124498,1.0,1.0,44/164,23.20%,FOXA2;CDC20;SOX6;AURKA;FBXO5;PA2G4;TFRC;CLASP1;DCN;ZBTB16;LLPH;RBM19;CPEB3;NR2C2;RELN;KMT5C;PLCB1;TAPT1;FIS1;PAXIP1;BMPR1A;NUMA1;MCU;PSEN1;DAG1;FGFR1;VHL;RIF1;SIRT1;XBP1;TRPM4;ARHGEF7;NRXN1;PAX2;AGO2;ALK;BNIP3;RPS6KA3;ZDHHC6;PHLDB1;ACVR1B;NIBAN2;NCOA3;SRC
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.3879024137583079,0.8190252071651983,0.7063679245283019,1.0,1.0,4/24,8.37%,ITPR1;HTR2A;IBTK;PLCG2
prerank,response to calcium ion (GO:0051592),0.3419247912237454,0.8187839901055697,0.783756345177665,1.0,1.0,14/102,14.77%,ECT2;SLC25A12;PPP3CA;CRHBP;SYT8;CAV1;DPEP1;PEF1;PLCG2;SYT3;SEC31A;SLC25A13;ANXA11;ADGRV1
prerank,glial cell differentiation (GO:0010001),-0.24033536194365895,-0.818725198211625,0.7786259541984732,0.9103089089039056,1.0,16/28,30.91%,PTPRZ1;SLC8A3;CDH2;GPR157;STAT3;CDK5;SOX4;ADGRG6;SOX11;SOX8;SOX10;NFIB;SOX9;EGR2;GPC1;METRN
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.2700515411337325,-0.8186833412018385,0.7309417040358744,0.9091914600083332,1.0,2/18,1.45%,RGS10;GNA15
prerank,cellular response to organic substance (GO:0071310),0.3410364391912437,0.8185638633432059,0.8002018163471241,1.0,1.0,27/116,20.40%,CYP1B1;LEF1;RAMP1;DCPS;HDAC6;CIB1;SOCS2;PARK7;EMD;PTPN7;PTPN14;FLT3;SLIT3;BMPR1A;STAT5B;RACK1;PTPN5;HCLS1;ARL6IP5;LDLRAP1;CXCR4;PTPN13;LRRK2;TRAF6;MME;NCOA2;ACVR2B
prerank,regulation of neurotransmitter secretion (GO:0046928),0.37339202671499117,0.8184131807161047,0.7126168224299065,1.0,1.0,10/32,21.64%,CHRNB4;BAIAP3;DTNBP1;GSK3B;RAB5A;MCTP1;LRRK2;HCRT;RIMS3;MCTP2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3490324185442958,0.8182105914831965,0.7317073170731707,1.0,1.0,10/59,17.07%,SDK1;PECAM1;HMCN1;IGSF21;BSG;PALLD;NECTIN1;KIRREL3;CDH4;EMB
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3597992314340803,0.8180275265618412,0.7013574660633484,1.0,1.0,6/36,9.19%,DDAH2;CAV1;TERF2;NUS1;LYPLA1;EGFR
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.3094364617255973,-0.8178474427025939,0.7153846153846154,0.9095365379548886,1.0,2/13,1.27%,TGFBR1;RBPMS
prerank,negative regulation of immune response (GO:0050777),0.3403934303746293,0.8175808896871022,0.8442211055276382,1.0,1.0,26/154,18.88%,RNF26;VIPR2;IAPP;RAMP1;FYN;DHX58;CCR2;PTHLH;DPEP1;NPSR1;MAPK14;PRKACA;INSL3;PLCG2;PCBP2;CALCRL;ADCYAP1;RC3H1;NLRC3;PLCG1;ADCY8;TRAFD1;FCGR2B;CREB1;PTGER4;PPM1B
prerank,negative regulation of ossification (GO:0030279),0.38397231096040474,0.8172736328324538,0.7060931899641577,1.0,1.0,5/23,20.56%,LRP4;NOTCH1;CHSY1;TRPM4;RBPJ
prerank,inner mitochondrial membrane organization (GO:0007007),-0.21947911720419738,-0.8172318847097159,0.8028169014084507,0.9095806624652688,1.0,25/47,32.77%,MICOS10;GHITM;APOO;AGK;MTX2;LETM1;ATP5F1C;MTX3;SPG7;ATP5MC3;MAIP1;TIMM22;TIMM10B;AFG3L2;ATP5MC1;MTX1;TIMM13;CHCHD6;TIMM8B;TMEM11;ROMO1;TIMM29;UQCC3;IMMT;ATP5MG
prerank,cardiac cell development (GO:0055006),-0.32330380549361826,-0.817000846996956,0.7142857142857143,0.9087865288364304,1.0,4/11,16.67%,VEGFA;SLC8A1;JAG1;CXADR
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.4046962614374159,0.8169133504543171,0.6666666666666666,1.0,1.0,2/14,7.70%,SULF2;FUZ
prerank,linoleic acid metabolic process (GO:0043651),0.3935465896916931,0.8168286874860231,0.6899618805590851,1.0,1.0,2/17,14.45%,ABCD1;ELOVL5
prerank,glycoprotein catabolic process (GO:0006516),-0.27559041740472656,-0.8167919281943685,0.7327586206896551,0.9079621728866797,1.0,3/17,3.74%,MANBA;NGLY1;STT3B
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.42679326254042366,0.8167892836633452,0.678939617083947,1.0,1.0,6/10,29.47%,ACTN4;RXRB;RARG;RXRG;RXRA;SNW1
prerank,ganglioside metabolic process (GO:0001573),-0.27425958794473787,-0.8167667690099274,0.7486338797814208,0.9067987966966975,1.0,7/20,20.64%,HEXB;ST6GALNAC4;ST6GALNAC6;B4GALNT1;ST6GALNAC3;CLN6;ST8SIA3
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3891038358891904,0.8162425715817684,0.6947890818858561,1.0,1.0,2/21,4.01%,PGM2;H6PD
prerank,protein transport (GO:0015031),0.33701404759901854,0.8159137157163467,0.912,1.0,1.0,66/332,17.84%,CENPF;NEURL1B;TFR2;TBC1D1;NDC1;RAMP1;TBC1D8B;RCN3;CD74;STX17;SNX33;TBC1D22B;ARL5C;NAPG;TFRC;TLK1;EVI5;ARL11;SYS1;RAB1B;RAB22A;YWHAH;STX5;ARF4;HDAC6;ARFGAP3;SNX9;RAB8A;SLC10A7;CLTC;PICK1;BLZF1;SEC13;MIA2;STX11;CALCRL;GGA1;KIF13A;IL10RA;RAB8B;PRKCB;ARF3;SEC31A;RAB11B;RAB43;CANX;LMTK2;CHMP1B;ATP6V0E1;COPZ1;VPS33B;SCAMP1;TBC1D25;ARL4C;ATP6AP1;RAB5A;STEAP3;CHMP3;NAPB;ATP6V0D1;CHMP2B;ADPRH;HSP90B1;ARL6IP5;EIF2D;GGA2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4106725825280802,0.8158668145360977,0.6679841897233202,1.0,1.0,6/14,23.11%,ABCA7;DYRK1A;PSEN1;ADAM10;CLN3;ADAM17
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.30991898741021506,-0.8156685550954983,0.6888888888888889,0.9076246648243532,1.0,5/13,18.89%,NRP2;PLXNA4;PLXNA1;SEMA3A;PLXNB3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.25618241106435835,-0.8156520279493256,0.7810650887573964,0.9064406766406482,1.0,9/24,24.56%,EPN2;ARNT;ITGA5;ITGB3;GRB10;DAB2IP;HIF1A;MT3;VTN
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.3408899451896025,-0.8155884748639791,0.6790540540540541,0.9053684362960541,1.0,7/10,33.71%,NEXMIF;PPM1F;VEGFA;BMP6;RGCC;NOTCH4;MAD2L2
prerank,toll-like receptor signaling pathway (GO:0002224),0.3367729541272823,0.8153433174452697,0.7464212678936605,1.0,1.0,27/84,21.33%,S100A9;MAPKAPK3;IKBKG;S100A8;TRAF3;BIRC2;HMGB1;MAP3K1;TAB1;PLCG2;TAB3;BTK;MYD88;CTSK;TLR5;TLR6;HSP90B1;EPG5;UBA52;MAP3K7;COLEC12;TRAF6;LGALS9;CASP8;RIPK1;IKBKB;RPS6KA3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3585619582125553,0.8150006672420386,0.735973597359736,1.0,1.0,13/42,21.03%,PLEKHA2;CDK6;CIB1;GFUS;EFEMP2;NRP1;GSK3B;LIMS1;RAC1;CCL25;UTRN;S100A10;ROCK1
prerank,response to reactive oxygen species (GO:0000302),0.3500300698429967,0.8147855049666821,0.7462526766595289,1.0,1.0,14/54,21.27%,STK26;MAPK1;FYN;STK24;EGFR;JUN;APTX;MPV17;PDCD10;ERCC6L2;SIRT1;RPS3;PKD2;MAPT
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.2655263518691058,-0.8136535117462357,0.7287234042553191,0.9077734750060653,1.0,2/21,1.27%,TGFBR1;RBPMS
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.2653044884202763,-0.813609016356428,0.7368421052631579,0.9066561821278272,1.0,8/18,43.95%,SLC8B1;MDK;LYN;PTK2B;MTUS1;F7;SLIT2;IL6
prerank,cellular response to retinoic acid (GO:0071300),0.3521771865445992,0.8134513363362691,0.7189189189189189,1.0,1.0,4/42,9.24%,AQP1;ATM;SETX;EPHA3
prerank,cellular polysaccharide catabolic process (GO:0044247),0.39646368977326313,0.8133106832578578,0.6870925684485006,1.0,1.0,2/16,12.06%,PGM2;PHKA2
prerank,lamellipodium organization (GO:0097581),0.37031744130155814,0.8127588042942424,0.7060889929742389,1.0,1.0,16/29,29.18%,CCDC88A;ABLIM3;WHAMM;PARVB;RAC1;ARHGEF7;ABLIM2;GOLPH3;VCL;ABLIM1;ARHGEF6;WASF1;SNX1;ARHGEF4;CARMIL1;KIT
prerank,intracellular protein transport (GO:0006886),0.33504476428685387,0.8124814018716799,0.893,1.0,1.0,82/304,21.72%,ANKLE1;XPO1;POM121;TBC1D1;C2CD5;TBC1D8B;CD74;STX17;NUP107;CCHCR1;TBC1D22B;ARL5C;NAPG;TNPO1;TLK1;EVI5;NUP42;IPO13;ARL11;RAB1B;RAB22A;YWHAH;NUP50;STX5;AP4B1;ARF4;AP1S3;HDAC6;DESI1;NUP214;ARFGAP3;SNX9;CLTC;PICK1;SEC13;IPO7;AP4E1;NUP188;STX11;RANBP6;GGA1;KIF13A;ARF3;SEC31A;HAP1;RAB43;RPAIN;COPZ1;VPS33B;BAG3;E2F3;TBC1D25;APPL1;ARL4C;IPO5;RAB5A;XPO4;KPNB1;LMAN1;NAPB;ADPRH;EIF2D;GGA2;STAM;RAB6A;EIF4ENIF1;SAR1B;NUP85;TRAK2;SGSM3;HPS4;MMP12;TPR;TNPO2;ARL5B;TBC1D15;SNX13;TNPO3;TMED10;SYK;EVI5L;AP3B1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.33501813976563083,0.8120311073590348,0.7860040567951319,1.0,1.0,26/110,20.39%,HJURP;IAPP;RB1;TFRC;FAF1;GSN;LCMT1;HDAC6;RIOK3;PARK7;SUMO1;HCFC1;RACK1;TFIP11;LATS1;GSK3B;BRK1;ATF7IP;AIDA;NAPB;GNL3L;SAR1B;SLF1;RPS3;SVIP;NCLN
prerank,regulation of actin filament-based process (GO:0032970),0.3423722202726826,0.8119901195180277,0.7533539731682146,1.0,1.0,11/70,13.16%,ARHGEF5;CCDC88A;EZR;CNN2;RND3;ARHGAP35;EPHA3;MLST8;CRK;ROCK2;RAC2
prerank,regulation of translation (GO:0006417),0.33788927820137943,0.811804484990362,0.842,1.0,1.0,59/173,23.97%,ZCCHC4;EIF4B;EIF2A;RBM3;EIF3E;RPS4X;CSDE1;EIF4A3;NIBAN1;MTG2;MTPN;NCBP1;CPEB3;PUM3;TCOF1;TYMS;DHX9;IGF2BP3;UPF3B;FXR1;RACK1;PRKDC;LSM14A;PAIP1;NSUN3;CNOT1;PLD1;METTL14;PYM1;SAMD4A;EEF2;VIM;NAT10;LARP4B;POLDIP3;GSPT1;EPRS1;ELAVL1;EIF4ENIF1;RPL5;NCBP2;RPS3;DAPK1;CNOT8;RBM4B;SYNCRIP;EIF6;CNOT7;GLE1;GAPDH;RPS6KA3;RPL13A;EIF4E2;RPL10;YBX1;NCL;CIRBP;NPM1;DAPK3
prerank,iron ion homeostasis (GO:0055072),0.34248894128379476,0.8116288015638339,0.7381203801478353,1.0,1.0,10/58,17.11%,TFR2;HEPH;ALAS2;CYBRD1;TFRC;B2M;SMAD4;MYC;ATP6AP1;ATP6V0D1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3464692233083181,0.811600753651986,0.7310195227765727,1.0,1.0,16/56,17.72%,S100A9;MAPKAPK3;S100A8;TRAF3;HMGB1;TAB1;PLCG2;TAB3;TIFA;MYD88;CTSK;TLR5;TLR6;HSP90B1;UBA52;MAP3K7
prerank,ceramide transport (GO:0035627),0.41530320694063305,0.8114516924690167,0.6698240866035182,1.0,1.0,2/12,9.29%,ABCA13;ABCA2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3700270887281583,0.8110340444189509,0.7210648148148148,1.0,1.0,10/31,22.39%,POLR2I;POLR2A;CMTR2;NCBP1;ERCC3;POLR2K;POLR2J;NCBP2;RNMT;POLR2B
prerank,7-methylguanosine RNA capping (GO:0009452),0.3700270887281583,0.8110340444189509,0.7210648148148148,1.0,1.0,10/31,22.39%,POLR2I;POLR2A;CMTR2;NCBP1;ERCC3;POLR2K;POLR2J;NCBP2;RNMT;POLR2B
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.34165818399375697,0.8109202344361307,0.8366733466933868,1.0,1.0,25/142,19.21%,S1PR4;CXCR5;IAPP;CAV1;CCR2;HMGB1;PRKACA;CAV2;P2RY1;CCR6;SLC35G1;FIS1;ADCYAP1;F2R;LPAR1;GPR35;CD24;TRPM4;ADCY8;SPPL3;CXCR4;YWHAE;PTGER4;CLN3;CD55
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.33626546994067474,0.8107296892542946,0.8261306532663316,1.0,1.0,40/129,24.09%,PSMB7;PSMD11;AXIN1;PSMF1;GPRC5B;CAV1;PSMC1;PIN1;CSNK1G2;EGFR;PSMC3;PSMA4;RUVBL1;XIAP;CCAR2;PSMC4;PSMD13;LRRK1;PSME1;PSMB1;EGF;PSMD8;LGR4;PSME4;PSMD4;TRPM4;PTK7;LRRK2;PPM1B;TBL1XR1;USP34;ILK;USP47;CAPRIN2;ZEB2;PSME2;FGFR2;DAAM2;DAPK3;PSME3
prerank,regulation of protein phosphorylation (GO:0001932),0.3383386847127236,0.8105818958683331,0.8978978978978979,1.0,1.0,67/256,23.11%,ECT2;MEN1;PECAM1;CCDC88A;FYN;CCN1;CD74;PML;AXIN1;BRAT1;PGF;PPP2R5E;TFRC;RASGRP1;CRKL;PPP2R5A;CCDC88C;SMG8;BRD4;PIN1;NIBAN1;CIB1;IBTK;EGFR;P2RY1;PARK7;WDFY2;FGF9;FAS;PTEN;CDK5RAP3;FXR1;ROCK2;RACK1;FLOT1;PRKDC;FAM20A;PPIA;MYDGF;STK4;FKBP8;PPP2R5D;LIMK2;RAC1;PDE8A;SIRT1;FN1;PTPN13;LRRK2;MOB1B;AKTIP;PPP2CA;EPHA7;CCND3;PRR5L;ILK;SLCO3A1;RIPK1;CADM4;FGR;PPP1R15B;EFNA1;NTRK3;NSD1;TWF1;TARDBP;ADAM17
prerank,regulation of calcium ion import (GO:0090279),-0.2547484472948708,-0.8104408167094277,0.7204301075268817,0.9112023657896484,1.0,8/21,22.61%,CTNNB1;PSEN2;PLPP4;TRIM27;PRNP;CCL3;SPHK2;SLC30A1
prerank,protein acylation (GO:0043543),-0.2202543844517266,-0.8093875278951331,0.8241758241758241,0.91192982273288,1.0,16/38,26.30%,GLUL;ZDHHC17;ZDHHC13;ZDHHC5;ZDHHC8;SELENOK;KAT2A;NAT9;ZDHHC16;ING4;ZDHHC20;ZDHHC15;GTF2B;ZDHHC3;NAA10;ZDHHC12
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3381466266706115,-0.8093611873332982,0.7180327868852459,0.9107695137612195,1.0,6/10,27.50%,DLGAP4;DLGAP2;DLGAP3;NPTX1;DLGAP1;BEGAIN
prerank,T cell migration (GO:0072678),-0.2970926809983955,-0.8089685693769739,0.6826568265682657,0.9103245118913309,1.0,3/13,9.52%,SLC12A2;PIK3CD;S1PR1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.30877993965534417,-0.8083656981240646,0.6557377049180327,0.9102393237942071,1.0,1/13,0.15%,HEXB
prerank,embryonic hemopoiesis (GO:0035162),0.4127211725955705,0.8083625968903178,0.6980609418282548,1.0,1.0,4/12,17.70%,ZFPM1;KMT2A;THOC5;KITLG
prerank,negative regulation of receptor binding (GO:1900121),-0.3315718765103894,-0.8080628751497315,0.7147540983606557,0.9096628753048935,1.0,1/10,2.03%,ADAM15
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.40592152605999693,0.807893765725669,0.6648793565683646,1.0,1.0,3/12,21.89%,ABCD1;ELOVL5;ACOT8
prerank,dephosphorylation (GO:0016311),0.33562048393115046,0.8078270700468192,0.8413654618473896,1.0,1.0,32/147,18.15%,PLPPR3;ALPL;PPM1D;PTPRA;PPP3CA;FBXW11;PTPN22;PPP2R5E;STK11;PPP1CB;PPP2R5A;EPHX2;MTMR2;TAB1;PPP2CB;PTPN7;PTPN14;PPP1CC;MTMR6;PTEN;PPP3CC;PPP1R12A;PLPPR4;PTPN5;PPP6C;MTM1;PTPRU;PPP2R5D;DUSP12;PTPN13;PPP1CA;ILKAP
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.21816452759703125,-0.8076272223208597,0.8194444444444444,0.9092826892964698,1.0,11/46,13.85%,OPHN1;SYT1;CDH2;GRM5;DGKI;CACNG7;CACNG2;DGKZ;CDK5;UNC13A;GRM8
prerank,positive regulation of cellular catabolic process (GO:0031331),0.33730258745226244,0.8076123984254435,0.8048289738430584,1.0,1.0,39/132,21.03%,MEFV;NRDC;EZR;TWIST1;SNX33;STK11;ABCD1;ZC3H18;FOXO1;FAF1;PIM2;HMGB1;DCN;SNX9;ENTPD5;MSN;ORMDL3;ATF6;RDX;TRIM68;RNF152;DXO;PSEN1;TRIM5;IRS1;GSK3B;CNOT1;RC3H1;SNCA;LRRK2;ZBTB20;DAPK1;SVIP;CNOT8;PNPT1;PRR5L;CNOT7;BNIP3;ROCK1
prerank,glycogen catabolic process (GO:0005980),0.4020227601091282,0.8073660861127345,0.7020997375328084,1.0,1.0,2/15,12.06%,PGM2;PHKA2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.3679385730694358,0.8072655524205062,0.6848989298454221,1.0,1.0,2/25,4.43%,PMAIP1;TNFSF10
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3330285148560654,0.8068958310638685,0.8878878878878879,1.0,1.0,66/248,21.57%,JADE1;PSMB7;LRP4;PSMD11;AXIN1;PSMF1;STK11;GPRC5B;CAV1;CCDC88C;CSNK1A1;PSMC1;PIN1;CSNK1G2;FUZ;TLE4;EGFR;CUL3;PFDN5;PSMC3;AMFR;RUVBL2;EMD;PSMA4;RUVBL1;XIAP;CCAR2;PSMC4;TMEM131L;PSMD13;LRRK1;PSME1;DDIT3;LATS1;PSEN1;PSMB1;GSK3B;STK4;LIMD1;EGF;PTPRU;PSMD8;TCF7L2;CTNND2;LGR4;PSME4;PSMD4;LMBR1L;TRPM4;PTK7;TMEM170B;PPP1CA;AMER2;LRRK2;TLE3;PPM1B;HDAC1;STK3;TBL1XR1;USP34;NPHP4;ILK;KREMEN1;USP47;CAPRIN2;ZEB2
prerank,pseudouridine synthesis (GO:0001522),0.4023113610331927,0.8067797384473094,0.6795727636849133,1.0,1.0,4/13,17.99%,NOP10;PUS3;TRUB2;DKC1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3426147802332256,0.8065159410691819,0.7784615384615384,1.0,1.0,18/80,20.49%,ANLN;CCDC88A;PALM;RIPOR2;ARHGAP35;FUZ;TAPT1;CDC42EP3;NRP1;RAC2;BBS4;BRK1;MARK4;RAC1;PIK3CA;CDC42EP1;PLEKHM1;CROCC
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.30862526287832964,-0.8059768842231086,0.7126436781609196,0.9110607493948661,1.0,3/12,11.75%,APOD;PTPRJ;NDRG4
prerank,negative regulation of cell growth (GO:0030308),0.33534427595398647,0.8056553017724446,0.8235887096774194,1.0,1.0,21/121,16.94%,CDKN2C;JADE1;PPP1R9B;RB1;TCHP;PML;STK11;CDKN2A;SMARCA4;CDKN2D;SMAD4;CCAR2;SLIT3;FGF13;RACK1;SERTAD2;BCL6;TP53;NDRG3;TGFB2;SIRT1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.4258629706060111,0.8054132252994045,0.6924198250728864,1.0,1.0,3/10,22.28%,TUT4;UBA52;NEDD8
prerank,transcription preinitiation complex assembly (GO:0070897),0.42499523656719673,0.8050674625670683,0.6806495263870095,1.0,1.0,4/12,21.59%,TAF1;TAF7;GTF2A2;TAF11
prerank,negative regulation of synaptic transmission (GO:0050805),0.3777511431171988,0.8046074364207633,0.7165259348612787,1.0,1.0,7/23,21.19%,MTMR2;PICK1;PTEN;SLC24A2;LRRK2;ATAD1;GRIK3
prerank,negative regulation of leukocyte migration (GO:0002686),-0.33750453789907575,-0.8045705404913169,0.6892307692307692,0.9123327008818056,1.0,6/10,34.21%,CD300A;CD200;HMOX1;HOXA7;BMP5;EMILIN1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.22803916337202104,-0.8043911010110945,0.828125,0.911425973372701,1.0,10/34,24.04%,AKIRIN1;PIK3R1;ARPC2;ABI2;TWF2;CDC42;PLXNB3;CAPZB;CYFIP1;FER
prerank,cell differentiation in hindbrain (GO:0021533),-0.32180628526571264,-0.8035376384029672,0.7168458781362007,0.9118520024702131,1.0,3/11,8.45%,OPHN1;KNDC1;FAIM2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.33804359091223035,0.8031079727819377,0.7951070336391437,1.0,1.0,23/86,17.60%,PSMB7;PSMD11;PSMF1;CHEK1;PSMC1;PSMC3;PSMA4;PSMC4;NFE2L2;PSMD13;PSME1;DDIT3;CREBBP;BAG3;PSMB1;TP53;LIMD1;PSMD8;PSME4;VHL;PSMD4;DNAJB1;UBA52
prerank,protein localization to organelle (GO:0033365),0.3370806627493109,0.8031055643967064,0.8185483870967742,1.0,1.0,30/133,18.44%,RAB33B;RPA2;CNTLN;CSRP3;SYS1;STX5;GBP2;DDRGK1;CEP250;ZBTB7A;RPA1;PPP1R15A;ABCA7;EMD;TOR1A;DHX9;VAPA;DCP1A;CNEP1R1;PACSIN2;BBS4;RAB35;RIPOR1;SCG3;IFT140;BBS9;TMEM30A;YWHAE;LRRK2;RAB6A
prerank,axoneme assembly (GO:0035082),-0.23113027069054148,-0.8030531235578772,0.8359375,0.911479336576981,1.0,23/31,46.29%,CFAP74;TOGARAM1;DCX;TTC12;CCDC39;SPAG16;TTLL3;DNAAF3;CFAP46;CCDC40;RSPH9;FOXJ1;JHY;DNAJB13;DRC1;SPAG17;GAS8;DNAAF2;RSPH1;RP1;RSPH4A;DNAAF1;CCDC65
prerank,sulfur compound biosynthetic process (GO:0044272),0.33637062738742785,0.8023101206857632,0.7963340122199593,1.0,1.0,16/104,16.29%,CHST3;FMOD;CSGALNACT2;ST3GAL1;DCN;SLC35D2;ST3GAL2;SLC10A7;B3GNT2;CHST12;OGN;METTL16;PAPSS2;TPK1;GSTM1;CHSY1
prerank,protein localization to Golgi apparatus (GO:0034067),0.37093714804599753,0.8022832722217444,0.7276887871853547,1.0,1.0,9/27,21.37%,RAB33B;ARL5C;SYS1;RIPOR1;VPS13A;RAB6A;GOLPH3;ARL5B;TMED10
prerank,odontogenesis (GO:0042476),0.3643237874624002,0.8021911506381536,0.7186788154897494,1.0,1.0,7/35,23.07%,AQP1;COL1A2;ANKRD11;TGFB2;HDAC1;FGFR2;OSR1
prerank,regulation of fibroblast migration (GO:0010762),0.3800935714935905,0.8021242956237186,0.6924034869240349,1.0,1.0,9/20,24.01%,PRKCE;HAS1;APPL1;RAC1;ARHGEF7;CLN3;PRR5L;DDR2;ITGB1BP1
prerank,excitatory postsynaptic potential (GO:0060079),0.38544351000658167,0.8021009445206979,0.71,1.0,1.0,5/19,21.57%,MPP2;ARRB2;GSK3B;LRRK2;GRIN2D
prerank,long-term synaptic potentiation (GO:0060291),-0.2646874868924984,-0.8020507391423618,0.7696335078534031,0.9120895172173826,1.0,4/21,9.83%,STX4;SLC8A3;VAMP2;SHANK2
prerank,cellular response to cadmium ion (GO:0071276),0.36537695463205333,0.8017037484767144,0.6980676328502415,1.0,1.0,4/24,11.47%,MAPK1;EGFR;SUMO1;JUN
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.39417930350751207,0.8013098401283553,0.6756756756756757,1.0,1.0,2/14,4.94%,TWIST1;ABCD1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.410060494897389,0.8012424180156974,0.6883656509695291,1.0,1.0,2/12,4.94%,TWIST1;ABCD1
prerank,positive regulation of cell differentiation (GO:0045597),0.33248577554859093,0.8009912821070426,0.9069069069069069,1.0,1.0,38/237,17.11%,ECT2;EZH2;SOX6;LEF1;FBXO5;CTNNA1;TIAM1;CCN1;TWIST1;CCN4;RIPOR2;PA2G4;GPRC5B;MMD2;TCF3;ZFP36L1;LRP3;MMD;MAPK14;ZBTB16;ZEB1;SMAD4;WDFY2;PLCB1;BCL9L;BMPR1A;NELL1;NRCAM;HOXB4;SPAG9;SIN3A;TCF4;FGFR1;ATP6AP1;TGFB2;VHL;XBP1;TRPM4
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3698400278051214,0.8007475458221904,0.7013142174432497,1.0,1.0,3/23,12.08%,PMAIP1;TIMM9;TOMM70
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.39513786811299656,0.8006379929148778,0.7123115577889447,1.0,1.0,7/19,21.10%,PRKACA;CBFB;ROCK2;RUNX1;NPHP4;ROCK1;IKBKB
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.2906947634657876,-0.8005871985544606,0.7172995780590717,0.9134936082208137,1.0,3/14,8.96%,ACOX3;ECI2;SCP2
prerank,positive regulation of transporter activity (GO:0032411),0.40321800555352844,0.7995362048160498,0.7103448275862069,1.0,1.0,5/13,27.36%,KMT2A;STK39;NR1H3;WNK3;RXRA
prerank,morphogenesis of an epithelium (GO:0002009),0.3712847082948792,0.7993842884540554,0.7089820359281437,1.0,1.0,8/25,23.42%,TIMELESS;LAMA5;PRKX;DAG1;KDM2B;ACTG1;FGFR2;VCL
prerank,aorta morphogenesis (GO:0035909),0.3896445906149758,0.7990267311296488,0.7178841309823678,1.0,1.0,5/17,20.56%,HEY2;EFEMP2;BMPR1A;PROX1;RBPJ
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.37816919168779717,0.7990146279222177,0.7072879330943848,1.0,1.0,7/21,21.24%,DNMT1;JUN;FGF9;BMPR1A;ADAMTS1;LDLRAP1;MEF2D
prerank,regulation of protein kinase B signaling (GO:0051896),0.33548376435472343,0.7983257134530664,0.8798798798798799,1.0,1.0,35/193,17.70%,CD19;IAPP;PHLPP2;ERBB3;FYN;RCN3;PHLDA3;BANK1;TGFA;CIB1;GRB2;STRN;EGFR;PDPK1;TXN;PARK7;FGF9;FLT3;PTEN;ARRB2;F3;RACK1;RAC2;DDIT3;MYDGF;DAG1;IRS1;EGF;TCF7L2;FGFR1;RAC1;PIK3CA;SIRT1;HCLS1;KITLG
prerank,response to laminar fluid shear stress (GO:0034616),-0.3294209476786074,-0.7983083604482084,0.7124600638977636,0.9163885820556307,1.0,6/10,25.26%,ABCA1;SMAD6;SMAD7;KLF2;MAPK7;KLF4
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3849293565000185,0.7976814188653927,0.7029702970297029,1.0,1.0,6/19,16.35%,DHX9;CBFB;ELF1;RUNX1;CD24;TAF9
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.27085118610776754,-0.7972933626920066,0.7684729064039408,0.9170017819944295,1.0,8/18,25.49%,ENY2;SARNP;DDX19A;DDX19B;NUP133;PABPN1;ZC3H11A;MCM3AP
prerank,cytoplasmic sequestering of protein (GO:0051220),0.3970439693775477,0.796861521951042,0.7012448132780082,1.0,1.0,5/13,20.36%,FLNA;LATS1;SUFU;PKD2;KEAP1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3319349480635896,0.7965543658515263,0.8677354709418837,1.0,1.0,48/182,22.08%,HEY2;RB1;AURKA;PTPN22;RBL1;FOXP1;CRKL;RIN3;TAF1;TERF2;TNRC6C;LRP3;TNRC6B;NOTCH1;MTMR2;DDRGK1;ABCC2;ZNF148;PARP14;MECP2;DNMT1;PARK7;SETDB2;BMPR1A;ROCK2;RACK1;PSEN1;PDCD10;RUNX1;MAP2K1;TGFB2;ANKRD13A;VHL;SIRT1;CNPY2;APLN;FLOT2;ADAM10;SETDB1;HDAC1;LGALS9;AGO2;CNOT7;CITED2;MAPT;CELF1;AGO1;ATP2B4
prerank,regulation of RNA export from nucleus (GO:0046831),0.41052066290670797,0.7959945472813322,0.6997282608695652,1.0,1.0,6/11,27.05%,IWS1;DHX9;NCBP2;TPR;SETD2;CPSF6
prerank,regulation of ruffle assembly (GO:1900027),-0.257486059177143,-0.7958406050841461,0.7771739130434783,0.918272416687365,1.0,7/23,20.08%,EVL;PFN1;P2RY12;EPS8;PFN2;ARHGAP24;P2RX4
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3438769779209372,0.7958306661475762,0.7543859649122807,1.0,1.0,11/46,14.03%,CHCHD4;TOMM34;TSPO;PITRM1;TIMM9;DNAJC15;GDAP1;FIS1;TOMM70;TIMM23;GRPEL2
prerank,mRNA polyadenylation (GO:0006378),0.3673722639126434,0.7958289788297934,0.7363530778164924,1.0,1.0,12/26,23.32%,CPSF2;CSTF3;TUT1;SCAF8;PCF11;CPSF1;CLP1;TENT2;PNPT1;WDR33;PAPOLA;LEO1
prerank,RNA polyadenylation (GO:0043631),0.3673722639126434,0.7958289788297934,0.7363530778164924,1.0,1.0,12/26,23.32%,CPSF2;CSTF3;TUT1;SCAF8;PCF11;CPSF1;CLP1;TENT2;PNPT1;WDR33;PAPOLA;LEO1
prerank,actin filament depolymerization (GO:0030042),0.4197092719994897,0.7953438872869172,0.6952908587257618,1.0,1.0,2/11,8.95%,GSN;CFL2
prerank,mitochondrial membrane organization (GO:0007006),-0.23290705435879352,-0.7948626133543326,0.8333333333333334,0.918907047615186,1.0,17/32,28.91%,BCL2L1;MICOS10;GHITM;MFN2;APOO;MTX2;MTX3;SPG7;MAIP1;BAD;MTX1;SLC25A5;CHCHD6;BCL2;TMEM11;MFN1;TIMM50
prerank,limb morphogenesis (GO:0035108),-0.2618703499881258,-0.794830023833527,0.7722772277227723,0.9177617486417954,1.0,4/20,12.87%,PCSK5;IQCE;BMPR1B;GLI3
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.25917033978865084,-0.7944080936456627,0.7865168539325843,0.9173149583161843,1.0,2/22,0.92%,MBP;GCNT2
prerank,programmed necrotic cell death (GO:0097300),-0.27683506929242296,-0.7943260814357613,0.7317073170731707,0.9162468721667733,1.0,9/18,27.41%,ITPK1;DNM1L;TLR4;LY96;TICAM1;IPMK;TICAM2;MLKL;CD14
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.1912453455991689,-0.7943109639331719,0.8888888888888888,0.9150899517214555,1.0,10/70,13.74%,PLA2G15;LPIN1;PLA2G7;ENPP2;SLC27A1;MBOAT1;CHPT1;ABHD3;PLA2G6;LPCAT1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.39885784551981995,0.7936932886992147,0.726530612244898,1.0,1.0,6/14,26.12%,DDRGK1;DNAJB9;UFL1;TMEM33;BCL2L11;BAK1
prerank,cellular amide metabolic process (GO:0043603),0.32784253660345275,0.7936068144173681,0.794949494949495,1.0,1.0,24/102,23.86%,DNPEP;PANK2;ACOT11;CPM;ST3GAL1;MTHFD2L;ACOT13;ACOT2;ABCA2;NAPEPLD;ORMDL3;SLC19A1;MCCC1;CPD;ALDH1L1;MTHFD1L;PPP2CA;MME;NAAA;HLCS;ACOT8;ACSL6;PLPP1;SMPD1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.2693810588829858,-0.7930137908813131,0.7333333333333333,0.9161118936045025,1.0,3/18,8.98%,PAG1;DUSP3;MIA3
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.30248396002142747,-0.7929345190177938,0.7408759124087592,0.9150766917813676,1.0,6/13,26.60%,FEZ2;FEZ1;PINK1;CHMP4B;CHMP4A;SEC22B
prerank,maintenance of protein localization in organelle (GO:0072595),0.3800926741247979,0.7926704715584291,0.7097591888466414,1.0,1.0,7/19,19.94%,PML;TAPT1;CHCHD10;HNRNPU;BBS4;MORC3;TAF3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.38940579198692077,0.7926605738089558,0.731016731016731,1.0,1.0,6/16,24.65%,ATP5F1E;ATP5F1D;ATP5MC2;ATP5F1B;ATP5MF;ATP5ME
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.32345408405303594,-0.7924088922523966,0.7440273037542662,0.9148012280238035,1.0,4/11,17.87%,SLC27A1;SCARB1;CTDNEP1;GPLD1
prerank,regulation of cell migration (GO:0030334),0.32970161734051573,0.7921778596416739,0.953,1.0,1.0,58/382,15.53%,KIF14;GTSE1;ARHGEF39;CYP1B1;STK26;LEF1;PECAM1;SYNE2;TIAM1;FLNA;SLK;SUN2;PPP3CA;CCN1;LMO4;CD74;ULK4;NEDD9;ARID2;DACH1;AMOTL2;CAV1;ATM;TRADD;DPEP1;NOTCH1;DDRGK1;FUZ;CIB1;PRKX;PRKCA;PLXNA2;CYRIB;STK24;EGFR;NTNG2;CBLL1;KIF2A;ZMYND8;FGF9;RDX;PTEN;F3;ROCK2;RACK1;ACTN4;SLURP1;ARSB;RNF20;DAG1;SGK3;PDCD10;RIPOR1;EGF;F2R;APPL1;SPAG9;PTPRU
prerank,response to organophosphorus (GO:0046683),-0.28163136717156567,-0.7916395432990011,0.8034188034188035,0.9149781957720473,1.0,6/16,28.15%,DGKQ;TRPC3;P2RX4;VGF;NDUFS4;ABCC9
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.38503449477435925,0.7915916191249085,0.7090680100755667,1.0,1.0,6/18,18.66%,CTNNA1;POLR1A;LATS1;GSK3B;SIN3A;SUFU
prerank,peptidyl-amino acid modification (GO:0018193),0.4135590850460894,0.7913679508045008,0.7102272727272727,1.0,1.0,2/10,10.65%,METAP2;ATP7A
prerank,peptidyl-proline modification (GO:0018208),0.3664920438897824,0.791206885444352,0.7184466019417476,1.0,1.0,11/25,23.78%,PPIL3;PIN1;PPWD1;PPIG;PPIA;PPIE;PPIH;PPIL1;FKBP1A;CWC27;NKTR
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3316393291975613,0.7909951200068297,0.8105369807497467,1.0,1.0,32/100,23.35%,PLK1;XPO1;GLMN;TAF1;CSNK1A1;DESI1;DDRGK1;PARK7;SUMO1;RAD23A;CCAR2;UCHL5;RACK1;SUMO2;ARIH2;PABIR1;GSK3B;PIAS1;TAF9;UBXN1;CAMLG;RNF19A;USP7;LRRK2;ARAF;KEAP1;MDM2;CBFA2T3;HECTD1;DDA1;BBS7;UFL1
prerank,NAD biosynthetic process (GO:0009435),0.3770258775699662,0.7909515128864264,0.7178217821782178,1.0,1.0,1/20,2.64%,HAAO
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.38789271814570153,0.7909098621135198,0.718397997496871,1.0,1.0,2/17,7.95%,GPD1L;NEDD4L
prerank,negative regulation of heart contraction (GO:0045822),-0.30957831275351,-0.7899797499893783,0.725,0.9167133871998021,1.0,5/11,33.12%,ZC3H12A;SRI;ATP1A2;FKBP1B;SPTBN4
prerank,ventricular septum morphogenesis (GO:0060412),0.35851102291221415,0.7898586802551809,0.7361751152073732,1.0,1.0,9/27,20.79%,HEY2;ZFPM1;NOTCH1;SMAD4;SLIT3;BMPR1A;TGFB2;PROX1;CITED2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.21547615543506385,-0.7896614379485983,0.8478260869565217,0.9160888080258978,1.0,8/39,17.38%,SALL1;CTNNB1;SEMA3E;ENG;PKD1;VEGFA;FGF2;TGFBR2
prerank,cellular defense response (GO:0006968),0.3458735068723693,0.7890980210726719,0.7435344827586207,1.0,1.0,6/40,14.45%,SPN;LSP1;ZNF148;CCR6;BECN1;TYROBP
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.25367893579356177,-0.7889141124896445,0.7875647668393783,0.9162267557764948,1.0,10/20,23.09%,SMAD1;RELA;CARF;ATF4;VEGFA;SESN2;SMAD9;CREB3;HIF1A;MT3
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.3945835257433551,0.7885978706518517,0.7232947232947233,1.0,1.0,3/14,10.95%,ENTPD3;ENTPD5;NUDT9
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3481898938543788,0.788536719807931,0.7224118316268487,1.0,1.0,6/36,10.29%,SP100;NOTCH1;HMGB1;DCN;MECP2;NR2F2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.32947462052201665,0.7882347123928979,0.8243654822335026,1.0,1.0,27/108,21.18%,DEPDC1B;TIAM1;SULF2;AXIN1;SNX3;NXN;DISC1;TCF7L1;SMARCA4;TMEM237;HMGXB4;EMD;CBFB;RACK1;SKI;PSEN1;RUNX1;CTNND2;PTK7;PPP1CA;AMER2;LRRK2;RNF43;PPP2CA;RSPO2;SPIN1;KREMEN1
prerank,regulation of mitochondrion organization (GO:0010821),0.33699572882609496,0.7874589665357975,0.7510729613733905,1.0,1.0,11/47,19.75%,PISD;IAPP;HDAC6;PDE2A;CYRIB;FIS1;SIRT7;GSK3B;LRRK2;SREBF2;GOLPH3
prerank,lipoprotein catabolic process (GO:0042159),0.40270559684826535,0.7873605785773996,0.7013698630136986,1.0,1.0,3/11,10.64%,ABHD17A;LYPLA1;ABHD17B
prerank,regulation of interleukin-4 production (GO:0032673),0.3732061945810246,0.7869736717114241,0.7336683417085427,1.0,1.0,2/21,3.56%,LEF1;ZFPM1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3255333236013264,0.7869079147196373,0.8708708708708709,1.0,1.0,35/173,15.33%,SPTA1;F5;STX17;ATL2;RAB1B;ANK1;STX5;PEF1;ARF4;TGFA;DYNC1H1;ARFGAP3;ARFGAP1;SEC24B;ZW10;SEC24A;CUL3;SEC13;ERGIC2;WHAMM;TRAPPC4;MIA2;BET1;COG6;VAPA;SEC31A;TMEM115;KDELR2;COPZ1;PGAP1;RAB2A;NRBP1;DYNLL1;CNIH1;SPTAN1
prerank,protein mannosylation (GO:0035268),-0.2502098199120865,-0.786613931188943,0.7921348314606742,0.918954765436976,1.0,3/22,6.81%,CRPPA;LARGE1;FKTN
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.37677348673223743,0.7864707272027214,0.7064102564102565,1.0,1.0,7/18,17.99%,EMD;PEX2;SKI;MYC;TP53;NLRC3;MORC3
prerank,positive regulation of cellular component organization (GO:0051130),0.32842617294892656,0.7860685497185108,0.8397565922920892,1.0,1.0,25/107,19.26%,CDC20;TFR2;RB1;LRP4;TFRC;FAF1;NEDD4L;PPP1R15A;CBLL1;PARK7;SUMO1;RELN;RACK1;FLOT1;GSK3B;BRK1;RUNX1;TGFB2;LMAN1;TMEM30A;SNCA;GNL3L;NRXN1;SLF1;RPS3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3607675240248876,0.7858625982574371,0.7295373665480427,1.0,1.0,6/24,14.97%,MBTPS2;NOTCH1;ATF6;NFE2L2;DDIT3;TP53
prerank,neuromuscular process controlling balance (GO:0050885),0.4031609173974377,0.7858549713697521,0.7208976157082749,1.0,1.0,4/12,18.91%,PAFAH1B1;TIFAB;CLN3;NRXN1
prerank,response to steroid hormone (GO:0048545),0.3550995509591674,0.7857865445857841,0.7335680751173709,1.0,1.0,3/31,9.29%,CATSPERB;CAV1;ABCA2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3344693749414437,0.7851280165497486,0.767590618336887,1.0,1.0,11/57,14.97%,PMAIP1;AURKA;TNFSF10;BOK;DCN;PARK7;FIS1;CHCHD10;MCU;GSK3B;TP53
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3922260512649557,0.7850698882546973,0.7182175622542595,1.0,1.0,5/15,21.72%,BLOC1S4;AP3M2;DTNBP1;AP3M1;AP3B1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3922260512649557,0.7850698882546973,0.7182175622542595,1.0,1.0,5/15,21.72%,BLOC1S4;AP3M2;DTNBP1;AP3M1;AP3B1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3368892492241808,0.784806429790296,0.7648305084745762,1.0,1.0,15/52,22.43%,HAAO;L2HGDH;MTHFD2L;ME3;SLC19A1;PHYH;SDHAF3;IDH2;ASS1;ALDH1L1;MDH2;MTHFD1L;GCLM;ACOT8;GCLC
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3687069925643438,0.7846827061915075,0.720677146311971,1.0,1.0,5/22,13.07%,NOTCH1;PRKCA;MTPN;SMAD4;ROCK2
prerank,regulation of TOR signaling (GO:0032006),0.32982303942567237,0.7842499403811066,0.7822916666666667,1.0,1.0,15/67,20.72%,FAM83D;TTI1;GPAT3;LARS1;SEC13;UBR2;MLST8;LAMTOR4;LAMTOR3;NPRL3;PIK3CA;SIRT1;GOLPH3;ARAF;RRAGB
prerank,endodermal cell differentiation (GO:0035987),-0.23662993351643685,-0.7840360515862033,0.8360655737704918,0.9221863030032564,1.0,5/31,7.91%,ITGB5;CTR9;ITGA5;COL11A1;MMP14
prerank,sphingoid metabolic process (GO:0046519),-0.30630312011255,-0.7836899908630521,0.7411347517730497,0.9215675540936173,1.0,4/12,23.91%,SGPP1;SPHK2;PLPP3;DEGS2
prerank,regulation of tumor necrosis factor production (GO:0032680),0.3255760649305407,0.783493955495425,0.8381909547738694,1.0,1.0,11/112,8.54%,CD2;SPN;CD47;TWIST1;PTPN22;FOXP1;CCR2;RASGRP1;HMGB1;PLCG2;JAK2
prerank,protein prenylation (GO:0018342),-0.3241978924860204,-0.783408049126478,0.7249190938511327,0.9208427775814235,1.0,1/10,0.93%,PGGT1B
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.2490867042775362,-0.783025578129795,0.7516778523489933,0.920373154012181,1.0,13/25,30.65%,EVL;CDK10;TBC1D30;ARHGAP44;CEP97;PFN2;ARHGAP24;PLXNB3;CAPZB;YAP1;ODF2L;TBC1D7;KANK1
prerank,cellular response to fluid shear stress (GO:0071498),0.4056958728605222,0.7829394380887121,0.7104136947218259,1.0,1.0,5/12,19.97%,MTSS1;NFE2L2;ASS1;SREBF2;PKD2
prerank,receptor internalization (GO:0031623),0.3430419727151175,0.7827731303047785,0.7658862876254181,1.0,1.0,11/44,17.91%,RAMP1;TFRC;CAV1;CLTC;GRB2;CALCRL;ARRB2;GRK2;RAB5A;LDLRAP1;SNCA
prerank,melanosome organization (GO:0032438),0.3656301247038153,0.7827546093461774,0.7511682242990654,1.0,1.0,6/26,21.72%,BLOC1S4;SHROOM2;KIF13A;DTNBP1;HPS4;AP3B1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.37879382529060635,0.7825375843188166,0.7468671679197995,1.0,1.0,2/20,7.15%,HEY2;NOTCH1
prerank,myotube cell development (GO:0014904),0.414511348128936,0.7823080283281805,0.7323741007194244,1.0,1.0,2/10,13.77%,CAV2;SKI
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3239618587077919,0.7822189424954596,0.951,1.0,1.0,40/308,13.65%,FOXA2;NKX6-1;EZH2;PLA2R1;SOX6;LEF1;FBXO5;GLMN;TIAM1;BATF;TWIST1;RPS19;TFRC;AGPAT1;CAV1;CCR2;NFAM1;DYNC1H1;ALMS1;ZBTB16;JAK2;UCP2;RBM19;NR2C2;ABCA7;CARD9;EHMT1;SMAD4;KMT5C;PLCB1;TAPT1;ADIPOR1;PAXIP1;BCL9L;HAP1;BMPR1A;ZBTB7B;FLOT1;NUMA1;ADCYAP1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.3768467824075072,0.7813210461509945,0.7251533742331289,1.0,1.0,4/20,13.01%,S100A11;CCN4;BMPR1A;NRP1
prerank,GPI anchor biosynthetic process (GO:0006506),0.3545242015992741,0.7813181763571913,0.7219679633867276,1.0,1.0,9/30,22.42%,PIGH;PIGF;PIGA;PIGT;PGAP1;PIGU;PIGM;PGAP2;DPM2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.36889258682587306,0.7812916160938829,0.7320987654320987,1.0,1.0,5/22,16.34%,PSMB7;PSMA4;NFE2L2;PSMB1;PSME4
prerank,regulation of interleukin-6 production (GO:0032675),0.3252755666933049,0.780909879862198,0.8289205702647657,1.0,1.0,19/96,17.97%,POU2AF1;CD47;TWIST1;CD74;IL16;PTPN22;HMGB1;PLCG2;IL17RA;CARD9;DHX9;MYD88;TLR6;TYROBP;F2R;NLRC3;CYBA;XBP1;POU2F2
prerank,regulation of cytoplasmic translation (GO:2000765),0.3974206186443284,0.780908176713818,0.7416331994645248,1.0,1.0,2/14,11.45%,CPEB3;DHX9
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4095360511073666,0.7808168748852926,0.7095375722543352,1.0,1.0,3/10,21.74%,PTPN22;IFI35;NR1H3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3422234485944775,0.7807748612258611,0.7522421524663677,1.0,1.0,8/38,16.74%,CD47;DDAH2;CAV1;JAK2;ROCK2;TLR6;ASS1;RAC1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.36307344230086114,0.7805235531613526,0.7347670250896058,1.0,1.0,7/25,17.53%,SCAF11;TXNL4A;SRSF4;PRPF4;SRSF10;SNRNP40;PRPF8
prerank,regulation of monooxygenase activity (GO:0032768),0.3608438430078688,0.7802042292373461,0.7368421052631579,1.0,1.0,7/23,18.68%,DDAH2;CAV1;LYPLA1;EGFR;NOSIP;SNCA;NOSTRIN
prerank,platelet degranulation (GO:0002576),0.3256887603836504,0.7799632151180299,0.8484848484848485,1.0,1.0,17/118,17.71%,BLK;F5;PECAM1;FLNA;PHACTR2;CYRIB;ACTN2;APOOL;BRPF3;ABCC4;OLA1;ACTN4;EGF;TGFB2;SCG3;FN1;F13A1
prerank,bone development (GO:0060348),0.3465643103960486,0.7797690087071846,0.7605790645879733,1.0,1.0,6/39,14.97%,SULF2;MBTPS2;SLC10A7;DYM;SKI;TP53
prerank,fatty acid metabolic process (GO:0006631),0.32227113300351085,0.7796305302670004,0.8340080971659919,1.0,1.0,21/115,17.05%,CEL;ACADM;ACOT11;ACBD5;CPT1B;CBR4;NUDT19;HPGD;ACOT2;ALKBH7;SLC27A2;PEX2;FASN;ADIPOR1;CPT1A;PON3;ACSL5;CPT2;NDUFAB1;ELOVL4;XBP1
prerank,smooth muscle contraction (GO:0006939),-0.2979125186855304,-0.7796099436936581,0.7741935483870968,0.9249165998920806,1.0,4/14,20.98%,TPCN2;ADRA1A;SLC8A1;EDNRA
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3516488105014676,0.7794257779722629,0.7390776699029126,1.0,1.0,6/26,14.89%,TFDP1;MTBP;EGFR;RDX;PLCB1;ADAMTS1
prerank,female gonad development (GO:0008585),0.36586949658780443,0.7792486729674996,0.7128589263420724,1.0,1.0,2/19,10.29%,NUP107;NR2F2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.39372554677300853,0.7786152299446677,0.7236662106703147,1.0,1.0,3/14,15.12%,RFK;IMPDH2;ADSL
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.35860483807757587,0.7785879377450239,0.7250308261405672,1.0,1.0,5/21,13.07%,SLK;PTPRA;CLASP1;EPHA3;ROCK2
prerank,ncRNA metabolic process (GO:0034660),0.34325784737540044,0.7783242010725177,0.7522123893805309,1.0,1.0,8/37,23.35%,NIFK;TUT4;DTD2;TARBP2;ZCCHC8;AGO2;MAPT;DTD1
prerank,myoblast differentiation (GO:0045445),0.38292587198269,0.7783155953951594,0.6958277254374159,1.0,1.0,1/14,2.67%,RB1
prerank,protein insertion into ER membrane (GO:0045048),0.34456432459327935,0.7781818182013183,0.7485779294653014,1.0,1.0,7/37,12.03%,EMC6;EMC10;STX5;EMC3;GET3;EMD;VAPA
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.26032070275625707,-0.777904135030992,0.7890295358649789,0.9264605268764904,1.0,6/20,18.05%,RAP1GDS1;SELENOK;TGM2;BCAP31;THADA;WFS1
prerank,regulation of fat cell differentiation (GO:0045598),0.3272529810429927,0.7776994044215546,0.7817622950819673,1.0,1.0,16/74,18.48%,E2F1;ZFPM1;NR1D1;FOXO1;FTO;ZFP36L1;LRP3;ZBTB16;ASXL1;WDFY2;ZFP36L2;SIRT1;XBP1;TRPM4;CREB1;AAMDC
prerank,dopamine metabolic process (GO:0042417),0.37880075399211394,0.7775136269008165,0.7281795511221946,1.0,1.0,5/18,17.91%,ATP7A;LRTOMT;TGFB2;MAOA;SNCA
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.28091005627562293,-0.777505485816592,0.7868852459016393,0.9258995475001703,1.0,9/14,35.35%,CMPK1;SMPDL3A;ITPA;AK1;AK7;ENPP3;AK4;AK8;NME2
prerank,pulmonary valve development (GO:0003177),0.37392065448430983,0.7772687726259935,0.7214554579673776,1.0,1.0,2/18,7.15%,HEY2;NOTCH1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.353585015997552,0.7767977736152539,0.7581395348837209,1.0,1.0,10/29,22.08%,ZC3H7A;PUM2;HNRNPA2B1;SRRT;TUT4;PUM1;TARBP2;AGO2;SMAD2;AGO1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.3101898356038168,-0.7767925448697416,0.7152777777777778,0.9258020417219068,1.0,3/11,10.55%,RNF185;AUP1;BAG6
prerank,GPI anchor metabolic process (GO:0006505),0.3598261072311408,0.776307467535309,0.7260920897284534,1.0,1.0,8/26,22.42%,PIGH;PIGF;PIGA;PGAP1;PIGU;PIGM;PGAP2;DPM2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.23000210028481788,-0.7761510993380192,0.8691588785046729,0.9256780854552594,1.0,12/33,28.45%,TNFAIP3;KRIT1;ANGPT1;TNIP2;SERPINE1;MDK;WFS1;MAPK7;NDNF;YAP1;KDR;ICAM1
prerank,spinal cord development (GO:0021510),-0.30140881614083403,-0.7759366258044865,0.7831325301204819,0.9249164331271762,1.0,5/12,19.01%,NF1;PKD1;SOX4;LOXL3;SOX11
prerank,regulation of vasculature development (GO:1901342),-0.24073418136683805,-0.7758740933801658,0.8013245033112583,0.9238504604257344,1.0,8/26,22.03%,EGLN1;CTNNB1;NF1;HMOX1;FGF2;VASH1;BMPER;TSPAN12
prerank,body fluid secretion (GO:0007589),-0.27576297066188493,-0.7757744719737857,0.7550200803212851,0.9228403613621748,1.0,3/15,14.06%,ERBB4;PRLR;VEGFA
prerank,negative regulation of signal transduction (GO:0009968),0.3202788422102366,0.7750873518833467,0.923,1.0,1.0,38/249,18.66%,IL12A;EZH2;NR4A2;PHACTR4;CD47;RB1;ERBB3;PALM;NTN1;SULF2;CRHBP;NXN;MTMR2;DCN;RNF157;LRRC14;ZBTB7A;EGFR;ASXL1;KCTD21;HMGXB4;PRKCB;PTEN;HHIP;RACK1;IRS1;CNOT1;EGF;APPL1;HGS;LGR4;NLRP2B;APLN;PIP4K2A;SNCA;LRRK2;RNF43;SUFU
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3634227718676591,0.7749096997463222,0.7290400972053463,1.0,1.0,5/21,16.74%,CAV1;GPD1L;PTEN;RACK1;NLRP2B
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.32355942736989246,0.7748498169589608,0.835030549898167,1.0,1.0,17/87,19.07%,SDHAF4;PET100;NDUFS8;CHCHD4;NDUFAF8;NDUFB7;NDUFAF1;NDUFAF7;NDUFA1;NDUFAF5;FOXRED1;SDHAF3;UQCC1;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,I-kappaB phosphorylation (GO:0007252),-0.3132148861495515,-0.7747437837884504,0.7371794871794872,0.9233677367821419,1.0,4/10,16.97%,TLR7;TLR4;CHUK;DAB2IP
prerank,positive regulation of protein secretion (GO:0050714),0.3272373460891712,0.7737697708646564,0.7948453608247422,1.0,1.0,9/69,16.72%,BLK;EZR;MYOM1;MYH10;MCU;PPIA;TCF7L2;TGFB2;CAPN10
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3386006254334924,0.7736219970379126,0.7585071350164654,1.0,1.0,3/44,2.78%,ARHGEF5;CD47;CCDC88A
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.3625554793725233,0.7735375775113131,0.7651869158878505,1.0,1.0,4/26,8.37%,ITPR1;HTR2A;IBTK;PLCG2
prerank,response to peptide hormone (GO:0043434),0.34246290296092446,0.7734210818705298,0.7769145394006659,1.0,1.0,13/43,21.03%,CAV1;ZFP36L1;GNAI1;STAT5B;ROCK2;ZBTB7B;IRS1;SIRT1;XBP1;CREB1;EIF6;EIF2B5;ROCK1
prerank,eye morphogenesis (GO:0048592),0.3706991993591823,0.7733239524946974,0.72544080604534,1.0,1.0,5/19,18.04%,AGTPBP1;SHROOM2;NIPBL;SKI;RARG
prerank,secretory granule organization (GO:0033363),0.4150016940694574,0.7729839236341179,0.7286135693215339,1.0,1.0,3/10,15.39%,VPS33B;DTNBP1;F2R
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.31581119085530934,-0.7728644831938086,0.7550335570469798,0.9251804565803576,1.0,3/11,6.35%,RREB1;ENPP2;CORO1C
prerank,maintenance of blood-brain barrier (GO:0035633),0.35084345789800475,0.7722162752102824,0.7654609101516919,1.0,1.0,4/30,9.15%,PECAM1;TJP3;LAMC1;JAM2
prerank,response to leucine (GO:0043201),0.40897826462965214,0.7707905251125505,0.7463126843657817,1.0,1.0,3/10,16.77%,LARS1;UBR2;KLHL22
prerank,cellular response to leucine (GO:0071233),0.40897826462965214,0.7707905251125505,0.7463126843657817,1.0,1.0,3/10,16.77%,LARS1;UBR2;KLHL22
prerank,cellular response to type I interferon (GO:0071357),0.34091632797933064,0.7705149376263188,0.7704194260485652,1.0,1.0,8/41,15.34%,SP100;IRF9;GBP2;XAF1;EGR1;MYD88;IFITM3;IRF8
prerank,type I interferon signaling pathway (GO:0060337),0.34091632797933064,0.7705149376263188,0.7704194260485652,1.0,1.0,8/41,15.34%,SP100;IRF9;GBP2;XAF1;EGR1;MYD88;IFITM3;IRF8
prerank,regulation of amyloid fibril formation (GO:1905906),0.38328348572255605,0.7703622993786136,0.738544474393531,1.0,1.0,4/15,14.04%,IAPP;VBP1;PFDN5;PSEN1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3596467504626979,0.7702390359164512,0.7385377942998761,1.0,1.0,7/23,17.78%,NPLOC4;FAF2;SEC13;DERL2;LMAN1;HSP90B1;SYVN1
prerank,phosphate ion homeostasis (GO:0055062),0.41704852175004703,0.770193937859866,0.7546099290780142,1.0,1.0,10/10,58.32%,XPR1;SFRP4;ENPP1;SLC34A2;SLC34A3;SLC34A1;GCM2;FGF23;FGFR4;TFAP2B
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.23305120776182664,-0.7701924563782422,0.852112676056338,0.9283247880403652,1.0,6/28,14.35%,ARRDC1;ARRB1;YTHDF2;MMP14;TSPAN15;FBXW7
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3195792575892946,0.7697990504760741,0.9209209209209209,1.0,1.0,51/208,21.15%,ECT2;TRIM59;FLNA;CD74;PIDD1;TANK;TNFSF10;GPRC5B;TFRC;NR1D1;IKBKG;TRADD;TRAF3;BIRC2;BRD4;PIM2;UBE2V1;PLCG2;TAB3;PDPK1;RIOK3;TIFA;CARD9;PRKCB;MYD88;TRIM68;VAPA;CC2D1A;CFLAR;TLR6;TRIM5;RBCK1;F2R;LPAR1;NLRC3;TRAF3IP2;SIRT1;NLRX1;CANT1;MAP3K7;MALT1;PPM1B;TRAF6;LGALS9;CASP8;UBE2N;SLC44A2;RIPK1;IKBKB;OTUD7A;GAPDH
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.40276540513135456,0.769736693163391,0.744413407821229,1.0,1.0,2/11,5.83%,TJP3;RAB1B
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.27822542185719745,-0.7697363940217888,0.7661290322580645,0.9279095594795181,1.0,10/14,35.35%,CMPK1;ME1;NMNAT3;NMNAT1;AK1;NMNAT2;AK7;AK4;AK8;NME2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.31983894333640756,0.769416230422166,0.952,1.0,1.0,81/348,22.33%,BRCA1;HEY2;MAPK1;LEF1;E2F1;EZR;TWIST1;CD74;PTPN22;CTCF;TFRC;RPS7;GSN;ATM;TERF2;MYOM1;EPHX2;PDE2A;TNRC6C;LRP3;TNRC6B;NOTCH1;DDRGK1;MAPK14;PLCG2;PICK1;MTPN;EGR1;DNMT1;MSN;PARK7;FGF9;RDX;MYD88;ARRB2;SETDB2;HCFC1;F3;NFE2L2;ROCK2;ZBTB7B;MYC;GABPA;PSEN1;TLR6;DTNBP1;TYROBP;GSK3B;TADA3;LIMS1;ATF7IP;PDCD10;TP53;EGF;HGS;MAP2K1;TASOR;TRIM28;FN1;SNCA;MED1;ATAD1;SETDB1;RPL5;RPS3;LGALS9;DNMT3B;AGO2;INPP5F;RPL23;RAB27A;RBPJ;CITED2;PRKAG1;ROCK1;CELF1;CALCOCO1;AGO1;ACTG1;MED23;NTRK3
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3739646029615825,0.7690565338410735,0.7326343381389253,1.0,1.0,5/16,18.99%,SMCHD1;KMT5C;PRKDC;RIF1;WRAP53
prerank,purine nucleotide catabolic process (GO:0006195),0.40086154524627865,0.7686976972200494,0.739652870493992,1.0,1.0,3/13,19.48%,GDA;NT5C2;PNP
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.38523038807210175,0.7682211749705168,0.7506963788300836,1.0,1.0,2/14,5.73%,KCNN4;IKBKG
prerank,regulation of smooth muscle contraction (GO:0006940),0.36559574340885864,0.7676203928228704,0.7522123893805309,1.0,1.0,4/20,15.39%,CAV1;CHRM3;NMU;F2R
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.31911431953604424,0.7672400029319294,0.8907815631262525,1.0,1.0,38/158,21.15%,ECT2;FLNA;CD74;TNFSF10;GPRC5B;TFRC;IKBKG;TRADD;BIRC2;BRD4;PIM2;UBE2V1;TAB3;TIFA;CARD9;PRKCB;MYD88;TRIM68;VAPA;CC2D1A;CFLAR;TLR6;TRIM5;RBCK1;F2R;LPAR1;TRAF3IP2;CANT1;MAP3K7;MALT1;TRAF6;LGALS9;CASP8;UBE2N;SLC44A2;RIPK1;IKBKB;GAPDH
prerank,regulation of protein targeting to membrane (GO:0090313),0.351120940035499,0.7670739407626781,0.7580645161290323,1.0,1.0,4/28,12.03%,C2CD5;FYN;CIB1;FIS1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.2619271306305804,-0.766784138284498,0.8130434782608695,0.9313295702813796,1.0,4/17,16.39%,SLC12A2;SLC9A1;HCN2;SLC8A1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.36189585675279307,0.7663253522483262,0.742749054224464,1.0,1.0,2/21,6.63%,OSBPL5;MBOAT2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.32110375092875143,0.7661895387009648,0.8496468213925328,1.0,1.0,26/101,23.92%,EZH2;INCENP;CCNYL1;RASGRP1;MAPRE3;CIB1;EGFR;FLT3;PDCD10;EGF;MAP2K1;FGFR1;CD24;SIRT1;SNCA;LRRK2;PROX1;PPP2CA;PKD2;CCND3;CALM3;ATP2B4;ADAM17;SRC;TELO2;HMGA2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.2865103075293154,-0.7658568484888826,0.7969348659003831,0.9316299959582949,1.0,3/13,11.45%,ASPH;TBC1D10A;LGMN
prerank,negative regulation of JNK cascade (GO:0046329),0.3434064284433107,0.7645086237455927,0.771264367816092,1.0,1.0,2/31,4.25%,MEN1;PTPN22
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.40664357681661123,0.7640485670617275,0.7485795454545454,1.0,1.0,3/11,17.99%,EXOSC10;FBL;DKC1
prerank,autophagosome maturation (GO:0097352),0.3443323332802315,0.7636266958774417,0.7697594501718213,1.0,1.0,16/32,27.16%,STX17;LIX1;UBQLN1;VPS16;VPS33B;RUBCNL;CHMP3;EPG5;CLN3;VMP1;TSG101;VCP;VIPAS39;ATG14;GABARAP;ATP2A2
prerank,rRNA pseudouridine synthesis (GO:0031118),0.39837557156386816,0.7635426123832023,0.729957805907173,1.0,1.0,1/10,3.55%,NOP10
prerank,retrograde axonal transport (GO:0008090),0.36722345321814703,0.7635151862184012,0.7275132275132276,1.0,1.0,4/16,12.37%,FBXW11;DYNC1H1;PAFAH1B1;HAP1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3615322629883365,0.7632108227309334,0.7472256473489519,1.0,1.0,1/21,3.29%,FLNA
prerank,positive regulation of histone deacetylation (GO:0031065),-0.28603907408017504,-0.763080235828868,0.7708333333333334,0.9348202790059539,1.0,3/12,6.25%,PRKD1;AKAP8L;SAP30BP
prerank,positive regulation of endocytosis (GO:0045807),0.33061265556908476,0.762310915175758,0.7795527156549521,1.0,1.0,11/45,18.69%,TFR2;ABCA13;NEDD4L;CBLL1;TOR1A;B2M;FLOT1;ANO6;LDLRAP1;SNCA;CLN3
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.34463517130474136,0.7619704907345052,0.7668997668997669,1.0,1.0,7/29,19.38%,RAB33B;NAPG;COG6;COPZ1;VTI1A;RAB6A;TRAPPC3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.38952286101872435,0.7619002375189036,0.7386363636363636,1.0,1.0,3/11,13.09%,NONO;PARK7;RACK1
prerank,positive regulation of cation channel activity (GO:2001259),-0.20417822651301396,-0.7618616332523594,0.8846153846153846,0.9354955281508438,1.0,3/40,4.89%,CTSS;ANK3;ANK2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.36807126799772316,0.7616787158853863,0.7171052631578947,1.0,1.0,4/15,14.45%,RIPOR2;MAPK14;FLOT1;TYROBP
prerank,protein targeting to mitochondrion (GO:0006626),0.3270251908837087,0.7614614538060944,0.7921653971708379,1.0,1.0,11/52,14.03%,CHCHD4;TOMM34;TSPO;PITRM1;TIMM9;DNAJC15;GDAP1;FIS1;TOMM70;TIMM23;GRPEL2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.22592233908145554,-0.7609192749930125,0.8958333333333334,0.9357426901241767,1.0,9/30,19.01%,SMAD3;PCSK6;FSTL1;ENG;LATS2;SMAD7;TGFBR3;SMURF2;SOX11
prerank,negative regulation of stress fiber assembly (GO:0051497),0.35090475427910156,0.7604644321272777,0.7625730994152047,1.0,1.0,3/24,5.95%,STMN1;ARHGEF18;CLASP1
prerank,embryonic skeletal system development (GO:0048706),0.33520780347258067,0.7601086280787251,0.7820658342792282,1.0,1.0,3/35,7.70%,DEAF1;SULF2;FUZ
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.23756141126087804,-0.7600979199423848,0.8,0.9357397149442969,1.0,7/24,22.78%,AKIRIN1;PIK3R1;ARPC2;ABI2;TWF2;CDC42;CYFIP1
prerank,autophagy of peroxisome (GO:0030242),0.39029499666619877,0.7599542910201246,0.7640449438202247,1.0,1.0,2/12,5.98%,ACBD5;ATM
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3415617958753554,0.7590221114941473,0.7846674182638106,1.0,1.0,10/37,19.34%,IFT80;TNPO1;SSX2IP;PCM1;IFT57;DYNLL1;KIFAP3;IFT172;IFT140;DYNLRB1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.36060352442918137,0.758877612254339,0.758578431372549,1.0,1.0,4/20,18.14%,BRCA1;ABCA2;WDTC1;PRMT3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.32876230746999435,0.7587758222294945,0.7818181818181819,1.0,1.0,14/50,19.79%,FBXO5;NXN;CAV1;TAF1;PRR7;PARK7;ARRB2;SIRT7;UBXN1;CAMLG;PRMT3;GNL3L;RPS3;HDAC8
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.40312314290228735,0.7587732837180121,0.7301587301587301,1.0,1.0,3/10,20.55%,CSGALNACT2;B3GAT2;B3GAT1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.23568750604983646,-0.7586392509987896,0.8546511627906976,0.9367598341642613,1.0,5/24,11.49%,IGF1;AKT2;IRS2;GSK3A;SELENOS
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3542920886803536,0.7586360326843009,0.7506024096385542,1.0,1.0,9/24,19.06%,SEC24B;TAP1;SEC24A;SEC13;B2M;SEC31A;CANX;ERAP1;SAR1B
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3301310756004904,0.7580204692944745,0.8068303094983992,1.0,1.0,9/52,13.09%,CNPY4;PRKCE;SORBS1;CIB1;EGFR;EPHA3;PDPK1;CNST;RACK1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.33903111306789013,0.7577427735146649,0.757679180887372,1.0,1.0,3/29,8.69%,ACOT11;ACOT13;ACOT2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.33903111306789013,0.7577427735146649,0.757679180887372,1.0,1.0,3/29,8.69%,ACOT11;ACOT13;ACOT2
prerank,positive regulation of neuron death (GO:1901216),0.329449472296427,0.757705159062365,0.7948717948717948,1.0,1.0,13/46,21.27%,FYN;EIF2S1;MAP3K5;EGR1;DDIT3;TLR6;TYROBP;GSK3B;TGFB2;FCGR2B;SNCA;EPHA7;MAPT
prerank,stem cell development (GO:0048864),0.3684988650888314,0.7576915562205231,0.7265725288831836,1.0,1.0,3/16,11.80%,PEF1;TCOF1;TAPT1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.36658476797912976,0.7572926337257384,0.7433510638297872,1.0,1.0,3/15,22.46%,TGFB2;JAK3;CUEDC2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.35689626772846017,0.7568756423010664,0.7734741784037559,1.0,1.0,8/25,17.77%,BRD4;RNF168;RNF8;NELFA;HNRNPU;NELFB;TCERG1;HEXIM1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.33444841135209286,0.7566952562976568,0.78125,1.0,1.0,16/45,23.07%,POLR2A;ZC3H18;SETX;EGFR;DYRK1A;DXO;SIRT7;TP53;DIMT1;MAP2K1;RIOK1;HNRNPLL;PNPT1;RIPK1;TRMT112;ZPR1
prerank,retina homeostasis (GO:0001895),0.3509414894728325,0.7560480330931371,0.7552019583843329,1.0,1.0,3/23,13.42%,POC1B;B2M;BBS4
prerank,sensory perception of chemical stimulus (GO:0007606),-0.2721794687169108,-0.7557122932489659,0.7748917748917749,0.9400418964426035,1.0,7/15,33.13%,GNAS;C5AR1;CD36;UBR3;GNAL;MKKS;DRD2
prerank,cellular response to copper ion (GO:0071280),0.36581455235739313,0.7556532293511832,0.7532637075718016,1.0,1.0,1/16,1.86%,AQP1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.3829390480182381,0.7554441408293221,0.7431318681318682,1.0,1.0,5/12,24.04%,PLCG2;TLR6;CYBA;RAB27A;SLC5A3
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3116638670201908,0.755176293358837,0.976,1.0,1.0,91/390,22.52%,SHCBP1;BLK;NTF4;STMN1;MAPK1;ERBB3;FYN;TIAM1;POLR2I;SULF2;POLR2A;NEDD9;FLRT2;PGF;MAPKAPK3;CYFIP2;GFRA2;HNRNPM;FOXO1;SORBS1;SETX;NUS1;MAPK14;GRB2;JAK2;SOS1;ITGAV;NCBP1;EGFR;EPHA3;CAV2;ANKS1A;SOCS2;MTSS1;FGF9;PLCB1;FLT3;CRK;ARHGEF28;AP2B1;HAP1;LMTK2;NRP1;ROCK2;SPRED2;ATP6V0E1;PSEN1;IRS1;GSK3B;BRK1;CEP57;APPL1;CYBB;ELMO2;ANKS1B;FGFR1;FIBP;PAK2;ATP6AP1;POLR2K;RAC1;PIK3CA;CYBA;ATP6V0D1;POLR2J;SDC2;ARHGEF7;KIF16B;POLR1G;HNRNPA1;NCBP2;NCF4;GRB14;PRKD2;ALK;EPHA7;MET;SIPA1L1;ROCK1;SH2D2A;VAV3;EPHA10;SYK;FGR;RBFOX2;ACTG1;EFNA1;NTRK3;DDR2;POLR2B;PXN
prerank,calcium ion transport (GO:0006816),0.3182566649339439,0.7551403888307013,0.867274569402229,1.0,1.0,20/113,17.46%,MS4A1;CACNA1I;RAMP1;ITPR1;FYN;KCNN4;CAV1;ORAI2;TRPM7;ITGAV;CALCRL;CRACR2A;MICU1;PSEN1;TPT1;SLC24A4;SLC24A2;TRPM4;CACNA1B;ANO6
prerank,regulation of neutrophil migration (GO:1902622),-0.3142688519554223,-0.7545577406890525,0.7966666666666666,0.9406672525668297,1.0,4/10,14.55%,MPP1;RHOG;NCKAP1L;RHOH
prerank,modified amino acid transport (GO:0072337),0.36950287177462615,0.7545245441366364,0.7433862433862434,1.0,1.0,2/15,11.15%,SLC16A12;SLC19A1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3389584205650223,0.7544778059768685,0.7929864253393665,1.0,1.0,6/33,15.38%,CCDC88A;SHKBP1;TGFA;HAP1;DGKD;EGF
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3563601812463716,0.7540605413188789,0.7460122699386503,1.0,1.0,7/19,22.91%,XRCC6;PPP2R3C;BTK;PRKDC;XBP1;SYK;ZBTB1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.34303759187410693,0.7540027803411185,0.7743467933491687,1.0,1.0,2/29,7.15%,ZFPM1;NOTCH1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.28971332205165456,-0.7539596571152583,0.7730769230769231,0.9404603201302006,1.0,3/12,16.45%,BASP1;PTPRO;JAG1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.32822718327435263,0.7536923045339095,0.7844638949671773,1.0,1.0,11/45,17.24%,EIF2A;RBM3;ZC3H7A;PUM2;MTPN;PUM3;TCOF1;PUM1;METTL16;RC3H1;TDRD7
prerank,membrane depolarization (GO:0051899),0.3374938104097658,0.7535472142475113,0.784738041002278,1.0,1.0,3/32,6.13%,CACNA1I;CAV1;YWHAH
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.24004095225391878,-0.7533132169198968,0.8457446808510638,0.9403322090021439,1.0,9/22,27.73%,RELA;GSK3A;CASP3;EPHA4;RANBP9;LYN;PICALM;CHRNA7;LRRTM3
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.3692190023836578,0.7525757015378962,0.7455012853470437,1.0,1.0,4/14,16.78%,PGF;NUS1;NRP1;PIK3CA
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.28238450120208325,-0.7524744907299465,0.8149466192170819,0.940373877049889,1.0,1/13,0.52%,EPN2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3294531344771905,0.7521897621301357,0.7989130434782609,1.0,1.0,8/46,14.93%,AGPAT1;AGPAT4;GPD1L;GPAT3;AGPAT3;PLD2;DGKD;PLD1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.3873720422540927,0.7520540467157778,0.7519893899204244,1.0,1.0,3/13,14.99%,L2HGDH;PHYH;IDH2
prerank,establishment of melanosome localization (GO:0032401),0.3534910734980014,0.7519966317391832,0.7615480649188514,1.0,1.0,8/19,24.62%,SHROOM2;RAB11B;BBS4;MREG;RAB27A;RAB27B;BBS7;BBS2
prerank,muscle tissue development (GO:0060537),0.3835749374290942,0.7512214869256831,0.7472677595628415,1.0,1.0,2/13,9.10%,CSRP3;CSRP1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.34735969440701153,0.7510226986019477,0.7713625866050808,1.0,1.0,8/29,20.19%,CCR2;JAK2;SOCS2;STAT5B;PIAS1;JAK3;PKD2;SOCS6
prerank,early endosome to Golgi transport (GO:0034498),0.38625975314312055,0.7507800437555533,0.7221438645980254,1.0,1.0,4/11,21.61%,STX5;LMAN1;RAB6A;TRAPPC10
prerank,Golgi organization (GO:0007030),0.31318534717343915,0.7506067507722225,0.8909090909090909,1.0,1.0,31/112,21.37%,CDK1;ATP8B4;STX17;ATL2;CLASP1;STX5;NPLOC4;CSNK1A1;ZW10;BLZF1;DYM;BET1;VRK1;RAB43;PI4K2B;RAB2A;VCPIP1;PDCD10;FAM174B;SYNE1;LMAN1;GORASP1;LRRK2;ARHGEF7;VTI1A;FBXW8;GOLPH3;GORASP2;ATP8B2;VAMP4;TMED10
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.31391701249346493,0.7506038994176679,0.8195020746887967,1.0,1.0,21/67,21.23%,FYN;PGF;MAPKAPK3;CYFIP2;MAPK14;ITGAV;CRK;NRP1;ROCK2;BRK1;CYBB;ELMO2;PAK2;RAC1;PIK3CA;CYBA;NCF4;PRKD2;ROCK1;SH2D2A;VAV3
prerank,negative regulation of kinase activity (GO:0033673),0.32352320772238413,0.7503512723528185,0.8109243697478992,1.0,1.0,14/62,17.91%,RB1;PPP2R5A;TAF7;CEP85;TAB1;PDPK1;PARK7;HNRNPU;PRKAG2;PPIA;DTNBP1;TARBP2;PAK2;SNCA
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.3600672320786046,0.7503057902479932,0.7746305418719212,1.0,1.0,4/20,13.28%,LY6H;PLCB1;GRK2;CHRM3
prerank,cellular response to oxygen levels (GO:0071453),0.3943525641052534,0.7503019004185676,0.760932944606414,1.0,1.0,3/10,17.11%,PICK1;ATP6AP1;ATP6V0D1
prerank,fatty acid transmembrane transport (GO:1902001),0.35677783506248617,0.749781588498237,0.7553865652724968,1.0,1.0,7/19,18.79%,ABCD1;CPT1B;CPT1A;PRKAG2;CPT2;SLC2A1;ABCD4
prerank,myotube differentiation (GO:0014902),0.3674827519665606,0.7495466442270707,0.7374517374517374,1.0,1.0,4/17,16.93%,MYEF2;JAM2;SKI;ADAMTS5
prerank,carbohydrate derivative transport (GO:1901264),-0.25334887305595677,-0.7495319179471452,0.8,0.9435122426309476,1.0,5/18,18.29%,SLC15A3;PLTP;SCARB1;NPC2;VLDLR
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.36699112475709295,0.7494613416140966,0.7881462799495587,1.0,1.0,5/18,16.94%,NONO;PARK7;NFE2L2;PPIA;SIRT1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.2730010604750887,-0.7490960268142127,0.8132780082987552,0.9429814550932668,1.0,6/15,24.04%,CDH13;MVB12B;LGMN;CEACAM1;RHBDF2;FER
prerank,calcium import into the mitochondrion (GO:0036444),0.3900095838414941,0.7489920112989097,0.7537619699042407,1.0,1.0,3/10,14.01%,MICU3;MICU1;MCU
prerank,positive regulation of bone mineralization (GO:0030501),-0.21125504956112018,-0.7488047596231734,0.91,0.9422052074704335,1.0,8/35,17.77%,ACVR1;BMPR2;ATRAID;ALOX5;BMPR1B;SLC8A1;PKDCC;BMP6
prerank,positive regulation of monooxygenase activity (GO:0032770),0.347145302224482,0.7479916912844298,0.7842669845053635,1.0,1.0,4/26,10.75%,TERF2;NUS1;ATP7A;PARK7
prerank,regulation of protein modification process (GO:0031399),0.3282070466427647,0.7479349677892715,0.8189563365282215,1.0,1.0,15/50,22.66%,CCDC88A;PML;CCDC88C;PIN1;ABCA2;PUM3;CCAR2;KAT2B;SPRED2;FN1;PPP1R16A;PPP2CA;CADM4;PPP1R16B;ASPSCR1
prerank,membrane raft organization (GO:0031579),0.36538608991161275,0.747924851358687,0.7554417413572343,1.0,1.0,5/15,19.13%,ABCA7;FLOT1;FLOT2;CLN3;S100A10
prerank,nucleotide-sugar metabolic process (GO:0009225),0.37843408208278656,0.747805486216812,0.7581329561527581,1.0,1.0,4/12,18.81%,GFUS;FUT8;GFPT2;GMDS
prerank,genitalia development (GO:0048806),-0.2902941325475865,-0.7476778157533599,0.8174603174603174,0.9426446410796016,1.0,3/12,18.78%,DNAJC19;PKD1;CHD7
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3192060000062025,0.7475856495680124,0.8402061855670103,1.0,1.0,23/76,23.20%,PLK1;AXIN1;TAF1;CSNK1A1;DDRGK1;SUMO1;RAD23A;PTEN;CDK5RAP3;RACK1;SUMO2;ARIH2;PABIR1;GSK3B;PIAS1;RNF19A;LRRK2;KEAP1;MDM2;CBFA2T3;HECTD1;DDA1;BBS7
prerank,cochlea morphogenesis (GO:0090103),0.3990901583546098,0.747550202970089,0.7642752562225475,1.0,1.0,2/10,19.35%,TIFAB;PAX2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.36313030787973155,0.7474994041975415,0.7551546391752577,1.0,1.0,7/17,23.22%,MBTPS2;SEC14L2;ABCA2;KPNB1;SREBF2;SCAP;LPCAT3
prerank,sensory perception of smell (GO:0007608),0.39528069943873034,0.7473423926026712,0.7748251748251749,1.0,1.0,2/11,15.70%,BBS4;SLC24A4
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3651306631930727,0.7473251327871512,0.7760617760617761,1.0,1.0,6/17,24.65%,ATP5F1E;ATP5F1D;ATP5MC2;ATP5F1B;ATP5MF;ATP5ME
prerank,chloride transmembrane transport (GO:1902476),0.33001096240279215,0.7473024939910385,0.7963558413719185,1.0,1.0,7/48,12.59%,SLC12A3;SLC12A7;SLC12A1;GABRA4;GABRA5;ANO3;SLC12A6
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3646668912406578,0.7472557083656363,0.7812895069532237,1.0,1.0,1/17,2.29%,CACNA1I
prerank,proton transmembrane transport (GO:1902600),-0.20551097603179597,-0.7472309959993504,0.8910891089108911,0.9422020060474103,1.0,13/36,29.41%,SLC9A1;ATP1A1;ATP6V1H;ATP6V1A;ATP6V1F;ATP1A2;NNT;ATP6V0C;SLC36A1;ATP1A3;SLC25A27;ATP6V0E2;SLC46A1
prerank,regulation of signal transduction (GO:0009966),0.3096200582806593,0.7471515327274986,0.9269269269269269,1.0,1.0,51/190,23.20%,CD177;RGS12;ERBB3;FYN;AXIN1;NUCKS1;SNX3;SP100;GRK6;SIK2;TCF7L1;GIT2;FUZ;TMEM237;MFNG;SOCS2;AMFR;PLCB1;CRK;CBFB;HHIP;GRK2;ZDHHC7;TMEM204;ADCYAP1;CREBBP;PPIA;ZFAND2B;DTNBP1;TRIM5;ELF1;RUNX1;CD24;SIRT1;TSPEAR;LRRK2;CD55;SREBF2;PPP2CA;NCLN;ILK;POFUT1;GRK3;CDC42SE2;IGFBP7;YWHAG;PXN;FGFR2;INTU;IGFBP2;SRC
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.36703108561216974,0.7469145212427771,0.7791164658634538,1.0,1.0,5/17,17.78%,NPLOC4;FAF2;DERL2;HSP90B1;SYVN1
prerank,bone morphogenesis (GO:0060349),-0.2768892953509381,-0.7465300603479975,0.78515625,0.9420192525986124,1.0,2/14,8.92%,BMPR2;BMPR1B
prerank,embryonic appendage morphogenesis (GO:0035113),0.3795976521308486,0.746376134018523,0.7805212620027435,1.0,1.0,3/12,22.36%,SKI;TGFB2;MEGF8
prerank,ESCRT III complex disassembly (GO:1904903),0.39423308569084436,0.7461848941188094,0.762982689747004,1.0,1.0,6/10,27.75%,CHMP1B;CHMP2B;VTA1;VPS4A;CHMP5;VPS4B
prerank,ESCRT complex disassembly (GO:1904896),0.39423308569084436,0.7461848941188094,0.762982689747004,1.0,1.0,6/10,27.75%,CHMP1B;CHMP2B;VTA1;VPS4A;CHMP5;VPS4B
prerank,negative regulation of RNA splicing (GO:0033119),0.35679408973602666,0.7461563229604862,0.7759699624530664,1.0,1.0,10/19,28.15%,SAP18;SRSF4;RNPS1;SRSF10;SRSF7;PTBP2;PTBP1;SFSWAP;RPS13;PTBP3
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3445388910748147,0.7456746049513528,0.7658536585365854,1.0,1.0,5/21,17.59%,PTPN22;BANK1;PIBF1;JAK3;FCGR2B
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.344759981170879,0.7448861935570729,0.7940119760479042,1.0,1.0,8/26,21.74%,PTPN22;CAV1;HMGB1;FLOT1;TLR5;CYBA;IFI35;NR1H3
prerank,ganglioside biosynthetic process (GO:0001574),0.3639113094604544,0.7442573347080602,0.7519685039370079,1.0,1.0,5/15,20.14%,ST3GAL1;ST3GAL2;ST8SIA4;ST3GAL5;ST8SIA6
prerank,negative regulation of GTPase activity (GO:0034260),-0.2436935222507395,-0.7440595957651711,0.8360655737704918,0.9444956143026556,1.0,7/22,20.88%,F11R;RASA4;RCC2;DAB2IP;ARL2;PLXNB3;TMED2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.2899112364061235,-0.7438398310928056,0.797979797979798,0.9436632475063748,1.0,8/11,29.60%,NAGK;PGM3;GNPDA1;GNPDA2;AMDHD2;GNPNAT1;GFPT1;RENBP
prerank,regulation of small molecule metabolic process (GO:0062012),0.3352552728013862,0.7438322157052032,0.7636786961583236,1.0,1.0,6/28,16.94%,PANK2;EPHX2;FMO5;ADIPOR1;FOXK2;SIRT1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.3914870059323049,0.743694420228898,0.7510853835021708,1.0,1.0,2/10,17.91%,HDAC6;SNCA
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.2409144112661155,-0.7436055522425176,0.8728323699421965,0.9428715885529327,1.0,7/23,19.01%,SMAD3;ENG;LATS2;SMAD7;TGFBR3;SMURF2;SOX11
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.3826573250530357,0.7429970644647638,0.7335164835164835,1.0,1.0,4/12,17.63%,CIB1;CAMTA1;STIMATE;SPPL3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.3826573250530357,0.7429970644647638,0.7335164835164835,1.0,1.0,4/12,17.63%,CIB1;CAMTA1;STIMATE;SPPL3
prerank,regulation of angiogenesis (GO:0045765),0.30684745912511435,0.7427716570156505,0.9329329329329329,1.0,1.0,32/192,17.58%,CYP1B1;BRCA1;AQP1;HSPG2;TWIST1;EMC10;PML;PGF;SP100;CCR2;DCN;PRKCA;SMOC2;MECP2;PDPK1;HIPK2;CEMIP2;VASH2;PRKCB;F3;AGGF1;ROCK2;MYDGF;HTATIP2;ADAMTS1;RUNX1;HGS;TGFB2;PLCG1;SIRT1;XBP1;PGK1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.29740593597128584,-0.7426285705468979,0.8263888888888888,0.9431708722720078,1.0,6/11,35.49%,STMN2;TRPV4;PLEK;NES;KATNB1;PDXP
prerank,negative regulation of defense response (GO:0031348),0.31189471195666396,0.7425782720858765,0.8621399176954733,1.0,1.0,5/77,5.37%,RNF26;MEFV;RB1;DHX58;NR1D1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.35054460482413374,0.7421736353676184,0.7772277227722773,1.0,1.0,5/21,15.17%,ZFP36L1;CBFB;CTSK;ROCK2;RUNX1
prerank,regulation of BMP signaling pathway (GO:0030510),0.31138503471167767,0.7421391335922259,0.84346035015448,1.0,1.0,11/73,13.77%,FBXL15;CCN1;UBE2O;NOTCH1;HIPK2;TRIM33;SMAD4;XIAP;BMPR1A;NUMA1;SKI
prerank,sterol homeostasis (GO:0055092),0.3147696904728521,0.7415979454126471,0.8275862068965517,1.0,1.0,17/65,23.72%,ABCD1;CAV1;NR1D1;EPHX2;RALY;ABCA2;LIMA1;CD24;SIRT1;XBP1;LDLRAP1;NR1H3;HDAC9;LDLR;SOAT1;TTC39B;EHD1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.37033171918166496,0.7411201199628513,0.7875862068965517,1.0,1.0,1/13,2.20%,XPO1
prerank,regulation of secretion (GO:0051046),0.37323285101146925,0.741061485429971,0.762550881953867,1.0,1.0,1/13,2.98%,ERBB3
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3068288331638895,0.7409434284692605,0.992,1.0,1.0,113/509,21.15%,CD19;ECT2;PMAIP1;IAPP;RPS20;ERBB3;FYN;FLNA;DHX58;CD74;S100A9;TNFSF10;GPRC5B;TFRC;CGAS;CAV1;IKBKG;S100A8;TRADD;TGFA;BIRC2;BRD4;PUM2;PIM2;HMGB1;BOK;DCN;UBE2V1;HCST;GRB2;PLCG2;JAK2;ITGAV;STRN;TAB3;LARS1;EGFR;CAV2;PDPK1;SEC13;TXN;RIT2;TIFA;TRIM44;CARD9;PARK7;RELN;PUM1;MLST8;FGF9;BECN1;FLT3;PRKCB;MYD88;TRIM68;VAPA;FIS1;CDK5RAP3;F3;ROCK2;RACK1;RAC2;CC2D1A;ACTN4;DDIT3;LAMTOR4;CFLAR;MYDGF;TLR6;USP15;TRIM5;IRS1;RBCK1;LAMTOR3;ADGRV1;LIMS1;TP53;EGF;F2R;LPAR1;TCF7L2;FGFR1;TGFB2;TRAF3IP2;RAC1;PIK3CA;SIRT1;CANT1;HCLS1;FN1;KITLG;MAP3K7;HEXIM1;IQGAP1;MALT1;KSR1;RPS3;TRAF6;LGALS9;CASP8;IFI35;GOLPH3;PRKD2;RPL23;MET;ILK;UBE2N;SLC44A2;RRAGB;RIPK1;ROCK1;IKBKB;GAPDH
prerank,cell-substrate junction assembly (GO:0007044),0.3398153224131587,0.7407941699529677,0.7911464245175936,1.0,1.0,9/33,18.19%,SORBS1;LAMC1;LAMB3;WHAMM;ACTN2;TESK2;BCR;FN1;ARHGEF7
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.3010944525934387,-0.7407859805807167,0.802547770700637,0.9446710305289003,1.0,5/10,27.92%,SMOX;ALDH7A1;SARDH;CHDH;HNMT
prerank,heterocycle biosynthetic process (GO:0018130),0.3745130229111021,0.7406810902590872,0.7433862433862434,1.0,1.0,1/14,2.57%,PYCR3
prerank,regulation of protein neddylation (GO:2000434),0.38901502124150017,0.7405995379624717,0.7686781609195402,1.0,1.0,1/10,4.63%,COPS9
prerank,regulation of interleukin-2 production (GO:0032663),0.3252667073098017,0.7403629069388199,0.8097826086956522,1.0,1.0,12/43,19.97%,GLMN;EZR;CCR2;PLCG2;RUNX1;HOMER2;MAP3K7;MALT1;RPS3;TRAF6;PNP;PRKD2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.3453768465099652,0.739453597853034,0.794047619047619,1.0,1.0,6/25,21.57%,MPP2;ARRB2;GSK3B;LRRK2;GLRA1;GRIN2D
prerank,regulation of synapse organization (GO:0050807),0.3438449945827875,0.7391834521327594,0.7820965842167256,1.0,1.0,8/26,22.99%,ABHD17A;ABHD17B;MDGA1;PDLIM5;CLN3;SLITRK2;SETD5;NEDD4
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3084556231207584,0.7390391774534409,0.9328657314629258,1.0,1.0,32/190,16.99%,CIT;PHLPP2;TRIM59;ITPR1;TWIST1;TANK;PHLDA3;CAV1;BANK1;NR1D1;GPD1L;PDE2A;CIB1;MAPK14;RNF157;CYRIB;RIOK3;ABCA7;UBR2;ADIPOR1;PTEN;ARRB2;RACK1;DGKD;DDIT3;UACA;DAG1;LIMD1;NPRL3;NLRC3;SIRT1;NLRX1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.3065684684196882,-0.7388527344614405,0.78,0.9460959750583925,1.0,5/10,32.25%,BIN1;ATP1A2;CBARP;FKBP1B;ADRA2A
prerank,regulation of receptor binding (GO:1900120),-0.29904297166903865,-0.738462655582898,0.8286604361370716,0.9454958235377495,1.0,2/10,12.60%,ADAM15;GREM2
prerank,cellular response to calcium ion (GO:0071277),0.3140784436610313,0.7384351404510247,0.8484848484848485,1.0,1.0,5/67,8.37%,ECT2;CRHBP;SYT8;DPEP1;PLCG2
prerank,negative regulation of cell death (GO:0060548),0.309069609035532,0.7379370485737794,0.866869918699187,1.0,1.0,18/88,19.47%,FYN;CCN1;CCN4;DCPS;IKBKG;INPP5A;PDE12;RAD18;NENF;PARK7;BECN1;GSK3B;TMEM109;PDE8A;SNCA;LRRK2;PAX2;NPAS2
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3431314773846898,0.7374586221932391,0.7922885572139303,1.0,1.0,6/25,17.91%,CAV1;TRPM7;KCNA1;TMTC2;FAM20A;SNCA
prerank,DNA catabolic process (GO:0006308),0.38372544967751265,0.737322549344374,0.772027972027972,1.0,1.0,2/11,13.47%,DNASE1L1;REXO4
prerank,negative regulation of cytokine production (GO:0001818),0.30574336238385463,0.7371422424413292,0.9226130653266331,1.0,1.0,29/163,17.59%,IL12A;MEFV;LEF1;EZR;DHX58;ZFPM1;PPP1R11;PTPN22;RPS6KA5;ABCD1;NPLOC4;PIN1;HMGB1;ASB1;PCBP2;DDIT3;PIBF1;TLR6;TYROBP;GPATCH3;OTUD5;LGR4;NLRC3;HOMER2;JAK3;RAC1;NLRX1;FN1;FCGR2B
prerank,protein dephosphorylation (GO:0006470),0.3074506757723011,0.7368955200563538,0.9153225806451613,1.0,1.0,37/135,20.51%,PPM1D;PTPRA;PPP3CA;FBXW11;PTPN22;PPP2R5E;STK11;PPP1CB;PPP2R5A;MTMR2;EYA3;TAB1;PPP2CB;PPP1R15A;PTPN7;PTPN14;PPP1CC;RPRD1B;MTMR6;PTEN;PPP3CC;PPP1R12A;EYA1;PTPN5;PPP6C;MTM1;PTPRU;PPP2R5D;DUSP22;DUSP12;PTPN13;PPP1CA;ILKAP;PPM1B;PPP2CA;RPAP2;DUSP16
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.35059478717554426,0.7363592588820365,0.792336217552534,1.0,1.0,8/21,20.76%,PNLDC1;TUT4;CNOT4;CNOT1;CNOT6;SAMD4A;CNOT8;CNOT7
prerank,positive regulation of interleukin-17 production (GO:0032740),0.35057229104135246,0.736346580974732,0.7874692874692875,1.0,1.0,3/22,13.13%,CARD9;MYD88;ZBTB7B
prerank,endoderm formation (GO:0001706),-0.20908212721384614,-0.7363340633171996,0.936,0.9472989159726632,1.0,4/35,7.91%,ITGB5;ITGA5;COL11A1;MMP14
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.2838389415613497,-0.7358965324362791,0.7769516728624535,0.9457001191105097,1.0,5/11,31.41%,SRI;CALM1;GSTO1;FKBP1B;CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.2838389415613497,-0.7358965324362791,0.7769516728624535,0.9457001191105097,1.0,5/11,31.41%,SRI;CALM1;GSTO1;FKBP1B;CALM2
prerank,copper ion homeostasis (GO:0055070),0.35718140636092444,0.7355119235587569,0.7802746566791511,1.0,1.0,3/17,11.30%,CUTC;ATP7A;XIAP
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3172161610467551,0.7346815580643938,0.8226495726495726,1.0,1.0,8/51,16.74%,ARHGEF5;CD47;CCDC88A;SYNPO2;NRP1;ROCK2;LPAR1;RAC1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.35035755973857385,0.7344642179157884,0.7975903614457831,1.0,1.0,3/22,8.41%,DDX11;SMARCA4;NOL11
prerank,negative regulation of protein phosphorylation (GO:0001933),0.305857248975547,0.7338725615592718,0.9115577889447236,1.0,1.0,41/150,23.15%,MEN1;RB1;TWIST1;CAV1;CRKL;GPD1L;PMEPA1;TAF7;NIBAN1;CEP85;CIB1;TAB1;IBTK;PDPK1;PARK7;SNX25;PTEN;CDK5RAP3;RACK1;SPRED2;PRKDC;PRKAG2;PPIA;DTNBP1;FKBP8;TARBP2;PAK2;NLRP2B;PTPN13;SNCA;LRRK2;PRR5L;DNAJC3;CADM4;CALM3;PPP1R15B;YWHAG;NTRK3;TARDBP;PPM1E;PRKCD
prerank,snRNA 3'-end processing (GO:0034472),0.3601927076788919,0.7336111802660703,0.7757731958762887,1.0,1.0,5/19,20.66%,EXOSC8;INTS1;INTS14;TUT1;INTS12
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.35453083031693067,0.7329735040918063,0.7650834403080873,1.0,1.0,3/17,14.64%,GMFG;PICK1;BRK1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.200487345683023,-0.7328912494372756,0.9662921348314607,0.9483993114562519,1.0,8/39,17.77%,MBP;NEXMIF;MIA3;PPM1F;PTK2;VEGFA;JAG1;BMP6
prerank,positive regulation of cell growth (GO:0030307),0.30938769946316136,0.732828766993201,0.8833671399594321,1.0,1.0,15/96,11.37%,NTN1;S100A9;BRAT1;DDX49;S100A8;H3-3A;CIB1;NEDD4L;DBNL;RNF157;MTPN;NCBP1;EGFR;DERL2;SYT3
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3143305345851269,0.7325505313978158,0.8331573389651531,1.0,1.0,16/54,23.29%,IKBKG;TRADD;TRAIP;BIRC2;UBE2K;SPATA2;RACK1;CFLAR;RBCK1;NLRP2B;CASP8;RIPK1;IKBKB;SYK;ADAM17;HIPK1
prerank,cellular response to amino acid starvation (GO:0034198),0.31096677073551476,0.732040041135565,0.8601036269430051,1.0,1.0,15/71,17.11%,DAP;MAPK1;EIF2S1;MAP3K5;LARS1;SEC13;SZT2;MLST8;FAS;RNF152;ATP6V0E1;LAMTOR4;LAMTOR3;NPRL3;ATP6V0D1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.3840113730836583,0.7319038575176908,0.7568345323741007,1.0,1.0,3/10,19.10%,MTHFD2L;TYMS;MTHFD1L
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.35101735008387486,0.7315827923744292,0.7841634738186463,1.0,1.0,7/17,23.42%,S1PR2;ROCK2;PPP1R12A;ROCK1;IKBKB;ZDHHC21;VCL
prerank,regulation of blood circulation (GO:1903522),0.32708135534642174,0.7314320745093127,0.8076490438695163,1.0,1.0,1/34,1.71%,DES
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.378058946230479,0.7313067131210993,0.7817919075144508,1.0,1.0,2/12,10.83%,PAFAH1B1;SZT2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3107921444928739,0.7312605017992139,0.8541666666666666,1.0,1.0,15/68,19.10%,PANK2;MTHFD2L;RFK;SLC52A1;SLC19A1;MTR;MCCC1;TPK1;PDXK;MMAA;SLC2A3;ALDH1L1;SLC2A1;ABCD4;MTHFD1L
prerank,receptor-mediated endocytosis (GO:0006898),0.30204365614262896,0.7311211125110318,0.9083585095669687,1.0,1.0,27/132,18.69%,TFR2;RAMP1;HSPG2;AP1G2;TFRC;CAV1;LRP3;SNX9;CLTC;GRB2;PDLIM7;CAV2;M6PR;AP4E1;CALCRL;DNAJC13;ARRB2;AP2B1;CANX;GRK2;LMBR1L;HSP90B1;FCGR2B;LDLRAP1;COLEC12;SNCA;CLN3
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.3829529600756606,0.7305720861935601,0.7692307692307693,1.0,1.0,3/10,18.39%,CAV1;SUMO1;KCNRG
prerank,phagosome-lysosome fusion (GO:0090385),-0.29672676654370594,-0.7303209170892455,0.8387096774193549,0.9506128587603334,1.0,2/10,10.80%,RAB20;SYT7
prerank,regulation of mitochondrial fission (GO:0090140),0.33623286128101293,0.7301671139253573,0.791871921182266,1.0,1.0,8/24,21.27%,AURKA;DCN;CYRIB;FIS1;MCU;LRRK2;BNIP3;MAPT
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.30842580691800353,0.7300503960638125,0.884928716904277,1.0,1.0,24/100,17.75%,MAPK1;ERBB3;TWIST1;PIP5K1B;DCN;HCST;ENTPD5;JAK2;EGFR;BECN1;FLT3;PTEN;MYDGF;EGF;F2R;FGFR1;TGFB2;NLRC3;PIK3CA;SIRT1;PIP4K2A;HCLS1;FN1;PTPN13
prerank,negative regulation of myotube differentiation (GO:0010832),0.3767482054858462,0.7290903610412008,0.778393351800554,1.0,1.0,6/12,26.75%,NOTCH1;XBP1;HDAC4;HDAC1;BDNF;TMEM119
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.20393776305561123,-0.729083388828078,0.9305555555555556,0.9510742523856687,1.0,9/44,13.27%,APOE;PTPRJ;CD300A;NF1;DUSP10;SH2B3;PIK3CB;DUSP7;PAQR3
prerank,anterior/posterior pattern specification (GO:0009952),-0.18471305649400982,-0.72900840401785,0.9833333333333333,0.9500260816601667,1.0,5/53,3.96%,TGFBR1;BASP1;BMPR2;WLS;PCSK5
prerank,regulation of NMDA receptor activity (GO:2000310),0.3300793649026826,0.7285385487559748,0.795045045045045,1.0,1.0,6/32,11.51%,CRHBP;CCR2;CAPN1;ACTN2;RELN;GRIA3
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.38203190908762497,0.728334111505848,0.7751060820367751,1.0,1.0,3/10,23.16%,NUMA1;MED1;NCOA3
prerank,response to amino acid starvation (GO:1990928),0.3089909707200754,0.7281855947044484,0.8614270941054809,1.0,1.0,15/72,17.11%,DAP;MAPK1;EIF2S1;MAP3K5;LARS1;SEC13;SZT2;MLST8;FAS;RNF152;ATP6V0E1;LAMTOR4;LAMTOR3;NPRL3;ATP6V0D1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3842124371633684,0.7271694282587684,0.7717842323651453,1.0,1.0,6/11,25.21%,IMPA1;INPP5A;PTEN;OCRL;IMPA2;INPP5B
prerank,inositol phosphate dephosphorylation (GO:0046855),0.3842124371633684,0.7271694282587684,0.7717842323651453,1.0,1.0,6/11,25.21%,IMPA1;INPP5A;PTEN;OCRL;IMPA2;INPP5B
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3131639189660616,0.727168578624483,0.841831425598335,1.0,1.0,15/67,19.50%,CDKL1;TBC1D1;TBC1D22B;CAV1;EVI5;RDX;FXR1;PLD1;DYNLT2B;SDCCAG8;RAB5A;RAC1;IFT140;RABEP2;SGSM3
prerank,regulation of cellular catabolic process (GO:0031329),0.3118725572551254,0.7270740626351536,0.8449367088607594,1.0,1.0,15/62,21.27%,DAPK2;ITPR1;ABCD1;ATM;HDAC6;BOK;RAB8A;DDIT3;PIP4K2A;LRRK2;DAPK1;KEAP1;RRAGB;ROCK1;MAPT
prerank,ERBB2 signaling pathway (GO:0038128),0.33647158395168,0.726911427789315,0.798876404494382,1.0,1.0,7/31,16.78%,ERBB3;PRKCA;GRB2;SOS1;EGFR;EGF;PIK3CA
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.23811318384523583,-0.726734818098436,0.8613861386138614,0.9518321568136846,1.0,20/20,76.22%,GSK3A;CRY1;WNT4;EP300;C1QTNF3;CDA;UGT1A8;C1QTNF12;SLC22A13;MST1;ACMSD;ERFE;DKKL1;ADIPOQ;NCOR1;SIK1;GCK;BCKDK;PGP;CLK2
prerank,protein ADP-ribosylation (GO:0006471),0.33484718930293544,0.7266782247521231,0.815035799522673,1.0,1.0,9/28,26.52%,ART3;ARF4;PARP14;SIRT1;SIRT4;PARP11;ZC3HAV1;PARP1;PARP9
prerank,endothelial tube morphogenesis (GO:0061154),0.37358772690775366,0.7264599560944119,0.7954545454545454,1.0,1.0,3/10,20.56%,CCM2;PRKD2;RBPJ
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.30769288337629325,0.7262400606829489,0.8609680741503605,1.0,1.0,10/75,13.65%,PPP1R9B;RGS12;GRK6;GIT2;METAP2;RNF157;PLCB1;ROCK2;ZDHHC7;ADCYAP1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3015509308418228,0.7262029024233355,0.9092741935483871,1.0,1.0,13/138,12.67%,BLK;NTF4;ERBB3;FYN;NPPC;NEDD9;GFRA2;JAK2;EGFR;EPHA3;MTSS1;FLT3;LMTK2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.3324231544985237,0.7261758239695525,0.8052256532066508,1.0,1.0,9/26,24.09%,MEFV;FYN;ROCK2;PSME1;USP50;AIM2;EFNA1;PSME2;PSME3
prerank,regulation of AMPA receptor activity (GO:2000311),-0.22519709296008655,-0.7259662915597493,0.9144736842105263,0.9515307567315511,1.0,8/25,19.82%,MINK1;SHISA6;CACNG7;CACNG2;SHANK3;ADRB2;GSG1L;PRRT1
prerank,cellular response to oxidative stress (GO:0034599),0.30079550758048984,0.7252993988219734,0.8997995991983968,1.0,1.0,28/118,20.36%,PLA2R1;MAPK1;EIF2S1;FOXO1;MSRA;SETX;EGFR;LONP1;PARK7;JUN;NFE2L2;PPIA;RAD52;MPV17;TP53;CYBB;ERCC6L2;FANCC;CYBA;SNCA;LRRK2;RPS3;NCF4;PKD2;DAPK1;PNPT1;PRR5L;KEAP1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3443630472313982,0.7249442412776365,0.78875,1.0,1.0,2/21,6.31%,NPPC;GUCY1A1
prerank,TOR signaling (GO:0031929),0.33055595534414567,0.7249440722971168,0.8229665071770335,1.0,1.0,6/26,20.28%,CCDC88A;MLST8;NPRL3;RPS6;MAPKAP1;PRR5L
prerank,dorsal/ventral pattern formation (GO:0009953),0.3420740261243346,0.7248688181084971,0.7856257744733581,1.0,1.0,3/20,15.71%,FBXL15;BMPR1A;AIDA
prerank,mesenchyme morphogenesis (GO:0072132),0.3507093335763343,0.7247573466745311,0.7777777777777778,1.0,1.0,5/17,20.75%,MDM4;NOTCH1;BMPR1A;TGFB2;SMAD2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.342945274159392,0.7236267227633516,0.7719072164948454,1.0,1.0,4/18,14.01%,AURKA;DCN;FIS1;MCU
prerank,positive regulation of endothelial cell migration (GO:0010595),0.3029163876074477,0.7236168773432611,0.8613963039014374,1.0,1.0,21/84,20.33%,EMC10;FOXP1;NUS1;HMGB1;AKT3;MAPK14;PRKCA;GFUS;SMOC2;PDPK1;NRP1;ROCK2;EGF;FGFR1;PLCG1;RAC1;SIRT1;ATP5F1B;PROX1;PRKD2;MET
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.2348206006255938,-0.7236015859666691,0.8690476190476191,0.9533687250171514,1.0,3/23,7.91%,MAML1;IGF1;MMP14
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.32513687270688807,0.7232953728067913,0.776878612716763,1.0,1.0,9/26,24.04%,ABCD1;PLCG2;PARK7;TLR6;CYBA;SNCA;RAB27A;ABCB7;SLC5A3
prerank,negative regulation of viral transcription (GO:0032897),-0.2745129436419542,-0.7230642110077735,0.8023255813953488,0.9528582052118716,1.0,6/13,20.44%,MID2;TRIM27;ZFP36;LARP7;UBP1;TRIM32
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.34474186698229375,0.7213248092045035,0.803030303030303,1.0,1.0,6/20,22.08%,ZC3H7A;PUM2;PUM1;TARBP2;AGO2;AGO1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.1765211939716552,-0.7211179799694996,1.0,0.9541988084475945,1.0,21/79,22.40%,EPN2;VWC2L;SMAD1;BMPR2;SPART;SMAD6;BMPR1B;UBE2D1;SKIL;SULF1;LEMD2;SMAD7;FGF2;HTRA3;DAB2IP;SMURF2;THBS1;BMPER;AGT;ADAMTS12;SMAD9
prerank,actin cytoskeleton reorganization (GO:0031532),0.31027249194463297,0.7211166398554796,0.851890756302521,1.0,1.0,14/63,17.35%,FLNA;EZR;NEDD9;GSN;GRB2;WHAMM;S1PR2;NRP1;MCU;DTNBP1;PARVB;CAPN10;PARVA;PTK7
prerank,receptor signaling pathway via STAT (GO:0097696),0.33669461008497625,0.7201247042017848,0.7856301531213192,1.0,1.0,7/25,20.19%,CCR2;JAK2;SOCS2;STAT5B;PIAS1;PKD2;SOCS6
prerank,autonomic nervous system development (GO:0048483),0.3497985463434011,0.7200799383569773,0.7919896640826873,1.0,1.0,3/17,17.49%,PHACTR4;NRP1;FN1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.26146599233731666,-0.7198060663548734,0.87109375,0.9547296476659011,1.0,4/15,16.59%,KCNN2;ATP1A1;ATP1B1;KCND3
prerank,response to muscle stretch (GO:0035994),0.36100143662045103,0.7197771388431475,0.7843388960205392,1.0,1.0,2/15,5.93%,CSRP3;GSN
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3681908284178693,0.7196422005779388,0.7835926449787836,1.0,1.0,6/12,26.12%,BOK;ATF6;XBP1;TMEM33;BCL2L11;BAK1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.30716696674568245,0.7191106833477832,0.8553590010405827,1.0,1.0,11/62,18.13%,DDIAS;CDKN2D;PARK7;CCAR2;NFE2L2;PPIA;TPT1;SIRT1;XBP1;SYVN1;LRRK2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.32673959003433006,0.7188254781390241,0.813441483198146,1.0,1.0,3/27,5.95%,STMN1;ARHGEF18;CLASP1
prerank,artery morphogenesis (GO:0048844),0.32694008413212067,0.7183686514728234,0.8339100346020761,1.0,1.0,6/30,16.39%,HEY2;NOTCH1;HPGD;BMPR1A;NRP1;TGFB2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.3796397666105771,0.7182270927626326,0.7742382271468145,1.0,1.0,3/10,16.70%,JAK2;STAT5B;JAK3
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.37399305759220286,0.7181999673868743,0.7988587731811697,1.0,1.0,3/11,23.93%,CARD9;MALT1;PRKCQ
prerank,B cell homeostasis (GO:0001782),0.38131101611082246,0.7179513230314813,0.7862371888726208,1.0,1.0,4/10,23.23%,PPP2R3C;TNFRSF13B;CAMLG;DOCK10
prerank,protein catabolic process (GO:0030163),0.3038473677544088,0.7175030647137853,0.8562300319488818,1.0,1.0,6/59,8.46%,PMAIP1;CHEK2;PRPF19;NR1D1;FBXO44;FBXO17
prerank,positive regulation of lipid catabolic process (GO:0050996),0.345250355520093,0.7174924788175399,0.8069948186528497,1.0,1.0,2/19,4.94%,TWIST1;ABCD1
prerank,diterpenoid metabolic process (GO:0016101),0.31184211818412333,0.71727056035883,0.8474399164054337,1.0,1.0,2/55,3.43%,LRAT;HSPG2
prerank,transferrin transport (GO:0033572),0.3195743131080572,0.7172692639062772,0.835990888382688,1.0,1.0,9/33,17.11%,TFR2;TFRC;CLTC;RAB11B;LMTK2;ATP6V0E1;ATP6AP1;STEAP3;ATP6V0D1
prerank,receptor recycling (GO:0001881),-0.30343701994498323,-0.7170235938567898,0.8348623853211009,0.9570470351685428,1.0,1/10,0.16%,ARFGEF2
prerank,negative regulation of ATP metabolic process (GO:1903579),0.3562424254900438,0.7169143671361478,0.799475753604194,1.0,1.0,7/17,27.73%,PDE12;FIS1;HDAC4;CBFA2T3;PARP1;PID1;NUPR1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3641758659212755,0.7167056355724537,0.79890560875513,1.0,1.0,3/13,16.26%,HACD4;ELOVL5;ELOVL4
prerank,positive regulation of tissue remodeling (GO:0034105),0.374178239623449,0.7162916194717005,0.7679083094555874,1.0,1.0,2/10,21.03%,ROCK2;ROCK1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3693832865278653,0.7157905944832282,0.7751724137931034,1.0,1.0,2/12,13.25%,CD44;FLOT1
prerank,amino sugar biosynthetic process (GO:0046349),-0.27206591462600027,-0.7152497976242603,0.8493150684931506,0.9579998343339253,1.0,8/12,29.60%,NAGK;PGM3;GNPDA1;GNPDA2;AMDHD2;GNPNAT1;GFPT1;RENBP
prerank,sensory perception of pain (GO:0019233),-0.2253683316245888,-0.7151999584366757,0.8723404255319149,0.9569079027756733,1.0,12/21,40.00%,SCN9A;KCNA2;NIPSNAP1;P2RX4;PTGES;CHRNA4;CCL2;OPRL1;OPRK1;ALOXE3;KCNK4;CHRNB2
prerank,mRNA splice site selection (GO:0006376),0.3236136514253063,0.715106280017814,0.7997685185185185,1.0,1.0,11/30,26.09%,SNRPC;SETX;PSIP1;LUC7L2;SRSF10;SF3A2;KHDC4;CELF1;SFSWAP;YTHDC1;PRPF39
prerank,phosphatidic acid metabolic process (GO:0046473),0.312486112403395,0.7151047551187371,0.8291621327529923,1.0,1.0,8/48,14.93%,AGPAT1;AGPAT4;GPD1L;GPAT3;AGPAT3;PLD2;DGKD;PLD1
prerank,amino sugar metabolic process (GO:0006040),0.3766256749172848,0.7144638322239736,0.7838616714697406,1.0,1.0,2/10,13.51%,ST3GAL1;GFPT2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.31454066080557785,0.7143884392896815,0.800942285041225,1.0,1.0,11/30,20.09%,DDRGK1;PARK7;CCAR2;UCHL5;USP14;STYX;TAF9;UBXN1;CAMLG;USP7;SVIP
prerank,modulation by host of viral genome replication (GO:0044827),0.364043461303127,0.7139907446125284,0.7950481430536451,1.0,1.0,3/13,14.75%,NUCKS1;VAPA;CCNK
prerank,regulation of endothelial cell proliferation (GO:0001936),0.3010775094078781,0.7139162197334712,0.875,1.0,1.0,14/88,15.38%,HMGB2;EMC10;PGF;CAV1;AKT3;PRKCA;CAV2;NR2F2;VASH2;F3;AGGF1;NRP1;MYDGF;EGF
prerank,negative regulation of inflammatory response (GO:0050728),0.29482580298998207,0.7135604262876467,0.951,1.0,1.0,15/182,8.37%,VIPR2;IAPP;MEFV;RB1;RAMP1;FYN;RPS19;NR1D1;PTHLH;DPEP1;NPSR1;MAPK14;PRKACA;INSL3;PLCG2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3004634399568499,0.713489907769372,0.8852459016393442,1.0,1.0,20/88,15.64%,EXOC2;STXBP6;BLOC1S4;EXOC4;AP1G2;SYS1;OSBPL5;AP4B1;AP1S3;RP2;CLTC;AP4E1;PUM1;STEAP2;EXOC5;AP1S2;DTNBP1;SCAMP1;VPS13A;HGS
prerank,metanephric mesenchyme development (GO:0072075),-0.29569842331642493,-0.7130969293485412,0.8122866894197952,0.9582554742286147,1.0,1/10,2.29%,BASP1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.34045112494036717,0.7129859597234163,0.8067632850241546,1.0,1.0,7/22,17.17%,BRD4;CCNT1;THOC5;CCNK;TCERG1;SCAF8;DDX39B
prerank,barbed-end actin filament capping (GO:0051016),0.3453837010504395,0.7128512075527041,0.7997399219765929,1.0,1.0,6/18,23.01%,GSN;FLII;ADD2;TRIOBP;SVIL;TWF1
prerank,actin filament capping (GO:0051693),0.3453837010504395,0.7128512075527041,0.7997399219765929,1.0,1.0,6/18,23.01%,GSN;FLII;ADD2;TRIOBP;SVIL;TWF1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3142088005616126,0.7126269681301381,0.8403547671840355,1.0,1.0,8/41,22.79%,HEY2;NOTCH1;BMPR1A;TGFB2;PROX1;RBPJ;FGFR2;FKBP1A
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2945909087458548,0.7125525761699413,0.95995995995996,1.0,1.0,32/214,16.79%,FAM83D;ARHGEF5;EZR;HTR2A;CCN1;CD74;CD44;PTPN22;RASGRP1;CRKL;NOTCH1;PIN1;HMGB1;CIB1;PRKCA;EGFR;P2RY1;ABCA7;CARD9;SMAD4;RPS6KA6;PTEN;ARRB2;NRP1;SPRED2;ADCYAP1;F2R;MAP2K1;STYX;ATP6AP1;CCL25;PDE8A
prerank,neuron projection fasciculation (GO:0106030),-0.2872498065416421,-0.7122502282801054,0.8159722222222222,0.9581039228591739,1.0,3/10,16.29%,RTN4;CDK5R1;EPHA4
prerank,positive regulation of ERAD pathway (GO:1904294),0.35340582751981786,0.7120643220950098,0.7927807486631016,1.0,1.0,3/13,12.99%,CAV1;UBQLN1;NFE2L2
prerank,eye photoreceptor cell development (GO:0042462),-0.25839306343601465,-0.711965831607042,0.8558951965065502,0.9572773190797887,1.0,3/15,17.90%,MYO7A;VEGFA;THY1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.29897433871211576,0.7116055035915064,0.8548895899053628,1.0,1.0,9/66,11.46%,BRCA2;CDK6;CAV1;RUNX3;CAV2;NR2F2;B2M;MTSS1;PEX2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.23586230388620064,-0.7115027076613188,0.892018779342723,0.9567532968025838,1.0,9/18,29.20%,PTPRZ1;TNFRSF1B;NF1;MDK;TNFRSF21;TMEM98;TENM4;SLC45A3;IL34
prerank,positive regulation of dendritic spine development (GO:0060999),0.3380369420241853,0.7111473332182672,0.7874692874692875,1.0,1.0,5/20,14.04%,DBNL;LLPH;CPEB3;RELN;PSEN1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.29199033812522995,-0.7105513587197262,0.842443729903537,0.956730959746314,1.0,5/10,21.57%,UBAC2;OS9;INSIG1;ERLEC1;UBE2G2
prerank,purine nucleotide metabolic process (GO:0006163),-0.22183203749225028,-0.7105291008520901,0.89171974522293,0.9556339907098678,1.0,10/24,25.01%,HPRT1;PRPS2;PPAT;GPX1;FHIT;ITPA;NT5C;GART;PRPSAP2;NT5E
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.22363102748285096,-0.7098870324781124,0.8791946308724832,0.9552688928710051,1.0,9/25,22.39%,TMEM50B;UBXN6;LEPROTL1;TMEM50A;SORT1;CHMP7;LEPROT;CHMP4B;CHMP4A
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.24884341934694143,-0.7094213196401873,0.897196261682243,0.9546677857294164,1.0,8/17,26.18%,CD180;CARD16;LY96;CD36;BMP6;TRIB1;CACTIN;SCIMP
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.30274572072490474,0.7091299087593619,0.8516542155816436,1.0,1.0,15/54,19.79%,COPS9;NXN;CAV1;PIAS3;PRR7;PARK7;ARRB2;SIRT7;UBXN1;CAMLG;PRMT3;GNL3L;RPL5;RPS3;HDAC8
prerank,central nervous system neuron differentiation (GO:0021953),0.3133024418373437,0.7078373278774263,0.823463687150838,1.0,1.0,6/33,15.85%,NR4A2;AGTPBP1;GBA2;ATP7A;MDGA1;SIN3A
prerank,regulation of stress fiber assembly (GO:0051492),0.29852004747916744,0.7078107906338396,0.8740894901144641,1.0,1.0,7/74,7.68%,ARHGEF5;STMN1;CD47;CCDC88A;ARHGEF18;CLASP1;ALMS1
prerank,positive regulation of calcium ion transport (GO:0051928),-0.20010023032639065,-0.7070716122656087,0.9491525423728814,0.9562116481335023,1.0,9/36,20.11%,CACNB2;ANK2;CCL4;TRPC3;WFS1;CCL3;ORAI1;P2RX4;SPHK2
prerank,negative regulation of myoblast differentiation (GO:0045662),0.3553854807405108,0.7069313324468224,0.8030095759233926,1.0,1.0,1/13,7.15%,NOTCH1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3386797195440298,0.7068942256850278,0.8157894736842105,1.0,1.0,7/20,20.97%,BIRC2;SPATA2;FLOT1;CFLAR;FLOT2;CASP8;RIPK1
prerank,cellular response to heat (GO:0034605),0.32071230669152234,0.7063879205558111,0.8275084554678692,1.0,1.0,8/35,21.27%,HSBP1L1;PRKACA;SUMO1;CLPB;BAG3;YWHAE;TPR;MAPT
prerank,sterol transport (GO:0015918),0.33333941492717134,0.7051985758539453,0.8038709677419354,1.0,1.0,2/19,6.20%,CAV1;OSBPL5
prerank,endothelial cell differentiation (GO:0045446),-0.2776872321756725,-0.7049212398708594,0.823943661971831,0.9575706453628231,1.0,7/12,27.62%,BMPR2;FSTL1;ACVRL1;JAG1;KDM6B;SCUBE1;KDR
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.32770398443216087,0.7046745675430718,0.8169856459330144,1.0,1.0,5/26,16.72%,C2CD5;SORBS1;IRS1;APPL1;CAPN10
prerank,cellular response to oxygen-containing compound (GO:1901701),0.29112726530379857,0.7045753605068215,0.989,1.0,1.0,41/291,17.46%,GFI1;HMGB2;SLC5A5;AQP1;MAPK1;EZR;HCN3;CRHBP;NR1D1;TAF1;FOXO1;ATM;DPEP1;SETX;ZFP36L1;PDE2A;HMGB1;AHR;MAPK14;LARS1;EGFR;EPHA3;P2RY1;EGR1;CPEB3;RUVBL2;KCNC2;JUN;MYD88;ROCK2;LAMTOR4;MTR;IRS1;MPV17;LAMTOR3;IPO5;ERCC6L2;VIM;XBP1;PTK7;HSP90B1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2955601938280948,0.70453382665777,0.9469469469469469,1.0,1.0,41/172,21.30%,PISD;MTMR12;CHKB;PLEKHA2;AGPAT1;AGPAT4;PCYT2;IMPA1;GPD1L;GPAT3;PIP5K1B;MTMR2;PLCG2;AGPAT3;CDIPT;MTMR14;MTMR6;PTEN;ARF3;SLC44A1;INPP4A;PLD2;PI4K2B;DGKD;SELENOI;PLD1;MTM1;RAB5A;PIK3CA;PIP4K2A;FAR1;PTPN13;RUFY1;CLN3;OCRL;INPP5F;GPD1;SLC44A2;CHKA;PTDSS1;DGKE
prerank,calcium ion import across plasma membrane (GO:0098703),-0.25630080991029053,-0.7042579288813969,0.8775510204081632,0.9571712685366391,1.0,5/14,30.17%,SLC8A3;TRPV4;SLC8A1;TRPM2;SLC8A2
prerank,regulation of lipid biosynthetic process (GO:0046890),0.31388646763763706,0.7037451864713854,0.8137931034482758,1.0,1.0,9/32,24.16%,SORBS1;ADIPOR1;PRKAG2;CREB1;ZBTB20;EIF6;SIRT4;C3;PRKAB2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.29454868092414566,0.703464278788134,0.9121212121212121,1.0,1.0,28/109,19.71%,MTMR12;PLEKHA2;IMPA1;PIP5K1B;MTMR2;PLCG2;PIP4P2;CDIPT;PLBD1;MTMR14;PLCB1;MTMR6;PTEN;ARF3;INPP4A;PLCB3;PI4K2B;PGAP1;PLCD1;MTM1;RAB5A;PLCG1;PIK3CA;PIP4K2A;PTPN13;RUFY1;OCRL;INPP5F
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.31360094134667865,0.7034634038577907,0.8238573021181717,1.0,1.0,7/40,18.13%,PMAIP1;ABCD1;PPA2;PARK7;ARL6IP5;NDUFS1;LRRK2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.31378018251933193,0.702902377364316,0.8529411764705882,1.0,1.0,9/39,18.34%,ITGA1;TGFA;GRB2;EGFR;EGF;HGS;RNF115;ARHGEF7;STAM
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.22073942253556045,-0.7020253900989006,0.8984771573604061,0.9573721385761381,1.0,9/21,31.77%,BCL2L1;MCL1;IL1A;UNC5B;EYA2;MAPK7;BCL2;PF4;IL1B
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.22073942253556045,-0.7020253900989006,0.8984771573604061,0.9573721385761381,1.0,9/21,31.77%,BCL2L1;MCL1;IL1A;UNC5B;EYA2;MAPK7;BCL2;PF4;IL1B
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.2699290869494178,-0.7018443871936341,0.8484848484848485,0.9564509307536431,1.0,3/12,16.80%,MIA3;MDK;SKAP1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.35181004559998597,0.7007147344557404,0.8199737187910644,1.0,1.0,2/13,8.29%,ENTPD3;ENTPD5
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.32312315122740115,0.7006332445890735,0.8028846153846154,1.0,1.0,11/25,25.61%,GLMN;EGFR;NRP1;PSEN1;EGF;SNCA;ILK;SRC;DSCAM;MIF;ITGA6
prerank,triglyceride biosynthetic process (GO:0019432),0.34404846991916005,0.7005643419896804,0.8133333333333334,1.0,1.0,2/18,7.36%,GPAT3;MOGAT2
prerank,muscle cell differentiation (GO:0042692),0.315176781703779,0.7005509729854363,0.8553672316384181,1.0,1.0,2/32,3.02%,HEY2;GLMN
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.2567722524541144,-0.7005064743883219,0.8628318584070797,0.9567718900377058,1.0,10/16,39.99%,GSK3A;SLC39A14;PRMT5;PDE6H;MRAP2;CHGA;ACP3;GRP;PDE6G;NECAB2
prerank,glycolipid biosynthetic process (GO:0009247),0.31273493908351485,0.700377890734519,0.8458942632170978,1.0,1.0,11/38,22.42%,PIGH;PIGF;PIGA;ST3GAL2;PIGU;ST3GAL5;GBGT1;PIGM;ST8SIA6;PGAP2;DPM2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3564377606731164,0.700023437479057,0.7854251012145749,1.0,1.0,1/12,5.28%,CAV1
prerank,metanephros development (GO:0001656),-0.21664965149362939,-0.6998403264695251,0.9161676646706587,0.9563634287959585,1.0,3/26,10.26%,BASP1;NF1;PKD1
prerank,metal ion transport (GO:0030001),0.296433609666584,0.6995166238398594,0.890495867768595,1.0,1.0,18/86,19.97%,RAMP1;MAGT1;ITPR1;FYN;KCNN4;CAV1;TRPM7;CALCRL;PSEN1;TPT1;TUSC3;NIPAL4;CACNA1B;SLC30A5;CACNG8;NIPA2;NIPAL3;PKD2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.20429595119081506,-0.6990428642776687,0.917910447761194,0.9561356730340546,1.0,10/30,24.82%,PTPN2;PTPN6;CD300A;SH2B3;MVP;THY1;PPP2R1A;SH3BP5L;SEMA4D;SAMSN1
prerank,regulation of inflammatory response (GO:0050727),0.2899061761991295,0.6986712366931941,0.9679037111334002,1.0,1.0,23/190,11.92%,MEFV;CD47;RB1;CCN4;IL16;S100A9;GPRC5B;FOXP1;CCR2;NR1D1;S100A8;TRADD;PDE2A;BIRC2;BRD4;JAK2;IL17RA;NAPEPLD;IL1R1;PARK7;XIAP;DHX9;MYD88
prerank,negative regulation of TOR signaling (GO:0032007),0.31338282616890606,0.6983651511871974,0.8308740068104427,1.0,1.0,7/36,16.94%,STK11;ATM;SZT2;UBR2;RNF152;NPRL3;SIRT1
prerank,autophagy of nucleus (GO:0044804),0.3428911625160157,0.6983557947225495,0.7969543147208121,1.0,1.0,1/16,2.51%,ATG13
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3157829662359796,0.6978102263679985,0.8278965129358831,1.0,1.0,1/33,0.60%,E2F2
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.3526756878131998,0.6977661466449762,0.8043775649794802,1.0,1.0,5/14,22.45%,PKIG;SIRT1;PRKAR2A;ATP2B4;PKIA
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.2568418399842807,-0.6972483645329484,0.8560885608856088,0.9568677696918793,1.0,8/13,29.60%,NAGK;PGM3;GNPDA1;GNPDA2;AMDHD2;GNPNAT1;GFPT1;RENBP
prerank,protein hydroxylation (GO:0018126),0.34507157065432337,0.697175269699338,0.8037383177570093,1.0,1.0,4/15,14.65%,PLOD3;JMJD4;VPS33B;P3H4
prerank,cellular response to lipopolysaccharide (GO:0071222),0.29179153326877005,0.6970169094063859,0.9112008072653885,1.0,1.0,7/101,8.10%,GFI1;HMGB2;PRKCE;PTPN22;NR1D1;HMGB1;MAPK14
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.2933422173646422,0.6967599167340699,0.9009287925696594,1.0,1.0,20/86,22.05%,CDK5RAP2;RB1;PRKCE;CLASP1;SYNPO2;SNX9;CFL2;SLAIN2;CDC42EP3;EFEMP2;NUMA1;PSEN1;RAC1;DRG1;CDC42EP1;PROX1;RPS3;MET;MAPT;DCTN1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.2998967286561016,0.6966046627735238,0.8404710920770878,1.0,1.0,13/51,21.37%,IL16;HMGB1;JAK2;EGR1;MYD88;TLR6;TYROBP;USP50;MALT1;LGALS9;CASP8;AIM2;TMED10
prerank,purine-containing compound catabolic process (GO:0072523),0.35735175208739417,0.6964364037280794,0.8034300791556728,1.0,1.0,2/13,9.67%,GDA;NT5C2
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.2455288382650065,-0.6963175235616926,0.9276018099547512,0.9567876436863998,1.0,2/17,4.61%,VSIR;HDAC2
prerank,mesonephric tubule development (GO:0072164),-0.26032000624168783,-0.6960901142613595,0.8658536585365854,0.9559350070705521,1.0,2/15,10.26%,SALL1;PKD1
prerank,regulation of aerobic respiration (GO:1903715),0.34606155975519304,0.6960681570518513,0.8207792207792208,1.0,1.0,2/15,10.65%,ABCD1;ATP7A
prerank,arachidonic acid metabolic process (GO:0019369),0.3082940278566038,0.6959501959824774,0.8387458006718925,1.0,1.0,3/35,6.72%,CYP1B1;CYP2A6;EPHX2
prerank,regulation of cholesterol esterification (GO:0010872),-0.2856033533242358,-0.6957452726650868,0.863481228668942,0.9551720555171804,1.0,5/10,33.64%,APOE;APOC1;AGT;LAMTOR1;STARD4
prerank,endocardial cushion morphogenesis (GO:0003203),0.3342477525837827,0.6955103549307116,0.8055555555555556,1.0,1.0,4/18,16.39%,MDM4;NOTCH1;BMPR1A;TGFB2
prerank,negative regulation of cell projection organization (GO:0031345),0.29952277278237077,0.6954925815641513,0.8593073593073594,1.0,1.0,8/48,17.16%,GFI1;FYN;YWHAH;CIB1;PTEN;LPAR1;MYLIP;GORASP1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3040191721031585,0.6950664748986508,0.852017937219731,1.0,1.0,11/38,21.13%,TRIM59;TANK;NR1D1;RIOK3;NLRC3;SIRT1;NLRX1;PPM1B;CASP8;RIPK1;OTUD7A
prerank,regulation of viral genome replication (GO:0045069),0.29708309396670374,0.6949423439765832,0.8594080338266384,1.0,1.0,14/56,20.76%,SLPI;PDE12;PKN2;RAD23A;FAM111A;IFITM3;PPIA;STAU1;TARBP2;SRPK1;PPIE;PPIH;PROX1;CNOT7
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.2989334664718923,0.6948275533091895,0.8769551616266945,1.0,1.0,8/57,17.28%,FLNA;AKAP12;PDE2A;GNAI1;INSL3;CHRM3;LPAR1;ADCY8
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3294978094863572,0.6945619906043624,0.8254364089775561,1.0,1.0,5/22,21.03%,SORBS1;CREB1;ZBTB20;PPARD;SIRT4
prerank,iron ion transport (GO:0006826),0.2999091328209661,0.6945307063193089,0.8583877995642701,1.0,1.0,10/47,17.11%,TFR2;HEPH;TFRC;CLTC;RAB11B;LMTK2;ATP6V0E1;ATP6AP1;STEAP3;ATP6V0D1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.35384005253610784,0.6943968065473375,0.8162450066577897,1.0,1.0,5/14,22.04%,PPP3CA;PPP2CB;PPP1CA;PPP2CA;PPP1R15B
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.29105800096355583,0.6940300710838658,0.8704663212435233,1.0,1.0,13/74,17.29%,BRCA1;TNFSF10;TRADD;EYA3;BIRC6;ITGAV;PARK7;FAS;CFLAR;GSK3B;EYA1;TCF7L2;SH3RF1
prerank,cellular protein localization (GO:0034613),0.28728354592612715,0.6939365002721842,0.986,1.0,1.0,68/285,21.72%,CD177;CNTLN;HEY2;TBC1D1;ATG13;TBC1D8B;FLNA;ABHD17A;CSRP3;CD74;PRPF19;STX17;TBC1D22B;ARL5C;NAPG;TLK1;EVI5;ARL11;RAB1B;RAB22A;YWHAH;STX5;ARF4;HDAC6;ARFGAP3;SNX9;CEP250;CLTC;PICK1;EGFR;SEC13;STX11;GGA1;KIF13A;ARF3;SEC31A;RAB43;BBS4;NIPBL;COPZ1;VPS33B;PIGU;LAMTOR3;TBC1D25;ARL4C;PTPRU;HGS;RAB5A;SEPTIN9;NAPB;ADPRH;EIF2D;GGA2;LRRK2;RAB6A;SAR1B;TM9SF1;SGSM3;CROCC;FBLN5;RRAGB;WDR45B;ARL5B;TBC1D15;SNX13;TMED10;EVI5L;AP3B1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.35462855944781657,0.69384710418667,0.8005427408412483,1.0,1.0,3/12,13.15%,LAMA5;FUZ;ZDHHC7
prerank,peptidyl-lysine methylation (GO:0018022),0.3186036245799248,0.6927762616645626,0.8183990442054958,1.0,1.0,1/26,1.50%,SUV39H1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.2974735164669299,0.6925337104918777,0.8569903948772679,1.0,1.0,15/54,23.11%,NUS1;HMGB1;AKT3;MAPK14;PRKCA;MECP2;PDPK1;FGFR1;PLCG1;SIRT1;ATP5F1B;PRKD2;PRCP;ATP2B4;ADAM17
prerank,cAMP-mediated signaling (GO:0019933),0.3215002078116119,0.6922861695631299,0.827710843373494,1.0,1.0,6/24,20.63%,PDE7B;PDE2A;AHR;ADCYAP1;KSR1;PDE7A
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.2589043598972691,-0.6922434633690276,0.8661417322834646,0.9576854647338058,1.0,7/13,38.56%,RELA;REST;NFIB;SOX9;SRF;PPARG;BMP4
prerank,cellular response to misfolded protein (GO:0071218),0.33178959738105124,0.6918557919330016,0.8217821782178217,1.0,1.0,12/20,28.05%,DNAJC18;CUL3;TOR1A;KLHL15;DNAJB12;DNAJB14;DERL1;POMT2;VCP;UBE2W;UGGT1;UGGT2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.34171599880538694,0.6918172318220553,0.8201342281879195,1.0,1.0,2/16,7.04%,TERF2;NUS1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.2906255107710668,0.6916614092674502,0.9418837675350702,1.0,1.0,24/150,17.70%,CD19;IAPP;ERBB3;FYN;TGFA;GRB2;STRN;EGFR;PDPK1;TXN;PARK7;FGF9;FLT3;F3;RAC2;MYDGF;IRS1;EGF;TCF7L2;FGFR1;RAC1;PIK3CA;HCLS1;KITLG
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.35618917218032065,0.6897270950702254,0.8157142857142857,1.0,1.0,3/11,17.67%,KCNJ3;KCNJ2;YWHAE
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.23715617008862416,-0.6896032690245432,0.92,0.95934953722919,1.0,8/17,31.08%,BCL2L1;DNM1L;MFF;BAD;BCL2;SOD2;TIMM50;BBC3
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3089395596166532,0.6892420157066489,0.8262910798122066,1.0,1.0,5/32,10.87%,EIF2A;RBM3;MTPN;PUM3;TCOF1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.2923451991102197,0.689174995433675,0.8801261829652997,1.0,1.0,21/70,23.20%,MAPK1;FYN;PRKCE;CYFIP2;GRB2;PLCG2;CRK;PLD2;BRK1;ELMO2;PLCG1;RAC1;PIK3CA;FCGR2B;VAV3;SYK;FGR;ACTG1;NCKIPSD;PRKCD;SRC
prerank,neural crest cell migration (GO:0001755),-0.19033229633309764,-0.6887843209414968,0.9646017699115044,0.9591026905746797,1.0,5/36,6.35%,ERBB4;SEMA3D;SEMA3E;SEMA4C;CORO1C
prerank,extracellular matrix disassembly (GO:0022617),0.29346207679204367,0.6887178749204241,0.8727076591154261,1.0,1.0,12/53,19.89%,CD44;GSN;LAMC1;CAPN1;TLL2;BSG;CTSK;FLOT1;MMP19;ADAMTS5;ADAM10;MMP12
prerank,protein targeting to membrane (GO:0006612),0.28758845359752994,0.688687794559941,0.9001019367991845,1.0,1.0,25/83,24.21%,PEX26;ABCD1;ACBD5;ARL6IP1;PEX11B;PXMP4;GET3;GDAP1;PEX2;RAB8B;FIS1;ZDHHC7;SSR1;SEC63;PEX14;ATAD1;ICMT;SEC62;ZDHHC6;NACA;SSR2;CHM;ZDHHC21;PEX3;YIF1B
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.2858327051945606,-0.6881296293557133,0.8652482269503546,0.9586870547596176,1.0,4/11,26.59%,PRDX2;GPX1;PRDX3;PRDX4
prerank,catecholamine biosynthetic process (GO:0042423),0.358194155926139,0.6879466477146355,0.8241758241758241,1.0,1.0,2/11,17.91%,TGFB2;SNCA
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.28658859831184447,0.6876157896608573,0.9144602851323829,1.0,1.0,16/87,18.06%,ARHGEF5;CCDC88A;EZR;ARHGDIB;RND3;ARHGAP35;EPHA3;MLST8;CRK;ROCK2;RAC2;ARHGDIA;RAC1;PIK3CA;IQGAP1;TAOK1
prerank,myelination in peripheral nervous system (GO:0022011),-0.25772658266798476,-0.687305685007233,0.8674242424242424,0.9584275914830392,1.0,9/13,38.67%,NF1;ADGRG6;ARHGEF10;PARD3;CNTNAP1;NCMAP;SIRT2;MYOC;PRX
prerank,oxoacid metabolic process (GO:0043436),0.31684760227507813,0.6872127752519147,0.8145539906103286,1.0,1.0,4/27,13.19%,TPST1;PPA2;BPNT2;SULT6B1
prerank,amino acid import (GO:0043090),0.3268216881414421,0.6867262701133041,0.8194945848375451,1.0,1.0,3/21,18.18%,SLC7A1;SFXN1;SLC22A4
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2913311290130122,0.6866783866438858,0.9016393442622951,1.0,1.0,30/84,25.27%,PIN1;EIF4A3;CPEB3;ABCA7;ORMDL3;TYMS;IGF2BP3;HAP1;FXR1;RACK1;LSM14A;CNOT1;SAMD4A;RTN3;EPRS1;EIF4ENIF1;RPS3;DAPK1;CNOT8;SYNCRIP;CNOT7;ROCK1;GAPDH;RPL13A;EIF4E2;YBX1;NCL;DAPK3;EIF2AK2;GIGYF2
prerank,cellular component disassembly (GO:0022411),0.29176459202920746,0.6862473268343363,0.8802588996763754,1.0,1.0,12/53,19.89%,CD44;GSN;LAMC1;CAPN1;TLL2;BSG;CTSK;FLOT1;MMP19;ADAMTS5;ADAM10;MMP12
prerank,positive regulation of T cell differentiation (GO:0045582),0.3076343152930866,0.6861992423942429,0.847682119205298,1.0,1.0,6/36,19.48%,LEF1;NKAP;BCL6;SART1;XBP1;PNP
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3151559009839874,0.6861857001445971,0.8175438596491228,1.0,1.0,5/28,12.48%,AXIN1;DDRGK1;PSMC3;PTEN;CDK5RAP3
prerank,nervous system development (GO:0007399),0.28292873672093766,0.6861740711649531,0.998,1.0,1.0,54/429,15.93%,STIL;ECT2;VAX2;NTF4;SDK1;CDK5RAP2;WDR62;SOX6;ERBB3;LIG4;ANKLE2;WDPCP;APAF1;LRCH4;LY6H;HAPLN2;GFRA2;GSN;GDA;GBA2;NRSN2;DBNL;ZBTB16;ST8SIA4;PMP22;IRF2BPL;NR2C2;RBFOX3;DYRK1A;SZT2;DNER;RELN;TRIM3;IGF2BP3;RPS6KA6;PTEN;CYP46A1;HAP1;NELL1;FGF13;CHRM3;NRCAM;ADGRL3;GFRA1;MTR;KIRREL3;ADGRV1;NRXN2;ARHGAP26;LPAR1;JARID2;MYLIP;PPP2R5D;MARK4
prerank,protein deneddylation (GO:0000338),0.35687519725664074,0.686094668315812,0.8103448275862069,1.0,1.0,4/10,22.07%,TOR1A;COPS3;COPS2;COPS4
prerank,cellular response to peptide (GO:1901653),0.2951132563038545,0.6856443867032455,0.8791092258748674,1.0,1.0,13/56,17.59%,DDX11;FYN;TIMELESS;PTPN22;CAV1;ZFP36L1;PSEN1;TLR6;GSK3B;TP53;VIM;XBP1;FCGR2B
prerank,positive regulation of signal transduction (GO:0009967),0.2827986396688464,0.6851624326149447,0.982,1.0,1.0,57/238,21.73%,DEPDC1B;FGFBP3;IL7R;SLC2A4;FLNA;CD74;TEDC2;SULF2;AGPAT1;DISC1;SORBS1;NOTCH1;SMARCA4;PRKCA;JAK2;ITGAV;SMOC2;CAV2;ASXL1;TRIM44;RELN;KAT2B;FAS;PRKCB;PTEN;HAP1;F3;UCHL5;NRP1;ZBTB7B;ING5;CREBBP;SKI;IRS1;CCBE1;TUBD1;LIMS1;PDCD10;TGFB2;SIRT1;XBP1;TSPAN5;TXNDC15;LRRK2;NRXN1;RPS3;RSPO2;PRKD2;PKD2;DSTYK;ILK;RBPJ;SPIN1;CITED2;SASH1;RAB34;ADAMTS3
prerank,heart process (GO:0003015),0.3379539128365121,0.6850337724280842,0.8163804491413474,1.0,1.0,1/14,3.04%,FYN
prerank,negative regulation of neurogenesis (GO:0050768),0.3086733236895711,0.6849561453505665,0.8406285072951739,1.0,1.0,8/34,17.16%,LRP4;YWHAH;NOTCH1;PCM1;B2M;PTEN;ARHGDIA;GORASP1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3041192287965646,0.684605837921475,0.852513966480447,1.0,1.0,4/38,5.28%,ERBB3;NEDD9;GPRC5B;CAV1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.29379334178271066,0.6840592341722183,0.8769551616266945,1.0,1.0,14/62,17.19%,POLR2I;POLR2A;IWS1;NCBP1;ERCC3;RTF1;NELFA;CCNT1;CCNK;ELOF1;NELFB;POLR2K;MLLT1;POLR2J
prerank,aerobic respiration (GO:0009060),0.32901250496564816,0.6839706866230051,0.835633626097867,1.0,1.0,5/20,20.68%,NDUFS8;ME3;ATP5F1D;MDH2;UQCRH
prerank,membrane organization (GO:0061024),0.28382793416541074,0.6838650897221377,0.984,1.0,1.0,38/227,17.61%,CEP55;KIF20A;NEMP1;IL7R;CCDC88A;REEP4;SUN2;SNX3;TMCC1;NAPG;TFRC;SLC2A8;TGFA;SNX9;CLTC;GRB2;PICK1;EGFR;M6PR;STX11;EMD;TOR1A;VAPA;ARRB2;AP2B1;PACSIN2;CHMP1B;STON2;VPS33B;REPS1;GCA;EGF;HGS;RAB5A;CHMP3;CHMP2B;UBA52;LDLRAP1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.28617068445168886,-0.6835898588929076,0.8618421052631579,0.9608826860258393,1.0,4/10,25.49%,BAG6;BTLA;CD40;LYN
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.2864328856619303,0.6832617525598119,0.9294354838709677,1.0,1.0,23/113,19.97%,HMGB2;EMC10;PGF;TGFA;AKT3;PRKCA;LAMC1;EGFR;VASH2;FGF9;F3;AGGF1;NRP1;MYC;MYDGF;EGF;TCF7L2;SIRT1;XBP1;PROX1;PAX2;MMP12;PRKD2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2902761759441483,0.6828990079708939,0.916076845298281,1.0,1.0,23/93,21.69%,EMC10;AXIN1;RASGRP1;TRAF3;MAP3K5;HMGB1;MAP4K2;HIPK2;MAP3K11;CARD9;PLCB1;PDCD10;DUSP22;TGFB2;SH3RF1;RELL1;ARL6IP5;FCGR2B;TAOK1;TRAF6;RIPK1;SASH1;MTURN
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3122145836040541,0.6826897698092537,0.8284371327849589,1.0,1.0,6/25,19.36%,PLCG2;B2M;MAP3K7;MALT1;CD55;TRAF6
prerank,negative regulation of establishment of protein localization (GO:1904950),0.35457274086703244,0.6826683098026697,0.8234463276836158,1.0,1.0,2/10,9.01%,SNX3;TERF1
prerank,regulation of cell death (GO:0010941),0.2897264644040852,0.6825775142466403,0.9228426395939087,1.0,1.0,16/94,18.13%,CCN1;NOA1;CCN4;FAF1;PDE12;GPR75;PRODH;RAD18;PRR7;PARK7;BECN1;TMEM109;ACER3;PDE8A;SNCA;LRRK2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.2754705980414562,-0.6825730822358063,0.8607594936708861,0.9608092050037498,1.0,5/10,22.53%,ATRAID;EPHA4;DAB2IP;ANXA2;RGP1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.32020472522152227,0.6818253680689734,0.8407079646017699,1.0,1.0,5/21,21.54%,TEDC2;UCHL5;TUBD1;TXNDC15;RAB34
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.2848757197225403,-0.6812514508498092,0.8713235294117647,0.9610139637651309,1.0,7/10,42.32%,DNAJB6;SACS;SORL1;DNAJA4;HSPA1A;HSPA2;HSPA1B
prerank,ameboidal-type cell migration (GO:0001667),0.29705318960881005,0.6805999531432415,0.880085653104925,1.0,1.0,4/51,7.47%,PHACTR4;ITGB7;AMOTL2;PKN2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.2990334944012375,0.6801627489384974,0.8599348534201955,1.0,1.0,2/41,4.94%,CYP1B1;ABCD1
prerank,protein neddylation (GO:0045116),-0.25816813034447245,-0.6800303088181473,0.875,0.9611279827268513,1.0,6/13,32.12%,UBE2F;DCUN1D2;RNF7;DCUN1D1;NAE1;UBA3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.35078439323733157,0.6795123347216493,0.825531914893617,1.0,1.0,2/12,6.44%,JMJD4;SETX
prerank,stress fiber assembly (GO:0043149),0.3375437094082555,0.6792547056449686,0.8326585695006747,1.0,1.0,5/15,14.92%,SORBS1;TNFAIP1;CUL3;FAM171A1;PDCD10
prerank,contractile actin filament bundle assembly (GO:0030038),0.3375437094082555,0.6792547056449686,0.8326585695006747,1.0,1.0,5/15,14.92%,SORBS1;TNFAIP1;CUL3;FAM171A1;PDCD10
prerank,energy reserve metabolic process (GO:0006112),0.3264331035526309,0.6791797329084711,0.8451776649746193,1.0,1.0,5/19,15.37%,GFPT2;PRKAG2;MYC;GSK3B;GBE1
prerank,cell-matrix adhesion (GO:0007160),0.2837529860780473,0.679111765965705,0.9149590163934426,1.0,1.0,25/95,24.18%,ITGA1;ECM2;ITGB7;TIAM1;CD44;SORBS1;ITGAV;WHAMM;ACTN2;TESK2;ITGA8;BCR;RAC1;FN1;ARHGEF7;ZYX;ILK;FBLN5;ITGA4;ACTN1;SRC;VCL;ITGB1BP1;NPNT;ADAMTS9
prerank,positive regulation of macrophage differentiation (GO:0045651),0.34940392937771303,0.6788801738687424,0.8198581560283688,1.0,1.0,3/11,20.97%,PRKCA;CASP8;RIPK1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.283466612069515,0.67837097281697,0.9123343527013251,1.0,1.0,20/88,22.47%,SLX4;TFRC;FAF1;SYNPO2;PRKCA;PARK7;SUMO1;RACK1;FLOT1;GSK3B;BRK1;HGS;STAM;GNL3L;SLF1;RPS3;TPR;SYK;VPS4A;SPIDR
prerank,cellular glucose homeostasis (GO:0001678),0.2954962380610467,0.6781059921964742,0.8593406593406593,1.0,1.0,12/41,21.23%,NUCKS1;NR1D1;FOXO1;PRKACA;RACK1;FOXK2;SIRT1;XBP1;ADCY8;ZBTB20;PAX2;PCK2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.359511551082245,0.6779850274418904,0.8422575976845152,1.0,1.0,4/10,23.93%,ZBTB7B;CD55;LGALS9;PRKCQ
prerank,protein localization to membrane (GO:0072657),0.28238986946100847,0.6778734461724508,0.95995995995996,1.0,1.0,30/187,15.80%,ITGB7;C2CD5;NDC1;RAMP1;FLNA;ABHD17A;EZR;ARL5C;CAV1;ANK1;DENND4C;RAB8A;PICK1;TSPAN33;P2RY1;ACTN2;SYNE3;BSG;RDX;RAB8B;CYP46A1;PRAM1;RAB11B;FGF13;ROCK2;FLOT1;TTC7A;NRXN2;HGS;PACS1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.32801463054895735,0.6766536916912232,0.8304862023653088,1.0,1.0,3/17,16.34%,CAV1;PRKX;CD24
prerank,regulation of protein localization (GO:0032880),0.2874672200957821,0.6760460594040523,0.8739406779661016,1.0,1.0,10/58,14.47%,BORA;WDPCP;MMD2;MMD;SUMO1;TRIM68;RACK1;ZDHHC7;ADCYAP1;TRIM5
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.29687315055097707,0.6757680058898904,0.8588362068965517,1.0,1.0,8/43,17.61%,CCN4;FOXP1;DNMT1;JUN;FGF9;BMPR1A;ADAMTS1;LDLRAP1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.2899228566393398,0.6757424669196583,0.8852971845672576,1.0,1.0,14/64,17.19%,POLR2I;POLR2A;IWS1;NCBP1;ERCC3;RTF1;NELFA;CCNT1;CCNK;ELOF1;NELFB;POLR2K;MLLT1;POLR2J
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3083725369350065,0.6755370626225394,0.8477751756440282,1.0,1.0,10/25,24.75%,DNAJC18;DNAJC7;BAG1;SDF2;DNAJB4;DNAJB1;DNAJB12;DNAJB14;HSPE1;HSPA9
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.343817365488164,0.6755200709116773,0.8423988842398884,1.0,1.0,4/12,26.84%,GSK3B;HOMER2;ATP2B4;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.343817365488164,0.6755200709116773,0.8423988842398884,1.0,1.0,4/12,26.84%,GSK3B;HOMER2;ATP2B4;DYRK2
prerank,ERAD pathway (GO:0036503),0.2836274773269613,0.6754754606468514,0.8991769547325102,1.0,1.0,18/83,17.78%,RCN3;NPLOC4;FBXO44;UBE4B;FAF2;DNAJC18;FBXO17;UBQLN1;DERL2;AMFR;TOR1A;RHBDD2;YOD1;DNAJB9;RNF103-CHMP3;HSP90B1;FAM8A1;SYVN1
prerank,establishment of epithelial cell polarity (GO:0090162),0.3208974516779809,0.6753572824568648,0.8414948453608248,1.0,1.0,5/19,19.75%,EZR;CLASP1;MSN;CYTH1;GOLPH3
prerank,mitochondrion transport along microtubule (GO:0047497),0.33273153774779535,0.6752243336755697,0.8270777479892761,1.0,1.0,1/13,2.47%,UXT
prerank,fatty acid biosynthetic process (GO:0006633),0.28495166661405674,0.6748447937775067,0.8921161825726142,1.0,1.0,10/63,17.05%,HACD4;ABCD1;EPHX2;CBR4;HPGD;LTA4H;ELOVL5;NDUFAB1;ELOVL4;XBP1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.2430819573462894,-0.6748132273386145,0.8888888888888888,0.9649957437675867,1.0,7/15,30.27%,NSMAF;SIRT3;PLA2G6;SPHK2;ORMDL2;ORMDL1;SMPD2
prerank,glucose homeostasis (GO:0042593),0.2830683967652736,0.6744136089053984,0.904320987654321,1.0,1.0,14/83,17.28%,SLC2A4;USF1;NUCKS1;STK11;NR1D1;FOXO1;PARK7;ADIPOR1;MCU;IRS1;TCF7L2;FOXK2;SIRT1;ADCY8
prerank,cell projection organization (GO:0030030),0.3051101982845111,0.6743859562985421,0.8521939953810623,1.0,1.0,7/30,16.79%,GSN;RHOU;PACSIN2;RAC2;PARVB;RAC1;PARVA
prerank,cellular biogenic amine metabolic process (GO:0006576),0.3496521368567753,0.6743221000065538,0.8415977961432507,1.0,1.0,3/12,16.76%,ATP7A;SMS;MAOA
prerank,coenzyme A metabolic process (GO:0015936),0.3391081642758399,0.6740220580475798,0.8298429319371727,1.0,1.0,3/14,12.95%,PANK2;SLC25A16;DCAKD
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.29605503265919214,0.6739167314724893,0.8716814159292036,1.0,1.0,12/43,23.93%,NUCKS1;SIK2;SORBS1;PRKCB;ZBTB7B;IRS1;SIRT1;PIP4K2A;GRB14;PTPN11;PRKCD;PRKCQ
prerank,protein O-linked glycosylation (GO:0006493),0.28552679461288516,0.6734959290726488,0.9274770173646578,1.0,1.0,8/96,10.98%,MUC19;GALNT10;PLOD3;GXYLT1;ST3GAL1;ST3GAL2;B3GNT2;TMTC2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.28531300387323943,0.673434167925572,0.9019812304483837,1.0,1.0,13/65,18.34%,ITGA1;CCDC88A;SHKBP1;TGFA;GRB2;EGFR;HAP1;DGKD;EGF;HGS;RNF115;ARHGEF7;STAM
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.31957335371264894,0.6734226041027924,0.8489388264669163,1.0,1.0,5/20,17.46%,MEFV;ENTPD5;TXN;PSTPIP1;ANO6
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.33810584196547894,0.6732089204185022,0.825065274151436,1.0,1.0,3/16,17.72%,HNRNPM;DHX9;RSRC1
prerank,"phototransduction, visible light (GO:0007603)",-0.2607615505421576,-0.6730676683046158,0.8786764705882353,0.9655344616596411,1.0,8/14,49.99%,GNAQ;SAG;PDE6G;PDE6B;ABCA4;RP1;PDE6A;CNGB1
prerank,peptide metabolic process (GO:0006518),0.2819259679880001,0.6728331534782764,0.9020833333333333,1.0,1.0,15/75,21.62%,DNPEP;RHD;CPM;DPEP1;SPCS1;LTA4H;PSEN1;PCSK1;GSTM1;CPD;SPPL3;ERAP1;MME;SPCS3;ETHE1
prerank,fat cell differentiation (GO:0045444),0.28992395878820687,0.6727733493683168,0.8863157894736842,1.0,1.0,10/57,18.40%,NR4A2;FOXO1;ZBTB7A;ATF5;BBS4;TCF7L2;SIRT1;BBS9;MED1;ERAP1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.3170004658320913,0.6722867977237282,0.847255369928401,1.0,1.0,3/24,8.10%,CTNNA1;TCF3;MAPK14
prerank,cholesterol transport (GO:0030301),0.29368809808041346,0.6721050327079968,0.8914728682170543,1.0,1.0,6/45,11.42%,CEL;CAV1;OSBPL5;LIMA1;ABCA7;STARD5
prerank,lipid catabolic process (GO:0016042),0.32393882550477093,0.6719903862548514,0.8208762886597938,1.0,1.0,1/18,3.01%,CEL
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.28635196407361524,0.6718675742475775,0.8893528183716075,1.0,1.0,16/69,17.78%,NPLOC4;FBXO44;UBE4B;FAF2;DNAJC18;FBXO17;UBQLN1;DERL2;AMFR;RHBDD2;YOD1;DNAJB9;RNF103-CHMP3;HSP90B1;FAM8A1;SYVN1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.34902500298273353,0.6705454598679564,0.8248587570621468,1.0,1.0,3/11,15.17%,ETV6;ARIH2;RUNX1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.31097316431955346,0.6705402372842778,0.848180677540778,1.0,1.0,7/22,23.04%,PPM1D;PPP2CB;PPP1CA;PPM1B;PPP2CA;DUSP16;PPM1E
prerank,positive regulation of JNK cascade (GO:0046330),0.2862799659497677,0.6705069011508844,0.8957055214723927,1.0,1.0,17/70,21.69%,AXIN1;RASGRP1;TRAF3;MAP3K5;HMGB1;MAP4K2;HIPK2;MAP3K11;CARD9;PLCB1;DUSP22;SH3RF1;FCGR2B;TAOK1;TRAF6;RIPK1;MTURN
prerank,cellular response to chemical stress (GO:0062197),0.28140671186267197,0.6699969779534798,0.9202020202020202,1.0,1.0,23/96,20.36%,EIF2S1;CAV1;FOXO1;MSRA;ATM;SETX;LONP1;PARK7;FAS;NFE2L2;PPIA;RAD52;CYBB;FANCC;PIK3CA;CYBA;SNCA;LRRK2;NCF4;PKD2;PNPT1;PRR5L;KEAP1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.2835054717433747,0.6694547408373454,0.8969505783385909,1.0,1.0,21/71,23.20%,MAPK1;FYN;PRKCE;CYFIP2;GRB2;PLCG2;CRK;PLD2;BRK1;ELMO2;PLCG1;RAC1;PIK3CA;FCGR2B;VAV3;SYK;FGR;ACTG1;NCKIPSD;PRKCD;SRC
prerank,myelin maintenance (GO:0043217),0.35876136449943014,0.6693638524684457,0.8345534407027818,1.0,1.0,3/10,17.65%,ABCD1;PTEN;CXCR4
prerank,Golgi to plasma membrane transport (GO:0006893),0.29529212670019644,0.6691971896623767,0.8851570964247021,1.0,1.0,10/47,14.33%,EXOC2;STXBP6;EXOC4;SYS1;OSBPL5;BLZF1;GGA1;KIF13A;STEAP2;EXOC5
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.3258793344912019,0.6691023424461445,0.83375,1.0,1.0,3/18,10.75%,RFK;ATP7A;PARK7
prerank,positive regulation of MAPK cascade (GO:0043410),0.2767733750526802,0.668308395327811,0.983,1.0,1.0,41/245,18.13%,EZH2;IAPP;HTR2A;CD74;CD44;PTPN22;RASGRP1;CRKL;NOTCH1;HMGB1;CIB1;PRKCA;PLCG2;EGFR;CAV2;P2RY1;RIT2;ABCA7;CARD9;FLT3;ARRB2;NRP1;ROCK2;ADCYAP1;MYDGF;TRIM5;PDCD10;EGF;F2R;LPAR1;MAP2K1;FGFR1;ATP6AP1;CD24;TGFB2;CCL25;PDE8A;ARL6IP5;IQGAP1;TAOK1;LRRK2
prerank,fatty acid catabolic process (GO:0009062),0.28261528923311047,0.668204741537073,0.9021852237252862,1.0,1.0,18/67,21.89%,CEL;ACADM;ABCD1;ACBD5;NUDT19;AUH;SLC27A2;PEX2;PHYH;CPT2;HADHA;MMAA;HADHB;ABCD4;DECR1;PPARD;ABHD2;ACOT8
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.3295649667127564,0.6677385026414915,0.833116036505867,1.0,1.0,6/15,25.04%,PRKCA;MTPN;ROCK2;ROCK1;IL6ST;PARP1
prerank,axon guidance (GO:0007411),0.2774187898694457,0.6674913023574,0.977,1.0,1.0,49/201,23.30%,SPTA1;MAPK1;FYN;NTN1;EZR;PTPRA;RPS6KA5;GFRA2;LAMA5;NOTCH1;ARHGAP35;PRKCA;GRB2;PLXNA2;SOS1;PDLIM7;EPHA3;DOK2;RELN;BSG;SLIT3;SLIT1;TMEFF1;NRP1;RAC2;PALLD;GFRA1;DAG1;SPTAN1;PLCG1;RAC1;PIK3CA;EMB;CXCR4;NRXN1;SEMA4A;TUBB3;EPHA7;EPHA10;ALCAM;SEMA6A;EFNA1;PLXNC1;CNTN4;NIBAN2;PTPN11;SRC;DSCAM;SPTB
prerank,reticulophagy (GO:0061709),-0.2572277790728025,-0.6673507946166409,0.8961538461538462,0.9695734220466355,1.0,5/12,20.46%,ULK1;UFC1;TEX264;UBA5;ULK2
prerank,presynaptic endocytosis (GO:0140238),0.31204165399793654,0.6671880565022938,0.8628158844765343,1.0,1.0,5/24,13.27%,CEL;SYT8;STON1;CANX;STON2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.2651371301723124,-0.6665523059925657,0.8758620689655172,0.9691449019946512,1.0,4/11,26.18%,UNC93B1;TNIP2;TICAM1;SCIMP
prerank,lipid modification (GO:0030258),0.29784468058029756,0.6665020245057771,0.8625277161862528,1.0,1.0,3/37,6.72%,PLPPR3;MBOAT2;EPHX2
prerank,SNARE complex assembly (GO:0035493),0.35085681255072754,0.6652845265615343,0.8232044198895028,1.0,1.0,1/10,2.92%,STXBP6
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.29515692798030385,0.6648869242288314,0.8592508513053349,1.0,1.0,8/33,24.01%,CYP1B1;CIB1;DPP4;TGFB2;SYK;EFNA1;PTPN11;ITGB1BP1
prerank,regulation of cell killing (GO:0031341),0.33168493305140234,0.6648080546024859,0.8547557840616966,1.0,1.0,5/16,19.21%,CR1L;TGFB2;RAC1;CYBA;CD55
prerank,response to amino acid (GO:0043200),0.2981767422141801,0.6644529426874415,0.8543352601156069,1.0,1.0,8/31,20.72%,LARS1;CPEB3;LAMTOR4;LAMTOR3;IPO5;XBP1;GLRA1;RRAGB
prerank,cholesterol homeostasis (GO:0042632),0.2831428961484752,0.6642187161091561,0.8947368421052632,1.0,1.0,16/64,23.72%,CAV1;NR1D1;EPHX2;RALY;ABCA2;LIMA1;CD24;SIRT1;XBP1;LDLRAP1;NR1H3;HDAC9;LDLR;SOAT1;TTC39B;EHD1
prerank,polyol metabolic process (GO:0019751),0.28899318401821206,0.6633811155852204,0.8658008658008658,1.0,1.0,10/46,16.54%,IMPA1;INPP5A;PLCG2;NUDT4;PLCB1;PTEN;INPP4A;PLCB3;PLCD1;PLCG1
prerank,serine family amino acid catabolic process (GO:0009071),-0.27412869263441286,-0.6625763974314741,0.9006849315068494,0.9715860138961718,1.0,8/10,47.47%,AMT;SHMT2;SHMT1;CBS;THNSL2;DAO;GLDC;SDS
prerank,alanine transport (GO:0032328),-0.2700391253162204,-0.6625573293571968,0.8903225806451613,0.9705062063600921,1.0,9/10,54.16%,SLC36A4;SLC36A1;SLC7A10;SLC6A17;SLC36A2;SLC36A3;SLC6A6;SLC6A14;SLC38A3
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.30782929564271094,0.6624454592021145,0.845223700120919,1.0,1.0,9/24,23.22%,PARK7;RACK1;USP25;XBP1;UBXN1;SYVN1;LRRK2;NR1H3;LPCAT3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.27830880623694126,0.6624127102862541,0.9433771486349848,1.0,1.0,34/119,22.42%,PIGH;MTMR12;PIGF;PLEKHA2;IMPA1;PIGA;PIP5K1B;MTMR2;PLCG2;SOCS2;CDIPT;MTMR14;MTMR6;PTEN;ARF3;INPP4A;PI4K2B;TTC7A;PIGU;MTM1;RAB5A;PIK3CA;PIP4K2A;PTPN13;RUFY1;PIGM;OCRL;INPP5F;SOCS6;SOCS4;PGAP2;PLEKHA1;EFR3A;DPM2
prerank,synaptic vesicle recycling (GO:0036465),0.30024781430353564,0.6611891054503644,0.8690614136732329,1.0,1.0,8/31,17.91%,CEL;SYT8;STON1;PLD2;CANX;STON2;RAB5A;SNCA
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.30121416703793064,0.661105951386422,0.8586448598130841,1.0,1.0,7/28,26.82%,TRADD;DELE1;BAG3;CASP8;CRADD;CASP8AP2;GABARAP
prerank,inflammatory response (GO:0006954),0.2735270523068465,0.6606779591241839,0.9819819819819819,1.0,1.0,29/195,17.98%,MEFV;LY75;IL2RA;HSPG2;CD44;CRHBP;S100A9;CCR2;IKBKG;S100A8;NFAM1;HMGB1;TPST1;IL22;HNRNPA0;TLR5;NFX1;TLR6;F2R;CYBB;TRAF3IP2;NFATC3;RAC1;CCL25;CYBA;ADCY8;FCGR2B;CXCR4;HDAC4
prerank,dendrite self-avoidance (GO:0070593),0.3221336358017205,0.6604342718468951,0.8519480519480519,1.0,1.0,5/16,23.27%,BSG;PALLD;EMB;CNTN4;DSCAM
prerank,peptidyl-lysine acetylation (GO:0018394),0.3460522432988298,0.6603635789026919,0.8196248196248196,1.0,1.0,3/10,16.94%,KAT2B;CREBBP;SIRT1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.27853660146787823,0.6602299794585961,0.9144329896907216,1.0,1.0,12/75,19.26%,SLC12A3;SLC12A7;SLC12A1;KCNJ3;SLC12A6;KCNJ2;SLC24A2;SLC9A9;TRPM4;KCNJ10;SLC9A7;SLC9A6
prerank,response to copper ion (GO:0046688),0.31285994162436986,0.6601238853188165,0.849435382685069,1.0,1.0,1/20,1.86%,AQP1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.25615490135775987,-0.6594983753863798,0.906896551724138,0.9718742265058536,1.0,4/12,17.87%,STX4;PLA2G6;C2CD2L;GPLD1
prerank,blood circulation (GO:0008015),0.28769067648778923,0.6593638467293589,0.9022556390977443,1.0,1.0,9/49,24.01%,F5;GUCY1A1;ROCK2;ELN;SGCG;ROCK1;GCLM;GCLC;ITGB1BP1
prerank,tRNA wobble uridine modification (GO:0002098),-0.242321681949928,-0.6592185867786338,0.9011406844106464,0.9709857643532527,1.0,9/14,39.31%,MTO1;DPH3;GTPBP3;TRMT9B;CTU2;TRMU;CTU1;MOCS3;KTI12
prerank,circulatory system development (GO:0072359),0.2755197012910639,0.6581169873019047,0.9486921529175051,1.0,1.0,30/118,23.39%,HEY2;ERBB3;HSPG2;ZFPM1;STK11;NXN;NOTCH1;PDLIM7;HEG1;SMYD4;KAT2B;PTEN;SMG9;POU6F1;TGFB2;CRIP1;PIK3CA;FN1;PDLIM5;CDKN1A;CASP8;NCOA6;PKD2;CITED2;NTRK3;CDKN1B;HDAC9;PTPN11;OSR1;KDM6A
prerank,hemopoiesis (GO:0030097),0.27559239643831507,0.6581132914334609,0.9298067141403866,1.0,1.0,18/87,17.70%,ZFPM1;RUNX3;PRKX;ZBTB16;ETV6;KAT6A;MELK;TNFRSF13B;FLT3;KMT2A;ARIH2;PRRC2C;KIRREL3;TP53;RUNX1;ZFP36L2;TGFB2;KITLG
prerank,positive regulation of innate immune response (GO:0045089),0.29685633886812995,0.6578303465128381,0.8787185354691075,1.0,1.0,4/30,11.45%,RPS19;UBE2K;RIOK3;DHX9
prerank,vitamin transport (GO:0051180),0.29970496379041106,0.6577667914792232,0.8719441210710128,1.0,1.0,3/29,11.15%,SLC2A8;SLC52A1;SLC19A1
prerank,positive regulation of response to wounding (GO:1903036),0.31569667137603086,0.6577481273393679,0.8619854721549637,1.0,1.0,2/24,8.36%,PRKCE;INSL3
prerank,striated muscle tissue development (GO:0014706),0.29939151589827373,0.6575091710067661,0.8844807467911319,1.0,1.0,6/29,21.08%,CSRP3;CAV1;CFLAR;SGCG;ZBTB18;SVIL
prerank,response to ATP (GO:0033198),0.30960655737223364,0.6568212999153464,0.8622908622908623,1.0,1.0,3/18,17.46%,TAF1;P2RY1;HSP90B1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.29800862537866907,0.6568038974244151,0.8632580261593341,1.0,1.0,10/28,24.16%,CD47;JAK2;ADIPOR1;PRKAG2;RAC1;SIRT1;MED1;EIF6;C3;PRKAB2
prerank,inositol phosphate metabolic process (GO:0043647),0.28582214367383874,0.6567180297837373,0.8745945945945945,1.0,1.0,10/46,16.54%,IMPA1;INPP5A;PLCG2;NUDT4;PLCB1;PTEN;INPP4A;PLCB3;PLCD1;PLCG1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.336369662748217,0.6566958433918867,0.8335588633288228,1.0,1.0,2/12,14.89%,FGF9;ADAMTS1
prerank,positive regulation of type I interferon production (GO:0032481),0.28007888145525645,0.6565687405861209,0.9132231404958677,1.0,1.0,14/73,16.44%,DHX58;PTPN22;CGAS;XRCC6;RIOK3;DHX9;MYD88;TOMM70;FLOT1;PRKDC;CREBBP;POLR1C;LRRFIP1;POLR2K
prerank,inositol phosphate catabolic process (GO:0071545),0.34491671361661697,0.6562613688185543,0.8422496570644719,1.0,1.0,3/12,11.98%,IMPA1;INPP5A;PTEN
prerank,membrane repolarization during action potential (GO:0086011),-0.252778317448809,-0.6561097693468237,0.8973384030418251,0.9725339704284951,1.0,3/13,16.59%,ATP1A1;ATP1B1;KCND3
prerank,intracellular lipid transport (GO:0032365),0.31119614870095147,0.6560177780079206,0.8524590163934426,1.0,1.0,6/21,18.79%,ABCD1;CPT1B;CPT1A;PRKAG2;CPT2;ABCD4
prerank,regulation of defense response (GO:0031347),0.2740587365975877,0.6559045527663241,0.9218274111675127,1.0,1.0,15/76,15.40%,DHX58;PTPN22;FOXP1;CCR2;TRAF3;BIRC2;BRD4;JAK2;IL1R1;PARK7;XIAP;MYD88;SPATA2;BCL6;APPL1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.31154302722566385,0.6558865521905495,0.8371501272264631,1.0,1.0,5/19,17.68%,MPI;UAP1;GFPT2;PMM2;UAP1L1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3123434172084779,0.6558310927125806,0.8484076433121019,1.0,1.0,5/18,26.58%,CRHBP;IRS1;SIRT4;KCNB1;PSMD9
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3266153459150609,0.6556281866333951,0.8517006802721089,1.0,1.0,1/13,3.12%,KRI1
prerank,glutamate metabolic process (GO:0006536),0.3185417378452914,0.6554172177739419,0.8542713567839196,1.0,1.0,2/19,7.18%,GLS2;PRODH
prerank,regulation of lamellipodium organization (GO:1902743),0.33204338617616797,0.6553240760186309,0.8519003931847968,1.0,1.0,1/14,3.89%,CD44
prerank,phospholipid metabolic process (GO:0006644),0.27582140903227803,0.6549248623413946,0.9133611691022965,1.0,1.0,9/71,15.04%,PLPPR3;AGPAT1;AGPAT4;PCYT2;ABCA2;AGPAT3;PLBD1;PLCD1;PLPPR4
prerank,protein heterooligomerization (GO:0051291),0.3185752181933938,0.6549081754741644,0.874189364461738,1.0,1.0,5/17,21.78%,CBR4;KCNC2;PKD2;CPSF7;MAT2A
prerank,sulfur amino acid metabolic process (GO:0000096),0.3063619503052728,0.6547963397598487,0.8668280871670703,1.0,1.0,4/24,14.42%,MSRA;DPEP1;SMS;MTR
prerank,oligodendrocyte differentiation (GO:0048709),0.30451449648538276,0.6545718855631271,0.8371794871794872,1.0,1.0,1/19,1.98%,SOX6
prerank,mitochondrion organization (GO:0007005),0.27210487236473335,0.6545091833909339,0.9588353413654619,1.0,1.0,28/165,15.29%,PISD;PTCD2;CHCHD4;TOMM34;AGTPBP1;TSPO;AKT3;TFB1M;GABPB1;TFB2M;PITRM1;NRF1;CAV2;LONP1;TIMM9;ATP7A;PARK7;GDAP1;FIS1;TOMM70;HAP1;HCFC1;CHCHD10;TIMM23;GABPA;MPV17;ATP5F1D;MTM1
prerank,cellular amino acid catabolic process (GO:0009063),0.27697602894254975,0.6544375531727674,0.9283520982599796,1.0,1.0,9/87,14.97%,SLC25A21;HAAO;KMO;GLS2;PRODH;AUH;FAH;IVD;MCCC1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.3425022287764221,0.6539373120815252,0.8579881656804734,1.0,1.0,3/10,17.64%,SIRT7;SDHAF3;USP7
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3146143170042658,0.6535628312352738,0.8663366336633663,1.0,1.0,2/18,7.77%,AKT3;CIB1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.29256798052418725,0.6530207640403688,0.8826135105204873,1.0,1.0,9/37,16.46%,MEFV;ABCD1;MAPK14;IL17RA;CARD9;MYD88;TLR6;APPL1;NLRC3
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3160292900167485,0.6523391153340015,0.8589580686149937,1.0,1.0,3/18,14.59%,BOK;CHCHD10;GSK3B
prerank,negative regulation of viral process (GO:0048525),0.27907436492291804,0.6523188733531475,0.8868729989327642,1.0,1.0,12/57,18.94%,PML;SLPI;TRIM11;FAM111A;IFITM3;PPIA;TRIM5;TRIM28;SRPK1;CHMP3;HEXIM1;PROX1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.33230742451982803,0.6515994379482581,0.864314789687924,1.0,1.0,2/13,12.09%,CIAO2A;ISCA2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.2805145020065295,0.6512795018959914,0.8917470525187567,1.0,1.0,15/50,23.09%,TEDC2;FUZ;KCTD21;UCHL5;HHIP;RACK1;CREBBP;TUBD1;TXNDC15;SUFU;RAB34;MEGF8;FGFR2;BTRC;INTU
prerank,regulation of JNK cascade (GO:0046328),0.27388652999491914,0.6512301500316551,0.9375,1.0,1.0,13/101,11.64%,MEN1;ULK4;AXIN1;RASGRP1;TRAF3;MAP3K5;HMGB1;MAP4K2;EGFR;HIPK2;MAP3K11;CARD9;PLCB1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3444135360373305,0.6510685046725911,0.8512160228898427,1.0,1.0,3/10,23.11%,TGFA;EGF;ADAM17
prerank,regulation of autophagy (GO:0010506),0.269665240664767,0.6509402740011293,0.97997997997998,1.0,1.0,51/216,21.60%,DAP;MEFV;ATG13;DAPK2;ITPR1;PTPN22;STK11;EXOC4;FOXO1;ATM;HDAC6;PIM2;HMGB1;BOK;DCN;RAB8A;PRKACA;UBQLN1;TAB3;CAPN1;ORMDL3;ATF6;MLST8;IL10RA;TRIM68;RNF152;ATP6V0E1;DDIT3;PRKAG2;LAMTOR4;TRIM5;GSK3B;LAMTOR3;ATG101;FOXK2;KLHL22;ATP6V0D1;PIP4K2A;LRRK2;SREBF2;DAPK1;SVIP;MET;KEAP1;RRAGB;PRKAG1;BNIP3;ROCK1;GAPDH;MAPT;UBQLN2
prerank,bile acid metabolic process (GO:0008206),0.29264532469190485,0.650910151068759,0.8665893271461717,1.0,1.0,5/27,12.04%,GBA2;OSBPL3;CYP27A1;SLC27A2;CYP46A1
prerank,stabilization of membrane potential (GO:0030322),0.313990686158269,0.6501500539010484,0.8562005277044855,1.0,1.0,4/16,16.66%,KCNN4;CHCHD10;KCNK12;KCNK2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.3253536251931008,0.6500457121323991,0.8466494845360825,1.0,1.0,4/14,16.70%,JAK2;SOCS2;STAT5B;JAK3
prerank,positive regulation of autophagy (GO:0010508),0.27446840036670944,0.6500325379013152,0.930327868852459,1.0,1.0,24/81,23.35%,MEFV;STK11;IKBKG;FOXO1;PIM2;HMGB1;DCN;PARK7;ORMDL3;ATF6;TRIM68;RNF152;TRIM5;GSK3B;SIRT1;MAP3K7;LRRK2;DAPK1;SVIP;BNIP3;ROCK1;PHB2;TRIM65;UFL1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.3312593270108898,0.6499661082632529,0.8602442333785617,1.0,1.0,5/13,22.74%,NOTCH1;PIM1;BMPR1A;RBPJ;FGFR2
prerank,cellular response to insulin stimulus (GO:0032869),0.2717765435216049,0.6498736629141386,0.9464105156723963,1.0,1.0,25/124,17.66%,C2CD5;SLC2A4;USF1;FOXO1;DENND4C;SORBS1;ZFP36L1;RAB8A;GRB2;SOS1;CAV2;PDPK1;KAT2B;RAB8B;ZDHHC7;ATP6V0E1;PRKDC;IRS1;GSK3B;APPL1;ATP6AP1;CAPN10;XBP1;ATP6V0D1;EPRS1
prerank,positive regulation of phosphorylation (GO:0042327),0.2694240691015041,0.6494703308125631,0.982,1.0,1.0,60/240,23.41%,PECAM1;ERBB3;GLMN;CCN1;LMO4;CD74;AXIN1;BRAT1;PGF;TFRC;RASGRP1;CRKL;PIN1;NIBAN1;CIB1;ENTPD5;EGFR;EPHA3;P2RY1;WDFY2;FGF9;FLT3;FAS;LMTK2;FXR1;NRP1;ROCK2;RACK1;FLOT1;FAM20A;PSEN1;PPIA;MYDGF;STK4;RAD50;EGF;FGFR1;LIMK2;RAC1;PDE8A;SIRT1;LRRK2;ZBTB20;AKTIP;ALK;EPHA7;DSTYK;CCND3;MET;ILK;SLCO3A1;RIPK1;EPHA10;EFNA1;NTRK3;DDR2;FGFR2;ADAM17;DSCAM;C3
prerank,transcription by RNA polymerase III (GO:0006383),0.3050743407250461,0.6493593454262305,0.882830626450116,1.0,1.0,3/27,9.11%,GTF3C5;BRF1;SNAPC3
prerank,sulfation (GO:0051923),-0.25163373071507456,-0.6489786980953527,0.9351535836177475,0.9770580112583862,1.0,4/11,31.38%,UST;HS3ST5;SULT1A1;SULT4A1
prerank,negative regulation of anoikis (GO:2000811),0.3243250981838485,0.6488834078164242,0.8457374830852503,1.0,1.0,2/14,7.15%,CAV1;NOTCH1
prerank,axonal fasciculation (GO:0007413),0.32789247648363734,0.648289200180375,0.8515519568151148,1.0,1.0,5/12,22.56%,ARHGAP35;EPHA3;NRCAM;MEGF8;CNTN4
prerank,regulation of necroptotic process (GO:0060544),0.3046291011429603,0.6482759423843393,0.8682926829268293,1.0,1.0,7/23,20.97%,BIRC2;SPATA2;FLOT1;CFLAR;FLOT2;CASP8;RIPK1
prerank,regulation of histone deacetylation (GO:0031063),0.32528909027148367,0.6476021352440586,0.8535564853556485,1.0,1.0,3/13,13.53%,ZBTB7B;ING2;NIPBL
prerank,acyl-CoA metabolic process (GO:0006637),0.2864405827407426,0.6472764672698904,0.8754208754208754,1.0,1.0,3/35,8.69%,ACOT11;ACOT13;ACOT2
prerank,cellular response to acid chemical (GO:0071229),0.29550128750016147,0.6469137907913666,0.8623529411764705,1.0,1.0,8/27,20.72%,LARS1;CPEB3;LAMTOR4;LAMTOR3;IPO5;XBP1;GLRA1;RRAGB
prerank,regulation of osteoblast proliferation (GO:0033688),0.307878349168241,0.6469033237879601,0.8440366972477065,1.0,1.0,2/17,13.00%,CCN1;NELL1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.30385192044273723,0.6468992256713112,0.875,1.0,1.0,2/22,5.31%,PALM;CCR2
prerank,regulation of vacuole organization (GO:0044088),0.30872339444318997,0.6465826267806374,0.8813131313131313,1.0,1.0,6/20,17.28%,RAB1B;ENO4;MTM1;NPRL3;RAB5A;ADPRH
prerank,polarized epithelial cell differentiation (GO:0030859),0.3265962140958216,0.6464014154574319,0.8717241379310345,1.0,1.0,3/13,13.15%,EZR;MSN;ZDHHC7
prerank,cardiac muscle contraction (GO:0060048),0.291966632948231,0.6462543587918986,0.8875,1.0,1.0,4/34,16.78%,CSRP3;GSN;GRK2;PIK3CA
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.27674398959382834,0.6461483881407053,0.9267782426778243,1.0,1.0,12/65,17.60%,VASN;CAV1;PMEPA1;PIN1;ZBTB7A;PDPK1;SNX25;BCL9L;SPRED2;SKI;SIRT1;UBA52
prerank,cell part morphogenesis (GO:0032990),0.3239191332006285,0.6449922452963293,0.840877914951989,1.0,1.0,6/13,26.87%,FIS1;PACSIN2;MTM1;PNPT1;PID1;WASF1
prerank,regulation of ion transport (GO:0043269),0.2710059469430305,0.6449165427952643,0.923155737704918,1.0,1.0,12/76,14.43%,NKAIN4;SYT8;YWHAH;NEDD4L;KCNJ3;TOR1A;B2M;SYT3;RAB11B;NKAIN3;KCNJ2;DTNBP1
prerank,regulation of myotube differentiation (GO:0010830),0.30236285166937316,0.6447211002656353,0.8781664656212304,1.0,1.0,10/24,26.75%,NOTCH1;MAPK14;XBP1;HDAC4;HDAC1;ATP11A;HDAC9;PIEZO1;BDNF;TMEM119
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3211058604973869,0.6446783045249487,0.8588082901554405,1.0,1.0,4/15,20.33%,NOTCH1;SMOC2;PRKD2;MET
prerank,autophagy of mitochondrion (GO:0000422),0.2896527342231362,0.6446277110183564,0.8998875140607424,1.0,1.0,6/38,12.38%,ATG13;MARK2;BECN1;AMBRA1;FIS1;CTSK
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.2881453923436516,0.6443291919682225,0.888,1.0,1.0,3/31,11.37%,CACNA1I;SYT8;SYT3
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.2681005427914697,0.6442615632187793,0.9678714859437751,1.0,1.0,23/151,16.79%,HTR2A;CD74;CD44;PTPN22;RASGRP1;CRKL;NOTCH1;HMGB1;CIB1;PRKCA;EGFR;P2RY1;ABCA7;CARD9;ARRB2;NRP1;ADCYAP1;F2R;MAP2K1;TNFRSF11A;ATP6AP1;CCL25;PDE8A
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.28105693868685,0.6442491652294043,0.8805460750853242,1.0,1.0,10/36,17.64%,PSMF1;DDRGK1;PARK7;CCAR2;UCHL5;TAF9;USP25;UBXN1;CAMLG;USP7
prerank,integrated stress response signaling (GO:0140467),0.320030421387468,0.6438785005961898,0.88,1.0,1.0,3/14,13.56%,EIF2S1;NFE2L2;DDIT3
prerank,positive regulation of T cell activation (GO:0050870),0.2774419009735245,0.6438103105979215,0.8941299790356394,1.0,1.0,5/62,8.62%,CD47;SLC7A1;TFRC;CCR2;CYRIB
prerank,cellular response to superoxide (GO:0071451),-0.2621837237043724,-0.6431749795995985,0.90625,0.9803683647532926,1.0,4/10,26.52%,ADPRS;PRDX2;MT3;SOD2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.2859166703295193,0.6427472802444693,0.8930131004366813,1.0,1.0,9/41,22.08%,ITPR1;HTR2A;IBTK;PLCG2;F2R;SLC24A2;PKD2;GRIN2D;ATP2B4
prerank,protein localization to plasma membrane (GO:0072659),0.26643550102931507,0.6417582077274769,0.9507537688442211,1.0,1.0,19/129,13.69%,C2CD5;RAMP1;CCDC88A;FLNA;EZR;ANK1;DENND4C;RAB8A;TSPAN33;P2RY1;ACTN2;BSG;RDX;RAB8B;PRAM1;FGF13;ROCK2;FLOT1;TTC7A
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.18196221184227224,-0.6415716232997102,0.9583333333333334,0.9804075188988395,1.0,5/32,13.74%,LPIN1;SLC27A1;CHPT1;ABHD3;LPCAT1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3123837149782536,0.641481782635581,0.8695121951219512,1.0,1.0,3/21,9.67%,PDE2A;NUDT4;NT5C2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.28070100671323406,0.6410751997454436,0.9081746920492721,1.0,1.0,10/43,20.19%,ITGA1;TGFA;GRB2;EGFR;EGF;HGS;RNF115;ARHGEF7;STAM;SOCS4
prerank,RNA interference (GO:0016246),0.3124865105740753,0.6410110669575996,0.8613989637305699,1.0,1.0,6/17,22.08%,DHX9;TARBP2;CLP1;AGO2;CELF1;AGO1
prerank,protein glycosylation (GO:0006486),0.27014315430700453,0.6408606580443593,0.9597989949748744,1.0,1.0,20/125,16.23%,MAGT1;GALNT10;KRTCAP2;PLOD3;ALG8;MPI;STT3A;NUS1;MGAT2;ST3GAL1;ST3GAL2;ENTPD5;ST8SIA4;B3GNT2;FUT8;GFPT2;ST3GAL5;PMM2;TUSC3;POMT1
prerank,negative regulation of cell motility (GO:2000146),0.268009891855077,0.6399684970127937,0.9374369323915237,1.0,1.0,17/108,16.22%,CYP1B1;STK26;CD74;ARID2;DACH1;DPEP1;PIN1;FUZ;STK24;ZMYND8;CRK;PTEN;SLURP1;RNF20;DAG1;PTPRU;DUSP22
prerank,positive regulation of exocytosis (GO:0045921),0.2832076174942677,0.6387998750883487,0.9003397508493771,1.0,1.0,11/35,24.87%,CLASP1;HGS;ATP6AP1;RAB5A;SNCA;STAM;RAB27A;VPS4A;RAB27B;RAB9A;TSG101
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.2833403526461229,0.6387283217875458,0.8716136631330977,1.0,1.0,3/31,7.70%,TWIST1;EIF4A3;FUZ
prerank,response to interferon-alpha (GO:0035455),-0.2272639257909094,-0.6385590640513914,0.9302325581395349,0.9814882097603878,1.0,5/16,18.03%,ADAR;BST2;AXL;RO60;IFNAR1
prerank,Rac protein signal transduction (GO:0016601),0.31127425450655366,0.6381363946673443,0.8845654993514915,1.0,1.0,5/18,16.74%,TIAM1;DBNL;RAC2;BRK1;RAC1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.28088241903912886,0.637951414399822,0.8943355119825708,1.0,1.0,9/38,19.07%,NDUFS8;NDUFB7;NDUFAF1;NDUFA1;NDUFA4;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,positive regulation of biomineral tissue development (GO:0070169),0.2812754466517638,0.63667101743678,0.9031903190319032,1.0,1.0,6/40,17.46%,FBXO5;CCN1;BMPR1A;NELL1;ADGRV1;ANO6
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.21520495248216484,-0.6362570726757897,0.9285714285714286,0.9820402524934605,1.0,7/18,27.73%,RELA;GSK3A;CASP3;EPHA4;PICALM;CHRNA7;LRRTM3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.2977403929434108,0.6361074894247611,0.8810679611650486,1.0,1.0,9/23,26.52%,JAK2;PARP14;SUMO1;PIAS1;NR1H3;IFNGR1;NR1H2;JAK1;PARP9
prerank,regulation of interleukin-10 production (GO:0032653),0.27839953084123575,0.6359258846779604,0.9074889867841409,1.0,1.0,9/44,21.45%,CD47;HMGB1;PLCG2;PIBF1;TYROBP;JAK3;FCGR2B;LGALS9;SYK
prerank,regulation of fatty acid oxidation (GO:0046320),-0.2162581334273833,-0.6357587046193731,0.9396551724137931,0.9812787328267837,1.0,7/16,26.96%,APPL2;ACADL;LONP2;MLYCD;PPARGC1A;SOX9;TYSND1
prerank,regulation of axon regeneration (GO:0048679),-0.2509371391100366,-0.6356596549552771,0.9047619047619048,0.9802530153212654,1.0,2/12,4.63%,GRN;PTPRS
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3018646022303236,0.6354938029279088,0.8613138686131386,1.0,1.0,8/22,24.23%,MAPRE3;GBA2;PARK7;EFEMP2;PIK3CA;MAPT;CAMSAP1;AKAP13
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.1979416880385627,-0.6353304894312742,0.9477124183006536,0.9793675271406829,1.0,11/24,33.72%,SRI;DMD;CALM1;JPH4;SELENON;GSTO1;FKBP1B;CAMK2D;CALM2;NOS1;JPH3
prerank,lung development (GO:0030324),-0.17801280944263878,-0.6352878826726469,0.9596774193548387,0.9782901471210066,1.0,19/33,38.56%,PKD1;BAG6;NPHP3;VEGFA;FGF2;LOXL3;SOX11;CCDC39;RBP4;PDPN;ERRFI1;ITGA3;CCDC40;ABCA3;GLI2;FOXJ1;WNT7B;FGF7;BMP4
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.278580504109131,0.6350381483049046,0.9044516829533116,1.0,1.0,6/43,13.00%,FBXO5;CCN1;CCN4;LRP3;BMPR1A;NELL1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3343115196382962,0.6350095551619809,0.8544395924308588,1.0,1.0,4/10,19.71%,PARP14;PIBF1;PPP2CA;INPP5F
prerank,ureteric bud development (GO:0001657),-0.22480309369413837,-0.6345684536309031,0.9551569506726457,0.9776416004637039,1.0,2/17,10.51%,SALL1;GPC3
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2712551836563018,0.6343014080008278,0.9236479321314952,1.0,1.0,16/54,23.75%,RPL7;RPL14;RPL23A;RPLP0;WDR74;NSA2;RPL3;PES1;RPL5;EIF6;RSL24D1;RPL24;RPL10;RPF1;MRPL20;NPM1
prerank,cellular metal ion homeostasis (GO:0006875),0.2670531557995081,0.6340319918286623,0.9544072948328267,1.0,1.0,7/102,8.24%,TMPRSS3;HTR2A;CSRP3;CAV1;CCR2;NEDD4L;SLC10A7
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.2813255897252619,0.6337149648874405,0.8948571428571429,1.0,1.0,5/35,11.79%,ACSS3;CBR4;HPGD;BDH1;FASN
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3115774892687935,0.6336033597626755,0.8699494949494949,1.0,1.0,7/17,24.68%,CARD9;PDCD10;TGFB2;ARL6IP5;TAOK1;STK25;EIF2AK2
prerank,glial cell development (GO:0021782),0.2929880697897449,0.6335845098957451,0.8858173076923077,1.0,1.0,3/25,8.51%,S100A9;CDK6;PICK1
prerank,regulation of mitochondrial translation (GO:0070129),0.2933410421151177,0.6328058136789207,0.8895781637717122,1.0,1.0,4/21,16.57%,MPV17L2;MTG2;NSUN3;TRUB2
prerank,regulation of phospholipase C activity (GO:1900274),0.3202994483827399,0.6322241156019073,0.877038895859473,1.0,1.0,4/15,22.33%,RASGRP1;FGFR1;PLCG1;NTRK3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.31413129237181736,0.6319790880725107,0.8780177890724269,1.0,1.0,4/18,20.97%,EGFR;TP53;MAP2K1;RIPK1
prerank,positive regulation of rRNA processing (GO:2000234),-0.2684560798716386,-0.6317462762127115,0.8986013986013986,0.9785726598881199,1.0,5/10,23.27%,HEATR1;WDR75;BUD23;RIOK2;WDR43
prerank,neuron projection morphogenesis (GO:0048812),0.2620831377423632,0.6314197238270634,0.966900702106319,1.0,1.0,29/137,23.23%,KIF20B;NTF4;LRP4;RAB8A;DBNL;NTNG2;ATP7A;PTEN;LMTK2;NRCAM;DTNBP1;PLPPR4;CTNND2;SDC2;IQGAP1;TAOK1;LRRK2;SLC9A6;PAX2;SLITRK2;ROCK1;NEFH;BRSK1;ALCAM;CNTN4;FGFR2;S100A6;RAB10;DOCK10
prerank,positive regulation of potassium ion transport (GO:0043268),0.2766006575336968,0.6303114769240405,0.8942632170978627,1.0,1.0,5/38,13.00%,FLNA;KCNN4;KCNJ3;ACTN2;KCNJ2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.2379786566227244,-0.6294459745407232,0.9449838187702265,0.9790643117736604,1.0,11/11,76.22%,CRY1;EP300;C1QTNF3;C1QTNF12;MST1;ERFE;ADIPOQ;SIK1;GCK;PGP;CLK2
prerank,regulation of cellular respiration (GO:0043457),0.30998154090911856,0.6291731549069723,0.8944723618090452,1.0,1.0,5/17,26.47%,NOA1;PNPT1;CBFA2T3;VCP;TRAP1
prerank,protein localization to cell periphery (GO:1990778),0.2618082048077737,0.6286975396395723,0.964859437751004,1.0,1.0,19/133,13.69%,C2CD5;RAMP1;FLNA;EZR;CAV1;ANK1;DENND4C;RAB8A;TSPAN33;P2RY1;ACTN2;BSG;RDX;RAB8B;PRAM1;FGF13;ROCK2;FLOT1;TTC7A
prerank,negative regulation of angiogenesis (GO:0016525),0.26348834366364826,0.6285398633909923,0.9355168884339816,1.0,1.0,17/84,22.88%,E2F2;HSPG2;PML;CCR2;DCN;MECP2;ROCK2;ADAMTS1;HGS;TGFB2;PGK1;ROCK1;SEMA6A;AGO1;ATP2B4;NIBAN2;APOH
prerank,fatty acid oxidation (GO:0019395),0.26599694708374294,0.6275357912944503,0.9205851619644723,1.0,1.0,13/57,20.75%,ACADM;ABCD1;AUH;SLC27A2;PEX2;ADIPOR1;PHYH;CPT2;HADHA;HADHB;ABCD4;DECR1;PPARD
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.31237086690047333,0.6274514525645711,0.8658367911479945,1.0,1.0,5/14,23.52%,FAF1;SUFU;PKD2;KEAP1;G3BP2
prerank,response to peptide (GO:1901652),0.2852189666682961,0.6271731656506183,0.9048152295632699,1.0,1.0,7/33,20.88%,FYN;GNAI1;STAT5B;IRS1;CACNA1B;MMP12;EIF2B5
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.18742835036455452,-0.6268078569233998,0.9701492537313433,0.9797461849085218,1.0,8/31,19.82%,OPTN;ERN1;TM7SF3;PRKN;ATXN3;HSPA5;DAB2IP;HSPA13
prerank,monocarboxylic acid metabolic process (GO:0032787),0.25777490267343806,0.6262606531196646,0.9613428280773143,1.0,1.0,15/117,14.97%,PANK2;ACOT11;PDHA1;CPT1B;GBA2;SLC16A1;ACOT2;ME3;DLAT;ALKBH7;BSG;FASN;CPT1A;GLO1;MCCC1
prerank,regulation of actomyosin structure organization (GO:0110020),0.3204409094615199,0.6260041479977956,0.8565400843881856,1.0,1.0,7/13,24.23%,ALMS1;ROCK2;RAC1;PTGER4;ROCK1;ACTG1;AKAP13
prerank,regulation of transforming growth factor beta production (GO:0071634),0.30334427981718187,0.6258356441581874,0.889168765743073,1.0,1.0,5/18,19.38%,ITGAV;SMAD4;TGFB2;FN1;LGALS9
prerank,integrin-mediated signaling pathway (GO:0007229),0.26604840993199036,0.6257810431756949,0.9233160621761658,1.0,1.0,10/73,13.01%,ITGB7;CD47;PTPRA;NEDD9;LAMA5;CCM2;ITGAV;CUL3;PRAM1;NRP1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.26436951316322604,0.6257327473690469,0.9469928644240571,1.0,1.0,29/88,25.42%,HDAC6;EIF4A3;CPEB3;TYMS;IGF2BP3;CDK5RAP3;FXR1;NELL1;RACK1;LSM14A;CNOT1;SAMD4A;EPRS1;CLN3;EIF4ENIF1;RPS3;DAPK1;CNOT8;SYNCRIP;CNOT7;GAPDH;RPL13A;EIF4E2;YBX1;NCL;DAPK3;EIF2AK2;GIGYF2;CST3
prerank,sphingolipid biosynthetic process (GO:0030148),0.26267939184720995,0.6257161890213999,0.9431818181818182,1.0,1.0,12/71,16.65%,SGMS2;HACD4;PRKD3;CSNK1G2;VAPA;CERS4;SGMS1;ELOVL5;ST3GAL5;ELOVL4;CERS6;ACER3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.19941372088240025,-0.6254382906673115,0.9273743016759777,0.9794912788929211,1.0,8/23,35.63%,GSK3A;TIGAR;PLEK;CRY1;GIT1;PFKFB1;EP300;C1QTNF3
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2754162912236772,0.6253941730175778,0.9107142857142857,1.0,1.0,10/39,20.63%,RCN3;ARFGAP3;RAB8A;MIA2;RAB8B;CANX;STEAP3;PPY;GOLPH3;TVP23A
prerank,endocardial cushion development (GO:0003197),0.2941696185715005,0.6253440262631215,0.8802902055622733,1.0,1.0,4/21,16.39%,MDM4;NOTCH1;BMPR1A;TGFB2
prerank,lipid homeostasis (GO:0055088),0.2673543705909584,0.6245837485571033,0.9260042283298098,1.0,1.0,6/57,10.93%,RCN3;USF1;POLD1;ABCD1;ABCA2;ORMDL3
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.26539498623075997,0.6245514048470564,0.937952430196484,1.0,1.0,13/69,19.07%,SDHD;NDUFS8;COA6;NDUFB7;NDUFAF1;COX10;COX4I1;NDUFA1;NDUFA4;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,negative regulation of blood pressure (GO:0045776),-0.23126821446858492,-0.6240696244961385,0.9305019305019305,0.9792268070877947,1.0,1/13,3.18%,BMPR2
prerank,relaxation of muscle (GO:0090075),0.3156932460551605,0.6236484358722798,0.8728010825439784,1.0,1.0,3/13,16.78%,GSN;KCNJ2;PIK3CA
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2619069455667474,0.6230986955962617,0.934156378600823,1.0,1.0,19/76,22.65%,EZR;PTPN22;TRADD;EGFR;TRIM44;ADIPOR1;ACTN4;UACA;LIMS1;NLRC3;PPM1B;RPS3;TRAF6;LGALS9;IFI35;ILK;SASH1;RTKN2;PHB2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.32576314822953834,0.6230259884002317,0.8561151079136691,1.0,1.0,4/11,22.08%,TNRC6C;AGO2;EIF6;AGO1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.32576314822953834,0.6230259884002317,0.8561151079136691,1.0,1.0,4/11,22.08%,TNRC6C;AGO2;EIF6;AGO1
prerank,response to glucose (GO:0009749),0.26839711321311943,0.6226295072867095,0.9016393442622951,1.0,1.0,10/46,21.23%,NKX6-1;PRKACA;RACK1;TCF7L2;XBP1;ADCY8;ZBTB20;PAX2;EIF2B5;PCK2
prerank,response to UV-A (GO:0070141),0.3095067188933668,0.6225342854048488,0.8983957219251337,1.0,1.0,2/14,19.90%,EGFR;MME
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.2813707423564722,0.6224888951524654,0.890888638920135,1.0,1.0,6/33,16.78%,ERBB3;HTR2A;ZFP36L1;PTEN;IRS1;PIK3CA
prerank,ribosomal large subunit assembly (GO:0000027),0.2822785285103801,0.6224337778059063,0.8948598130841121,1.0,1.0,10/24,26.05%,RPL23A;RPLP0;RPL3;RPL5;RSL24D1;RPL24;RPL10;MRPL20;DDX28;FASTKD2
prerank,positive regulation of T cell proliferation (GO:0042102),0.2698106704119326,0.6221475998152373,0.9309978768577495,1.0,1.0,4/55,7.33%,SLC7A1;TFRC;CCR2;HMGB1
prerank,regulation of protein localization to membrane (GO:1905475),0.2808114928487403,0.6220881652127287,0.8808411214953271,1.0,1.0,7/28,21.46%,FYN;GSN;ZDHHC7;APPL1;LDLRAP1;CLN3;VPS4A
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.21812997735986567,-0.6220738301075572,0.9210526315789473,0.9795147237322464,1.0,9/16,43.33%,IGF1;IGFBP4;IGFBP6;IGFBP3;BMP5;PHIP;BMP2;IGFBP5;CDH3
prerank,central nervous system development (GO:0007417),0.25760223890293565,0.621956377148364,0.995995995995996,1.0,1.0,30/250,14.60%,VAX2;CDK5RAP2;NR4A2;SOX6;PBX4;HSPG2;LIG4;UTP3;ANKLE2;PBX3;HAPLN2;GSN;GBA2;SHROOM2;ZBTB16;SHROOM4;SZT2;DNER;RELN;RPS6KA6;PTEN;HAP1;CDK5RAP3;SMG9;MDGA1;NRCAM;NIPBL;POU6F1;ADGRL3;PBX2
prerank,regulation of protein secretion (GO:0050708),0.25923188893565574,0.621308581191862,0.958627648839556,1.0,1.0,10/119,11.88%,IL12A;ITPR1;EZR;MYOM1;PRKCA;PICK1;MYH10;KCNC2;DPP4;EIPR1
prerank,positive regulation of heart contraction (GO:0045823),-0.21127520344827172,-0.6207889792337311,0.9362745098039216,0.9792794708010722,1.0,5/19,21.86%,RYR2;GSK3A;ADRA1A;ATP1A2;SCN3B
prerank,long-chain fatty acid import into cell (GO:0044539),-0.24791026265906516,-0.6203881237662962,0.9228295819935691,0.9784588177467822,1.0,3/10,18.07%,SLC27A1;CD36;SLC27A4
prerank,cellular response to lipid (GO:0071396),0.25753918180573776,0.6199977091867417,0.987,1.0,1.0,16/191,10.65%,GFI1;HMGB2;AQP1;CRHBP;MAP4K1;NR1D1;ATM;SETX;HMGB1;AHR;GNAI1;MAPK14;EGFR;EPHA3;RUVBL2;MSN
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.28016073293003896,0.6199272562525615,0.8692579505300353,1.0,1.0,2/26,5.15%,ZFPM1;CDK6
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.19992052221958412,-0.6194422927855602,0.9547738693467337,0.9779595375825108,1.0,7/23,26.89%,CALM1;METAP1;CAMKMT;NMT1;FNTB;SAG;GUCA1B
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.29064023224776997,0.6194015835610348,0.8980815347721822,1.0,1.0,4/25,13.37%,CCDC88A;SHKBP1;HAP1;DGKD
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.30524279564090184,0.6191117756399799,0.9109159347553325,1.0,1.0,2/17,9.77%,BACH2;BTN3A3
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2591283709270878,0.6187035561638247,0.9545454545454546,1.0,1.0,21/112,17.72%,SOX6;ARHGEF18;CRKL;COL1A2;ZFP36L1;PDE2A;HPGD;SMAD4;JUN;ARRB2;BMPR1A;SKI;USP15;LIMS1;APPL1;ZFP36L2;DUSP22;TGFB2;SIRT1;UBA52;MAP3K7
prerank,protein kinase B signaling (GO:0043491),0.2894296082775876,0.6185345882202616,0.8838630806845966,1.0,1.0,3/23,11.98%,SETX;ZFP36L1;PTEN
prerank,cellular response to estrogen stimulus (GO:0071391),0.30993924094202074,0.6183574021612455,0.8842530282637954,1.0,1.0,2/14,11.94%,CRHBP;PELP1
prerank,histone H4 deacetylation (GO:0070933),0.327929029930731,0.6180026351256596,0.8814055636896047,1.0,1.0,5/10,22.55%,HDAC4;HDAC1;HDAC8;SMARCAD1;HDAC9
prerank,regulated exocytosis (GO:0045055),0.25568062070079073,0.6176900588399006,0.986986986986987,1.0,1.0,37/173,23.64%,BLK;F5;PECAM1;FLNA;CRHBP;SYT8;PHACTR2;CYRIB;ACTN2;APOOL;SYT3;BRPF3;ABCC4;OLA1;RAB11B;STEAP2;ACTN4;EGF;TGFB2;SCG3;FN1;F13A1;SNCA;NHLRC2;TAGLN2;ENDOD1;SYT2;RIMS3;TMED10;STXBP2;RAB27B;ACTN1;APOH;RAB10;VCL;DNAJC5;MYH9
prerank,regulation of cell junction assembly (GO:1901888),0.28799620018499383,0.6174838713924379,0.9020070838252656,1.0,1.0,8/27,22.73%,PRKACA;CBFB;ROCK2;FLOT1;RUNX1;PDLIM5;ROCK1;SETD5
prerank,regulation of cell-matrix adhesion (GO:0001952),0.26119543438132975,0.6173249381814969,0.9247083775185578,1.0,1.0,8/64,9.24%,SLK;PTPRA;PLEKHA2;CDK6;CDKN2A;CLASP1;CIB1;EPHA3
prerank,histone lysine demethylation (GO:0070076),0.28808213340768,0.6169003556927818,0.8955042527339003,1.0,1.0,3/25,7.94%,RIOX1;KDM3B;PHF2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.27798792707688724,0.6168451123780792,0.8978185993111366,1.0,1.0,6/28,17.45%,GBA2;ARHGAP35;DBNL;LATS1;BRK1;HCLS1
prerank,regulation of axon guidance (GO:1902667),0.32742821009998524,0.6166652429995267,0.8869814020028612,1.0,1.0,2/10,13.01%,ZSWIM4;NRP1
prerank,mesoderm formation (GO:0001707),-0.21131647770490963,-0.6159886008607031,0.958139534883721,0.9790405172545633,1.0,7/17,37.47%,BMPR2;ITGB3;KDM6B;ITGB4;ITGA3;ITGB1;SCX
prerank,regulation of innate immune response (GO:0045088),0.2597045929289866,0.6158028444060715,0.9298618490967057,1.0,1.0,19/57,24.31%,DHX58;PTPN22;BIRC2;RIOK3;XIAP;DHX9;APPL1;NLRC3;TRAFD1;FCGR2B;ERAP1;CASP8;IFI35;POLR3B;FGR;AKIRIN2;PTPN11;ABCE1;SAMHD1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3032114290292908,0.6148459113031706,0.8712737127371274,1.0,1.0,1/15,3.11%,TIAM1
prerank,superoxide anion generation (GO:0042554),0.3099022027236188,0.6145415187036513,0.8816326530612245,1.0,1.0,3/13,19.37%,CYBB;CYBA;NCF4
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.2627591099872454,0.6141290344932946,0.9379600420609885,1.0,1.0,12/56,19.07%,NDUFS8;NDUFAF8;NDUFB7;NDUFAF1;NDUFAF7;NDUFA1;NDUFAF5;FOXRED1;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.2627591099872454,0.6141290344932946,0.9379600420609885,1.0,1.0,12/56,19.07%,NDUFS8;NDUFAF8;NDUFB7;NDUFAF1;NDUFAF7;NDUFA1;NDUFAF5;FOXRED1;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2579920083045975,0.613784027744063,0.9575328614762386,1.0,1.0,6/95,8.62%,GFI1;HMGB2;NR1D1;HMGB1;MAPK14;CYRIB
prerank,synapse assembly (GO:0007416),0.2608203374754992,0.6129382339363468,0.940625,1.0,1.0,9/67,14.88%,SDK1;DBNL;DNER;PTEN;FGF13;NRCAM;ADGRL3;KIRREL3;NRXN2
prerank,positive regulation of protein polymerization (GO:0032273),0.25863061922819625,0.6123104286403168,0.9380252100840336,1.0,1.0,14/65,22.05%,CDK5RAP2;PRKCE;CLASP1;SNX9;SLAIN2;CDC42EP3;NUMA1;RAC1;DRG1;CDC42EP1;RPS3;MET;MAPT;DCTN1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.2930428524591542,0.61219772651105,0.8948717948717949,1.0,1.0,4/18,19.97%,RPS6KA5;RELN;ADCY8;PRKD2
prerank,carboxylic acid metabolic process (GO:0019752),-0.17303666754570451,-0.6119207058914328,0.9838709677419355,0.9803959778232868,1.0,7/33,22.43%,TBXAS1;LIAS;GLUD1;GNE;CYB5R3;AGXT;GSTO1
prerank,cardiac myofibril assembly (GO:0055003),0.30632353237922094,0.6119037548217403,0.8905852417302799,1.0,1.0,1/15,3.63%,CSRP3
prerank,long-chain fatty acid transport (GO:0015909),0.27430960637303725,0.6118050098184504,0.8977932636469221,1.0,1.0,6/30,15.06%,ABCD1;CPT1B;SLC27A2;CPT1A;PRKAG2;CPT2
prerank,macroautophagy (GO:0016236),0.25241484927908814,0.6105348153829036,0.9616161616161616,1.0,1.0,30/118,21.46%,ATG13;STX17;HDAC10;ACBD5;LIX1;UBQLN1;ATG4B;VPS16;MTMR14;BECN1;AMBRA1;TOMM70;PRKAG2;VPS33B;RUBCNL;DYNLL1;ATG101;HGS;YOD1;CHMP3;PIP4K2A;CHMP2B;EPG5;VTA1;STAM;CLN3;PLEKHM1;PRKAG1;NBR1;VPS4A
prerank,polyol biosynthetic process (GO:0046173),-0.21225863451805274,-0.6103476756954396,0.9484978540772532,0.9801912242197114,1.0,5/16,22.92%,ITPKB;IP6K1;FGF2;IPMK;IPPK
prerank,visual perception (GO:0007601),0.25992565531318024,0.6102603109258713,0.9553299492385787,1.0,1.0,8/84,14.77%,CRYBG3;CRYBA1;EYA3;RP2;CEP250;ATF6;RDH10;ADGRV1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3167695662638499,0.6101111202482469,0.8935532233883059,1.0,1.0,4/10,27.35%,FTO;ALKBH5;ASCC3;MGMT
prerank,DNA dealkylation (GO:0035510),0.3167695662638499,0.6101111202482469,0.8935532233883059,1.0,1.0,4/10,27.35%,FTO;ALKBH5;ASCC3;MGMT
prerank,inorganic cation transmembrane transport (GO:0098662),0.2523526254527811,0.6099356126219886,0.99,1.0,1.0,36/268,20.04%,RHAG;SLC6A12;SLC12A3;RHD;SLC6A2;SLC6A5;HCN3;KCNN4;SLC12A1;TRPM7;ITGAV;UCP2;KCNA1;KCNC2;KCNH7;KCNJ2;ATP6V0E1;KCNK12;SLC9A8;SLC24A4;SLC24A2;HVCN1;SLC9A9;KCNK2;ATP6V0D1;TRPM4;ANO6;SLC30A5;KCNQ5;ATP5F1B;KCNJ10;SLC9A7;SLC9A6;PKD2;KCNC1;SLC30A6
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.29976381628421445,0.609594936647453,0.8872180451127819,1.0,1.0,10/18,29.16%,JAK2;SMAD4;PTPN11;SRC;IL6ST;CBL;JAK1;ST18;CEBPA;IL6R
prerank,positive regulation of secretion by cell (GO:1903532),0.25975798029701835,0.6090989914466959,0.9355179704016914,1.0,1.0,17/70,22.85%,EZR;CLASP1;MYOM1;MYH10;GRK2;BAIAP3;PPIA;DTNBP1;ATP6AP1;TGFB2;RAB5A;SNCA;GOLPH3;RAB27A;TMED10;RAB27B;RAB9A
prerank,positive regulation of acute inflammatory response (GO:0002675),0.30969701937860833,0.6090083982708993,0.8811369509043928,1.0,1.0,1/14,10.75%,PARK7
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.2964435787225083,0.6085375579518335,0.9036295369211514,1.0,1.0,3/20,9.55%,CCT2;NDUFAF1;LONP1
prerank,positive regulation of type 2 immune response (GO:0002830),0.3054755716550941,0.6084446472066147,0.9040735873850198,1.0,1.0,2/14,12.47%,CD74;DENND1B
prerank,respiratory system development (GO:0060541),0.27286430902742426,0.6083421429757084,0.9073226544622426,1.0,1.0,3/32,11.48%,SMCHD1;SPEF2;FGF9
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.25270159523535757,0.6082330500100258,0.9769076305220884,1.0,1.0,29/151,21.62%,RHD;SGMS2;ALAS2;HACD4;CHKB;PRKD3;CSNK1G2;ST3GAL2;NMRAL1;VAPA;SLC44A1;CERS4;SGMS1;ELOVL5;PCSK1;ASL;GPHN;ASS1;GSTM1;ELOVL4;CERS6;ACER3;CERS2;GOLPH3;PRKD2;SLC44A2;GCNT1;CHKA;MGST3
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.2810326173195271,0.6075607027564439,0.903755868544601,1.0,1.0,7/25,17.17%,ZNF326;CCAR2;CCNT1;THOC5;CCNK;SCAF8;DDX39B
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.312835983534247,0.6073372499486179,0.8770949720670391,1.0,1.0,2/11,15.88%,RIN3;SLAMF8
prerank,central nervous system neuron axonogenesis (GO:0021955),0.3104262905577009,0.6070355737186757,0.884180790960452,1.0,1.0,2/12,11.98%,ARHGAP35;PTEN
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.19100466176666744,-0.6064491457820672,0.9720670391061452,0.9813297600826425,1.0,7/23,24.20%,ZFYVE28;ZGPAT;MVP;SNX6;THY1;SH3BP5L;SOCS5
prerank,aminoglycan biosynthetic process (GO:0006023),0.26611844728715933,0.606369880133078,0.9221052631578948,1.0,1.0,5/49,9.89%,HSPG2;HAS1;EXT1;SLC35D2;B3GNT2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2815367435685743,0.6063122364898698,0.8962148962148963,1.0,1.0,8/23,25.99%,UBA52;DDB2;COPS3;COPS2;COPS4;XPA;PARP1;RBX1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.2742468812187562,0.6056506327803742,0.9224441833137486,1.0,1.0,8/29,23.15%,CLASP1;CYRIB;LIMA1;SMAD4;PIK3CA;SSH2;TWF1;PRKCD
prerank,epithelial cell morphogenesis (GO:0003382),0.2934069446834137,0.6045777727741412,0.8975979772439949,1.0,1.0,1/17,6.10%,CCDC88C
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.32050163266485243,0.6044761891352829,0.895500725689405,1.0,1.0,4/10,25.68%,ABCD1;ELOVL5;NR1H3;NR1H2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.27945598338322486,0.6044590185978237,0.9053254437869822,1.0,1.0,3/26,12.75%,SUV39H1;KMT5C;KMT2A
prerank,relaxation of cardiac muscle (GO:0055119),0.30477911390951495,0.6041310743045357,0.8822733423545331,1.0,1.0,3/13,16.78%,GSN;KCNJ2;PIK3CA
prerank,regulation of lipid catabolic process (GO:0050994),0.2836783314195269,0.6031794145674436,0.8949320148331273,1.0,1.0,1/19,4.94%,ABCD1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.2912660665981148,0.6021989497290817,0.9054916985951469,1.0,1.0,7/16,26.85%,PRKCA;MTPN;ROCK2;ROCK1;IL6ST;PARP1;AKAP6
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3070987823203426,0.601339049654168,0.8712871287128713,1.0,1.0,2/11,16.94%,EGR1;SIRT1
prerank,organic hydroxy compound transport (GO:0015850),0.2645344829042297,0.6012424971707043,0.9122222222222223,1.0,1.0,4/36,11.68%,SLC16A1;ABCC2;STARD5;ABCC4
prerank,regulation of bone mineralization (GO:0030500),0.25547139488516957,0.6012049858624713,0.9417989417989417,1.0,1.0,12/55,23.07%,SGMS2;CCN1;TWIST1;BMPR1A;NELL1;ADGRV1;TRPM4;ANO6;ACVR2B;NBR1;DDR2;OSR1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.2611203719774057,0.6007195576509289,0.9315789473684211,1.0,1.0,5/54,7.95%,HSPG2;HAS1;HPSE2;EXT1;SLC35D2
prerank,regulation of cell communication (GO:0010646),0.2732408402429564,0.600654728472627,0.9156355455568054,1.0,1.0,9/35,22.27%,GRK6;SOCS2;CRK;GRK2;NCLN;GRK3;CDC42SE2;IGFBP7;YWHAG
prerank,neuron cell-cell adhesion (GO:0007158),0.29548100135831334,0.5995829683510794,0.91268758526603,1.0,1.0,6/14,27.42%,CEL;NRXN2;NRXN1;CNTN4;NLGN2;NLGN1
prerank,proteoglycan metabolic process (GO:0006029),0.27609603380405434,0.598783192978095,0.916267942583732,1.0,1.0,5/26,17.96%,CSGALNACT2;SULF2;CHST12;CANT1;FAM20B
prerank,peptidyl-glutamic acid modification (GO:0018200),0.28318806450870465,0.5983364408771319,0.9043683589138135,1.0,1.0,8/24,25.04%,AGTPBP1;TTLL1;TTLL9;TTLL10;TTLL5;TTLL11;TTLL4;PARP1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.21702262091368818,-0.5980811583216105,0.9715447154471545,0.9847186374566024,1.0,5/15,26.35%,ERN1;TSEN15;RTRAF;FAM98B;DDX1
prerank,macrophage migration (GO:1905517),0.2940346693243429,0.5970703467236274,0.9010989010989011,1.0,1.0,1/13,5.31%,CCR2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.2975009418560845,0.5966105345978651,0.9064935064935065,1.0,1.0,15/15,70.28%,NUMA1;MED1;NCOA3;PRKCH;SFRP4;CYP27B1;VDR;KDF1;SULT2B1;TRIM16;SFN;BMP4;NME2;FOXC1;ETV4
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.21555070919748845,-0.5966065868087823,0.9364406779661016,0.9843443868855145,1.0,10/16,39.75%,PPAT;LHPP;AMPD2;GART;NUDT2;AMPD3;ADSS1;ADSS2;IMPDH1;ATIC
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2522188495121763,0.5965335398999113,0.9424083769633508,1.0,1.0,14/66,20.56%,MEFV;FOXP1;JAK2;EGR1;MYD88;TLR6;TYROBP;F2R;USP50;NLRP2B;MALT1;LGALS9;CASP8;AIM2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.23354446360600656,-0.5958071289161233,0.9647887323943662,0.9836321953475412,1.0,5/12,24.86%,RER1;OS9;HSPA5;INSIG1;GPAA1
prerank,ethanol metabolic process (GO:0006067),-0.2396258396635068,-0.59571764700968,0.9343065693430657,0.9826048524121598,1.0,12/12,76.06%,ALDH1A1;SULT1A1;ALDH1B1;SULT2A1;SULT1C4;ADH7;ADH1A;ADH4;ACSS2;ACSS1;ALDH2;ADH5
prerank,cellular response to interferon-beta (GO:0035458),-0.230291538023944,-0.5951584682015899,0.9573643410852714,0.9817745948453352,1.0,3/14,9.33%,IRF1;IRGM;HTRA2
prerank,platelet aggregation (GO:0070527),0.26336988046655835,0.5950499191217642,0.9316338354577057,1.0,1.0,11/33,23.64%,FLNA;CSRP1;CLIC1;PPIA;FIBP;FN1;ILK;ACTG1;ACTN1;VCL;MYH9
prerank,hemidesmosome assembly (GO:0031581),0.3145142780537371,0.5943470783658931,0.8887303851640513,1.0,1.0,2/11,8.60%,LAMC1;LAMB3
prerank,modulation of chemical synaptic transmission (GO:0050804),0.25029303167140216,0.5943463734136755,0.9684317718940937,1.0,1.0,22/107,21.64%,CHRNB4;NTF4;CEL;CACNG5;RELN;PTEN;CNTNAP4;BAIAP3;NMU;BCR;BTBD9;CACNA1B;MCTP1;LRRK2;CLN3;GRM3;HCRT;RIMS3;GRIK5;GRIK3;USP46;MCTP2
prerank,endomembrane system organization (GO:0010256),0.24679061083297577,0.5943085252090641,0.9859719438877755,1.0,1.0,34/178,18.50%,RNF26;ATP8B4;REEP4;SUN2;STX17;SNX33;ATL2;TMCC1;WASHC4;RAB22A;CLASP1;NPLOC4;CSNK1A1;ZW10;BLZF1;CAV2;DYM;TOR1A;VAPA;DNAJC13;SEC31A;RAB43;PI4K2B;RAB2A;VPS33B;FAM174B;USP50;SYNE1;LMAN1;GORASP1;CHMP2B;LRRK2;ARHGEF7;FBXW8
prerank,peroxisome organization (GO:0007031),0.2700039036321164,0.5939661129668166,0.9237187127532777,1.0,1.0,8/25,23.59%,ABCD1;PEX11B;PEX2;FIS1;PEX14;ABCD4;ACOT8;PEX3
prerank,hexose metabolic process (GO:0019318),0.2612084894630742,0.5937075311603018,0.9326599326599326,1.0,1.0,8/39,22.15%,BRAT1;DCXR;SLC35A2;GALM;PMM2;FUCA1;PPARD;GDPGP1
prerank,fatty acid beta-oxidation (GO:0006635),0.2544960861084888,0.593032668600008,0.94,1.0,1.0,17/51,24.49%,ACADM;ABCD1;AUH;SLC27A2;PEX2;IVD;CPT2;HADHA;HADHB;ABCD4;DECR1;PPARD;ACOT8;DECR2;ETFDH;ETFA;ETFB
prerank,keratinocyte differentiation (GO:0030216),-0.1708416284607695,-0.5927581604755434,0.9724137931034482,0.9818626412516431,1.0,4/29,16.45%,ST14;CASP3;ADAM9;JAG1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.24838862876468362,0.5926418840779835,0.9644670050761421,1.0,1.0,15/104,13.77%,VASN;CAV1;PMEPA1;NOTCH1;PIN1;ZBTB7A;PDPK1;HIPK2;TRIM33;SMAD4;SNX25;BCL9L;BMPR1A;SPRED2;SKI
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.29161752062048313,0.5923989851694856,0.9074550128534704,1.0,1.0,4/17,16.94%,UBQLN1;NFE2L2;PPIA;SIRT1
prerank,T cell differentiation (GO:0030217),0.2588074394593093,0.5913408789645411,0.9423913043478261,1.0,1.0,3/40,6.62%,LIG4;PTPN22;ZFP36L1
prerank,cellular glucan metabolic process (GO:0006073),0.3076012727439445,0.59016111983383,0.8929577464788733,1.0,1.0,4/11,22.44%,PRKAG2;GSK3B;GBE1;PHKB
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.2256639618082478,-0.5900436732959852,0.9593220338983051,0.9821249477183067,1.0,1/12,6.30%,ZC3H12A
prerank,potassium ion transmembrane transport (GO:0071805),0.24344303469389317,0.5899962301000742,0.9768611670020121,1.0,1.0,23/135,19.98%,SLC12A3;HCN3;KCNN4;SLC12A7;SLC12A1;KCNA1;KCNJ3;KCNC2;KCNH7;SLC12A6;KCNJ2;KCNK12;SLC9A8;SLC24A4;SLC24A2;SLC9A9;KCNK2;KCNQ5;KCNJ10;SLC9A7;SLC9A6;PKD2;KCNC1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.2777732036643425,0.58988110441484,0.9199491740787802,1.0,1.0,1/18,3.58%,PET100
prerank,regulation of trophoblast cell migration (GO:1901163),0.2989467054958262,0.58981479409766,0.8974358974358975,1.0,1.0,1/14,4.79%,ARHGDIB
prerank,GTP metabolic process (GO:0046039),-0.21234523176813178,-0.5896048339578772,0.9532374100719424,0.9812149726919593,1.0,5/15,19.70%,ENTPD7;GNAI3;RHOQ;RAN;GTPBP1
prerank,protein homotetramerization (GO:0051289),0.25439424087179113,0.5891526035235835,0.9469214437367304,1.0,1.0,5/49,13.00%,TK1;CBR4;ACOT13;B2M;KCNJ2
prerank,regulation of anoikis (GO:2000209),0.28309515819728936,0.5890269210139032,0.9147869674185464,1.0,1.0,2/19,7.15%,CAV1;NOTCH1
prerank,regulation of muscle cell differentiation (GO:0051147),0.2691564379729372,0.5890005099569877,0.930635838150289,1.0,1.0,3/31,8.10%,CTNNA1;TCF3;MAPK14
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.264364134987614,0.5886742740516282,0.9258836944127709,1.0,1.0,6/33,17.20%,SMARCA4;EGR1;JUN;TP53;TGFB2;APLN
prerank,lipoxygenase pathway (GO:0019372),0.2965063295817388,0.5883691574584029,0.9121887287024901,1.0,1.0,3/14,20.50%,HPGD;PON3;PON2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.26865155082867104,0.5882253039973699,0.9204152249134948,1.0,1.0,6/31,17.05%,TFRC;KMT5C;PAXIP1;DNAJB9;RIF1;XBP1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.27310204140220523,0.5875589808974396,0.9284833538840938,1.0,1.0,7/22,24.75%,CIAO2A;ISCA2;CIAO3;MMS19;ABCB7;FXN;HSPA9
prerank,aorta development (GO:0035904),0.29254315843063816,0.5871351875057309,0.910427807486631,1.0,1.0,5/14,24.18%,PDE2A;EFEMP2;PKD2;HECTD1;ADAMTS9
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.28792372867627414,0.5868546259043679,0.9006535947712418,1.0,1.0,6/16,20.99%,HDAC6;TBC1D25;GSPT1;CLN3;BNIP3;GLE1
prerank,aminoglycan catabolic process (GO:0006026),0.2701227037577638,0.5865098886041562,0.9187358916478555,1.0,1.0,2/28,4.74%,HSPG2;HPSE2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.20324955658373114,-0.586319811188196,0.9493087557603687,0.9816415381217789,1.0,9/17,35.91%,BAIAP2;FES;CDK5;CDC42;HRAS;HCK;TEK;STAP1;BAIAP2L2
prerank,regulation of protein ubiquitination (GO:0031396),0.2442813435237918,0.5857445142420021,0.9625126646403243,1.0,1.0,24/108,20.53%,BRCA1;AXIN1;NXN;CAV1;BIRC2;UBQLN1;CUL3;PRR7;PARK7;XIAP;PAXIP1;ARRB2;CDK5RAP3;SIRT7;UBXN1;CAMLG;LRRK2;PRMT3;MALT1;GNL3L;RPS3;TRAF6;HDAC8;UBE2N
prerank,protein import into mitochondrial matrix (GO:0030150),0.2807666102403025,0.5855619599506521,0.9210866752910737,1.0,1.0,4/18,14.03%,DNAJC15;TOMM70;TIMM23;GRPEL2
prerank,sphingosine metabolic process (GO:0006670),-0.205108695993005,-0.5854747139412845,0.9601990049751243,0.9809742085995687,1.0,2/17,5.28%,SPTLC1;SGPP1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.24890129464621502,0.5854413501916012,0.9565677966101694,1.0,1.0,13/54,22.99%,FLNA;KCNN4;CAV1;NEDD4L;KCNJ3;KCNJ2;STK39;YWHAE;KCNJ10;GNB1;KCNN3;KCNIP1;NEDD4
prerank,regulation of exocytosis (GO:0017157),0.25429858389341664,0.5853030465086132,0.9491341991341992,1.0,1.0,14/46,22.97%,STXBP6;CLASP1;RAB8A;LGI3;RAB8B;HAP1;ATP6AP1;RAB5A;CHMP3;SNCA;RAB27A;RAB27B;RAB9A;RAB10
prerank,positive regulation of cell killing (GO:0031343),-0.2215435852480422,-0.585251976783831,0.9494163424124513,0.9800238210198757,1.0,6/13,31.67%,NOX1;MAPK8;DVL2;NOXO1;FZD7;WNT5A
prerank,negative regulation of locomotion (GO:0040013),0.2968484598677964,0.5852272161898716,0.8980716253443526,1.0,1.0,2/12,11.74%,PIN1;CRK
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2491251388236522,0.5849792148990824,0.9571577847439916,1.0,1.0,8/68,13.19%,ACOT11;PTHLH;TPST1;ACOT13;ACOT2;NT5C2;BPNT2;SULT6B1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.25526801220603007,0.5844235210865066,0.9381898454746137,1.0,1.0,8/42,18.22%,ECM2;NOTCH1;JAK2;RAC2;RSU1;LIMS1;RAC1;TBCD
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.2644477771890526,0.5839878344408326,0.9294117647058824,1.0,1.0,8/29,22.59%,SORBS1;CNEP1R1;ELOVL5;CREB1;ZBTB20;SIRT4;NR1H3;LDLR
prerank,regulation of response to interferon-gamma (GO:0060330),0.2889395259844318,0.5832701834153602,0.8961892247043364,1.0,1.0,7/14,28.49%,JAK2;SUMO1;PIAS1;IFNGR1;JAK1;PARP9;HSP90AB1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.28381847527324544,0.5831314476257633,0.9290240811153359,1.0,1.0,4/15,19.00%,ENTPD3;ENTPD5;AK5;CMPK2
prerank,pigment granule transport (GO:0051904),0.27754458161108214,0.5827393771032637,0.9223918575063613,1.0,1.0,7/18,24.62%,RAB11B;BBS4;MREG;RAB27A;RAB27B;BBS7;BBS2
prerank,melanosome transport (GO:0032402),0.27754458161108214,0.5827393771032637,0.9223918575063613,1.0,1.0,7/18,24.62%,RAB11B;BBS4;MREG;RAB27A;RAB27B;BBS7;BBS2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.18965950496293504,-0.5825879529235954,0.9836065573770492,0.9801082478216476,1.0,23/23,81.07%,SMAD7;ID2;TGFBR3;DSG2;PKP2;MYL2;MYBPC3;ISL1;TNNC1;TNNI3;TNNT2;MYH6;MYL3;IRX3;MYH7;TBX5;TPM1;TGFB1;ADAMTS9;FKBP1A;FGFR2;HOPX;PROX1
prerank,regulation of TORC1 signaling (GO:1903432),0.2680457903467275,0.5824395595421223,0.9270588235294117,1.0,1.0,5/33,12.60%,STK11;ATM;LARS1;SZT2;RNF152
prerank,positive regulation of fat cell differentiation (GO:0045600),0.2523687596225529,0.5816162684076649,0.9485213581599123,1.0,1.0,11/47,18.48%,ZFP36L1;ZBTB16;PIM1;NAPEPLD;WDFY2;ZBTB7B;HNRNPU;XBP1;TRPM4;CREB1;AAMDC
prerank,regulation of calcium-mediated signaling (GO:0050848),0.2683727099191721,0.5807464335883541,0.9224343675417661,1.0,1.0,3/25,10.32%,ITPR1;PLCG2;RIT2
prerank,negative chemotaxis (GO:0050919),0.25994331697637046,0.5796841530044995,0.9255441008018328,1.0,1.0,4/33,11.67%,NTN1;ITGAV;SLIT3;SLIT1
prerank,multivesicular body organization (GO:0036257),0.2632119500228633,0.5794551438863114,0.9337142857142857,1.0,1.0,14/31,28.71%,CHMP1B;HGS;CHMP3;CHMP2B;VTA1;STAM;RAB27A;VPS4A;CHMP5;TSG101;VPS37A;STAM2;VPS4B;VPS37B
prerank,protein polyglutamylation (GO:0018095),0.303857779242641,0.5790384288348125,0.9191489361702128,1.0,1.0,5/11,24.14%,TTLL1;TTLL9;TTLL5;TTLL11;TTLL4
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.24075715037918782,0.5790317594644273,0.9573170731707317,1.0,1.0,20/86,23.20%,PECAM1;FYN;CD74;CD44;BANK1;PLCG2;JAK2;EGFR;RELN;NRP1;TP53;PAK2;HCLS1;EPHA7;CNOT7;CADM4;EFNA1;PTPN11;PRKCD;SRC
prerank,positive regulation of cellular respiration (GO:1901857),-0.2318158396093955,-0.5789253682515385,0.9473684210526315,0.9806843598661884,1.0,4/11,26.75%,PINK1;ISCU;IFNAR1;PRELID1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.24960688442767948,0.5788620763844756,0.9463307776560789,1.0,1.0,10/44,23.60%,FLNA;KCNN4;KCNJ3;ACTN2;KCNJ2;ANO6;KCNJ10;GNB1;KCNN3;WNK3
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2478445710380124,0.5772526582920665,0.9573304157549234,1.0,1.0,5/44,11.94%,PRKCE;GSN;SNX9;WHAMM;CDC42EP3
prerank,response to growth factor (GO:0070848),0.2508391100576756,0.5760394455401165,0.9372972972972973,1.0,1.0,7/41,13.88%,HDAC6;CIB1;EMD;BMPR1A;STAT5B;RACK1;MYC
prerank,positive regulation of ossification (GO:0045778),0.2507849386617287,0.5759511688181522,0.9434167573449401,1.0,1.0,10/39,23.07%,CCN1;ZBTB16;BMPR1A;NELL1;ADGRV1;TGFB2;ANO6;ACVR2B;PTPN11;OSR1
prerank,renal water homeostasis (GO:0003091),0.27222232042182504,0.5758517602027995,0.910757946210269,1.0,1.0,2/23,8.22%,AQP1;PRKACA
prerank,response to endoplasmic reticulum stress (GO:0034976),0.23947864762844606,0.5747865005870649,0.9745934959349594,1.0,1.0,20/107,17.78%,ITPR1;EIF2S1;RCN3;MBTPS2;MAP3K5;DDRGK1;NIBAN1;UBQLN1;PPP1R15A;ATF6;JUN;CDK5RAP3;FLOT1;DDIT3;TMX1;GSK3B;TP53;DNAJB9;HSP90B1;SYVN1
prerank,cellular response to BMP stimulus (GO:0071773),0.24485212683627625,0.5747141877825418,0.9536842105263158,1.0,1.0,7/66,16.39%,ADAMTS7;SMAD4;BMPR1A;SLC33A1;USP15;HIVEP1;TGFB2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2691063258485411,0.5746396856469637,0.9281288723667905,1.0,1.0,4/20,16.87%,IMPDH2;NT5C2;ADSL;AK3
prerank,negative regulation of biosynthetic process (GO:0009890),0.2790967795392864,0.5743775837098611,0.9237726098191215,1.0,1.0,2/16,10.75%,ABCD1;PARK7
prerank,amyloid-beta metabolic process (GO:0050435),0.28175127777977105,0.5743163285241847,0.9209486166007905,1.0,1.0,4/16,19.90%,ABCA7;DYRK1A;PSEN1;MME
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.28016676610354185,0.5729645626621978,0.9151898734177215,1.0,1.0,2/17,7.33%,CCR2;HMGB1
prerank,negative regulation of response to external stimulus (GO:0032102),0.23967066156399375,0.5726979208314563,0.9705882352941176,1.0,1.0,5/105,5.37%,RNF26;MEFV;RB1;DHX58;NR1D1
prerank,carbohydrate homeostasis (GO:0033500),0.24185500388099357,0.572105028014256,0.9563409563409564,1.0,1.0,10/67,19.03%,SLC2A4;USF1;STK11;PARK7;ADIPOR1;MCU;IRS1;TCF7L2;ADCY8;RPS6
prerank,anterograde trans-synaptic signaling (GO:0098916),0.2379320962599642,0.5718501319745277,0.997997997997998,1.0,1.0,21/224,13.28%,CHRNB4;MAPK1;CEL;PDE7B;SLC6A2;SLC6A5;HTR2A;EXOC4;SLC12A7;GABRA4;PRKACA;KCNA1;BSN;PMP22;GABRA5;RIT2;PAFAH1B1;GRIA3;HAP1;SLC12A6;CHRM3
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.2930361019176549,0.5717632860427412,0.909221902017291,1.0,1.0,2/11,12.08%,TIMM9;TOMM70
prerank,androgen receptor signaling pathway (GO:0030521),0.29855213795630264,0.5717244896631062,0.9076923076923077,1.0,1.0,3/11,23.37%,PMEPA1;TMF1;PLPP1
prerank,purine ribonucleotide transport (GO:0015868),0.28011252410366433,0.5711009278967284,0.910761154855643,1.0,1.0,3/16,11.68%,LRRC8C;SLC19A1;ABCC4
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.2864761141120876,0.5706670155637934,0.903448275862069,1.0,1.0,2/11,15.36%,NT5C3A;TPK1
prerank,bile acid and bile salt transport (GO:0015721),0.2646123360758358,0.5696673681399625,0.9317365269461078,1.0,1.0,3/24,11.68%,ABCC2;STARD5;ABCC4
prerank,myoblast fusion (GO:0007520),0.29113119860875425,0.5693897863888886,0.9253521126760563,1.0,1.0,2/12,16.93%,JAM2;ADAMTS5
prerank,regulation of macroautophagy (GO:0016241),0.23695674256060742,0.5692696836664334,0.9817813765182186,1.0,1.0,36/105,26.72%,ATG13;EXOC4;IKBKG;HDAC6;DCN;PRKACA;UBQLN1;CAPN1;MLST8;ATP6V0E1;PRKAG2;LAMTOR4;LAMTOR3;TBC1D25;ATG101;PIK3CA;SIRT1;ATP6V0D1;MAP3K7;LRRK2;CLN3;RRAGB;PRKAG1;BNIP3;GAPDH;UBQLN2;NEDD4;SMG1;PRKAB2;USP36;QSOX1;SESN1;UCHL1;SMCR8;ATP6V1G1;BNIP3L
prerank,positive regulation of axonogenesis (GO:0050772),0.2483765527181709,0.5692112479385597,0.9457111834961998,1.0,1.0,4/43,8.45%,TIAM1;NTN1;DBNL;PLXNA2
prerank,positive regulation of wound healing (GO:0090303),0.25745096423184655,0.5691765768508512,0.9450056116722784,1.0,1.0,8/36,23.94%,PRKCE;INSL3;SMOC2;F2R;XBP1;ACTG1;APOH;ENPP4
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.2653582434305893,0.5676103707904219,0.9386068476977568,1.0,1.0,7/23,22.85%,KCTD21;HHIP;RACK1;RFX4;SUFU;MEGF8;BTRC
prerank,ephrin receptor signaling pathway (GO:0048013),0.23741475274366441,0.5670547475744454,0.9691358024691358,1.0,1.0,22/82,23.20%,FYN;TIAM1;EPHA3;ANKS1A;CRK;ARHGEF28;AP2B1;ROCK2;PSEN1;ANKS1B;RAC1;SDC2;ARHGEF7;EPHA7;SIPA1L1;ROCK1;VAV3;EPHA10;ACTG1;EFNA1;PTPN11;SRC
prerank,phosphate-containing compound metabolic process (GO:0006796),0.234357996801809,0.5667160900449586,0.991,1.0,1.0,37/198,20.51%,PLPPR3;ALPL;PPP3CA;PANK2;AGPAT1;IMPA1;INPP5A;EPHX2;PPA2;PLCG2;NUDT4;PLBD1;PLCB1;PTEN;INPP4A;PLCB3;GFPT2;PLCD1;GPD2;PLPPR4;LIMD1;LIMK2;PAK2;PLCG1;PIK3CA;DUSP12;PIP4K2A;PGK1;PPP1CA;TAOK1;LRRK2;ACYP1;OCRL;NADK;ALK;EPHA7;DUSP16
prerank,negative regulation of ion transport (GO:0043271),0.2686435886159451,0.5653731155920155,0.9319562575941677,1.0,1.0,24/24,73.18%,ACTN2;SNCA;NEDD4;PXK;WNK3;CD33;WNK1;INPP5K;LILRB1;CAV3;GPM6B;WNK4;CASQ2;HRH3;VIP;STC1;PLN;HTR1B;NOS1;ADRA2A;PACSIN3;SYT11;PTK2B;WNK2
prerank,negative regulation of mitochondrion organization (GO:0010823),0.253687401626031,0.565060011072461,0.935374149659864,1.0,1.0,2/33,5.04%,IAPP;TFRC
prerank,epithelial cell development (GO:0002064),0.2662918276724374,0.5649233553597369,0.927960927960928,1.0,1.0,19/20,62.83%,LRTOMT;SLC4A7;CLDN3;RAB25;EXPH5;ROS1;POF1B;RILPL2;PDZD7;TMEM79;GRHL2;ACTA2;PKHD1;DACT2;RILPL1;BFSP1;WNT7A;WNT7B;SIPA1L3
prerank,cellular response to purine-containing compound (GO:0071415),0.3017739874943643,0.5647332942122767,0.9393939393939394,1.0,1.0,1/10,9.48%,P2RY1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.2294481892771399,-0.5643524841268397,0.965034965034965,0.985707589567417,1.0,5/10,35.12%,GNB5;CALM1;CBARP;DRD2;CRHR1
prerank,lipid transport (GO:0006869),0.23447203417345658,0.5640253612410193,0.981651376146789,1.0,1.0,12/97,12.40%,ABCA13;ABCD1;OSBPL5;ABCC2;ABCA2;NME4;PRELID3B;ABCA7;STARD5;ATP8A1;ABCC4;SLCO2A1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.2955447455727728,0.5637594124863596,0.9182209469153515,1.0,1.0,1/10,8.54%,JAK2
prerank,positive regulation of neuron projection development (GO:0010976),0.23685505735083529,0.5634820790935612,0.9695431472081218,1.0,1.0,10/85,11.03%,S100A9;SNX3;KIDINS220;SETX;ARHGAP35;DBNL;MARK2;EPHA3;RIT2;RELN
prerank,positive regulation of phospholipase activity (GO:0010518),0.26876328664771076,0.5633870910966974,0.9229813664596274,1.0,1.0,6/22,22.74%,ARF4;PDPK1;FGFR1;PLCG1;NTRK3;FGFR2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.2828012475468381,0.5633082177236051,0.9350473612990527,1.0,1.0,4/14,18.13%,PARK7;XBP1;SYVN1;LRRK2
prerank,regulation of response to oxidative stress (GO:1902882),0.28994518162367766,0.5616845544202237,0.9257221458046767,1.0,1.0,1/11,4.94%,ABCD1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.27267316270966147,0.5605728147606758,0.9227799227799228,1.0,1.0,5/18,21.97%,DERL2;AMFR;UBA52;SYVN1;RNF103
prerank,limb development (GO:0060173),0.25516514466635665,0.5603859066755443,0.9324009324009324,1.0,1.0,7/28,23.09%,LRP4;KAT2B;MAP3K20;RSPO2;KREMEN1;MEGF8;INTU
prerank,axonogenesis (GO:0007409),0.23207426217756838,0.5603732026339562,1.0,1.0,1.0,56/237,23.30%,SPTA1;MAPK1;FYN;EZR;PTPRA;RPS6KA5;GFRA2;LAMA5;NOTCH1;ARHGAP35;RAB8A;PRKCA;GRB2;SOS1;NTNG2;PDLIM7;EPHA3;DOK2;RELN;BSG;SLIT3;SLIT1;PTEN;LMTK2;NRP1;NRCAM;PALLD;GFRA1;DAG1;PLPPR4;SPTAN1;PLCG1;PIK3CA;EMB;CXCR4;NRXN1;SEMA4A;SLC9A6;PAX2;TUBB3;SLITRK2;EPHA7;EPHA10;NEFH;BRSK1;SEMA6A;EFNA1;CNTN4;NIBAN2;FGFR2;PTPN11;S100A6;RAB10;SRC;DSCAM;SPTB
prerank,negative regulation of cation channel activity (GO:2001258),-0.16709020745092765,-0.5601310836003935,1.0,0.9862236359109838,1.0,11/26,35.42%,KCNAB1;SRI;GNB5;CALM1;CBARP;GSTO1;FKBP1B;CALM2;DRD2;CRHR1;EPHB2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.2607298269014293,0.559071115455205,0.9381818181818182,1.0,1.0,2/23,10.99%,MBOAT2;PLBD1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.2489162325473246,0.5590550603237726,0.9581447963800905,1.0,1.0,4/34,8.10%,PGF;NUS1;NOTCH1;MAPK14
prerank,positive regulation of exosomal secretion (GO:1903543),0.27343656052877535,0.5586261599767616,0.9254901960784314,1.0,1.0,6/15,29.31%,HGS;STAM;VPS4A;TSG101;VPS4B;SMPD3
prerank,ceramide biosynthetic process (GO:0046513),0.24403277209198204,0.558361511093099,0.967032967032967,1.0,1.0,8/40,20.14%,SGMS2;ST8SIA4;CERS4;SGMS1;ST3GAL5;CERS6;CERS2;ST8SIA6
prerank,negative regulation of innate immune response (GO:0045824),0.24904551432356115,0.5582766814971986,0.95578231292517,1.0,1.0,6/34,17.54%,DHX58;RPS19;USP15;SLAMF8;NLRC3;TRAFD1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.257858282987549,0.558145087425851,0.941108545034642,1.0,1.0,8/27,24.42%,PML;PPP1CB;PPP1CC;TP53;PPP1CA;RBM4B;BHLHE40;FBXL12
prerank,cellular response to nutrient levels (GO:0031669),0.23645581782371353,0.5577240591405239,0.9684542586750788,1.0,1.0,12/62,20.91%,STK26;FOXO1;KLF10;STK24;RIPOR1;SIRT1;XBP1;LRRK2;SREBF2;RRAGB;WDR45B;WRN
prerank,organic cation transport (GO:0015695),0.2683074171052853,0.5574368338791615,0.9421686746987952,1.0,1.0,4/20,20.66%,SLC44A1;SLC22A4;SEC14L1;SLC44A2
prerank,folic acid metabolic process (GO:0046655),0.27257505987974295,0.5572767500827107,0.9361979166666666,1.0,1.0,4/18,19.10%,MTHFD2L;SLC19A1;ALDH1L1;MTHFD1L
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.2619957243698334,0.5572736688315326,0.929471032745592,1.0,1.0,6/22,21.74%,PTPN22;NR1D1;FLOT1;APPL1;IFI35;NR1H3
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.25159048391266725,0.5569311716614774,0.9478357380688124,1.0,1.0,8/34,21.57%,GABRA4;MPP2;GABRA5;ARRB2;GSK3B;LRRK2;GLRA1;GRIN2D
prerank,neural crest cell differentiation (GO:0014033),0.27108264462230103,0.5562508161720431,0.9267990074441688,1.0,1.0,3/18,11.80%,PEF1;TCOF1;TAPT1
prerank,regulation of MAP kinase activity (GO:0043405),0.23500797656761846,0.5561969864661218,0.9703476482617587,1.0,1.0,11/92,16.34%,EZH2;RASGRP1;STK38;EGFR;FLT3;CDK5RAP3;PDCD10;EGF;HGS;FGFR1;CD24
prerank,regulation of translational initiation (GO:0006446),0.2353079360485786,0.5557474193684775,0.9688149688149689,1.0,1.0,14/63,22.04%,EIF4B;EIF3E;BOLL;CSDE1;EIF4EBP3;NCBP1;PAIP1;NCBP2;AGO2;TPR;EIF2B5;GLE1;DNAJC3;PPP1R15B
prerank,regulation of leukocyte activation (GO:0002694),0.2773557640728455,0.5556064398616509,0.9353099730458221,1.0,1.0,1/14,3.68%,CD74
prerank,leukotriene biosynthetic process (GO:0019370),-0.20410986784505203,-0.5539391194159561,0.9672131147540983,0.9873522085142348,1.0,5/14,30.94%,ALOX5;GGT5;ALOX5AP;PLA2G4A;LTC4S
prerank,neuromuscular junction development (GO:0007528),0.26224167626070644,0.5537209108034383,0.9399509803921569,1.0,1.0,8/24,24.30%,LRP4;F2R;GPHN;PPFIBP1;LRRK2;DCTN1;NEDD4;DNAJA3
prerank,regulation of exosomal secretion (GO:1903541),-0.18857881486667782,-0.5534598754817467,0.98989898989899,0.9864520306583837,1.0,3/19,12.27%,ATP9A;PDCD6IP;PRKN
prerank,cellular calcium ion homeostasis (GO:0006874),0.23316897161033093,0.5530891666482971,0.992964824120603,1.0,1.0,19/133,17.67%,HTR2A;CSRP3;PML;CAV1;CCR2;PRKACA;SLC10A7;CAV2;SLC35G1;PDZD8;MICU3;MICU1;MCU;PSEN1;TPT1;SLC24A4;SLC24A2;ADCY8;YWHAE
prerank,aerobic electron transport chain (GO:0019646),0.2352014134277691,0.5530288098341254,0.9710743801652892,1.0,1.0,12/68,19.07%,SDHD;NDUFS8;NDUFB7;NDUFAF1;COX10;COX4I1;NDUFA1;NDUFA4;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,triglyceride metabolic process (GO:0006641),0.23935572862553878,0.5528733905165087,0.9523809523809523,1.0,1.0,3/48,7.36%,CAV1;GPAT3;MOGAT2
prerank,tRNA methylation (GO:0030488),0.24327282541851813,0.5527568830025215,0.9523269012485811,1.0,1.0,9/34,23.19%,TRMO;TRDMT1;TRMT5;TYW3;PRORP;THUMPD3;TRMT112;TRMT10C;DALRD3
prerank,negative regulation of neuron differentiation (GO:0045665),0.2617936597219803,0.5527484987407053,0.9324324324324325,1.0,1.0,4/22,22.56%,B2M;GSK3B;MED1;CNTN4
prerank,photoperiodism (GO:0009648),0.25526496705357415,0.5522544343859572,0.9516685845799769,1.0,1.0,8/28,24.42%,PML;PPP1CB;PPP1CC;TP53;PPP1CA;RBM4B;BHLHE40;FBXL12
prerank,positive regulation of translational initiation (GO:0045948),0.2668920701471757,0.551778700323132,0.9252577319587629,1.0,1.0,10/18,30.51%,BOLL;EIF2B5;CDC123;YTHDF1;YTHDF3;RPS6KB1;KHDRBS1;HABP4;POLR2G;MTOR
prerank,negative regulation of viral genome replication (GO:0045071),0.24088972105498904,0.5506527306482504,0.9558011049723757,1.0,1.0,11/40,24.68%,SLPI;FAM111A;IFITM3;TASOR;SRPK1;SETDB1;PROX1;ZC3HAV1;HMGA2;RESF1;EIF2AK2
prerank,cristae formation (GO:0042407),0.2526003141878772,0.5506168190611367,0.9423529411764706,1.0,1.0,6/27,20.51%,ATP5F1E;APOOL;ATP5F1D;ATP5MC2;ATP5F1B;ATP5MF
prerank,T cell mediated immunity (GO:0002456),0.281415736100444,0.5503487542708876,0.9304123711340206,1.0,1.0,4/13,25.95%,BTN3A3;CD55;MYO1G;CTSH
prerank,cell junction assembly (GO:0034329),0.23053863216156806,0.550117843135685,0.9828629032258065,1.0,1.0,28/100,25.61%,SDK1;FLNA;DBNL;CDH18;CDH24;DNER;PTEN;NRCAM;ADGRL3;KIRREL3;GJA4;LIMS1;NRXN2;CTNND2;FN1;NRXN1;CDH20;CDH19;CDH7;ILK;ACTG1;ARVCF;DSCAM;VMP1;PKP4;DCHS1;BDNF;ITGA6
prerank,regulation of axonogenesis (GO:0050770),0.23884677131895443,0.5497950930030848,0.9644779332615716,1.0,1.0,9/51,16.37%,TIAM1;LRP4;ARHGAP35;PLXNA2;MARK2;PTEN;GSK3B;PAK2;ARHGDIA
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.280618340010908,0.5497367367691863,0.9308885754583921,1.0,1.0,2/12,15.12%,IMPDH2;ADSL
prerank,neuron projection organization (GO:0106027),0.2732591752771069,0.5493211266704381,0.9276485788113695,1.0,1.0,4/15,14.59%,ABCD1;PICK1;PSEN1;GSK3B
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.25243047564318427,0.5483209645839793,0.9534883720930233,1.0,1.0,8/31,22.79%,NOTCH1;SMAD4;BMPR1A;TGFB2;PROX1;RBPJ;FGFR2;FKBP1A
prerank,protein heterotetramerization (GO:0051290),0.27703026385955026,0.548229930206436,0.945872801082544,1.0,1.0,3/13,20.17%,CBR4;PKD2;CPSF7
prerank,regulation of dendrite morphogenesis (GO:0048814),0.24684237130595799,0.5474195444572886,0.9534883720930233,1.0,1.0,10/32,22.99%,YWHAH;NEDD4L;CUX1;GSK3B;GORASP1;SDC2;FBXW8;CAPRIN2;HECW2;NEDD4
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.22808877732919816,0.5467325203178531,0.9929718875502008,1.0,1.0,17/159,17.07%,CD177;SDK1;CLDN18;PECAM1;MILR1;HMCN1;CDH18;CDH24;IGSF21;BSG;PALLD;ADGRL3;NECTIN1;KIRREL3;CDH4;TGFB2;EMB
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.26551685019024696,0.5464549457238427,0.9401273885350319,1.0,1.0,3/17,13.44%,COX10;COX4I1;NDUFA4
prerank,response to muramyl dipeptide (GO:0032495),0.28286607714446793,0.5461274499837565,0.9391424619640387,1.0,1.0,1/12,4.25%,PTPN22
prerank,positive regulation of protein processing (GO:0010954),0.26417131236905594,0.5453314585661528,0.940026075619296,1.0,1.0,5/19,25.59%,GSN;CCBE1;LPCAT3;MYH9;NLRC4
prerank,folic acid-containing compound metabolic process (GO:0006760),0.26637249462291457,0.5451429339302981,0.9485861182519281,1.0,1.0,4/19,19.10%,MTHFD2L;SLC19A1;ALDH1L1;MTHFD1L
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2322059249388225,0.5446301418937199,0.9723643807574207,1.0,1.0,21/85,23.20%,PLK1;TAF1;CSNK1A1;DDRGK1;PSMC3;SUMO1;RAD23A;RACK1;SUMO2;ARIH2;PABIR1;GSK3B;PIAS1;RNF19A;LRRK2;KEAP1;MDM2;CBFA2T3;HECTD1;DDA1;BBS7
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.25522772009504824,0.5445099809053396,0.941031941031941,1.0,1.0,3/22,17.11%,CCR2;BTK;TRPM4
prerank,adenine nucleotide transport (GO:0051503),0.26380164261493466,0.5439286218344592,0.9276485788113695,1.0,1.0,3/17,11.68%,LRRC8C;SLC19A1;ABCC4
prerank,vasculature development (GO:0001944),0.26506195747512484,0.5426145350246984,0.9315589353612167,1.0,1.0,3/16,20.40%,STK11;PIK3CA;ACVR2B
prerank,neuron projection regeneration (GO:0031102),-0.223245760230377,-0.5423573461975651,0.9684542586750788,0.9890011681386517,1.0,4/10,26.57%,GAP43;MAPK8IP3;OMG;DHFR
prerank,collagen fibril organization (GO:0030199),0.23088639538559452,0.5422893048155565,0.9816326530612245,1.0,1.0,12/88,17.16%,CYP1B1;PLOD3;CRTAP;COL1A2;COL4A4;LAMB3;ATP7A;TLL2;COL23A1;P3H4;TGFB2;COL4A1
prerank,negative regulation of insulin secretion (GO:0046676),0.25681900422880377,0.5420959952381653,0.9370179948586118,1.0,1.0,5/17,26.58%,PIM3;IRS1;SIRT4;KCNB1;PSMD9
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.2892950591090278,0.5416486842666409,0.9378612716763006,1.0,1.0,3/10,23.89%,CDC42EP3;CDC42EP1;CDC42EP4
prerank,regulation of pseudopodium assembly (GO:0031272),0.2892950591090278,0.5416486842666409,0.9378612716763006,1.0,1.0,3/10,23.89%,CDC42EP3;CDC42EP1;CDC42EP4
prerank,skin development (GO:0043588),0.23148113653948918,0.5414233179268806,0.9863731656184487,1.0,1.0,3/65,10.65%,STMN1;COL1A2;ATP7A
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.27006626099374487,0.541149783826383,0.9452411994784876,1.0,1.0,3/16,12.63%,NOTCH1;PIM1;BMPR1A
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.2267853416491558,0.5410236113536667,0.9761410788381742,1.0,1.0,16/75,22.88%,HSPG2;PML;CCR2;DCN;MECP2;ROCK2;ADAMTS1;HGS;TGFB2;PGK1;ROCK1;SEMA6A;AGO1;ATP2B4;NIBAN2;APOH
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.26458605578796734,0.5407545681314688,0.9427083333333334,1.0,1.0,3/16,16.42%,RUNX1;F2R;VIM
prerank,icosanoid secretion (GO:0032309),0.27377738715550237,0.5403703429776927,0.9436038514442916,1.0,1.0,12/12,72.64%,ABCC4;PLA2G1B;DRD4;NOS2;ACE;DRD3;PLA2G5;BDKRB2;NMUR2;PNPLA8;DRD2;ANXA1
prerank,striated muscle cell differentiation (GO:0051146),0.26625371036788753,0.5400298960745511,0.933852140077821,1.0,1.0,2/16,13.77%,MYEF2;SKI
prerank,Golgi localization (GO:0051645),0.2786726644748132,0.5397516838958002,0.9418439716312057,1.0,1.0,6/11,28.35%,PDCD10;RIPOR1;STK25;TBCCD1;YWHAZ;COPG1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.25642778842881897,0.5392838921081087,0.9413265306122449,1.0,1.0,2/17,14.19%,PTPN22;TLR6
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.285318980676414,0.5371315950196381,0.9439655172413793,1.0,1.0,3/11,21.45%,ARRB2;GRK2;GRK3
prerank,regulation of vasoconstriction (GO:0019229),0.2438759055350576,0.5365607837459977,0.9414575866188769,1.0,1.0,4/27,17.11%,CAV1;CHRM3;F2R;TRPM4
prerank,neutrophil chemotaxis (GO:0030593),0.22977132410529358,0.5361993783298787,0.9712765957446808,1.0,1.0,6/53,16.77%,S100A9;S100A8;BSG;PPIA;TGFB2;CCL25
prerank,regulation of glycogen metabolic process (GO:0070873),0.2793019021909725,0.535170957450502,0.9441340782122905,1.0,1.0,12/12,72.09%,RUBCNL;INPP5K;PPP1R3B;PPP1R3G;GCGR;AKT1;PPP1R3A;PPP1R3E;PPP1R3C;PPP1R3D;KHK;PPP1R3F
prerank,ubiquinone biosynthetic process (GO:0006744),0.26543311066277625,0.5347201162581212,0.9424836601307189,1.0,1.0,4/15,18.63%,COQ10B;PDSS2;COQ5;FDXR
prerank,multivesicular body assembly (GO:0036258),0.24417223022276913,0.5339314877413127,0.9642445213379469,1.0,1.0,13/30,28.71%,CHMP1B;HGS;CHMP3;CHMP2B;VTA1;STAM;VPS4A;CHMP5;TSG101;VPS37A;STAM2;VPS4B;VPS37B
prerank,quinone biosynthetic process (GO:1901663),0.2688919601805662,0.5338128955932869,0.9534574468085106,1.0,1.0,4/14,18.63%,COQ10B;PDSS2;COQ5;FDXR
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.22851888138152499,0.5337991468607448,0.9713983050847458,1.0,1.0,13/50,22.65%,TRADD;EGFR;TRIM44;ACTN4;LIMS1;RPS3;TRAF6;LGALS9;IFI35;ILK;SASH1;RTKN2;PHB2
prerank,nucleotide catabolic process (GO:0009166),0.26790401442958234,0.533515463203657,0.9580152671755725,1.0,1.0,2/16,9.67%,GDA;NT5C2
prerank,central nervous system myelination (GO:0022010),0.2783688059001214,0.5309177607422115,0.9426111908177905,1.0,1.0,2/11,11.98%,ABCA2;PTEN
prerank,peptidyl-lysine monomethylation (GO:0018026),0.27608733302934974,0.5301366954841366,0.95355587808418,1.0,1.0,4/10,26.05%,EHMT1;SETD7;EEF1AKMT2;SETD2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.2567554638513264,0.5292287157207952,0.96,1.0,1.0,5/19,21.55%,DBNL;CUX1;RELN;FBXW8;CAPRIN2
prerank,glucose metabolic process (GO:0006006),0.22494669876483037,0.528788488105785,0.9821989528795811,1.0,1.0,11/58,22.15%,SLC25A12;BRAT1;DCXR;GALM;SLC25A13;PGK1;MDH2;PPARD;GAPDH;PCK2;GDPGP1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.21134266157042503,-0.5284316072747908,0.9701492537313433,0.9919432455251748,1.0,7/11,41.10%,CTNNBIP1;TGFBR2;SOX9;WNT5A;LRP5;PDGFA;CHRD
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2621169526040935,0.5278411698858073,0.9601648351648352,1.0,1.0,4/14,26.05%,MPV17L2;TRUB2;TRMT10C;FASTKD2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.24178888900679016,0.5270841389427837,0.957983193277311,1.0,1.0,4/25,19.97%,DDAH2;TLR6;ASS1;PKD2
prerank,vitamin D metabolic process (GO:0042359),-0.19568058452871878,-0.5264958151675221,0.9757085020242915,0.9913129315892972,1.0,2/13,21.17%,LGMN;PIAS4
prerank,cognition (GO:0050890),0.23140385492722887,0.5262766454197854,0.9737991266375546,1.0,1.0,8/42,17.24%,MAGT1;JAKMIP1;SHROOM4;BBS4;NIPBL;SOBP;TUSC3;CHMP2B
prerank,negative regulation of actin filament polymerization (GO:0030837),0.24891722293754986,0.525895070181543,0.9585365853658536,1.0,1.0,2/22,8.62%,GSN;CYRIB
prerank,regulation of cell-cell adhesion (GO:0022407),0.23220561900655964,0.5242029034019928,0.9755011135857461,1.0,1.0,9/39,23.56%,CD47;DPP4;MAGI1;MDGA1;FLOT2;EPHA7;CITED2;SRC;FUT9
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.229692436172391,0.5239781223749008,0.9651795429815017,1.0,1.0,7/43,17.20%,SMARCA4;EGR1;JUN;TP53;TGFB2;NFATC3;APLN
prerank,iron-sulfur cluster assembly (GO:0016226),0.24062984323210712,0.5235834063431316,0.9647201946472019,1.0,1.0,7/24,24.75%,CIAO2A;ISCA2;CIAO3;MMS19;ABCB7;FXN;HSPA9
prerank,acylglycerol biosynthetic process (GO:0046463),0.24697429844837016,0.5224457502667131,0.9618226600985221,1.0,1.0,2/23,7.36%,GPAT3;MOGAT2
prerank,response to interferon-beta (GO:0035456),0.24676625862718793,0.5213590556684506,0.9473039215686274,1.0,1.0,5/22,20.56%,UBE2K;XAF1;IFITM3;PNPT1;AIM2
prerank,regulation of mitochondrial fusion (GO:0010635),0.269888613651855,0.5200313215312816,0.9442857142857143,1.0,1.0,1/11,5.04%,TFRC
prerank,granulocyte chemotaxis (GO:0071621),0.22185675654319548,0.5198191021222677,0.9725738396624473,1.0,1.0,6/55,16.77%,S100A9;S100A8;BSG;PPIA;TGFB2;CCL25
prerank,positive regulation of cell projection organization (GO:0031346),0.21819383132142364,0.5192357940375841,0.9949545913218971,1.0,1.0,12/115,11.03%,TIAM1;S100A9;SNX3;KIDINS220;SETX;ARHGAP35;PLXNA2;MARK2;EPHA3;RIT2;CUX1;RELN
prerank,response to fatty acid (GO:0070542),0.25309343441971677,0.5187278269902895,0.9410994764397905,1.0,1.0,2/17,14.53%,FOXO1;IRS1
prerank,cellular response to hexose stimulus (GO:0071331),0.2378853508691181,0.5172218872949572,0.9670731707317073,1.0,1.0,7/23,21.23%,PRKACA;RACK1;XBP1;ADCY8;ZBTB20;PAX2;PCK2
prerank,regulation of secretion by cell (GO:1903530),0.2256940727135762,0.5153633411373859,0.9767195767195768,1.0,1.0,5/54,12.37%,CHRNB4;RAB8A;LGI3;RAB8B;HAP1
prerank,sphingoid biosynthetic process (GO:0046520),0.27282582275925366,0.5137398314443891,0.9562841530054644,1.0,1.0,2/11,16.65%,ABCA2;ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.27282582275925366,0.5137398314443891,0.9562841530054644,1.0,1.0,2/11,16.65%,ABCA2;ACER3
prerank,secondary alcohol metabolic process (GO:1902652),0.22451636887444032,0.5136889488394571,0.9757709251101322,1.0,1.0,10/42,22.60%,OSBPL5;GBA2;CYP27A1;NSDHL;IDH2;LDLRAP1;PPARD;OSBPL1A;SCAP;SOAT1
prerank,regulation of stem cell population maintenance (GO:2000036),0.24773180665436756,0.512640382748114,0.9694656488549618,1.0,1.0,6/18,25.74%,MYC;CNOT1;ELAVL1;NCOA3;HMGA2;PTN
prerank,neuropeptide signaling pathway (GO:0007218),0.22260180254455308,0.5121419722477173,0.9840255591054313,1.0,1.0,6/58,19.48%,AGRP;SORCS2;NMU;ADCYAP1;GLRA1;PPY
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.19368407835258666,-0.5121360248003134,0.984,0.9937405238692283,1.0,13/13,80.65%,RELA;MDK;ITGB2;ETS1;IL6;FUT7;TNF;NFAT5;RHOA;IRAK1;FUT9;ZDHHC21;TRAF6
prerank,positive regulation of phospholipid transport (GO:2001140),0.26674765459402094,0.5112289234622773,0.9544159544159544,1.0,1.0,2/10,17.42%,ABCA7;TMEM30A
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.21361325133458453,-0.5104952109921105,0.9802631578947368,0.99300502160609,1.0,1/10,3.20%,FERMT3
prerank,inner dynein arm assembly (GO:0036159),0.25854379545674017,0.5088575957995822,0.961864406779661,1.0,1.0,1/11,10.61%,CFAP73
prerank,regulation of actin filament polymerization (GO:0030833),0.21303885973870793,0.5086521030868432,0.9854166666666667,1.0,1.0,8/69,13.59%,PRKCE;GBA2;SNX9;DBNL;CYRIB;MTPN;CDC42EP3;LATS1
prerank,potassium ion transport (GO:0006813),0.2093944586327063,0.5076102567784863,0.9908814589665653,1.0,1.0,20/120,19.98%,AQP1;HCN3;KCNN4;KCNA1;KCNJ3;KCNC2;KCNH7;KCNJ2;KCNK12;SLC9A8;SLC24A4;SLC24A2;SLC9A9;KCNK2;KCNQ5;KCNJ10;SLC9A7;SLC9A6;PKD2;KCNC1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.2629539607278897,0.5074008343369891,0.9592944369063772,1.0,1.0,2/12,14.53%,SORBS1;IRS1
prerank,urogenital system development (GO:0001655),0.2623979912115505,0.5052264403678521,0.9550561797752809,1.0,1.0,11/11,73.78%,PAX2;OSR1;AMH;OSR2;SHH;EPHB3;LHX1;EPHB2;PAX8;ANXA1;SOX9
prerank,endodermal cell fate commitment (GO:0001711),0.26553563398073265,0.5041380908526952,0.9444444444444444,1.0,1.0,2/10,23.32%,RTF1;LEO1
prerank,ubiquinone metabolic process (GO:0006743),0.25100148246117077,0.5035448577418259,0.9658344283837057,1.0,1.0,4/15,18.63%,COQ10B;PDSS2;COQ5;FDXR
prerank,mitochondrion morphogenesis (GO:0070584),0.26062372601584693,0.5029138447544339,0.9392655367231638,1.0,1.0,5/11,26.87%,FIS1;MTM1;PNPT1;PID1;WASF1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.26853308073002735,0.5028403540898159,0.9614855570839065,1.0,1.0,1/10,7.28%,MTMR2
prerank,cellular response to UV-A (GO:0071492),0.2605775266792215,0.5027228305809937,0.961864406779661,1.0,1.0,11/11,73.96%,MME;MMP1;OPN1SW;MMP3;OPN5;PPID;MMP9;TIMP1;OPN3;MMP2;CERS1
prerank,striated muscle contraction (GO:0006941),0.2177148872087878,0.5020241836359706,0.9807486631016042,1.0,1.0,2/53,4.08%,CSRP3;CCDC78
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.21589231614043633,0.501007778498082,0.9794594594594594,1.0,1.0,10/45,20.56%,JAK2;EGR1;MYD88;TLR6;TYROBP;USP50;MALT1;LGALS9;CASP8;AIM2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.25469147119871927,0.4999623711114182,0.9659863945578231,1.0,1.0,7/13,28.94%,MBTPS2;FCGR2B;NR1H3;LPCAT3;NR1H2;NUPR1;CLU
prerank,oligosaccharide biosynthetic process (GO:0009312),0.23504363891095637,0.4987484186141794,0.9661016949152542,1.0,1.0,2/20,11.71%,ST3GAL2;FUT8
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.2404548272937966,0.4985712940864471,0.9720101781170484,1.0,1.0,5/18,25.58%,HMGB1;CD24;RPS3;IGFBP2;ICOSLG
prerank,gastrulation (GO:0007369),-0.18449843041634903,-0.49819226904174696,0.9915254237288136,0.9942336459598031,1.0,7/15,38.62%,GPC3;NPHP3;UGDH;LMBRD1;MKKS;LRP5;LHX1
prerank,pre-miRNA processing (GO:0031054),0.2458681358725598,0.4965848247901925,0.9640479360852197,1.0,1.0,4/14,22.08%,TUT4;TARBP2;AGO2;AGO1
prerank,ureteric bud morphogenesis (GO:0060675),0.24245553663780228,0.4959807046918953,0.9640102827763496,1.0,1.0,5/16,24.10%,MYC;PAX2;PKD2;GDNF;NPNT
prerank,regulation of monocyte chemotaxis (GO:0090025),0.23355916571403273,0.4956060605322499,0.9785202863961814,1.0,1.0,4/24,17.46%,CCR2;HMGB1;SLAMF8;ANO6
prerank,tyrosine metabolic process (GO:0006570),0.2588635849668358,0.4955006327161182,0.9579375848032564,1.0,1.0,1/11,11.99%,FAH
prerank,negative regulation of signaling receptor activity (GO:2000272),0.22837382482197247,0.49493289727376505,0.9755799755799756,1.0,1.0,6/25,27.29%,CRHBP;CNRIP1;SOCS4;TSG101;CBL;SLC6A9
prerank,cAMP metabolic process (GO:0046058),0.2510059241022601,0.49440495902634085,0.9670184696569921,1.0,1.0,3/13,21.63%,PTHLH;ADCY8;ADCY9
prerank,regulation of viral life cycle (GO:1903900),0.2343785317772223,0.49209034805480506,0.9761006289308176,1.0,1.0,7/21,28.14%,TRIM68;PPIA;TRIM5;VPS4A;TSG101;TRIM62;TRIM21
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.22435501249594397,0.4899946169926393,0.9819277108433735,1.0,1.0,4/26,19.97%,DDAH2;TLR6;ASS1;PKD2
prerank,cardiocyte differentiation (GO:0035051),0.2579046495460586,0.48723317761555135,0.9704641350210971,1.0,1.0,5/10,30.75%,TGFB2;AKAP13;CBY1;NRG1;SIK1
prerank,digestive tract morphogenesis (GO:0048546),0.23944555309153953,0.4871058464578409,0.9636118598382749,1.0,1.0,3/14,23.20%,NIPBL;FGFR2;BBS7
prerank,calcium ion homeostasis (GO:0055074),0.20446942960868433,0.48570859335950073,0.9938775510204082,1.0,1.0,10/95,15.70%,HTR2A;CSRP3;CAV1;CCR2;SLC10A7;TMTC2;FAM20A;TPT1;SLC24A4;SLC24A2
prerank,sensory perception of light stimulus (GO:0050953),0.20598435858144104,0.4847613255984428,0.9969604863221885,1.0,1.0,7/87,14.77%,CRYBG3;CRYBA1;EYA3;RP2;ATF6;RDH10;ADGRV1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.25673215742891226,0.48389731358090293,0.972181551976574,1.0,1.0,10/10,74.34%,GNB1;RHO;CNGA1;GRK1;GNAT1;CNGB1;PDE6A;PDE6B;PDE6G;SAG
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.23709721421919494,0.48375497436427684,0.9741267787839586,1.0,1.0,3/16,16.94%,ADIPOR1;FOXK2;SIRT1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.2565080675895698,0.4835649598496411,0.9652677279305355,1.0,1.0,3/10,21.57%,ATP7A;APPL1;ZEB2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.23956703192904352,0.48333949060602366,0.9632063074901446,1.0,1.0,5/16,24.10%,MYC;PAX2;PKD2;GDNF;NPNT
prerank,eye photoreceptor cell differentiation (GO:0001754),0.24824817134302574,0.48263879258394077,0.9590723055934516,1.0,1.0,1/12,6.05%,AGTPBP1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.16069023282682754,-0.4790215152056189,1.0,0.9960516560988915,1.0,6/19,26.92%,NOX1;PRDX2;GPX1;PRDX3;PRDX4;MAOB
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.2150695267872763,0.478197173127029,0.9864406779661017,1.0,1.0,11/35,23.37%,PMEPA1;TADA3;TMF1;MED1;SAFB;DDX54;CALCOCO1;RBFOX2;NEDD4;SRC;PLPP1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.2498553459416764,0.477730151263894,0.9726618705035971,1.0,1.0,3/10,26.92%,ATP7A;QDPR;ASRGL1
prerank,regulation of autophagosome maturation (GO:1901096),0.24388734811469703,0.4770860103694751,0.9598337950138505,1.0,1.0,5/13,26.65%,TBC1D25;FYCO1;CLN3;PHF23;SMCR8
prerank,carbohydrate biosynthetic process (GO:0016051),0.22210693242083526,0.47621242607868486,0.9725536992840096,1.0,1.0,7/21,29.70%,ST3GAL2;FUT8;ST8SIA6;FUT9;B3GALT1;MPDU1;ST3GAL3
prerank,ceramide metabolic process (GO:0006672),0.20543862216133246,0.47571192108370186,0.990343347639485,1.0,1.0,9/49,19.69%,SGMS2;ABCA2;ORMDL3;CERS4;SGMS1;CERS6;ACER3;CERS2;PPP2CA
prerank,regulation of collagen biosynthetic process (GO:0032965),0.2287689244353203,0.4751953775014829,0.9773584905660377,1.0,1.0,4/19,21.47%,RUNX1;F2R;VIM;CIITA
prerank,negative regulation of protein kinase activity (GO:0006469),0.20143475547072753,0.4743268324265564,0.9938650306748467,1.0,1.0,13/88,16.20%,RB1;CAV1;TAF7;CEP85;TAB1;PDPK1;PARK7;CDK5RAP3;PRKAG2;PPIA;DTNBP1;TARBP2;PAK2
prerank,chemical synaptic transmission (GO:0007268),0.1959143658278037,0.47156997800820416,0.999,1.0,1.0,45/284,21.65%,CHRNB4;MAPK1;CEL;PDE7B;SLC6A2;SLC6A5;HTR2A;CRHBP;EXOC4;SLC12A7;GABRA4;PRKACA;ERC1;KCNA1;BSN;PMP22;GABRA5;RIT2;PAFAH1B1;GRIA3;PTEN;HAP1;SLC12A6;CHRM3;NRXN2;GRIA2;NAPB;CACNA1B;SNCA;TSPOAP1;ERC2;NRXN1;GRM3;GLRA1;PRKAR2A;GABRB2;HCRT;NAAA;APBA1;GRIK5;GRIK3;SLC1A4;RPS6KA3;GRIN2D;BRSK1
prerank,sphingolipid metabolic process (GO:0006665),0.19535287899439377,0.47139029276613403,0.9939148073022313,1.0,1.0,27/108,25.10%,SGMS2;HACD4;PRKD3;GBA2;CSNK1G2;ABCA2;ORMDL3;VAPA;CERS4;SUMF1;SGMS1;ELOVL5;ELOVL4;CERS6;ACER3;SUMF2;CERS2;PPP2CA;PRKD2;GLTP;NEU1;PLPP1;SMPD1;PPM1L;ESYT2;PDXDC1;B3GALNT1
prerank,negative regulation of complement activation (GO:0045916),0.2516609555555501,0.4713383056981088,0.9757142857142858,1.0,1.0,2/10,19.21%,CR1L;CD55
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.23942256839593873,0.47020349105434495,0.98,1.0,1.0,1/13,9.89%,B3GNT2
prerank,regulation of protein processing (GO:0070613),0.22355467956266167,0.4699263649047043,0.98,1.0,1.0,6/21,25.59%,CCBE1;RUNX1;LRRK2;CLN3;TMEM59;NLRC4
prerank,negative regulation of hydrolase activity (GO:0051346),0.20693164041731235,0.4697559978800717,0.9914712153518124,1.0,1.0,5/49,11.59%,TERF2;NEIL1;GMIP;PPP1R35;RDX
prerank,regulation of rRNA processing (GO:2000232),0.23044718523176275,0.4690107144536424,0.9782330345710627,1.0,1.0,6/16,24.71%,KAT2B;SIRT7;DIMT1;RIOK1;TRMT112;USP36
prerank,protein alkylation (GO:0008213),0.21742946482806202,0.4681650924584066,0.9795180722891567,1.0,1.0,5/22,22.65%,LCMT1;GSPT1;PRMT3;SNRPB;EEF1AKMT2
prerank,tRNA metabolic process (GO:0006399),0.22936011444362248,0.46725096078867384,0.9883116883116884,1.0,1.0,5/17,23.50%,DTD2;YARS2;RPP30;DTD1;KARS1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.23578242650387077,0.46478385135259487,0.985254691689008,1.0,1.0,4/15,20.33%,SMOC2;FGFR1;PRKD2;MET
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.23942878003845497,0.4628793968797812,0.9783783783783784,1.0,1.0,1/12,9.89%,B3GNT2
prerank,regulation of catecholamine secretion (GO:0050433),0.20958404798040464,0.4621122284339472,0.9874141876430206,1.0,1.0,6/29,20.94%,SYT8;SYT3;GRK2;DTNBP1;SNCA;SYT2
prerank,mitochondrion disassembly (GO:0061726),0.2103842337229291,0.46147906670605643,0.9896313364055299,1.0,1.0,8/34,20.90%,MARK2;BECN1;AMBRA1;FIS1;CTSK;ATG2B;WDR45B;BNIP3
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.22820747502896616,0.4612995758996704,0.9825970548862115,1.0,1.0,3/14,18.88%,CPSF1;CLP1;RTCB
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.24125220006116582,0.460898103093007,0.9797979797979798,1.0,1.0,2/10,16.52%,ATP5F1D;ATP5MC2
prerank,neural crest cell development (GO:0014032),0.20399891083100297,0.45779383660593465,0.9934138309549945,1.0,1.0,4/44,11.80%,PHACTR4;PEF1;TCOF1;TAPT1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.21966842501883965,0.45245921288890306,0.9808673469387755,1.0,1.0,17/17,78.06%,PLBD1;LCLAT1;PLAAT3;LPGAT1;PLA2G1B;PLA2G2F;PLA2G2E;PLA2G4D;PLA2G10;PLA2G2D;PLA2G4F;PLA2G5;PLA2G4C;MBOAT7;PLA2G4A;PLA2G12A;PLA2G4E
prerank,protein localization to synapse (GO:0035418),0.23440648025895922,0.45211427065865495,0.9792243767313019,1.0,1.0,6/12,28.12%,BSN;NRXN2;NRXN1;NLGN2;NLGN1;SHANK1
prerank,superoxide metabolic process (GO:0006801),0.20209724778034044,0.4511207985234802,0.9872832369942196,1.0,1.0,6/29,22.29%,ATP7A;CYBB;CYBA;NCF4;SH3PXD2A;NRROS
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.19535480840216057,0.4508224796349894,0.9957894736842106,1.0,1.0,3/53,13.28%,HTR2A;CALCRL;CHRM3
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.2237850056511363,0.44499240117044675,0.9828496042216359,1.0,1.0,15/15,77.64%,ELOVL5;PPARD;NR1H3;NR1H2;LPGAT1;ADIPOQ;APOA1;NR4A3;PPARA;PPARG;MLXIPL;SLC45A3;MID1IP1;PPARGC1A;MLYCD
prerank,negative regulation of lipid metabolic process (GO:0045833),0.20751210795661765,0.44434293062164465,0.9939467312348669,1.0,1.0,1/22,5.70%,PPP2R5A
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.22343294231117455,0.444258267333911,0.9889655172413793,1.0,1.0,1/13,8.54%,JAK2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2011566129688629,0.4432143587170362,0.9907084785133565,1.0,1.0,2/29,10.99%,MBOAT2;PLBD1
prerank,heart trabecula morphogenesis (GO:0061384),0.21236395858632082,0.4431535232938926,0.9889025893958077,1.0,1.0,5/18,22.79%,NOTCH1;BMPR1A;TGFB2;RBPJ;FKBP1A
prerank,peptide hormone secretion (GO:0030072),0.20345276604695334,0.4428978279638689,0.991812865497076,1.0,1.0,3/26,13.66%,PARK7;ADCYAP1;CDK16
prerank,regulation of dopamine secretion (GO:0014059),0.2024168484774826,0.4415860985164043,0.9883855981416957,1.0,1.0,7/25,25.33%,SYT8;SYT3;DTNBP1;SNCA;SYT2;GDNF;SYT10
prerank,monocyte chemotaxis (GO:0002548),0.19721852688805674,0.4408362459405589,0.9954075774971297,0.9998198092618706,1.0,3/32,16.77%,RPS19;TNFRSF11A;CCL25
prerank,tRNA 5'-end processing (GO:0099116),0.21301313845581266,0.4349734686430898,0.9844357976653697,1.0,1.0,4/15,22.78%,PRORP;POP4;TRMT10C;RPP30
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.22030938690774354,0.427947100263234,0.9873417721518988,1.0,1.0,2/12,15.88%,PLCB1;SLAMF8
prerank,lysosome localization (GO:0032418),0.19017033405948267,0.4263225977674414,0.9955801104972376,1.0,1.0,8/37,24.72%,MILR1;HDAC6;VPS33B;SPAG9;PLEKHM1;RAB34;MYH9;BORCS5
prerank,protein mono-ADP-ribosylation (GO:0140289),0.22411005310049878,0.42570617961729185,0.9872701555869873,1.0,1.0,5/11,29.58%,PARP14;PARP11;PARP9;TIPARP;PARP8
prerank,lymphocyte migration (GO:0072676),0.1887351101927908,0.4228610886341907,0.9966024915062288,1.0,1.0,3/32,16.77%,CCR6;MSN;CCL25
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.20605607056156972,0.4171140086431926,0.9889349930843707,1.0,1.0,4/13,23.37%,MED1;ABHD2;CALCOCO1;PLPP1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.1946174834787653,0.41651591300512397,0.9965397923875432,1.0,1.0,6/26,22.79%,UBQLN1;GPR35;YWHAE;PKD2;CALM3;FKBP1A
prerank,response to prostaglandin E (GO:0034695),0.22051353712295885,0.4150301294229433,0.9899280575539569,1.0,1.0,2/10,22.06%,PTGER4;GNB1
prerank,icosanoid biosynthetic process (GO:0046456),0.21830354330587043,0.41343481269165094,0.9857549857549858,1.0,1.0,2/10,21.62%,LTA4H;MGST3
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.19882123781950337,0.4054035342364029,0.9919571045576407,1.0,1.0,4/17,23.57%,CIB1;TGFB2;SYK;PIEZO1
prerank,negative regulation of ATPase activity (GO:0032780),-0.1497645211930926,-0.40214493434407916,1.0,0.9995829239960443,1.0,16/16,85.04%,TSC1;THADA;PAM16;IFIT1;PPIF;TLR9;PLN;LTF;VCPKMT;TNNI3;TNNT2;OXA1L;ATP5IF1;PXK;SIRT1;TP53
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.2111111111111111,0.4020893922712688,0.9916317991631799,1.0,1.0,11/11,78.90%,TGFB2;TGFB1;WNT3A;TBX5;GATA4;MYOCD;GPER1;GREM1;DHX36;MEF2C;EFNB2
prerank,miRNA metabolic process (GO:0010586),0.19073396739656626,0.39998057266322246,0.9936788874841972,1.0,1.0,3/20,19.64%,TUT4;TARBP2;AGO2
prerank,regulation of gluconeogenesis (GO:0006111),0.17865568488015635,0.39349751557978685,0.994131455399061,1.0,1.0,6/27,23.83%,SIRT7;SDHAF3;SIRT1;USP7;CLK2;PGP
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.20336296491227035,0.38955584603836907,0.9929178470254958,1.0,1.0,2/10,22.74%,MYC;FGFR2
prerank,negative regulation of glycolytic process (GO:0045820),0.20229647504080323,0.3826781585750087,0.9971305595408895,1.0,1.0,3/10,27.73%,HDAC4;CBFA2T3;NUPR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.20229647504080323,0.3826781585750087,0.9971305595408895,1.0,1.0,3/10,27.73%,HDAC4;CBFA2T3;NUPR1
prerank,diol biosynthetic process (GO:0034312),0.18989668876664748,0.37866005936611136,0.9973992197659298,1.0,1.0,2/15,16.65%,ABCA2;ACER3
prerank,negative regulation of RNA metabolic process (GO:0051253),0.18216187029269384,0.37745799210693437,0.9987341772151899,1.0,1.0,6/18,28.15%,KAT2B;PTBP2;PTBP1;NCOR2;RPS13;PTBP3
prerank,tRNA 5'-leader removal (GO:0001682),0.18631973724566733,0.372644569966216,0.9960212201591512,1.0,1.0,3/13,22.78%,PRORP;POP4;RPP30
prerank,phasic smooth muscle contraction (GO:0014821),0.19616320623482336,0.3724375659041301,0.9985835694050992,1.0,1.0,2/10,23.61%,TIFAB;GDNF
prerank,response to organonitrogen compound (GO:0010243),0.1618092022086176,0.36611514225446234,1.0,1.0,1.0,8/38,25.74%,RCN3;SYVN1;GLRA1;CCDC47;HLCS;DNAJB12;DERL1;VCP
prerank,embryonic eye morphogenesis (GO:0048048),0.1902685637656711,0.3641448121067591,0.997275204359673,0.9997927869139482,1.0,2/11,18.10%,RARG;KDM2B
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.15912794486726606,0.3416884243092311,1.0,1.0,1.0,6/23,27.92%,ACSL5;ELOVL5;FAR1;ACSL6;ACSL4;ACOT7
prerank,inner ear morphogenesis (GO:0042472),0.15689570366061123,0.3280256659841187,1.0,1.0,1.0,3/22,22.74%,TIFAB;PAX2;FGFR2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.15493503213715973,0.3212726339463019,1.0,0.9997953738605359,1.0,2/18,14.45%,ACSL5;ELOVL5
